CAS No. | Saflık | Ürün Adı | BOSTON KODU |
---|---|---|---|
Cas.: 53636-68-3 | Purity: 96% | 3-Amino-5-chloropicolinic acid | ESD-896644-5G |
Cas.: 944902-17-4 | Purity: ≥95% | 3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-896645-100MG |
Cas.: 944902-17-4 | Purity: ≥95% | 3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-896645-250MG |
Cas.: 944902-17-4 | Purity: ≥95% | 3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-896645-1G |
Cas.: 944902-17-4 | Purity: ≥95% | 3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-896645-5G |
Cas.: 919286-71-8 | Purity: 97% | (S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate | ESD-896646-100MG |
Cas.: 919286-71-8 | Purity: 97% | (S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate | ESD-896646-250MG |
Cas.: 919286-71-8 | Purity: 97% | (S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate | ESD-896646-1G |
Cas.: 919286-71-8 | Purity: 97% | (S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate | ESD-896646-5G |
Cas.: 10394-40-8 | Purity: ≥95% | 1,6-Dimethyl-1H-benzo[d]imidazole | ESD-896647-100MG |
Cas.: 10394-40-8 | Purity: ≥95% | 1,6-Dimethyl-1H-benzo[d]imidazole | ESD-896647-250MG |
Cas.: 10394-40-8 | Purity: ≥95% | 1,6-Dimethyl-1H-benzo[d]imidazole | ESD-896647-1G |
Cas.: 10394-40-8 | Purity: ≥95% | 1,6-Dimethyl-1H-benzo[d]imidazole | ESD-896647-5G |
Cas.: 850689-27-9 | Purity: ≥95% | Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-896648-100MG |
Cas.: 850689-27-9 | Purity: ≥95% | Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-896648-250MG |
Cas.: 850689-27-9 | Purity: ≥95% | Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-896648-1G |
Cas.: 850689-27-9 | Purity: ≥95% | Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | ESD-896648-5G |
Cas.: 51786-11-9 | Purity: 97% | 2-Chloro-3-hydroxybenzonitrile | ESD-896649-100MG |
Cas.: 51786-11-9 | Purity: 97% | 2-Chloro-3-hydroxybenzonitrile | ESD-896649-250MG |
Cas.: 51786-11-9 | Purity: 97% | 2-Chloro-3-hydroxybenzonitrile | ESD-896649-1G |
Cas.: 51786-11-9 | Purity: 97% | 2-Chloro-3-hydroxybenzonitrile | ESD-896649-5G |
Cas.: 259793-90-3 | Purity: ≥95% | 6-Chloro-3-hydroxypyrazine-2-carboxamide | ESD-896650-100MG |
Cas.: 259793-90-3 | Purity: ≥95% | 6-Chloro-3-hydroxypyrazine-2-carboxamide | ESD-896650-250MG |
Cas.: 259793-90-3 | Purity: ≥95% | 6-Chloro-3-hydroxypyrazine-2-carboxamide | ESD-896650-1G |
Cas.: 259793-90-3 | Purity: ≥95% | 6-Chloro-3-hydroxypyrazine-2-carboxamide | ESD-896650-5G |
Cas.: 507462-88-6 | Purity: 97% | 3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-896651-100MG |
Cas.: 507462-88-6 | Purity: 97% | 3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-896651-250MG |
Cas.: 507462-88-6 | Purity: 97% | 3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-896651-1G |
Cas.: 507462-88-6 | Purity: 97% | 3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-896651-5G |
Cas.: 35418-07-6 | Purity: 95% | Methyl 3-(4-aminophenyl)propanoate | ESD-896652-100MG |
Cas.: 35418-07-6 | Purity: 95% | Methyl 3-(4-aminophenyl)propanoate | ESD-896652-250MG |
Cas.: 35418-07-6 | Purity: 95% | Methyl 3-(4-aminophenyl)propanoate | ESD-896652-1G |
Cas.: 35418-07-6 | Purity: 95% | Methyl 3-(4-aminophenyl)propanoate | ESD-896652-5G |
Cas.: 55052-26-1 | Purity: 95% | 1H-Pyrrolo[2,3-b]pyridin-6-ol | ESD-896653-100MG |
Cas.: 55052-26-1 | Purity: 95% | 1H-Pyrrolo[2,3-b]pyridin-6-ol | ESD-896653-250MG |
Cas.: 55052-26-1 | Purity: 95% | 1H-Pyrrolo[2,3-b]pyridin-6-ol | ESD-896653-1G |
Cas.: 55052-26-1 | Purity: 95% | 1H-Pyrrolo[2,3-b]pyridin-6-ol | ESD-896653-5G |
Cas.: 872091-00-4 | Purity: 98% | 3-(2-Cyanopropan-2-yl)benzoic acid | ESD-896654-100MG |
Cas.: 872091-00-4 | Purity: 98% | 3-(2-Cyanopropan-2-yl)benzoic acid | ESD-896654-250MG |
Cas.: 872091-00-4 | Purity: 98% | 3-(2-Cyanopropan-2-yl)benzoic acid | ESD-896654-1G |
Cas.: 872091-00-4 | Purity: 98% | 3-(2-Cyanopropan-2-yl)benzoic acid | ESD-896654-5G |
Cas.: 85604-06-4 | Purity: 97% | 5-(Benzyloxy)-2-bromobenzaldehyde | ESD-896655-100MG |
Cas.: 85604-06-4 | Purity: 97% | 5-(Benzyloxy)-2-bromobenzaldehyde | ESD-896655-250MG |
Cas.: 85604-06-4 | Purity: 97% | 5-(Benzyloxy)-2-bromobenzaldehyde | ESD-896655-1G |
Cas.: 85604-06-4 | Purity: 97% | 5-(Benzyloxy)-2-bromobenzaldehyde | ESD-896655-5G |
Cas.: 7695-63-8 | Purity: 98% | 1-(Isopropylamino)-3-phenoxypropan-2-ol | ESD-896656-100MG |
Cas.: 7695-63-8 | Purity: 98% | 1-(Isopropylamino)-3-phenoxypropan-2-ol | ESD-896656-250MG |
Cas.: 7695-63-8 | Purity: 98% | 1-(Isopropylamino)-3-phenoxypropan-2-ol | ESD-896656-1G |
Cas.: 7695-63-8 | Purity: 98% | 1-(Isopropylamino)-3-phenoxypropan-2-ol | ESD-896656-5G |
Cas.: 89179-62-4 | Purity: 98% | 1-Methyl-1H-pyrazole-3-carboxamide | ESD-896657-100MG |
Cas.: 89179-62-4 | Purity: 98% | 1-Methyl-1H-pyrazole-3-carboxamide | ESD-896657-250MG |
Cas.: 89179-62-4 | Purity: 98% | 1-Methyl-1H-pyrazole-3-carboxamide | ESD-896657-1G |
Cas.: 89179-62-4 | Purity: 98% | 1-Methyl-1H-pyrazole-3-carboxamide | ESD-896657-5G |
Cas.: 170655-44-4 | Purity: 98% | 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide | ESD-896658-100MG |
Cas.: 170655-44-4 | Purity: 98% | 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide | ESD-896658-250MG |
Cas.: 170655-44-4 | Purity: 98% | 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide | ESD-896658-1G |
Cas.: 170655-44-4 | Purity: 98% | 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide | ESD-896658-5G |
Cas.: 730980-51-5 | Purity: ≥95% | (R)-6-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-896659-100MG |
Cas.: 730980-51-5 | Purity: ≥95% | (R)-6-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-896659-250MG |
Cas.: 730980-51-5 | Purity: ≥95% | (R)-6-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-896659-1G |
Cas.: 730980-51-5 | Purity: ≥95% | (R)-6-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-896659-5G |
Cas.: 1236357-65-5 | Purity: ≥95% | Methyl 1-(4-bromophenyl)cyclobutanecarboxylate | ESD-896660-100MG |
Cas.: 1236357-65-5 | Purity: ≥95% | Methyl 1-(4-bromophenyl)cyclobutanecarboxylate | ESD-896660-250MG |
Cas.: 1236357-65-5 | Purity: ≥95% | Methyl 1-(4-bromophenyl)cyclobutanecarboxylate | ESD-896660-1G |
Cas.: 1236357-65-5 | Purity: ≥95% | Methyl 1-(4-bromophenyl)cyclobutanecarboxylate | ESD-896660-5G |
Cas.: 1140512-58-8 | Purity: 97% | Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-896661-100MG |
Cas.: 1140512-58-8 | Purity: 97% | Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-896661-250MG |
Cas.: 1140512-58-8 | Purity: 97% | Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-896661-1G |
Cas.: 1140512-58-8 | Purity: 97% | Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-896661-5G |
Cas.: 71831-21-5 | Purity: 97% | (4-(Bromomethyl)phenyl)methanol | ESD-896662-100MG |
Cas.: 71831-21-5 | Purity: 97% | (4-(Bromomethyl)phenyl)methanol | ESD-896662-250MG |
Cas.: 71831-21-5 | Purity: 97% | (4-(Bromomethyl)phenyl)methanol | ESD-896662-1G |
Cas.: 71831-21-5 | Purity: 97% | (4-(Bromomethyl)phenyl)methanol | ESD-896662-5G |
Cas.: 1196156-59-8 | Purity: ≥95% | 2,6-Dibromo-4-chloropyridine | ESD-896663-100MG |
Cas.: 1196156-59-8 | Purity: ≥95% | 2,6-Dibromo-4-chloropyridine | ESD-896663-250MG |
Cas.: 1196156-59-8 | Purity: ≥95% | 2,6-Dibromo-4-chloropyridine | ESD-896663-1G |
Cas.: 1196156-59-8 | Purity: ≥95% | 2,6-Dibromo-4-chloropyridine | ESD-896663-5G |
Cas.: 6645-69-8 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)acetic acid | ESD-896664-100MG |
Cas.: 6645-69-8 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)acetic acid | ESD-896664-250MG |
Cas.: 6645-69-8 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)acetic acid | ESD-896664-1G |
Cas.: 6645-69-8 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)acetic acid | ESD-896664-5G |
Cas.: 1218791-44-6 | Purity: ≥95% | N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-896665-100MG |
Cas.: 1218791-44-6 | Purity: ≥95% | N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-896665-250MG |
Cas.: 1218791-44-6 | Purity: ≥95% | N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-896665-1G |
Cas.: 1218791-44-6 | Purity: ≥95% | N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-896665-5G |
Cas.: 151978-58-4 | Purity: ≥95% | tert-Butylhex-5-yn-1-ylcarbamate | ESD-896666-100MG |
Cas.: 151978-58-4 | Purity: ≥95% | tert-Butylhex-5-yn-1-ylcarbamate | ESD-896666-250MG |
Cas.: 151978-58-4 | Purity: ≥95% | tert-Butylhex-5-yn-1-ylcarbamate | ESD-896666-1G |
Cas.: 151978-58-4 | Purity: ≥95% | tert-Butylhex-5-yn-1-ylcarbamate | ESD-896666-5G |
Cas.: 878197-68-3 | Purity: ≥95% | 5-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-896667-100MG |
Cas.: 878197-68-3 | Purity: ≥95% | 5-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-896667-250MG |
Cas.: 878197-68-3 | Purity: ≥95% | 5-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-896667-1G |
Cas.: 878197-68-3 | Purity: ≥95% | 5-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-896667-5G |
Cas.: 77903-28-7 | Purity: 98% | 5-Methoxy-4-methylpyridin-3-amine | ESD-896668-100MG |
Cas.: 77903-28-7 | Purity: 98% | 5-Methoxy-4-methylpyridin-3-amine | ESD-896668-250MG |
Cas.: 77903-28-7 | Purity: 98% | 5-Methoxy-4-methylpyridin-3-amine | ESD-896668-1G |
Cas.: 77903-28-7 | Purity: 98% | 5-Methoxy-4-methylpyridin-3-amine | ESD-896668-5G |
Cas.: 1227311-09-2 | Purity: ≥95% | 4-Iodo-3,5-dimethylbenzonitrile | ESD-896669-100MG |
Cas.: 1227311-09-2 | Purity: ≥95% | 4-Iodo-3,5-dimethylbenzonitrile | ESD-896669-250MG |
Cas.: 1227311-09-2 | Purity: ≥95% | 4-Iodo-3,5-dimethylbenzonitrile | ESD-896669-1G |
Cas.: 1227311-09-2 | Purity: ≥95% | 4-Iodo-3,5-dimethylbenzonitrile | ESD-896669-5G |
Cas.: 32618-85-2 | Purity: ≥95% | 6-Nitroquinazoline-2,4-diol | ESD-896670-100MG |
Cas.: 32618-85-2 | Purity: ≥95% | 6-Nitroquinazoline-2,4-diol | ESD-896670-250MG |
Cas.: 32618-85-2 | Purity: ≥95% | 6-Nitroquinazoline-2,4-diol | ESD-896670-1G |
Cas.: 32618-85-2 | Purity: ≥95% | 6-Nitroquinazoline-2,4-diol | ESD-896670-5G |
Cas.: 478366-05-1 | Purity: 97% | 2-Cyclopropylthiazole-4-carboxylic acid | ESD-896671-100MG |
Cas.: 478366-05-1 | Purity: 97% | 2-Cyclopropylthiazole-4-carboxylic acid | ESD-896671-250MG |
Cas.: 478366-05-1 | Purity: 97% | 2-Cyclopropylthiazole-4-carboxylic acid | ESD-896671-1G |
Cas.: 478366-05-1 | Purity: 97% | 2-Cyclopropylthiazole-4-carboxylic acid | ESD-896671-5G |
Cas.: 180573-13-1 | Purity: 97% | Diethyl 3-oxocyclopentane-1,1-dicarboxylate | ESD-896672-100MG |
Cas.: 180573-13-1 | Purity: 97% | Diethyl 3-oxocyclopentane-1,1-dicarboxylate | ESD-896672-250MG |
Cas.: 180573-13-1 | Purity: 97% | Diethyl 3-oxocyclopentane-1,1-dicarboxylate | ESD-896672-1G |
Cas.: 180573-13-1 | Purity: 97% | Diethyl 3-oxocyclopentane-1,1-dicarboxylate | ESD-896672-5G |
Cas.: 89415-54-3 | Purity: ≥95% | 5-Bromo-N2-methylpyridine-2,3-diamine | ESD-896673-100MG |
Cas.: 89415-54-3 | Purity: ≥95% | 5-Bromo-N2-methylpyridine-2,3-diamine | ESD-896673-250MG |
Cas.: 89415-54-3 | Purity: ≥95% | 5-Bromo-N2-methylpyridine-2,3-diamine | ESD-896673-1G |
Cas.: 89415-54-3 | Purity: ≥95% | 5-Bromo-N2-methylpyridine-2,3-diamine | ESD-896673-5G |
Cas.: 1834-27-1 | Purity: ≥97% | 6-Chloro-4-methylpyridazin-3(2H)-one | ESD-896674-100MG |
Cas.: 1834-27-1 | Purity: ≥97% | 6-Chloro-4-methylpyridazin-3(2H)-one | ESD-896674-250MG |
Cas.: 1834-27-1 | Purity: ≥97% | 6-Chloro-4-methylpyridazin-3(2H)-one | ESD-896674-1G |
Cas.: 1834-27-1 | Purity: ≥97% | 6-Chloro-4-methylpyridazin-3(2H)-one | ESD-896674-5G |
Cas.: 898747-32-5 | Purity: ≥95% | Methyl 5-bromo-2-oxoindoline-7-carboxylate | ESD-896675-100MG |
Cas.: 898747-32-5 | Purity: ≥95% | Methyl 5-bromo-2-oxoindoline-7-carboxylate | ESD-896675-250MG |
Cas.: 898747-32-5 | Purity: ≥95% | Methyl 5-bromo-2-oxoindoline-7-carboxylate | ESD-896675-1G |
Cas.: 898747-32-5 | Purity: ≥95% | Methyl 5-bromo-2-oxoindoline-7-carboxylate | ESD-896675-5G |
Cas.: 1532517-95-5 | Purity: 97% | 5-Bromo-3-fluoro-2-nitropyridine | ESD-896676-100MG |
Cas.: 1532517-95-5 | Purity: 97% | 5-Bromo-3-fluoro-2-nitropyridine | ESD-896676-250MG |
Cas.: 1532517-95-5 | Purity: 97% | 5-Bromo-3-fluoro-2-nitropyridine | ESD-896676-1G |
Cas.: 1532517-95-5 | Purity: 97% | 5-Bromo-3-fluoro-2-nitropyridine | ESD-896676-5G |
Cas.: 767337-59-7 | Purity: 98% | 3-(Trifluoromethyl)thiophene-2-carboxylic acid | ESD-896677-100MG |
Cas.: 767337-59-7 | Purity: 98% | 3-(Trifluoromethyl)thiophene-2-carboxylic acid | ESD-896677-250MG |
Cas.: 767337-59-7 | Purity: 98% | 3-(Trifluoromethyl)thiophene-2-carboxylic acid | ESD-896677-1G |
Cas.: 767337-59-7 | Purity: 98% | 3-(Trifluoromethyl)thiophene-2-carboxylic acid | ESD-896677-5G |
Cas.: 1226808-75-8 | Purity: 95% | 5-Bromo-4-fluorobenzo[d][1,3]dioxole | ESD-896678-100MG |
Cas.: 1226808-75-8 | Purity: 95% | 5-Bromo-4-fluorobenzo[d][1,3]dioxole | ESD-896678-250MG |
Cas.: 1226808-75-8 | Purity: 95% | 5-Bromo-4-fluorobenzo[d][1,3]dioxole | ESD-896678-1G |
Cas.: 1226808-75-8 | Purity: 95% | 5-Bromo-4-fluorobenzo[d][1,3]dioxole | ESD-896678-5G |
Cas.: 354793-04-7 | Purity: ≥95% | Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate | ESD-896679-100MG |
Cas.: 354793-04-7 | Purity: ≥95% | Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate | ESD-896679-250MG |
Cas.: 354793-04-7 | Purity: ≥95% | Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate | ESD-896679-1G |
Cas.: 354793-04-7 | Purity: ≥95% | Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate | ESD-896679-5G |
Cas.: 71738-83-5 | Purity: 97% | 8-Fluoroquinolin-2(1H)-one | ESD-896680-100MG |
Cas.: 71738-83-5 | Purity: 97% | 8-Fluoroquinolin-2(1H)-one | ESD-896680-250MG |
Cas.: 71738-83-5 | Purity: 97% | 8-Fluoroquinolin-2(1H)-one | ESD-896680-1G |
Cas.: 71738-83-5 | Purity: 97% | 8-Fluoroquinolin-2(1H)-one | ESD-896680-5G |
Cas.: 1990-24-5 | Purity: 98% | 1-(2-Hydroxy-5-propylphenyl)ethanone | ESD-896681-100MG |
Cas.: 1990-24-5 | Purity: 98% | 1-(2-Hydroxy-5-propylphenyl)ethanone | ESD-896681-250MG |
Cas.: 1990-24-5 | Purity: 98% | 1-(2-Hydroxy-5-propylphenyl)ethanone | ESD-896681-1G |
Cas.: 1990-24-5 | Purity: 98% | 1-(2-Hydroxy-5-propylphenyl)ethanone | ESD-896681-5G |
Cas.: 381-97-5 | Purity: 98% | 3,3,3-Trifluoro-2-methylpropanoic acid | ESD-896682-100MG |
Cas.: 381-97-5 | Purity: 98% | 3,3,3-Trifluoro-2-methylpropanoic acid | ESD-896682-250MG |
Cas.: 381-97-5 | Purity: 98% | 3,3,3-Trifluoro-2-methylpropanoic acid | ESD-896682-1G |
Cas.: 381-97-5 | Purity: 98% | 3,3,3-Trifluoro-2-methylpropanoic acid | ESD-896682-5G |
Cas.: 27609-91-2 | Purity: 97% | 4-Formyl-3-methylbenzonitrile | ESD-896683-100MG |
Cas.: 27609-91-2 | Purity: 97% | 4-Formyl-3-methylbenzonitrile | ESD-896683-250MG |
Cas.: 27609-91-2 | Purity: 97% | 4-Formyl-3-methylbenzonitrile | ESD-896683-1G |
Cas.: 27609-91-2 | Purity: 97% | 4-Formyl-3-methylbenzonitrile | ESD-896683-5G |
Cas.: 217435-65-9 | Purity: 97% | 6-Bromo-8-methylimidazo[1,2-a]pyridine | ESD-896684-100MG |
Cas.: 217435-65-9 | Purity: 97% | 6-Bromo-8-methylimidazo[1,2-a]pyridine | ESD-896684-250MG |
Cas.: 217435-65-9 | Purity: 97% | 6-Bromo-8-methylimidazo[1,2-a]pyridine | ESD-896684-1G |
Cas.: 217435-65-9 | Purity: 97% | 6-Bromo-8-methylimidazo[1,2-a]pyridine | ESD-896684-5G |
Cas.: 21172-88-3 | Purity: 95% | 2-Chloro-5,6,7,8-tetrahydroquinoline | ESD-896685-100MG |
Cas.: 21172-88-3 | Purity: 95% | 2-Chloro-5,6,7,8-tetrahydroquinoline | ESD-896685-250MG |
Cas.: 21172-88-3 | Purity: 95% | 2-Chloro-5,6,7,8-tetrahydroquinoline | ESD-896685-1G |
Cas.: 21172-88-3 | Purity: 95% | 2-Chloro-5,6,7,8-tetrahydroquinoline | ESD-896685-5G |
Cas.: 68034-76-4 | Purity: 97% | 3-(2,5-Dichlorophenyl)propanoic acid | ESD-896686-100MG |
Cas.: 68034-76-4 | Purity: 97% | 3-(2,5-Dichlorophenyl)propanoic acid | ESD-896686-250MG |
Cas.: 68034-76-4 | Purity: 97% | 3-(2,5-Dichlorophenyl)propanoic acid | ESD-896686-1G |
Cas.: 68034-76-4 | Purity: 97% | 3-(2,5-Dichlorophenyl)propanoic acid | ESD-896686-5G |
Cas.: 1187830-61-0 | Purity: ≥95% | 4-Aminoisothiochroman 2,2-dioxide hydrochloride | ESD-896687-100MG |
Cas.: 1187830-61-0 | Purity: ≥95% | 4-Aminoisothiochroman 2,2-dioxide hydrochloride | ESD-896687-250MG |
Cas.: 1187830-61-0 | Purity: ≥95% | 4-Aminoisothiochroman 2,2-dioxide hydrochloride | ESD-896687-1G |
Cas.: 1187830-61-0 | Purity: ≥95% | 4-Aminoisothiochroman 2,2-dioxide hydrochloride | ESD-896687-5G |
Cas.: 177363-10-9 | Purity: 97% | 1-Fluoro-2-iodo-4-nitrobenzene | ESD-896688-100MG |
Cas.: 177363-10-9 | Purity: 97% | 1-Fluoro-2-iodo-4-nitrobenzene | ESD-896688-250MG |
Cas.: 177363-10-9 | Purity: 97% | 1-Fluoro-2-iodo-4-nitrobenzene | ESD-896688-1G |
Cas.: 177363-10-9 | Purity: 97% | 1-Fluoro-2-iodo-4-nitrobenzene | ESD-896688-5G |
Cas.: 102185-45-5 | Purity: ≥95% | Boc-DN-Me-Phe DCHA | ESD-896689-100MG |
Cas.: 102185-45-5 | Purity: ≥95% | Boc-DN-Me-Phe DCHA | ESD-896689-250MG |
Cas.: 102185-45-5 | Purity: ≥95% | Boc-DN-Me-Phe DCHA | ESD-896689-1G |
Cas.: 102185-45-5 | Purity: ≥95% | Boc-DN-Me-Phe DCHA | ESD-896689-5G |
Cas.: 106651-81-4 | Purity: 97% | 5-(Chloromethyl)-2-methylpyridine hydrochloride | ESD-896690-100MG |
Cas.: 106651-81-4 | Purity: 97% | 5-(Chloromethyl)-2-methylpyridine hydrochloride | ESD-896690-250MG |
Cas.: 106651-81-4 | Purity: 97% | 5-(Chloromethyl)-2-methylpyridine hydrochloride | ESD-896690-1G |
Cas.: 106651-81-4 | Purity: 97% | 5-(Chloromethyl)-2-methylpyridine hydrochloride | ESD-896690-5G |
Cas.: 25563-04-6 | Purity: ≥95% | 2-(2-(4-Chlorophenoxy)phenyl)acetic acid | ESD-896691-100MG |
Cas.: 25563-04-6 | Purity: ≥95% | 2-(2-(4-Chlorophenoxy)phenyl)acetic acid | ESD-896691-250MG |
Cas.: 25563-04-6 | Purity: ≥95% | 2-(2-(4-Chlorophenoxy)phenyl)acetic acid | ESD-896691-1G |
Cas.: 25563-04-6 | Purity: ≥95% | 2-(2-(4-Chlorophenoxy)phenyl)acetic acid | ESD-896691-5G |
Cas.: 353277-27-7 | Purity: 98% | 6-Chloro-5-nitropicolinic acid | ESD-896692-100MG |
Cas.: 353277-27-7 | Purity: 98% | 6-Chloro-5-nitropicolinic acid | ESD-896692-250MG |
Cas.: 353277-27-7 | Purity: 98% | 6-Chloro-5-nitropicolinic acid | ESD-896692-1G |
Cas.: 353277-27-7 | Purity: 98% | 6-Chloro-5-nitropicolinic acid | ESD-896692-5G |
Cas.: 1142188-60-0 | Purity: ≥95% | tert-Butyl 4-hydroxy-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-896693-100MG |
Cas.: 1142188-60-0 | Purity: ≥95% | tert-Butyl 4-hydroxy-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-896693-250MG |
Cas.: 1142188-60-0 | Purity: ≥95% | tert-Butyl 4-hydroxy-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-896693-1G |
Cas.: 1142188-60-0 | Purity: ≥95% | tert-Butyl 4-hydroxy-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-896693-5G |
Cas.: 66582-32-9 | Purity: 95% | 3-(Benzyloxy)-2,2-dimethylpropan-1-ol | ESD-896694-100MG |
Cas.: 66582-32-9 | Purity: 95% | 3-(Benzyloxy)-2,2-dimethylpropan-1-ol | ESD-896694-250MG |
Cas.: 66582-32-9 | Purity: 95% | 3-(Benzyloxy)-2,2-dimethylpropan-1-ol | ESD-896694-1G |
Cas.: 66582-32-9 | Purity: 95% | 3-(Benzyloxy)-2,2-dimethylpropan-1-ol | ESD-896694-5G |
Cas.: 1170568-70-3 | Purity: ≥95% | Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride | ESD-896695-100MG |
Cas.: 1170568-70-3 | Purity: ≥95% | Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride | ESD-896695-250MG |
Cas.: 1170568-70-3 | Purity: ≥95% | Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride | ESD-896695-1G |
Cas.: 1170568-70-3 | Purity: ≥95% | Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride | ESD-896695-5G |
Cas.: 89640-81-3 | Purity: ≥95% | Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate | ESD-896696-100MG |
Cas.: 89640-81-3 | Purity: ≥95% | Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate | ESD-896696-250MG |
Cas.: 89640-81-3 | Purity: ≥95% | Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate | ESD-896696-1G |
Cas.: 89640-81-3 | Purity: ≥95% | Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate | ESD-896696-5G |
Cas.: 80051-07-6 | Purity: 97% | Methyl 4-(1-aminoethyl)benzoate | ESD-896697-100MG |
Cas.: 80051-07-6 | Purity: 97% | Methyl 4-(1-aminoethyl)benzoate | ESD-896697-250MG |
Cas.: 80051-07-6 | Purity: 97% | Methyl 4-(1-aminoethyl)benzoate | ESD-896697-1G |
Cas.: 80051-07-6 | Purity: 97% | Methyl 4-(1-aminoethyl)benzoate | ESD-896697-5G |
Cas.: 1218935-60-4 | Purity: ≥95% | (R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride | ESD-896698-100MG |
Cas.: 1218935-60-4 | Purity: ≥95% | (R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride | ESD-896698-250MG |
Cas.: 1218935-60-4 | Purity: ≥95% | (R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride | ESD-896698-1G |
Cas.: 1218935-60-4 | Purity: ≥95% | (R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride | ESD-896698-5G |
Cas.: 169457-73-2 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate | ESD-896699-100MG |
Cas.: 169457-73-2 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate | ESD-896699-250MG |
Cas.: 169457-73-2 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate | ESD-896699-1G |
Cas.: 169457-73-2 | Purity: 97% | tert-Butyl 4-(2-bromoethyl)piperidine-1-carboxylate | ESD-896699-5G |
Cas.: 6825-71-4 | Purity: ≥95% | Ethyl 3,5-diamino-1H-pyrazole-4-carboxylate | ESD-896700-100MG |
Cas.: 6825-71-4 | Purity: ≥95% | Ethyl 3,5-diamino-1H-pyrazole-4-carboxylate | ESD-896700-250MG |
Cas.: 6825-71-4 | Purity: ≥95% | Ethyl 3,5-diamino-1H-pyrazole-4-carboxylate | ESD-896700-1G |
Cas.: 6825-71-4 | Purity: ≥95% | Ethyl 3,5-diamino-1H-pyrazole-4-carboxylate | ESD-896700-5G |
Cas.: 1041423-26-0 | Purity: ≥95% | 1,3-Dichloro-6-fluoroisoquinoline | ESD-896701-100MG |
Cas.: 1041423-26-0 | Purity: ≥95% | 1,3-Dichloro-6-fluoroisoquinoline | ESD-896701-250MG |
Cas.: 1041423-26-0 | Purity: ≥95% | 1,3-Dichloro-6-fluoroisoquinoline | ESD-896701-1G |
Cas.: 1041423-26-0 | Purity: ≥95% | 1,3-Dichloro-6-fluoroisoquinoline | ESD-896701-5G |
Cas.: 133446-99-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-4-nitrobenzoate | ESD-896702-100MG |
Cas.: 133446-99-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-4-nitrobenzoate | ESD-896702-250MG |
Cas.: 133446-99-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-4-nitrobenzoate | ESD-896702-1G |
Cas.: 133446-99-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-4-nitrobenzoate | ESD-896702-5G |
Cas.: 1427195-24-1 | Purity: 97% | Methyl 6-methoxy-3-nitropicolinate | ESD-896703-100MG |
Cas.: 1427195-24-1 | Purity: 97% | Methyl 6-methoxy-3-nitropicolinate | ESD-896703-250MG |
Cas.: 1427195-24-1 | Purity: 97% | Methyl 6-methoxy-3-nitropicolinate | ESD-896703-1G |
Cas.: 1427195-24-1 | Purity: 97% | Methyl 6-methoxy-3-nitropicolinate | ESD-896703-5G |
Cas.: 908847-42-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-896704-100MG |
Cas.: 908847-42-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-896704-250MG |
Cas.: 908847-42-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-896704-1G |
Cas.: 908847-42-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-896704-5G |
Cas.: 21236-97-5 | Purity: 97% | 6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-896705-100MG |
Cas.: 21236-97-5 | Purity: 97% | 6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-896705-250MG |
Cas.: 21236-97-5 | Purity: 97% | 6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-896705-1G |
Cas.: 21236-97-5 | Purity: 97% | 6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-896705-5G |
Cas.: 27387-23-1 | Purity: 97% | 2-(2-Bromo-5-methoxyphenyl)acetonitrile | ESD-896706-100MG |
Cas.: 27387-23-1 | Purity: 97% | 2-(2-Bromo-5-methoxyphenyl)acetonitrile | ESD-896706-250MG |
Cas.: 27387-23-1 | Purity: 97% | 2-(2-Bromo-5-methoxyphenyl)acetonitrile | ESD-896706-1G |
Cas.: 27387-23-1 | Purity: 97% | 2-(2-Bromo-5-methoxyphenyl)acetonitrile | ESD-896706-5G |
Cas.: 69696-37-3 | Purity: 98% | 5-Bromo-2,4-dimethylpyrimidine | ESD-896707-100MG |
Cas.: 69696-37-3 | Purity: 98% | 5-Bromo-2,4-dimethylpyrimidine | ESD-896707-250MG |
Cas.: 69696-37-3 | Purity: 98% | 5-Bromo-2,4-dimethylpyrimidine | ESD-896707-1G |
Cas.: 69696-37-3 | Purity: 98% | 5-Bromo-2,4-dimethylpyrimidine | ESD-896707-5G |
Cas.: 1261269-84-4 | Purity: 97% | 3,5-Dibromo-6-chloropyridin-2-amine | ESD-896708-100MG |
Cas.: 1261269-84-4 | Purity: 97% | 3,5-Dibromo-6-chloropyridin-2-amine | ESD-896708-250MG |
Cas.: 1261269-84-4 | Purity: 97% | 3,5-Dibromo-6-chloropyridin-2-amine | ESD-896708-1G |
Cas.: 1261269-84-4 | Purity: 97% | 3,5-Dibromo-6-chloropyridin-2-amine | ESD-896708-5G |
Cas.: 18672-03-2 | Purity: 96% | 5,6-Dichloro-1H-benzo[d]imidazol-2-amine | ESD-896709-100MG |
Cas.: 18672-03-2 | Purity: 96% | 5,6-Dichloro-1H-benzo[d]imidazol-2-amine | ESD-896709-250MG |
Cas.: 18672-03-2 | Purity: 96% | 5,6-Dichloro-1H-benzo[d]imidazol-2-amine | ESD-896709-1G |
Cas.: 18672-03-2 | Purity: 96% | 5,6-Dichloro-1H-benzo[d]imidazol-2-amine | ESD-896709-5G |
Cas.: 713141-12-9 | Purity: 97% | 4-Bromo-2-formylbenzonitrile | ESD-896710-100MG |
Cas.: 713141-12-9 | Purity: 97% | 4-Bromo-2-formylbenzonitrile | ESD-896710-250MG |
Cas.: 713141-12-9 | Purity: 97% | 4-Bromo-2-formylbenzonitrile | ESD-896710-1G |
Cas.: 713141-12-9 | Purity: 97% | 4-Bromo-2-formylbenzonitrile | ESD-896710-5G |
Cas.: 909717-95-9 | Purity: ≥95% | Ethyl 4-methoxypyrazolo[1,5-a]pyridine-3-carboxylate | ESD-896711-100MG |
Cas.: 909717-95-9 | Purity: ≥95% | Ethyl 4-methoxypyrazolo[1,5-a]pyridine-3-carboxylate | ESD-896711-250MG |
Cas.: 909717-95-9 | Purity: ≥95% | Ethyl 4-methoxypyrazolo[1,5-a]pyridine-3-carboxylate | ESD-896711-1G |
Cas.: 909717-95-9 | Purity: ≥95% | Ethyl 4-methoxypyrazolo[1,5-a]pyridine-3-carboxylate | ESD-896711-5G |
Cas.: 864265-77-0 | Purity: ≥95% | 2-Bromobenzo[d]thiazole-6-carbonitrile | ESD-896713-100MG |
Cas.: 864265-77-0 | Purity: ≥95% | 2-Bromobenzo[d]thiazole-6-carbonitrile | ESD-896713-250MG |
Cas.: 864265-77-0 | Purity: ≥95% | 2-Bromobenzo[d]thiazole-6-carbonitrile | ESD-896713-1G |
Cas.: 864265-77-0 | Purity: ≥95% | 2-Bromobenzo[d]thiazole-6-carbonitrile | ESD-896713-5G |
Cas.: 1363382-02-8 | Purity: 97% | 4-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-896714-100MG |
Cas.: 1363382-02-8 | Purity: 97% | 4-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-896714-250MG |
Cas.: 1363382-02-8 | Purity: 97% | 4-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-896714-1G |
Cas.: 1363382-02-8 | Purity: 97% | 4-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-896714-5G |
Cas.: 847906-27-8 | Purity: ≥95% | 3-Iodo-7-methyl-1H-indazole | ESD-896715-100MG |
Cas.: 847906-27-8 | Purity: ≥95% | 3-Iodo-7-methyl-1H-indazole | ESD-896715-250MG |
Cas.: 847906-27-8 | Purity: ≥95% | 3-Iodo-7-methyl-1H-indazole | ESD-896715-1G |
Cas.: 847906-27-8 | Purity: ≥95% | 3-Iodo-7-methyl-1H-indazole | ESD-896715-5G |
Cas.: 140373-17-7 | Purity: ≥95% | 2-Amino-2-(4-fluorophenyl)ethanol | ESD-896716-100MG |
Cas.: 140373-17-7 | Purity: ≥95% | 2-Amino-2-(4-fluorophenyl)ethanol | ESD-896716-250MG |
Cas.: 140373-17-7 | Purity: ≥95% | 2-Amino-2-(4-fluorophenyl)ethanol | ESD-896716-1G |
Cas.: 140373-17-7 | Purity: ≥95% | 2-Amino-2-(4-fluorophenyl)ethanol | ESD-896716-5G |
Cas.: 848360-85-0 | Purity: 96% | 1-Bromo-2-methoxy-4-(trifluoromethoxy)benzene | ESD-896717-100MG |
Cas.: 848360-85-0 | Purity: 96% | 1-Bromo-2-methoxy-4-(trifluoromethoxy)benzene | ESD-896717-250MG |
Cas.: 848360-85-0 | Purity: 96% | 1-Bromo-2-methoxy-4-(trifluoromethoxy)benzene | ESD-896717-1G |
Cas.: 848360-85-0 | Purity: 96% | 1-Bromo-2-methoxy-4-(trifluoromethoxy)benzene | ESD-896717-5G |
Cas.: 25391-60-0 | Purity: ≥95% | 2-Chloro-3-iodo-5-nitropyridine | ESD-896718-100MG |
Cas.: 25391-60-0 | Purity: ≥95% | 2-Chloro-3-iodo-5-nitropyridine | ESD-896718-250MG |
Cas.: 25391-60-0 | Purity: ≥95% | 2-Chloro-3-iodo-5-nitropyridine | ESD-896718-1G |
Cas.: 25391-60-0 | Purity: ≥95% | 2-Chloro-3-iodo-5-nitropyridine | ESD-896718-5G |
Cas.: 1190423-36-9 | Purity: ≥95% | Imidodicarbonic acid, 2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-, 1,3-bis(1,1-dimethylethyl) ester | ESD-896719-100MG |
Cas.: 1190423-36-9 | Purity: ≥95% | Imidodicarbonic acid, 2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-, 1,3-bis(1,1-dimethylethyl) ester | ESD-896719-250MG |
Cas.: 1190423-36-9 | Purity: ≥95% | Imidodicarbonic acid, 2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-, 1,3-bis(1,1-dimethylethyl) ester | ESD-896719-1G |
Cas.: 1190423-36-9 | Purity: ≥95% | Imidodicarbonic acid, 2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrimidinyl]-, 1,3-bis(1,1-dimethylethyl) ester | ESD-896719-5G |
Cas.: 117087-18-0 | Purity: 97% | 2-((Benzyloxy)methyl)propane-1,3-diol | ESD-896720-100MG |
Cas.: 117087-18-0 | Purity: 97% | 2-((Benzyloxy)methyl)propane-1,3-diol | ESD-896720-250MG |
Cas.: 117087-18-0 | Purity: 97% | 2-((Benzyloxy)methyl)propane-1,3-diol | ESD-896720-1G |
Cas.: 117087-18-0 | Purity: 97% | 2-((Benzyloxy)methyl)propane-1,3-diol | ESD-896720-5G |
Cas.: 17231-50-4 | Purity: ≥95% | 3-Amino-6-chloro-2-pyrazinecarbonitrile | ESD-896721-100MG |
Cas.: 17231-50-4 | Purity: ≥95% | 3-Amino-6-chloro-2-pyrazinecarbonitrile | ESD-896721-250MG |
Cas.: 17231-50-4 | Purity: ≥95% | 3-Amino-6-chloro-2-pyrazinecarbonitrile | ESD-896721-1G |
Cas.: 17231-50-4 | Purity: ≥95% | 3-Amino-6-chloro-2-pyrazinecarbonitrile | ESD-896721-5G |
Cas.: 235093-98-8 | Purity: 97% | (R)-3-Methylpyrrolidine hydrochloride | ESD-896722-100MG |
Cas.: 235093-98-8 | Purity: 97% | (R)-3-Methylpyrrolidine hydrochloride | ESD-896722-250MG |
Cas.: 235093-98-8 | Purity: 97% | (R)-3-Methylpyrrolidine hydrochloride | ESD-896722-1G |
Cas.: 235093-98-8 | Purity: 97% | (R)-3-Methylpyrrolidine hydrochloride | ESD-896722-5G |
Cas.: 83259-30-7 | Purity: 97% | 2-Chlorothieno[2,3-d]pyrimidine | ESD-896723-100MG |
Cas.: 83259-30-7 | Purity: 97% | 2-Chlorothieno[2,3-d]pyrimidine | ESD-896723-250MG |
Cas.: 83259-30-7 | Purity: 97% | 2-Chlorothieno[2,3-d]pyrimidine | ESD-896723-1G |
Cas.: 83259-30-7 | Purity: 97% | 2-Chlorothieno[2,3-d]pyrimidine | ESD-896723-5G |
Cas.: 116986-09-5 | Purity: 97% | Methyl 3-(bromomethyl)picolinate | ESD-896724-100MG |
Cas.: 116986-09-5 | Purity: 97% | Methyl 3-(bromomethyl)picolinate | ESD-896724-250MG |
Cas.: 116986-09-5 | Purity: 97% | Methyl 3-(bromomethyl)picolinate | ESD-896724-1G |
Cas.: 116986-09-5 | Purity: 97% | Methyl 3-(bromomethyl)picolinate | ESD-896724-5G |
Cas.: 35570-68-4 | Purity: 97% | 6-Chlorooxazolo[4,5-b]pyridin-2(3H)-one | ESD-896725-100MG |
Cas.: 35570-68-4 | Purity: 97% | 6-Chlorooxazolo[4,5-b]pyridin-2(3H)-one | ESD-896725-250MG |
Cas.: 35570-68-4 | Purity: 97% | 6-Chlorooxazolo[4,5-b]pyridin-2(3H)-one | ESD-896725-1G |
Cas.: 35570-68-4 | Purity: 97% | 6-Chlorooxazolo[4,5-b]pyridin-2(3H)-one | ESD-896725-5G |
Cas.: 1219-33-6 | Purity: 96% | 5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-896726-100MG |
Cas.: 1219-33-6 | Purity: 96% | 5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-896726-250MG |
Cas.: 1219-33-6 | Purity: 96% | 5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-896726-1G |
Cas.: 1219-33-6 | Purity: 96% | 5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-896726-5G |
Cas.: 175347-95-2 | Purity: ≥95% | 1-Benzyl-4-bromo-1,2,3,6-tetrahydropyridine | ESD-896727-100MG |
Cas.: 175347-95-2 | Purity: ≥95% | 1-Benzyl-4-bromo-1,2,3,6-tetrahydropyridine | ESD-896727-250MG |
Cas.: 175347-95-2 | Purity: ≥95% | 1-Benzyl-4-bromo-1,2,3,6-tetrahydropyridine | ESD-896727-1G |
Cas.: 175347-95-2 | Purity: ≥95% | 1-Benzyl-4-bromo-1,2,3,6-tetrahydropyridine | ESD-896727-5G |
Cas.: 89281-44-7 | Purity: 95% | 2-Methylthiazol-5-amine | ESD-896728-100MG |
Cas.: 89281-44-7 | Purity: 95% | 2-Methylthiazol-5-amine | ESD-896728-250MG |
Cas.: 89281-44-7 | Purity: 95% | 2-Methylthiazol-5-amine | ESD-896728-1G |
Cas.: 89281-44-7 | Purity: 95% | 2-Methylthiazol-5-amine | ESD-896728-5G |
Cas.: 1261216-28-7 | Purity: 97% | 5-Bromo-2-chloro-1-fluoro-3-methoxybenzene | ESD-896729-100MG |
Cas.: 1261216-28-7 | Purity: 97% | 5-Bromo-2-chloro-1-fluoro-3-methoxybenzene | ESD-896729-250MG |
Cas.: 1261216-28-7 | Purity: 97% | 5-Bromo-2-chloro-1-fluoro-3-methoxybenzene | ESD-896729-1G |
Cas.: 1261216-28-7 | Purity: 97% | 5-Bromo-2-chloro-1-fluoro-3-methoxybenzene | ESD-896729-5G |
Cas.: 77123-60-5 | Purity: 97% | 3-Ethynyl-4-fluoroaniline | ESD-896730-100MG |
Cas.: 77123-60-5 | Purity: 97% | 3-Ethynyl-4-fluoroaniline | ESD-896730-250MG |
Cas.: 77123-60-5 | Purity: 97% | 3-Ethynyl-4-fluoroaniline | ESD-896730-1G |
Cas.: 77123-60-5 | Purity: 97% | 3-Ethynyl-4-fluoroaniline | ESD-896730-5G |
Cas.: 929617-30-1 | Purity: ≥97% | 5-Bromo-3-methyl-1H-pyrazolo[3,4-c]pyridine | ESD-896731-100MG |
Cas.: 929617-30-1 | Purity: ≥97% | 5-Bromo-3-methyl-1H-pyrazolo[3,4-c]pyridine | ESD-896731-250MG |
Cas.: 929617-30-1 | Purity: ≥97% | 5-Bromo-3-methyl-1H-pyrazolo[3,4-c]pyridine | ESD-896731-1G |
Cas.: 929617-30-1 | Purity: ≥97% | 5-Bromo-3-methyl-1H-pyrazolo[3,4-c]pyridine | ESD-896731-5G |
Cas.: 863578-21-6 | Purity: 97% | 5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896732-100MG |
Cas.: 863578-21-6 | Purity: 97% | 5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896732-250MG |
Cas.: 863578-21-6 | Purity: 97% | 5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896732-1G |
Cas.: 863578-21-6 | Purity: 97% | 5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896732-5G |
Cas.: 123688-59-5 | Purity: 97% | 4-Bromo-3,5-difluorobenzonitrile | ESD-896733-100MG |
Cas.: 123688-59-5 | Purity: 97% | 4-Bromo-3,5-difluorobenzonitrile | ESD-896733-250MG |
Cas.: 123688-59-5 | Purity: 97% | 4-Bromo-3,5-difluorobenzonitrile | ESD-896733-1G |
Cas.: 123688-59-5 | Purity: 97% | 4-Bromo-3,5-difluorobenzonitrile | ESD-896733-5G |
Cas.: 114040-06-1 | Purity: 97% | 3-Bromo-5,7-dichloropyrazolo[1,5-a]pyrimidine | ESD-896734-100MG |
Cas.: 114040-06-1 | Purity: 97% | 3-Bromo-5,7-dichloropyrazolo[1,5-a]pyrimidine | ESD-896734-250MG |
Cas.: 114040-06-1 | Purity: 97% | 3-Bromo-5,7-dichloropyrazolo[1,5-a]pyrimidine | ESD-896734-1G |
Cas.: 114040-06-1 | Purity: 97% | 3-Bromo-5,7-dichloropyrazolo[1,5-a]pyrimidine | ESD-896734-5G |
Cas.: 1351479-18-9 | Purity: ≥95% | Methyl 4-chloronicotinate hydrochloride | ESD-896735-100MG |
Cas.: 1351479-18-9 | Purity: ≥95% | Methyl 4-chloronicotinate hydrochloride | ESD-896735-250MG |
Cas.: 1351479-18-9 | Purity: ≥95% | Methyl 4-chloronicotinate hydrochloride | ESD-896735-1G |
Cas.: 1351479-18-9 | Purity: ≥95% | Methyl 4-chloronicotinate hydrochloride | ESD-896735-5G |
Cas.: 59340-27-1 | Purity: 97% | 1,3,5-Trimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-896736-100MG |
Cas.: 59340-27-1 | Purity: 97% | 1,3,5-Trimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-896736-250MG |
Cas.: 59340-27-1 | Purity: 97% | 1,3,5-Trimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-896736-1G |
Cas.: 59340-27-1 | Purity: 97% | 1,3,5-Trimethyl-1H-pyrazole-4-sulfonyl chloride | ESD-896736-5G |
Cas.: 945950-37-8 | Purity: 97% | 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-896737-100MG |
Cas.: 945950-37-8 | Purity: 97% | 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-896737-250MG |
Cas.: 945950-37-8 | Purity: 97% | 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-896737-1G |
Cas.: 945950-37-8 | Purity: 97% | 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-896737-5G |
Cas.: 130340-04-4 | Purity: 97% | trans-2-Fluorocyclopropanecarboxylic acid | ESD-896738-100MG |
Cas.: 130340-04-4 | Purity: 97% | trans-2-Fluorocyclopropanecarboxylic acid | ESD-896738-250MG |
Cas.: 130340-04-4 | Purity: 97% | trans-2-Fluorocyclopropanecarboxylic acid | ESD-896738-1G |
Cas.: 130340-04-4 | Purity: 97% | trans-2-Fluorocyclopropanecarboxylic acid | ESD-896738-5G |
Cas.: 1240602-95-2 | Purity: ≥97% | (6-Chloropyrazin-2-yl)methanol | ESD-896739-100MG |
Cas.: 1240602-95-2 | Purity: ≥97% | (6-Chloropyrazin-2-yl)methanol | ESD-896739-250MG |
Cas.: 1240602-95-2 | Purity: ≥97% | (6-Chloropyrazin-2-yl)methanol | ESD-896739-1G |
Cas.: 1240602-95-2 | Purity: ≥97% | (6-Chloropyrazin-2-yl)methanol | ESD-896739-5G |
Cas.: 367500-94-5 | Purity: 97% | 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896740-100MG |
Cas.: 367500-94-5 | Purity: 97% | 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896740-250MG |
Cas.: 367500-94-5 | Purity: 97% | 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896740-1G |
Cas.: 367500-94-5 | Purity: 97% | 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896740-5G |
Cas.: 50727-04-3 | Purity: 97% | 5-Methoxyisoindoline-1,3-dione | ESD-896741-100MG |
Cas.: 50727-04-3 | Purity: 97% | 5-Methoxyisoindoline-1,3-dione | ESD-896741-250MG |
Cas.: 50727-04-3 | Purity: 97% | 5-Methoxyisoindoline-1,3-dione | ESD-896741-1G |
Cas.: 50727-04-3 | Purity: 97% | 5-Methoxyisoindoline-1,3-dione | ESD-896741-5G |
Cas.: 1523541-84-5 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-896742-100MG |
Cas.: 1523541-84-5 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-896742-250MG |
Cas.: 1523541-84-5 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-896742-1G |
Cas.: 1523541-84-5 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-896742-5G |
Cas.: 7752-48-9 | Purity: ≥95% | 5-Bromo-6-methylpyrimidin-4-amine | ESD-896743-100MG |
Cas.: 7752-48-9 | Purity: ≥95% | 5-Bromo-6-methylpyrimidin-4-amine | ESD-896743-250MG |
Cas.: 7752-48-9 | Purity: ≥95% | 5-Bromo-6-methylpyrimidin-4-amine | ESD-896743-1G |
Cas.: 7752-48-9 | Purity: ≥95% | 5-Bromo-6-methylpyrimidin-4-amine | ESD-896743-5G |
Cas.: 110221-26-6 | Purity: 97% | (2S,6R)-6-Amino-2-(thiophen-2-yl)-1,4-thiazepan-5-one | ESD-896744-100MG |
Cas.: 110221-26-6 | Purity: 97% | (2S,6R)-6-Amino-2-(thiophen-2-yl)-1,4-thiazepan-5-one | ESD-896744-250MG |
Cas.: 110221-26-6 | Purity: 97% | (2S,6R)-6-Amino-2-(thiophen-2-yl)-1,4-thiazepan-5-one | ESD-896744-1G |
Cas.: 110221-26-6 | Purity: 97% | (2S,6R)-6-Amino-2-(thiophen-2-yl)-1,4-thiazepan-5-one | ESD-896744-5G |
Cas.: 157327-45-2 | Purity: ≥95% | 4,5,6,7-Tetrahydro-2-methyl-2H-pyrazolo[4,3-c]pyridine dihydrochloride | ESD-896745-100MG |
Cas.: 157327-45-2 | Purity: ≥95% | 4,5,6,7-Tetrahydro-2-methyl-2H-pyrazolo[4,3-c]pyridine dihydrochloride | ESD-896745-250MG |
Cas.: 157327-45-2 | Purity: ≥95% | 4,5,6,7-Tetrahydro-2-methyl-2H-pyrazolo[4,3-c]pyridine dihydrochloride | ESD-896745-1G |
Cas.: 157327-45-2 | Purity: ≥95% | 4,5,6,7-Tetrahydro-2-methyl-2H-pyrazolo[4,3-c]pyridine dihydrochloride | ESD-896745-5G |
Cas.: 710322-57-9 | Purity: 98% | Methyl 5-formylpyrazine-2-carboxylate | ESD-896746-100MG |
Cas.: 710322-57-9 | Purity: 98% | Methyl 5-formylpyrazine-2-carboxylate | ESD-896746-250MG |
Cas.: 710322-57-9 | Purity: 98% | Methyl 5-formylpyrazine-2-carboxylate | ESD-896746-1G |
Cas.: 710322-57-9 | Purity: 98% | Methyl 5-formylpyrazine-2-carboxylate | ESD-896746-5G |
Cas.: 23761-24-2 | Purity: 97% | 3-Bromocyclobutanone | ESD-896747-100MG |
Cas.: 23761-24-2 | Purity: 97% | 3-Bromocyclobutanone | ESD-896747-250MG |
Cas.: 23761-24-2 | Purity: 97% | 3-Bromocyclobutanone | ESD-896747-1G |
Cas.: 23761-24-2 | Purity: 97% | 3-Bromocyclobutanone | ESD-896747-5G |
Cas.: 1110782-41-6 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)nicotinic acid | ESD-896748-100MG |
Cas.: 1110782-41-6 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)nicotinic acid | ESD-896748-250MG |
Cas.: 1110782-41-6 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)nicotinic acid | ESD-896748-1G |
Cas.: 1110782-41-6 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)nicotinic acid | ESD-896748-5G |
Cas.: 5539-46-8 | Purity: 98% | 5-Aminothiazole-4-carboxamide | ESD-896749-100MG |
Cas.: 5539-46-8 | Purity: 98% | 5-Aminothiazole-4-carboxamide | ESD-896749-250MG |
Cas.: 5539-46-8 | Purity: 98% | 5-Aminothiazole-4-carboxamide | ESD-896749-1G |
Cas.: 5539-46-8 | Purity: 98% | 5-Aminothiazole-4-carboxamide | ESD-896749-5G |
Cas.: 158962-92-6 | Purity: ≥95% | 2,3-Dihydrothieno[3,4-b][1,4]dithiine | ESD-896750-100MG |
Cas.: 158962-92-6 | Purity: ≥95% | 2,3-Dihydrothieno[3,4-b][1,4]dithiine | ESD-896750-250MG |
Cas.: 158962-92-6 | Purity: ≥95% | 2,3-Dihydrothieno[3,4-b][1,4]dithiine | ESD-896750-1G |
Cas.: 158962-92-6 | Purity: ≥95% | 2,3-Dihydrothieno[3,4-b][1,4]dithiine | ESD-896750-5G |
Cas.: 106157-82-8 | Purity: 95% | 1-(2-Aminopyrimidin-4-yl)ethanone | ESD-896751-100MG |
Cas.: 106157-82-8 | Purity: 95% | 1-(2-Aminopyrimidin-4-yl)ethanone | ESD-896751-250MG |
Cas.: 106157-82-8 | Purity: 95% | 1-(2-Aminopyrimidin-4-yl)ethanone | ESD-896751-1G |
Cas.: 106157-82-8 | Purity: 95% | 1-(2-Aminopyrimidin-4-yl)ethanone | ESD-896751-5G |
Cas.: 91407-41-9 | Purity: 98% | 5-Fluoro-2-hydroxybenzonitrile | ESD-896752-100MG |
Cas.: 91407-41-9 | Purity: 98% | 5-Fluoro-2-hydroxybenzonitrile | ESD-896752-250MG |
Cas.: 91407-41-9 | Purity: 98% | 5-Fluoro-2-hydroxybenzonitrile | ESD-896752-1G |
Cas.: 91407-41-9 | Purity: 98% | 5-Fluoro-2-hydroxybenzonitrile | ESD-896752-5G |
Cas.: 410090-37-8 | Purity: ≥95% | cis-3-(Boc-amino)cyclopentanecarboxylic Acid | ESD-896753-100MG |
Cas.: 410090-37-8 | Purity: ≥95% | cis-3-(Boc-amino)cyclopentanecarboxylic Acid | ESD-896753-250MG |
Cas.: 410090-37-8 | Purity: ≥95% | cis-3-(Boc-amino)cyclopentanecarboxylic Acid | ESD-896753-1G |
Cas.: 410090-37-8 | Purity: ≥95% | cis-3-(Boc-amino)cyclopentanecarboxylic Acid | ESD-896753-5G |
Cas.: 1162674-74-9 | Purity: 95% | 5-Bromo-3-fluoro-2-methylpyridine | ESD-896754-100MG |
Cas.: 1162674-74-9 | Purity: 95% | 5-Bromo-3-fluoro-2-methylpyridine | ESD-896754-250MG |
Cas.: 1162674-74-9 | Purity: 95% | 5-Bromo-3-fluoro-2-methylpyridine | ESD-896754-1G |
Cas.: 1162674-74-9 | Purity: 95% | 5-Bromo-3-fluoro-2-methylpyridine | ESD-896754-5G |
Cas.: 1065100-83-5 | Purity: ≥97% | (1H-Pyrrolo[2,3-b]pyridin-3-yl)methanol | ESD-896755-100MG |
Cas.: 1065100-83-5 | Purity: ≥97% | (1H-Pyrrolo[2,3-b]pyridin-3-yl)methanol | ESD-896755-250MG |
Cas.: 1256358-90-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-896756-100MG |
Cas.: 1256358-90-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-896756-250MG |
Cas.: 1256358-90-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-896756-1G |
Cas.: 1256358-90-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-896756-5G |
Cas.: 851916-84-2 | Purity: ≥95% | 6-Bromo-2-chloroimidazo[1,2-a]pyridine | ESD-896757-100MG |
Cas.: 851916-84-2 | Purity: ≥95% | 6-Bromo-2-chloroimidazo[1,2-a]pyridine | ESD-896757-250MG |
Cas.: 851916-84-2 | Purity: ≥95% | 6-Bromo-2-chloroimidazo[1,2-a]pyridine | ESD-896757-1G |
Cas.: 851916-84-2 | Purity: ≥95% | 6-Bromo-2-chloroimidazo[1,2-a]pyridine | ESD-896757-5G |
Cas.: 1245643-11-1 | Purity: 98% | Methyl 3,4-diamino-5-bromobenzoate | ESD-896758-100MG |
Cas.: 1245643-11-1 | Purity: 98% | Methyl 3,4-diamino-5-bromobenzoate | ESD-896758-250MG |
Cas.: 1245643-11-1 | Purity: 98% | Methyl 3,4-diamino-5-bromobenzoate | ESD-896758-1G |
Cas.: 1245643-11-1 | Purity: 98% | Methyl 3,4-diamino-5-bromobenzoate | ESD-896758-5G |
Cas.: 518990-21-1 | Purity: 97% | Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-896759-100MG |
Cas.: 518990-21-1 | Purity: 97% | Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-896759-250MG |
Cas.: 518990-21-1 | Purity: 97% | Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-896759-1G |
Cas.: 518990-21-1 | Purity: 97% | Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-896759-5G |
Cas.: 908268-52-0 | Purity: 96% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896760-100MG |
Cas.: 908268-52-0 | Purity: 96% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896760-250MG |
Cas.: 908268-52-0 | Purity: 96% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896760-1G |
Cas.: 908268-52-0 | Purity: 96% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896760-5G |
Cas.: 1206896-20-9 | Purity: 97% | 2-(tert-Butyl)-6-chloro-N-methoxy-N-methylbenzo[d]oxazole-7-sulfonamide | ESD-896761-100MG |
Cas.: 1206896-20-9 | Purity: 97% | 2-(tert-Butyl)-6-chloro-N-methoxy-N-methylbenzo[d]oxazole-7-sulfonamide | ESD-896761-250MG |
Cas.: 1206896-20-9 | Purity: 97% | 2-(tert-Butyl)-6-chloro-N-methoxy-N-methylbenzo[d]oxazole-7-sulfonamide | ESD-896761-1G |
Cas.: 1206896-20-9 | Purity: 97% | 2-(tert-Butyl)-6-chloro-N-methoxy-N-methylbenzo[d]oxazole-7-sulfonamide | ESD-896761-5G |
Cas.: 898747-00-7 | Purity: 95% | 6-Bromo-1H-indazole-4-carbonitrile | ESD-896762-100MG |
Cas.: 898747-00-7 | Purity: 95% | 6-Bromo-1H-indazole-4-carbonitrile | ESD-896762-250MG |
Cas.: 898747-00-7 | Purity: 95% | 6-Bromo-1H-indazole-4-carbonitrile | ESD-896762-1G |
Cas.: 898747-00-7 | Purity: 95% | 6-Bromo-1H-indazole-4-carbonitrile | ESD-896762-5G |
Cas.: 1012341-50-2 | Purity: ≥95% | (2R,4S)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | ESD-896763-100MG |
Cas.: 1012341-50-2 | Purity: ≥95% | (2R,4S)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | ESD-896763-250MG |
Cas.: 1012341-50-2 | Purity: ≥95% | (2R,4S)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | ESD-896763-1G |
Cas.: 1012341-50-2 | Purity: ≥95% | (2R,4S)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | ESD-896763-5G |
Cas.: 156817-72-0 | Purity: 97% | 3-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-896764-100MG |
Cas.: 156817-72-0 | Purity: 97% | 3-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-896764-250MG |
Cas.: 156817-72-0 | Purity: 97% | 3-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-896764-1G |
Cas.: 156817-72-0 | Purity: 97% | 3-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-896764-5G |
Cas.: 6332-83-8 | Purity: 98% | 2-(4-Chlorophenyl)acetophenone | ESD-896765-100MG |
Cas.: 6332-83-8 | Purity: 98% | 2-(4-Chlorophenyl)acetophenone | ESD-896765-250MG |
Cas.: 6332-83-8 | Purity: 98% | 2-(4-Chlorophenyl)acetophenone | ESD-896765-1G |
Cas.: 6332-83-8 | Purity: 98% | 2-(4-Chlorophenyl)acetophenone | ESD-896765-5G |
Cas.: 952183-44-7 | Purity: ≥95% | 4-Methyl-1H-indazol-7-amine | ESD-896766-100MG |
Cas.: 952183-44-7 | Purity: ≥95% | 4-Methyl-1H-indazol-7-amine | ESD-896766-250MG |
Cas.: 952183-44-7 | Purity: ≥95% | 4-Methyl-1H-indazol-7-amine | ESD-896766-1G |
Cas.: 952183-44-7 | Purity: ≥95% | 4-Methyl-1H-indazol-7-amine | ESD-896766-5G |
Cas.: 100367-36-0 | Purity: ≥95% | 3-Amino-2-bromophenol | ESD-896767-100MG |
Cas.: 100367-36-0 | Purity: ≥95% | 3-Amino-2-bromophenol | ESD-896767-250MG |
Cas.: 100367-36-0 | Purity: ≥95% | 3-Amino-2-bromophenol | ESD-896767-1G |
Cas.: 100367-36-0 | Purity: ≥95% | 3-Amino-2-bromophenol | ESD-896767-5G |
Cas.: 7361-31-1 | Purity: ≥95% | Methyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate hydrochloride | ESD-896768-100MG |
Cas.: 7361-31-1 | Purity: ≥95% | Methyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate hydrochloride | ESD-896768-250MG |
Cas.: 7361-31-1 | Purity: ≥95% | Methyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate hydrochloride | ESD-896768-1G |
Cas.: 7361-31-1 | Purity: ≥95% | Methyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate hydrochloride | ESD-896768-5G |
Cas.: 120276-59-7 | Purity: ≥95% | 3-Chloro-6-(chloromethyl)pyridazine | ESD-896769-100MG |
Cas.: 120276-59-7 | Purity: ≥95% | 3-Chloro-6-(chloromethyl)pyridazine | ESD-896769-250MG |
Cas.: 120276-59-7 | Purity: ≥95% | 3-Chloro-6-(chloromethyl)pyridazine | ESD-896769-1G |
Cas.: 120276-59-7 | Purity: ≥95% | 3-Chloro-6-(chloromethyl)pyridazine | ESD-896769-5G |
Cas.: 900514-10-5 | Purity: ≥97% | 5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-896770-100MG |
Cas.: 900514-10-5 | Purity: ≥97% | 5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-896770-250MG |
Cas.: 900514-10-5 | Purity: ≥97% | 5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-896770-1G |
Cas.: 900514-10-5 | Purity: ≥97% | 5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine | ESD-896770-5G |
Cas.: 53439-88-6 | Purity: ≥95% | 5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-896771-100MG |
Cas.: 53439-88-6 | Purity: ≥95% | 5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-896771-250MG |
Cas.: 53439-88-6 | Purity: ≥95% | 5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-896771-1G |
Cas.: 53439-88-6 | Purity: ≥95% | 5-Amino-1,3-dimethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-896771-5G |
Cas.: 74695-44-6 | Purity: 98% | 5,7-Dichlorothieno[3,2-b]pyridine | ESD-896772-100MG |
Cas.: 74695-44-6 | Purity: 98% | 5,7-Dichlorothieno[3,2-b]pyridine | ESD-896772-250MG |
Cas.: 74695-44-6 | Purity: 98% | 5,7-Dichlorothieno[3,2-b]pyridine | ESD-896772-1G |
Cas.: 74695-44-6 | Purity: 98% | 5,7-Dichlorothieno[3,2-b]pyridine | ESD-896772-5G |
Cas.: 425392-45-6 | Purity: 97% | Ethyl 5-chlorothiazole-4-carboxylate | ESD-896773-100MG |
Cas.: 425392-45-6 | Purity: 97% | Ethyl 5-chlorothiazole-4-carboxylate | ESD-896773-250MG |
Cas.: 425392-45-6 | Purity: 97% | Ethyl 5-chlorothiazole-4-carboxylate | ESD-896773-1G |
Cas.: 425392-45-6 | Purity: 97% | Ethyl 5-chlorothiazole-4-carboxylate | ESD-896773-5G |
Cas.: 97456-81-0 | Purity: 97% | 1-Bromo-3-iodo-2-methylbenzene | ESD-896774-100MG |
Cas.: 97456-81-0 | Purity: 97% | 1-Bromo-3-iodo-2-methylbenzene | ESD-896774-250MG |
Cas.: 97456-81-0 | Purity: 97% | 1-Bromo-3-iodo-2-methylbenzene | ESD-896774-1G |
Cas.: 97456-81-0 | Purity: 97% | 1-Bromo-3-iodo-2-methylbenzene | ESD-896774-5G |
Cas.: 1235440-18-2 | Purity: ≥95% | 5-Aminopipidin-2-one hydrochloride | ESD-896775-100MG |
Cas.: 1235440-18-2 | Purity: ≥95% | 5-Aminopipidin-2-one hydrochloride | ESD-896775-250MG |
Cas.: 1235440-18-2 | Purity: ≥95% | 5-Aminopipidin-2-one hydrochloride | ESD-896775-1G |
Cas.: 1235440-18-2 | Purity: ≥95% | 5-Aminopipidin-2-one hydrochloride | ESD-896775-5G |
Cas.: 103030-10-0 | Purity: 97% | Methyl 2,3-dioxoindoline-7-carboxylate | ESD-896776-100MG |
Cas.: 103030-10-0 | Purity: 97% | Methyl 2,3-dioxoindoline-7-carboxylate | ESD-896776-250MG |
Cas.: 103030-10-0 | Purity: 97% | Methyl 2,3-dioxoindoline-7-carboxylate | ESD-896776-1G |
Cas.: 103030-10-0 | Purity: 97% | Methyl 2,3-dioxoindoline-7-carboxylate | ESD-896776-5G |
Cas.: 577780-05-3 | Purity: 96% | 3-(Hydroxymethyl)-1-methylpyrrolidin-2-one | ESD-896777-100MG |
Cas.: 577780-05-3 | Purity: 96% | 3-(Hydroxymethyl)-1-methylpyrrolidin-2-one | ESD-896777-250MG |
Cas.: 577780-05-3 | Purity: 96% | 3-(Hydroxymethyl)-1-methylpyrrolidin-2-one | ESD-896777-1G |
Cas.: 577780-05-3 | Purity: 96% | 3-(Hydroxymethyl)-1-methylpyrrolidin-2-one | ESD-896777-5G |
Cas.: 1017412-53-1 | Purity: 97% | 5-Bromoquinoline-2-carboxylic acid | ESD-896778-100MG |
Cas.: 1017412-53-1 | Purity: 97% | 5-Bromoquinoline-2-carboxylic acid | ESD-896778-250MG |
Cas.: 1017412-53-1 | Purity: 97% | 5-Bromoquinoline-2-carboxylic acid | ESD-896778-1G |
Cas.: 1017412-53-1 | Purity: 97% | 5-Bromoquinoline-2-carboxylic acid | ESD-896778-5G |
Cas.: 848139-78-6 | Purity: ≥95% | 6-Amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile | ESD-896779-100MG |
Cas.: 848139-78-6 | Purity: ≥95% | 6-Amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile | ESD-896779-250MG |
Cas.: 848139-78-6 | Purity: ≥95% | 6-Amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile | ESD-896779-1G |
Cas.: 848139-78-6 | Purity: ≥95% | 6-Amino-4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinoline-3-carbonitrile | ESD-896779-5G |
Cas.: 867333-43-5 | Purity: 97% | (5-Cyano-2-methylphenyl)boronic acid | ESD-896780-100MG |
Cas.: 867333-43-5 | Purity: 97% | (5-Cyano-2-methylphenyl)boronic acid | ESD-896780-250MG |
Cas.: 867333-43-5 | Purity: 97% | (5-Cyano-2-methylphenyl)boronic acid | ESD-896780-1G |
Cas.: 867333-43-5 | Purity: 97% | (5-Cyano-2-methylphenyl)boronic acid | ESD-896780-5G |
Cas.: 54681-68-4 | Purity: 98% | 5-Bromo-3-methyl-1,2,4-thiadiazole | ESD-896781-100MG |
Cas.: 54681-68-4 | Purity: 98% | 5-Bromo-3-methyl-1,2,4-thiadiazole | ESD-896781-250MG |
Cas.: 54681-68-4 | Purity: 98% | 5-Bromo-3-methyl-1,2,4-thiadiazole | ESD-896781-1G |
Cas.: 54681-68-4 | Purity: 98% | 5-Bromo-3-methyl-1,2,4-thiadiazole | ESD-896781-5G |
Cas.: 98019-60-4 | Purity: 97% | Isoxazol-5-ylmethanol | ESD-896782-100MG |
Cas.: 98019-60-4 | Purity: 97% | Isoxazol-5-ylmethanol | ESD-896782-250MG |
Cas.: 98019-60-4 | Purity: 97% | Isoxazol-5-ylmethanol | ESD-896782-1G |
Cas.: 98019-60-4 | Purity: 97% | Isoxazol-5-ylmethanol | ESD-896782-5G |
Cas.: 223376-47-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridine-2-carboxamide | ESD-896783-100MG |
Cas.: 223376-47-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridine-2-carboxamide | ESD-896783-250MG |
Cas.: 223376-47-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridine-2-carboxamide | ESD-896783-1G |
Cas.: 223376-47-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridine-2-carboxamide | ESD-896783-5G |
Cas.: 60025-06-1 | Purity: 97% | 1-(4,6-Dichloropyrimidin-5-yl)ethanone | ESD-896784-100MG |
Cas.: 60025-06-1 | Purity: 97% | 1-(4,6-Dichloropyrimidin-5-yl)ethanone | ESD-896784-250MG |
Cas.: 60025-06-1 | Purity: 97% | 1-(4,6-Dichloropyrimidin-5-yl)ethanone | ESD-896784-1G |
Cas.: 60025-06-1 | Purity: 97% | 1-(4,6-Dichloropyrimidin-5-yl)ethanone | ESD-896784-5G |
Cas.: 406913-88-0 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanol | ESD-896785-100MG |
Cas.: 406913-88-0 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanol | ESD-896785-250MG |
Cas.: 406913-88-0 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanol | ESD-896785-1G |
Cas.: 406913-88-0 | Purity: 97% | (R)-(1,4-Dioxan-2-yl)methanol | ESD-896785-5G |
Cas.: 1018446-60-0 | Purity: 95% | Methyl 5-hydroxy-1H-pyrazole-3-carboxylate | ESD-896786-100MG |
Cas.: 1018446-60-0 | Purity: 95% | Methyl 5-hydroxy-1H-pyrazole-3-carboxylate | ESD-896786-250MG |
Cas.: 1018446-60-0 | Purity: 95% | Methyl 5-hydroxy-1H-pyrazole-3-carboxylate | ESD-896786-1G |
Cas.: 1018446-60-0 | Purity: 95% | Methyl 5-hydroxy-1H-pyrazole-3-carboxylate | ESD-896786-5G |
Cas.: 847818-62-6 | Purity: 96% | (1,3,5-Trimethyl-1H-pyrazol-4-yl)boronic acid | ESD-896787-100MG |
Cas.: 847818-62-6 | Purity: 96% | (1,3,5-Trimethyl-1H-pyrazol-4-yl)boronic acid | ESD-896787-250MG |
Cas.: 847818-62-6 | Purity: 96% | (1,3,5-Trimethyl-1H-pyrazol-4-yl)boronic acid | ESD-896787-1G |
Cas.: 847818-62-6 | Purity: 96% | (1,3,5-Trimethyl-1H-pyrazol-4-yl)boronic acid | ESD-896787-5G |
Cas.: 1256359-15-5 | Purity: 97% | 1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896788-100MG |
Cas.: 1256359-15-5 | Purity: 97% | 1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896788-250MG |
Cas.: 1256359-15-5 | Purity: 97% | 1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896788-1G |
Cas.: 1256359-15-5 | Purity: 97% | 1-(tert-Butyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896788-5G |
Cas.: 54346-18-8 | Purity: ≥95% | 2-(Methylthio)pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-896789-100MG |
Cas.: 54346-18-8 | Purity: ≥95% | 2-(Methylthio)pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-896789-250MG |
Cas.: 54346-18-8 | Purity: ≥95% | 2-(Methylthio)pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-896789-1G |
Cas.: 54346-18-8 | Purity: ≥95% | 2-(Methylthio)pyrazolo[1,5-a][1,3,5]triazin-4(3H)-one | ESD-896789-5G |
Cas.: 1260798-62-6 | Purity: 97% | 5-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896790-100MG |
Cas.: 1260798-62-6 | Purity: 97% | 5-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896790-250MG |
Cas.: 1260798-62-6 | Purity: 97% | 5-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896790-1G |
Cas.: 1260798-62-6 | Purity: 97% | 5-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896790-5G |
Cas.: 89466-19-3 | Purity: ≥95% | 5-Bromo-2,3-dimethoxypyrazine | ESD-896791-100MG |
Cas.: 89466-19-3 | Purity: ≥95% | 5-Bromo-2,3-dimethoxypyrazine | ESD-896791-250MG |
Cas.: 89466-19-3 | Purity: ≥95% | 5-Bromo-2,3-dimethoxypyrazine | ESD-896791-1G |
Cas.: 89466-19-3 | Purity: ≥95% | 5-Bromo-2,3-dimethoxypyrazine | ESD-896791-5G |
Cas.: 582313-57-3 | Purity: ≥95% | 4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine | ESD-896792-100MG |
Cas.: 582313-57-3 | Purity: ≥95% | 4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine | ESD-896792-250MG |
Cas.: 582313-57-3 | Purity: ≥95% | 4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine | ESD-896792-1G |
Cas.: 582313-57-3 | Purity: ≥95% | 4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine | ESD-896792-5G |
Cas.: 41046-70-2 | Purity: 97% | 2-Iodo-5-methoxyphenol | ESD-896793-100MG |
Cas.: 41046-70-2 | Purity: 97% | 2-Iodo-5-methoxyphenol | ESD-896793-250MG |
Cas.: 41046-70-2 | Purity: 97% | 2-Iodo-5-methoxyphenol | ESD-896793-1G |
Cas.: 41046-70-2 | Purity: 97% | 2-Iodo-5-methoxyphenol | ESD-896793-5G |
Cas.: 53159-71-0 | Purity: ≥95% | 1-(2-Aminothiazol-5-yl)ethanone | ESD-896794-100MG |
Cas.: 53159-71-0 | Purity: ≥95% | 1-(2-Aminothiazol-5-yl)ethanone | ESD-896794-250MG |
Cas.: 53159-71-0 | Purity: ≥95% | 1-(2-Aminothiazol-5-yl)ethanone | ESD-896794-1G |
Cas.: 53159-71-0 | Purity: ≥95% | 1-(2-Aminothiazol-5-yl)ethanone | ESD-896794-5G |
Cas.: 172317-17-8 | Purity: 95% | tert-Butyl 2-(ethylamino)acetate | ESD-896795-100MG |
Cas.: 172317-17-8 | Purity: 95% | tert-Butyl 2-(ethylamino)acetate | ESD-896795-250MG |
Cas.: 172317-17-8 | Purity: 95% | tert-Butyl 2-(ethylamino)acetate | ESD-896795-1G |
Cas.: 172317-17-8 | Purity: 95% | tert-Butyl 2-(ethylamino)acetate | ESD-896795-5G |
Cas.: 84182-59-2 | Purity: 97% | cis-3-Aminocyclobutanecarboxylic acid hydrochloride | ESD-896796-100MG |
Cas.: 84182-59-2 | Purity: 97% | cis-3-Aminocyclobutanecarboxylic acid hydrochloride | ESD-896796-250MG |
Cas.: 84182-59-2 | Purity: 97% | cis-3-Aminocyclobutanecarboxylic acid hydrochloride | ESD-896796-1G |
Cas.: 84182-59-2 | Purity: 97% | cis-3-Aminocyclobutanecarboxylic acid hydrochloride | ESD-896796-5G |
Cas.: 38275-42-2 | Purity: 97% | 5-Chloro-2-(methylthio)pyrimidine | ESD-896797-100MG |
Cas.: 38275-42-2 | Purity: 97% | 5-Chloro-2-(methylthio)pyrimidine | ESD-896797-250MG |
Cas.: 38275-42-2 | Purity: 97% | 5-Chloro-2-(methylthio)pyrimidine | ESD-896797-1G |
Cas.: 38275-42-2 | Purity: 97% | 5-Chloro-2-(methylthio)pyrimidine | ESD-896797-5G |
Cas.: 1192755-14-8 | Purity: 97% | 2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896798-100MG |
Cas.: 1192755-14-8 | Purity: 97% | 2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896798-250MG |
Cas.: 1192755-14-8 | Purity: 97% | 2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896798-1G |
Cas.: 1192755-14-8 | Purity: 97% | 2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896798-5G |
Cas.: 91182-60-4 | Purity: 97% | 5-(4-Bromophenyl)-3-methylisoxazole-4-carboxylic acid | ESD-896799-100MG |
Cas.: 91182-60-4 | Purity: 97% | 5-(4-Bromophenyl)-3-methylisoxazole-4-carboxylic acid | ESD-896799-250MG |
Cas.: 91182-60-4 | Purity: 97% | 5-(4-Bromophenyl)-3-methylisoxazole-4-carboxylic acid | ESD-896799-1G |
Cas.: 91182-60-4 | Purity: 97% | 5-(4-Bromophenyl)-3-methylisoxazole-4-carboxylic acid | ESD-896799-5G |
Cas.: 1150164-80-9 | Purity: 90% | ethyl 2,2-difluoro-2-(2-methoxyphenyl)acetate | ESD-896800-100MG |
Cas.: 1150164-80-9 | Purity: 90% | ethyl 2,2-difluoro-2-(2-methoxyphenyl)acetate | ESD-896800-250MG |
Cas.: 1150164-80-9 | Purity: 90% | ethyl 2,2-difluoro-2-(2-methoxyphenyl)acetate | ESD-896800-1G |
Cas.: 1150164-80-9 | Purity: 90% | ethyl 2,2-difluoro-2-(2-methoxyphenyl)acetate | ESD-896800-5G |
Cas.: 1219022-46-4 | Purity: 97% | 6-Bromo-1,2,3,4-tetrahydro-1,5-naphthyridine | ESD-896801-100MG |
Cas.: 1219022-46-4 | Purity: 97% | 6-Bromo-1,2,3,4-tetrahydro-1,5-naphthyridine | ESD-896801-250MG |
Cas.: 1219022-46-4 | Purity: 97% | 6-Bromo-1,2,3,4-tetrahydro-1,5-naphthyridine | ESD-896801-1G |
Cas.: 1219022-46-4 | Purity: 97% | 6-Bromo-1,2,3,4-tetrahydro-1,5-naphthyridine | ESD-896801-5G |
Cas.: 90111-15-2 | Purity: 98% | 3-Hydroxy-2-methylbenzaldehyde | ESD-896802-100MG |
Cas.: 90111-15-2 | Purity: 98% | 3-Hydroxy-2-methylbenzaldehyde | ESD-896802-250MG |
Cas.: 313337-33-6 | Purity: 97% | 4-Fluoro-1H-indole-7-carbonitrile | ESD-896803-100MG |
Cas.: 313337-33-6 | Purity: 97% | 4-Fluoro-1H-indole-7-carbonitrile | ESD-896803-250MG |
Cas.: 313337-33-6 | Purity: 97% | 4-Fluoro-1H-indole-7-carbonitrile | ESD-896803-1G |
Cas.: 313337-33-6 | Purity: 97% | 4-Fluoro-1H-indole-7-carbonitrile | ESD-896803-5G |
Cas.: 1172986-17-2 | Purity: 97% | 4-Amino-6-bromothiochroman 1,1-dioxide hydrochloride | ESD-896804-100MG |
Cas.: 1172986-17-2 | Purity: 97% | 4-Amino-6-bromothiochroman 1,1-dioxide hydrochloride | ESD-896804-250MG |
Cas.: 1172986-17-2 | Purity: 97% | 4-Amino-6-bromothiochroman 1,1-dioxide hydrochloride | ESD-896804-1G |
Cas.: 1172986-17-2 | Purity: 97% | 4-Amino-6-bromothiochroman 1,1-dioxide hydrochloride | ESD-896804-5G |
Cas.: 113975-33-0 | Purity: ≥95% | N-(3-Iodopyridin-4-yl)pivalamide | ESD-896805-100MG |
Cas.: 113975-33-0 | Purity: ≥95% | N-(3-Iodopyridin-4-yl)pivalamide | ESD-896805-250MG |
Cas.: 113975-33-0 | Purity: ≥95% | N-(3-Iodopyridin-4-yl)pivalamide | ESD-896805-1G |
Cas.: 113975-33-0 | Purity: ≥95% | N-(3-Iodopyridin-4-yl)pivalamide | ESD-896805-5G |
Cas.: 1283720-88-6 | Purity: ≥95% | Benzyl 3,3-difluoro-4-oxopiperidine-1-carboxylate | ESD-896806-100MG |
Cas.: 1283720-88-6 | Purity: ≥95% | Benzyl 3,3-difluoro-4-oxopiperidine-1-carboxylate | ESD-896806-250MG |
Cas.: 1283720-88-6 | Purity: ≥95% | Benzyl 3,3-difluoro-4-oxopiperidine-1-carboxylate | ESD-896806-1G |
Cas.: 1283720-88-6 | Purity: ≥95% | Benzyl 3,3-difluoro-4-oxopiperidine-1-carboxylate | ESD-896806-5G |
Cas.: 1260648-73-4 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-3-carboxylic acid | ESD-896807-100MG |
Cas.: 1260648-73-4 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-3-carboxylic acid | ESD-896807-250MG |
Cas.: 1260648-73-4 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-3-carboxylic acid | ESD-896807-1G |
Cas.: 1260648-73-4 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-3-carboxylic acid | ESD-896807-5G |
Cas.: 1064783-29-4 | Purity: 98% | 5-Chloro-3-fluoro-2-nitropyridine | ESD-896808-100MG |
Cas.: 1064783-29-4 | Purity: 98% | 5-Chloro-3-fluoro-2-nitropyridine | ESD-896808-250MG |
Cas.: 1064783-29-4 | Purity: 98% | 5-Chloro-3-fluoro-2-nitropyridine | ESD-896808-1G |
Cas.: 1064783-29-4 | Purity: 98% | 5-Chloro-3-fluoro-2-nitropyridine | ESD-896808-5G |
Cas.: 942070-88-4 | Purity: 97% | 4-Bromo-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896809-100MG |
Cas.: 942070-88-4 | Purity: 97% | 4-Bromo-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896809-250MG |
Cas.: 942070-88-4 | Purity: 97% | 4-Bromo-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896809-1G |
Cas.: 942070-88-4 | Purity: 97% | 4-Bromo-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896809-5G |
Cas.: 367500-93-4 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-2-carboxylate | ESD-896810-100MG |
Cas.: 367500-93-4 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-2-carboxylate | ESD-896810-250MG |
Cas.: 367500-93-4 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-2-carboxylate | ESD-896810-1G |
Cas.: 367500-93-4 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-2-carboxylate | ESD-896810-5G |
Cas.: 885275-77-4 | Purity: ≥95% | 5-Bromoimidazo[1,5-a]pyridine | ESD-896811-100MG |
Cas.: 885275-77-4 | Purity: ≥95% | 5-Bromoimidazo[1,5-a]pyridine | ESD-896811-250MG |
Cas.: 885275-77-4 | Purity: ≥95% | 5-Bromoimidazo[1,5-a]pyridine | ESD-896811-1G |
Cas.: 885275-77-4 | Purity: ≥95% | 5-Bromoimidazo[1,5-a]pyridine | ESD-896811-5G |
Cas.: 1256355-56-2 | Purity: 97% | (5-(Hydroxymethyl)furan-2-yl)boronic acid | ESD-896812-100MG |
Cas.: 1256355-56-2 | Purity: 97% | (5-(Hydroxymethyl)furan-2-yl)boronic acid | ESD-896812-250MG |
Cas.: 1256355-56-2 | Purity: 97% | (5-(Hydroxymethyl)furan-2-yl)boronic acid | ESD-896812-1G |
Cas.: 1256355-56-2 | Purity: 97% | (5-(Hydroxymethyl)furan-2-yl)boronic acid | ESD-896812-5G |
Cas.: 548772-41-4 | Purity: 97% | (5-Chlorothiophen-2-yl)methanamine hydrochloride | ESD-896813-100MG |
Cas.: 548772-41-4 | Purity: 97% | (5-Chlorothiophen-2-yl)methanamine hydrochloride | ESD-896813-250MG |
Cas.: 548772-41-4 | Purity: 97% | (5-Chlorothiophen-2-yl)methanamine hydrochloride | ESD-896813-1G |
Cas.: 548772-41-4 | Purity: 97% | (5-Chlorothiophen-2-yl)methanamine hydrochloride | ESD-896813-5G |
Cas.: 141196-38-5 | Purity: ≥95% | (S)-2-(Methoxymethyl)morpholine hydrochloride | ESD-896814-100MG |
Cas.: 141196-38-5 | Purity: ≥95% | (S)-2-(Methoxymethyl)morpholine hydrochloride | ESD-896814-250MG |
Cas.: 141196-38-5 | Purity: ≥95% | (S)-2-(Methoxymethyl)morpholine hydrochloride | ESD-896814-1G |
Cas.: 141196-38-5 | Purity: ≥95% | (S)-2-(Methoxymethyl)morpholine hydrochloride | ESD-896814-5G |
Cas.: 885520-70-7 | Purity: 95% | 4-Bromo-6-fluoro-1H-indole | ESD-896815-100MG |
Cas.: 885520-70-7 | Purity: 95% | 4-Bromo-6-fluoro-1H-indole | ESD-896815-250MG |
Cas.: 885520-70-7 | Purity: 95% | 4-Bromo-6-fluoro-1H-indole | ESD-896815-1G |
Cas.: 885520-70-7 | Purity: 95% | 4-Bromo-6-fluoro-1H-indole | ESD-896815-5G |
Cas.: 55198-89-5 | Purity: ≥95% | 3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one | ESD-896816-100MG |
Cas.: 55198-89-5 | Purity: ≥95% | 3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one | ESD-896816-250MG |
Cas.: 55198-89-5 | Purity: ≥95% | 3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one | ESD-896816-1G |
Cas.: 55198-89-5 | Purity: ≥95% | 3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one | ESD-896816-5G |
Cas.: 1359655-87-0 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896817-100MG |
Cas.: 1359655-87-0 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896817-250MG |
Cas.: 1359655-87-0 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896817-1G |
Cas.: 1359655-87-0 | Purity: 97% | Ethyl 6-fluoroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896817-5G |
Cas.: 1234319-14-2 | Purity: ≥95% | 2-(4-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896818-100MG |
Cas.: 1234319-14-2 | Purity: ≥95% | 2-(4-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896818-250MG |
Cas.: 1234319-14-2 | Purity: ≥95% | 2-(4-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896818-1G |
Cas.: 1234319-14-2 | Purity: ≥95% | 2-(4-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-896818-5G |
Cas.: 54230-90-9 | Purity: ≥95% | 8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-896819-100MG |
Cas.: 54230-90-9 | Purity: ≥95% | 8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-896819-250MG |
Cas.: 54230-90-9 | Purity: ≥95% | 8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-896819-1G |
Cas.: 54230-90-9 | Purity: ≥95% | 8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-896819-5G |
Cas.: 1375301-91-9 | Purity: 97% | 2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | ESD-896820-100MG |
Cas.: 1375301-91-9 | Purity: 97% | 2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | ESD-896820-250MG |
Cas.: 1375301-91-9 | Purity: 97% | 2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | ESD-896820-1G |
Cas.: 1375301-91-9 | Purity: 97% | 2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | ESD-896820-5G |
Cas.: 1095080-54-8 | Purity: 97% | (1-Ethyl-1H-pyrazol-5-yl)boronic acid | ESD-896821-100MG |
Cas.: 1095080-54-8 | Purity: 97% | (1-Ethyl-1H-pyrazol-5-yl)boronic acid | ESD-896821-250MG |
Cas.: 1095080-54-8 | Purity: 97% | (1-Ethyl-1H-pyrazol-5-yl)boronic acid | ESD-896821-1G |
Cas.: 1095080-54-8 | Purity: 97% | (1-Ethyl-1H-pyrazol-5-yl)boronic acid | ESD-896821-5G |
Cas.: 139503-12-1 | Purity: ≥95% | 4-(3,5-Difluorophenyl)tetrahydro-2H-pyran-4-ol | ESD-896822-100MG |
Cas.: 139503-12-1 | Purity: ≥95% | 4-(3,5-Difluorophenyl)tetrahydro-2H-pyran-4-ol | ESD-896822-250MG |
Cas.: 139503-12-1 | Purity: ≥95% | 4-(3,5-Difluorophenyl)tetrahydro-2H-pyran-4-ol | ESD-896822-1G |
Cas.: 139503-12-1 | Purity: ≥95% | 4-(3,5-Difluorophenyl)tetrahydro-2H-pyran-4-ol | ESD-896822-5G |
Cas.: 485841-52-9 | Purity: ≥95% | (S)-1,2-Dimethylpiperazine | ESD-896823-100MG |
Cas.: 485841-52-9 | Purity: ≥95% | (S)-1,2-Dimethylpiperazine | ESD-896823-250MG |
Cas.: 485841-52-9 | Purity: ≥95% | (S)-1,2-Dimethylpiperazine | ESD-896823-1G |
Cas.: 485841-52-9 | Purity: ≥95% | (S)-1,2-Dimethylpiperazine | ESD-896823-5G |
Cas.: 854646-94-9 | Purity: 97% | 2-(5-Bromo-2-methylphenyl)acetic acid | ESD-896824-100MG |
Cas.: 854646-94-9 | Purity: 97% | 2-(5-Bromo-2-methylphenyl)acetic acid | ESD-896824-250MG |
Cas.: 854646-94-9 | Purity: 97% | 2-(5-Bromo-2-methylphenyl)acetic acid | ESD-896824-1G |
Cas.: 854646-94-9 | Purity: 97% | 2-(5-Bromo-2-methylphenyl)acetic acid | ESD-896824-5G |
Cas.: 1260169-02-5 | Purity: 96% | Ethyl 2-aminopyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-896825-100MG |
Cas.: 1260169-02-5 | Purity: 96% | Ethyl 2-aminopyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-896825-250MG |
Cas.: 1260169-02-5 | Purity: 96% | Ethyl 2-aminopyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-896825-1G |
Cas.: 1260169-02-5 | Purity: 96% | Ethyl 2-aminopyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-896825-5G |
Cas.: 1211516-09-4 | Purity: 97% | 6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine | ESD-896826-100MG |
Cas.: 1211516-09-4 | Purity: 97% | 6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine | ESD-896826-250MG |
Cas.: 1211516-09-4 | Purity: 97% | 6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine | ESD-896826-1G |
Cas.: 1211516-09-4 | Purity: 97% | 6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine | ESD-896826-5G |
Cas.: 15733-87-6 | Purity: 97% | 2-Bromoquinoline-4-carboxylic acid | ESD-896827-100MG |
Cas.: 15733-87-6 | Purity: 97% | 2-Bromoquinoline-4-carboxylic acid | ESD-896827-250MG |
Cas.: 15733-87-6 | Purity: 97% | 2-Bromoquinoline-4-carboxylic acid | ESD-896827-1G |
Cas.: 15733-87-6 | Purity: 97% | 2-Bromoquinoline-4-carboxylic acid | ESD-896827-5G |
Cas.: 660432-43-9 | Purity: 97% | (2-Fluoro-4-nitrophenyl)methanol | ESD-896828-100MG |
Cas.: 660432-43-9 | Purity: 97% | (2-Fluoro-4-nitrophenyl)methanol | ESD-896828-250MG |
Cas.: 660432-43-9 | Purity: 97% | (2-Fluoro-4-nitrophenyl)methanol | ESD-896828-1G |
Cas.: 660432-43-9 | Purity: 97% | (2-Fluoro-4-nitrophenyl)methanol | ESD-896828-5G |
Cas.: 219763-87-8 | Purity: ≥95% | 4-Bromoquinoline-6-carboxylic acid | ESD-896829-100MG |
Cas.: 219763-87-8 | Purity: ≥95% | 4-Bromoquinoline-6-carboxylic acid | ESD-896829-250MG |
Cas.: 219763-87-8 | Purity: ≥95% | 4-Bromoquinoline-6-carboxylic acid | ESD-896829-1G |
Cas.: 219763-87-8 | Purity: ≥95% | 4-Bromoquinoline-6-carboxylic acid | ESD-896829-5G |
Cas.: 1016163-89-5 | Purity: 95% | Methyl 5-bromo-2-formylbenzoate | ESD-896830-100MG |
Cas.: 1016163-89-5 | Purity: 95% | Methyl 5-bromo-2-formylbenzoate | ESD-896830-250MG |
Cas.: 1016163-89-5 | Purity: 95% | Methyl 5-bromo-2-formylbenzoate | ESD-896830-1G |
Cas.: 1016163-89-5 | Purity: 95% | Methyl 5-bromo-2-formylbenzoate | ESD-896830-5G |
Cas.: 1064721-11-4 | Purity: ≥95% | 7-Bromo-1H-benzo[d][1,2,3]triazole | ESD-896831-100MG |
Cas.: 1064721-11-4 | Purity: ≥95% | 7-Bromo-1H-benzo[d][1,2,3]triazole | ESD-896831-250MG |
Cas.: 1064721-11-4 | Purity: ≥95% | 7-Bromo-1H-benzo[d][1,2,3]triazole | ESD-896831-1G |
Cas.: 1064721-11-4 | Purity: ≥95% | 7-Bromo-1H-benzo[d][1,2,3]triazole | ESD-896831-5G |
Cas.: 1239647-60-9 | Purity: 97% | 6-Chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-896832-100MG |
Cas.: 1239647-60-9 | Purity: 97% | 6-Chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-896832-250MG |
Cas.: 1239647-60-9 | Purity: 97% | 6-Chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-896832-1G |
Cas.: 1239647-60-9 | Purity: 97% | 6-Chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-896832-5G |
Cas.: 944317-66-2 | Purity: 97% | Methyl 2-(4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-896833-100MG |
Cas.: 944317-66-2 | Purity: 97% | Methyl 2-(4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-896833-250MG |
Cas.: 944317-66-2 | Purity: 97% | Methyl 2-(4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-896833-1G |
Cas.: 944317-66-2 | Purity: 97% | Methyl 2-(4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-896833-5G |
Cas.: 1375964-39-8 | Purity: 98% | 3-Bromo-2-fluorophenylacetic acid | ESD-896834-100MG |
Cas.: 1375964-39-8 | Purity: 98% | 3-Bromo-2-fluorophenylacetic acid | ESD-896834-250MG |
Cas.: 1375964-39-8 | Purity: 98% | 3-Bromo-2-fluorophenylacetic acid | ESD-896834-1G |
Cas.: 1375964-39-8 | Purity: 98% | 3-Bromo-2-fluorophenylacetic acid | ESD-896834-5G |
Cas.: 62718-28-9 | Purity: 97% | 1-Methylpiperidine-4-carboxamide | ESD-896835-100MG |
Cas.: 62718-28-9 | Purity: 97% | 1-Methylpiperidine-4-carboxamide | ESD-896835-250MG |
Cas.: 62718-28-9 | Purity: 97% | 1-Methylpiperidine-4-carboxamide | ESD-896835-1G |
Cas.: 62718-28-9 | Purity: 97% | 1-Methylpiperidine-4-carboxamide | ESD-896835-5G |
Cas.: 39870-05-8 | Purity: ≥95% | 1-(Pyrimidin-4-yl)ethanone | ESD-896836-100MG |
Cas.: 39870-05-8 | Purity: ≥95% | 1-(Pyrimidin-4-yl)ethanone | ESD-896836-250MG |
Cas.: 39870-05-8 | Purity: ≥95% | 1-(Pyrimidin-4-yl)ethanone | ESD-896836-1G |
Cas.: 39870-05-8 | Purity: ≥95% | 1-(Pyrimidin-4-yl)ethanone | ESD-896836-5G |
Cas.: 870089-49-9 | Purity: 95% | tert-Butyl 3-acetylazetidine-1-carboxylate | ESD-896837-100MG |
Cas.: 870089-49-9 | Purity: 95% | tert-Butyl 3-acetylazetidine-1-carboxylate | ESD-896837-250MG |
Cas.: 870089-49-9 | Purity: 95% | tert-Butyl 3-acetylazetidine-1-carboxylate | ESD-896837-1G |
Cas.: 870089-49-9 | Purity: 95% | tert-Butyl 3-acetylazetidine-1-carboxylate | ESD-896837-5G |
Cas.: 54641-27-9 | Purity: 97% | N-(2-Aminoethyl)acrylamide hydrochloride | ESD-896838-100MG |
Cas.: 54641-27-9 | Purity: 97% | N-(2-Aminoethyl)acrylamide hydrochloride | ESD-896838-250MG |
Cas.: 54641-27-9 | Purity: 97% | N-(2-Aminoethyl)acrylamide hydrochloride | ESD-896838-1G |
Cas.: 54641-27-9 | Purity: 97% | N-(2-Aminoethyl)acrylamide hydrochloride | ESD-896838-5G |
Cas.: 1260797-60-1 | Purity: 97% | Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896839-100MG |
Cas.: 1260797-60-1 | Purity: 97% | Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896839-250MG |
Cas.: 1260797-60-1 | Purity: 97% | Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896839-1G |
Cas.: 1260797-60-1 | Purity: 97% | Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate | ESD-896839-5G |
Cas.: 1805523-44-7 | Purity: 97% | Methyl 2-bromo-3,6-difluorobenzoate | ESD-896840-100MG |
Cas.: 1805523-44-7 | Purity: 97% | Methyl 2-bromo-3,6-difluorobenzoate | ESD-896840-250MG |
Cas.: 1805523-44-7 | Purity: 97% | Methyl 2-bromo-3,6-difluorobenzoate | ESD-896840-1G |
Cas.: 1805523-44-7 | Purity: 97% | Methyl 2-bromo-3,6-difluorobenzoate | ESD-896840-5G |
Cas.: 1186608-73-0 | Purity: ≥95% | 3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-896841-100MG |
Cas.: 1186608-73-0 | Purity: ≥95% | 3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-896841-250MG |
Cas.: 1186608-73-0 | Purity: ≥95% | 3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-896841-1G |
Cas.: 1186608-73-0 | Purity: ≥95% | 3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-amine | ESD-896841-5G |
Cas.: 1197-13-3 | Purity: 97% | Methyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896842-100MG |
Cas.: 1197-13-3 | Purity: 97% | Methyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896842-250MG |
Cas.: 1197-13-3 | Purity: 97% | Methyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896842-1G |
Cas.: 1197-13-3 | Purity: 97% | Methyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896842-5G |
Cas.: 1211533-83-3 | Purity: 98% | 5-Bromo-6-methoxypyridin-2-amine | ESD-896843-100MG |
Cas.: 1211533-83-3 | Purity: 98% | 5-Bromo-6-methoxypyridin-2-amine | ESD-896843-250MG |
Cas.: 1211533-83-3 | Purity: 98% | 5-Bromo-6-methoxypyridin-2-amine | ESD-896843-1G |
Cas.: 1211533-83-3 | Purity: 98% | 5-Bromo-6-methoxypyridin-2-amine | ESD-896843-5G |
Cas.: 33588-64-6 | Purity: 97% | Ethyl 2-(1H-indol-2-yl)acetate | ESD-896844-100MG |
Cas.: 33588-64-6 | Purity: 97% | Ethyl 2-(1H-indol-2-yl)acetate | ESD-896844-250MG |
Cas.: 33588-64-6 | Purity: 97% | Ethyl 2-(1H-indol-2-yl)acetate | ESD-896844-1G |
Cas.: 33588-64-6 | Purity: 97% | Ethyl 2-(1H-indol-2-yl)acetate | ESD-896844-5G |
Cas.: 832735-56-5 | Purity: 97% | 4-Bromo-2-(difluoromethoxy)pyridine | ESD-896845-100MG |
Cas.: 832735-56-5 | Purity: 97% | 4-Bromo-2-(difluoromethoxy)pyridine | ESD-896845-250MG |
Cas.: 832735-56-5 | Purity: 97% | 4-Bromo-2-(difluoromethoxy)pyridine | ESD-896845-1G |
Cas.: 832735-56-5 | Purity: 97% | 4-Bromo-2-(difluoromethoxy)pyridine | ESD-896845-5G |
Cas.: 936353-84-3 | Purity: 95% | (6-(4-Methylpiperazin-1-yl)pyridin-3-yl)boronic acid | ESD-896846-100MG |
Cas.: 936353-84-3 | Purity: 95% | (6-(4-Methylpiperazin-1-yl)pyridin-3-yl)boronic acid | ESD-896846-250MG |
Cas.: 936353-84-3 | Purity: 95% | (6-(4-Methylpiperazin-1-yl)pyridin-3-yl)boronic acid | ESD-896846-1G |
Cas.: 936353-84-3 | Purity: 95% | (6-(4-Methylpiperazin-1-yl)pyridin-3-yl)boronic acid | ESD-896846-5G |
Cas.: 886361-98-4 | Purity: 97% | Methyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-896847-100MG |
Cas.: 886361-98-4 | Purity: 97% | Methyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-896847-250MG |
Cas.: 886361-98-4 | Purity: 97% | Methyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-896847-1G |
Cas.: 886361-98-4 | Purity: 97% | Methyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-896847-5G |
Cas.: 2732-28-7 | Purity: 97% | 1-(2-Methylpyridin-4-yl)ethanone | ESD-896848-100MG |
Cas.: 2732-28-7 | Purity: 97% | 1-(2-Methylpyridin-4-yl)ethanone | ESD-896848-250MG |
Cas.: 2732-28-7 | Purity: 97% | 1-(2-Methylpyridin-4-yl)ethanone | ESD-896848-1G |
Cas.: 2732-28-7 | Purity: 97% | 1-(2-Methylpyridin-4-yl)ethanone | ESD-896848-5G |
Cas.: 17407-56-6 | Purity: 97% | (R)-2-Hydroxy-3-methylbutanoic acid | ESD-896849-100MG |
Cas.: 17407-56-6 | Purity: 97% | (R)-2-Hydroxy-3-methylbutanoic acid | ESD-896849-250MG |
Cas.: 17407-56-6 | Purity: 97% | (R)-2-Hydroxy-3-methylbutanoic acid | ESD-896849-1G |
Cas.: 17407-56-6 | Purity: 97% | (R)-2-Hydroxy-3-methylbutanoic acid | ESD-896849-5G |
Cas.: 947249-27-6 | Purity: ≥95% | 2-Bromo-3-(difluoromethoxy)pyridine | ESD-896850-100MG |
Cas.: 947249-27-6 | Purity: ≥95% | 2-Bromo-3-(difluoromethoxy)pyridine | ESD-896850-250MG |
Cas.: 947249-27-6 | Purity: ≥95% | 2-Bromo-3-(difluoromethoxy)pyridine | ESD-896850-1G |
Cas.: 947249-27-6 | Purity: ≥95% | 2-Bromo-3-(difluoromethoxy)pyridine | ESD-896850-5G |
Cas.: 103285-22-9 | Purity: ≥95% | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H ,3H)-dione | ESD-896851-100MG |
Cas.: 103285-22-9 | Purity: ≥95% | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H ,3H)-dione | ESD-896851-250MG |
Cas.: 103285-22-9 | Purity: ≥95% | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H ,3H)-dione | ESD-896851-1G |
Cas.: 103285-22-9 | Purity: ≥95% | 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H ,3H)-dione | ESD-896851-5G |
Cas.: 130931-83-8 | Purity: 97% | (1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3-one | ESD-896852-100MG |
Cas.: 130931-83-8 | Purity: 97% | (1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3-one | ESD-896852-250MG |
Cas.: 130931-83-8 | Purity: 97% | (1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3-one | ESD-896852-1G |
Cas.: 130931-83-8 | Purity: 97% | (1S,4R)-2-Azabicyclo[2.2.1]hept-5-en-3-one | ESD-896852-5G |
Cas.: 1026201-45-5 | Purity: ≥95% | 8-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896853-100MG |
Cas.: 1026201-45-5 | Purity: ≥95% | 8-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896853-250MG |
Cas.: 1026201-45-5 | Purity: ≥95% | 8-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896853-1G |
Cas.: 1026201-45-5 | Purity: ≥95% | 8-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-896853-5G |
Cas.: 1408075-90-0 | Purity: ≥95% | tert-Butyl 7-oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate | ESD-896854-100MG |
Cas.: 1408075-90-0 | Purity: ≥95% | tert-Butyl 7-oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate | ESD-896854-250MG |
Cas.: 1408075-90-0 | Purity: ≥95% | tert-Butyl 7-oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate | ESD-896854-1G |
Cas.: 1408075-90-0 | Purity: ≥95% | tert-Butyl 7-oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate | ESD-896854-5G |
Cas.: 353245-98-4 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-896855-100MG |
Cas.: 353245-98-4 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-896855-250MG |
Cas.: 353245-98-4 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-896855-1G |
Cas.: 353245-98-4 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-896855-5G |
Cas.: 233763-40-1 | Purity: 95% | Tetrahydro-2H-thiopyran-4-amine hydrochloride | ESD-896856-100MG |
Cas.: 233763-40-1 | Purity: 95% | Tetrahydro-2H-thiopyran-4-amine hydrochloride | ESD-896856-250MG |
Cas.: 233763-40-1 | Purity: 95% | Tetrahydro-2H-thiopyran-4-amine hydrochloride | ESD-896856-1G |
Cas.: 233763-40-1 | Purity: 95% | Tetrahydro-2H-thiopyran-4-amine hydrochloride | ESD-896856-5G |
Cas.: 167946-94-3 | Purity: ≥95% | 2,2-Dimethylmorpholine hydrochloride | ESD-896857-100MG |
Cas.: 167946-94-3 | Purity: ≥95% | 2,2-Dimethylmorpholine hydrochloride | ESD-896857-250MG |
Cas.: 167946-94-3 | Purity: ≥95% | 2,2-Dimethylmorpholine hydrochloride | ESD-896857-1G |
Cas.: 167946-94-3 | Purity: ≥95% | 2,2-Dimethylmorpholine hydrochloride | ESD-896857-5G |
Cas.: 140690-56-8 | Purity: 95% | 1-(Bromomethyl)-2,4-bis(trifluoromethyl)benzene | ESD-896858-100MG |
Cas.: 140690-56-8 | Purity: 95% | 1-(Bromomethyl)-2,4-bis(trifluoromethyl)benzene | ESD-896858-250MG |
Cas.: 140690-56-8 | Purity: 95% | 1-(Bromomethyl)-2,4-bis(trifluoromethyl)benzene | ESD-896858-1G |
Cas.: 140690-56-8 | Purity: 95% | 1-(Bromomethyl)-2,4-bis(trifluoromethyl)benzene | ESD-896858-5G |
Cas.: 884494-35-3 | Purity: 98% | 2-Chloro-5-fluoropyridin-3-ol | ESD-896859-100MG |
Cas.: 884494-35-3 | Purity: 98% | 2-Chloro-5-fluoropyridin-3-ol | ESD-896859-250MG |
Cas.: 884494-35-3 | Purity: 98% | 2-Chloro-5-fluoropyridin-3-ol | ESD-896859-1G |
Cas.: 884494-35-3 | Purity: 98% | 2-Chloro-5-fluoropyridin-3-ol | ESD-896859-5G |
Cas.: 898746-96-8 | Purity: 95% | 4-Bromo-1H-indazole-6-carbonitrile | ESD-896860-100MG |
Cas.: 898746-96-8 | Purity: 95% | 4-Bromo-1H-indazole-6-carbonitrile | ESD-896860-250MG |
Cas.: 898746-96-8 | Purity: 95% | 4-Bromo-1H-indazole-6-carbonitrile | ESD-896860-1G |
Cas.: 898746-96-8 | Purity: 95% | 4-Bromo-1H-indazole-6-carbonitrile | ESD-896860-5G |
Cas.: 42487-72-9 | Purity: ≥95% | 2-(Diethylamino)-6-methylpyrimidin-4-ol | ESD-896861-100MG |
Cas.: 42487-72-9 | Purity: ≥95% | 2-(Diethylamino)-6-methylpyrimidin-4-ol | ESD-896861-250MG |
Cas.: 42487-72-9 | Purity: ≥95% | 2-(Diethylamino)-6-methylpyrimidin-4-ol | ESD-896861-1G |
Cas.: 42487-72-9 | Purity: ≥95% | 2-(Diethylamino)-6-methylpyrimidin-4-ol | ESD-896861-5G |
Cas.: 298694-30-1 | Purity: 95% | 4-Bromo-2-methylthiazole | ESD-896862-100MG |
Cas.: 298694-30-1 | Purity: 95% | 4-Bromo-2-methylthiazole | ESD-896862-250MG |
Cas.: 298694-30-1 | Purity: 95% | 4-Bromo-2-methylthiazole | ESD-896862-1G |
Cas.: 298694-30-1 | Purity: 95% | 4-Bromo-2-methylthiazole | ESD-896862-5G |
Cas.: 940890-90-4 | Purity: ≥95% | (S)-tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate | ESD-896863-100MG |
Cas.: 940890-90-4 | Purity: ≥95% | (S)-tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate | ESD-896863-250MG |
Cas.: 940890-90-4 | Purity: ≥95% | (S)-tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate | ESD-896863-1G |
Cas.: 1188313-15-6 | Purity: 95% | 4-Chloro-1H-pyrrolo[2,3-c]pyridine | ESD-896864-100MG |
Cas.: 1188313-15-6 | Purity: 95% | 4-Chloro-1H-pyrrolo[2,3-c]pyridine | ESD-896864-250MG |
Cas.: 1188313-15-6 | Purity: 95% | 4-Chloro-1H-pyrrolo[2,3-c]pyridine | ESD-896864-1G |
Cas.: 1188313-15-6 | Purity: 95% | 4-Chloro-1H-pyrrolo[2,3-c]pyridine | ESD-896864-5G |
Cas.: 82090-52-6 | Purity: 90% | Imidazo[1,2-a]pyridin-2-ylmethanol | ESD-896865-100MG |
Cas.: 82090-52-6 | Purity: 90% | Imidazo[1,2-a]pyridin-2-ylmethanol | ESD-896865-250MG |
Cas.: 82090-52-6 | Purity: 90% | Imidazo[1,2-a]pyridin-2-ylmethanol | ESD-896865-1G |
Cas.: 82090-52-6 | Purity: 90% | Imidazo[1,2-a]pyridin-2-ylmethanol | ESD-896865-5G |
Cas.: 863111-48-2 | Purity: 97% | 2-Bromo-5-chloro-4-(trifluoromethyl)aniline | ESD-896866-100MG |
Cas.: 863111-48-2 | Purity: 97% | 2-Bromo-5-chloro-4-(trifluoromethyl)aniline | ESD-896866-250MG |
Cas.: 863111-48-2 | Purity: 97% | 2-Bromo-5-chloro-4-(trifluoromethyl)aniline | ESD-896866-1G |
Cas.: 863111-48-2 | Purity: 97% | 2-Bromo-5-chloro-4-(trifluoromethyl)aniline | ESD-896866-5G |
Cas.: 638218-78-7 | Purity: 97% | 2-(6-Bromopyridin-2-yl)propan-2-ol | ESD-896867-100MG |
Cas.: 638218-78-7 | Purity: 97% | 2-(6-Bromopyridin-2-yl)propan-2-ol | ESD-896867-250MG |
Cas.: 638218-78-7 | Purity: 97% | 2-(6-Bromopyridin-2-yl)propan-2-ol | ESD-896867-1G |
Cas.: 638218-78-7 | Purity: 97% | 2-(6-Bromopyridin-2-yl)propan-2-ol | ESD-896867-5G |
Cas.: 1220696-34-3 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-896868-100MG |
Cas.: 1220696-34-3 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-896868-250MG |
Cas.: 1220696-34-3 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-896868-1G |
Cas.: 1220696-34-3 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-896868-5G |
Cas.: 869481-94-7 | Purity: 97% | (3S,4R)-rel-3,4-Difluoropyrrolidine hydrochloride | ESD-896869-100MG |
Cas.: 869481-94-7 | Purity: 97% | (3S,4R)-rel-3,4-Difluoropyrrolidine hydrochloride | ESD-896869-250MG |
Cas.: 869481-94-7 | Purity: 97% | (3S,4R)-rel-3,4-Difluoropyrrolidine hydrochloride | ESD-896869-1G |
Cas.: 869481-94-7 | Purity: 97% | (3S,4R)-rel-3,4-Difluoropyrrolidine hydrochloride | ESD-896869-5G |
Cas.: 186519-92-6 | Purity: 98% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid | ESD-896870-100MG |
Cas.: 186519-92-6 | Purity: 98% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid | ESD-896870-250MG |
Cas.: 186519-92-6 | Purity: 98% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid | ESD-896870-1G |
Cas.: 186519-92-6 | Purity: 98% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid | ESD-896870-5G |
Cas.: 75705-21-4 | Purity: 97% | 4-Aminomethylphenylboronic acid hydrochloride | ESD-896871-100MG |
Cas.: 75705-21-4 | Purity: 97% | 4-Aminomethylphenylboronic acid hydrochloride | ESD-896871-250MG |
Cas.: 75705-21-4 | Purity: 97% | 4-Aminomethylphenylboronic acid hydrochloride | ESD-896871-1G |
Cas.: 75705-21-4 | Purity: 97% | 4-Aminomethylphenylboronic acid hydrochloride | ESD-896871-5G |
Cas.: 380238-10-8 | Purity: 95% | 3-Methyl-1-(2-(trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-896872-100MG |
Cas.: 380238-10-8 | Purity: 95% | 3-Methyl-1-(2-(trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-896872-250MG |
Cas.: 380238-10-8 | Purity: 95% | 3-Methyl-1-(2-(trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-896872-1G |
Cas.: 380238-10-8 | Purity: 95% | 3-Methyl-1-(2-(trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-896872-5G |
Cas.: 83774-13-4 | Purity: 97% | 4-Chloro-6-isopropoxypyrimidine | ESD-896873-100MG |
Cas.: 83774-13-4 | Purity: 97% | 4-Chloro-6-isopropoxypyrimidine | ESD-896873-250MG |
Cas.: 83774-13-4 | Purity: 97% | 4-Chloro-6-isopropoxypyrimidine | ESD-896873-1G |
Cas.: 83774-13-4 | Purity: 97% | 4-Chloro-6-isopropoxypyrimidine | ESD-896873-5G |
Cas.: 2314-37-6 | Purity: 98% | 3-Iodo-4-methoxybenzaldehyde | ESD-896874-100MG |
Cas.: 2314-37-6 | Purity: 98% | 3-Iodo-4-methoxybenzaldehyde | ESD-896874-250MG |
Cas.: 2314-37-6 | Purity: 98% | 3-Iodo-4-methoxybenzaldehyde | ESD-896874-1G |
Cas.: 2314-37-6 | Purity: 98% | 3-Iodo-4-methoxybenzaldehyde | ESD-896874-5G |
Cas.: 731018-54-5 | Purity: 97% | tert-Butyl (5-fluorothiazol-2-yl)carbamate | ESD-896875-100MG |
Cas.: 731018-54-5 | Purity: 97% | tert-Butyl (5-fluorothiazol-2-yl)carbamate | ESD-896875-250MG |
Cas.: 731018-54-5 | Purity: 97% | tert-Butyl (5-fluorothiazol-2-yl)carbamate | ESD-896875-1G |
Cas.: 731018-54-5 | Purity: 97% | tert-Butyl (5-fluorothiazol-2-yl)carbamate | ESD-896875-5G |
Cas.: 1215387-58-8 | Purity: 98% | 5-Bromo-1H-pyrrolo[2,3-c]pyridine | ESD-896876-100MG |
Cas.: 1215387-58-8 | Purity: 98% | 5-Bromo-1H-pyrrolo[2,3-c]pyridine | ESD-896876-250MG |
Cas.: 1215387-58-8 | Purity: 98% | 5-Bromo-1H-pyrrolo[2,3-c]pyridine | ESD-896876-1G |
Cas.: 1215387-58-8 | Purity: 98% | 5-Bromo-1H-pyrrolo[2,3-c]pyridine | ESD-896876-5G |
Cas.: 1095661-17-8 | Purity: ≥95% | 4-Aminomethylquinoline hydrochloride | ESD-896877-100MG |
Cas.: 1095661-17-8 | Purity: ≥95% | 4-Aminomethylquinoline hydrochloride | ESD-896877-250MG |
Cas.: 1095661-17-8 | Purity: ≥95% | 4-Aminomethylquinoline hydrochloride | ESD-896877-1G |
Cas.: 1095661-17-8 | Purity: ≥95% | 4-Aminomethylquinoline hydrochloride | ESD-896877-5G |
Cas.: 676371-64-5 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate | ESD-896878-100MG |
Cas.: 676371-64-5 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate | ESD-896878-250MG |
Cas.: 676371-64-5 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate | ESD-896878-1G |
Cas.: 676371-64-5 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylate | ESD-896878-5G |
Cas.: 644970-36-5 | Purity: ≥95% | tert-Butyl 3-hydroxy-3-(trifluoromethyl)pyrrolidine-1-carboxylate | ESD-896879-100MG |
Cas.: 644970-36-5 | Purity: ≥95% | tert-Butyl 3-hydroxy-3-(trifluoromethyl)pyrrolidine-1-carboxylate | ESD-896879-250MG |
Cas.: 644970-36-5 | Purity: ≥95% | tert-Butyl 3-hydroxy-3-(trifluoromethyl)pyrrolidine-1-carboxylate | ESD-896879-1G |
Cas.: 644970-36-5 | Purity: ≥95% | tert-Butyl 3-hydroxy-3-(trifluoromethyl)pyrrolidine-1-carboxylate | ESD-896879-5G |
Cas.: 1148148-01-9 | Purity: ≥98% | Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine-(2-(2-aminoethyl)phenyl)palladium(II) chloride | ESD-896880-100MG |
Cas.: 1148148-01-9 | Purity: ≥98% | Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine-(2-(2-aminoethyl)phenyl)palladium(II) chloride | ESD-896880-250MG |
Cas.: 1148148-01-9 | Purity: ≥98% | Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine-(2-(2-aminoethyl)phenyl)palladium(II) chloride | ESD-896880-1G |
Cas.: 1148148-01-9 | Purity: ≥98% | Dicyclohexyl(2′,4′,6′-triisopropyl-3,6-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine-(2-(2-aminoethyl)phenyl)palladium(II) chloride | ESD-896880-5G |
Cas.: 2343-25-1 | Purity: ≥97% | 1-(2-Amino-5-fluorophenyl)ethanone | ESD-896881-100MG |
Cas.: 2343-25-1 | Purity: ≥97% | 1-(2-Amino-5-fluorophenyl)ethanone | ESD-896881-250MG |
Cas.: 2343-25-1 | Purity: ≥97% | 1-(2-Amino-5-fluorophenyl)ethanone | ESD-896881-1G |
Cas.: 2343-25-1 | Purity: ≥97% | 1-(2-Amino-5-fluorophenyl)ethanone | ESD-896881-5G |
Cas.: 1017781-52-0 | Purity: 97% | 4-Bromothiazole-2-carbonitrile | ESD-896882-100MG |
Cas.: 1017781-52-0 | Purity: 97% | 4-Bromothiazole-2-carbonitrile | ESD-896882-250MG |
Cas.: 1017781-52-0 | Purity: 97% | 4-Bromothiazole-2-carbonitrile | ESD-896882-1G |
Cas.: 1017781-52-0 | Purity: 97% | 4-Bromothiazole-2-carbonitrile | ESD-896882-5G |
Cas.: 208641-98-9 | Purity: 97% | (3,5-Difluoro-4-methoxyphenyl)boronic acid | ESD-896883-100MG |
Cas.: 208641-98-9 | Purity: 97% | (3,5-Difluoro-4-methoxyphenyl)boronic acid | ESD-896883-250MG |
Cas.: 208641-98-9 | Purity: 97% | (3,5-Difluoro-4-methoxyphenyl)boronic acid | ESD-896883-1G |
Cas.: 208641-98-9 | Purity: 97% | (3,5-Difluoro-4-methoxyphenyl)boronic acid | ESD-896883-5G |
Cas.: 858643-92-2 | Purity: 95% | tert-Butyl 3-acetylpiperidine-1-carboxylate | ESD-896884-100MG |
Cas.: 858643-92-2 | Purity: 95% | tert-Butyl 3-acetylpiperidine-1-carboxylate | ESD-896884-250MG |
Cas.: 858643-92-2 | Purity: 95% | tert-Butyl 3-acetylpiperidine-1-carboxylate | ESD-896884-1G |
Cas.: 858643-92-2 | Purity: 95% | tert-Butyl 3-acetylpiperidine-1-carboxylate | ESD-896884-5G |
Cas.: 1232431-11-6 | Purity: ≥95% | 5-Bromo-4-methoxypyridin-2-amine | ESD-896885-100MG |
Cas.: 1232431-11-6 | Purity: ≥95% | 5-Bromo-4-methoxypyridin-2-amine | ESD-896885-250MG |
Cas.: 1232431-11-6 | Purity: ≥95% | 5-Bromo-4-methoxypyridin-2-amine | ESD-896885-1G |
Cas.: 1232431-11-6 | Purity: ≥95% | 5-Bromo-4-methoxypyridin-2-amine | ESD-896885-5G |
Cas.: 41252-95-3 | Purity: 97% | 1-Chloro-4-iodo-2-nitrobenzene | ESD-896886-100MG |
Cas.: 41252-95-3 | Purity: 97% | 1-Chloro-4-iodo-2-nitrobenzene | ESD-896886-250MG |
Cas.: 41252-95-3 | Purity: 97% | 1-Chloro-4-iodo-2-nitrobenzene | ESD-896886-1G |
Cas.: 41252-95-3 | Purity: 97% | 1-Chloro-4-iodo-2-nitrobenzene | ESD-896886-5G |
Cas.: 62484-16-6 | Purity: 97% | 6-Methylquinazoline-2,4(1H,3H)-dione | ESD-896887-100MG |
Cas.: 62484-16-6 | Purity: 97% | 6-Methylquinazoline-2,4(1H,3H)-dione | ESD-896887-250MG |
Cas.: 62484-16-6 | Purity: 97% | 6-Methylquinazoline-2,4(1H,3H)-dione | ESD-896887-1G |
Cas.: 62484-16-6 | Purity: 97% | 6-Methylquinazoline-2,4(1H,3H)-dione | ESD-896887-5G |
Cas.: 126712-07-0 | Purity: ≥95% | 2-Bromo-6-methoxybenzaldehyde | ESD-896888-100MG |
Cas.: 126712-07-0 | Purity: ≥95% | 2-Bromo-6-methoxybenzaldehyde | ESD-896888-250MG |
Cas.: 126712-07-0 | Purity: ≥95% | 2-Bromo-6-methoxybenzaldehyde | ESD-896888-1G |
Cas.: 126712-07-0 | Purity: ≥95% | 2-Bromo-6-methoxybenzaldehyde | ESD-896888-5G |
Cas.: 38446-95-6 | Purity: 97% | tert-Butyl 4-oxocyclohexanecarboxylate | ESD-896889-100MG |
Cas.: 38446-95-6 | Purity: 97% | tert-Butyl 4-oxocyclohexanecarboxylate | ESD-896889-250MG |
Cas.: 38446-95-6 | Purity: 97% | tert-Butyl 4-oxocyclohexanecarboxylate | ESD-896889-1G |
Cas.: 38446-95-6 | Purity: 97% | tert-Butyl 4-oxocyclohexanecarboxylate | ESD-896889-5G |
Cas.: 603311-76-8 | Purity: ≥95% | Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate | ESD-896890-100MG |
Cas.: 603311-76-8 | Purity: ≥95% | Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate | ESD-896890-250MG |
Cas.: 603311-76-8 | Purity: ≥95% | Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate | ESD-896890-1G |
Cas.: 603311-76-8 | Purity: ≥95% | Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate | ESD-896890-5G |
Cas.: 1227958-32-8 | Purity: 96% | tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate | ESD-896891-100MG |
Cas.: 1227958-32-8 | Purity: 96% | tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate | ESD-896891-250MG |
Cas.: 1227958-32-8 | Purity: 96% | tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate | ESD-896891-1G |
Cas.: 1227958-32-8 | Purity: 96% | tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate | ESD-896891-5G |
Cas.: 1003298-73-4 | Purity: 97% | 2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-896892-100MG |
Cas.: 1003298-73-4 | Purity: 97% | 2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-896892-250MG |
Cas.: 1003298-73-4 | Purity: 97% | 2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-896892-1G |
Cas.: 1003298-73-4 | Purity: 97% | 2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-896892-5G |
Cas.: 474799-41-2 | Purity: ≥95% | 6-Nitroindolin-2-one | ESD-896893-100MG |
Cas.: 474799-41-2 | Purity: ≥95% | 6-Nitroindolin-2-one | ESD-896893-250MG |
Cas.: 474799-41-2 | Purity: ≥95% | 6-Nitroindolin-2-one | ESD-896893-1G |
Cas.: 474799-41-2 | Purity: ≥95% | 6-Nitroindolin-2-one | ESD-896893-5G |
Cas.: 89323-09-1 | Purity: 98% | 5-Aminopyrazine-2-carboxamide | ESD-896894-100MG |
Cas.: 89323-09-1 | Purity: 98% | 5-Aminopyrazine-2-carboxamide | ESD-896894-250MG |
Cas.: 89323-09-1 | Purity: 98% | 5-Aminopyrazine-2-carboxamide | ESD-896894-1G |
Cas.: 89323-09-1 | Purity: 98% | 5-Aminopyrazine-2-carboxamide | ESD-896894-5G |
Cas.: 900514-07-0 | Purity: 97% | 3-Iodo-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896895-100MG |
Cas.: 900514-07-0 | Purity: 97% | 3-Iodo-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896895-250MG |
Cas.: 900514-07-0 | Purity: 97% | 3-Iodo-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896895-1G |
Cas.: 900514-07-0 | Purity: 97% | 3-Iodo-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896895-5G |
Cas.: 143679-80-5 | Purity: ≥95% | (1S,2S)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-896896-100MG |
Cas.: 143679-80-5 | Purity: ≥95% | (1S,2S)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-896896-250MG |
Cas.: 143679-80-5 | Purity: ≥95% | (1S,2S)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-896896-1G |
Cas.: 143679-80-5 | Purity: ≥95% | (1S,2S)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-896896-5G |
Cas.: 360575-29-7 | Purity: 97% | Methyl 4-bromobenzo[b]thiophene-2-carboxylate | ESD-896897-100MG |
Cas.: 360575-29-7 | Purity: 97% | Methyl 4-bromobenzo[b]thiophene-2-carboxylate | ESD-896897-250MG |
Cas.: 360575-29-7 | Purity: 97% | Methyl 4-bromobenzo[b]thiophene-2-carboxylate | ESD-896897-1G |
Cas.: 360575-29-7 | Purity: 97% | Methyl 4-bromobenzo[b]thiophene-2-carboxylate | ESD-896897-5G |
Cas.: 1190309-69-3 | Purity: 97% | 3-Bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile | ESD-896898-100MG |
Cas.: 1190309-69-3 | Purity: 97% | 3-Bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile | ESD-896898-250MG |
Cas.: 1190309-69-3 | Purity: 97% | 3-Bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile | ESD-896898-1G |
Cas.: 1190309-69-3 | Purity: 97% | 3-Bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile | ESD-896898-5G |
Cas.: 953411-10-4 | Purity: 98% | 7-Bromo-1H-indazol-5-amine | ESD-896899-100MG |
Cas.: 953411-10-4 | Purity: 98% | 7-Bromo-1H-indazol-5-amine | ESD-896899-250MG |
Cas.: 953411-10-4 | Purity: 98% | 7-Bromo-1H-indazol-5-amine | ESD-896899-1G |
Cas.: 953411-10-4 | Purity: 98% | 7-Bromo-1H-indazol-5-amine | ESD-896899-5G |
Cas.: 848192-96-1 | Purity: 98% | 3-(Trifluoromethyl)azetidin-3-ol hydrochloride | ESD-896900-100MG |
Cas.: 848192-96-1 | Purity: 98% | 3-(Trifluoromethyl)azetidin-3-ol hydrochloride | ESD-896900-250MG |
Cas.: 848192-96-1 | Purity: 98% | 3-(Trifluoromethyl)azetidin-3-ol hydrochloride | ESD-896900-1G |
Cas.: 848192-96-1 | Purity: 98% | 3-(Trifluoromethyl)azetidin-3-ol hydrochloride | ESD-896900-5G |
Cas.: 7126-50-3 | Purity: 97% | Ethyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896901-100MG |
Cas.: 7126-50-3 | Purity: 97% | Ethyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896901-250MG |
Cas.: 7126-50-3 | Purity: 97% | Ethyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896901-1G |
Cas.: 7126-50-3 | Purity: 97% | Ethyl 5-formyl-1H-pyrrole-2-carboxylate | ESD-896901-5G |
Cas.: 159635-22-0 | Purity: ≥95% | tert-Butyl 3-hydroxy-4-methylenepiperidine-1-carboxylate | ESD-896902-100MG |
Cas.: 159635-22-0 | Purity: ≥95% | tert-Butyl 3-hydroxy-4-methylenepiperidine-1-carboxylate | ESD-896902-250MG |
Cas.: 159635-22-0 | Purity: ≥95% | tert-Butyl 3-hydroxy-4-methylenepiperidine-1-carboxylate | ESD-896902-1G |
Cas.: 159635-22-0 | Purity: ≥95% | tert-Butyl 3-hydroxy-4-methylenepiperidine-1-carboxylate | ESD-896902-5G |
Cas.: 219834-94-3 | Purity: 95% | (3-Methoxynaphthalen-1-yl)boronic acid | ESD-896903-100MG |
Cas.: 219834-94-3 | Purity: 95% | (3-Methoxynaphthalen-1-yl)boronic acid | ESD-896903-250MG |
Cas.: 219834-94-3 | Purity: 95% | (3-Methoxynaphthalen-1-yl)boronic acid | ESD-896903-1G |
Cas.: 219834-94-3 | Purity: 95% | (3-Methoxynaphthalen-1-yl)boronic acid | ESD-896903-5G |
Cas.: 1211578-46-9 | Purity: 97% | 6-Chloro-2-fluoronicotinic acid | ESD-896904-100MG |
Cas.: 1211578-46-9 | Purity: 97% | 6-Chloro-2-fluoronicotinic acid | ESD-896904-250MG |
Cas.: 1211578-46-9 | Purity: 97% | 6-Chloro-2-fluoronicotinic acid | ESD-896904-1G |
Cas.: 1211578-46-9 | Purity: 97% | 6-Chloro-2-fluoronicotinic acid | ESD-896904-5G |
Cas.: 60166-43-0 | Purity: 97% | 1,4-Dimethyl-1H-1,2,3-triazole | ESD-896905-100MG |
Cas.: 60166-43-0 | Purity: 97% | 1,4-Dimethyl-1H-1,2,3-triazole | ESD-896905-250MG |
Cas.: 60166-43-0 | Purity: 97% | 1,4-Dimethyl-1H-1,2,3-triazole | ESD-896905-1G |
Cas.: 60166-43-0 | Purity: 97% | 1,4-Dimethyl-1H-1,2,3-triazole | ESD-896905-5G |
Cas.: 103438-86-4 | Purity: 98% | 2-Fluoro-3-hydroxybenzaldehyde | ESD-896906-100MG |
Cas.: 103438-86-4 | Purity: 98% | 2-Fluoro-3-hydroxybenzaldehyde | ESD-896906-250MG |
Cas.: 103438-86-4 | Purity: 98% | 2-Fluoro-3-hydroxybenzaldehyde | ESD-896906-1G |
Cas.: 103438-86-4 | Purity: 98% | 2-Fluoro-3-hydroxybenzaldehyde | ESD-896906-5G |
Cas.: 3484-23-9 | Purity: 97%(HPLC) | 2-Methyl-6-nitro-1H-indole | ESD-896907-100MG |
Cas.: 3484-23-9 | Purity: 97%(HPLC) | 2-Methyl-6-nitro-1H-indole | ESD-896907-250MG |
Cas.: 3484-23-9 | Purity: 97%(HPLC) | 2-Methyl-6-nitro-1H-indole | ESD-896907-1G |
Cas.: 3484-23-9 | Purity: 97%(HPLC) | 2-Methyl-6-nitro-1H-indole | ESD-896907-5G |
Cas.: 935466-69-6 | Purity: ≥95% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-896908-100MG |
Cas.: 935466-69-6 | Purity: ≥95% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-896908-250MG |
Cas.: 935466-69-6 | Purity: ≥95% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-896908-1G |
Cas.: 935466-69-6 | Purity: ≥95% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-896908-5G |
Cas.: 65156-94-7 | Purity: 97% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine | ESD-896909-100MG |
Cas.: 65156-94-7 | Purity: 97% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine | ESD-896909-250MG |
Cas.: 65156-94-7 | Purity: 97% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine | ESD-896909-1G |
Cas.: 65156-94-7 | Purity: 97% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine | ESD-896909-5G |
Cas.: 81971-38-2 | Purity: ≥95% | 3-Bromo-1-methylpyridin-2(1H)-one | ESD-896910-100MG |
Cas.: 81971-38-2 | Purity: ≥95% | 3-Bromo-1-methylpyridin-2(1H)-one | ESD-896910-250MG |
Cas.: 81971-38-2 | Purity: ≥95% | 3-Bromo-1-methylpyridin-2(1H)-one | ESD-896910-1G |
Cas.: 81971-38-2 | Purity: ≥95% | 3-Bromo-1-methylpyridin-2(1H)-one | ESD-896910-5G |
Cas.: 943320-61-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-b]pyridazine | ESD-896911-100MG |
Cas.: 943320-61-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-b]pyridazine | ESD-896911-250MG |
Cas.: 943320-61-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-b]pyridazine | ESD-896911-1G |
Cas.: 943320-61-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-b]pyridazine | ESD-896911-5G |
Cas.: 1256794-24-7 | Purity: ≥95% | 6-Chloropyridazine-4-carboxylic acid | ESD-896912-100MG |
Cas.: 1256794-24-7 | Purity: ≥95% | 6-Chloropyridazine-4-carboxylic acid | ESD-896912-250MG |
Cas.: 1256794-24-7 | Purity: ≥95% | 6-Chloropyridazine-4-carboxylic acid | ESD-896912-1G |
Cas.: 1256794-24-7 | Purity: ≥95% | 6-Chloropyridazine-4-carboxylic acid | ESD-896912-5G |
Cas.: 63485-50-7 | Purity: ≥95% | cis-Methyl 3-hydroxycyclobutanecarboxylate | ESD-896913-100MG |
Cas.: 63485-50-7 | Purity: ≥95% | cis-Methyl 3-hydroxycyclobutanecarboxylate | ESD-896913-250MG |
Cas.: 63485-50-7 | Purity: ≥95% | cis-Methyl 3-hydroxycyclobutanecarboxylate | ESD-896913-1G |
Cas.: 63485-50-7 | Purity: ≥95% | cis-Methyl 3-hydroxycyclobutanecarboxylate | ESD-896913-5G |
Cas.: 105614-25-3 | Purity: 95% | 2,2-Difluorocyclopropylamine hydrochloride | ESD-896914-100MG |
Cas.: 105614-25-3 | Purity: 95% | 2,2-Difluorocyclopropylamine hydrochloride | ESD-896914-250MG |
Cas.: 105614-25-3 | Purity: 95% | 2,2-Difluorocyclopropylamine hydrochloride | ESD-896914-1G |
Cas.: 105614-25-3 | Purity: 95% | 2,2-Difluorocyclopropylamine hydrochloride | ESD-896914-5G |
Cas.: 656257-45-3 | Purity: ≥95% | 4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester | ESD-896915-100MG |
Cas.: 656257-45-3 | Purity: ≥95% | 4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester | ESD-896915-250MG |
Cas.: 656257-45-3 | Purity: ≥95% | 4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester | ESD-896915-1G |
Cas.: 656257-45-3 | Purity: ≥95% | 4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester | ESD-896915-5G |
Cas.: 353281-15-9 | Purity: 97% | 2-Chloro-3-nitroisonicotinic acid | ESD-896916-100MG |
Cas.: 353281-15-9 | Purity: 97% | 2-Chloro-3-nitroisonicotinic acid | ESD-896916-250MG |
Cas.: 353281-15-9 | Purity: 97% | 2-Chloro-3-nitroisonicotinic acid | ESD-896916-1G |
Cas.: 353281-15-9 | Purity: 97% | 2-Chloro-3-nitroisonicotinic acid | ESD-896916-5G |
Cas.: 557756-85-1 | Purity: 98% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid | ESD-896917-100MG |
Cas.: 557756-85-1 | Purity: 98% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid | ESD-896917-250MG |
Cas.: 557756-85-1 | Purity: 98% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid | ESD-896917-1G |
Cas.: 557756-85-1 | Purity: 98% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid | ESD-896917-5G |
Cas.: 114744-51-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydroquinoline | ESD-896918-100MG |
Cas.: 114744-51-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydroquinoline | ESD-896918-250MG |
Cas.: 114744-51-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydroquinoline | ESD-896918-1G |
Cas.: 114744-51-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydroquinoline | ESD-896918-5G |
Cas.: 957187-27-8 | Purity: 97% | 8-Bromo-6-chloroimidazo[1,2-a]pyridine | ESD-896919-100MG |
Cas.: 957187-27-8 | Purity: 97% | 8-Bromo-6-chloroimidazo[1,2-a]pyridine | ESD-896919-250MG |
Cas.: 957187-27-8 | Purity: 97% | 8-Bromo-6-chloroimidazo[1,2-a]pyridine | ESD-896919-1G |
Cas.: 957187-27-8 | Purity: 97% | 8-Bromo-6-chloroimidazo[1,2-a]pyridine | ESD-896919-5G |
Cas.: 832735-60-1 | Purity: 98% | 7-Bromo-[1,2,4]triazolo[4,3-a]pyridine | ESD-896920-100MG |
Cas.: 832735-60-1 | Purity: 98% | 7-Bromo-[1,2,4]triazolo[4,3-a]pyridine | ESD-896920-250MG |
Cas.: 832735-60-1 | Purity: 98% | 7-Bromo-[1,2,4]triazolo[4,3-a]pyridine | ESD-896920-1G |
Cas.: 832735-60-1 | Purity: 98% | 7-Bromo-[1,2,4]triazolo[4,3-a]pyridine | ESD-896920-5G |
Cas.: 1204742-76-6 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896921-100MG |
Cas.: 1204742-76-6 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896921-250MG |
Cas.: 1204742-76-6 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896921-1G |
Cas.: 1204742-76-6 | Purity: 95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine | ESD-896921-5G |
Cas.: 50672-84-9 | Purity: 97% | 4-Bromo-1-naphthaldehyde | ESD-896922-100MG |
Cas.: 50672-84-9 | Purity: 97% | 4-Bromo-1-naphthaldehyde | ESD-896922-250MG |
Cas.: 50672-84-9 | Purity: 97% | 4-Bromo-1-naphthaldehyde | ESD-896922-1G |
Cas.: 50672-84-9 | Purity: 97% | 4-Bromo-1-naphthaldehyde | ESD-896922-5G |
Cas.: 61494-55-1 | Purity: 97% | 2-(2-Chloropyridin-3-yl)acetic acid | ESD-896923-100MG |
Cas.: 61494-55-1 | Purity: 97% | 2-(2-Chloropyridin-3-yl)acetic acid | ESD-896923-250MG |
Cas.: 61494-55-1 | Purity: 97% | 2-(2-Chloropyridin-3-yl)acetic acid | ESD-896923-1G |
Cas.: 61494-55-1 | Purity: 97% | 2-(2-Chloropyridin-3-yl)acetic acid | ESD-896923-5G |
Cas.: 651027-00-8 | Purity: 95% | 4-Bromo-3,5-difluorobenzoic acid | ESD-896924-100MG |
Cas.: 651027-00-8 | Purity: 95% | 4-Bromo-3,5-difluorobenzoic acid | ESD-896924-250MG |
Cas.: 651027-00-8 | Purity: 95% | 4-Bromo-3,5-difluorobenzoic acid | ESD-896924-1G |
Cas.: 651027-00-8 | Purity: 95% | 4-Bromo-3,5-difluorobenzoic acid | ESD-896924-5G |
Cas.: 6924-71-6 | Purity: 98% | Methyl quinoxaline-5-carboxylate | ESD-896925-100MG |
Cas.: 6924-71-6 | Purity: 98% | Methyl quinoxaline-5-carboxylate | ESD-896925-250MG |
Cas.: 6924-71-6 | Purity: 98% | Methyl quinoxaline-5-carboxylate | ESD-896925-1G |
Cas.: 6924-71-6 | Purity: 98% | Methyl quinoxaline-5-carboxylate | ESD-896925-5G |
Cas.: 688363-66-8 | Purity: 95% | 1-Boc-2,6-dimethylpiperazine | ESD-896926-100MG |
Cas.: 688363-66-8 | Purity: 95% | 1-Boc-2,6-dimethylpiperazine | ESD-896926-250MG |
Cas.: 688363-66-8 | Purity: 95% | 1-Boc-2,6-dimethylpiperazine | ESD-896926-1G |
Cas.: 688363-66-8 | Purity: 95% | 1-Boc-2,6-dimethylpiperazine | ESD-896926-5G |
Cas.: 849067-90-9 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896927-100MG |
Cas.: 849067-90-9 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896927-250MG |
Cas.: 849067-90-9 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896927-1G |
Cas.: 849067-90-9 | Purity: 98% | 1H-Pyrrolo[2,3-b]pyridine-5-carbaldehyde | ESD-896927-5G |
Cas.: 1190319-59-5 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carbonitrile | ESD-896928-100MG |
Cas.: 1190319-59-5 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carbonitrile | ESD-896928-250MG |
Cas.: 1190319-59-5 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carbonitrile | ESD-896928-1G |
Cas.: 1190319-59-5 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carbonitrile | ESD-896928-5G |
Cas.: 331646-98-1 | Purity: 97% | 8-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-896929-100MG |
Cas.: 331646-98-1 | Purity: 97% | 8-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-896929-250MG |
Cas.: 331646-98-1 | Purity: 97% | 8-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-896929-1G |
Cas.: 331646-98-1 | Purity: 97% | 8-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-896929-5G |
Cas.: 134517-33-2 | Purity: 97% | 5-Bromo-2-chloroquinazoline | ESD-896930-100MG |
Cas.: 134517-33-2 | Purity: 97% | 5-Bromo-2-chloroquinazoline | ESD-896930-250MG |
Cas.: 134517-33-2 | Purity: 97% | 5-Bromo-2-chloroquinazoline | ESD-896930-1G |
Cas.: 134517-33-2 | Purity: 97% | 5-Bromo-2-chloroquinazoline | ESD-896930-5G |
Cas.: 40353-62-6 | Purity: 97% | 1-(2-Amino-5-methylthiazol-4-yl)ethanone | ESD-896931-100MG |
Cas.: 40353-62-6 | Purity: 97% | 1-(2-Amino-5-methylthiazol-4-yl)ethanone | ESD-896931-250MG |
Cas.: 40353-62-6 | Purity: 97% | 1-(2-Amino-5-methylthiazol-4-yl)ethanone | ESD-896931-1G |
Cas.: 40353-62-6 | Purity: 97% | 1-(2-Amino-5-methylthiazol-4-yl)ethanone | ESD-896931-5G |
Cas.: 1169563-99-8 | Purity: ≥95% | tert-Butyl 4-(5-amino-1H-pyrazol-3-yl)piperidine-1-carboxylate | ESD-896932-100MG |
Cas.: 1169563-99-8 | Purity: ≥95% | tert-Butyl 4-(5-amino-1H-pyrazol-3-yl)piperidine-1-carboxylate | ESD-896932-250MG |
Cas.: 1169563-99-8 | Purity: ≥95% | tert-Butyl 4-(5-amino-1H-pyrazol-3-yl)piperidine-1-carboxylate | ESD-896932-1G |
Cas.: 1169563-99-8 | Purity: ≥95% | tert-Butyl 4-(5-amino-1H-pyrazol-3-yl)piperidine-1-carboxylate | ESD-896932-5G |
Cas.: 20924-56-5 | Purity: 96% | Isochroman-4-one | ESD-896933-100MG |
Cas.: 20924-56-5 | Purity: 96% | Isochroman-4-one | ESD-896933-250MG |
Cas.: 20924-56-5 | Purity: 96% | Isochroman-4-one | ESD-896933-1G |
Cas.: 165253-29-2 | Purity: ≥95% | 3-(Bromomethyl)tetrahydrofuran | ESD-896934-100MG |
Cas.: 165253-29-2 | Purity: ≥95% | 3-(Bromomethyl)tetrahydrofuran | ESD-896934-250MG |
Cas.: 165253-29-2 | Purity: ≥95% | 3-(Bromomethyl)tetrahydrofuran | ESD-896934-1G |
Cas.: 165253-29-2 | Purity: ≥95% | 3-(Bromomethyl)tetrahydrofuran | ESD-896934-5G |
Cas.: 56842-95-6 | Purity: ≥95% | Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid | ESD-896935-100MG |
Cas.: 56842-95-6 | Purity: ≥95% | Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid | ESD-896935-250MG |
Cas.: 56842-95-6 | Purity: ≥95% | Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid | ESD-896935-1G |
Cas.: 1159977-65-7 | Purity: ≥95% | 6-Bromoimidazo[1,2-b]pyridazine | ESD-896936-100MG |
Cas.: 1159977-65-7 | Purity: ≥95% | 6-Bromoimidazo[1,2-b]pyridazine | ESD-896936-250MG |
Cas.: 1159977-65-7 | Purity: ≥95% | 6-Bromoimidazo[1,2-b]pyridazine | ESD-896936-1G |
Cas.: 1159977-65-7 | Purity: ≥95% | 6-Bromoimidazo[1,2-b]pyridazine | ESD-896936-5G |
Cas.: 1060812-84-1 | Purity: 97% | 5-Bromopyrazolo[1,5-a]pyridine | ESD-896937-100MG |
Cas.: 1060812-84-1 | Purity: 97% | 5-Bromopyrazolo[1,5-a]pyridine | ESD-896937-250MG |
Cas.: 1060812-84-1 | Purity: 97% | 5-Bromopyrazolo[1,5-a]pyridine | ESD-896937-1G |
Cas.: 1060812-84-1 | Purity: 97% | 5-Bromopyrazolo[1,5-a]pyridine | ESD-896937-5G |
Cas.: 84547-87-5 | Purity: 96% | 4-Chloro-1H-pyrazole-5-carboxylic acid | ESD-896938-100MG |
Cas.: 84547-87-5 | Purity: 96% | 4-Chloro-1H-pyrazole-5-carboxylic acid | ESD-896938-250MG |
Cas.: 84547-87-5 | Purity: 96% | 4-Chloro-1H-pyrazole-5-carboxylic acid | ESD-896938-1G |
Cas.: 84547-87-5 | Purity: 96% | 4-Chloro-1H-pyrazole-5-carboxylic acid | ESD-896938-5G |
Cas.: 927679-54-7 | Purity: 99% | exo-3-Boc-3-azabicyclo[3.1.0]hexane-6-carboxylic acid | ESD-896939-100MG |
Cas.: 927679-54-7 | Purity: 99% | exo-3-Boc-3-azabicyclo[3.1.0]hexane-6-carboxylic acid | ESD-896939-250MG |
Cas.: 927679-54-7 | Purity: 99% | exo-3-Boc-3-azabicyclo[3.1.0]hexane-6-carboxylic acid | ESD-896939-1G |
Cas.: 927679-54-7 | Purity: 99% | exo-3-Boc-3-azabicyclo[3.1.0]hexane-6-carboxylic acid | ESD-896939-5G |
Cas.: 1227068-67-8 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone | ESD-896940-100MG |
Cas.: 1227068-67-8 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone | ESD-896940-250MG |
Cas.: 1227068-67-8 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone | ESD-896940-1G |
Cas.: 1227068-67-8 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone | ESD-896940-5G |
Cas.: 74592-33-9 | Purity: 95% | 1-(Aminomethyl)cyclopropanol | ESD-896941-100MG |
Cas.: 74592-33-9 | Purity: 95% | 1-(Aminomethyl)cyclopropanol | ESD-896941-250MG |
Cas.: 74592-33-9 | Purity: 95% | 1-(Aminomethyl)cyclopropanol | ESD-896941-1G |
Cas.: 74592-33-9 | Purity: 95% | 1-(Aminomethyl)cyclopropanol | ESD-896941-5G |
Cas.: 637031-88-0 | Purity: 97% | 3,3-Difluorocyclobutanol | ESD-896942-100MG |
Cas.: 637031-88-0 | Purity: 97% | 3,3-Difluorocyclobutanol | ESD-896942-250MG |
Cas.: 637031-88-0 | Purity: 97% | 3,3-Difluorocyclobutanol | ESD-896942-1G |
Cas.: 637031-88-0 | Purity: 97% | 3,3-Difluorocyclobutanol | ESD-896942-5G |
Cas.: 1029715-63-6 | Purity: ≥95% | 1-(Tetrahydrofuran-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896943-100MG |
Cas.: 1029715-63-6 | Purity: ≥95% | 1-(Tetrahydrofuran-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896943-250MG |
Cas.: 1029715-63-6 | Purity: ≥95% | 1-(Tetrahydrofuran-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896943-1G |
Cas.: 1029715-63-6 | Purity: ≥95% | 1-(Tetrahydrofuran-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-896943-5G |
Cas.: 588702-62-9 | Purity: 97% | 4-(Trifluoromethyl)picolinic acid | ESD-896944-100MG |
Cas.: 588702-62-9 | Purity: 97% | 4-(Trifluoromethyl)picolinic acid | ESD-896944-250MG |
Cas.: 588702-62-9 | Purity: 97% | 4-(Trifluoromethyl)picolinic acid | ESD-896944-1G |
Cas.: 588702-62-9 | Purity: 97% | 4-(Trifluoromethyl)picolinic acid | ESD-896944-5G |
Cas.: 89182-17-2 | Purity: 98% | 6-Chloro-3,4-pyridinediamine | ESD-896945-100MG |
Cas.: 89182-17-2 | Purity: 98% | 6-Chloro-3,4-pyridinediamine | ESD-896945-250MG |
Cas.: 89182-17-2 | Purity: 98% | 6-Chloro-3,4-pyridinediamine | ESD-896945-1G |
Cas.: 89182-17-2 | Purity: 98% | 6-Chloro-3,4-pyridinediamine | ESD-896945-5G |
Cas.: 31224-82-5 | Purity: ≥95% | 5-(Trifluoromethyl)picolinaldehyde | ESD-896946-100MG |
Cas.: 31224-82-5 | Purity: ≥95% | 5-(Trifluoromethyl)picolinaldehyde | ESD-896946-250MG |
Cas.: 31224-82-5 | Purity: ≥95% | 5-(Trifluoromethyl)picolinaldehyde | ESD-896946-1G |
Cas.: 31224-82-5 | Purity: ≥95% | 5-(Trifluoromethyl)picolinaldehyde | ESD-896946-5G |
Cas.: 1093860-48-0 | Purity: ≥98% | Methyl 6-chloropyridazine-4-carboxylate | ESD-896947-100MG |
Cas.: 1093860-48-0 | Purity: ≥98% | Methyl 6-chloropyridazine-4-carboxylate | ESD-896947-250MG |
Cas.: 1093860-48-0 | Purity: ≥98% | Methyl 6-chloropyridazine-4-carboxylate | ESD-896947-1G |
Cas.: 1093860-48-0 | Purity: ≥98% | Methyl 6-chloropyridazine-4-carboxylate | ESD-896947-5G |
Cas.: 882670-69-1 | Purity: ≥95% | 4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896948-100MG |
Cas.: 882670-69-1 | Purity: ≥95% | 4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896948-250MG |
Cas.: 882670-69-1 | Purity: ≥95% | 4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896948-1G |
Cas.: 882670-69-1 | Purity: ≥95% | 4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-896948-5G |
Cas.: 866594-60-7 | Purity: 97% | (3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one | ESD-896949-250MG |
Cas.: 866594-60-7 | Purity: 97% | (3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one | ESD-896949-1G |
Cas.: 866594-60-7 | Purity: 97% | (3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one | ESD-896949-5G |
Cas.: 866594-60-7 | Purity: 97% | (3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one | ESD-896949-10G |
Cas.: 90766-97-5 | Purity: ≥97% | 5-Bromo-6-phenylpyridazin-3(2H)-one | ESD-896950-250MG |
Cas.: 90766-97-5 | Purity: ≥97% | 5-Bromo-6-phenylpyridazin-3(2H)-one | ESD-896950-1G |
Cas.: 90766-97-5 | Purity: ≥97% | 5-Bromo-6-phenylpyridazin-3(2H)-one | ESD-896950-5G |
Cas.: 90766-97-5 | Purity: ≥97% | 5-Bromo-6-phenylpyridazin-3(2H)-one | ESD-896950-10G |
Cas.: 3445-00-9 | Purity: ≥95% | 2-(4-(3-Chloropropyl)piperazin-1-yl)ethanol dihydrochloride | ESD-896951-250MG |
Cas.: 3445-00-9 | Purity: ≥95% | 2-(4-(3-Chloropropyl)piperazin-1-yl)ethanol dihydrochloride | ESD-896951-1G |
Cas.: 3445-00-9 | Purity: ≥95% | 2-(4-(3-Chloropropyl)piperazin-1-yl)ethanol dihydrochloride | ESD-896951-5G |
Cas.: 3445-00-9 | Purity: ≥95% | 2-(4-(3-Chloropropyl)piperazin-1-yl)ethanol dihydrochloride | ESD-896951-10G |
Cas.: 66195-39-9 | Purity: 97% | 2-Iodo-6-methoxybenzoic acid | ESD-896952-250MG |
Cas.: 66195-39-9 | Purity: 97% | 2-Iodo-6-methoxybenzoic acid | ESD-896952-1G |
Cas.: 66195-39-9 | Purity: 97% | 2-Iodo-6-methoxybenzoic acid | ESD-896952-5G |
Cas.: 66195-39-9 | Purity: 97% | 2-Iodo-6-methoxybenzoic acid | ESD-896952-10G |
Cas.: 116622-38-9 | Purity: 97% | (S)-2-Amino-4-cyclohexylbutanoic acid | ESD-896953-250MG |
Cas.: 116622-38-9 | Purity: 97% | (S)-2-Amino-4-cyclohexylbutanoic acid | ESD-896953-1G |
Cas.: 116622-38-9 | Purity: 97% | (S)-2-Amino-4-cyclohexylbutanoic acid | ESD-896953-5G |
Cas.: 116622-38-9 | Purity: 97% | (S)-2-Amino-4-cyclohexylbutanoic acid | ESD-896953-10G |
Cas.: 1211526-51-0 | Purity: 95% | 5-Bromo-2-methyl-3-(trifluoromethyl)pyridine | ESD-896954-250MG |
Cas.: 1211526-51-0 | Purity: 95% | 5-Bromo-2-methyl-3-(trifluoromethyl)pyridine | ESD-896954-1G |
Cas.: 1211526-51-0 | Purity: 95% | 5-Bromo-2-methyl-3-(trifluoromethyl)pyridine | ESD-896954-5G |
Cas.: 1211526-51-0 | Purity: 95% | 5-Bromo-2-methyl-3-(trifluoromethyl)pyridine | ESD-896954-10G |
Cas.: 78222-69-2 | Purity: 98% | 2,4-Dibromobenzonitrile | ESD-896955-250MG |
Cas.: 78222-69-2 | Purity: 98% | 2,4-Dibromobenzonitrile | ESD-896955-1G |
Cas.: 78222-69-2 | Purity: 98% | 2,4-Dibromobenzonitrile | ESD-896955-5G |
Cas.: 78222-69-2 | Purity: 98% | 2,4-Dibromobenzonitrile | ESD-896955-10G |
Cas.: 51984-62-4 | Purity: 98% | 3-Chloro-2-methyl-5-nitropyridine | ESD-896956-250MG |
Cas.: 51984-62-4 | Purity: 98% | 3-Chloro-2-methyl-5-nitropyridine | ESD-896956-1G |
Cas.: 51984-62-4 | Purity: 98% | 3-Chloro-2-methyl-5-nitropyridine | ESD-896956-5G |
Cas.: 51984-62-4 | Purity: 98% | 3-Chloro-2-methyl-5-nitropyridine | ESD-896956-10G |
Cas.: 16250-08-1 | Purity: 97% | 6-Aminopyridine-3-sulfonic acid | ESD-896957-250MG |
Cas.: 16250-08-1 | Purity: 97% | 6-Aminopyridine-3-sulfonic acid | ESD-896957-1G |
Cas.: 16250-08-1 | Purity: 97% | 6-Aminopyridine-3-sulfonic acid | ESD-896957-5G |
Cas.: 16250-08-1 | Purity: 97% | 6-Aminopyridine-3-sulfonic acid | ESD-896957-10G |
Cas.: 933585-42-3 | Purity: ≥95% | Ethyl 4-bromo-3-methoxybenzoate | ESD-896958-250MG |
Cas.: 933585-42-3 | Purity: ≥95% | Ethyl 4-bromo-3-methoxybenzoate | ESD-896958-1G |
Cas.: 933585-42-3 | Purity: ≥95% | Ethyl 4-bromo-3-methoxybenzoate | ESD-896958-5G |
Cas.: 933585-42-3 | Purity: ≥95% | Ethyl 4-bromo-3-methoxybenzoate | ESD-896958-10G |
Cas.: 65581-25-1 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate | ESD-896959-250MG |
Cas.: 65581-25-1 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate | ESD-896959-1G |
Cas.: 65581-25-1 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate | ESD-896959-5G |
Cas.: 65581-25-1 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate | ESD-896959-10G |
Cas.: 75932-02-4 | Purity: 96% | Fmoc-D-Lys(Fmoc)-OH | ESD-896960-250MG |
Cas.: 75932-02-4 | Purity: 96% | Fmoc-D-Lys(Fmoc)-OH | ESD-896960-1G |
Cas.: 75932-02-4 | Purity: 96% | Fmoc-D-Lys(Fmoc)-OH | ESD-896960-5G |
Cas.: 75932-02-4 | Purity: 96% | Fmoc-D-Lys(Fmoc)-OH | ESD-896960-10G |
Cas.: 37585-16-3 | Purity: ≥97% | (2-Amino-4-chlorophenyl)methanol | ESD-896961-250MG |
Cas.: 37585-16-3 | Purity: ≥97% | (2-Amino-4-chlorophenyl)methanol | ESD-896961-1G |
Cas.: 37585-16-3 | Purity: ≥97% | (2-Amino-4-chlorophenyl)methanol | ESD-896961-5G |
Cas.: 37585-16-3 | Purity: ≥97% | (2-Amino-4-chlorophenyl)methanol | ESD-896961-10G |
Cas.: 133565-45-4 | Purity: ≥95% | Fmoc-Asp(OtBu)-OL | ESD-896962-250MG |
Cas.: 133565-45-4 | Purity: ≥95% | Fmoc-Asp(OtBu)-OL | ESD-896962-1G |
Cas.: 133565-45-4 | Purity: ≥95% | Fmoc-Asp(OtBu)-OL | ESD-896962-5G |
Cas.: 133565-45-4 | Purity: ≥95% | Fmoc-Asp(OtBu)-OL | ESD-896962-10G |
Cas.: 171557-31-6 | Purity: 97% | 2-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)acetic acid | ESD-896963-250MG |
Cas.: 171557-31-6 | Purity: 97% | 2-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)acetic acid | ESD-896963-1G |
Cas.: 171557-31-6 | Purity: 97% | 2-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)acetic acid | ESD-896963-5G |
Cas.: 171557-31-6 | Purity: 97% | 2-(Bis(2-(tert-butoxy)-2-oxoethyl)amino)acetic acid | ESD-896963-10G |
Cas.: 2463-16-3 | Purity: 98% | Ethyl 3-cyanobenzoate | ESD-896964-250MG |
Cas.: 2463-16-3 | Purity: 98% | Ethyl 3-cyanobenzoate | ESD-896964-1G |
Cas.: 2463-16-3 | Purity: 98% | Ethyl 3-cyanobenzoate | ESD-896964-5G |
Cas.: 2463-16-3 | Purity: 98% | Ethyl 3-cyanobenzoate | ESD-896964-10G |
Cas.: 1052538-72-3 | Purity: ≥95% | 3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride | ESD-896965-250MG |
Cas.: 1052538-72-3 | Purity: ≥95% | 3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride | ESD-896965-1G |
Cas.: 1052538-72-3 | Purity: ≥95% | 3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride | ESD-896965-5G |
Cas.: 1052538-72-3 | Purity: ≥95% | 3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride | ESD-896965-10G |
Cas.: 34582-30-4 | Purity: 97% | (S)-1-tert-Butyl 4-methyl 2-aminosuccinate hydrochloride | ESD-896966-250MG |
Cas.: 34582-30-4 | Purity: 97% | (S)-1-tert-Butyl 4-methyl 2-aminosuccinate hydrochloride | ESD-896966-1G |
Cas.: 34582-30-4 | Purity: 97% | (S)-1-tert-Butyl 4-methyl 2-aminosuccinate hydrochloride | ESD-896966-5G |
Cas.: 34582-30-4 | Purity: 97% | (S)-1-tert-Butyl 4-methyl 2-aminosuccinate hydrochloride | ESD-896966-10G |
Cas.: 853909-08-7 | Purity: 97% | 5-Ethynyl-2-fluoropyridine | ESD-896967-250MG |
Cas.: 853909-08-7 | Purity: 97% | 5-Ethynyl-2-fluoropyridine | ESD-896967-1G |
Cas.: 853909-08-7 | Purity: 97% | 5-Ethynyl-2-fluoropyridine | ESD-896967-5G |
Cas.: 853909-08-7 | Purity: 97% | 5-Ethynyl-2-fluoropyridine | ESD-896967-10G |
Cas.: 220526-76-1 | Purity: ≥95% | (5-Chlorobenzofuran-2-yl)(4-methoxyphenyl)methanone | ESD-896968-250MG |
Cas.: 220526-76-1 | Purity: ≥95% | (5-Chlorobenzofuran-2-yl)(4-methoxyphenyl)methanone | ESD-896968-1G |
Cas.: 144644-00-8 | Purity: 98% | HD-Cha-OMe.HCl | ESD-896969-250MG |
Cas.: 144644-00-8 | Purity: 98% | HD-Cha-OMe.HCl | ESD-896969-1G |
Cas.: 144644-00-8 | Purity: 98% | HD-Cha-OMe.HCl | ESD-896969-5G |
Cas.: 144644-00-8 | Purity: 98% | HD-Cha-OMe.HCl | ESD-896969-10G |
Cas.: 52221-07-5 | Purity: 97% | 6-(tert-Butoxy)-6-oxohexanoic acid | ESD-896970-250MG |
Cas.: 52221-07-5 | Purity: 97% | 6-(tert-Butoxy)-6-oxohexanoic acid | ESD-896970-1G |
Cas.: 52221-07-5 | Purity: 97% | 6-(tert-Butoxy)-6-oxohexanoic acid | ESD-896970-5G |
Cas.: 52221-07-5 | Purity: 97% | 6-(tert-Butoxy)-6-oxohexanoic acid | ESD-896970-10G |
Cas.: 106014-21-5 | Purity: 96% | Dimethyl 3-chloropyridine-2,5-dicarboxylate | ESD-896971-250MG |
Cas.: 106014-21-5 | Purity: 96% | Dimethyl 3-chloropyridine-2,5-dicarboxylate | ESD-896971-1G |
Cas.: 106014-21-5 | Purity: 96% | Dimethyl 3-chloropyridine-2,5-dicarboxylate | ESD-896971-5G |
Cas.: 106014-21-5 | Purity: 96% | Dimethyl 3-chloropyridine-2,5-dicarboxylate | ESD-896971-10G |
Cas.: 645411-16-1 | Purity: 97% | 3-(Methylamino)-1-(thiophen-2-yl)propan-1-one hydrochloride | ESD-896972-250MG |
Cas.: 645411-16-1 | Purity: 97% | 3-(Methylamino)-1-(thiophen-2-yl)propan-1-one hydrochloride | ESD-896972-1G |
Cas.: 645411-16-1 | Purity: 97% | 3-(Methylamino)-1-(thiophen-2-yl)propan-1-one hydrochloride | ESD-896972-5G |
Cas.: 243469-66-1 | Purity: 97% | 6-Methoxy-4-methylnicotinonitrile | ESD-896973-250MG |
Cas.: 243469-66-1 | Purity: 97% | 6-Methoxy-4-methylnicotinonitrile | ESD-896973-1G |
Cas.: 243469-66-1 | Purity: 97% | 6-Methoxy-4-methylnicotinonitrile | ESD-896973-5G |
Cas.: 243469-66-1 | Purity: 97% | 6-Methoxy-4-methylnicotinonitrile | ESD-896973-10G |
Cas.: 117738-81-5 | Purity: 97% | Methyl 4-bromo-3,5-dichlorobenzoate | ESD-896974-250MG |
Cas.: 117738-81-5 | Purity: 97% | Methyl 4-bromo-3,5-dichlorobenzoate | ESD-896974-1G |
Cas.: 117738-81-5 | Purity: 97% | Methyl 4-bromo-3,5-dichlorobenzoate | ESD-896974-5G |
Cas.: 117738-81-5 | Purity: 97% | Methyl 4-bromo-3,5-dichlorobenzoate | ESD-896974-10G |
Cas.: 1807135-08-5 | Purity: 95% | 2-Bromo-1,5-difluoro-3-methylbenzene | ESD-896975-250MG |
Cas.: 1807135-08-5 | Purity: 95% | 2-Bromo-1,5-difluoro-3-methylbenzene | ESD-896975-1G |
Cas.: 1807135-08-5 | Purity: 95% | 2-Bromo-1,5-difluoro-3-methylbenzene | ESD-896975-5G |
Cas.: 1807135-08-5 | Purity: 95% | 2-Bromo-1,5-difluoro-3-methylbenzene | ESD-896975-10G |
Cas.: 69189-19-1 | Purity: 97% | 4-Bromo-1,2-bis(bromomethyl)benzene | ESD-896976-250MG |
Cas.: 69189-19-1 | Purity: 97% | 4-Bromo-1,2-bis(bromomethyl)benzene | ESD-896976-1G |
Cas.: 69189-19-1 | Purity: 97% | 4-Bromo-1,2-bis(bromomethyl)benzene | ESD-896976-5G |
Cas.: 69189-19-1 | Purity: 97% | 4-Bromo-1,2-bis(bromomethyl)benzene | ESD-896976-10G |
Cas.: 195505-47-6 | Purity: 97% | Ethyl 2-(benzo[c][1,2,5]thiadiazol-5-yl)acetate | ESD-896977-250MG |
Cas.: 195505-47-6 | Purity: 97% | Ethyl 2-(benzo[c][1,2,5]thiadiazol-5-yl)acetate | ESD-896977-1G |
Cas.: 195505-47-6 | Purity: 97% | Ethyl 2-(benzo[c][1,2,5]thiadiazol-5-yl)acetate | ESD-896977-5G |
Cas.: 195505-47-6 | Purity: 97% | Ethyl 2-(benzo[c][1,2,5]thiadiazol-5-yl)acetate | ESD-896977-10G |
Cas.: 197892-69-6 | Purity: 97% | (E)-4-(Piperidin-1-yl)but-2-enoic acid hydrochloride | ESD-896978-250MG |
Cas.: 197892-69-6 | Purity: 97% | (E)-4-(Piperidin-1-yl)but-2-enoic acid hydrochloride | ESD-896978-1G |
Cas.: 197892-69-6 | Purity: 97% | (E)-4-(Piperidin-1-yl)but-2-enoic acid hydrochloride | ESD-896978-5G |
Cas.: 197892-69-6 | Purity: 97% | (E)-4-(Piperidin-1-yl)but-2-enoic acid hydrochloride | ESD-896978-10G |
Cas.: 23123-19-5 | Purity: ≥95% | 1-(3-Hydroxypyrrolidin-1-yl)ethanone | ESD-896979-250MG |
Cas.: 23123-19-5 | Purity: ≥95% | 1-(3-Hydroxypyrrolidin-1-yl)ethanone | ESD-896979-1G |
Cas.: 23123-19-5 | Purity: ≥95% | 1-(3-Hydroxypyrrolidin-1-yl)ethanone | ESD-896979-5G |
Cas.: 23123-19-5 | Purity: ≥95% | 1-(3-Hydroxypyrrolidin-1-yl)ethanone | ESD-896979-10G |
Cas.: 1429056-25-6 | Purity: ≥95% | 6-Hydroxy-5-iodopyrimidin-4(3H)-one | ESD-896980-250MG |
Cas.: 1429056-25-6 | Purity: ≥95% | 6-Hydroxy-5-iodopyrimidin-4(3H)-one | ESD-896980-1G |
Cas.: 1429056-25-6 | Purity: ≥95% | 6-Hydroxy-5-iodopyrimidin-4(3H)-one | ESD-896980-5G |
Cas.: 1429056-25-6 | Purity: ≥95% | 6-Hydroxy-5-iodopyrimidin-4(3H)-one | ESD-896980-10G |
Cas.: 169045-12-9 | Purity: ≥95% | (6-Methoxypyridin-3-yl)methanamine dihydrochloride | ESD-896981-250MG |
Cas.: 169045-12-9 | Purity: ≥95% | (6-Methoxypyridin-3-yl)methanamine dihydrochloride | ESD-896981-1G |
Cas.: 169045-12-9 | Purity: ≥95% | (6-Methoxypyridin-3-yl)methanamine dihydrochloride | ESD-896981-5G |
Cas.: 169045-12-9 | Purity: ≥95% | (6-Methoxypyridin-3-yl)methanamine dihydrochloride | ESD-896981-10G |
Cas.: 174132-32-2 | Purity: 97% | 1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-896982-250MG |
Cas.: 174132-32-2 | Purity: 97% | 1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-896982-1G |
Cas.: 174132-32-2 | Purity: 97% | 1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-896982-5G |
Cas.: 174132-32-2 | Purity: 97% | 1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-896982-10G |
Cas.: 210095-58-2 | Purity: 97% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate | ESD-896983-250MG |
Cas.: 210095-58-2 | Purity: 97% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate | ESD-896983-1G |
Cas.: 210095-58-2 | Purity: 97% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate | ESD-896983-5G |
Cas.: 210095-58-2 | Purity: 97% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate | ESD-896983-10G |
Cas.: 855400-82-7 | Purity: 95% | 5-Bromo-4-chloro-2-nitrophenol | ESD-896984-250MG |
Cas.: 855400-82-7 | Purity: 95% | 5-Bromo-4-chloro-2-nitrophenol | ESD-896984-1G |
Cas.: 855400-82-7 | Purity: 95% | 5-Bromo-4-chloro-2-nitrophenol | ESD-896984-5G |
Cas.: 855400-82-7 | Purity: 95% | 5-Bromo-4-chloro-2-nitrophenol | ESD-896984-10G |
Cas.: 908581-18-0 | Purity: ≥95% | Methyl 6-bromoimidazo[1,2-a]pyridine-8-carboxylate | ESD-896985-250MG |
Cas.: 908581-18-0 | Purity: ≥95% | Methyl 6-bromoimidazo[1,2-a]pyridine-8-carboxylate | ESD-896985-1G |
Cas.: 908581-18-0 | Purity: ≥95% | Methyl 6-bromoimidazo[1,2-a]pyridine-8-carboxylate | ESD-896985-5G |
Cas.: 908581-18-0 | Purity: ≥95% | Methyl 6-bromoimidazo[1,2-a]pyridine-8-carboxylate | ESD-896985-10G |
Cas.: 14328-62-2 | Purity: 97% | (S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride | ESD-896986-250MG |
Cas.: 14328-62-2 | Purity: 97% | (S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride | ESD-896986-1G |
Cas.: 14328-62-2 | Purity: 97% | (S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride | ESD-896986-5G |
Cas.: 14328-62-2 | Purity: 97% | (S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride | ESD-896986-10G |
Cas.: 5751-52-0 | Purity: 98% | 7-Methoxy-4H-chromen-4-one | ESD-896987-250MG |
Cas.: 5751-52-0 | Purity: 98% | 7-Methoxy-4H-chromen-4-one | ESD-896987-1G |
Cas.: 5751-52-0 | Purity: 98% | 7-Methoxy-4H-chromen-4-one | ESD-896987-5G |
Cas.: 5751-52-0 | Purity: 98% | 7-Methoxy-4H-chromen-4-one | ESD-896987-10G |
Cas.: 19231-06-2 | Purity: ≥95% | Bis(4-methoxyphenyl)iodonium bromide | ESD-896988-250MG |
Cas.: 19231-06-2 | Purity: ≥95% | Bis(4-methoxyphenyl)iodonium bromide | ESD-896988-1G |
Cas.: 19231-06-2 | Purity: ≥95% | Bis(4-methoxyphenyl)iodonium bromide | ESD-896988-5G |
Cas.: 19231-06-2 | Purity: ≥95% | Bis(4-methoxyphenyl)iodonium bromide | ESD-896988-10G |
Cas.: 3415-08-5 | Purity: 97% | (S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione | ESD-896989-250MG |
Cas.: 3415-08-5 | Purity: 97% | (S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione | ESD-896989-1G |
Cas.: 3415-08-5 | Purity: 97% | (S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione | ESD-896989-5G |
Cas.: 3415-08-5 | Purity: 97% | (S)-4-(4-Hydroxybenzyl)oxazolidine-2,5-dione | ESD-896989-10G |
Cas.: 172281-90-2 | Purity: ≥95% | N,N-Dimethylpiperidin-4-amine hydrochloride | ESD-896990-250MG |
Cas.: 172281-90-2 | Purity: ≥95% | N,N-Dimethylpiperidin-4-amine hydrochloride | ESD-896990-1G |
Cas.: 172281-90-2 | Purity: ≥95% | N,N-Dimethylpiperidin-4-amine hydrochloride | ESD-896990-5G |
Cas.: 172281-90-2 | Purity: ≥95% | N,N-Dimethylpiperidin-4-amine hydrochloride | ESD-896990-10G |
Cas.: 1413945-87-5 | Purity: 97% | 2-(Dimethylamino)acetaldehyde sulfite | ESD-896991-250MG |
Cas.: 1413945-87-5 | Purity: 97% | 2-(Dimethylamino)acetaldehyde sulfite | ESD-896991-1G |
Cas.: 1413945-87-5 | Purity: 97% | 2-(Dimethylamino)acetaldehyde sulfite | ESD-896991-5G |
Cas.: 1413945-87-5 | Purity: 97% | 2-(Dimethylamino)acetaldehyde sulfite | ESD-896991-10G |
Cas.: 1175536-50-1 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate | ESD-896992-250MG |
Cas.: 1175536-50-1 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate | ESD-896992-1G |
Cas.: 1175536-50-1 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate | ESD-896992-5G |
Cas.: 1175536-50-1 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate | ESD-896992-10G |
Cas.: 1261802-66-7 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridin-2-ol | ESD-896993-250MG |
Cas.: 1261802-66-7 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridin-2-ol | ESD-896993-1G |
Cas.: 1261802-66-7 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridin-2-ol | ESD-896993-5G |
Cas.: 1261802-66-7 | Purity: ≥95% | 1H-Pyrrolo[2,3-b]pyridin-2-ol | ESD-896993-10G |
Cas.: 152312-71-5 | Purity: 97% | Potassium 2-hydroxy-4-methoxybenzoate | ESD-896994-250MG |
Cas.: 152312-71-5 | Purity: 97% | Potassium 2-hydroxy-4-methoxybenzoate | ESD-896994-1G |
Cas.: 152312-71-5 | Purity: 97% | Potassium 2-hydroxy-4-methoxybenzoate | ESD-896994-5G |
Cas.: 152312-71-5 | Purity: 97% | Potassium 2-hydroxy-4-methoxybenzoate | ESD-896994-10G |
Cas.: 64282-12-8 | Purity: 97% | Methyl 2-amino-3-(4-fluorophenyl)propanoate hydrochloride | ESD-896995-250MG |
Cas.: 64282-12-8 | Purity: 97% | Methyl 2-amino-3-(4-fluorophenyl)propanoate hydrochloride | ESD-896995-1G |
Cas.: 64282-12-8 | Purity: 97% | Methyl 2-amino-3-(4-fluorophenyl)propanoate hydrochloride | ESD-896995-5G |
Cas.: 64282-12-8 | Purity: 97% | Methyl 2-amino-3-(4-fluorophenyl)propanoate hydrochloride | ESD-896995-10G |
Cas.: 18368-61-1 | Purity: ≥95% | 2-Methyl-6-nitropyridine | ESD-896996-250MG |
Cas.: 18368-61-1 | Purity: ≥95% | 2-Methyl-6-nitropyridine | ESD-896996-1G |
Cas.: 18368-61-1 | Purity: ≥95% | 2-Methyl-6-nitropyridine | ESD-896996-5G |
Cas.: 18368-61-1 | Purity: ≥95% | 2-Methyl-6-nitropyridine | ESD-896996-10G |
Cas.: 131852-54-5 | Purity: 97% | (S)-1-Benzylpyrrolidin-3-amine dihydrochloride | ESD-896997-250MG |
Cas.: 131852-54-5 | Purity: 97% | (S)-1-Benzylpyrrolidin-3-amine dihydrochloride | ESD-896997-1G |
Cas.: 131852-54-5 | Purity: 97% | (S)-1-Benzylpyrrolidin-3-amine dihydrochloride | ESD-896997-5G |
Cas.: 131852-54-5 | Purity: 97% | (S)-1-Benzylpyrrolidin-3-amine dihydrochloride | ESD-896997-10G |
Cas.: 438197-19-4 | Purity: ≥95% | 2,3-Dichlorobenzohydrazide | ESD-896998-250MG |
Cas.: 438197-19-4 | Purity: ≥95% | 2,3-Dichlorobenzohydrazide | ESD-896998-1G |
Cas.: 438197-19-4 | Purity: ≥95% | 2,3-Dichlorobenzohydrazide | ESD-896998-5G |
Cas.: 438197-19-4 | Purity: ≥95% | 2,3-Dichlorobenzohydrazide | ESD-896998-10G |
Cas.: 1664-62-6 | Purity: 97% | Methyl 3-(2-aminophenyl)acrylate | ESD-896999-250MG |
Cas.: 1664-62-6 | Purity: 97% | Methyl 3-(2-aminophenyl)acrylate | ESD-896999-1G |
Cas.: 1664-62-6 | Purity: 97% | Methyl 3-(2-aminophenyl)acrylate | ESD-896999-5G |
Cas.: 1664-62-6 | Purity: 97% | Methyl 3-(2-aminophenyl)acrylate | ESD-896999-10G |
Cas.: 113336-23-5 | Purity: 95% | 2-(4-Chloro-1H-pyrazol-1-yl)acetonitrile | ESD-897000-250MG |
Cas.: 113336-23-5 | Purity: 95% | 2-(4-Chloro-1H-pyrazol-1-yl)acetonitrile | ESD-897000-1G |
Cas.: 113336-23-5 | Purity: 95% | 2-(4-Chloro-1H-pyrazol-1-yl)acetonitrile | ESD-897000-5G |
Cas.: 113336-23-5 | Purity: 95% | 2-(4-Chloro-1H-pyrazol-1-yl)acetonitrile | ESD-897000-10G |
Cas.: 146346-81-8 | Purity: 97% | Fmoc-Ser(TBDMS)-OH | ESD-897001-250MG |
Cas.: 146346-81-8 | Purity: 97% | Fmoc-Ser(TBDMS)-OH | ESD-897001-1G |
Cas.: 146346-81-8 | Purity: 97% | Fmoc-Ser(TBDMS)-OH | ESD-897001-5G |
Cas.: 146346-81-8 | Purity: 97% | Fmoc-Ser(TBDMS)-OH | ESD-897001-10G |
Cas.: 142186-36-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-fluorophenyl)acetic acid | ESD-897002-250MG |
Cas.: 142186-36-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-fluorophenyl)acetic acid | ESD-897002-1G |
Cas.: 142186-36-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-fluorophenyl)acetic acid | ESD-897002-5G |
Cas.: 142186-36-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-fluorophenyl)acetic acid | ESD-897002-10G |
Cas.: 204070-00-8 | Purity: ≥95% | Boc-Arg HCl H2O | ESD-897003-250MG |
Cas.: 204070-00-8 | Purity: ≥95% | Boc-Arg HCl H2O | ESD-897003-1G |
Cas.: 204070-00-8 | Purity: ≥95% | Boc-Arg HCl H2O | ESD-897003-5G |
Cas.: 204070-00-8 | Purity: ≥95% | Boc-Arg HCl H2O | ESD-897003-10G |
Cas.: 1214375-24-2 | Purity: 97% | Methyl 5,6-dichloropicolinate | ESD-897004-250MG |
Cas.: 1214375-24-2 | Purity: 97% | Methyl 5,6-dichloropicolinate | ESD-897004-1G |
Cas.: 1214375-24-2 | Purity: 97% | Methyl 5,6-dichloropicolinate | ESD-897004-5G |
Cas.: 1214375-24-2 | Purity: 97% | Methyl 5,6-dichloropicolinate | ESD-897004-10G |
Cas.: 17090-15-2 | Purity: 97% | N-(3-Nitrophenyl)acrylamide | ESD-897005-250MG |
Cas.: 17090-15-2 | Purity: 97% | N-(3-Nitrophenyl)acrylamide | ESD-897005-1G |
Cas.: 17090-15-2 | Purity: 97% | N-(3-Nitrophenyl)acrylamide | ESD-897005-5G |
Cas.: 17090-15-2 | Purity: 97% | N-(3-Nitrophenyl)acrylamide | ESD-897005-10G |
Cas.: 446286-94-8 | Purity: ≥95% | 5-Bromo-N,N-dimethylpyrazin-2-amine | ESD-897006-250MG |
Cas.: 446286-94-8 | Purity: ≥95% | 5-Bromo-N,N-dimethylpyrazin-2-amine | ESD-897006-1G |
Cas.: 446286-94-8 | Purity: ≥95% | 5-Bromo-N,N-dimethylpyrazin-2-amine | ESD-897006-5G |
Cas.: 446286-94-8 | Purity: ≥95% | 5-Bromo-N,N-dimethylpyrazin-2-amine | ESD-897006-10G |
Cas.: 102170-53-6 | Purity: ≥95% | 4-Bromo-5-chloro-2-methoxyaniline | ESD-897007-250MG |
Cas.: 102170-53-6 | Purity: ≥95% | 4-Bromo-5-chloro-2-methoxyaniline | ESD-897007-1G |
Cas.: 102170-53-6 | Purity: ≥95% | 4-Bromo-5-chloro-2-methoxyaniline | ESD-897007-5G |
Cas.: 102170-53-6 | Purity: ≥95% | 4-Bromo-5-chloro-2-methoxyaniline | ESD-897007-10G |
Cas.: 751470-47-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-sulfopropanoic acid | ESD-897008-250MG |
Cas.: 751470-47-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-sulfopropanoic acid | ESD-897008-1G |
Cas.: 751470-47-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-sulfopropanoic acid | ESD-897008-5G |
Cas.: 751470-47-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-sulfopropanoic acid | ESD-897008-10G |
Cas.: 200190-89-2 | Purity: 97% | Z-Arg(Pbf)-OH.CHA | ESD-897009-250MG |
Cas.: 200190-89-2 | Purity: 97% | Z-Arg(Pbf)-OH.CHA | ESD-897009-1G |
Cas.: 200190-89-2 | Purity: 97% | Z-Arg(Pbf)-OH.CHA | ESD-897009-5G |
Cas.: 200190-89-2 | Purity: 97% | Z-Arg(Pbf)-OH.CHA | ESD-897009-10G |
Cas.: 204246-17-3 | Purity: ≥95% | Fmoc-D-Asp-Oall | ESD-897010-250MG |
Cas.: 204246-17-3 | Purity: ≥95% | Fmoc-D-Asp-Oall | ESD-897010-1G |
Cas.: 204246-17-3 | Purity: ≥95% | Fmoc-D-Asp-Oall | ESD-897010-5G |
Cas.: 204246-17-3 | Purity: ≥95% | Fmoc-D-Asp-Oall | ESD-897010-10G |
Cas.: 33733-83-4 | Purity: 98% | 1-(tert-Butyl)-3-methoxybenzene | ESD-897011-250MG |
Cas.: 33733-83-4 | Purity: 98% | 1-(tert-Butyl)-3-methoxybenzene | ESD-897011-1G |
Cas.: 33733-83-4 | Purity: 98% | 1-(tert-Butyl)-3-methoxybenzene | ESD-897011-5G |
Cas.: 33733-83-4 | Purity: 98% | 1-(tert-Butyl)-3-methoxybenzene | ESD-897011-10G |
Cas.: 118684-31-4 | Purity: 97% | tert-Butyl (3-(hydroxymethyl)phenyl)carbamate | ESD-897012-250MG |
Cas.: 118684-31-4 | Purity: 97% | tert-Butyl (3-(hydroxymethyl)phenyl)carbamate | ESD-897012-1G |
Cas.: 118684-31-4 | Purity: 97% | tert-Butyl (3-(hydroxymethyl)phenyl)carbamate | ESD-897012-5G |
Cas.: 118684-31-4 | Purity: 97% | tert-Butyl (3-(hydroxymethyl)phenyl)carbamate | ESD-897012-10G |
Cas.: 10304-09-3 | Purity: 97% | Potassium 2-methoxy-2-oxoacetate | ESD-897013-250MG |
Cas.: 10304-09-3 | Purity: 97% | Potassium 2-methoxy-2-oxoacetate | ESD-897013-1G |
Cas.: 10304-09-3 | Purity: 97% | Potassium 2-methoxy-2-oxoacetate | ESD-897013-5G |
Cas.: 10304-09-3 | Purity: 97% | Potassium 2-methoxy-2-oxoacetate | ESD-897013-10G |
Cas.: 69304-45-6 | Purity: 97% | (6AR,8R,9R,9aS)-8-(6-amino-9H-purin-9-yl)-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3 ,5,2,4]trioxadisilocin-9-ol | ESD-897014-250MG |
Cas.: 69304-45-6 | Purity: 97% | (6AR,8R,9R,9aS)-8-(6-amino-9H-purin-9-yl)-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3 ,5,2,4]trioxadisilocin-9-ol | ESD-897014-1G |
Cas.: 69304-45-6 | Purity: 97% | (6AR,8R,9R,9aS)-8-(6-amino-9H-purin-9-yl)-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3 ,5,2,4]trioxadisilocin-9-ol | ESD-897014-5G |
Cas.: 69304-45-6 | Purity: 97% | (6AR,8R,9R,9aS)-8-(6-amino-9H-purin-9-yl)-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3 ,5,2,4]trioxadisilocin-9-ol | ESD-897014-10G |
Cas.: 368443-82-7 | Purity: 97% | Fmoc-D-Asp-OMe | ESD-897015-250MG |
Cas.: 368443-82-7 | Purity: 97% | Fmoc-D-Asp-OMe | ESD-897015-1G |
Cas.: 368443-82-7 | Purity: 97% | Fmoc-D-Asp-OMe | ESD-897015-5G |
Cas.: 368443-82-7 | Purity: 97% | Fmoc-D-Asp-OMe | ESD-897015-10G |
Cas.: 58123-62-9 | Purity: 97% | (R)-1-Methylpyrrolidine-2-carboxylic acid | ESD-897016-250MG |
Cas.: 58123-62-9 | Purity: 97% | (R)-1-Methylpyrrolidine-2-carboxylic acid | ESD-897016-1G |
Cas.: 58123-62-9 | Purity: 97% | (R)-1-Methylpyrrolidine-2-carboxylic acid | ESD-897016-5G |
Cas.: 58123-62-9 | Purity: 97% | (R)-1-Methylpyrrolidine-2-carboxylic acid | ESD-897016-10G |
Cas.: 147034-01-3 | Purity: 98% | (2,5-Dibromophenyl)methanol | ESD-897017-250MG |
Cas.: 147034-01-3 | Purity: 98% | (2,5-Dibromophenyl)methanol | ESD-897017-1G |
Cas.: 147034-01-3 | Purity: 98% | (2,5-Dibromophenyl)methanol | ESD-897017-5G |
Cas.: 147034-01-3 | Purity: 98% | (2,5-Dibromophenyl)methanol | ESD-897017-10G |
Cas.: 119483-45-3 | Purity: 97% | (S)-tert-Butyl 2-amino-3,3-dimethylbutanoate hydrochloride | ESD-897018-250MG |
Cas.: 119483-45-3 | Purity: 97% | (S)-tert-Butyl 2-amino-3,3-dimethylbutanoate hydrochloride | ESD-897018-1G |
Cas.: 119483-45-3 | Purity: 97% | (S)-tert-Butyl 2-amino-3,3-dimethylbutanoate hydrochloride | ESD-897018-5G |
Cas.: 119483-45-3 | Purity: 97% | (S)-tert-Butyl 2-amino-3,3-dimethylbutanoate hydrochloride | ESD-897018-10G |
Cas.: 26562-81-2 | Purity: 97% | Adamantane-1,3-diamine dihydrochloride | ESD-897019-250MG |
Cas.: 26562-81-2 | Purity: 97% | Adamantane-1,3-diamine dihydrochloride | ESD-897019-1G |
Cas.: 26562-81-2 | Purity: 97% | Adamantane-1,3-diamine dihydrochloride | ESD-897019-5G |
Cas.: 26562-81-2 | Purity: 97% | Adamantane-1,3-diamine dihydrochloride | ESD-897019-10G |
Cas.: 1280210-79-8 | Purity: 97% | tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-897020-250MG |
Cas.: 1280210-79-8 | Purity: 97% | tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-897020-1G |
Cas.: 1280210-79-8 | Purity: 97% | tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-897020-5G |
Cas.: 1280210-79-8 | Purity: 97% | tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-897020-10G |
Cas.: 139592-37-3 | Purity: 97% | (Fmoc-Cys-Otbu)2 | ESD-897021-250MG |
Cas.: 139592-37-3 | Purity: 97% | (Fmoc-Cys-Otbu)2 | ESD-897021-1G |
Cas.: 139592-37-3 | Purity: 97% | (Fmoc-Cys-Otbu)2 | ESD-897021-5G |
Cas.: 139592-37-3 | Purity: 97% | (Fmoc-Cys-Otbu)2 | ESD-897021-10G |
Cas.: 3339-43-3 | Purity: 97% | (2S,3S)-Methyl 3-methyl-2-(methylamino)pentanoate hydrochloride | ESD-897022-250MG |
Cas.: 3339-43-3 | Purity: 97% | (2S,3S)-Methyl 3-methyl-2-(methylamino)pentanoate hydrochloride | ESD-897022-1G |
Cas.: 3339-43-3 | Purity: 97% | (2S,3S)-Methyl 3-methyl-2-(methylamino)pentanoate hydrochloride | ESD-897022-5G |
Cas.: 3339-43-3 | Purity: 97% | (2S,3S)-Methyl 3-methyl-2-(methylamino)pentanoate hydrochloride | ESD-897022-10G |
Cas.: 2182-39-0 | Purity: ≥95% | 2-(Phenylamino)propanenitrile | ESD-897023-250MG |
Cas.: 2182-39-0 | Purity: ≥95% | 2-(Phenylamino)propanenitrile | ESD-897023-1G |
Cas.: 2182-39-0 | Purity: ≥95% | 2-(Phenylamino)propanenitrile | ESD-897023-5G |
Cas.: 2182-39-0 | Purity: ≥95% | 2-(Phenylamino)propanenitrile | ESD-897023-10G |
Cas.: 24006-09-5 | Purity: ≥95% | Mesiylhydrazine hydrochloride | ESD-897024-250MG |
Cas.: 24006-09-5 | Purity: ≥95% | Mesiylhydrazine hydrochloride | ESD-897024-1G |
Cas.: 24006-09-5 | Purity: ≥95% | Mesiylhydrazine hydrochloride | ESD-897024-5G |
Cas.: 24006-09-5 | Purity: ≥95% | Mesiylhydrazine hydrochloride | ESD-897024-10G |
Cas.: 882772-99-8 | Purity: 97% | 3-Bromo-2-nitrobenzaldehyde | ESD-897025-250MG |
Cas.: 882772-99-8 | Purity: 97% | 3-Bromo-2-nitrobenzaldehyde | ESD-897025-1G |
Cas.: 882772-99-8 | Purity: 97% | 3-Bromo-2-nitrobenzaldehyde | ESD-897025-5G |
Cas.: 882772-99-8 | Purity: 97% | 3-Bromo-2-nitrobenzaldehyde | ESD-897025-10G |
Cas.: 147751-16-4 | Purity: 97% | tert-Butyl methylsulfonylcarbamate | ESD-897026-250MG |
Cas.: 147751-16-4 | Purity: 97% | tert-Butyl methylsulfonylcarbamate | ESD-897026-1G |
Cas.: 147751-16-4 | Purity: 97% | tert-Butyl methylsulfonylcarbamate | ESD-897026-5G |
Cas.: 147751-16-4 | Purity: 97% | tert-Butyl methylsulfonylcarbamate | ESD-897026-10G |
Cas.: 184970-28-3 | Purity: 95% | 4-Bromo-2-(bromomethyl)-1-methoxybenzene | ESD-897027-250MG |
Cas.: 184970-28-3 | Purity: 95% | 4-Bromo-2-(bromomethyl)-1-methoxybenzene | ESD-897027-1G |
Cas.: 184970-28-3 | Purity: 95% | 4-Bromo-2-(bromomethyl)-1-methoxybenzene | ESD-897027-5G |
Cas.: 184970-28-3 | Purity: 95% | 4-Bromo-2-(bromomethyl)-1-methoxybenzene | ESD-897027-10G |
Cas.: 881883-32-5 | Purity: ≥95% | 1-(2-Chloro-6-methoxyphenyl)ethanone | ESD-897028-250MG |
Cas.: 881883-32-5 | Purity: ≥95% | 1-(2-Chloro-6-methoxyphenyl)ethanone | ESD-897028-1G |
Cas.: 881883-32-5 | Purity: ≥95% | 1-(2-Chloro-6-methoxyphenyl)ethanone | ESD-897028-5G |
Cas.: 881883-32-5 | Purity: ≥95% | 1-(2-Chloro-6-methoxyphenyl)ethanone | ESD-897028-10G |
Cas.: 63516-30-3 | Purity: ≥95% | endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride | ESD-897029-250MG |
Cas.: 63516-30-3 | Purity: ≥95% | endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride | ESD-897029-1G |
Cas.: 63516-30-3 | Purity: ≥95% | endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride | ESD-897029-5G |
Cas.: 63516-30-3 | Purity: ≥95% | endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride | ESD-897029-10G |
Cas.: 89584-24-7 | Purity: ≥95% | Methyl 4-(methylamino)butanoate hcl | ESD-897030-250MG |
Cas.: 89584-24-7 | Purity: ≥95% | Methyl 4-(methylamino)butanoate hcl | ESD-897030-1G |
Cas.: 89584-24-7 | Purity: ≥95% | Methyl 4-(methylamino)butanoate hcl | ESD-897030-5G |
Cas.: 89584-24-7 | Purity: ≥95% | Methyl 4-(methylamino)butanoate hcl | ESD-897030-10G |
Cas.: 78086-72-3 | Purity: ≥95% | (4R,5S)-Methyl 2,2,5-trimethyl-1,3-dioxolane-4-carboxylate | ESD-897031-250MG |
Cas.: 78086-72-3 | Purity: ≥95% | (4R,5S)-Methyl 2,2,5-trimethyl-1,3-dioxolane-4-carboxylate | ESD-897031-1G |
Cas.: 78086-72-3 | Purity: ≥95% | (4R,5S)-Methyl 2,2,5-trimethyl-1,3-dioxolane-4-carboxylate | ESD-897031-5G |
Cas.: 78086-72-3 | Purity: ≥95% | (4R,5S)-Methyl 2,2,5-trimethyl-1,3-dioxolane-4-carboxylate | ESD-897031-10G |
Cas.: 847547-06-2 | Purity: 97% | 5-Nitro-2-(trifluoromethyl)benzoic acid | ESD-897032-250MG |
Cas.: 847547-06-2 | Purity: 97% | 5-Nitro-2-(trifluoromethyl)benzoic acid | ESD-897032-1G |
Cas.: 847547-06-2 | Purity: 97% | 5-Nitro-2-(trifluoromethyl)benzoic acid | ESD-897032-5G |
Cas.: 847547-06-2 | Purity: 97% | 5-Nitro-2-(trifluoromethyl)benzoic acid | ESD-897032-10G |
Cas.: 1072944-96-7 | Purity: ≥95% | tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-897033-250MG |
Cas.: 1072944-96-7 | Purity: ≥95% | tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-897033-1G |
Cas.: 1072944-96-7 | Purity: ≥95% | tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-897033-5G |
Cas.: 1072944-96-7 | Purity: ≥95% | tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-897033-10G |
Cas.: 675198-19-3 | Purity: 97% | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol hydrochloride | ESD-897034-250MG |
Cas.: 675198-19-3 | Purity: 97% | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol hydrochloride | ESD-897034-1G |
Cas.: 675198-19-3 | Purity: 97% | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol hydrochloride | ESD-897034-5G |
Cas.: 675198-19-3 | Purity: 97% | (4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol hydrochloride | ESD-897034-10G |
Cas.: 15846-15-8 | Purity: 95% | 4,6-Dimethoxypyrimidin-5-amine | ESD-897035-250MG |
Cas.: 15846-15-8 | Purity: 95% | 4,6-Dimethoxypyrimidin-5-amine | ESD-897035-1G |
Cas.: 15846-15-8 | Purity: 95% | 4,6-Dimethoxypyrimidin-5-amine | ESD-897035-5G |
Cas.: 15846-15-8 | Purity: 95% | 4,6-Dimethoxypyrimidin-5-amine | ESD-897035-10G |
Cas.: 1277179-33-5 | Purity: ≥95% | 2-Amino-4,6-dichloropyrimidine-5-carbonitrile | ESD-897036-250MG |
Cas.: 1277179-33-5 | Purity: ≥95% | 2-Amino-4,6-dichloropyrimidine-5-carbonitrile | ESD-897036-1G |
Cas.: 1277179-33-5 | Purity: ≥95% | 2-Amino-4,6-dichloropyrimidine-5-carbonitrile | ESD-897036-5G |
Cas.: 1277179-33-5 | Purity: ≥95% | 2-Amino-4,6-dichloropyrimidine-5-carbonitrile | ESD-897036-10G |
Cas.: 226578-51-4 | Purity: ≥95% | Levofloxacin mesylate | ESD-897037-250MG |
Cas.: 226578-51-4 | Purity: ≥95% | Levofloxacin mesylate | ESD-897037-1G |
Cas.: 226578-51-4 | Purity: ≥95% | Levofloxacin mesylate | ESD-897037-5G |
Cas.: 226578-51-4 | Purity: ≥95% | Levofloxacin mesylate | ESD-897037-10G |
Cas.: 184576-63-4 | Purity: 97% | HD-Orn(Boc)-OH | ESD-897038-250MG |
Cas.: 184576-63-4 | Purity: 97% | HD-Orn(Boc)-OH | ESD-897038-1G |
Cas.: 184576-63-4 | Purity: 97% | HD-Orn(Boc)-OH | ESD-897038-5G |
Cas.: 184576-63-4 | Purity: 97% | HD-Orn(Boc)-OH | ESD-897038-10G |
Cas.: 906811-49-2 | Purity: ≥95% | (2-Amino-3-fluorophenyl)methanol | ESD-897039-250MG |
Cas.: 906811-49-2 | Purity: ≥95% | (2-Amino-3-fluorophenyl)methanol | ESD-897039-1G |
Cas.: 906811-49-2 | Purity: ≥95% | (2-Amino-3-fluorophenyl)methanol | ESD-897039-5G |
Cas.: 906811-49-2 | Purity: ≥95% | (2-Amino-3-fluorophenyl)methanol | ESD-897039-10G |
Cas.: 186698-61-3 | Purity: ≥95% | Boc-D-Arg(Pbf)-OH | ESD-897040-250MG |
Cas.: 186698-61-3 | Purity: ≥95% | Boc-D-Arg(Pbf)-OH | ESD-897040-1G |
Cas.: 186698-61-3 | Purity: ≥95% | Boc-D-Arg(Pbf)-OH | ESD-897040-5G |
Cas.: 186698-61-3 | Purity: ≥95% | Boc-D-Arg(Pbf)-OH | ESD-897040-10G |
Cas.: 130879-62-8 | Purity: ≥95% | 3,5-Dichloropyrazin-2(1H)-one | ESD-897041-250MG |
Cas.: 130879-62-8 | Purity: ≥95% | 3,5-Dichloropyrazin-2(1H)-one | ESD-897041-1G |
Cas.: 130879-62-8 | Purity: ≥95% | 3,5-Dichloropyrazin-2(1H)-one | ESD-897041-5G |
Cas.: 130879-62-8 | Purity: ≥95% | 3,5-Dichloropyrazin-2(1H)-one | ESD-897041-10G |
Cas.: 79383-44-1 | Purity: 98% | Methyl 2-methoxy-6-methylbenzoate | ESD-897042-250MG |
Cas.: 79383-44-1 | Purity: 98% | Methyl 2-methoxy-6-methylbenzoate | ESD-897042-1G |
Cas.: 79383-44-1 | Purity: 98% | Methyl 2-methoxy-6-methylbenzoate | ESD-897042-5G |
Cas.: 79383-44-1 | Purity: 98% | Methyl 2-methoxy-6-methylbenzoate | ESD-897042-10G |
Cas.: 79996-99-9 | Purity: 97% | 1-Bromo-4-(bromomethyl)naphthalene | ESD-897043-250MG |
Cas.: 79996-99-9 | Purity: 97% | 1-Bromo-4-(bromomethyl)naphthalene | ESD-897043-1G |
Cas.: 79996-99-9 | Purity: 97% | 1-Bromo-4-(bromomethyl)naphthalene | ESD-897043-5G |
Cas.: 79996-99-9 | Purity: 97% | 1-Bromo-4-(bromomethyl)naphthalene | ESD-897043-10G |
Cas.: 1046861-20-4 | Purity: 97% | (4-Bromo-2-chlorophenyl)boronic acid | ESD-897044-250MG |
Cas.: 1046861-20-4 | Purity: 97% | (4-Bromo-2-chlorophenyl)boronic acid | ESD-897044-1G |
Cas.: 1046861-20-4 | Purity: 97% | (4-Bromo-2-chlorophenyl)boronic acid | ESD-897044-5G |
Cas.: 1046861-20-4 | Purity: 97% | (4-Bromo-2-chlorophenyl)boronic acid | ESD-897044-10G |
Cas.: 109745-15-5 | Purity: ≥95% | Fmoc-D-Glu-OtBu | ESD-897045-250MG |
Cas.: 109745-15-5 | Purity: ≥95% | Fmoc-D-Glu-OtBu | ESD-897045-1G |
Cas.: 109745-15-5 | Purity: ≥95% | Fmoc-D-Glu-OtBu | ESD-897045-5G |
Cas.: 109745-15-5 | Purity: ≥95% | Fmoc-D-Glu-OtBu | ESD-897045-10G |
Cas.: 88550-19-0 | Purity: ≥95% | 2-(Methoxymethyl)benzoic acid | ESD-897046-250MG |
Cas.: 88550-19-0 | Purity: ≥95% | 2-(Methoxymethyl)benzoic acid | ESD-897046-1G |
Cas.: 88550-19-0 | Purity: ≥95% | 2-(Methoxymethyl)benzoic acid | ESD-897046-5G |
Cas.: 88550-19-0 | Purity: ≥95% | 2-(Methoxymethyl)benzoic acid | ESD-897046-10G |
Cas.: 491833-36-4 | Purity: ≥95% | (S)-5-Phenylmorpholin-2-one hydrochloride | ESD-897047-250MG |
Cas.: 491833-36-4 | Purity: ≥95% | (S)-5-Phenylmorpholin-2-one hydrochloride | ESD-897047-1G |
Cas.: 491833-36-4 | Purity: ≥95% | (S)-5-Phenylmorpholin-2-one hydrochloride | ESD-897047-5G |
Cas.: 491833-36-4 | Purity: ≥95% | (S)-5-Phenylmorpholin-2-one hydrochloride | ESD-897047-10G |
Cas.: 1072946-45-2 | Purity: 97% | (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride | ESD-897048-250MG |
Cas.: 1072946-45-2 | Purity: 97% | (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride | ESD-897048-1G |
Cas.: 1072946-45-2 | Purity: 97% | (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride | ESD-897048-5G |
Cas.: 1072946-45-2 | Purity: 97% | (4-(Aminomethyl)-3-fluorophenyl)boronic acid hydrochloride | ESD-897048-10G |
Cas.: 209252-16-4 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-phenylbutanoic acid | ESD-897049-250MG |
Cas.: 209252-16-4 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-phenylbutanoic acid | ESD-897049-1G |
Cas.: 209252-16-4 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-phenylbutanoic acid | ESD-897049-5G |
Cas.: 209252-16-4 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-phenylbutanoic acid | ESD-897049-10G |
Cas.: 169624-67-3 | Purity: 95% | Fmoc-Phe-Gly | ESD-897050-250MG |
Cas.: 169624-67-3 | Purity: 95% | Fmoc-Phe-Gly | ESD-897050-1G |
Cas.: 169624-67-3 | Purity: 95% | Fmoc-Phe-Gly | ESD-897050-5G |
Cas.: 169624-67-3 | Purity: 95% | Fmoc-Phe-Gly | ESD-897050-10G |
Cas.: 477584-30-8 | Purity: 97% | tert-Butyl (2-hydroxycyclohexyl)carbamate | ESD-897051-250MG |
Cas.: 477584-30-8 | Purity: 97% | tert-Butyl (2-hydroxycyclohexyl)carbamate | ESD-897051-1G |
Cas.: 477584-30-8 | Purity: 97% | tert-Butyl (2-hydroxycyclohexyl)carbamate | ESD-897051-5G |
Cas.: 229009-42-1 | Purity: 97% | (4-(Piperidin-1-yl)phenyl)boronic acid | ESD-897052-250MG |
Cas.: 229009-42-1 | Purity: 97% | (4-(Piperidin-1-yl)phenyl)boronic acid | ESD-897052-1G |
Cas.: 1187932-25-7 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)ethyl)carbamate | ESD-897053-250MG |
Cas.: 1187932-25-7 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)ethyl)carbamate | ESD-897053-1G |
Cas.: 1187932-25-7 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)ethyl)carbamate | ESD-897053-5G |
Cas.: 1187932-25-7 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)ethyl)carbamate | ESD-897053-10G |
Cas.: 100487-82-9 | Purity: 97% | Methyl 2-(4-bromo-2-nitrophenyl)acetate | ESD-897054-250MG |
Cas.: 100487-82-9 | Purity: 97% | Methyl 2-(4-bromo-2-nitrophenyl)acetate | ESD-897054-1G |
Cas.: 100487-82-9 | Purity: 97% | Methyl 2-(4-bromo-2-nitrophenyl)acetate | ESD-897054-5G |
Cas.: 100487-82-9 | Purity: 97% | Methyl 2-(4-bromo-2-nitrophenyl)acetate | ESD-897054-10G |
Cas.: 439863-62-4 | Purity: 97% | (4-Fluoro-2-methylphenyl)hydrazine hydrochloride | ESD-897055-250MG |
Cas.: 439863-62-4 | Purity: 97% | (4-Fluoro-2-methylphenyl)hydrazine hydrochloride | ESD-897055-1G |
Cas.: 439863-62-4 | Purity: 97% | (4-Fluoro-2-methylphenyl)hydrazine hydrochloride | ESD-897055-5G |
Cas.: 439863-62-4 | Purity: 97% | (4-Fluoro-2-methylphenyl)hydrazine hydrochloride | ESD-897055-10G |
Cas.: 4770-39-2 | Purity: 97% | 5-Methoxyindoline hydrochloride | ESD-897056-250MG |
Cas.: 4770-39-2 | Purity: 97% | 5-Methoxyindoline hydrochloride | ESD-897056-1G |
Cas.: 4770-39-2 | Purity: 97% | 5-Methoxyindoline hydrochloride | ESD-897056-5G |
Cas.: 4770-39-2 | Purity: 97% | 5-Methoxyindoline hydrochloride | ESD-897056-10G |
Cas.: 90004-80-1 | Purity: 97% | 2-(3-Bromo-4-chlorophenyl)acetic acid | ESD-897057-250MG |
Cas.: 90004-80-1 | Purity: 97% | 2-(3-Bromo-4-chlorophenyl)acetic acid | ESD-897057-1G |
Cas.: 90004-80-1 | Purity: 97% | 2-(3-Bromo-4-chlorophenyl)acetic acid | ESD-897057-5G |
Cas.: 90004-80-1 | Purity: 97% | 2-(3-Bromo-4-chlorophenyl)acetic acid | ESD-897057-10G |
Cas.: 81246-80-2 | Purity: 97% | 5′-O-DMT-2′-TBDMS-Uridine | ESD-897058-250MG |
Cas.: 81246-80-2 | Purity: 97% | 5′-O-DMT-2′-TBDMS-Uridine | ESD-897058-1G |
Cas.: 81246-80-2 | Purity: 97% | 5′-O-DMT-2′-TBDMS-Uridine | ESD-897058-5G |
Cas.: 81246-80-2 | Purity: 97% | 5′-O-DMT-2′-TBDMS-Uridine | ESD-897058-10G |
Cas.: 1189653-33-5 | Purity: ≥95% | 4-(2-Fluoro-4-nitrophenoxy)piperidine hydrochloride | ESD-897059-250MG |
Cas.: 1189653-33-5 | Purity: ≥95% | 4-(2-Fluoro-4-nitrophenoxy)piperidine hydrochloride | ESD-897059-1G |
Cas.: 1189653-33-5 | Purity: ≥95% | 4-(2-Fluoro-4-nitrophenoxy)piperidine hydrochloride | ESD-897059-5G |
Cas.: 1189653-33-5 | Purity: ≥95% | 4-(2-Fluoro-4-nitrophenoxy)piperidine hydrochloride | ESD-897059-10G |
Cas.: 177359-60-3 | Purity: ≥95% | 5-Methylpicolinic acid hydrochloride | ESD-897060-250MG |
Cas.: 177359-60-3 | Purity: ≥95% | 5-Methylpicolinic acid hydrochloride | ESD-897060-1G |
Cas.: 177359-60-3 | Purity: ≥95% | 5-Methylpicolinic acid hydrochloride | ESD-897060-5G |
Cas.: 177359-60-3 | Purity: ≥95% | 5-Methylpicolinic acid hydrochloride | ESD-897060-10G |
Cas.: 13940-96-0 | Purity: 98% | 4-Phenoxybenzene-1,2-diamine | ESD-897061-250MG |
Cas.: 13940-96-0 | Purity: 98% | 4-Phenoxybenzene-1,2-diamine | ESD-897061-1G |
Cas.: 13940-96-0 | Purity: 98% | 4-Phenoxybenzene-1,2-diamine | ESD-897061-5G |
Cas.: 13940-96-0 | Purity: 98% | 4-Phenoxybenzene-1,2-diamine | ESD-897061-10G |
Cas.: 438050-05-6 | Purity: 95% | (3-Bromo-2,6-difluorophenyl)methanol | ESD-897062-250MG |
Cas.: 438050-05-6 | Purity: 95% | (3-Bromo-2,6-difluorophenyl)methanol | ESD-897062-1G |
Cas.: 438050-05-6 | Purity: 95% | (3-Bromo-2,6-difluorophenyl)methanol | ESD-897062-5G |
Cas.: 438050-05-6 | Purity: 95% | (3-Bromo-2,6-difluorophenyl)methanol | ESD-897062-10G |
Cas.: 177609-12-0 | Purity: ≥95% | Fmoc-D-Asp(oall)-OH | ESD-897063-250MG |
Cas.: 177609-12-0 | Purity: ≥95% | Fmoc-D-Asp(oall)-OH | ESD-897063-1G |
Cas.: 177609-12-0 | Purity: ≥95% | Fmoc-D-Asp(oall)-OH | ESD-897063-5G |
Cas.: 177609-12-0 | Purity: ≥95% | Fmoc-D-Asp(oall)-OH | ESD-897063-10G |
Cas.: 934236-41-6 | Purity: 97% | Methyl 2-chlorooxazole-5-carboxylate | ESD-897064-250MG |
Cas.: 934236-41-6 | Purity: 97% | Methyl 2-chlorooxazole-5-carboxylate | ESD-897064-1G |
Cas.: 934236-41-6 | Purity: 97% | Methyl 2-chlorooxazole-5-carboxylate | ESD-897064-5G |
Cas.: 934236-41-6 | Purity: 97% | Methyl 2-chlorooxazole-5-carboxylate | ESD-897064-10G |
Cas.: 136630-36-9 | Purity: ≥97% | 4,4′-Dibromo-[1,1′-biphenyl]-2,2′-diamine | ESD-897065-250MG |
Cas.: 136630-36-9 | Purity: ≥97% | 4,4′-Dibromo-[1,1′-biphenyl]-2,2′-diamine | ESD-897065-1G |
Cas.: 136630-36-9 | Purity: ≥97% | 4,4′-Dibromo-[1,1′-biphenyl]-2,2′-diamine | ESD-897065-5G |
Cas.: 136630-36-9 | Purity: ≥97% | 4,4′-Dibromo-[1,1′-biphenyl]-2,2′-diamine | ESD-897065-10G |
Cas.: 49564-57-0 | Purity: 98% | 4-Amino-5-methoxy-N,2-dimethylbenzenesulfonamide | ESD-897066-250MG |
Cas.: 49564-57-0 | Purity: 98% | 4-Amino-5-methoxy-N,2-dimethylbenzenesulfonamide | ESD-897066-1G |
Cas.: 49564-57-0 | Purity: 98% | 4-Amino-5-methoxy-N,2-dimethylbenzenesulfonamide | ESD-897066-5G |
Cas.: 49564-57-0 | Purity: 98% | 4-Amino-5-methoxy-N,2-dimethylbenzenesulfonamide | ESD-897066-10G |
Cas.: 855198-37-7 | Purity: 98% | 2-Bromo-3-iodobenzoic acid | ESD-897067-250MG |
Cas.: 855198-37-7 | Purity: 98% | 2-Bromo-3-iodobenzoic acid | ESD-897067-1G |
Cas.: 855198-37-7 | Purity: 98% | 2-Bromo-3-iodobenzoic acid | ESD-897067-5G |
Cas.: 855198-37-7 | Purity: 98% | 2-Bromo-3-iodobenzoic acid | ESD-897067-10G |
Cas.: 68282-47-3 | Purity: 95% | 2-Phenyl-1H-imidazole-4-carbaldehyde | ESD-897068-250MG |
Cas.: 68282-47-3 | Purity: 95% | 2-Phenyl-1H-imidazole-4-carbaldehyde | ESD-897068-1G |
Cas.: 68282-47-3 | Purity: 95% | 2-Phenyl-1H-imidazole-4-carbaldehyde | ESD-897068-5G |
Cas.: 68282-47-3 | Purity: 95% | 2-Phenyl-1H-imidazole-4-carbaldehyde | ESD-897068-10G |
Cas.: 1171331-39-7 | Purity: ≥95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride | ESD-897069-250MG |
Cas.: 1171331-39-7 | Purity: ≥95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride | ESD-897069-1G |
Cas.: 1171331-39-7 | Purity: ≥95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride | ESD-897069-5G |
Cas.: 1171331-39-7 | Purity: ≥95% | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride | ESD-897069-10G |
Cas.: 718608-10-7 | Purity: 95% | 5-(Bromomethyl)-2-methylpyridine hydrobromide | ESD-897070-250MG |
Cas.: 718608-10-7 | Purity: 95% | 5-(Bromomethyl)-2-methylpyridine hydrobromide | ESD-897070-1G |
Cas.: 718608-10-7 | Purity: 95% | 5-(Bromomethyl)-2-methylpyridine hydrobromide | ESD-897070-5G |
Cas.: 718608-10-7 | Purity: 95% | 5-(Bromomethyl)-2-methylpyridine hydrobromide | ESD-897070-10G |
Cas.: 1184918-22-6 | Purity: 97% | 2-Bromo-1-(bromomethyl)-3-fluorobenzene | ESD-897071-250MG |
Cas.: 1184918-22-6 | Purity: 97% | 2-Bromo-1-(bromomethyl)-3-fluorobenzene | ESD-897071-1G |
Cas.: 1184918-22-6 | Purity: 97% | 2-Bromo-1-(bromomethyl)-3-fluorobenzene | ESD-897071-5G |
Cas.: 1184918-22-6 | Purity: 97% | 2-Bromo-1-(bromomethyl)-3-fluorobenzene | ESD-897071-10G |
Cas.: 928758-19-4 | Purity: ≥95% | 4-Bromo-1-chloro-2-(chloromethyl)benzene | ESD-897072-250MG |
Cas.: 928758-19-4 | Purity: ≥95% | 4-Bromo-1-chloro-2-(chloromethyl)benzene | ESD-897072-1G |
Cas.: 928758-19-4 | Purity: ≥95% | 4-Bromo-1-chloro-2-(chloromethyl)benzene | ESD-897072-5G |
Cas.: 928758-19-4 | Purity: ≥95% | 4-Bromo-1-chloro-2-(chloromethyl)benzene | ESD-897072-10G |
Cas.: 42027-81-6 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)ethanol | ESD-897073-250MG |
Cas.: 42027-81-6 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)ethanol | ESD-897073-1G |
Cas.: 42027-81-6 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)ethanol | ESD-897073-5G |
Cas.: 42027-81-6 | Purity: ≥95% | 2-(4-Nitro-1H-pyrazol-1-yl)ethanol | ESD-897073-10G |
Cas.: 55305-43-6 | Purity: ≥95% | N-Cyano-4-methyl-N-phenylbenzenesulfonamide | ESD-897074-250MG |
Cas.: 55305-43-6 | Purity: ≥95% | N-Cyano-4-methyl-N-phenylbenzenesulfonamide | ESD-897074-1G |
Cas.: 55305-43-6 | Purity: ≥95% | N-Cyano-4-methyl-N-phenylbenzenesulfonamide | ESD-897074-5G |
Cas.: 55305-43-6 | Purity: ≥95% | N-Cyano-4-methyl-N-phenylbenzenesulfonamide | ESD-897074-10G |
Cas.: 897957-06-1 | Purity: 95% | 6-Bromo-1-methylindolin-2-one | ESD-897075-250MG |
Cas.: 897957-06-1 | Purity: 95% | 6-Bromo-1-methylindolin-2-one | ESD-897075-1G |
Cas.: 897957-06-1 | Purity: 95% | 6-Bromo-1-methylindolin-2-one | ESD-897075-5G |
Cas.: 897957-06-1 | Purity: 95% | 6-Bromo-1-methylindolin-2-one | ESD-897075-10G |
Cas.: 6287-86-1 | Purity: ≥95% | Ethyl 4-formylbenzoate | ESD-897076-250MG |
Cas.: 6287-86-1 | Purity: ≥95% | Ethyl 4-formylbenzoate | ESD-897076-1G |
Cas.: 6287-86-1 | Purity: ≥95% | Ethyl 4-formylbenzoate | ESD-897076-5G |
Cas.: 6287-86-1 | Purity: ≥95% | Ethyl 4-formylbenzoate | ESD-897076-10G |
Cas.: 76629-10-2 | Purity: ≥95% | 7-Chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-897077-250MG |
Cas.: 76629-10-2 | Purity: ≥95% | 7-Chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-897077-1G |
Cas.: 76629-10-2 | Purity: ≥95% | 7-Chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-897077-5G |
Cas.: 76629-10-2 | Purity: ≥95% | 7-Chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one | ESD-897077-10G |
Cas.: 200354-34-3 | Purity: ≥95% | Fmoc-Cys(Et)-OH | ESD-897078-250MG |
Cas.: 200354-34-3 | Purity: ≥95% | Fmoc-Cys(Et)-OH | ESD-897078-1G |
Cas.: 200354-34-3 | Purity: ≥95% | Fmoc-Cys(Et)-OH | ESD-897078-5G |
Cas.: 200354-34-3 | Purity: ≥95% | Fmoc-Cys(Et)-OH | ESD-897078-10G |
Cas.: 85774-09-0 | Purity: 98% | HD-2-Abu-Ome.HCl | ESD-897079-250MG |
Cas.: 85774-09-0 | Purity: 98% | HD-2-Abu-Ome.HCl | ESD-897079-1G |
Cas.: 85774-09-0 | Purity: 98% | HD-2-Abu-Ome.HCl | ESD-897079-5G |
Cas.: 85774-09-0 | Purity: 98% | HD-2-Abu-Ome.HCl | ESD-897079-10G |
Cas.: 1548-62-5 | Purity: 98% | 2-Nitro-6-(trifluoromethyl)phenol | ESD-897080-250MG |
Cas.: 1548-62-5 | Purity: 98% | 2-Nitro-6-(trifluoromethyl)phenol | ESD-897080-1G |
Cas.: 1548-62-5 | Purity: 98% | 2-Nitro-6-(trifluoromethyl)phenol | ESD-897080-5G |
Cas.: 1548-62-5 | Purity: 98% | 2-Nitro-6-(trifluoromethyl)phenol | ESD-897080-10G |
Cas.: 165049-28-5 | Purity: 97% | (S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate 4 -methylbenzenesulfonate | ESD-897081-250MG |
Cas.: 165049-28-5 | Purity: 97% | (S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate 4 -methylbenzenesulfonate | ESD-897081-1G |
Cas.: 165049-28-5 | Purity: 97% | (S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate 4 -methylbenzenesulfonate | ESD-897081-5G |
Cas.: 165049-28-5 | Purity: 97% | (S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate 4 -methylbenzenesulfonate | ESD-897081-10G |
Cas.: 49755-94-4 | Purity: 97% | H-Gly-NHMe HCl | ESD-897082-250MG |
Cas.: 49755-94-4 | Purity: 97% | H-Gly-NHMe HCl | ESD-897082-1G |
Cas.: 49755-94-4 | Purity: 97% | H-Gly-NHMe HCl | ESD-897082-5G |
Cas.: 49755-94-4 | Purity: 97% | H-Gly-NHMe HCl | ESD-897082-10G |
Cas.: 91523-50-1 | Purity: 97% | 6-Hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | ESD-897083-250MG |
Cas.: 91523-50-1 | Purity: 97% | 6-Hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | ESD-897083-1G |
Cas.: 91523-50-1 | Purity: 97% | 6-Hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | ESD-897083-5G |
Cas.: 91523-50-1 | Purity: 97% | 6-Hydroxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | ESD-897083-10G |
Cas.: 154704-35-5 | Purity: 97% | 2-Methylimidazo[1,2-b]pyridazin-6-amine | ESD-897084-250MG |
Cas.: 154704-35-5 | Purity: 97% | 2-Methylimidazo[1,2-b]pyridazin-6-amine | ESD-897084-1G |
Cas.: 154704-35-5 | Purity: 97% | 2-Methylimidazo[1,2-b]pyridazin-6-amine | ESD-897084-5G |
Cas.: 154704-35-5 | Purity: 97% | 2-Methylimidazo[1,2-b]pyridazin-6-amine | ESD-897084-10G |
Cas.: 1197953-49-3 | Purity: 96% | (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide | ESD-897085-250MG |
Cas.: 1197953-49-3 | Purity: 96% | (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide | ESD-897085-1G |
Cas.: 1197953-49-3 | Purity: 96% | (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide | ESD-897085-5G |
Cas.: 1197953-49-3 | Purity: 96% | (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide | ESD-897085-10G |
Cas.: 63057-72-7 | Purity: 97% | 1-(Benzyloxy)-4-bromo-2-methoxybenzene | ESD-897086-250MG |
Cas.: 63057-72-7 | Purity: 97% | 1-(Benzyloxy)-4-bromo-2-methoxybenzene | ESD-897086-1G |
Cas.: 63057-72-7 | Purity: 97% | 1-(Benzyloxy)-4-bromo-2-methoxybenzene | ESD-897086-5G |
Cas.: 63057-72-7 | Purity: 97% | 1-(Benzyloxy)-4-bromo-2-methoxybenzene | ESD-897086-10G |
Cas.: 199786-58-8 | Purity: 97% | (5-Bromo-2-iodophenyl)methanol | ESD-897087-250MG |
Cas.: 199786-58-8 | Purity: 97% | (5-Bromo-2-iodophenyl)methanol | ESD-897087-1G |
Cas.: 199786-58-8 | Purity: 97% | (5-Bromo-2-iodophenyl)methanol | ESD-897087-5G |
Cas.: 199786-58-8 | Purity: 97% | (5-Bromo-2-iodophenyl)methanol | ESD-897087-10G |
Cas.: 850589-36-5 | Purity: ≥95% | (2-(Aminomethyl)phenyl)boronic acid hydrochloride | ESD-897088-250MG |
Cas.: 850589-36-5 | Purity: ≥95% | (2-(Aminomethyl)phenyl)boronic acid hydrochloride | ESD-897088-1G |
Cas.: 850589-36-5 | Purity: ≥95% | (2-(Aminomethyl)phenyl)boronic acid hydrochloride | ESD-897088-5G |
Cas.: 850589-36-5 | Purity: ≥95% | (2-(Aminomethyl)phenyl)boronic acid hydrochloride | ESD-897088-10G |
Cas.: 15008-33-0 | Purity: 98% | 5-Bromo-N,N,N-trimethylpentan-1-aminium bromide | ESD-897089-250MG |
Cas.: 15008-33-0 | Purity: 98% | 5-Bromo-N,N,N-trimethylpentan-1-aminium bromide | ESD-897089-1G |
Cas.: 15008-33-0 | Purity: 98% | 5-Bromo-N,N,N-trimethylpentan-1-aminium bromide | ESD-897089-5G |
Cas.: 15008-33-0 | Purity: 98% | 5-Bromo-N,N,N-trimethylpentan-1-aminium bromide | ESD-897089-10G |
Cas.: 126055-32-1 | Purity: ≥95% | 1-(2-Chloroethyl)-4-methylpiperazine hydrochloride | ESD-897090-250MG |
Cas.: 126055-32-1 | Purity: ≥95% | 1-(2-Chloroethyl)-4-methylpiperazine hydrochloride | ESD-897090-1G |
Cas.: 946493-27-2 | Purity: 98% | 3,5-Dimethylpyrazine-2-carboxylic acid | ESD-897091-250MG |
Cas.: 946493-27-2 | Purity: 98% | 3,5-Dimethylpyrazine-2-carboxylic acid | ESD-897091-1G |
Cas.: 946493-27-2 | Purity: 98% | 3,5-Dimethylpyrazine-2-carboxylic acid | ESD-897091-5G |
Cas.: 946493-27-2 | Purity: 98% | 3,5-Dimethylpyrazine-2-carboxylic acid | ESD-897091-10G |
Cas.: 23927-40-4 | Purity: 97% | Racemic-4,12-dibromo[2.2]paracyclophane | ESD-897092-250MG |
Cas.: 23927-40-4 | Purity: 97% | Racemic-4,12-dibromo[2.2]paracyclophane | ESD-897092-1G |
Cas.: 23927-40-4 | Purity: 97% | Racemic-4,12-dibromo[2.2]paracyclophane | ESD-897092-5G |
Cas.: 710-43-0 | Purity: ≥95% | cis-Diethyl cyclopropane-1,2-dicarboxylate | ESD-897093-250MG |
Cas.: 710-43-0 | Purity: ≥95% | cis-Diethyl cyclopropane-1,2-dicarboxylate | ESD-897093-1G |
Cas.: 710-43-0 | Purity: ≥95% | cis-Diethyl cyclopropane-1,2-dicarboxylate | ESD-897093-5G |
Cas.: 710-43-0 | Purity: ≥95% | cis-Diethyl cyclopropane-1,2-dicarboxylate | ESD-897093-10G |
Cas.: 19647-68-8 | Purity: ≥95% | (S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate | ESD-897094-250MG |
Cas.: 19647-68-8 | Purity: ≥95% | (S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate | ESD-897094-1G |
Cas.: 19647-68-8 | Purity: ≥95% | (S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate | ESD-897094-5G |
Cas.: 19647-68-8 | Purity: ≥95% | (S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate | ESD-897094-10G |
Cas.: 178924-05-5 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((allyloxy)carbonyl)amino)propanoic acid | ESD-897095-250MG |
Cas.: 178924-05-5 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((allyloxy)carbonyl)amino)propanoic acid | ESD-897095-1G |
Cas.: 178924-05-5 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((allyloxy)carbonyl)amino)propanoic acid | ESD-897095-5G |
Cas.: 178924-05-5 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((allyloxy)carbonyl)amino)propanoic acid | ESD-897095-10G |
Cas.: 42186-06-1 | Purity: ≥95% | 2-(4-Bromophenyl)propanenitrile | ESD-897096-250MG |
Cas.: 42186-06-1 | Purity: ≥95% | 2-(4-Bromophenyl)propanenitrile | ESD-897096-1G |
Cas.: 42186-06-1 | Purity: ≥95% | 2-(4-Bromophenyl)propanenitrile | ESD-897096-5G |
Cas.: 42186-06-1 | Purity: ≥95% | 2-(4-Bromophenyl)propanenitrile | ESD-897096-10G |
Cas.: 1027642-25-6 | Purity: ≥95% | Potassium ((benzyloxy)methyl)trifluoroborate | ESD-897097-250MG |
Cas.: 1027642-25-6 | Purity: ≥95% | Potassium ((benzyloxy)methyl)trifluoroborate | ESD-897097-1G |
Cas.: 1027642-25-6 | Purity: ≥95% | Potassium ((benzyloxy)methyl)trifluoroborate | ESD-897097-5G |
Cas.: 1027642-25-6 | Purity: ≥95% | Potassium ((benzyloxy)methyl)trifluoroborate | ESD-897097-10G |
Cas.: 914349-15-8 | Purity: ≥95% | tert-Butyl 3-(hydroxymethyl)-7-nitro-1H-indole-1-carboxylate | ESD-897098-250MG |
Cas.: 914349-15-8 | Purity: ≥95% | tert-Butyl 3-(hydroxymethyl)-7-nitro-1H-indole-1-carboxylate | ESD-897098-1G |
Cas.: 914349-15-8 | Purity: ≥95% | tert-Butyl 3-(hydroxymethyl)-7-nitro-1H-indole-1-carboxylate | ESD-897098-5G |
Cas.: 914349-15-8 | Purity: ≥95% | tert-Butyl 3-(hydroxymethyl)-7-nitro-1H-indole-1-carboxylate | ESD-897098-10G |
Cas.: 7477-13-6 | Purity: 95% | Tetrazolo[1,5-a]pyridine-6-carboxylic acid | ESD-897099-250MG |
Cas.: 7477-13-6 | Purity: 95% | Tetrazolo[1,5-a]pyridine-6-carboxylic acid | ESD-897099-1G |
Cas.: 7477-13-6 | Purity: 95% | Tetrazolo[1,5-a]pyridine-6-carboxylic acid | ESD-897099-5G |
Cas.: 7477-13-6 | Purity: 95% | Tetrazolo[1,5-a]pyridine-6-carboxylic acid | ESD-897099-10G |
Cas.: 15783-48-9 | Purity: 95% | 2,4-Dichlorofuro[3,4-d]pyrimidin-7(5H)-one | ESD-897100-250MG |
Cas.: 15783-48-9 | Purity: 95% | 2,4-Dichlorofuro[3,4-d]pyrimidin-7(5H)-one | ESD-897100-1G |
Cas.: 15783-48-9 | Purity: 95% | 2,4-Dichlorofuro[3,4-d]pyrimidin-7(5H)-one | ESD-897100-5G |
Cas.: 15783-48-9 | Purity: 95% | 2,4-Dichlorofuro[3,4-d]pyrimidin-7(5H)-one | ESD-897100-10G |
Cas.: 146306-75-4 | Purity: ≥95% | Fmoc-allo-Thr-OH | ESD-897101-250MG |
Cas.: 146306-75-4 | Purity: ≥95% | Fmoc-allo-Thr-OH | ESD-897101-1G |
Cas.: 146306-75-4 | Purity: ≥95% | Fmoc-allo-Thr-OH | ESD-897101-5G |
Cas.: 146306-75-4 | Purity: ≥95% | Fmoc-allo-Thr-OH | ESD-897101-10G |
Cas.: 89466-16-0 | Purity: 97% | 6-Bromo-3-methylpyridin-2-amine | ESD-897102-250MG |
Cas.: 89466-16-0 | Purity: 97% | 6-Bromo-3-methylpyridin-2-amine | ESD-897102-1G |
Cas.: 89466-16-0 | Purity: 97% | 6-Bromo-3-methylpyridin-2-amine | ESD-897102-5G |
Cas.: 89466-16-0 | Purity: 97% | 6-Bromo-3-methylpyridin-2-amine | ESD-897102-10G |
Cas.: 923977-15-5 | Purity: 97% | 3-(3,5-Dibromophenyl)propanoic acid | ESD-897103-250MG |
Cas.: 923977-15-5 | Purity: 97% | 3-(3,5-Dibromophenyl)propanoic acid | ESD-897103-1G |
Cas.: 923977-15-5 | Purity: 97% | 3-(3,5-Dibromophenyl)propanoic acid | ESD-897103-5G |
Cas.: 923977-15-5 | Purity: 97% | 3-(3,5-Dibromophenyl)propanoic acid | ESD-897103-10G |
Cas.: 23361-28-6 | Purity: ≥95% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897104-250MG |
Cas.: 23361-28-6 | Purity: ≥95% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897104-1G |
Cas.: 23361-28-6 | Purity: ≥95% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897104-5G |
Cas.: 23361-28-6 | Purity: ≥95% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897104-10G |
Cas.: 1150655-02-9 | Purity: ≥95% | Potassium trifluoro(neopentyl)borate | ESD-897105-250MG |
Cas.: 1150655-02-9 | Purity: ≥95% | Potassium trifluoro(neopentyl)borate | ESD-897105-1G |
Cas.: 1150655-02-9 | Purity: ≥95% | Potassium trifluoro(neopentyl)borate | ESD-897105-5G |
Cas.: 1150655-02-9 | Purity: ≥95% | Potassium trifluoro(neopentyl)borate | ESD-897105-10G |
Cas.: 867044-28-8 | Purity: ≥95% | (9,10-Di(naphthalen-2-yl)anthracen-2-yl)boronic acid | ESD-897106-250MG |
Cas.: 867044-28-8 | Purity: ≥95% | (9,10-Di(naphthalen-2-yl)anthracen-2-yl)boronic acid | ESD-897106-1G |
Cas.: 867044-28-8 | Purity: ≥95% | (9,10-Di(naphthalen-2-yl)anthracen-2-yl)boronic acid | ESD-897106-5G |
Cas.: 867044-28-8 | Purity: ≥95% | (9,10-Di(naphthalen-2-yl)anthracen-2-yl)boronic acid | ESD-897106-10G |
Cas.: 16230-24-3 | Purity: 97% | N-(3-Aminophenyl)acrylamide | ESD-897107-250MG |
Cas.: 16230-24-3 | Purity: 97% | N-(3-Aminophenyl)acrylamide | ESD-897107-1G |
Cas.: 16230-24-3 | Purity: 97% | N-(3-Aminophenyl)acrylamide | ESD-897107-5G |
Cas.: 16230-24-3 | Purity: 97% | N-(3-Aminophenyl)acrylamide | ESD-897107-10G |
Cas.: 163277-80-3 | Purity: 97% | (2S,3R)-2-Acetamido-3-(tert-butoxy)butanoic acid | ESD-897108-250MG |
Cas.: 163277-80-3 | Purity: 97% | (2S,3R)-2-Acetamido-3-(tert-butoxy)butanoic acid | ESD-897108-1G |
Cas.: 163277-80-3 | Purity: 97% | (2S,3R)-2-Acetamido-3-(tert-butoxy)butanoic acid | ESD-897108-5G |
Cas.: 163277-80-3 | Purity: 97% | (2S,3R)-2-Acetamido-3-(tert-butoxy)butanoic acid | ESD-897108-10G |
Cas.: 84937-82-6 | Purity: 97% | Methyl 2,6-difluoro-4-methoxybenzoate | ESD-897109-250MG |
Cas.: 84937-82-6 | Purity: 97% | Methyl 2,6-difluoro-4-methoxybenzoate | ESD-897109-1G |
Cas.: 84937-82-6 | Purity: 97% | Methyl 2,6-difluoro-4-methoxybenzoate | ESD-897109-5G |
Cas.: 84937-82-6 | Purity: 97% | Methyl 2,6-difluoro-4-methoxybenzoate | ESD-897109-10G |
Cas.: 103997-23-5 | Purity: ≥95% | 5-Chloro-6-methylpyridin-2-ol | ESD-897110-250MG |
Cas.: 103997-23-5 | Purity: ≥95% | 5-Chloro-6-methylpyridin-2-ol | ESD-897110-1G |
Cas.: 103997-23-5 | Purity: ≥95% | 5-Chloro-6-methylpyridin-2-ol | ESD-897110-5G |
Cas.: 103997-23-5 | Purity: ≥95% | 5-Chloro-6-methylpyridin-2-ol | ESD-897110-10G |
Cas.: 877676-50-1 | Purity: 95% | (R)-2-Chloro-7-ethyl-8-isopropyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-897111-250MG |
Cas.: 877676-50-1 | Purity: 95% | (R)-2-Chloro-7-ethyl-8-isopropyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-897111-1G |
Cas.: 877676-50-1 | Purity: 95% | (R)-2-Chloro-7-ethyl-8-isopropyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-897111-5G |
Cas.: 877676-50-1 | Purity: 95% | (R)-2-Chloro-7-ethyl-8-isopropyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-897111-10G |
Cas.: 256935-69-0 | Purity: 97% | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxybenzoic acid | ESD-897112-250MG |
Cas.: 256935-69-0 | Purity: 97% | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxybenzoic acid | ESD-897112-1G |
Cas.: 256935-69-0 | Purity: 97% | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxybenzoic acid | ESD-897112-5G |
Cas.: 256935-69-0 | Purity: 97% | 3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methoxybenzoic acid | ESD-897112-10G |
Cas.: 71404-98-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-3-chloropropanoic acid | ESD-897113-250MG |
Cas.: 71404-98-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-3-chloropropanoic acid | ESD-897113-1G |
Cas.: 71404-98-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-3-chloropropanoic acid | ESD-897113-5G |
Cas.: 71404-98-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-3-chloropropanoic acid | ESD-897113-10G |
Cas.: 1557921-62-6 | Purity: ≥95% | (6-Chloropyridin-2-yl)methanamine dihydrochloride | ESD-897114-250MG |
Cas.: 1557921-62-6 | Purity: ≥95% | (6-Chloropyridin-2-yl)methanamine dihydrochloride | ESD-897114-1G |
Cas.: 1557921-62-6 | Purity: ≥95% | (6-Chloropyridin-2-yl)methanamine dihydrochloride | ESD-897114-5G |
Cas.: 1557921-62-6 | Purity: ≥95% | (6-Chloropyridin-2-yl)methanamine dihydrochloride | ESD-897114-10G |
Cas.: 28269-03-6 | Purity: 98% | (1R,2R)-rel-Dimethyl 4-oxocyclopentane-1,2-dicarboxylate | ESD-897115-250MG |
Cas.: 28269-03-6 | Purity: 98% | (1R,2R)-rel-Dimethyl 4-oxocyclopentane-1,2-dicarboxylate | ESD-897115-1G |
Cas.: 28269-03-6 | Purity: 98% | (1R,2R)-rel-Dimethyl 4-oxocyclopentane-1,2-dicarboxylate | ESD-897115-5G |
Cas.: 28269-03-6 | Purity: 98% | (1R,2R)-rel-Dimethyl 4-oxocyclopentane-1,2-dicarboxylate | ESD-897115-10G |
Cas.: 135321-84-5 | Purity: ≥95% | Methyl 4-(N-(tert-butoxycarbonyl)carbamimidoyl)benzoate | ESD-897116-250MG |
Cas.: 135321-84-5 | Purity: ≥95% | Methyl 4-(N-(tert-butoxycarbonyl)carbamimidoyl)benzoate | ESD-897116-1G |
Cas.: 135321-84-5 | Purity: ≥95% | Methyl 4-(N-(tert-butoxycarbonyl)carbamimidoyl)benzoate | ESD-897116-5G |
Cas.: 135321-84-5 | Purity: ≥95% | Methyl 4-(N-(tert-butoxycarbonyl)carbamimidoyl)benzoate | ESD-897116-10G |
Cas.: 457097-93-7 | Purity: ≥95% | Methyl 4-amino-3-(trifluoromethoxy)benzoate | ESD-897117-250MG |
Cas.: 457097-93-7 | Purity: ≥95% | Methyl 4-amino-3-(trifluoromethoxy)benzoate | ESD-897117-1G |
Cas.: 457097-93-7 | Purity: ≥95% | Methyl 4-amino-3-(trifluoromethoxy)benzoate | ESD-897117-5G |
Cas.: 457097-93-7 | Purity: ≥95% | Methyl 4-amino-3-(trifluoromethoxy)benzoate | ESD-897117-10G |
Cas.: 1211520-77-2 | Purity: ≥95% | 3-Bromo-2-(difluoromethyl)pyridine | ESD-897118-250MG |
Cas.: 1211520-77-2 | Purity: ≥95% | 3-Bromo-2-(difluoromethyl)pyridine | ESD-897118-1G |
Cas.: 1211520-77-2 | Purity: ≥95% | 3-Bromo-2-(difluoromethyl)pyridine | ESD-897118-5G |
Cas.: 1211520-77-2 | Purity: ≥95% | 3-Bromo-2-(difluoromethyl)pyridine | ESD-897118-10G |
Cas.: 113712-05-3 | Purity: 97% | ZD-Arg-OH.HCl | ESD-897119-250MG |
Cas.: 113712-05-3 | Purity: 97% | ZD-Arg-OH.HCl | ESD-897119-1G |
Cas.: 113712-05-3 | Purity: 97% | ZD-Arg-OH.HCl | ESD-897119-5G |
Cas.: 113712-05-3 | Purity: 97% | ZD-Arg-OH.HCl | ESD-897119-10G |
Cas.: 1266114-75-3 | Purity: 97% | 4-Bromo-1H-benzo[d]imidazol-2-amine | ESD-897120-250MG |
Cas.: 1266114-75-3 | Purity: 97% | 4-Bromo-1H-benzo[d]imidazol-2-amine | ESD-897120-1G |
Cas.: 1266114-75-3 | Purity: 97% | 4-Bromo-1H-benzo[d]imidazol-2-amine | ESD-897120-5G |
Cas.: 1266114-75-3 | Purity: 97% | 4-Bromo-1H-benzo[d]imidazol-2-amine | ESD-897120-10G |
Cas.: 15862-86-9 | Purity: ≥95% | Piperidine-2-carboxylic acid hydrochloride | ESD-897121-250MG |
Cas.: 15862-86-9 | Purity: ≥95% | Piperidine-2-carboxylic acid hydrochloride | ESD-897121-1G |
Cas.: 15862-86-9 | Purity: ≥95% | Piperidine-2-carboxylic acid hydrochloride | ESD-897121-5G |
Cas.: 15862-86-9 | Purity: ≥95% | Piperidine-2-carboxylic acid hydrochloride | ESD-897121-10G |
Cas.: 25100-12-3 | Purity: ≥95% | N-Cyclohexylhydroxylamine hydrochloride | ESD-897122-250MG |
Cas.: 25100-12-3 | Purity: ≥95% | N-Cyclohexylhydroxylamine hydrochloride | ESD-897122-1G |
Cas.: 25100-12-3 | Purity: ≥95% | N-Cyclohexylhydroxylamine hydrochloride | ESD-897122-5G |
Cas.: 25100-12-3 | Purity: ≥95% | N-Cyclohexylhydroxylamine hydrochloride | ESD-897122-10G |
Cas.: 10045-45-1 | Purity: 97% | 1-Ethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-897123-250MG |
Cas.: 10045-45-1 | Purity: 97% | 1-Ethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-897123-1G |
Cas.: 10045-45-1 | Purity: 97% | 1-Ethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-897123-5G |
Cas.: 10045-45-1 | Purity: 97% | 1-Ethyl-1H-benzo[d]imidazol-2(3H)-one | ESD-897123-10G |
Cas.: 58577-95-0 | Purity: ≥95% | (R)-2-Amino-3-(benzyloxy)propan-1-ol hydrochloride | ESD-897124-250MG |
Cas.: 58577-95-0 | Purity: ≥95% | (R)-2-Amino-3-(benzyloxy)propan-1-ol hydrochloride | ESD-897124-1G |
Cas.: 58577-95-0 | Purity: ≥95% | (R)-2-Amino-3-(benzyloxy)propan-1-ol hydrochloride | ESD-897124-5G |
Cas.: 58577-95-0 | Purity: ≥95% | (R)-2-Amino-3-(benzyloxy)propan-1-ol hydrochloride | ESD-897124-10G |
Cas.: 15813-07-7 | Purity: ≥95% | 5-Iodo-4-methyl-1H-imidazole | ESD-897125-250MG |
Cas.: 15813-07-7 | Purity: ≥95% | 5-Iodo-4-methyl-1H-imidazole | ESD-897125-1G |
Cas.: 15813-07-7 | Purity: ≥95% | 5-Iodo-4-methyl-1H-imidazole | ESD-897125-5G |
Cas.: 15813-07-7 | Purity: ≥95% | 5-Iodo-4-methyl-1H-imidazole | ESD-897125-10G |
Cas.: 6051-13-4 | Purity: 98% | 2-Cyclohexylpropanoic acid | ESD-897126-250MG |
Cas.: 6051-13-4 | Purity: 98% | 2-Cyclohexylpropanoic acid | ESD-897126-1G |
Cas.: 6051-13-4 | Purity: 98% | 2-Cyclohexylpropanoic acid | ESD-897126-5G |
Cas.: 6051-13-4 | Purity: 98% | 2-Cyclohexylpropanoic acid | ESD-897126-10G |
Cas.: 851392-68-2 | Purity: ≥95% | Fmoc-Dab(Mtt)-OH | ESD-897127-250MG |
Cas.: 851392-68-2 | Purity: ≥95% | Fmoc-Dab(Mtt)-OH | ESD-897127-1G |
Cas.: 851392-68-2 | Purity: ≥95% | Fmoc-Dab(Mtt)-OH | ESD-897127-5G |
Cas.: 851392-68-2 | Purity: ≥95% | Fmoc-Dab(Mtt)-OH | ESD-897127-10G |
Cas.: 216439-76-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid | ESD-897128-250MG |
Cas.: 216439-76-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid | ESD-897128-1G |
Cas.: 216439-76-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid | ESD-897128-5G |
Cas.: 216439-76-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid | ESD-897128-10G |
Cas.: 5438-07-3 | Purity: 97% | 2-Amino-2-phenylbutanoic acid | ESD-897129-250MG |
Cas.: 5438-07-3 | Purity: 97% | 2-Amino-2-phenylbutanoic acid | ESD-897129-1G |
Cas.: 5438-07-3 | Purity: 97% | 2-Amino-2-phenylbutanoic acid | ESD-897129-5G |
Cas.: 5438-07-3 | Purity: 97% | 2-Amino-2-phenylbutanoic acid | ESD-897129-10G |
Cas.: 64665-60-7 | Purity: ≥98% | Methyl 2-amino-2-methyl-3-phenylpropanoate hydrochloride | ESD-897130-250MG |
Cas.: 64665-60-7 | Purity: ≥98% | Methyl 2-amino-2-methyl-3-phenylpropanoate hydrochloride | ESD-897130-1G |
Cas.: 64665-60-7 | Purity: ≥98% | Methyl 2-amino-2-methyl-3-phenylpropanoate hydrochloride | ESD-897130-5G |
Cas.: 64665-60-7 | Purity: ≥98% | Methyl 2-amino-2-methyl-3-phenylpropanoate hydrochloride | ESD-897130-10G |
Cas.: 60481-38-1 | Purity: 97% | (2,3-Difluorophenyl)hydrazine hydrochloride | ESD-897131-250MG |
Cas.: 60481-38-1 | Purity: 97% | (2,3-Difluorophenyl)hydrazine hydrochloride | ESD-897131-1G |
Cas.: 60481-38-1 | Purity: 97% | (2,3-Difluorophenyl)hydrazine hydrochloride | ESD-897131-5G |
Cas.: 60481-38-1 | Purity: 97% | (2,3-Difluorophenyl)hydrazine hydrochloride | ESD-897131-10G |
Cas.: 1070879-27-4 | Purity: ≥95% | 4-Bromo-7-methoxyquinoline | ESD-897132-250MG |
Cas.: 1070879-27-4 | Purity: ≥95% | 4-Bromo-7-methoxyquinoline | ESD-897132-1G |
Cas.: 1070879-27-4 | Purity: ≥95% | 4-Bromo-7-methoxyquinoline | ESD-897132-5G |
Cas.: 1070879-27-4 | Purity: ≥95% | 4-Bromo-7-methoxyquinoline | ESD-897132-10G |
Cas.: 1353679-63-6 | Purity: ≥95% | 4-Bromo-1-methyl-1H-benzo[d]imidazole | ESD-897133-250MG |
Cas.: 1353679-63-6 | Purity: ≥95% | 4-Bromo-1-methyl-1H-benzo[d]imidazole | ESD-897133-1G |
Cas.: 1353679-63-6 | Purity: ≥95% | 4-Bromo-1-methyl-1H-benzo[d]imidazole | ESD-897133-5G |
Cas.: 1353679-63-6 | Purity: ≥95% | 4-Bromo-1-methyl-1H-benzo[d]imidazole | ESD-897133-10G |
Cas.: 763114-25-6 | Purity: 97% | 2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile | ESD-897134-250MG |
Cas.: 763114-25-6 | Purity: 97% | 2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile | ESD-897134-1G |
Cas.: 763114-25-6 | Purity: 97% | 2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile | ESD-897134-5G |
Cas.: 763114-25-6 | Purity: 97% | 2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile | ESD-897134-10G |
Cas.: 1217858-20-2 | Purity: ≥95% | (R)-tert-Butyl (pyrrolidin-3-ylmethyl)carbamate hydrochloride | ESD-897135-250MG |
Cas.: 1217858-20-2 | Purity: ≥95% | (R)-tert-Butyl (pyrrolidin-3-ylmethyl)carbamate hydrochloride | ESD-897135-1G |
Cas.: 1217858-20-2 | Purity: ≥95% | (R)-tert-Butyl (pyrrolidin-3-ylmethyl)carbamate hydrochloride | ESD-897135-5G |
Cas.: 1217858-20-2 | Purity: ≥95% | (R)-tert-Butyl (pyrrolidin-3-ylmethyl)carbamate hydrochloride | ESD-897135-10G |
Cas.: 63091-82-7 | Purity: ≥95% | Boc-D-Thz-OH | ESD-897136-250MG |
Cas.: 63091-82-7 | Purity: ≥95% | Boc-D-Thz-OH | ESD-897136-1G |
Cas.: 63091-82-7 | Purity: ≥95% | Boc-D-Thz-OH | ESD-897136-5G |
Cas.: 63091-82-7 | Purity: ≥95% | Boc-D-Thz-OH | ESD-897136-10G |
Cas.: 55289-05-9 | Purity: 97% | Methyl 3-hydroxy-2-methylbenzoate | ESD-897137-250MG |
Cas.: 55289-05-9 | Purity: 97% | Methyl 3-hydroxy-2-methylbenzoate | ESD-897137-1G |
Cas.: 55289-05-9 | Purity: 97% | Methyl 3-hydroxy-2-methylbenzoate | ESD-897137-5G |
Cas.: 55289-05-9 | Purity: 97% | Methyl 3-hydroxy-2-methylbenzoate | ESD-897137-10G |
Cas.: 247113-86-6 | Purity: ≥95% | Fmoc-Phe(4-CF3)-OH | ESD-897138-250MG |
Cas.: 247113-86-6 | Purity: ≥95% | Fmoc-Phe(4-CF3)-OH | ESD-897138-1G |
Cas.: 247113-86-6 | Purity: ≥95% | Fmoc-Phe(4-CF3)-OH | ESD-897138-5G |
Cas.: 247113-86-6 | Purity: ≥95% | Fmoc-Phe(4-CF3)-OH | ESD-897138-10G |
Cas.: 494747-09-0 | Purity: 97% | 6-Bromo-2-methyloxazolo[4,5-b]pyridine | ESD-897139-250MG |
Cas.: 494747-09-0 | Purity: 97% | 6-Bromo-2-methyloxazolo[4,5-b]pyridine | ESD-897139-1G |
Cas.: 494747-09-0 | Purity: 97% | 6-Bromo-2-methyloxazolo[4,5-b]pyridine | ESD-897139-5G |
Cas.: 4720-64-3 | Purity: 98% | 4-Methylpiperidin-2-one | ESD-897140-250MG |
Cas.: 4720-64-3 | Purity: 98% | 4-Methylpiperidin-2-one | ESD-897140-1G |
Cas.: 4720-64-3 | Purity: 98% | 4-Methylpiperidin-2-one | ESD-897140-5G |
Cas.: 4720-64-3 | Purity: 98% | 4-Methylpiperidin-2-one | ESD-897140-10G |
Cas.: 195140-86-4 | Purity: 98% | 6-Isopropoxynicotinonitrile | ESD-897141-250MG |
Cas.: 195140-86-4 | Purity: 98% | 6-Isopropoxynicotinonitrile | ESD-897141-1G |
Cas.: 195140-86-4 | Purity: 98% | 6-Isopropoxynicotinonitrile | ESD-897141-5G |
Cas.: 195140-86-4 | Purity: 98% | 6-Isopropoxynicotinonitrile | ESD-897141-10G |
Cas.: 572910-59-9 | Purity: 97% | Methyl 6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | ESD-897142-250MG |
Cas.: 572910-59-9 | Purity: 97% | Methyl 6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | ESD-897142-1G |
Cas.: 572910-59-9 | Purity: 97% | Methyl 6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | ESD-897142-5G |
Cas.: 572910-59-9 | Purity: 97% | Methyl 6-chloroimidazo[1,2-b]pyridazine-2-carboxylate | ESD-897142-10G |
Cas.: 214852-61-6 | Purity: 97% | Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate | ESD-897143-250MG |
Cas.: 214852-61-6 | Purity: 97% | Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate | ESD-897143-1G |
Cas.: 214852-61-6 | Purity: 97% | Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate | ESD-897143-5G |
Cas.: 214852-61-6 | Purity: 97% | Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate | ESD-897143-10G |
Cas.: 159877-47-1 | Purity: 97% | (R)-Methyl 3-((tert-butoxycarbonyl)amino)butanoate | ESD-897144-250MG |
Cas.: 159877-47-1 | Purity: 97% | (R)-Methyl 3-((tert-butoxycarbonyl)amino)butanoate | ESD-897144-1G |
Cas.: 159877-47-1 | Purity: 97% | (R)-Methyl 3-((tert-butoxycarbonyl)amino)butanoate | ESD-897144-5G |
Cas.: 159877-47-1 | Purity: 97% | (R)-Methyl 3-((tert-butoxycarbonyl)amino)butanoate | ESD-897144-10G |
Cas.: 858956-25-9 | Purity: 97% | 2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid | ESD-897145-250MG |
Cas.: 858956-25-9 | Purity: 97% | 2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid | ESD-897145-1G |
Cas.: 858956-25-9 | Purity: 97% | 2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid | ESD-897145-5G |
Cas.: 858956-25-9 | Purity: 97% | 2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid | ESD-897145-10G |
Cas.: 307951-53-7 | Purity: 95% | 4-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897146-250MG |
Cas.: 307951-53-7 | Purity: 95% | 4-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897146-1G |
Cas.: 307951-53-7 | Purity: 95% | 4-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897146-5G |
Cas.: 307951-53-7 | Purity: 95% | 4-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897146-10G |
Cas.: 248921-67-7 | Purity: 97% | Boc-D-Ser(tBu)-OH.DCHA | ESD-897147-250MG |
Cas.: 248921-67-7 | Purity: 97% | Boc-D-Ser(tBu)-OH.DCHA | ESD-897147-1G |
Cas.: 248921-67-7 | Purity: 97% | Boc-D-Ser(tBu)-OH.DCHA | ESD-897147-5G |
Cas.: 248921-67-7 | Purity: 97% | Boc-D-Ser(tBu)-OH.DCHA | ESD-897147-10G |
Cas.: 13735-13-2 | Purity: ≥95% | 6-Bromothiochroman-4-one | ESD-897148-250MG |
Cas.: 13735-13-2 | Purity: ≥95% | 6-Bromothiochroman-4-one | ESD-897148-1G |
Cas.: 13735-13-2 | Purity: ≥95% | 6-Bromothiochroman-4-one | ESD-897148-5G |
Cas.: 13735-13-2 | Purity: ≥95% | 6-Bromothiochroman-4-one | ESD-897148-10G |
Cas.: 1185156-19-7 | Purity: ≥95% | (1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-897149-250MG |
Cas.: 1185156-19-7 | Purity: ≥95% | (1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-897149-1G |
Cas.: 1185156-19-7 | Purity: ≥95% | (1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-897149-5G |
Cas.: 1185156-19-7 | Purity: ≥95% | (1,4-Dioxan-2-yl)methanamine hydrochloride | ESD-897149-10G |
Cas.: 6628-74-6 | Purity: 97% | 2-(Pyrrolidin-1-yl)acetic acid hydrochloride | ESD-897150-250MG |
Cas.: 6628-74-6 | Purity: 97% | 2-(Pyrrolidin-1-yl)acetic acid hydrochloride | ESD-897150-1G |
Cas.: 6628-74-6 | Purity: 97% | 2-(Pyrrolidin-1-yl)acetic acid hydrochloride | ESD-897150-5G |
Cas.: 6628-74-6 | Purity: 97% | 2-(Pyrrolidin-1-yl)acetic acid hydrochloride | ESD-897150-10G |
Cas.: 1211443-58-1 | Purity: ≥97% | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-897151-250MG |
Cas.: 1211443-58-1 | Purity: ≥97% | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-897151-1G |
Cas.: 1211443-58-1 | Purity: ≥97% | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-897151-5G |
Cas.: 1211443-58-1 | Purity: ≥97% | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-897151-10G |
Cas.: 134575-14-7 | Purity: ≥95% | exo-Benzyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | ESD-897152-250MG |
Cas.: 134575-14-7 | Purity: ≥95% | exo-Benzyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | ESD-897152-1G |
Cas.: 134575-14-7 | Purity: ≥95% | exo-Benzyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | ESD-897152-5G |
Cas.: 134575-14-7 | Purity: ≥95% | exo-Benzyl 6-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | ESD-897152-10G |
Cas.: 82317-82-6 | Purity: 97% | Boc-D-Phe(3-CF3)-OH | ESD-897153-250MG |
Cas.: 82317-82-6 | Purity: 97% | Boc-D-Phe(3-CF3)-OH | ESD-897153-1G |
Cas.: 82317-82-6 | Purity: 97% | Boc-D-Phe(3-CF3)-OH | ESD-897153-5G |
Cas.: 82317-82-6 | Purity: 97% | Boc-D-Phe(3-CF3)-OH | ESD-897153-10G |
Cas.: 51175-79-2 | Purity: 97% | Methyl 1-bromocyclobutanecarboxylate | ESD-897154-250MG |
Cas.: 51175-79-2 | Purity: 97% | Methyl 1-bromocyclobutanecarboxylate | ESD-897154-1G |
Cas.: 51175-79-2 | Purity: 97% | Methyl 1-bromocyclobutanecarboxylate | ESD-897154-5G |
Cas.: 51175-79-2 | Purity: 97% | Methyl 1-bromocyclobutanecarboxylate | ESD-897154-10G |
Cas.: 4042-35-7 | Purity: 98% | (S)-4-Methyloxazolidin-2-one | ESD-897155-250MG |
Cas.: 4042-35-7 | Purity: 98% | (S)-4-Methyloxazolidin-2-one | ESD-897155-1G |
Cas.: 4042-35-7 | Purity: 98% | (S)-4-Methyloxazolidin-2-one | ESD-897155-5G |
Cas.: 4042-35-7 | Purity: 98% | (S)-4-Methyloxazolidin-2-one | ESD-897155-10G |
Cas.: 380380-60-9 | Purity: 95% | 5-Bromo-2-(2H-tetrazol-5-yl)pyridine | ESD-897156-250MG |
Cas.: 380380-60-9 | Purity: 95% | 5-Bromo-2-(2H-tetrazol-5-yl)pyridine | ESD-897156-1G |
Cas.: 380380-60-9 | Purity: 95% | 5-Bromo-2-(2H-tetrazol-5-yl)pyridine | ESD-897156-5G |
Cas.: 380380-60-9 | Purity: 95% | 5-Bromo-2-(2H-tetrazol-5-yl)pyridine | ESD-897156-10G |
Cas.: 485841-48-3 | Purity: 98% | 5-Fluoro-1H-indazole-3-carbaldehyde | ESD-897157-250MG |
Cas.: 485841-48-3 | Purity: 98% | 5-Fluoro-1H-indazole-3-carbaldehyde | ESD-897157-1G |
Cas.: 485841-48-3 | Purity: 98% | 5-Fluoro-1H-indazole-3-carbaldehyde | ESD-897157-5G |
Cas.: 485841-48-3 | Purity: 98% | 5-Fluoro-1H-indazole-3-carbaldehyde | ESD-897157-10G |
Cas.: 951626-91-8 | Purity: 97% | 5-Bromo-3-chloro-1H-pyrrolo[2,3-b]pyridine | ESD-897158-250MG |
Cas.: 951626-91-8 | Purity: 97% | 5-Bromo-3-chloro-1H-pyrrolo[2,3-b]pyridine | ESD-897158-1G |
Cas.: 951626-91-8 | Purity: 97% | 5-Bromo-3-chloro-1H-pyrrolo[2,3-b]pyridine | ESD-897158-5G |
Cas.: 951626-91-8 | Purity: 97% | 5-Bromo-3-chloro-1H-pyrrolo[2,3-b]pyridine | ESD-897158-10G |
Cas.: 32946-56-8 | Purity: 97% | H-His(Trt)-OMe.HCl | ESD-897159-250MG |
Cas.: 32946-56-8 | Purity: 97% | H-His(Trt)-OMe.HCl | ESD-897159-1G |
Cas.: 32946-56-8 | Purity: 97% | H-His(Trt)-OMe.HCl | ESD-897159-5G |
Cas.: 32946-56-8 | Purity: 97% | H-His(Trt)-OMe.HCl | ESD-897159-10G |
Cas.: 5963-77-9 | Purity: ≥95% | Pent-2-ynoic acid | ESD-897160-250MG |
Cas.: 5963-77-9 | Purity: ≥95% | Pent-2-ynoic acid | ESD-897160-1G |
Cas.: 5963-77-9 | Purity: ≥95% | Pent-2-ynoic acid | ESD-897160-5G |
Cas.: 5963-77-9 | Purity: ≥95% | Pent-2-ynoic acid | ESD-897160-10G |
Cas.: 1312535-78-6 | Purity: 97% | 1-(2-Chloropyrimidin-4-yl)ethanone | ESD-897161-250MG |
Cas.: 1312535-78-6 | Purity: 97% | 1-(2-Chloropyrimidin-4-yl)ethanone | ESD-897161-1G |
Cas.: 1312535-78-6 | Purity: 97% | 1-(2-Chloropyrimidin-4-yl)ethanone | ESD-897161-5G |
Cas.: 1312535-78-6 | Purity: 97% | 1-(2-Chloropyrimidin-4-yl)ethanone | ESD-897161-10G |
Cas.: 37993-32-1 | Purity: ≥97% | Methyl 1-aminocyclohexanecarboxylate hydrochloride | ESD-897162-250MG |
Cas.: 37993-32-1 | Purity: ≥97% | Methyl 1-aminocyclohexanecarboxylate hydrochloride | ESD-897162-1G |
Cas.: 37993-32-1 | Purity: ≥97% | Methyl 1-aminocyclohexanecarboxylate hydrochloride | ESD-897162-5G |
Cas.: 37993-32-1 | Purity: ≥97% | Methyl 1-aminocyclohexanecarboxylate hydrochloride | ESD-897162-10G |
Cas.: 454-65-9 | Purity: 98% | 3-Bromobenzene-1-sulfonyl fluoride | ESD-897163-250MG |
Cas.: 454-65-9 | Purity: 98% | 3-Bromobenzene-1-sulfonyl fluoride | ESD-897163-1G |
Cas.: 454-65-9 | Purity: 98% | 3-Bromobenzene-1-sulfonyl fluoride | ESD-897163-5G |
Cas.: 454-65-9 | Purity: 98% | 3-Bromobenzene-1-sulfonyl fluoride | ESD-897163-10G |
Cas.: 1008361-65-6 | Purity: 97% | 5-Bromo-6-methoxy-1H-benzo[d]imidazole | ESD-897164-250MG |
Cas.: 1008361-65-6 | Purity: 97% | 5-Bromo-6-methoxy-1H-benzo[d]imidazole | ESD-897164-1G |
Cas.: 1008361-65-6 | Purity: 97% | 5-Bromo-6-methoxy-1H-benzo[d]imidazole | ESD-897164-5G |
Cas.: 1008361-65-6 | Purity: 97% | 5-Bromo-6-methoxy-1H-benzo[d]imidazole | ESD-897164-10G |
Cas.: 1260901-96-9 | Purity: 97% | 2-(2-Bromoethyl)-2H-1,2,3-triazole | ESD-897165-250MG |
Cas.: 1260901-96-9 | Purity: 97% | 2-(2-Bromoethyl)-2H-1,2,3-triazole | ESD-897165-1G |
Cas.: 1260901-96-9 | Purity: 97% | 2-(2-Bromoethyl)-2H-1,2,3-triazole | ESD-897165-5G |
Cas.: 1260901-96-9 | Purity: 97% | 2-(2-Bromoethyl)-2H-1,2,3-triazole | ESD-897165-10G |
Cas.: 182438-98-8 | Purity: 97% | 9-(4-Bromobutyl)-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide | ESD-897166-250MG |
Cas.: 182438-98-8 | Purity: 97% | 9-(4-Bromobutyl)-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide | ESD-897166-1G |
Cas.: 182438-98-8 | Purity: 97% | 9-(4-Bromobutyl)-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide | ESD-897166-5G |
Cas.: 182438-98-8 | Purity: 97% | 9-(4-Bromobutyl)-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide | ESD-897166-10G |
Cas.: 373608-42-5 | Purity: 97% | 1-(Cyclopropylmethyl)piperazine dihydrochloride | ESD-897167-250MG |
Cas.: 373608-42-5 | Purity: 97% | 1-(Cyclopropylmethyl)piperazine dihydrochloride | ESD-897167-1G |
Cas.: 373608-42-5 | Purity: 97% | 1-(Cyclopropylmethyl)piperazine dihydrochloride | ESD-897167-5G |
Cas.: 373608-42-5 | Purity: 97% | 1-(Cyclopropylmethyl)piperazine dihydrochloride | ESD-897167-10G |
Cas.: 1258283-17-8 | Purity: 97% | Ethyl 4-bromooxazole-5-carboxylate | ESD-897168-250MG |
Cas.: 1258283-17-8 | Purity: 97% | Ethyl 4-bromooxazole-5-carboxylate | ESD-897168-1G |
Cas.: 1258283-17-8 | Purity: 97% | Ethyl 4-bromooxazole-5-carboxylate | ESD-897168-5G |
Cas.: 1258283-17-8 | Purity: 97% | Ethyl 4-bromooxazole-5-carboxylate | ESD-897168-10G |
Cas.: 7556-37-8 | Purity: 97% | 1-Methyl-1H-indol-4-ol | ESD-897169-250MG |
Cas.: 7556-37-8 | Purity: 97% | 1-Methyl-1H-indol-4-ol | ESD-897169-1G |
Cas.: 7556-37-8 | Purity: 97% | 1-Methyl-1H-indol-4-ol | ESD-897169-5G |
Cas.: 7556-37-8 | Purity: 97% | 1-Methyl-1H-indol-4-ol | ESD-897169-10G |
Cas.: 113484-74-5 | Purity: 95% | Fmoc-Gly-OSu | ESD-897170-250MG |
Cas.: 113484-74-5 | Purity: 95% | Fmoc-Gly-OSu | ESD-897170-1G |
Cas.: 113484-74-5 | Purity: 95% | Fmoc-Gly-OSu | ESD-897170-5G |
Cas.: 113484-74-5 | Purity: 95% | Fmoc-Gly-OSu | ESD-897170-10G |
Cas.: 881381-12-0 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde | ESD-897171-250MG |
Cas.: 881381-12-0 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde | ESD-897171-1G |
Cas.: 881381-12-0 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde | ESD-897171-5G |
Cas.: 881381-12-0 | Purity: 98% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde | ESD-897171-10G |
Cas.: 1260242-01-0 | Purity: 97% | (5-Iodo-2-methylphenyl)methanol | ESD-897172-250MG |
Cas.: 1260242-01-0 | Purity: 97% | (5-Iodo-2-methylphenyl)methanol | ESD-897172-1G |
Cas.: 1260242-01-0 | Purity: 97% | (5-Iodo-2-methylphenyl)methanol | ESD-897172-5G |
Cas.: 1260242-01-0 | Purity: 97% | (5-Iodo-2-methylphenyl)methanol | ESD-897172-10G |
Cas.: 96799-02-9 | Purity: ≥95% | 3-(Furan-2-yl)-1H-pyrazol-5-amine | ESD-897173-250MG |
Cas.: 96799-02-9 | Purity: ≥95% | 3-(Furan-2-yl)-1H-pyrazol-5-amine | ESD-897173-1G |
Cas.: 96799-02-9 | Purity: ≥95% | 3-(Furan-2-yl)-1H-pyrazol-5-amine | ESD-897173-5G |
Cas.: 96799-02-9 | Purity: ≥95% | 3-(Furan-2-yl)-1H-pyrazol-5-amine | ESD-897173-10G |
Cas.: 774-67-4 | Purity: 97% | 4-Amino-N-isopropylbenzamide | ESD-897174-250MG |
Cas.: 774-67-4 | Purity: 97% | 4-Amino-N-isopropylbenzamide | ESD-897174-1G |
Cas.: 774-67-4 | Purity: 97% | 4-Amino-N-isopropylbenzamide | ESD-897174-5G |
Cas.: 774-67-4 | Purity: 97% | 4-Amino-N-isopropylbenzamide | ESD-897174-10G |
Cas.: 152775-45-6 | Purity: 97% | 4-Methoxy-3,5-dimethylbenzonitrile | ESD-897175-250MG |
Cas.: 152775-45-6 | Purity: 97% | 4-Methoxy-3,5-dimethylbenzonitrile | ESD-897175-1G |
Cas.: 152775-45-6 | Purity: 97% | 4-Methoxy-3,5-dimethylbenzonitrile | ESD-897175-5G |
Cas.: 152775-45-6 | Purity: 97% | 4-Methoxy-3,5-dimethylbenzonitrile | ESD-897175-10G |
Cas.: 884495-10-7 | Purity: 97% | 4-Bromo-2-chloro-5-fluoropyridine | ESD-897176-250MG |
Cas.: 884495-10-7 | Purity: 97% | 4-Bromo-2-chloro-5-fluoropyridine | ESD-897176-1G |
Cas.: 884495-10-7 | Purity: 97% | 4-Bromo-2-chloro-5-fluoropyridine | ESD-897176-5G |
Cas.: 884495-10-7 | Purity: 97% | 4-Bromo-2-chloro-5-fluoropyridine | ESD-897176-10G |
Cas.: 42972-13-4 | Purity: 95% | 1,4-Dioxo-1,2,3,4-tetrahydrophthalazine-6-carboxylic acid | ESD-897177-250MG |
Cas.: 42972-13-4 | Purity: 95% | 1,4-Dioxo-1,2,3,4-tetrahydrophthalazine-6-carboxylic acid | ESD-897177-1G |
Cas.: 42972-13-4 | Purity: 95% | 1,4-Dioxo-1,2,3,4-tetrahydrophthalazine-6-carboxylic acid | ESD-897177-5G |
Cas.: 1242336-69-1 | Purity: ≥95% | 6-Bromo-5-fluoro-1H-benzo[d][1,2,3]triazole | ESD-897178-250MG |
Cas.: 1242336-69-1 | Purity: ≥95% | 6-Bromo-5-fluoro-1H-benzo[d][1,2,3]triazole | ESD-897178-1G |
Cas.: 1242336-69-1 | Purity: ≥95% | 6-Bromo-5-fluoro-1H-benzo[d][1,2,3]triazole | ESD-897178-5G |
Cas.: 1242336-69-1 | Purity: ≥95% | 6-Bromo-5-fluoro-1H-benzo[d][1,2,3]triazole | ESD-897178-10G |
Cas.: 77476-95-0 | Purity: 98% | (5-Bromopyrimidin-2-yl)isopropylamine | ESD-897179-250MG |
Cas.: 77476-95-0 | Purity: 98% | (5-Bromopyrimidin-2-yl)isopropylamine | ESD-897179-1G |
Cas.: 77476-95-0 | Purity: 98% | (5-Bromopyrimidin-2-yl)isopropylamine | ESD-897179-5G |
Cas.: 77476-95-0 | Purity: 98% | (5-Bromopyrimidin-2-yl)isopropylamine | ESD-897179-10G |
Cas.: 1187595-85-2 | Purity: 97% | 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile | ESD-897180-250MG |
Cas.: 1187595-85-2 | Purity: 97% | 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile | ESD-897180-1G |
Cas.: 1187595-85-2 | Purity: 97% | 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile | ESD-897180-5G |
Cas.: 1187595-85-2 | Purity: 97% | 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile | ESD-897180-10G |
Cas.: 145934-89-0 | Purity: ≥95% | 2-Chloro-5-hydrazinylpyridine | ESD-897181-250MG |
Cas.: 145934-89-0 | Purity: ≥95% | 2-Chloro-5-hydrazinylpyridine | ESD-897181-1G |
Cas.: 145934-89-0 | Purity: ≥95% | 2-Chloro-5-hydrazinylpyridine | ESD-897181-5G |
Cas.: 145934-89-0 | Purity: ≥95% | 2-Chloro-5-hydrazinylpyridine | ESD-897181-10G |
Cas.: 2538-50-3 | Purity: 97% | 3-(Methylamino)-1-phenylpropan-1-one hydrochloride | ESD-897182-250MG |
Cas.: 2538-50-3 | Purity: 97% | 3-(Methylamino)-1-phenylpropan-1-one hydrochloride | ESD-897182-1G |
Cas.: 2538-50-3 | Purity: 97% | 3-(Methylamino)-1-phenylpropan-1-one hydrochloride | ESD-897182-5G |
Cas.: 2538-50-3 | Purity: 97% | 3-(Methylamino)-1-phenylpropan-1-one hydrochloride | ESD-897182-10G |
Cas.: 7147-90-2 | Purity: 98% | 5-Chloroisoindoline-1,3-dione | ESD-897183-250MG |
Cas.: 7147-90-2 | Purity: 98% | 5-Chloroisoindoline-1,3-dione | ESD-897183-1G |
Cas.: 7147-90-2 | Purity: 98% | 5-Chloroisoindoline-1,3-dione | ESD-897183-5G |
Cas.: 7147-90-2 | Purity: 98% | 5-Chloroisoindoline-1,3-dione | ESD-897183-10G |
Cas.: 1242339-67-8 | Purity: 97% | 2-Chloro-4,6-difluorobenzoic acid | ESD-897184-250MG |
Cas.: 1242339-67-8 | Purity: 97% | 2-Chloro-4,6-difluorobenzoic acid | ESD-897184-1G |
Cas.: 1242339-67-8 | Purity: 97% | 2-Chloro-4,6-difluorobenzoic acid | ESD-897184-5G |
Cas.: 1242339-67-8 | Purity: 97% | 2-Chloro-4,6-difluorobenzoic acid | ESD-897184-10G |
Cas.: 845866-92-4 | Purity: 97% | 6-Amino-3-bromo-2-fluorobenzonitrile | ESD-897185-250MG |
Cas.: 845866-92-4 | Purity: 97% | 6-Amino-3-bromo-2-fluorobenzonitrile | ESD-897185-1G |
Cas.: 845866-92-4 | Purity: 97% | 6-Amino-3-bromo-2-fluorobenzonitrile | ESD-897185-5G |
Cas.: 845866-92-4 | Purity: 97% | 6-Amino-3-bromo-2-fluorobenzonitrile | ESD-897185-10G |
Cas.: 103626-03-5 | Purity: 97% | Ethyl 1-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate | ESD-897186-250MG |
Cas.: 103626-03-5 | Purity: 97% | Ethyl 1-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate | ESD-897186-1G |
Cas.: 103626-03-5 | Purity: 97% | Ethyl 1-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate | ESD-897186-5G |
Cas.: 103626-03-5 | Purity: 97% | Ethyl 1-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate | ESD-897186-10G |
Cas.: 1262396-04-2 | Purity: ≥95% | Methyl 2-bromo-4-fluoro-6-methylbenzoate | ESD-897187-250MG |
Cas.: 1262396-04-2 | Purity: ≥95% | Methyl 2-bromo-4-fluoro-6-methylbenzoate | ESD-897187-1G |
Cas.: 1262396-04-2 | Purity: ≥95% | Methyl 2-bromo-4-fluoro-6-methylbenzoate | ESD-897187-5G |
Cas.: 1262396-04-2 | Purity: ≥95% | Methyl 2-bromo-4-fluoro-6-methylbenzoate | ESD-897187-10G |
Cas.: 37805-78-0 | Purity: 98% | 6-Bromo-3-methyl-3H-imidazo[4,5-b]pyridine | ESD-897188-250MG |
Cas.: 37805-78-0 | Purity: 98% | 6-Bromo-3-methyl-3H-imidazo[4,5-b]pyridine | ESD-897188-1G |
Cas.: 37805-78-0 | Purity: 98% | 6-Bromo-3-methyl-3H-imidazo[4,5-b]pyridine | ESD-897188-5G |
Cas.: 37805-78-0 | Purity: 98% | 6-Bromo-3-methyl-3H-imidazo[4,5-b]pyridine | ESD-897188-10G |
Cas.: 1142191-66-9 | Purity: ≥95% | 5-Bromo-3-methoxypicolinic acid | ESD-897189-250MG |
Cas.: 1142191-66-9 | Purity: ≥95% | 5-Bromo-3-methoxypicolinic acid | ESD-897189-1G |
Cas.: 1142191-66-9 | Purity: ≥95% | 5-Bromo-3-methoxypicolinic acid | ESD-897189-5G |
Cas.: 1142191-66-9 | Purity: ≥95% | 5-Bromo-3-methoxypicolinic acid | ESD-897189-10G |
Cas.: 27762-64-7 | Purity: ≥95% | (Cyclohexylmethyl)boronic acid | ESD-897190-250MG |
Cas.: 27762-64-7 | Purity: ≥95% | (Cyclohexylmethyl)boronic acid | ESD-897190-1G |
Cas.: 27762-64-7 | Purity: ≥95% | (Cyclohexylmethyl)boronic acid | ESD-897190-5G |
Cas.: 27762-64-7 | Purity: ≥95% | (Cyclohexylmethyl)boronic acid | ESD-897190-10G |
Cas.: 60588-81-0 | Purity: 97% | (3-Chloropyridin-2-yl)methanol | ESD-897191-250MG |
Cas.: 60588-81-0 | Purity: 97% | (3-Chloropyridin-2-yl)methanol | ESD-897191-1G |
Cas.: 60588-81-0 | Purity: 97% | (3-Chloropyridin-2-yl)methanol | ESD-897191-5G |
Cas.: 60588-81-0 | Purity: 97% | (3-Chloropyridin-2-yl)methanol | ESD-897191-10G |
Cas.: 77603-45-3 | Purity: ≥95% | 5-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-897192-250MG |
Cas.: 77603-45-3 | Purity: ≥95% | 5-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-897192-1G |
Cas.: 77603-45-3 | Purity: ≥95% | 5-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-897192-5G |
Cas.: 77603-45-3 | Purity: ≥95% | 5-Bromo-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-897192-10G |
Cas.: 883231-23-0 | Purity: 97% | N-Boc-2-Amino-5-bromopyrimidine | ESD-897193-250MG |
Cas.: 883231-23-0 | Purity: 97% | N-Boc-2-Amino-5-bromopyrimidine | ESD-897193-1G |
Cas.: 883231-23-0 | Purity: 97% | N-Boc-2-Amino-5-bromopyrimidine | ESD-897193-5G |
Cas.: 883231-23-0 | Purity: 97% | N-Boc-2-Amino-5-bromopyrimidine | ESD-897193-10G |
Cas.: 1273577-14-2 | Purity: 97% | (R)-Morpholine-2-carboxylic acid hydrochloride | ESD-897194-250MG |
Cas.: 1273577-14-2 | Purity: 97% | (R)-Morpholine-2-carboxylic acid hydrochloride | ESD-897194-1G |
Cas.: 1273577-14-2 | Purity: 97% | (R)-Morpholine-2-carboxylic acid hydrochloride | ESD-897194-5G |
Cas.: 1273577-14-2 | Purity: 97% | (R)-Morpholine-2-carboxylic acid hydrochloride | ESD-897194-10G |
Cas.: 331765-71-0 | Purity: 96% | 3,5-Difluoro-2-nitrobenzoic acid | ESD-897195-250MG |
Cas.: 331765-71-0 | Purity: 96% | 3,5-Difluoro-2-nitrobenzoic acid | ESD-897195-1G |
Cas.: 331765-71-0 | Purity: 96% | 3,5-Difluoro-2-nitrobenzoic acid | ESD-897195-5G |
Cas.: 331765-71-0 | Purity: 96% | 3,5-Difluoro-2-nitrobenzoic acid | ESD-897195-10G |
Cas.: 55736-69-1 | Purity: 97% | 1-(2-Bromo-6-hydroxyphenyl)ethanone | ESD-897196-250MG |
Cas.: 55736-69-1 | Purity: 97% | 1-(2-Bromo-6-hydroxyphenyl)ethanone | ESD-897196-1G |
Cas.: 55736-69-1 | Purity: 97% | 1-(2-Bromo-6-hydroxyphenyl)ethanone | ESD-897196-5G |
Cas.: 55736-69-1 | Purity: 97% | 1-(2-Bromo-6-hydroxyphenyl)ethanone | ESD-897196-10G |
Cas.: 57053-02-8 | Purity: 98% | Dimethyl 2-aminoisophthalate | ESD-897197-250MG |
Cas.: 57053-02-8 | Purity: 98% | Dimethyl 2-aminoisophthalate | ESD-897197-1G |
Cas.: 57053-02-8 | Purity: 98% | Dimethyl 2-aminoisophthalate | ESD-897197-5G |
Cas.: 57053-02-8 | Purity: 98% | Dimethyl 2-aminoisophthalate | ESD-897197-10G |
Cas.: 16881-33-7 | Purity: 97% | Z-Tyr-OtBu | ESD-897198-250MG |
Cas.: 16881-33-7 | Purity: 97% | Z-Tyr-OtBu | ESD-897198-1G |
Cas.: 16881-33-7 | Purity: 97% | Z-Tyr-OtBu | ESD-897198-5G |
Cas.: 16881-33-7 | Purity: 97% | Z-Tyr-OtBu | ESD-897198-10G |
Cas.: 7498-54-6 | Purity: ≥95% | 3-(tert-Butyl)benzoic acid | ESD-897199-250MG |
Cas.: 7498-54-6 | Purity: ≥95% | 3-(tert-Butyl)benzoic acid | ESD-897199-1G |
Cas.: 7498-54-6 | Purity: ≥95% | 3-(tert-Butyl)benzoic acid | ESD-897199-5G |
Cas.: 7498-54-6 | Purity: ≥95% | 3-(tert-Butyl)benzoic acid | ESD-897199-10G |
Cas.: 935288-20-3 | Purity: 95% | 1-Bromo-4-fluoro-2-methoxy-5-nitrobenzene | ESD-897200-250MG |
Cas.: 935288-20-3 | Purity: 95% | 1-Bromo-4-fluoro-2-methoxy-5-nitrobenzene | ESD-897200-1G |
Cas.: 935288-20-3 | Purity: 95% | 1-Bromo-4-fluoro-2-methoxy-5-nitrobenzene | ESD-897200-5G |
Cas.: 935288-20-3 | Purity: 95% | 1-Bromo-4-fluoro-2-methoxy-5-nitrobenzene | ESD-897200-10G |
Cas.: 58142-97-5 | Purity: 97% | 1-Chloro-5-nitroisoquinoline | ESD-897201-250MG |
Cas.: 58142-97-5 | Purity: 97% | 1-Chloro-5-nitroisoquinoline | ESD-897201-1G |
Cas.: 139551-74-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4,4-dimethylpentanoic acid | ESD-897202-250MG |
Cas.: 139551-74-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4,4-dimethylpentanoic acid | ESD-897202-1G |
Cas.: 139551-74-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4,4-dimethylpentanoic acid | ESD-897202-5G |
Cas.: 139551-74-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4,4-dimethylpentanoic acid | ESD-897202-10G |
Cas.: 1228014-10-5 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2-((trimethylsilyl)oxy)propan-2-yl)pyridine | ESD-897203-250MG |
Cas.: 1228014-10-5 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2-((trimethylsilyl)oxy)propan-2-yl)pyridine | ESD-897203-1G |
Cas.: 1228014-10-5 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2-((trimethylsilyl)oxy)propan-2-yl)pyridine | ESD-897203-5G |
Cas.: 1228014-10-5 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2-((trimethylsilyl)oxy)propan-2-yl)pyridine | ESD-897203-10G |
Cas.: 14389-06-1 | Purity: 97% | 5-Chloro-7-methylindoline-2,3-dione | ESD-897204-250MG |
Cas.: 14389-06-1 | Purity: 97% | 5-Chloro-7-methylindoline-2,3-dione | ESD-897204-1G |
Cas.: 14389-06-1 | Purity: 97% | 5-Chloro-7-methylindoline-2,3-dione | ESD-897204-5G |
Cas.: 14389-06-1 | Purity: 97% | 5-Chloro-7-methylindoline-2,3-dione | ESD-897204-10G |
Cas.: 1314931-66-2 | Purity: 95% | tert-Butyloxazol-4-ylcarbamate | ESD-897205-250MG |
Cas.: 1314931-66-2 | Purity: 95% | tert-Butyloxazol-4-ylcarbamate | ESD-897205-1G |
Cas.: 1314931-66-2 | Purity: 95% | tert-Butyloxazol-4-ylcarbamate | ESD-897205-5G |
Cas.: 1314931-66-2 | Purity: 95% | tert-Butyloxazol-4-ylcarbamate | ESD-897205-10G |
Cas.: 83405-71-4 | Purity: ≥95% | 3-(tert-Butyl)-1H-pyrazole-5-carboxylic acid | ESD-897206-250MG |
Cas.: 83405-71-4 | Purity: ≥95% | 3-(tert-Butyl)-1H-pyrazole-5-carboxylic acid | ESD-897206-1G |
Cas.: 83405-71-4 | Purity: ≥95% | 3-(tert-Butyl)-1H-pyrazole-5-carboxylic acid | ESD-897206-5G |
Cas.: 83405-71-4 | Purity: ≥95% | 3-(tert-Butyl)-1H-pyrazole-5-carboxylic acid | ESD-897206-10G |
Cas.: 5767-35-1 | Purity: 98% | 4-Chloro-6-hydrazinopyrimidine | ESD-897207-250MG |
Cas.: 5767-35-1 | Purity: 98% | 4-Chloro-6-hydrazinopyrimidine | ESD-897207-1G |
Cas.: 5767-35-1 | Purity: 98% | 4-Chloro-6-hydrazinopyrimidine | ESD-897207-5G |
Cas.: 5767-35-1 | Purity: 98% | 4-Chloro-6-hydrazinopyrimidine | ESD-897207-10G |
Cas.: 170941-79-4 | Purity: 97% | Fmoc-Gly-Gly-Gly-OH | ESD-897208-250MG |
Cas.: 170941-79-4 | Purity: 97% | Fmoc-Gly-Gly-Gly-OH | ESD-897208-1G |
Cas.: 170941-79-4 | Purity: 97% | Fmoc-Gly-Gly-Gly-OH | ESD-897208-5G |
Cas.: 170941-79-4 | Purity: 97% | Fmoc-Gly-Gly-Gly-OH | ESD-897208-10G |
Cas.: 1289215-25-3 | Purity: 97% | 5-Bromo-2-chloro-4-isopropoxypyrimidine | ESD-897209-250MG |
Cas.: 1289215-25-3 | Purity: 97% | 5-Bromo-2-chloro-4-isopropoxypyrimidine | ESD-897209-1G |
Cas.: 1289215-25-3 | Purity: 97% | 5-Bromo-2-chloro-4-isopropoxypyrimidine | ESD-897209-5G |
Cas.: 1289215-25-3 | Purity: 97% | 5-Bromo-2-chloro-4-isopropoxypyrimidine | ESD-897209-10G |
Cas.: 6249-56-5 | Purity: 97% | 3-Carboxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-897210-250MG |
Cas.: 6249-56-5 | Purity: 97% | 3-Carboxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-897210-1G |
Cas.: 6249-56-5 | Purity: 97% | 3-Carboxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-897210-5G |
Cas.: 6249-56-5 | Purity: 97% | 3-Carboxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-897210-10G |
Cas.: 262353-35-5 | Purity: ≥95% | 2-Iodo-4-methoxypyrimidine | ESD-897211-250MG |
Cas.: 262353-35-5 | Purity: ≥95% | 2-Iodo-4-methoxypyrimidine | ESD-897211-1G |
Cas.: 262353-35-5 | Purity: ≥95% | 2-Iodo-4-methoxypyrimidine | ESD-897211-5G |
Cas.: 262353-35-5 | Purity: ≥95% | 2-Iodo-4-methoxypyrimidine | ESD-897211-10G |
Cas.: 478837-18-2 | Purity: 98% | tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-897212-250MG |
Cas.: 478837-18-2 | Purity: 98% | tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-897212-1G |
Cas.: 478837-18-2 | Purity: 98% | tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-897212-5G |
Cas.: 478837-18-2 | Purity: 98% | tert-Butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate | ESD-897212-10G |
Cas.: 1189169-37-6 | Purity: 98% | 1-(5-Bromopyrimidin-2-yl)ethanone | ESD-897213-250MG |
Cas.: 1189169-37-6 | Purity: 98% | 1-(5-Bromopyrimidin-2-yl)ethanone | ESD-897213-1G |
Cas.: 1189169-37-6 | Purity: 98% | 1-(5-Bromopyrimidin-2-yl)ethanone | ESD-897213-5G |
Cas.: 1189169-37-6 | Purity: 98% | 1-(5-Bromopyrimidin-2-yl)ethanone | ESD-897213-10G |
Cas.: 132213-07-1 | Purity: 97% | Imidazo[1,2-a]pyridin-6-ylmethanol | ESD-897214-250MG |
Cas.: 132213-07-1 | Purity: 97% | Imidazo[1,2-a]pyridin-6-ylmethanol | ESD-897214-1G |
Cas.: 132213-07-1 | Purity: 97% | Imidazo[1,2-a]pyridin-6-ylmethanol | ESD-897214-5G |
Cas.: 132213-07-1 | Purity: 97% | Imidazo[1,2-a]pyridin-6-ylmethanol | ESD-897214-10G |
Cas.: 3397-35-1 | Purity: ≥95% | Z-Leu-Osu | ESD-897215-250MG |
Cas.: 3397-35-1 | Purity: ≥95% | Z-Leu-Osu | ESD-897215-1G |
Cas.: 3397-35-1 | Purity: ≥95% | Z-Leu-Osu | ESD-897215-5G |
Cas.: 3397-35-1 | Purity: ≥95% | Z-Leu-Osu | ESD-897215-10G |
Cas.: 133427-08-4 | Purity: 97% | Imidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897216-250MG |
Cas.: 133427-08-4 | Purity: 97% | Imidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897216-1G |
Cas.: 133427-08-4 | Purity: 97% | Imidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897216-5G |
Cas.: 133427-08-4 | Purity: 97% | Imidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897216-10G |
Cas.: 51219-19-3 | Purity: 97% | Boc-Arg(Z)2-OH | ESD-897217-250MG |
Cas.: 51219-19-3 | Purity: 97% | Boc-Arg(Z)2-OH | ESD-897217-1G |
Cas.: 51219-19-3 | Purity: 97% | Boc-Arg(Z)2-OH | ESD-897217-5G |
Cas.: 51219-19-3 | Purity: 97% | Boc-Arg(Z)2-OH | ESD-897217-10G |
Cas.: 62456-15-9 | Purity: 97% | trans-Methyl 4-aminocyclohexanecarboxylate | ESD-897218-250MG |
Cas.: 62456-15-9 | Purity: 97% | trans-Methyl 4-aminocyclohexanecarboxylate | ESD-897218-1G |
Cas.: 62456-15-9 | Purity: 97% | trans-Methyl 4-aminocyclohexanecarboxylate | ESD-897218-5G |
Cas.: 62456-15-9 | Purity: 97% | trans-Methyl 4-aminocyclohexanecarboxylate | ESD-897218-10G |
Cas.: 71412-22-1 | Purity: ≥95% | 2,3-Dihydroquinolin-4(1H)-one hydrochloride | ESD-897219-250MG |
Cas.: 71412-22-1 | Purity: ≥95% | 2,3-Dihydroquinolin-4(1H)-one hydrochloride | ESD-897219-1G |
Cas.: 71412-22-1 | Purity: ≥95% | 2,3-Dihydroquinolin-4(1H)-one hydrochloride | ESD-897219-5G |
Cas.: 71412-22-1 | Purity: ≥95% | 2,3-Dihydroquinolin-4(1H)-one hydrochloride | ESD-897219-10G |
Cas.: 960225-75-6 | Purity: ≥95% | 5-Methyl-4-nitro-3-isoxazolecarboxylic acid | ESD-897220-250MG |
Cas.: 960225-75-6 | Purity: ≥95% | 5-Methyl-4-nitro-3-isoxazolecarboxylic acid | ESD-897220-1G |
Cas.: 960225-75-6 | Purity: ≥95% | 5-Methyl-4-nitro-3-isoxazolecarboxylic acid | ESD-897220-5G |
Cas.: 960225-75-6 | Purity: ≥95% | 5-Methyl-4-nitro-3-isoxazolecarboxylic acid | ESD-897220-10G |
Cas.: 98273-59-7 | Purity: 98% | 4-Bromo-2-iodo-1-methoxybenzene | ESD-897221-250MG |
Cas.: 98273-59-7 | Purity: 98% | 4-Bromo-2-iodo-1-methoxybenzene | ESD-897221-1G |
Cas.: 98273-59-7 | Purity: 98% | 4-Bromo-2-iodo-1-methoxybenzene | ESD-897221-5G |
Cas.: 98273-59-7 | Purity: 98% | 4-Bromo-2-iodo-1-methoxybenzene | ESD-897221-10G |
Cas.: 1219741-79-3 | Purity: ≥95% | 4-Bromo-5-fluoro-2-iodoaniline | ESD-897222-250MG |
Cas.: 1219741-79-3 | Purity: ≥95% | 4-Bromo-5-fluoro-2-iodoaniline | ESD-897222-1G |
Cas.: 1219741-79-3 | Purity: ≥95% | 4-Bromo-5-fluoro-2-iodoaniline | ESD-897222-5G |
Cas.: 1219741-79-3 | Purity: ≥95% | 4-Bromo-5-fluoro-2-iodoaniline | ESD-897222-10G |
Cas.: 1591-37-3 | Purity: 98% | 2-Amino-6-methoxybenzonitrile | ESD-897223-250MG |
Cas.: 1591-37-3 | Purity: 98% | 2-Amino-6-methoxybenzonitrile | ESD-897223-1G |
Cas.: 1591-37-3 | Purity: 98% | 2-Amino-6-methoxybenzonitrile | ESD-897223-5G |
Cas.: 1591-37-3 | Purity: 98% | 2-Amino-6-methoxybenzonitrile | ESD-897223-10G |
Cas.: 903129-78-2 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897224-250MG |
Cas.: 903129-78-2 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897224-1G |
Cas.: 903129-78-2 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897224-5G |
Cas.: 903129-78-2 | Purity: 97% | 6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid | ESD-897224-10G |
Cas.: 1039055-46-3 | Purity: 97% | tert-Butyl (5-aminopyridin-2-yl)(methyl)carbamate | ESD-897225-250MG |
Cas.: 1039055-46-3 | Purity: 97% | tert-Butyl (5-aminopyridin-2-yl)(methyl)carbamate | ESD-897225-1G |
Cas.: 1039055-46-3 | Purity: 97% | tert-Butyl (5-aminopyridin-2-yl)(methyl)carbamate | ESD-897225-5G |
Cas.: 1039055-46-3 | Purity: 97% | tert-Butyl (5-aminopyridin-2-yl)(methyl)carbamate | ESD-897225-10G |
Cas.: 307503-19-1 | Purity: ≥95% | 3-Iodoimidazo[1,2-a]pyridine | ESD-897226-250MG |
Cas.: 307503-19-1 | Purity: ≥95% | 3-Iodoimidazo[1,2-a]pyridine | ESD-897226-1G |
Cas.: 307503-19-1 | Purity: ≥95% | 3-Iodoimidazo[1,2-a]pyridine | ESD-897226-5G |
Cas.: 307503-19-1 | Purity: ≥95% | 3-Iodoimidazo[1,2-a]pyridine | ESD-897226-10G |
Cas.: 761440-26-0 | Purity: 98% | 1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine | ESD-897227-250MG |
Cas.: 761440-26-0 | Purity: 98% | 1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine | ESD-897227-1G |
Cas.: 761440-26-0 | Purity: 98% | 1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine | ESD-897227-5G |
Cas.: 761440-26-0 | Purity: 98% | 1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine | ESD-897227-10G |
Cas.: 63878-73-9 | Purity: 97% | (2-Fluoro-5-nitrophenyl)methanol | ESD-897228-250MG |
Cas.: 63878-73-9 | Purity: 97% | (2-Fluoro-5-nitrophenyl)methanol | ESD-897228-1G |
Cas.: 63878-73-9 | Purity: 97% | (2-Fluoro-5-nitrophenyl)methanol | ESD-897228-5G |
Cas.: 63878-73-9 | Purity: 97% | (2-Fluoro-5-nitrophenyl)methanol | ESD-897228-10G |
Cas.: 118863-62-0 | Purity: ≥95% | 3-(4-Bromophenyl)-1H-[1,2,4]triazole | ESD-897229-250MG |
Cas.: 118863-62-0 | Purity: ≥95% | 3-(4-Bromophenyl)-1H-[1,2,4]triazole | ESD-897229-1G |
Cas.: 118863-62-0 | Purity: ≥95% | 3-(4-Bromophenyl)-1H-[1,2,4]triazole | ESD-897229-5G |
Cas.: 118863-62-0 | Purity: ≥95% | 3-(4-Bromophenyl)-1H-[1,2,4]triazole | ESD-897229-10G |
Cas.: 1187190-69-7 | Purity: 96% | 6-Chloro-4-methoxynicotinonitrile | ESD-897230-250MG |
Cas.: 1187190-69-7 | Purity: 96% | 6-Chloro-4-methoxynicotinonitrile | ESD-897230-1G |
Cas.: 1187190-69-7 | Purity: 96% | 6-Chloro-4-methoxynicotinonitrile | ESD-897230-5G |
Cas.: 1187190-69-7 | Purity: 96% | 6-Chloro-4-methoxynicotinonitrile | ESD-897230-10G |
Cas.: 78537-14-1 | Purity: 97% | HD-Ser(tBu)-OMe.HCl | ESD-897231-250MG |
Cas.: 78537-14-1 | Purity: 97% | HD-Ser(tBu)-OMe.HCl | ESD-897231-1G |
Cas.: 78537-14-1 | Purity: 97% | HD-Ser(tBu)-OMe.HCl | ESD-897231-5G |
Cas.: 78537-14-1 | Purity: 97% | HD-Ser(tBu)-OMe.HCl | ESD-897231-10G |
Cas.: 916792-15-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzonitrile | ESD-897232-250MG |
Cas.: 916792-15-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzonitrile | ESD-897232-1G |
Cas.: 916792-15-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzonitrile | ESD-897232-5G |
Cas.: 916792-15-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzonitrile | ESD-897232-10G |
Cas.: 914348-76-8 | Purity: ≥95% | Methyl 2-amino-5-chlorothiazole-4-carboxylate | ESD-897233-250MG |
Cas.: 914348-76-8 | Purity: ≥95% | Methyl 2-amino-5-chlorothiazole-4-carboxylate | ESD-897233-1G |
Cas.: 914348-76-8 | Purity: ≥95% | Methyl 2-amino-5-chlorothiazole-4-carboxylate | ESD-897233-5G |
Cas.: 914348-76-8 | Purity: ≥95% | Methyl 2-amino-5-chlorothiazole-4-carboxylate | ESD-897233-10G |
Cas.: 25569-77-1 | Purity: ≥95% | 4-Fluorobenzoic anhydride | ESD-897234-250MG |
Cas.: 69209-73-0 | Purity: 95% | Boc-Val-Val | ESD-897235-250MG |
Cas.: 69209-73-0 | Purity: 95% | Boc-Val-Val | ESD-897235-1G |
Cas.: 69209-73-0 | Purity: 95% | Boc-Val-Val | ESD-897235-5G |
Cas.: 69209-73-0 | Purity: 95% | Boc-Val-Val | ESD-897235-10G |
Cas.: 79055-63-3 | Purity: 97% | 2-Chloro-6-methylpyridin-4-amine | ESD-897236-250MG |
Cas.: 79055-63-3 | Purity: 97% | 2-Chloro-6-methylpyridin-4-amine | ESD-897236-1G |
Cas.: 79055-63-3 | Purity: 97% | 2-Chloro-6-methylpyridin-4-amine | ESD-897236-5G |
Cas.: 79055-63-3 | Purity: 97% | 2-Chloro-6-methylpyridin-4-amine | ESD-897236-10G |
Cas.: 1124382-72-4 | Purity: 97% | 2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine | ESD-897237-250MG |
Cas.: 1124382-72-4 | Purity: 97% | 2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine | ESD-897237-1G |
Cas.: 1124382-72-4 | Purity: 97% | 2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine | ESD-897237-5G |
Cas.: 1124382-72-4 | Purity: 97% | 2-Amino-8-bromo[1,2,4]triazolo[1,5-a]pyridine | ESD-897237-10G |
Cas.: 69214-22-8 | Purity: ≥95% | Imidazo[1,2-a]pyridin-8-ol | ESD-897238-250MG |
Cas.: 69214-22-8 | Purity: ≥95% | Imidazo[1,2-a]pyridin-8-ol | ESD-897238-1G |
Cas.: 69214-22-8 | Purity: ≥95% | Imidazo[1,2-a]pyridin-8-ol | ESD-897238-5G |
Cas.: 69214-22-8 | Purity: ≥95% | Imidazo[1,2-a]pyridin-8-ol | ESD-897238-10G |
Cas.: 1638761-56-4 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-897239-250MG |
Cas.: 1638761-56-4 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-897239-1G |
Cas.: 1638761-56-4 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-897239-5G |
Cas.: 1638761-56-4 | Purity: 97% | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-897239-10G |
Cas.: 306937-20-2 | Purity: 97% | 5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid | ESD-897240-250MG |
Cas.: 306937-20-2 | Purity: 97% | 5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid | ESD-897240-1G |
Cas.: 306937-20-2 | Purity: 97% | 5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid | ESD-897240-5G |
Cas.: 306937-20-2 | Purity: 97% | 5-Bromo-2-((tert-butoxycarbonyl)amino)benzoic acid | ESD-897240-10G |
Cas.: 914349-51-2 | Purity: ≥95% | 2-(6-Bromopyridin-2-yl)benzaldehyde | ESD-897241-250MG |
Cas.: 914349-51-2 | Purity: ≥95% | 2-(6-Bromopyridin-2-yl)benzaldehyde | ESD-897241-1G |
Cas.: 914349-51-2 | Purity: ≥95% | 2-(6-Bromopyridin-2-yl)benzaldehyde | ESD-897241-5G |
Cas.: 914349-51-2 | Purity: ≥95% | 2-(6-Bromopyridin-2-yl)benzaldehyde | ESD-897241-10G |
Cas.: 1444-12-8 | Purity: 95% | Methyl 1-methyl-1H-indole-4-carboxylate | ESD-897242-250MG |
Cas.: 1444-12-8 | Purity: 95% | Methyl 1-methyl-1H-indole-4-carboxylate | ESD-897242-1G |
Cas.: 1444-12-8 | Purity: 95% | Methyl 1-methyl-1H-indole-4-carboxylate | ESD-897242-5G |
Cas.: 1444-12-8 | Purity: 95% | Methyl 1-methyl-1H-indole-4-carboxylate | ESD-897242-10G |
Cas.: 108763-43-5 | Purity: ≥95% | 2-Amino-2-(1H-indol-5-yl)acetic acid | ESD-897243-250MG |
Cas.: 108763-43-5 | Purity: ≥95% | 2-Amino-2-(1H-indol-5-yl)acetic acid | ESD-897243-1G |
Cas.: 108763-43-5 | Purity: ≥95% | 2-Amino-2-(1H-indol-5-yl)acetic acid | ESD-897243-5G |
Cas.: 108763-43-5 | Purity: ≥95% | 2-Amino-2-(1H-indol-5-yl)acetic acid | ESD-897243-10G |
Cas.: 3542-13-0 | Purity: 97% | 2,2′-Diselanediyldiethanamine dihydrochloride | ESD-897244-250MG |
Cas.: 3542-13-0 | Purity: 97% | 2,2′-Diselanediyldiethanamine dihydrochloride | ESD-897244-1G |
Cas.: 3542-13-0 | Purity: 97% | 2,2′-Diselanediyldiethanamine dihydrochloride | ESD-897244-5G |
Cas.: 3542-13-0 | Purity: 97% | 2,2′-Diselanediyldiethanamine dihydrochloride | ESD-897244-10G |
Cas.: 125414-41-7 | Purity: ≥97% | tert-Butyl (1,3-dihydroxypropan-2-yl)carbamate | ESD-897245-250MG |
Cas.: 125414-41-7 | Purity: ≥97% | tert-Butyl (1,3-dihydroxypropan-2-yl)carbamate | ESD-897245-1G |
Cas.: 125414-41-7 | Purity: ≥97% | tert-Butyl (1,3-dihydroxypropan-2-yl)carbamate | ESD-897245-5G |
Cas.: 125414-41-7 | Purity: ≥97% | tert-Butyl (1,3-dihydroxypropan-2-yl)carbamate | ESD-897245-10G |
Cas.: 1231930-25-8 | Purity: 97% | 1-((6-Bromopyridin-3-yl)methyl)-4-ethylpiperazine | ESD-897246-250MG |
Cas.: 1231930-25-8 | Purity: 97% | 1-((6-Bromopyridin-3-yl)methyl)-4-ethylpiperazine | ESD-897246-1G |
Cas.: 1231930-25-8 | Purity: 97% | 1-((6-Bromopyridin-3-yl)methyl)-4-ethylpiperazine | ESD-897246-5G |
Cas.: 1231930-25-8 | Purity: 97% | 1-((6-Bromopyridin-3-yl)methyl)-4-ethylpiperazine | ESD-897246-10G |
Cas.: 1427587-32-3 | Purity: ≥95% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one | ESD-897247-250MG |
Cas.: 1427587-32-3 | Purity: ≥95% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one | ESD-897247-1G |
Cas.: 1427587-32-3 | Purity: ≥95% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one | ESD-897247-5G |
Cas.: 1427587-32-3 | Purity: ≥95% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one | ESD-897247-10G |
Cas.: 1206800-18-1 | Purity: 97% | 6-Bromo-1H-indazol-5-ol | ESD-897248-250MG |
Cas.: 1206800-18-1 | Purity: 97% | 6-Bromo-1H-indazol-5-ol | ESD-897248-1G |
Cas.: 1206800-18-1 | Purity: 97% | 6-Bromo-1H-indazol-5-ol | ESD-897248-5G |
Cas.: 1206800-18-1 | Purity: 97% | 6-Bromo-1H-indazol-5-ol | ESD-897248-10G |
Cas.: 1865-11-8 | Purity: 98% | Methyl quinoxaline-2-carboxylate | ESD-897249-250MG |
Cas.: 1865-11-8 | Purity: 98% | Methyl quinoxaline-2-carboxylate | ESD-897249-1G |
Cas.: 1865-11-8 | Purity: 98% | Methyl quinoxaline-2-carboxylate | ESD-897249-5G |
Cas.: 1865-11-8 | Purity: 98% | Methyl quinoxaline-2-carboxylate | ESD-897249-10G |
Cas.: 1008138-73-5 | Purity: ≥95% | Ethyl 5-amino-6-methylnicotinate | ESD-897250-250MG |
Cas.: 1008138-73-5 | Purity: ≥95% | Ethyl 5-amino-6-methylnicotinate | ESD-897250-1G |
Cas.: 1008138-73-5 | Purity: ≥95% | Ethyl 5-amino-6-methylnicotinate | ESD-897250-5G |
Cas.: 1008138-73-5 | Purity: ≥95% | Ethyl 5-amino-6-methylnicotinate | ESD-897250-10G |
Cas.: 78208-72-7 | Purity: 98% | Ethyl 3-isopropyl-1H-pyrazole-5-carboxylate | ESD-897251-250MG |
Cas.: 78208-72-7 | Purity: 98% | Ethyl 3-isopropyl-1H-pyrazole-5-carboxylate | ESD-897251-1G |
Cas.: 78208-72-7 | Purity: 98% | Ethyl 3-isopropyl-1H-pyrazole-5-carboxylate | ESD-897251-5G |
Cas.: 78208-72-7 | Purity: 98% | Ethyl 3-isopropyl-1H-pyrazole-5-carboxylate | ESD-897251-10G |
Cas.: 468718-65-2 | Purity: 97% | 4-Bromo-N-methylpyridin-2-amine | ESD-897252-250MG |
Cas.: 468718-65-2 | Purity: 97% | 4-Bromo-N-methylpyridin-2-amine | ESD-897252-1G |
Cas.: 468718-65-2 | Purity: 97% | 4-Bromo-N-methylpyridin-2-amine | ESD-897252-5G |
Cas.: 468718-65-2 | Purity: 97% | 4-Bromo-N-methylpyridin-2-amine | ESD-897252-10G |
Cas.: 917023-06-4 | Purity: 98% | Methyl 2-(5-bromopyridin-2-yl)acetate | ESD-897253-250MG |
Cas.: 917023-06-4 | Purity: 98% | Methyl 2-(5-bromopyridin-2-yl)acetate | ESD-897253-1G |
Cas.: 917023-06-4 | Purity: 98% | Methyl 2-(5-bromopyridin-2-yl)acetate | ESD-897253-5G |
Cas.: 917023-06-4 | Purity: 98% | Methyl 2-(5-bromopyridin-2-yl)acetate | ESD-897253-10G |
Cas.: 61032-41-5 | Purity: 95% | Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate | ESD-897254-250MG |
Cas.: 61032-41-5 | Purity: 95% | Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate | ESD-897254-1G |
Cas.: 61032-41-5 | Purity: 95% | Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate | ESD-897254-5G |
Cas.: 61032-41-5 | Purity: 95% | Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate | ESD-897254-10G |
Cas.: 1202450-63-2 | Purity: 97% | 6,8-Dibromoimidazo[1,2-a]pyridine | ESD-897255-250MG |
Cas.: 1202450-63-2 | Purity: 97% | 6,8-Dibromoimidazo[1,2-a]pyridine | ESD-897255-1G |
Cas.: 1202450-63-2 | Purity: 97% | 6,8-Dibromoimidazo[1,2-a]pyridine | ESD-897255-5G |
Cas.: 1202450-63-2 | Purity: 97% | 6,8-Dibromoimidazo[1,2-a]pyridine | ESD-897255-10G |
Cas.: 374633-32-6 | Purity: 98% | 2-Chloro-3-fluoro-6-methylpyridine | ESD-897256-250MG |
Cas.: 374633-32-6 | Purity: 98% | 2-Chloro-3-fluoro-6-methylpyridine | ESD-897256-1G |
Cas.: 374633-32-6 | Purity: 98% | 2-Chloro-3-fluoro-6-methylpyridine | ESD-897256-5G |
Cas.: 374633-32-6 | Purity: 98% | 2-Chloro-3-fluoro-6-methylpyridine | ESD-897256-10G |
Cas.: 817204-32-3 | Purity: 98% | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimdin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | ESD-897257-1G |
Cas.: 817204-32-3 | Purity: 98% | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimdin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | ESD-897257-5G |
Cas.: 817204-32-3 | Purity: 98% | (2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimdin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate | ESD-897257-10G |
Cas.: 885521-92-6 | Purity: 98% | 6-Bromo-1H-indazol-3-ol | ESD-897258-250MG |
Cas.: 885521-92-6 | Purity: 98% | 6-Bromo-1H-indazol-3-ol | ESD-897258-1G |
Cas.: 885521-92-6 | Purity: 98% | 6-Bromo-1H-indazol-3-ol | ESD-897258-5G |
Cas.: 885521-92-6 | Purity: 98% | 6-Bromo-1H-indazol-3-ol | ESD-897258-10G |
Cas.: 3080-99-7 | Purity: 97% | 3,4-Dihydro-2H-benzo[b][1,4]thiazine | ESD-897259-250MG |
Cas.: 3080-99-7 | Purity: 97% | 3,4-Dihydro-2H-benzo[b][1,4]thiazine | ESD-897259-1G |
Cas.: 3080-99-7 | Purity: 97% | 3,4-Dihydro-2H-benzo[b][1,4]thiazine | ESD-897259-5G |
Cas.: 3080-99-7 | Purity: 97% | 3,4-Dihydro-2H-benzo[b][1,4]thiazine | ESD-897259-10G |
Cas.: 122794-99-4 | Purity: ≥95% | Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate | ESD-897260-250MG |
Cas.: 122794-99-4 | Purity: ≥95% | Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate | ESD-897260-1G |
Cas.: 122794-99-4 | Purity: ≥95% | Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate | ESD-897260-5G |
Cas.: 122794-99-4 | Purity: ≥95% | Ethyl 6-bromo-4-hydroxyquinoline-3-carboxylate | ESD-897260-10G |
Cas.: 309740-49-6 | Purity: ≥98% | Methyl 1-methyl-4-nitro-1H-pyrazole-5-carboxylate | ESD-897261-250MG |
Cas.: 309740-49-6 | Purity: ≥98% | Methyl 1-methyl-4-nitro-1H-pyrazole-5-carboxylate | ESD-897261-1G |
Cas.: 309740-49-6 | Purity: ≥98% | Methyl 1-methyl-4-nitro-1H-pyrazole-5-carboxylate | ESD-897261-5G |
Cas.: 309740-49-6 | Purity: ≥98% | Methyl 1-methyl-4-nitro-1H-pyrazole-5-carboxylate | ESD-897261-10G |
Cas.: 140675-42-9 | Purity: 98% | 1-(3,5-Difluoro-2-hydroxyphenyl)ethanone | ESD-897262-250MG |
Cas.: 140675-42-9 | Purity: 98% | 1-(3,5-Difluoro-2-hydroxyphenyl)ethanone | ESD-897262-1G |
Cas.: 140675-42-9 | Purity: 98% | 1-(3,5-Difluoro-2-hydroxyphenyl)ethanone | ESD-897262-5G |
Cas.: 140675-42-9 | Purity: 98% | 1-(3,5-Difluoro-2-hydroxyphenyl)ethanone | ESD-897262-10G |
Cas.: 201611-77-0 | Purity: 97% | 2-Phenylpropan-2-yl benzodithioate | ESD-897263-250MG |
Cas.: 201611-77-0 | Purity: 97% | 2-Phenylpropan-2-yl benzodithioate | ESD-897263-1G |
Cas.: 72716-86-0 | Purity: 95% | 2-Methoxyisonicotinonitrile | ESD-897264-250MG |
Cas.: 72716-86-0 | Purity: 95% | 2-Methoxyisonicotinonitrile | ESD-897264-1G |
Cas.: 72716-86-0 | Purity: 95% | 2-Methoxyisonicotinonitrile | ESD-897264-5G |
Cas.: 72716-86-0 | Purity: 95% | 2-Methoxyisonicotinonitrile | ESD-897264-10G |
Cas.: 89245-41-0 | Purity: 98% | 4-Bromoindole-3-acetic Acid | ESD-897265-250MG |
Cas.: 89245-41-0 | Purity: 98% | 4-Bromoindole-3-acetic Acid | ESD-897265-1G |
Cas.: 89245-41-0 | Purity: 98% | 4-Bromoindole-3-acetic Acid | ESD-897265-5G |
Cas.: 89245-41-0 | Purity: 98% | 4-Bromoindole-3-acetic Acid | ESD-897265-10G |
Cas.: 1214353-57-7 | Purity: 98% | Methyl 3-fluoro-2-nitrobenzoate | ESD-897266-250MG |
Cas.: 1214353-57-7 | Purity: 98% | Methyl 3-fluoro-2-nitrobenzoate | ESD-897266-1G |
Cas.: 1214353-57-7 | Purity: 98% | Methyl 3-fluoro-2-nitrobenzoate | ESD-897266-5G |
Cas.: 1214353-57-7 | Purity: 98% | Methyl 3-fluoro-2-nitrobenzoate | ESD-897266-10G |
Cas.: 10531-41-6 | Purity: 98% | 2-Bromo-1-(thiophen-2-yl)ethanone | ESD-897267-250MG |
Cas.: 10531-41-6 | Purity: 98% | 2-Bromo-1-(thiophen-2-yl)ethanone | ESD-897267-1G |
Cas.: 10531-41-6 | Purity: 98% | 2-Bromo-1-(thiophen-2-yl)ethanone | ESD-897267-5G |
Cas.: 200352-28-9 | Purity: 98% | (1S,2R)-2-Aminocyclohexanol hydrochloride | ESD-897268-250MG |
Cas.: 200352-28-9 | Purity: 98% | (1S,2R)-2-Aminocyclohexanol hydrochloride | ESD-897268-1G |
Cas.: 200352-28-9 | Purity: 98% | (1S,2R)-2-Aminocyclohexanol hydrochloride | ESD-897268-5G |
Cas.: 200352-28-9 | Purity: 98% | (1S,2R)-2-Aminocyclohexanol hydrochloride | ESD-897268-10G |
Cas.: 850589-56-9 | Purity: ≥97% | 3-Benzyloxy-5-fluorophenylboronic acid | ESD-897269-250MG |
Cas.: 850589-56-9 | Purity: ≥97% | 3-Benzyloxy-5-fluorophenylboronic acid | ESD-897269-1G |
Cas.: 850589-56-9 | Purity: ≥97% | 3-Benzyloxy-5-fluorophenylboronic acid | ESD-897269-5G |
Cas.: 850589-56-9 | Purity: ≥97% | 3-Benzyloxy-5-fluorophenylboronic acid | ESD-897269-10G |
Cas.: 914347-25-4 | Purity: ≥97% | Methyl 2,5-dibromothiazole-4-carboxylate | ESD-897270-250MG |
Cas.: 914347-25-4 | Purity: ≥97% | Methyl 2,5-dibromothiazole-4-carboxylate | ESD-897270-1G |
Cas.: 914347-25-4 | Purity: ≥97% | Methyl 2,5-dibromothiazole-4-carboxylate | ESD-897270-5G |
Cas.: 914347-25-4 | Purity: ≥97% | Methyl 2,5-dibromothiazole-4-carboxylate | ESD-897270-10G |
Cas.: 92933-47-6 | Purity: 97% | 5-Isopropyl-1H-pyrazole-3-carboxylic acid | ESD-897271-250MG |
Cas.: 92933-47-6 | Purity: 97% | 5-Isopropyl-1H-pyrazole-3-carboxylic acid | ESD-897271-1G |
Cas.: 92933-47-6 | Purity: 97% | 5-Isopropyl-1H-pyrazole-3-carboxylic acid | ESD-897271-5G |
Cas.: 92933-47-6 | Purity: 97% | 5-Isopropyl-1H-pyrazole-3-carboxylic acid | ESD-897271-10G |
Cas.: 3069-67-8 | Purity: 98% | 5-Methyl-1,3,4-oxadiazol-2(3H)-one | ESD-897272-250MG |
Cas.: 3069-67-8 | Purity: 98% | 5-Methyl-1,3,4-oxadiazol-2(3H)-one | ESD-897272-1G |
Cas.: 3069-67-8 | Purity: 98% | 5-Methyl-1,3,4-oxadiazol-2(3H)-one | ESD-897272-5G |
Cas.: 112656-95-8 | Purity: ≥95% | 7-Nitroindoline-2,3-dione | ESD-897273-250MG |
Cas.: 112656-95-8 | Purity: ≥95% | 7-Nitroindoline-2,3-dione | ESD-897273-1G |
Cas.: 112656-95-8 | Purity: ≥95% | 7-Nitroindoline-2,3-dione | ESD-897273-5G |
Cas.: 112656-95-8 | Purity: ≥95% | 7-Nitroindoline-2,3-dione | ESD-897273-10G |
Cas.: 22532-60-1 | Purity: 98% | 2-Bromo-4-hydroxybenzaldehyde | ESD-897274-250MG |
Cas.: 22532-60-1 | Purity: 98% | 2-Bromo-4-hydroxybenzaldehyde | ESD-897274-1G |
Cas.: 22532-60-1 | Purity: 98% | 2-Bromo-4-hydroxybenzaldehyde | ESD-897274-5G |
Cas.: 22532-60-1 | Purity: 98% | 2-Bromo-4-hydroxybenzaldehyde | ESD-897274-10G |
Cas.: 22404-46-2 | Purity: 97% | 4-Chloro-N-methylpyrimidin-2-amine | ESD-897275-250MG |
Cas.: 22404-46-2 | Purity: 97% | 4-Chloro-N-methylpyrimidin-2-amine | ESD-897275-1G |
Cas.: 22404-46-2 | Purity: 97% | 4-Chloro-N-methylpyrimidin-2-amine | ESD-897275-5G |
Cas.: 22404-46-2 | Purity: 97% | 4-Chloro-N-methylpyrimidin-2-amine | ESD-897275-10G |
Cas.: 587-65-5 | Purity: ≥95% | 2-Chloro-N-phenylacetamide | ESD-897276-250MG |
Cas.: 587-65-5 | Purity: ≥95% | 2-Chloro-N-phenylacetamide | ESD-897276-1G |
Cas.: 587-65-5 | Purity: ≥95% | 2-Chloro-N-phenylacetamide | ESD-897276-5G |
Cas.: 587-65-5 | Purity: ≥95% | 2-Chloro-N-phenylacetamide | ESD-897276-10G |
Cas.: 31354-48-0 | Purity: 97% | N-(3-Hydroxypyridin-2-yl)acetamide | ESD-897277-250MG |
Cas.: 31354-48-0 | Purity: 97% | N-(3-Hydroxypyridin-2-yl)acetamide | ESD-897277-1G |
Cas.: 31354-48-0 | Purity: 97% | N-(3-Hydroxypyridin-2-yl)acetamide | ESD-897277-5G |
Cas.: 31354-48-0 | Purity: 97% | N-(3-Hydroxypyridin-2-yl)acetamide | ESD-897277-10G |
Cas.: 76265-70-8 | Purity: ≥95% | Fmoc-Met(O)-OH | ESD-897278-250MG |
Cas.: 76265-70-8 | Purity: ≥95% | Fmoc-Met(O)-OH | ESD-897278-1G |
Cas.: 76265-70-8 | Purity: ≥95% | Fmoc-Met(O)-OH | ESD-897278-5G |
Cas.: 76265-70-8 | Purity: ≥95% | Fmoc-Met(O)-OH | ESD-897278-10G |
Cas.: 10601-99-7 | Purity: 97% | 3-Ethynylbenzoic acid | ESD-897279-250MG |
Cas.: 10601-99-7 | Purity: 97% | 3-Ethynylbenzoic acid | ESD-897279-1G |
Cas.: 10601-99-7 | Purity: 97% | 3-Ethynylbenzoic acid | ESD-897279-5G |
Cas.: 10601-99-7 | Purity: 97% | 3-Ethynylbenzoic acid | ESD-897279-10G |
Cas.: 174886-05-6 | Purity: 97% | 1-Methylcyclobutanamine hydrochloride | ESD-897280-250MG |
Cas.: 174886-05-6 | Purity: 97% | 1-Methylcyclobutanamine hydrochloride | ESD-897280-1G |
Cas.: 174886-05-6 | Purity: 97% | 1-Methylcyclobutanamine hydrochloride | ESD-897280-5G |
Cas.: 849067-96-5 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-897281-250MG |
Cas.: 849067-96-5 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-897281-1G |
Cas.: 849067-96-5 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-897281-5G |
Cas.: 849067-96-5 | Purity: 95% | Methyl 1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-897281-10G |
Cas.: 947763-34-0 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-4-amine | ESD-897282-250MG |
Cas.: 947763-34-0 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-4-amine | ESD-897282-1G |
Cas.: 947763-34-0 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-4-amine | ESD-897282-5G |
Cas.: 947763-34-0 | Purity: 97% | 1-Ethyl-3-methyl-1H-pyrazol-4-amine | ESD-897282-10G |
Cas.: 4919-43-1 | Purity: 98% | 1-Amino-2-naphthoic acid | ESD-897283-250MG |
Cas.: 4919-43-1 | Purity: 98% | 1-Amino-2-naphthoic acid | ESD-897283-1G |
Cas.: 4919-43-1 | Purity: 98% | 1-Amino-2-naphthoic acid | ESD-897283-5G |
Cas.: 4919-43-1 | Purity: 98% | 1-Amino-2-naphthoic acid | ESD-897283-10G |
Cas.: 89891-69-0 | Purity: 97% | 3-Bromo-4-formylbenzonitrile | ESD-897284-250MG |
Cas.: 89891-69-0 | Purity: 97% | 3-Bromo-4-formylbenzonitrile | ESD-897284-1G |
Cas.: 89891-69-0 | Purity: 97% | 3-Bromo-4-formylbenzonitrile | ESD-897284-5G |
Cas.: 89891-69-0 | Purity: 97% | 3-Bromo-4-formylbenzonitrile | ESD-897284-10G |
Cas.: 947248-68-2 | Purity: ≥97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-897285-250MG |
Cas.: 947248-68-2 | Purity: ≥97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-897285-1G |
Cas.: 947248-68-2 | Purity: ≥97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-897285-5G |
Cas.: 947248-68-2 | Purity: ≥97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-897285-10G |
Cas.: 13484-04-3 | Purity: ≥95% | 3-(4-Bromophenyl)isoxazole | ESD-897286-250MG |
Cas.: 13484-04-3 | Purity: ≥95% | 3-(4-Bromophenyl)isoxazole | ESD-897286-1G |
Cas.: 13484-04-3 | Purity: ≥95% | 3-(4-Bromophenyl)isoxazole | ESD-897286-5G |
Cas.: 13484-04-3 | Purity: ≥95% | 3-(4-Bromophenyl)isoxazole | ESD-897286-10G |
Cas.: 1035818-91-7 | Purity: ≥95% | Methyl 3,5-dibromopyrazine-2-carboxylate | ESD-897287-250MG |
Cas.: 1035818-91-7 | Purity: ≥95% | Methyl 3,5-dibromopyrazine-2-carboxylate | ESD-897287-1G |
Cas.: 1035818-91-7 | Purity: ≥95% | Methyl 3,5-dibromopyrazine-2-carboxylate | ESD-897287-5G |
Cas.: 1035818-91-7 | Purity: ≥95% | Methyl 3,5-dibromopyrazine-2-carboxylate | ESD-897287-10G |
Cas.: 89976-75-0 | Purity: 97% | 6-Amino-2H-1,4-benzoxazin-3(4H)-one | ESD-897288-250MG |
Cas.: 89976-75-0 | Purity: 97% | 6-Amino-2H-1,4-benzoxazin-3(4H)-one | ESD-897288-1G |
Cas.: 89976-75-0 | Purity: 97% | 6-Amino-2H-1,4-benzoxazin-3(4H)-one | ESD-897288-5G |
Cas.: 89976-75-0 | Purity: 97% | 6-Amino-2H-1,4-benzoxazin-3(4H)-one | ESD-897288-10G |
Cas.: 287193-00-4 | Purity: 95% | 1-Boc-3-Ethynylpyrrolidine | ESD-897289-250MG |
Cas.: 287193-00-4 | Purity: 95% | 1-Boc-3-Ethynylpyrrolidine | ESD-897289-1G |
Cas.: 287193-00-4 | Purity: 95% | 1-Boc-3-Ethynylpyrrolidine | ESD-897289-5G |
Cas.: 287193-00-4 | Purity: 95% | 1-Boc-3-Ethynylpyrrolidine | ESD-897289-10G |
Cas.: 1206640-82-5 | Purity: 97% | 1-(Difluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897290-250MG |
Cas.: 1206640-82-5 | Purity: 97% | 1-(Difluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897290-1G |
Cas.: 1206640-82-5 | Purity: 97% | 1-(Difluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897290-5G |
Cas.: 1206640-82-5 | Purity: 97% | 1-(Difluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897290-10G |
Cas.: 60061-60-1 | Purity: 98% | 4-Bromo-3-isopropyl-1H-pyrazole | ESD-897291-250MG |
Cas.: 60061-60-1 | Purity: 98% | 4-Bromo-3-isopropyl-1H-pyrazole | ESD-897291-1G |
Cas.: 60061-60-1 | Purity: 98% | 4-Bromo-3-isopropyl-1H-pyrazole | ESD-897291-5G |
Cas.: 60061-60-1 | Purity: 98% | 4-Bromo-3-isopropyl-1H-pyrazole | ESD-897291-10G |
Cas.: 154476-57-0 | Purity: ≥95% | N,N’-Di-Boc-guanidine | ESD-897292-250MG |
Cas.: 154476-57-0 | Purity: ≥95% | N,N’-Di-Boc-guanidine | ESD-897292-1G |
Cas.: 154476-57-0 | Purity: ≥95% | N,N’-Di-Boc-guanidine | ESD-897292-5G |
Cas.: 154476-57-0 | Purity: ≥95% | N,N’-Di-Boc-guanidine | ESD-897292-10G |
Cas.: 1203099-07-3 | Purity: 97% | Benzyl azetidin-3-ylcarbamate hydrochloride | ESD-897293-250MG |
Cas.: 1203099-07-3 | Purity: 97% | Benzyl azetidin-3-ylcarbamate hydrochloride | ESD-897293-1G |
Cas.: 1203099-07-3 | Purity: 97% | Benzyl azetidin-3-ylcarbamate hydrochloride | ESD-897293-5G |
Cas.: 1203099-07-3 | Purity: 97% | Benzyl azetidin-3-ylcarbamate hydrochloride | ESD-897293-10G |
Cas.: 1026089-09-7 | Purity: 97% | 2-(4-Bromo-2-methoxyphenyl)acetic acid | ESD-897294-250MG |
Cas.: 1026089-09-7 | Purity: 97% | 2-(4-Bromo-2-methoxyphenyl)acetic acid | ESD-897294-1G |
Cas.: 1026089-09-7 | Purity: 97% | 2-(4-Bromo-2-methoxyphenyl)acetic acid | ESD-897294-5G |
Cas.: 1026089-09-7 | Purity: 97% | 2-(4-Bromo-2-methoxyphenyl)acetic acid | ESD-897294-10G |
Cas.: 400877-57-8 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-pyrazole-3-carboxylate | ESD-897295-250MG |
Cas.: 400877-57-8 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-pyrazole-3-carboxylate | ESD-897295-1G |
Cas.: 400877-57-8 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-pyrazole-3-carboxylate | ESD-897295-5G |
Cas.: 400877-57-8 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-pyrazole-3-carboxylate | ESD-897295-10G |
Cas.: 23462-75-1 | Purity: ≥95% | Dihydro-2H-pyran-3(4H)-one | ESD-897296-250MG |
Cas.: 23462-75-1 | Purity: ≥95% | Dihydro-2H-pyran-3(4H)-one | ESD-897296-1G |
Cas.: 23462-75-1 | Purity: ≥95% | Dihydro-2H-pyran-3(4H)-one | ESD-897296-5G |
Cas.: 23462-75-1 | Purity: ≥95% | Dihydro-2H-pyran-3(4H)-one | ESD-897296-10G |
Cas.: 884494-97-7 | Purity: 97% | 6-Fluoro-2-methylnicotinic acid | ESD-897297-250MG |
Cas.: 884494-97-7 | Purity: 97% | 6-Fluoro-2-methylnicotinic acid | ESD-897297-1G |
Cas.: 884494-97-7 | Purity: 97% | 6-Fluoro-2-methylnicotinic acid | ESD-897297-5G |
Cas.: 884494-97-7 | Purity: 97% | 6-Fluoro-2-methylnicotinic acid | ESD-897297-10G |
Cas.: 51647-90-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-5,7-diol | ESD-897298-250MG |
Cas.: 51647-90-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-5,7-diol | ESD-897298-1G |
Cas.: 51647-90-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-5,7-diol | ESD-897298-5G |
Cas.: 51647-90-6 | Purity: 97% | Imidazo[1,2-a]pyrimidine-5,7-diol | ESD-897298-10G |
Cas.: 1158098-73-7 | Purity: 97% | 2-Methyl-N-(oxetan-3-ylidene)propane-2-sulfinamide | ESD-897299-250MG |
Cas.: 1158098-73-7 | Purity: 97% | 2-Methyl-N-(oxetan-3-ylidene)propane-2-sulfinamide | ESD-897299-1G |
Cas.: 1158098-73-7 | Purity: 97% | 2-Methyl-N-(oxetan-3-ylidene)propane-2-sulfinamide | ESD-897299-5G |
Cas.: 1158098-73-7 | Purity: 97% | 2-Methyl-N-(oxetan-3-ylidene)propane-2-sulfinamide | ESD-897299-10G |
Cas.: 39998-25-9 | Purity: ≥95% | Methyl 2-(pyridin-3-yl)acetate | ESD-897300-250MG |
Cas.: 39998-25-9 | Purity: ≥95% | Methyl 2-(pyridin-3-yl)acetate | ESD-897300-1G |
Cas.: 39998-25-9 | Purity: ≥95% | Methyl 2-(pyridin-3-yl)acetate | ESD-897300-5G |
Cas.: 957230-68-1 | Purity: 95% | 3,6-Dibromo-2-pyrazinecarboxylic Acid | ESD-897301-250MG |
Cas.: 957230-68-1 | Purity: 95% | 3,6-Dibromo-2-pyrazinecarboxylic Acid | ESD-897301-1G |
Cas.: 957230-68-1 | Purity: 95% | 3,6-Dibromo-2-pyrazinecarboxylic Acid | ESD-897301-5G |
Cas.: 957230-68-1 | Purity: 95% | 3,6-Dibromo-2-pyrazinecarboxylic Acid | ESD-897301-10G |
Cas.: 383134-85-8 | Purity: 97% | 2-(5-Fluoro-2-methoxyphenyl)acetic acid | ESD-897302-250MG |
Cas.: 383134-85-8 | Purity: 97% | 2-(5-Fluoro-2-methoxyphenyl)acetic acid | ESD-897302-1G |
Cas.: 383134-85-8 | Purity: 97% | 2-(5-Fluoro-2-methoxyphenyl)acetic acid | ESD-897302-5G |
Cas.: 383134-85-8 | Purity: 97% | 2-(5-Fluoro-2-methoxyphenyl)acetic acid | ESD-897302-10G |
Cas.: 1212176-33-4 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-897303-250MG |
Cas.: 1212176-33-4 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-897303-1G |
Cas.: 1212176-33-4 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-897303-5G |
Cas.: 1212176-33-4 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-897303-10G |
Cas.: 13288-57-8 | Purity: ≥95% | H-Lys(Boc)-OtBu.HCl | ESD-897304-250MG |
Cas.: 13288-57-8 | Purity: ≥95% | H-Lys(Boc)-OtBu.HCl | ESD-897304-1G |
Cas.: 13288-57-8 | Purity: ≥95% | H-Lys(Boc)-OtBu.HCl | ESD-897304-5G |
Cas.: 13288-57-8 | Purity: ≥95% | H-Lys(Boc)-OtBu.HCl | ESD-897304-10G |
Cas.: 3599-89-1 | Purity: 97% | Propionimidamide hydrochloride | ESD-897305-250MG |
Cas.: 3599-89-1 | Purity: 97% | Propionimidamide hydrochloride | ESD-897305-1G |
Cas.: 3599-89-1 | Purity: 97% | Propionimidamide hydrochloride | ESD-897305-5G |
Cas.: 3599-89-1 | Purity: 97% | Propionimidamide hydrochloride | ESD-897305-10G |
Cas.: 365996-06-1 | Purity: ≥95% | tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate | ESD-897306-250MG |
Cas.: 365996-06-1 | Purity: ≥95% | tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate | ESD-897306-1G |
Cas.: 365996-06-1 | Purity: ≥95% | tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate | ESD-897306-5G |
Cas.: 365996-06-1 | Purity: ≥95% | tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate | ESD-897306-10G |
Cas.: 124668-46-8 | Purity: 97% | 3-Methylazetidin-3-ol hydrochloride | ESD-897307-250MG |
Cas.: 124668-46-8 | Purity: 97% | 3-Methylazetidin-3-ol hydrochloride | ESD-897307-1G |
Cas.: 124668-46-8 | Purity: 97% | 3-Methylazetidin-3-ol hydrochloride | ESD-897307-5G |
Cas.: 124668-46-8 | Purity: 97% | 3-Methylazetidin-3-ol hydrochloride | ESD-897307-10G |
Cas.: 1189513-55-0 | Purity: 97% | 3-Bromo-5-fluoropicolinic acid | ESD-897308-250MG |
Cas.: 1189513-55-0 | Purity: 97% | 3-Bromo-5-fluoropicolinic acid | ESD-897308-1G |
Cas.: 1189513-55-0 | Purity: 97% | 3-Bromo-5-fluoropicolinic acid | ESD-897308-5G |
Cas.: 1189513-55-0 | Purity: 97% | 3-Bromo-5-fluoropicolinic acid | ESD-897308-10G |
Cas.: 67475-55-2 | Purity: 98% | 3-Fluoro-4-methoxybenzene-1-sulfonyl chloride | ESD-897309-250MG |
Cas.: 67475-55-2 | Purity: 98% | 3-Fluoro-4-methoxybenzene-1-sulfonyl chloride | ESD-897309-1G |
Cas.: 67475-55-2 | Purity: 98% | 3-Fluoro-4-methoxybenzene-1-sulfonyl chloride | ESD-897309-5G |
Cas.: 67475-55-2 | Purity: 98% | 3-Fluoro-4-methoxybenzene-1-sulfonyl chloride | ESD-897309-10G |
Cas.: 57395-89-8 | Purity: 97% | 4-Fluoropiperidine hydrochloride | ESD-897310-250MG |
Cas.: 57395-89-8 | Purity: 97% | 4-Fluoropiperidine hydrochloride | ESD-897310-1G |
Cas.: 57395-89-8 | Purity: 97% | 4-Fluoropiperidine hydrochloride | ESD-897310-5G |
Cas.: 57395-89-8 | Purity: 97% | 4-Fluoropiperidine hydrochloride | ESD-897310-10G |
Cas.: 239074-29-4 | Purity: 97% | tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-897311-250MG |
Cas.: 239074-29-4 | Purity: 97% | tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-897311-1G |
Cas.: 239074-29-4 | Purity: 97% | tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-897311-5G |
Cas.: 239074-29-4 | Purity: 97% | tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-897311-10G |
Cas.: 103336-06-7 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid | ESD-897312-250MG |
Cas.: 103336-06-7 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid | ESD-897312-1G |
Cas.: 103336-06-7 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid | ESD-897312-5G |
Cas.: 103336-06-7 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid | ESD-897312-10G |
Cas.: 760207-86-1 | Purity: 97% | 3-Bromo-2-isopropoxy-5-methylpyridine | ESD-897313-1G |
Cas.: 760207-86-1 | Purity: 97% | 3-Bromo-2-isopropoxy-5-methylpyridine | ESD-897313-5G |
Cas.: 760207-86-1 | Purity: 97% | 3-Bromo-2-isopropoxy-5-methylpyridine | ESD-897313-10G |
Cas.: 760207-86-1 | Purity: 97% | 3-Bromo-2-isopropoxy-5-methylpyridine | ESD-897313-25G |
Cas.: 960541-42-8 | Purity: 97% | Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-897314-1G |
Cas.: 960541-42-8 | Purity: 97% | Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-897314-5G |
Cas.: 960541-42-8 | Purity: 97% | Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-897314-10G |
Cas.: 960541-42-8 | Purity: 97% | Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-897314-25G |
Cas.: 1214344-25-8 | Purity: 95% | 1-(Chloromethyl)-3-fluoro-5-nitrobenzene | ESD-897315-1G |
Cas.: 1214344-25-8 | Purity: 95% | 1-(Chloromethyl)-3-fluoro-5-nitrobenzene | ESD-897315-5G |
Cas.: 1214344-25-8 | Purity: 95% | 1-(Chloromethyl)-3-fluoro-5-nitrobenzene | ESD-897315-10G |
Cas.: 1214344-25-8 | Purity: 95% | 1-(Chloromethyl)-3-fluoro-5-nitrobenzene | ESD-897315-25G |
Cas.: 1214336-55-6 | Purity: 97% | Ethyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-897316-1G |
Cas.: 1214336-55-6 | Purity: 97% | Ethyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-897316-5G |
Cas.: 1214336-55-6 | Purity: 97% | Ethyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-897316-10G |
Cas.: 1214336-55-6 | Purity: 97% | Ethyl 2-bromo-5-(trifluoromethyl)benzoate | ESD-897316-25G |
Cas.: 112018-26-5 | Purity: 95% | (R)-Diethyl 2-aminosuccinate hydrochloride | ESD-897317-1G |
Cas.: 112018-26-5 | Purity: 95% | (R)-Diethyl 2-aminosuccinate hydrochloride | ESD-897317-5G |
Cas.: 112018-26-5 | Purity: 95% | (R)-Diethyl 2-aminosuccinate hydrochloride | ESD-897317-10G |
Cas.: 112018-26-5 | Purity: 95% | (R)-Diethyl 2-aminosuccinate hydrochloride | ESD-897317-25G |
Cas.: 167301-82-8 | Purity: 96% | (2,2-Dimethyl-1,3-dioxolan-4-yl)methanamine hydrochloride | ESD-897318-1G |
Cas.: 167301-82-8 | Purity: 96% | (2,2-Dimethyl-1,3-dioxolan-4-yl)methanamine hydrochloride | ESD-897318-5G |
Cas.: 167301-82-8 | Purity: 96% | (2,2-Dimethyl-1,3-dioxolan-4-yl)methanamine hydrochloride | ESD-897318-10G |
Cas.: 167301-82-8 | Purity: 96% | (2,2-Dimethyl-1,3-dioxolan-4-yl)methanamine hydrochloride | ESD-897318-25G |
Cas.: 222550-60-9 | Purity: ≥95% | (S)-Methyl 2-(ethylamino)-3-methylbutanoate | ESD-897319-1G |
Cas.: 222550-60-9 | Purity: ≥95% | (S)-Methyl 2-(ethylamino)-3-methylbutanoate | ESD-897319-5G |
Cas.: 222550-60-9 | Purity: ≥95% | (S)-Methyl 2-(ethylamino)-3-methylbutanoate | ESD-897319-10G |
Cas.: 222550-60-9 | Purity: ≥95% | (S)-Methyl 2-(ethylamino)-3-methylbutanoate | ESD-897319-25G |
Cas.: 878671-98-8 | Purity: 97% | Methyl 2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897320-1G |
Cas.: 878671-98-8 | Purity: 97% | Methyl 2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897320-5G |
Cas.: 878671-98-8 | Purity: 97% | Methyl 2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897320-10G |
Cas.: 878671-98-8 | Purity: 97% | Methyl 2-((5-amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897320-25G |
Cas.: 76445-65-3 | Purity: ≥95% | 4-Aminocyclohexanol hydrochloride | ESD-897321-1G |
Cas.: 76445-65-3 | Purity: ≥95% | 4-Aminocyclohexanol hydrochloride | ESD-897321-5G |
Cas.: 76445-65-3 | Purity: ≥95% | 4-Aminocyclohexanol hydrochloride | ESD-897321-10G |
Cas.: 76445-65-3 | Purity: ≥95% | 4-Aminocyclohexanol hydrochloride | ESD-897321-25G |
Cas.: 1138036-54-0 | Purity: 98% | (2-Chloro-3-fluorophenyl)hydrazine hydrochloride | ESD-897322-1G |
Cas.: 1138036-54-0 | Purity: 98% | (2-Chloro-3-fluorophenyl)hydrazine hydrochloride | ESD-897322-5G |
Cas.: 1138036-54-0 | Purity: 98% | (2-Chloro-3-fluorophenyl)hydrazine hydrochloride | ESD-897322-10G |
Cas.: 1138036-54-0 | Purity: 98% | (2-Chloro-3-fluorophenyl)hydrazine hydrochloride | ESD-897322-25G |
Cas.: 107922-46-3 | Purity: ≥95% | Methyl 3-benzenesulfonamidobenzoate | ESD-897323-1G |
Cas.: 107922-46-3 | Purity: ≥95% | Methyl 3-benzenesulfonamidobenzoate | ESD-897323-5G |
Cas.: 107922-46-3 | Purity: ≥95% | Methyl 3-benzenesulfonamidobenzoate | ESD-897323-10G |
Cas.: 107922-46-3 | Purity: ≥95% | Methyl 3-benzenesulfonamidobenzoate | ESD-897323-25G |
Cas.: 52186-89-7 | Purity: 98% | (1-(Ethoxycarbonyl)cyclopropyl)triphenylphosphonium tetrafluoroborate | ESD-897324-1G |
Cas.: 52186-89-7 | Purity: 98% | (1-(Ethoxycarbonyl)cyclopropyl)triphenylphosphonium tetrafluoroborate | ESD-897324-5G |
Cas.: 52186-89-7 | Purity: 98% | (1-(Ethoxycarbonyl)cyclopropyl)triphenylphosphonium tetrafluoroborate | ESD-897324-10G |
Cas.: 52186-89-7 | Purity: 98% | (1-(Ethoxycarbonyl)cyclopropyl)triphenylphosphonium tetrafluoroborate | ESD-897324-25G |
Cas.: 311-86-4 | Purity: 95% | 2-Bromo-3,3,3-trifluoropropan-1-ol | ESD-897325-1G |
Cas.: 311-86-4 | Purity: 95% | 2-Bromo-3,3,3-trifluoropropan-1-ol | ESD-897325-5G |
Cas.: 311-86-4 | Purity: 95% | 2-Bromo-3,3,3-trifluoropropan-1-ol | ESD-897325-10G |
Cas.: 311-86-4 | Purity: 95% | 2-Bromo-3,3,3-trifluoropropan-1-ol | ESD-897325-25G |
Cas.: 1316755-16-4 | Purity: 97% | EMA401 | ESD-897326-1MG |
Cas.: 1316755-16-4 | Purity: 97% | EMA401 | ESD-897326-5MG |
Cas.: 1316755-16-4 | Purity: 97% | EMA401 | ESD-897326-10MG |
Cas.: 1316755-16-4 | Purity: 97% | EMA401 | ESD-897326-25MG |
Cas.: 29365-05-7 | Purity: ≥95% | Boc-Asp(OtBu)-ONp | ESD-897327-1G |
Cas.: 29365-05-7 | Purity: ≥95% | Boc-Asp(OtBu)-ONp | ESD-897327-5G |
Cas.: 29365-05-7 | Purity: ≥95% | Boc-Asp(OtBu)-ONp | ESD-897327-10G |
Cas.: 29365-05-7 | Purity: ≥95% | Boc-Asp(OtBu)-ONp | ESD-897327-25G |
Cas.: 7218-04-4 | Purity: ≥95% | 2-Acetamido-3-mercaptopropanoic acid | ESD-897328-1G |
Cas.: 7218-04-4 | Purity: ≥95% | 2-Acetamido-3-mercaptopropanoic acid | ESD-897328-5G |
Cas.: 7218-04-4 | Purity: ≥95% | 2-Acetamido-3-mercaptopropanoic acid | ESD-897328-10G |
Cas.: 7218-04-4 | Purity: ≥95% | 2-Acetamido-3-mercaptopropanoic acid | ESD-897328-25G |
Cas.: 215190-22-0 | Purity: 98% | (9H-Fluoren-9-yl)methyl piperazine-1-carboxylate hydrochloride | ESD-897329-1G |
Cas.: 215190-22-0 | Purity: 98% | (9H-Fluoren-9-yl)methyl piperazine-1-carboxylate hydrochloride | ESD-897329-5G |
Cas.: 215190-22-0 | Purity: 98% | (9H-Fluoren-9-yl)methyl piperazine-1-carboxylate hydrochloride | ESD-897329-10G |
Cas.: 215190-22-0 | Purity: 98% | (9H-Fluoren-9-yl)methyl piperazine-1-carboxylate hydrochloride | ESD-897329-25G |
Cas.: 15754-60-6 | Purity: 98% | 1-(tert-Butyl)-1H-pyrazole | ESD-897330-1G |
Cas.: 15754-60-6 | Purity: 98% | 1-(tert-Butyl)-1H-pyrazole | ESD-897330-5G |
Cas.: 15754-60-6 | Purity: 98% | 1-(tert-Butyl)-1H-pyrazole | ESD-897330-10G |
Cas.: 15754-60-6 | Purity: 98% | 1-(tert-Butyl)-1H-pyrazole | ESD-897330-25G |
Cas.: 30561-07-0 | Purity: 97% | 2,4-Dimethoxy-5-nitropyrimidine | ESD-897331-1G |
Cas.: 30561-07-0 | Purity: 97% | 2,4-Dimethoxy-5-nitropyrimidine | ESD-897331-5G |
Cas.: 30561-07-0 | Purity: 97% | 2,4-Dimethoxy-5-nitropyrimidine | ESD-897331-10G |
Cas.: 30561-07-0 | Purity: 97% | 2,4-Dimethoxy-5-nitropyrimidine | ESD-897331-25G |
Cas.: 28394-58-3 | Purity: 98% | Ethyl 3,4-dichlorobenzoate | ESD-897332-1G |
Cas.: 28394-58-3 | Purity: 98% | Ethyl 3,4-dichlorobenzoate | ESD-897332-5G |
Cas.: 28394-58-3 | Purity: 98% | Ethyl 3,4-dichlorobenzoate | ESD-897332-10G |
Cas.: 28394-58-3 | Purity: 98% | Ethyl 3,4-dichlorobenzoate | ESD-897332-25G |
Cas.: 152192-95-5 | Purity: ≥95% | tert-Butyl ethyl(2-hydroxyethyl)carbamate | ESD-897333-1G |
Cas.: 152192-95-5 | Purity: ≥95% | tert-Butyl ethyl(2-hydroxyethyl)carbamate | ESD-897333-5G |
Cas.: 152192-95-5 | Purity: ≥95% | tert-Butyl ethyl(2-hydroxyethyl)carbamate | ESD-897333-10G |
Cas.: 152192-95-5 | Purity: ≥95% | tert-Butyl ethyl(2-hydroxyethyl)carbamate | ESD-897333-25G |
Cas.: 179756-58-2 | Purity: ≥98% | F 11440 | ESD-897334-1MG |
Cas.: 179756-58-2 | Purity: ≥98% | F 11440 | ESD-897334-5MG |
Cas.: 179756-58-2 | Purity: ≥98% | F 11440 | ESD-897334-10MG |
Cas.: 179756-58-2 | Purity: ≥98% | F 11440 | ESD-897334-25MG |
Cas.: 706792-04-3 | Purity: 98% | Methyl 3-amino-5-ethoxybenzoate | ESD-897335-1G |
Cas.: 706792-04-3 | Purity: 98% | Methyl 3-amino-5-ethoxybenzoate | ESD-897335-5G |
Cas.: 706792-04-3 | Purity: 98% | Methyl 3-amino-5-ethoxybenzoate | ESD-897335-10G |
Cas.: 706792-04-3 | Purity: 98% | Methyl 3-amino-5-ethoxybenzoate | ESD-897335-25G |
Cas.: 67861-96-5 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)pentanoate | ESD-897336-1G |
Cas.: 67861-96-5 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)pentanoate | ESD-897336-5G |
Cas.: 67861-96-5 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)pentanoate | ESD-897336-10G |
Cas.: 67861-96-5 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)pentanoate | ESD-897336-25G |
Cas.: 5293-83-4 | Purity: ≥95% | (Hydroxymethyl)triphenylphosphonium chloride | ESD-897337-1G |
Cas.: 5293-83-4 | Purity: ≥95% | (Hydroxymethyl)triphenylphosphonium chloride | ESD-897337-5G |
Cas.: 5293-83-4 | Purity: ≥95% | (Hydroxymethyl)triphenylphosphonium chloride | ESD-897337-10G |
Cas.: 5293-83-4 | Purity: ≥95% | (Hydroxymethyl)triphenylphosphonium chloride | ESD-897337-25G |
Cas.: 934240-30-9 | Purity: ≥98% | CNV1014802 | ESD-897338-1MG |
Cas.: 934240-30-9 | Purity: ≥98% | CNV1014802 | ESD-897338-5MG |
Cas.: 934240-30-9 | Purity: ≥98% | CNV1014802 | ESD-897338-10MG |
Cas.: 934240-30-9 | Purity: ≥98% | CNV1014802 | ESD-897338-25MG |
Cas.: 151360-57-5 | Purity: 97% | Methyl 2-chloro-6-fluorobenzoate | ESD-897339-1G |
Cas.: 151360-57-5 | Purity: 97% | Methyl 2-chloro-6-fluorobenzoate | ESD-897339-5G |
Cas.: 151360-57-5 | Purity: 97% | Methyl 2-chloro-6-fluorobenzoate | ESD-897339-10G |
Cas.: 151360-57-5 | Purity: 97% | Methyl 2-chloro-6-fluorobenzoate | ESD-897339-25G |
Cas.: 4467-55-4 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate | ESD-897340-1G |
Cas.: 4467-55-4 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate | ESD-897340-5G |
Cas.: 4467-55-4 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate | ESD-897340-10G |
Cas.: 4467-55-4 | Purity: 97% | (R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate | ESD-897340-25G |
Cas.: 2483-51-4 | Purity: 97% | Cbz-Ala-Ala-Ome | ESD-897341-1G |
Cas.: 2483-51-4 | Purity: 97% | Cbz-Ala-Ala-Ome | ESD-897341-5G |
Cas.: 2483-51-4 | Purity: 97% | Cbz-Ala-Ala-Ome | ESD-897341-10G |
Cas.: 2483-51-4 | Purity: 97% | Cbz-Ala-Ala-Ome | ESD-897341-25G |
Cas.: 1400809-84-8 | Purity: 97% | (4′-Butyl-3-fluoro-[1,1′-biphenyl]-4-yl)boronic acid | ESD-897342-1G |
Cas.: 1400809-84-8 | Purity: 97% | (4′-Butyl-3-fluoro-[1,1′-biphenyl]-4-yl)boronic acid | ESD-897342-5G |
Cas.: 1400809-84-8 | Purity: 97% | (4′-Butyl-3-fluoro-[1,1′-biphenyl]-4-yl)boronic acid | ESD-897342-10G |
Cas.: 1400809-84-8 | Purity: 97% | (4′-Butyl-3-fluoro-[1,1′-biphenyl]-4-yl)boronic acid | ESD-897342-25G |
Cas.: 870281-85-9 | Purity: ≥95% | (S)-tert-Butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate | ESD-897343-1G |
Cas.: 870281-85-9 | Purity: ≥95% | (S)-tert-Butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate | ESD-897343-5G |
Cas.: 870281-85-9 | Purity: ≥95% | (S)-tert-Butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate | ESD-897343-10G |
Cas.: 870281-85-9 | Purity: ≥95% | (S)-tert-Butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate | ESD-897343-25G |
Cas.: 1194550-59-8 | Purity: 97% | (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-897344-1G |
Cas.: 1194550-59-8 | Purity: 97% | (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-897344-5G |
Cas.: 1194550-59-8 | Purity: 97% | (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-897344-10G |
Cas.: 1194550-59-8 | Purity: 97% | (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | ESD-897344-25G |
Cas.: 1416354-40-9 | Purity: 97% | Methyl 6-chloro-3-(trifluoromethyl)picolinate | ESD-897345-1G |
Cas.: 1416354-40-9 | Purity: 97% | Methyl 6-chloro-3-(trifluoromethyl)picolinate | ESD-897345-5G |
Cas.: 1416354-40-9 | Purity: 97% | Methyl 6-chloro-3-(trifluoromethyl)picolinate | ESD-897345-10G |
Cas.: 1416354-40-9 | Purity: 97% | Methyl 6-chloro-3-(trifluoromethyl)picolinate | ESD-897345-25G |
Cas.: 42821-92-1 | Purity: ≥95% | Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-897346-1G |
Cas.: 42821-92-1 | Purity: ≥95% | Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-897346-5G |
Cas.: 42821-92-1 | Purity: ≥95% | Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-897346-10G |
Cas.: 42821-92-1 | Purity: ≥95% | Methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-897346-25G |
Cas.: 314776-92-6 | Purity: ≥98% | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide hydrochloride | ESD-897347-1MG |
Cas.: 314776-92-6 | Purity: ≥98% | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide hydrochloride | ESD-897347-5MG |
Cas.: 314776-92-6 | Purity: ≥98% | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide hydrochloride | ESD-897347-10MG |
Cas.: 314776-92-6 | Purity: ≥98% | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide hydrochloride | ESD-897347-25MG |
Cas.: 773135-55-0 | Purity: 97% | Ethyl 3-chloro-2-fluorobenzoate | ESD-897348-1G |
Cas.: 773135-55-0 | Purity: 97% | Ethyl 3-chloro-2-fluorobenzoate | ESD-897348-5G |
Cas.: 773135-55-0 | Purity: 97% | Ethyl 3-chloro-2-fluorobenzoate | ESD-897348-10G |
Cas.: 773135-55-0 | Purity: 97% | Ethyl 3-chloro-2-fluorobenzoate | ESD-897348-25G |
Cas.: 1852533-96-0 | Purity: 95% | 3-Aminophthalic acid hydrochloride dihydrate | ESD-897349-1G |
Cas.: 1852533-96-0 | Purity: 95% | 3-Aminophthalic acid hydrochloride dihydrate | ESD-897349-5G |
Cas.: 1852533-96-0 | Purity: 95% | 3-Aminophthalic acid hydrochloride dihydrate | ESD-897349-10G |
Cas.: 1852533-96-0 | Purity: 95% | 3-Aminophthalic acid hydrochloride dihydrate | ESD-897349-25G |
Cas.: 794592-13-5 | Purity: 99% | Ethyl 5-bromo-3-methylpicolinate | ESD-897350-1G |
Cas.: 794592-13-5 | Purity: 99% | Ethyl 5-bromo-3-methylpicolinate | ESD-897350-5G |
Cas.: 794592-13-5 | Purity: 99% | Ethyl 5-bromo-3-methylpicolinate | ESD-897350-10G |
Cas.: 794592-13-5 | Purity: 99% | Ethyl 5-bromo-3-methylpicolinate | ESD-897350-25G |
Cas.: 87694-53-9 | Purity: 98% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-897351-1G |
Cas.: 87694-53-9 | Purity: 98% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-897351-5G |
Cas.: 87694-53-9 | Purity: 98% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-897351-10G |
Cas.: 87694-53-9 | Purity: 98% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-897351-25G |
Cas.: 948570-75-0 | Purity: 97% | 1-(2-Methoxyethyl)-4-nitro-1H-pyrazole | ESD-897352-250MG |
Cas.: 948570-75-0 | Purity: 97% | 1-(2-Methoxyethyl)-4-nitro-1H-pyrazole | ESD-897352-1G |
Cas.: 948570-75-0 | Purity: 97% | 1-(2-Methoxyethyl)-4-nitro-1H-pyrazole | ESD-897352-5G |
Cas.: 948570-75-0 | Purity: 97% | 1-(2-Methoxyethyl)-4-nitro-1H-pyrazole | ESD-897352-25G |
Cas.: 14227-18-0 | Purity: 98% | 2,4,6-Trimethoxynitrobenzene | ESD-897354-250MG |
Cas.: 14227-18-0 | Purity: 98% | 2,4,6-Trimethoxynitrobenzene | ESD-897354-1G |
Cas.: 14227-18-0 | Purity: 98% | 2,4,6-Trimethoxynitrobenzene | ESD-897354-5G |
Cas.: 14227-18-0 | Purity: 98% | 2,4,6-Trimethoxynitrobenzene | ESD-897354-25G |
Cas.: 2097002-61-2 | Purity: 98% | Selitrectinib | ESD-897355-1MG |
Cas.: 2097002-61-2 | Purity: 98% | Selitrectinib | ESD-897355-5MG |
Cas.: 2097002-61-2 | Purity: 98% | Selitrectinib | ESD-897355-10MG |
Cas.: 2097002-61-2 | Purity: 98% | Selitrectinib | ESD-897355-25MG |
Cas.: 870544-59-5 | Purity: ≥98% | BPTU | ESD-897356-1MG |
Cas.: 870544-59-5 | Purity: ≥98% | BPTU | ESD-897356-5MG |
Cas.: 870544-59-5 | Purity: ≥98% | BPTU | ESD-897356-10MG |
Cas.: 870544-59-5 | Purity: ≥98% | BPTU | ESD-897356-25MG |
Cas.: 83791-90-6 | Purity: ≥95% | 2,4-Dichloro-3,6-dimethylpyridine | ESD-897357-1G |
Cas.: 83791-90-6 | Purity: ≥95% | 2,4-Dichloro-3,6-dimethylpyridine | ESD-897357-5G |
Cas.: 83791-90-6 | Purity: ≥95% | 2,4-Dichloro-3,6-dimethylpyridine | ESD-897357-10G |
Cas.: 83791-90-6 | Purity: ≥95% | 2,4-Dichloro-3,6-dimethylpyridine | ESD-897357-25G |
Cas.: 149177-75-3 | Purity: 97% | Chroman-2-ylmethanamine hydrochloride | ESD-897358-250MG |
Cas.: 149177-75-3 | Purity: 97% | Chroman-2-ylmethanamine hydrochloride | ESD-897358-1G |
Cas.: 149177-75-3 | Purity: 97% | Chroman-2-ylmethanamine hydrochloride | ESD-897358-5G |
Cas.: 149177-75-3 | Purity: 97% | Chroman-2-ylmethanamine hydrochloride | ESD-897358-25G |
Cas.: 1393124-08-7 | Purity: ≥98% | glucagon receptor antagonists-4 | ESD-897359-1MG |
Cas.: 1393124-08-7 | Purity: ≥98% | glucagon receptor antagonists-4 | ESD-897359-5MG |
Cas.: 1393124-08-7 | Purity: ≥98% | glucagon receptor antagonists-4 | ESD-897359-10MG |
Cas.: 1393124-08-7 | Purity: ≥98% | glucagon receptor antagonists-4 | ESD-897359-25MG |
Cas.: 78941-95-4 | Purity: 98% | 5-Chloro-8-methylquinoline | ESD-897360-1G |
Cas.: 78941-95-4 | Purity: 98% | 5-Chloro-8-methylquinoline | ESD-897360-5G |
Cas.: 78941-95-4 | Purity: 98% | 5-Chloro-8-methylquinoline | ESD-897360-10G |
Cas.: 78941-95-4 | Purity: 98% | 5-Chloro-8-methylquinoline | ESD-897360-25G |
Cas.: 956951-01-2 | Purity: 95% | 3-Nitro-1H-pyrazole-1-ethanol | ESD-897361-1G |
Cas.: 956951-01-2 | Purity: 95% | 3-Nitro-1H-pyrazole-1-ethanol | ESD-897361-5G |
Cas.: 956951-01-2 | Purity: 95% | 3-Nitro-1H-pyrazole-1-ethanol | ESD-897361-10G |
Cas.: 956951-01-2 | Purity: 95% | 3-Nitro-1H-pyrazole-1-ethanol | ESD-897361-25G |
Cas.: 14062-05-6 | Purity: 98% | N,N’-Bis(p-toluenesulfonyl)hydrazine | ESD-897362-250MG |
Cas.: 14062-05-6 | Purity: 98% | N,N’-Bis(p-toluenesulfonyl)hydrazine | ESD-897362-1G |
Cas.: 81108-81-8 | Purity: ≥95% | 2-Nitro-4-trifluoromethyl-benzoyl chloride | ESD-897363-1G |
Cas.: 81108-81-8 | Purity: ≥95% | 2-Nitro-4-trifluoromethyl-benzoyl chloride | ESD-897363-5G |
Cas.: 81108-81-8 | Purity: ≥95% | 2-Nitro-4-trifluoromethyl-benzoyl chloride | ESD-897363-10G |
Cas.: 81108-81-8 | Purity: ≥95% | 2-Nitro-4-trifluoromethyl-benzoyl chloride | ESD-897363-25G |
Cas.: 2302-88-7 | Purity: 97% | 2-Acetylhydrazinecarbothioamide | ESD-897364-1G |
Cas.: 2302-88-7 | Purity: 97% | 2-Acetylhydrazinecarbothioamide | ESD-897364-5G |
Cas.: 2302-88-7 | Purity: 97% | 2-Acetylhydrazinecarbothioamide | ESD-897364-10G |
Cas.: 2302-88-7 | Purity: 97% | 2-Acetylhydrazinecarbothioamide | ESD-897364-25G |
Cas.: 346694-73-3 | Purity: 97% | 1-Benzyl-3-piperidone Hydrochloride Hydrate | ESD-897365-1G |
Cas.: 346694-73-3 | Purity: 97% | 1-Benzyl-3-piperidone Hydrochloride Hydrate | ESD-897365-5G |
Cas.: 346694-73-3 | Purity: 97% | 1-Benzyl-3-piperidone Hydrochloride Hydrate | ESD-897365-10G |
Cas.: 346694-73-3 | Purity: 97% | 1-Benzyl-3-piperidone Hydrochloride Hydrate | ESD-897365-25G |
Cas.: 17605-27-5 | Purity: 97% | 5-Methoxy-1,3,4-thiadiazol-2-ol | ESD-897366-1G |
Cas.: 17605-27-5 | Purity: 97% | 5-Methoxy-1,3,4-thiadiazol-2-ol | ESD-897366-5G |
Cas.: 17605-27-5 | Purity: 97% | 5-Methoxy-1,3,4-thiadiazol-2-ol | ESD-897366-10G |
Cas.: 17605-27-5 | Purity: 97% | 5-Methoxy-1,3,4-thiadiazol-2-ol | ESD-897366-25G |
Cas.: 25341-42-8 | Purity: ≥95% | Z-Cha-OH | ESD-897367-1G |
Cas.: 25341-42-8 | Purity: ≥95% | Z-Cha-OH | ESD-897367-5G |
Cas.: 25341-42-8 | Purity: ≥95% | Z-Cha-OH | ESD-897367-10G |
Cas.: 25341-42-8 | Purity: ≥95% | Z-Cha-OH | ESD-897367-25G |
Cas.: 882167-77-3 | Purity: 97% | 4-Chloro-N-methylpicolinamide hydrochloride | ESD-897368-1G |
Cas.: 882167-77-3 | Purity: 97% | 4-Chloro-N-methylpicolinamide hydrochloride | ESD-897368-5G |
Cas.: 882167-77-3 | Purity: 97% | 4-Chloro-N-methylpicolinamide hydrochloride | ESD-897368-10G |
Cas.: 882167-77-3 | Purity: 97% | 4-Chloro-N-methylpicolinamide hydrochloride | ESD-897368-25G |
Cas.: 1217720-49-4 | Purity: 97% | (S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride | ESD-897369-1G |
Cas.: 1217720-49-4 | Purity: 97% | (S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride | ESD-897369-5G |
Cas.: 1217720-49-4 | Purity: 97% | (S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride | ESD-897369-10G |
Cas.: 1217720-49-4 | Purity: 97% | (S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride | ESD-897369-25G |
Cas.: 116970-50-4 | Purity: 97% | N-(2-Aminoethyl)isoquinoline-5-sulfonamide hydrochloride | ESD-897370-1G |
Cas.: 116970-50-4 | Purity: 97% | N-(2-Aminoethyl)isoquinoline-5-sulfonamide hydrochloride | ESD-897370-5G |
Cas.: 116970-50-4 | Purity: 97% | N-(2-Aminoethyl)isoquinoline-5-sulfonamide hydrochloride | ESD-897370-10G |
Cas.: 116970-50-4 | Purity: 97% | N-(2-Aminoethyl)isoquinoline-5-sulfonamide hydrochloride | ESD-897370-25G |
Cas.: 37551-43-2 | Purity: ≥95% | 5-Chloro-N,2-dihydroxybenzamide | ESD-897371-1G |
Cas.: 37551-43-2 | Purity: ≥95% | 5-Chloro-N,2-dihydroxybenzamide | ESD-897371-5G |
Cas.: 37551-43-2 | Purity: ≥95% | 5-Chloro-N,2-dihydroxybenzamide | ESD-897371-10G |
Cas.: 37551-43-2 | Purity: ≥95% | 5-Chloro-N,2-dihydroxybenzamide | ESD-897371-25G |
Cas.: 69901-85-5 | Purity: ≥95% | ZD-Chg-OH | ESD-897372-1G |
Cas.: 69901-85-5 | Purity: ≥95% | ZD-Chg-OH | ESD-897372-5G |
Cas.: 69901-85-5 | Purity: ≥95% | ZD-Chg-OH | ESD-897372-10G |
Cas.: 69901-85-5 | Purity: ≥95% | ZD-Chg-OH | ESD-897372-25G |
Cas.: 214839-73-3 | Purity: 95% | 4-(2-Aminoethyl)-5-methyl-1H-pyrazol-3(2H)-one | ESD-897373-1G |
Cas.: 214839-73-3 | Purity: 95% | 4-(2-Aminoethyl)-5-methyl-1H-pyrazol-3(2H)-one | ESD-897373-5G |
Cas.: 214839-73-3 | Purity: 95% | 4-(2-Aminoethyl)-5-methyl-1H-pyrazol-3(2H)-one | ESD-897373-10G |
Cas.: 214839-73-3 | Purity: 95% | 4-(2-Aminoethyl)-5-methyl-1H-pyrazol-3(2H)-one | ESD-897373-25G |
Cas.: 79992-76-0 | Purity: 98%, contains≤6%H2O | Magnesium(II) 2-Ethylbutyrate | ESD-897374-1G |
Cas.: 79992-76-0 | Purity: 98%, contains≤6%H2O | Magnesium(II) 2-Ethylbutyrate | ESD-897374-5G |
Cas.: 79992-76-0 | Purity: 98%, contains≤6%H2O | Magnesium(II) 2-Ethylbutyrate | ESD-897374-10G |
Cas.: 79992-76-0 | Purity: 98%, contains≤6%H2O | Magnesium(II) 2-Ethylbutyrate | ESD-897374-25G |
Cas.: 500912-15-2 | Purity: 95% | 2-(3-Fluoro-2-methylphenyl)acetonitrile | ESD-897375-1G |
Cas.: 500912-15-2 | Purity: 95% | 2-(3-Fluoro-2-methylphenyl)acetonitrile | ESD-897375-5G |
Cas.: 500912-15-2 | Purity: 95% | 2-(3-Fluoro-2-methylphenyl)acetonitrile | ESD-897375-10G |
Cas.: 500912-15-2 | Purity: 95% | 2-(3-Fluoro-2-methylphenyl)acetonitrile | ESD-897375-25G |
Cas.: 58610-42-7 | Purity: ≥95% | (R)-3-Aminobutanoic acid hydrochloride | ESD-897376-1G |
Cas.: 58610-42-7 | Purity: ≥95% | (R)-3-Aminobutanoic acid hydrochloride | ESD-897376-5G |
Cas.: 58610-42-7 | Purity: ≥95% | (R)-3-Aminobutanoic acid hydrochloride | ESD-897376-10G |
Cas.: 58610-42-7 | Purity: ≥95% | (R)-3-Aminobutanoic acid hydrochloride | ESD-897376-25G |
Cas.: 924473-59-6 | Purity: ≥98% | T 5601640 | ESD-897377-1MG |
Cas.: 924473-59-6 | Purity: ≥98% | T 5601640 | ESD-897377-5MG |
Cas.: 924473-59-6 | Purity: ≥98% | T 5601640 | ESD-897377-10MG |
Cas.: 924473-59-6 | Purity: ≥98% | T 5601640 | ESD-897377-25MG |
Cas.: 1374639-75-4 | Purity: 98% | LEE011 succinate | ESD-897378-1MG |
Cas.: 1374639-75-4 | Purity: 98% | LEE011 succinate | ESD-897378-5MG |
Cas.: 1374639-75-4 | Purity: 98% | LEE011 succinate | ESD-897378-10MG |
Cas.: 1374639-75-4 | Purity: 98% | LEE011 succinate | ESD-897378-25MG |
Cas.: 437763-66-1 | Purity: ≥95% | (R)-Chroman-2-ylmethanamine hydrochloride | ESD-897379-1G |
Cas.: 437763-66-1 | Purity: ≥95% | (R)-Chroman-2-ylmethanamine hydrochloride | ESD-897379-5G |
Cas.: 437763-66-1 | Purity: ≥95% | (R)-Chroman-2-ylmethanamine hydrochloride | ESD-897379-10G |
Cas.: 437763-66-1 | Purity: ≥95% | (R)-Chroman-2-ylmethanamine hydrochloride | ESD-897379-25G |
Cas.: 201217-86-9 | Purity: ≥95% | (2R,3S)-3-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)butanoic acid | ESD-897380-1G |
Cas.: 201217-86-9 | Purity: ≥95% | (2R,3S)-3-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)butanoic acid | ESD-897380-5G |
Cas.: 201217-86-9 | Purity: ≥95% | (2R,3S)-3-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)butanoic acid | ESD-897380-10G |
Cas.: 201217-86-9 | Purity: ≥95% | (2R,3S)-3-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)butanoic acid | ESD-897380-25G |
Cas.: 204138-23-8 | Purity: 96% | Boc-L-isoleucine hemihydrate | ESD-897381-1G |
Cas.: 204138-23-8 | Purity: 96% | Boc-L-isoleucine hemihydrate | ESD-897381-5G |
Cas.: 204138-23-8 | Purity: 96% | Boc-L-isoleucine hemihydrate | ESD-897381-10G |
Cas.: 204138-23-8 | Purity: 96% | Boc-L-isoleucine hemihydrate | ESD-897381-25G |
Cas.: 204320-60-5 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid | ESD-897382-250MG |
Cas.: 204320-60-5 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid | ESD-897382-1G |
Cas.: 204320-60-5 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid | ESD-897382-5G |
Cas.: 204320-60-5 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid | ESD-897382-25G |
Cas.: 59410-82-1 | Purity: 98% | H-Phg-OEt.HCl | ESD-897383-1G |
Cas.: 59410-82-1 | Purity: 98% | H-Phg-OEt.HCl | ESD-897383-5G |
Cas.: 59410-82-1 | Purity: 98% | H-Phg-OEt.HCl | ESD-897383-10G |
Cas.: 59410-82-1 | Purity: 98% | H-Phg-OEt.HCl | ESD-897383-25G |
Cas.: 3399-21-1 | Purity: ≥95% | cis-Dimethyl cyclohexane-1,4-dicarboxylate | ESD-897384-1G |
Cas.: 3399-21-1 | Purity: ≥95% | cis-Dimethyl cyclohexane-1,4-dicarboxylate | ESD-897384-5G |
Cas.: 3399-21-1 | Purity: ≥95% | cis-Dimethyl cyclohexane-1,4-dicarboxylate | ESD-897384-10G |
Cas.: 3399-21-1 | Purity: ≥95% | cis-Dimethyl cyclohexane-1,4-dicarboxylate | ESD-897384-25G |
Cas.: 233275-76-8 | Purity: 97% | MK 0343 | ESD-897385-1MG |
Cas.: 233275-76-8 | Purity: 97% | MK 0343 | ESD-897385-5MG |
Cas.: 233275-76-8 | Purity: 97% | MK 0343 | ESD-897385-10MG |
Cas.: 233275-76-8 | Purity: 97% | MK 0343 | ESD-897385-25MG |
Cas.: 133307-08-1 | Purity: 97% | 1,3-Dichloro-2-fluoro-5-iodobenzene | ESD-897386-1G |
Cas.: 133307-08-1 | Purity: 97% | 1,3-Dichloro-2-fluoro-5-iodobenzene | ESD-897386-5G |
Cas.: 133307-08-1 | Purity: 97% | 1,3-Dichloro-2-fluoro-5-iodobenzene | ESD-897386-10G |
Cas.: 133307-08-1 | Purity: 97% | 1,3-Dichloro-2-fluoro-5-iodobenzene | ESD-897386-25G |
Cas.: 1186403-17-7 | Purity: ≥95% | (3-Bromo-5-chlorophenyl)boronic acid | ESD-897387-1G |
Cas.: 1186403-17-7 | Purity: ≥95% | (3-Bromo-5-chlorophenyl)boronic acid | ESD-897387-5G |
Cas.: 1186403-17-7 | Purity: ≥95% | (3-Bromo-5-chlorophenyl)boronic acid | ESD-897387-10G |
Cas.: 1186403-17-7 | Purity: ≥95% | (3-Bromo-5-chlorophenyl)boronic acid | ESD-897387-25G |
Cas.: 181827-47-4 | Purity: 95% | (S)-1-((S)-2-((Methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897388-1G |
Cas.: 181827-47-4 | Purity: 95% | (S)-1-((S)-2-((Methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897388-5G |
Cas.: 181827-47-4 | Purity: 95% | (S)-1-((S)-2-((Methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897388-10G |
Cas.: 181827-47-4 | Purity: 95% | (S)-1-((S)-2-((Methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid | ESD-897388-25G |
Cas.: 1006333-32-9 | Purity: ≥95% | 1-Isobutyl-1H-pyrazole-4-carbaldehyde | ESD-897389-1G |
Cas.: 1006333-32-9 | Purity: ≥95% | 1-Isobutyl-1H-pyrazole-4-carbaldehyde | ESD-897389-5G |
Cas.: 1006333-32-9 | Purity: ≥95% | 1-Isobutyl-1H-pyrazole-4-carbaldehyde | ESD-897389-10G |
Cas.: 1006333-32-9 | Purity: ≥95% | 1-Isobutyl-1H-pyrazole-4-carbaldehyde | ESD-897389-25G |
Cas.: 97984-63-9 | Purity: ≥95% | (R)-Benzyl 2-amino-3-(4-hydroxyphenyl)propanoate 4-methylbenzenesulfonate | ESD-897390-1G |
Cas.: 97984-63-9 | Purity: ≥95% | (R)-Benzyl 2-amino-3-(4-hydroxyphenyl)propanoate 4-methylbenzenesulfonate | ESD-897390-5G |
Cas.: 97984-63-9 | Purity: ≥95% | (R)-Benzyl 2-amino-3-(4-hydroxyphenyl)propanoate 4-methylbenzenesulfonate | ESD-897390-10G |
Cas.: 97984-63-9 | Purity: ≥95% | (R)-Benzyl 2-amino-3-(4-hydroxyphenyl)propanoate 4-methylbenzenesulfonate | ESD-897390-25G |
Cas.: 97329-43-6 | Purity: 98% | 1-Bromo-2-chloro-3-methylbenzene | ESD-897391-1G |
Cas.: 97329-43-6 | Purity: 98% | 1-Bromo-2-chloro-3-methylbenzene | ESD-897391-5G |
Cas.: 97329-43-6 | Purity: 98% | 1-Bromo-2-chloro-3-methylbenzene | ESD-897391-10G |
Cas.: 97329-43-6 | Purity: 98% | 1-Bromo-2-chloro-3-methylbenzene | ESD-897391-25G |
Cas.: 291775-59-2 | Purity: 97% | (1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | ESD-897392-1G |
Cas.: 291775-59-2 | Purity: 97% | (1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | ESD-897392-5G |
Cas.: 291775-59-2 | Purity: 97% | (1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | ESD-897392-10G |
Cas.: 291775-59-2 | Purity: 97% | (1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | ESD-897392-25G |
Cas.: 61348-47-8 | Purity: 96% | 2-(Isoxazol-5-yl)phenol | ESD-897393-1G |
Cas.: 61348-47-8 | Purity: 96% | 2-(Isoxazol-5-yl)phenol | ESD-897393-5G |
Cas.: 61348-47-8 | Purity: 96% | 2-(Isoxazol-5-yl)phenol | ESD-897393-10G |
Cas.: 61348-47-8 | Purity: 96% | 2-(Isoxazol-5-yl)phenol | ESD-897393-25G |
Cas.: 10242-08-7 | Purity: 98% | 5-Methoxybenzofuran-2-carboxylic acid | ESD-897394-1G |
Cas.: 10242-08-7 | Purity: 98% | 5-Methoxybenzofuran-2-carboxylic acid | ESD-897394-5G |
Cas.: 113975-31-8 | Purity: 97% | N-(3-Iodopyridin-2-yl)pivalamide | ESD-897395-1G |
Cas.: 113975-31-8 | Purity: 97% | N-(3-Iodopyridin-2-yl)pivalamide | ESD-897395-5G |
Cas.: 113975-31-8 | Purity: 97% | N-(3-Iodopyridin-2-yl)pivalamide | ESD-897395-10G |
Cas.: 113975-31-8 | Purity: 97% | N-(3-Iodopyridin-2-yl)pivalamide | ESD-897395-25G |
Cas.: 217299-03-1 | Purity: ≥95% | 4-Aminotetrahydro-2H-pyran-4-carboxylic acid hydrochloride | ESD-897396-1G |
Cas.: 217299-03-1 | Purity: ≥95% | 4-Aminotetrahydro-2H-pyran-4-carboxylic acid hydrochloride | ESD-897396-5G |
Cas.: 217299-03-1 | Purity: ≥95% | 4-Aminotetrahydro-2H-pyran-4-carboxylic acid hydrochloride | ESD-897396-10G |
Cas.: 217299-03-1 | Purity: ≥95% | 4-Aminotetrahydro-2H-pyran-4-carboxylic acid hydrochloride | ESD-897396-25G |
Cas.: 100048-86-0 | Purity: ≥97% | 2-(Bromomethyl)-2-butylhexanoic acid | ESD-897397-1G |
Cas.: 100048-86-0 | Purity: ≥97% | 2-(Bromomethyl)-2-butylhexanoic acid | ESD-897397-5G |
Cas.: 100048-86-0 | Purity: ≥97% | 2-(Bromomethyl)-2-butylhexanoic acid | ESD-897397-10G |
Cas.: 100048-86-0 | Purity: ≥97% | 2-(Bromomethyl)-2-butylhexanoic acid | ESD-897397-25G |
Cas.: 81565-19-7 | Purity: 97% | 3-Chloro-4-(trifluoromethyl)pyridine | ESD-897398-1G |
Cas.: 81565-19-7 | Purity: 97% | 3-Chloro-4-(trifluoromethyl)pyridine | ESD-897398-5G |
Cas.: 81565-19-7 | Purity: 97% | 3-Chloro-4-(trifluoromethyl)pyridine | ESD-897398-10G |
Cas.: 81565-19-7 | Purity: 97% | 3-Chloro-4-(trifluoromethyl)pyridine | ESD-897398-25G |
Cas.: 5460-32-2 | Purity: 97% | 4-Iodo-1,2-dimethoxybenzene | ESD-897399-1G |
Cas.: 5460-32-2 | Purity: 97% | 4-Iodo-1,2-dimethoxybenzene | ESD-897399-5G |
Cas.: 5460-32-2 | Purity: 97% | 4-Iodo-1,2-dimethoxybenzene | ESD-897399-10G |
Cas.: 5460-32-2 | Purity: 97% | 4-Iodo-1,2-dimethoxybenzene | ESD-897399-25G |
Cas.: 866893-90-5 | Purity: 97% | Aftin-4 | ESD-897400-1MG |
Cas.: 866893-90-5 | Purity: 97% | Aftin-4 | ESD-897400-5MG |
Cas.: 866893-90-5 | Purity: 97% | Aftin-4 | ESD-897400-10MG |
Cas.: 866893-90-5 | Purity: 97% | Aftin-4 | ESD-897400-25MG |
Cas.: 111082-76-9 | Purity: ≥95% | (R)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-897401-1G |
Cas.: 111082-76-9 | Purity: ≥95% | (R)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-897401-5G |
Cas.: 111082-76-9 | Purity: ≥95% | (R)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-897401-10G |
Cas.: 111082-76-9 | Purity: ≥95% | (R)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-897401-25G |
Cas.: 5406-86-0 | Purity: 97% | 2-(4-(tert-Butyl)phenyl)ethanol | ESD-897402-1G |
Cas.: 5406-86-0 | Purity: 97% | 2-(4-(tert-Butyl)phenyl)ethanol | ESD-897402-5G |
Cas.: 5406-86-0 | Purity: 97% | 2-(4-(tert-Butyl)phenyl)ethanol | ESD-897402-10G |
Cas.: 5406-86-0 | Purity: 97% | 2-(4-(tert-Butyl)phenyl)ethanol | ESD-897402-25G |
Cas.: 1049730-84-8 | Purity: 97% | 1-Bromo-4-methoxy-2-(trifluoromethoxy)benzene | ESD-897403-1G |
Cas.: 1049730-84-8 | Purity: 97% | 1-Bromo-4-methoxy-2-(trifluoromethoxy)benzene | ESD-897403-5G |
Cas.: 1049730-84-8 | Purity: 97% | 1-Bromo-4-methoxy-2-(trifluoromethoxy)benzene | ESD-897403-10G |
Cas.: 1049730-84-8 | Purity: 97% | 1-Bromo-4-methoxy-2-(trifluoromethoxy)benzene | ESD-897403-25G |
Cas.: 1063734-49-5 | Purity: 97% | 1-Methyl-1H-pyrazol-4-amine dihydrochloride | ESD-897404-1G |
Cas.: 1063734-49-5 | Purity: 97% | 1-Methyl-1H-pyrazol-4-amine dihydrochloride | ESD-897404-5G |
Cas.: 1063734-49-5 | Purity: 97% | 1-Methyl-1H-pyrazol-4-amine dihydrochloride | ESD-897404-10G |
Cas.: 1063734-49-5 | Purity: 97% | 1-Methyl-1H-pyrazol-4-amine dihydrochloride | ESD-897404-25G |
Cas.: 106854-77-7 | Purity: 97% | 1-Bromo-4-(2,2,2-trifluoroethoxy)benzene | ESD-897405-1G |
Cas.: 106854-77-7 | Purity: 97% | 1-Bromo-4-(2,2,2-trifluoroethoxy)benzene | ESD-897405-5G |
Cas.: 1242157-23-8 | Purity: ≥95% | 4-Bromo-2-fluoro-6-methylbenzoic acid | ESD-897406-1G |
Cas.: 1242157-23-8 | Purity: ≥95% | 4-Bromo-2-fluoro-6-methylbenzoic acid | ESD-897406-5G |
Cas.: 1242157-23-8 | Purity: ≥95% | 4-Bromo-2-fluoro-6-methylbenzoic acid | ESD-897406-10G |
Cas.: 1242157-23-8 | Purity: ≥95% | 4-Bromo-2-fluoro-6-methylbenzoic acid | ESD-897406-25G |
Cas.: 2026-70-2 | Purity: ≥95% | N-Methyl-3-(trifluoromethyl)aniline | ESD-897407-1G |
Cas.: 2026-70-2 | Purity: ≥95% | N-Methyl-3-(trifluoromethyl)aniline | ESD-897407-5G |
Cas.: 2026-70-2 | Purity: ≥95% | N-Methyl-3-(trifluoromethyl)aniline | ESD-897407-10G |
Cas.: 2026-70-2 | Purity: ≥95% | N-Methyl-3-(trifluoromethyl)aniline | ESD-897407-25G |
Cas.: 85342-62-7 | Purity: 97% | 1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate | ESD-897408-1G |
Cas.: 85342-62-7 | Purity: 97% | 1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate | ESD-897408-5G |
Cas.: 85342-62-7 | Purity: 97% | 1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate | ESD-897408-10G |
Cas.: 85342-62-7 | Purity: 97% | 1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate | ESD-897408-25G |
Cas.: 229957-50-0 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate | ESD-897409-1G |
Cas.: 229957-50-0 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate | ESD-897409-5G |
Cas.: 229957-50-0 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate | ESD-897409-10G |
Cas.: 229957-50-0 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid hydrate | ESD-897409-25G |
Cas.: 73105-48-3 | Purity: 97% | 1-Methyl-5-nitro-1H-indazol-3-amine | ESD-897410-1G |
Cas.: 73105-48-3 | Purity: 97% | 1-Methyl-5-nitro-1H-indazol-3-amine | ESD-897410-5G |
Cas.: 73105-48-3 | Purity: 97% | 1-Methyl-5-nitro-1H-indazol-3-amine | ESD-897410-10G |
Cas.: 73105-48-3 | Purity: 97% | 1-Methyl-5-nitro-1H-indazol-3-amine | ESD-897410-25G |
Cas.: 5959-29-5 | Purity: ≥95% | (S)-2-Aminobutanoic acid hydrochloride | ESD-897411-1G |
Cas.: 5959-29-5 | Purity: ≥95% | (S)-2-Aminobutanoic acid hydrochloride | ESD-897411-5G |
Cas.: 5959-29-5 | Purity: ≥95% | (S)-2-Aminobutanoic acid hydrochloride | ESD-897411-10G |
Cas.: 5959-29-5 | Purity: ≥95% | (S)-2-Aminobutanoic acid hydrochloride | ESD-897411-25G |
Cas.: 71083-06-2 | Purity: 97% | Ethyl 8-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-897412-1G |
Cas.: 71083-06-2 | Purity: 97% | Ethyl 8-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-897412-5G |
Cas.: 71083-06-2 | Purity: 97% | Ethyl 8-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-897412-10G |
Cas.: 71083-06-2 | Purity: 97% | Ethyl 8-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-897412-25G |
Cas.: 129322-81-2 | Purity: 98% | 1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone | ESD-897413-1G |
Cas.: 129322-81-2 | Purity: 98% | 1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone | ESD-897413-5G |
Cas.: 129322-81-2 | Purity: 98% | 1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone | ESD-897413-10G |
Cas.: 129322-81-2 | Purity: 98% | 1-(2-Chloro-4-(trifluoromethyl)phenyl)ethanone | ESD-897413-25G |
Cas.: 133467-01-3 | Purity: 97% | Boc-D-Leu-OMe | ESD-897414-1G |
Cas.: 133467-01-3 | Purity: 97% | Boc-D-Leu-OMe | ESD-897414-5G |
Cas.: 133467-01-3 | Purity: 97% | Boc-D-Leu-OMe | ESD-897414-10G |
Cas.: 133467-01-3 | Purity: 97% | Boc-D-Leu-OMe | ESD-897414-25G |
Cas.: 34404-33-6 | Purity: 97% | Boc-D-Ala-OSu | ESD-897415-250MG |
Cas.: 34404-33-6 | Purity: 97% | Boc-D-Ala-OSu | ESD-897415-1G |
Cas.: 34404-33-6 | Purity: 97% | Boc-D-Ala-OSu | ESD-897415-5G |
Cas.: 34404-33-6 | Purity: 97% | Boc-D-Ala-OSu | ESD-897415-25G |
Cas.: 92822-03-2 | Purity: 97% | 4-(4-Fluorobenzyl)piperidine hydrochloride | ESD-897416-1G |
Cas.: 92822-03-2 | Purity: 97% | 4-(4-Fluorobenzyl)piperidine hydrochloride | ESD-897416-5G |
Cas.: 92822-03-2 | Purity: 97% | 4-(4-Fluorobenzyl)piperidine hydrochloride | ESD-897416-10G |
Cas.: 92822-03-2 | Purity: 97% | 4-(4-Fluorobenzyl)piperidine hydrochloride | ESD-897416-25G |
Cas.: 67515-57-5 | Purity: 97% | 4-Fluoro-3-(trifluoromethyl)benzamide | ESD-897417-1G |
Cas.: 67515-57-5 | Purity: 97% | 4-Fluoro-3-(trifluoromethyl)benzamide | ESD-897417-5G |
Cas.: 67515-57-5 | Purity: 97% | 4-Fluoro-3-(trifluoromethyl)benzamide | ESD-897417-10G |
Cas.: 1009119-83-8 | Purity: 97% | 4,4′-Bis(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,1′-biphenyl tetrahydrochloride | ESD-897418-1G |
Cas.: 1009119-83-8 | Purity: 97% | 4,4′-Bis(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,1′-biphenyl tetrahydrochloride | ESD-897418-5G |
Cas.: 1009119-83-8 | Purity: 97% | 4,4′-Bis(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,1′-biphenyl tetrahydrochloride | ESD-897418-10G |
Cas.: 1009119-83-8 | Purity: 97% | 4,4′-Bis(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,1′-biphenyl tetrahydrochloride | ESD-897418-25G |
Cas.: 152918-18-8 | Purity: ≥98% | IB-MECA | ESD-897419-2MG |
Cas.: 152918-18-8 | Purity: ≥98% | IB-MECA | ESD-897419-5MG |
Cas.: 152918-18-8 | Purity: ≥98% | IB-MECA | ESD-897419-10MG |
Cas.: 152918-18-8 | Purity: ≥98% | IB-MECA | ESD-897419-25MG |
Cas.: 14328-64-4 | Purity: ≥95% | (R)-Methyl 2-amino-2-cyclohexylacetate hydrochloride | ESD-897420-1G |
Cas.: 14328-64-4 | Purity: ≥95% | (R)-Methyl 2-amino-2-cyclohexylacetate hydrochloride | ESD-897420-5G |
Cas.: 14328-64-4 | Purity: ≥95% | (R)-Methyl 2-amino-2-cyclohexylacetate hydrochloride | ESD-897420-10G |
Cas.: 14328-64-4 | Purity: ≥95% | (R)-Methyl 2-amino-2-cyclohexylacetate hydrochloride | ESD-897420-25G |
Cas.: 113293-70-2 | Purity: 98% | 2,6-Dichloroisonicotinaldehyde | ESD-897421-1G |
Cas.: 113293-70-2 | Purity: 98% | 2,6-Dichloroisonicotinaldehyde | ESD-897421-5G |
Cas.: 113293-70-2 | Purity: 98% | 2,6-Dichloroisonicotinaldehyde | ESD-897421-10G |
Cas.: 113293-70-2 | Purity: 98% | 2,6-Dichloroisonicotinaldehyde | ESD-897421-25G |
Cas.: 1857-19-8 | Purity: 98% | 2-Amino-N,N-dimethylacetamide | ESD-897422-1G |
Cas.: 1857-19-8 | Purity: 98% | 2-Amino-N,N-dimethylacetamide | ESD-897422-5G |
Cas.: 177582-21-7 | Purity: 98% contains ca. 11% dioxane | Fmoc-Cys(MMt)-OH | ESD-897423-1G |
Cas.: 177582-21-7 | Purity: 98% contains ca. 11% dioxane | Fmoc-Cys(MMt)-OH | ESD-897423-5G |
Cas.: 177582-21-7 | Purity: 98% contains ca. 11% dioxane | Fmoc-Cys(MMt)-OH | ESD-897423-10G |
Cas.: 177582-21-7 | Purity: 98% contains ca. 11% dioxane | Fmoc-Cys(MMt)-OH | ESD-897423-25G |
Cas.: 45233-75-8 | Purity: 98% | Boc-Val-Gly-OH | ESD-897424-1G |
Cas.: 45233-75-8 | Purity: 98% | Boc-Val-Gly-OH | ESD-897424-5G |
Cas.: 45233-75-8 | Purity: 98% | Boc-Val-Gly-OH | ESD-897424-10G |
Cas.: 45233-75-8 | Purity: 98% | Boc-Val-Gly-OH | ESD-897424-25G |
Cas.: 108321-19-3 | Purity: 98% | L-Proline p-nitroanilide trifluoroacetate salt | ESD-897425-250MG |
Cas.: 108321-19-3 | Purity: 98% | L-Proline p-nitroanilide trifluoroacetate salt | ESD-897425-1G |
Cas.: 108321-19-3 | Purity: 98% | L-Proline p-nitroanilide trifluoroacetate salt | ESD-897425-5G |
Cas.: 108321-19-3 | Purity: 98% | L-Proline p-nitroanilide trifluoroacetate salt | ESD-897425-25G |
Cas.: 80082-65-1 | Purity: 97% | (2S,3S)-3-Amino-2-methyl-4-oxoazetidine-1-sulfonic acid | ESD-897426-1G |
Cas.: 80082-65-1 | Purity: 97% | (2S,3S)-3-Amino-2-methyl-4-oxoazetidine-1-sulfonic acid | ESD-897426-5G |
Cas.: 80082-65-1 | Purity: 97% | (2S,3S)-3-Amino-2-methyl-4-oxoazetidine-1-sulfonic acid | ESD-897426-10G |
Cas.: 80082-65-1 | Purity: 97% | (2S,3S)-3-Amino-2-methyl-4-oxoazetidine-1-sulfonic acid | ESD-897426-25G |
Cas.: 13099-95-1 | Purity: ≥95% | Ethyl 3-oxo-2,3-dihydrobenzofuran-2-carboxylate | ESD-897427-1G |
Cas.: 13099-95-1 | Purity: ≥95% | Ethyl 3-oxo-2,3-dihydrobenzofuran-2-carboxylate | ESD-897427-5G |
Cas.: 13099-95-1 | Purity: ≥95% | Ethyl 3-oxo-2,3-dihydrobenzofuran-2-carboxylate | ESD-897427-10G |
Cas.: 13099-95-1 | Purity: ≥95% | Ethyl 3-oxo-2,3-dihydrobenzofuran-2-carboxylate | ESD-897427-25G |
Cas.: 126759-30-6 | Purity: 97% | Methyl 3-bromo-4-nitrobenzoate | ESD-897428-250MG |
Cas.: 126759-30-6 | Purity: 97% | Methyl 3-bromo-4-nitrobenzoate | ESD-897428-1G |
Cas.: 126759-30-6 | Purity: 97% | Methyl 3-bromo-4-nitrobenzoate | ESD-897428-5G |
Cas.: 126759-30-6 | Purity: 97% | Methyl 3-bromo-4-nitrobenzoate | ESD-897428-25G |
Cas.: 856847-77-3 | Purity: ≥95% | 3-Chloropyridazine hydrochloride | ESD-897429-1G |
Cas.: 856847-77-3 | Purity: ≥95% | 3-Chloropyridazine hydrochloride | ESD-897429-5G |
Cas.: 856847-77-3 | Purity: ≥95% | 3-Chloropyridazine hydrochloride | ESD-897429-10G |
Cas.: 856847-77-3 | Purity: ≥95% | 3-Chloropyridazine hydrochloride | ESD-897429-25G |
Cas.: 314-41-0 | Purity: 97% | 1,2,3,5-Tetrafluoro-4-nitrobenzene | ESD-897430-1G |
Cas.: 314-41-0 | Purity: 97% | 1,2,3,5-Tetrafluoro-4-nitrobenzene | ESD-897430-5G |
Cas.: 314-41-0 | Purity: 97% | 1,2,3,5-Tetrafluoro-4-nitrobenzene | ESD-897430-10G |
Cas.: 314-41-0 | Purity: 97% | 1,2,3,5-Tetrafluoro-4-nitrobenzene | ESD-897430-25G |
Cas.: 848243-23-2 | Purity: 97% | 2-Ethoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897431-1G |
Cas.: 848243-23-2 | Purity: 97% | 2-Ethoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897431-5G |
Cas.: 848243-23-2 | Purity: 97% | 2-Ethoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897431-10G |
Cas.: 848243-23-2 | Purity: 97% | 2-Ethoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897431-25G |
Cas.: 69912-63-6 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-3-methoxypropanoate | ESD-897432-1G |
Cas.: 69912-63-6 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-3-methoxypropanoate | ESD-897432-5G |
Cas.: 69912-63-6 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-3-methoxypropanoate | ESD-897432-10G |
Cas.: 69912-63-6 | Purity: ≥95% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-3-methoxypropanoate | ESD-897432-25G |
Cas.: 127654-70-0 | Purity: 97% | 1-Chloro-3-fluoro-2-iodobenzene | ESD-897433-1G |
Cas.: 127654-70-0 | Purity: 97% | 1-Chloro-3-fluoro-2-iodobenzene | ESD-897433-5G |
Cas.: 127654-70-0 | Purity: 97% | 1-Chloro-3-fluoro-2-iodobenzene | ESD-897433-10G |
Cas.: 127654-70-0 | Purity: 97% | 1-Chloro-3-fluoro-2-iodobenzene | ESD-897433-25G |
Cas.: 1000018-58-5 | Purity: 97% | 3,5-Dibromo-2-chloro-6-methylpyridine | ESD-897434-1G |
Cas.: 1000018-58-5 | Purity: 97% | 3,5-Dibromo-2-chloro-6-methylpyridine | ESD-897434-5G |
Cas.: 1000018-58-5 | Purity: 97% | 3,5-Dibromo-2-chloro-6-methylpyridine | ESD-897434-10G |
Cas.: 1000018-58-5 | Purity: 97% | 3,5-Dibromo-2-chloro-6-methylpyridine | ESD-897434-25G |
Cas.: 258516-84-6 | Purity: ≥97% | Dibenzyl (chloromethyl) phosphate | ESD-897435-1G |
Cas.: 258516-84-6 | Purity: ≥97% | Dibenzyl (chloromethyl) phosphate | ESD-897435-5G |
Cas.: 258516-84-6 | Purity: ≥97% | Dibenzyl (chloromethyl) phosphate | ESD-897435-10G |
Cas.: 258516-84-6 | Purity: ≥97% | Dibenzyl (chloromethyl) phosphate | ESD-897435-25G |
Cas.: 54274-80-5 | Purity: 97% | trans-Methyl 4-formylcyclohexanecarboxylate | ESD-897436-1G |
Cas.: 54274-80-5 | Purity: 97% | trans-Methyl 4-formylcyclohexanecarboxylate | ESD-897436-5G |
Cas.: 54274-80-5 | Purity: 97% | trans-Methyl 4-formylcyclohexanecarboxylate | ESD-897436-10G |
Cas.: 54274-80-5 | Purity: 97% | trans-Methyl 4-formylcyclohexanecarboxylate | ESD-897436-25G |
Cas.: 854373-97-0 | Purity: 98% | (2-Ethoxypyridin-3-yl)boronic acid | ESD-897437-1G |
Cas.: 854373-97-0 | Purity: 98% | (2-Ethoxypyridin-3-yl)boronic acid | ESD-897437-5G |
Cas.: 854373-97-0 | Purity: 98% | (2-Ethoxypyridin-3-yl)boronic acid | ESD-897437-10G |
Cas.: 854373-97-0 | Purity: 98% | (2-Ethoxypyridin-3-yl)boronic acid | ESD-897437-25G |
Cas.: 144230-50-2 | Purity: 98% | 4-Methylenepiperidine hydrochloride | ESD-897438-1G |
Cas.: 144230-50-2 | Purity: 98% | 4-Methylenepiperidine hydrochloride | ESD-897438-5G |
Cas.: 144230-50-2 | Purity: 98% | 4-Methylenepiperidine hydrochloride | ESD-897438-10G |
Cas.: 144230-50-2 | Purity: 98% | 4-Methylenepiperidine hydrochloride | ESD-897438-25G |
Cas.: 87694-52-8 | Purity: 95% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate | ESD-897439-1G |
Cas.: 87694-52-8 | Purity: 95% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate | ESD-897439-5G |
Cas.: 87694-52-8 | Purity: 95% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate | ESD-897439-10G |
Cas.: 87694-52-8 | Purity: 95% | (S)-tert-Butyl (1-(methoxy(methyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate | ESD-897439-25G |
Cas.: 455941-82-9 | Purity: 97% | Methyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-897440-1G |
Cas.: 455941-82-9 | Purity: 97% | Methyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-897440-5G |
Cas.: 455941-82-9 | Purity: 97% | Methyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-897440-10G |
Cas.: 455941-82-9 | Purity: 97% | Methyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-897440-25G |
Cas.: 352535-86-5 | Purity: 97% | 2-Chloro-6-fluoro-5-methylphenylboronic acid | ESD-897441-1G |
Cas.: 352535-86-5 | Purity: 97% | 2-Chloro-6-fluoro-5-methylphenylboronic acid | ESD-897441-5G |
Cas.: 352535-86-5 | Purity: 97% | 2-Chloro-6-fluoro-5-methylphenylboronic acid | ESD-897441-10G |
Cas.: 352535-86-5 | Purity: 97% | 2-Chloro-6-fluoro-5-methylphenylboronic acid | ESD-897441-25G |
Cas.: 151651-44-4 | Purity: 97% | HD-Ser-OBzl.HCl | ESD-897442-1G |
Cas.: 151651-44-4 | Purity: 97% | HD-Ser-OBzl.HCl | ESD-897442-5G |
Cas.: 151651-44-4 | Purity: 97% | HD-Ser-OBzl.HCl | ESD-897442-10G |
Cas.: 151651-44-4 | Purity: 97% | HD-Ser-OBzl.HCl | ESD-897442-25G |
Cas.: 898746-91-3 | Purity: ≥95% | 6-Bromo-1H-indole-4-carboxylic acid | ESD-897443-1G |
Cas.: 898746-91-3 | Purity: ≥95% | 6-Bromo-1H-indole-4-carboxylic acid | ESD-897443-5G |
Cas.: 898746-91-3 | Purity: ≥95% | 6-Bromo-1H-indole-4-carboxylic acid | ESD-897443-10G |
Cas.: 898746-91-3 | Purity: ≥95% | 6-Bromo-1H-indole-4-carboxylic acid | ESD-897443-25G |
Cas.: 168759-60-2 | Purity: 98% | 7-Bromo-4H-chromen-4-one | ESD-897444-1G |
Cas.: 168759-60-2 | Purity: 98% | 7-Bromo-4H-chromen-4-one | ESD-897444-5G |
Cas.: 168759-60-2 | Purity: 98% | 7-Bromo-4H-chromen-4-one | ESD-897444-10G |
Cas.: 168759-60-2 | Purity: 98% | 7-Bromo-4H-chromen-4-one | ESD-897444-25G |
Cas.: 1000994-95-5 | Purity: 97% | 1-Bromo-4-(1,1-difluoroethyl)benzene | ESD-897445-1G |
Cas.: 1000994-95-5 | Purity: 97% | 1-Bromo-4-(1,1-difluoroethyl)benzene | ESD-897445-5G |
Cas.: 1000994-95-5 | Purity: 97% | 1-Bromo-4-(1,1-difluoroethyl)benzene | ESD-897445-10G |
Cas.: 1000994-95-5 | Purity: 97% | 1-Bromo-4-(1,1-difluoroethyl)benzene | ESD-897445-25G |
Cas.: 351003-02-6 | Purity: 97% | 5-Bromo-2-methylnicotinic acid | ESD-897446-250MG |
Cas.: 351003-02-6 | Purity: 97% | 5-Bromo-2-methylnicotinic acid | ESD-897446-1G |
Cas.: 351003-02-6 | Purity: 97% | 5-Bromo-2-methylnicotinic acid | ESD-897446-5G |
Cas.: 351003-02-6 | Purity: 97% | 5-Bromo-2-methylnicotinic acid | ESD-897446-25G |
Cas.: 133427-07-3 | Purity: 97% | Methyl imidazo[1,2-a]pyridine-8-carboxylate | ESD-897447-1G |
Cas.: 133427-07-3 | Purity: 97% | Methyl imidazo[1,2-a]pyridine-8-carboxylate | ESD-897447-5G |
Cas.: 133427-07-3 | Purity: 97% | Methyl imidazo[1,2-a]pyridine-8-carboxylate | ESD-897447-10G |
Cas.: 133427-07-3 | Purity: 97% | Methyl imidazo[1,2-a]pyridine-8-carboxylate | ESD-897447-25G |
Cas.: 89381-13-5 | Purity: 98% | 2-Aminocyclopentanol | ESD-897448-1G |
Cas.: 89381-13-5 | Purity: 98% | 2-Aminocyclopentanol | ESD-897448-5G |
Cas.: 89381-13-5 | Purity: 98% | 2-Aminocyclopentanol | ESD-897448-10G |
Cas.: 89381-13-5 | Purity: 98% | 2-Aminocyclopentanol | ESD-897448-25G |
Cas.: 27960-59-4 | Purity: 96% | trans-4-Aminocyclohexanecarboxylic acid hydrochloride | ESD-897449-1G |
Cas.: 27960-59-4 | Purity: 96% | trans-4-Aminocyclohexanecarboxylic acid hydrochloride | ESD-897449-5G |
Cas.: 27960-59-4 | Purity: 96% | trans-4-Aminocyclohexanecarboxylic acid hydrochloride | ESD-897449-10G |
Cas.: 27960-59-4 | Purity: 96% | trans-4-Aminocyclohexanecarboxylic acid hydrochloride | ESD-897449-25G |
Cas.: 14282-78-1 | Purity: 95% | 4-Methylthiophene-2-carboxylic acid | ESD-897450-1G |
Cas.: 14282-78-1 | Purity: 95% | 4-Methylthiophene-2-carboxylic acid | ESD-897450-5G |
Cas.: 14282-78-1 | Purity: 95% | 4-Methylthiophene-2-carboxylic acid | ESD-897450-10G |
Cas.: 14282-78-1 | Purity: 95% | 4-Methylthiophene-2-carboxylic acid | ESD-897450-25G |
Cas.: 925701-46-8 | Purity: ≥99% | KU-60019 | ESD-897451-1MG |
Cas.: 925701-46-8 | Purity: ≥99% | KU-60019 | ESD-897451-5MG |
Cas.: 925701-46-8 | Purity: ≥99% | KU-60019 | ESD-897451-10MG |
Cas.: 925701-46-8 | Purity: ≥99% | KU-60019 | ESD-897451-50MG |
Cas.: 729605-21-4 | Purity: ≥99% | (4-(3-Chlorophenyl)piperazin-1-yl)(3-methyl-1-phenyl-1H-pyrazol-5-yl)methanone | ESD-897452-5MG |
Cas.: 729605-21-4 | Purity: ≥99% | (4-(3-Chlorophenyl)piperazin-1-yl)(3-methyl-1-phenyl-1H-pyrazol-5-yl)methanone | ESD-897452-10MG |
Cas.: 729605-21-4 | Purity: ≥99% | (4-(3-Chlorophenyl)piperazin-1-yl)(3-methyl-1-phenyl-1H-pyrazol-5-yl)methanone | ESD-897452-25MG |
Cas.: 729605-21-4 | Purity: ≥99% | (4-(3-Chlorophenyl)piperazin-1-yl)(3-methyl-1-phenyl-1H-pyrazol-5-yl)methanone | ESD-897452-50MG |
Cas.: 870281-34-8 | Purity: ≥98% | Acalisib | ESD-897453-5MG |
Cas.: 870281-34-8 | Purity: ≥98% | Acalisib | ESD-897453-10MG |
Cas.: 870281-34-8 | Purity: ≥98% | Acalisib | ESD-897453-25MG |
Cas.: 870281-34-8 | Purity: ≥98% | Acalisib | ESD-897453-50MG |
Cas.: 1211443-80-9 | Purity: 98% | LEE011 hydrochloride | ESD-897454-2MG |
Cas.: 1211443-80-9 | Purity: 98% | LEE011 hydrochloride | ESD-897454-5MG |
Cas.: 1211443-80-9 | Purity: 98% | LEE011 hydrochloride | ESD-897454-10MG |
Cas.: 1211443-80-9 | Purity: 98% | LEE011 hydrochloride | ESD-897454-50MG |
Cas.: 920509-32-6 | Purity: ≥99% | MGL-3196 | ESD-897455-5MG |
Cas.: 920509-32-6 | Purity: ≥99% | MGL-3196 | ESD-897455-10MG |
Cas.: 920509-32-6 | Purity: ≥99% | MGL-3196 | ESD-897455-25MG |
Cas.: 920509-32-6 | Purity: ≥99% | MGL-3196 | ESD-897455-50MG |
Cas.: 1632051-40-1 | Purity: ≥98% | SAGE-217 | ESD-897456-1MG |
Cas.: 1632051-40-1 | Purity: ≥98% | SAGE-217 | ESD-897456-5MG |
Cas.: 1632051-40-1 | Purity: ≥98% | SAGE-217 | ESD-897456-10MG |
Cas.: 1632051-40-1 | Purity: ≥98% | SAGE-217 | ESD-897456-50MG |
Cas.: 1035979-44-2 | Purity: ≥95% | Sarecycline hydrochloride | ESD-897457-5MG |
Cas.: 1035979-44-2 | Purity: ≥95% | Sarecycline hydrochloride | ESD-897457-10MG |
Cas.: 1035979-44-2 | Purity: ≥95% | Sarecycline hydrochloride | ESD-897457-25MG |
Cas.: 1035979-44-2 | Purity: ≥95% | Sarecycline hydrochloride | ESD-897457-50MG |
Cas.: 1628260-79-6 | Purity: ≥98% | GLPG1690 | ESD-897458-5MG |
Cas.: 1628260-79-6 | Purity: ≥98% | GLPG1690 | ESD-897458-10MG |
Cas.: 1628260-79-6 | Purity: ≥98% | GLPG1690 | ESD-897458-50MG |
Cas.: 914462-92-3 | Purity: ≥95% | Rolapitant hydrochloride hydrate | ESD-897459-5MG |
Cas.: 914462-92-3 | Purity: ≥95% | Rolapitant hydrochloride hydrate | ESD-897459-10MG |
Cas.: 914462-92-3 | Purity: ≥95% | Rolapitant hydrochloride hydrate | ESD-897459-25MG |
Cas.: 914462-92-3 | Purity: ≥95% | Rolapitant hydrochloride hydrate | ESD-897459-50MG |
Cas.: 1239908-20-3 | Purity: ≥98% | Ixazomib citrate | ESD-897460-2MG |
Cas.: 1239908-20-3 | Purity: ≥98% | Ixazomib citrate | ESD-897460-5MG |
Cas.: 1239908-20-3 | Purity: ≥98% | Ixazomib citrate | ESD-897460-10MG |
Cas.: 1239908-20-3 | Purity: ≥98% | Ixazomib citrate | ESD-897460-50MG |
Cas.: 917393-39-6 | Purity: ≥98% | Lorediplon | ESD-897461-1MG |
Cas.: 917393-39-6 | Purity: ≥98% | Lorediplon | ESD-897461-5MG |
Cas.: 917393-39-6 | Purity: ≥98% | Lorediplon | ESD-897461-10MG |
Cas.: 917393-39-6 | Purity: ≥98% | Lorediplon | ESD-897461-50MG |
Cas.: 927871-76-9 | Purity: ≥95% | S107 | ESD-897462-1MG |
Cas.: 927871-76-9 | Purity: ≥95% | S107 | ESD-897462-5MG |
Cas.: 927871-76-9 | Purity: ≥95% | S107 | ESD-897462-10MG |
Cas.: 927871-76-9 | Purity: ≥95% | S107 | ESD-897462-50MG |
Cas.: 160067-63-0 | Purity: 98% | Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH | ESD-897463-1MG |
Cas.: 160067-63-0 | Purity: 98% | Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH | ESD-897463-5MG |
Cas.: 160067-63-0 | Purity: 98% | Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH | ESD-897463-25MG |
Cas.: 160067-63-0 | Purity: 98% | Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH | ESD-897463-50MG |
Cas.: 873305-35-2 | Purity: ≥98% | AIM-100 | ESD-897464-1MG |
Cas.: 873305-35-2 | Purity: ≥98% | AIM-100 | ESD-897464-5MG |
Cas.: 873305-35-2 | Purity: ≥98% | AIM-100 | ESD-897464-10MG |
Cas.: 873305-35-2 | Purity: ≥98% | AIM-100 | ESD-897464-50MG |
Cas.: 870070-55-6 | Purity: ≥98% | Tozadenant | ESD-897465-1MG |
Cas.: 870070-55-6 | Purity: ≥98% | Tozadenant | ESD-897465-5MG |
Cas.: 870070-55-6 | Purity: ≥98% | Tozadenant | ESD-897465-10MG |
Cas.: 870070-55-6 | Purity: ≥98% | Tozadenant | ESD-897465-50MG |
Cas.: 887650-05-7 | Purity: ≥98% | Lyn-IN-1 | ESD-897466-1MG |
Cas.: 887650-05-7 | Purity: ≥98% | Lyn-IN-1 | ESD-897466-5MG |
Cas.: 887650-05-7 | Purity: ≥98% | Lyn-IN-1 | ESD-897466-10MG |
Cas.: 887650-05-7 | Purity: ≥98% | Lyn-IN-1 | ESD-897466-50MG |
Cas.: 72926-24-0 | Purity: ≥98% | K858 | ESD-897467-5MG |
Cas.: 72926-24-0 | Purity: ≥98% | K858 | ESD-897467-10MG |
Cas.: 72926-24-0 | Purity: ≥98% | K858 | ESD-897467-25MG |
Cas.: 72926-24-0 | Purity: ≥98% | K858 | ESD-897467-50MG |
Cas.: 1014691-61-2 | Purity: ≥98% | GSK0660 | ESD-897468-1MG |
Cas.: 1014691-61-2 | Purity: ≥98% | GSK0660 | ESD-897468-5MG |
Cas.: 1014691-61-2 | Purity: ≥98% | GSK0660 | ESD-897468-10MG |
Cas.: 1014691-61-2 | Purity: ≥98% | GSK0660 | ESD-897468-50MG |
Cas.: 5545-54-0 | Purity: ≥95% | Z-Tyr(tBu)-OH | ESD-897469-5G |
Cas.: 5545-54-0 | Purity: ≥95% | Z-Tyr(tBu)-OH | ESD-897469-10G |
Cas.: 5545-54-0 | Purity: ≥95% | Z-Tyr(tBu)-OH | ESD-897469-25G |
Cas.: 5545-54-0 | Purity: ≥95% | Z-Tyr(tBu)-OH | ESD-897469-100G |
Cas.: 22568-07-6 | Purity: ≥98% | (E)-1-Chloro-2-(2-nitrovinyl)benzene | ESD-897470-1G |
Cas.: 22568-07-6 | Purity: ≥98% | (E)-1-Chloro-2-(2-nitrovinyl)benzene | ESD-897470-5G |
Cas.: 22568-07-6 | Purity: ≥98% | (E)-1-Chloro-2-(2-nitrovinyl)benzene | ESD-897470-25G |
Cas.: 22568-07-6 | Purity: ≥98% | (E)-1-Chloro-2-(2-nitrovinyl)benzene | ESD-897470-100G |
Cas.: 191611-20-8 | Purity: 97% | (S)-2-Amino-2-cyclohexylacetic acid hydrochloride | ESD-897471-5G |
Cas.: 191611-20-8 | Purity: 97% | (S)-2-Amino-2-cyclohexylacetic acid hydrochloride | ESD-897471-10G |
Cas.: 191611-20-8 | Purity: 97% | (S)-2-Amino-2-cyclohexylacetic acid hydrochloride | ESD-897471-25G |
Cas.: 191611-20-8 | Purity: 97% | (S)-2-Amino-2-cyclohexylacetic acid hydrochloride | ESD-897471-100G |
Cas.: 1391426-24-6 | Purity: 97% | Lys05 | ESD-897472-5MG |
Cas.: 1391426-24-6 | Purity: 97% | Lys05 | ESD-897472-10MG |
Cas.: 1391426-24-6 | Purity: 97% | Lys05 | ESD-897472-50MG |
Cas.: 1391426-24-6 | Purity: 97% | Lys05 | ESD-897472-100MG |
Cas.: 444777-67-7 | Purity: 97% | HD-Phe(4-NO2)-OH.H2O | ESD-897473-5G |
Cas.: 444777-67-7 | Purity: 97% | HD-Phe(4-NO2)-OH.H2O | ESD-897473-10G |
Cas.: 444777-67-7 | Purity: 97% | HD-Phe(4-NO2)-OH.H2O | ESD-897473-25G |
Cas.: 444777-67-7 | Purity: 97% | HD-Phe(4-NO2)-OH.H2O | ESD-897473-100G |
Cas.: 1026016-83-0 | Purity: ≥95% | Tetrabenazine (+)- | ESD-897474-5MG |
Cas.: 1026016-83-0 | Purity: ≥95% | Tetrabenazine (+)- | ESD-897474-10MG |
Cas.: 1026016-83-0 | Purity: ≥95% | Tetrabenazine (+)- | ESD-897474-50MG |
Cas.: 1026016-83-0 | Purity: ≥95% | Tetrabenazine (+)- | ESD-897474-100MG |
Cas.: 34570-17-7 | Purity: ≥97% | Malonamideamidine hydrochloride | ESD-897475-5G |
Cas.: 34570-17-7 | Purity: ≥97% | Malonamideamidine hydrochloride | ESD-897475-10G |
Cas.: 34570-17-7 | Purity: ≥97% | Malonamideamidine hydrochloride | ESD-897475-25G |
Cas.: 34570-17-7 | Purity: ≥97% | Malonamideamidine hydrochloride | ESD-897475-100G |
Cas.: 3940-27-0 | Purity: ≥97% | DL-serine ethyl ester hydrochloride | ESD-897476-5G |
Cas.: 3940-27-0 | Purity: ≥97% | DL-serine ethyl ester hydrochloride | ESD-897476-10G |
Cas.: 3940-27-0 | Purity: ≥97% | DL-serine ethyl ester hydrochloride | ESD-897476-25G |
Cas.: 3940-27-0 | Purity: ≥97% | DL-serine ethyl ester hydrochloride | ESD-897476-100G |
Cas.: 923288-90-8 | Purity: ≥98% | Nilotinib monohydrochloride monohydrate | ESD-897477-25MG |
Cas.: 923288-90-8 | Purity: ≥98% | Nilotinib monohydrochloride monohydrate | ESD-897477-50MG |
Cas.: 923288-90-8 | Purity: ≥98% | Nilotinib monohydrochloride monohydrate | ESD-897477-100MG |
Cas.: 923288-90-8 | Purity: ≥98% | Nilotinib monohydrochloride monohydrate | ESD-897477-250MG |
Cas.: 220199-85-9 | Purity: 97% | tert-Butyl morpholine-4-carboxylate | ESD-897478-5G |
Cas.: 220199-85-9 | Purity: 97% | tert-Butyl morpholine-4-carboxylate | ESD-897478-25G |
Cas.: 220199-85-9 | Purity: 97% | tert-Butyl morpholine-4-carboxylate | ESD-897478-100G |
Cas.: 220199-85-9 | Purity: 97% | tert-Butyl morpholine-4-carboxylate | ESD-897478-500G |
Cas.: 76535-74-5 | Purity: ≥95% | tert-Butyl piperazine-1-carboxylate hydrochloride | ESD-897479-10G |
Cas.: 76535-74-5 | Purity: ≥95% | tert-Butyl piperazine-1-carboxylate hydrochloride | ESD-897479-25G |
Cas.: 76535-74-5 | Purity: ≥95% | tert-Butyl piperazine-1-carboxylate hydrochloride | ESD-897479-100G |
Cas.: 76535-74-5 | Purity: ≥95% | tert-Butyl piperazine-1-carboxylate hydrochloride | ESD-897479-500G |
Cas.: 7556-90-3 | Purity: ≥95% | 5-Chloroquinazoline | ESD-897480-100MG |
Cas.: 7556-90-3 | Purity: ≥95% | 5-Chloroquinazoline | ESD-897480-250MG |
Cas.: 7556-90-3 | Purity: ≥95% | 5-Chloroquinazoline | ESD-897480-1G |
Cas.: 1597297-10-3 | Purity: 97% | 8-Bromo-4-methoxyquinoline-2-carboxylic acid | ESD-897481-100MG |
Cas.: 1597297-10-3 | Purity: 97% | 8-Bromo-4-methoxyquinoline-2-carboxylic acid | ESD-897481-250MG |
Cas.: 1597297-10-3 | Purity: 97% | 8-Bromo-4-methoxyquinoline-2-carboxylic acid | ESD-897481-1G |
Cas.: 91721-16-3 | Purity: 98% | 4-(4-Chlorophenyl)piperidine-4-carbonitrile | ESD-897482-100MG |
Cas.: 91721-16-3 | Purity: 98% | 4-(4-Chlorophenyl)piperidine-4-carbonitrile | ESD-897482-250MG |
Cas.: 91721-16-3 | Purity: 98% | 4-(4-Chlorophenyl)piperidine-4-carbonitrile | ESD-897482-1G |
Cas.: 811801-40-8 | Purity: ≥95% | (3-((Pyridin-4-ylthio)methyl)phenyl)methanol | ESD-897483-100MG |
Cas.: 811801-40-8 | Purity: ≥95% | (3-((Pyridin-4-ylthio)methyl)phenyl)methanol | ESD-897483-250MG |
Cas.: 811801-40-8 | Purity: ≥95% | (3-((Pyridin-4-ylthio)methyl)phenyl)methanol | ESD-897483-1G |
Cas.: 878739-46-9 | Purity: 97% | 1-Pentylpiperazine dihydrochloride | ESD-897484-100MG |
Cas.: 878739-46-9 | Purity: 97% | 1-Pentylpiperazine dihydrochloride | ESD-897484-250MG |
Cas.: 878739-46-9 | Purity: 97% | 1-Pentylpiperazine dihydrochloride | ESD-897484-1G |
Cas.: 1000340-38-4 | Purity: 97% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-3-amine | ESD-897485-100MG |
Cas.: 1000340-38-4 | Purity: 97% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-3-amine | ESD-897485-250MG |
Cas.: 1000340-38-4 | Purity: 97% | 4-Chloro-1H-pyrrolo[2,3-b]pyridin-3-amine | ESD-897485-1G |
Cas.: 321337-38-6 | Purity: 95% | tert-Butyl 4-(4-(hydroxymethyl)phenoxy)piperidine-1-carboxylate | ESD-897486-100MG |
Cas.: 321337-38-6 | Purity: 95% | tert-Butyl 4-(4-(hydroxymethyl)phenoxy)piperidine-1-carboxylate | ESD-897486-250MG |
Cas.: 321337-38-6 | Purity: 95% | tert-Butyl 4-(4-(hydroxymethyl)phenoxy)piperidine-1-carboxylate | ESD-897486-1G |
Cas.: 62921-76-0 | Purity: 95% | 2,5,8,11-Tetraoxatridecan-13-yl 4-methylbenzenesulfonate | ESD-897487-100MG |
Cas.: 62921-76-0 | Purity: 95% | 2,5,8,11-Tetraoxatridecan-13-yl 4-methylbenzenesulfonate | ESD-897487-250MG |
Cas.: 62921-76-0 | Purity: 95% | 2,5,8,11-Tetraoxatridecan-13-yl 4-methylbenzenesulfonate | ESD-897487-1G |
Cas.: 35313-50-9 | Purity: 95% | Ethyl 3,4-dimethyl-3H-pyrazole-5-carboxylate | ESD-897488-100MG |
Cas.: 35313-50-9 | Purity: 95% | Ethyl 3,4-dimethyl-3H-pyrazole-5-carboxylate | ESD-897488-250MG |
Cas.: 35313-50-9 | Purity: 95% | Ethyl 3,4-dimethyl-3H-pyrazole-5-carboxylate | ESD-897488-1G |
Cas.: 65962-15-4 | Purity: 95% | 1-(Dibromomethyl)-2-nitrobenzene | ESD-897489-100MG |
Cas.: 65962-15-4 | Purity: 95% | 1-(Dibromomethyl)-2-nitrobenzene | ESD-897489-250MG |
Cas.: 65962-15-4 | Purity: 95% | 1-(Dibromomethyl)-2-nitrobenzene | ESD-897489-1G |
Cas.: 477781-69-4 | Purity: 97% | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl methanesulfonate | ESD-897490-100MG |
Cas.: 477781-69-4 | Purity: 97% | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl methanesulfonate | ESD-897490-250MG |
Cas.: 477781-69-4 | Purity: 97% | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl methanesulfonate | ESD-897490-1G |
Cas.: 76240-49-8 | Purity: ≥95% | 6-Bromophthalazine-1,4-diol | ESD-897491-100MG |
Cas.: 76240-49-8 | Purity: ≥95% | 6-Bromophthalazine-1,4-diol | ESD-897491-250MG |
Cas.: 76240-49-8 | Purity: ≥95% | 6-Bromophthalazine-1,4-diol | ESD-897491-1G |
Cas.: 2044704-70-1 | Purity: 97% | N-((4-(4-Bromophenoxy)phenyl)sulfonyl)hexanamide | ESD-897492-100MG |
Cas.: 2044704-70-1 | Purity: 97% | N-((4-(4-Bromophenoxy)phenyl)sulfonyl)hexanamide | ESD-897492-250MG |
Cas.: 2044704-70-1 | Purity: 97% | N-((4-(4-Bromophenoxy)phenyl)sulfonyl)hexanamide | ESD-897492-1G |
Cas.: 30453-21-5 | Purity: 97% | 3,3′-Disulfanediylbis(propan-1-ol) | ESD-897493-100MG |
Cas.: 30453-21-5 | Purity: 97% | 3,3′-Disulfanediylbis(propan-1-ol) | ESD-897493-250MG |
Cas.: 30453-21-5 | Purity: 97% | 3,3′-Disulfanediylbis(propan-1-ol) | ESD-897493-1G |
Cas.: 101207-45-8 | Purity: 97% | 2-(4-Methylbenzyl)isoindoline-1,3-dione | ESD-897494-100MG |
Cas.: 101207-45-8 | Purity: 97% | 2-(4-Methylbenzyl)isoindoline-1,3-dione | ESD-897494-250MG |
Cas.: 101207-45-8 | Purity: 97% | 2-(4-Methylbenzyl)isoindoline-1,3-dione | ESD-897494-1G |
Cas.: 179072-14-1 | Purity: 97% | Methyl 5-(chloromethyl)nicotinate hydrochloride | ESD-897495-100MG |
Cas.: 179072-14-1 | Purity: 97% | Methyl 5-(chloromethyl)nicotinate hydrochloride | ESD-897495-250MG |
Cas.: 179072-14-1 | Purity: 97% | Methyl 5-(chloromethyl)nicotinate hydrochloride | ESD-897495-1G |
Cas.: 1261840-81-6 | Purity: ≥95% | Methyl 2-bromo-6-iodobenzoate | ESD-897496-100MG |
Cas.: 1261840-81-6 | Purity: ≥95% | Methyl 2-bromo-6-iodobenzoate | ESD-897496-250MG |
Cas.: 1261840-81-6 | Purity: ≥95% | Methyl 2-bromo-6-iodobenzoate | ESD-897496-1G |
Cas.: 475216-25-2 | Purity: 95% | 4-Fluoro-N-methyl-3-nitrobenzamide | ESD-897497-100MG |
Cas.: 475216-25-2 | Purity: 95% | 4-Fluoro-N-methyl-3-nitrobenzamide | ESD-897497-250MG |
Cas.: 475216-25-2 | Purity: 95% | 4-Fluoro-N-methyl-3-nitrobenzamide | ESD-897497-1G |
Cas.: 1203705-55-8 | Purity: 97% | 3-Bromo-1H-pyrazol-5-amine | ESD-897498-100MG |
Cas.: 1203705-55-8 | Purity: 97% | 3-Bromo-1H-pyrazol-5-amine | ESD-897498-250MG |
Cas.: 1203705-55-8 | Purity: 97% | 3-Bromo-1H-pyrazol-5-amine | ESD-897498-1G |
Cas.: 1844890-90-9 | Purity: 97% | Potassium trifluoro(3-phenylbicyclo[2.2.1]heptan-2-yl)borate | ESD-897499-100MG |
Cas.: 1844890-90-9 | Purity: 97% | Potassium trifluoro(3-phenylbicyclo[2.2.1]heptan-2-yl)borate | ESD-897499-250MG |
Cas.: 1844890-90-9 | Purity: 97% | Potassium trifluoro(3-phenylbicyclo[2.2.1]heptan-2-yl)borate | ESD-897499-1G |
Cas.: 857599-37-2 | Purity: ≥95% | Methyl 2-iodo-5-methoxybenzoate | ESD-897500-100MG |
Cas.: 857599-37-2 | Purity: ≥95% | Methyl 2-iodo-5-methoxybenzoate | ESD-897500-250MG |
Cas.: 857599-37-2 | Purity: ≥95% | Methyl 2-iodo-5-methoxybenzoate | ESD-897500-1G |
Cas.: 282540-12-9 | Purity: 97% | 3-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)thiophene | ESD-897501-100MG |
Cas.: 282540-12-9 | Purity: 97% | 3-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)thiophene | ESD-897501-250MG |
Cas.: 282540-12-9 | Purity: 97% | 3-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)thiophene | ESD-897501-1G |
Cas.: 1588440-90-7 | Purity: ≥95% | 7-Bromoquinolin-5-amine | ESD-897502-100MG |
Cas.: 1588440-90-7 | Purity: ≥95% | 7-Bromoquinolin-5-amine | ESD-897502-250MG |
Cas.: 1588440-90-7 | Purity: ≥95% | 7-Bromoquinolin-5-amine | ESD-897502-1G |
Cas.: 1622407-12-8 | Purity: 95% | tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate | ESD-897503-100MG |
Cas.: 1622407-12-8 | Purity: 95% | tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate | ESD-897503-250MG |
Cas.: 1622407-12-8 | Purity: 95% | tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate | ESD-897503-1G |
Cas.: 1841081-72-8 | Purity: 97% | 1-(2-Ethoxyethyl)-2-(pipidin-4-yl)-1H-benzo[d]imidazole hydrochloride | ESD-897504-100MG |
Cas.: 1841081-72-8 | Purity: 97% | 1-(2-Ethoxyethyl)-2-(pipidin-4-yl)-1H-benzo[d]imidazole hydrochloride | ESD-897504-250MG |
Cas.: 1841081-72-8 | Purity: 97% | 1-(2-Ethoxyethyl)-2-(pipidin-4-yl)-1H-benzo[d]imidazole hydrochloride | ESD-897504-1G |
Cas.: 2126144-78-1 | Purity: 97% | (R,E)-4-((tert-Butyldimethylsilyl)oxy)pent-2-enoic acid | ESD-897505-100MG |
Cas.: 2126144-78-1 | Purity: 97% | (R,E)-4-((tert-Butyldimethylsilyl)oxy)pent-2-enoic acid | ESD-897505-250MG |
Cas.: 2126144-78-1 | Purity: 97% | (R,E)-4-((tert-Butyldimethylsilyl)oxy)pent-2-enoic acid | ESD-897505-1G |
Cas.: 60760-04-5 | Purity: 97% | 3-((Dimethylamino)methyl)phenol | ESD-897506-100MG |
Cas.: 60760-04-5 | Purity: 97% | 3-((Dimethylamino)methyl)phenol | ESD-897506-250MG |
Cas.: 60760-04-5 | Purity: 97% | 3-((Dimethylamino)methyl)phenol | ESD-897506-1G |
Cas.: 1551728-64-3 | Purity: 97% | 4-(3-Bromo-4-fluorophenoxy)benzenesulfonamide | ESD-897507-100MG |
Cas.: 1551728-64-3 | Purity: 97% | 4-(3-Bromo-4-fluorophenoxy)benzenesulfonamide | ESD-897507-250MG |
Cas.: 1551728-64-3 | Purity: 97% | 4-(3-Bromo-4-fluorophenoxy)benzenesulfonamide | ESD-897507-1G |
Cas.: 107512-35-6 | Purity: 97% | 3,4-Dimethoxy-2-methylpyridine | ESD-897508-100MG |
Cas.: 107512-35-6 | Purity: 97% | 3,4-Dimethoxy-2-methylpyridine | ESD-897508-250MG |
Cas.: 107512-35-6 | Purity: 97% | 3,4-Dimethoxy-2-methylpyridine | ESD-897508-1G |
Cas.: 1808091-49-7 | Purity: ≥95% | 2,6-Diaminophenol hydrochloride | ESD-897509-100MG |
Cas.: 1808091-49-7 | Purity: ≥95% | 2,6-Diaminophenol hydrochloride | ESD-897509-250MG |
Cas.: 1808091-49-7 | Purity: ≥95% | 2,6-Diaminophenol hydrochloride | ESD-897509-1G |
Cas.: 1446507-38-5 | Purity: 97% | 6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione | ESD-897510-100MG |
Cas.: 1446507-38-5 | Purity: 97% | 6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione | ESD-897510-250MG |
Cas.: 1446507-38-5 | Purity: 97% | 6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione | ESD-897510-1G |
Cas.: 856163-79-6 | Purity: 97% | (4,6-Dichloropyridin-2-yl)methanol | ESD-897511-100MG |
Cas.: 856163-79-6 | Purity: 97% | (4,6-Dichloropyridin-2-yl)methanol | ESD-897511-250MG |
Cas.: 856163-79-6 | Purity: 97% | (4,6-Dichloropyridin-2-yl)methanol | ESD-897511-1G |
Cas.: 2006-00-0 | Purity: 95% | 4-Methoxy-2-methylpyrimidine-5-carbonitrile | ESD-897512-100MG |
Cas.: 2006-00-0 | Purity: 95% | 4-Methoxy-2-methylpyrimidine-5-carbonitrile | ESD-897512-250MG |
Cas.: 2006-00-0 | Purity: 95% | 4-Methoxy-2-methylpyrimidine-5-carbonitrile | ESD-897512-1G |
Cas.: 180863-55-2 | Purity: 97% | Methyl 3-(((tert-butoxycarbonyl)amino)methyl)benzoate | ESD-897513-100MG |
Cas.: 180863-55-2 | Purity: 97% | Methyl 3-(((tert-butoxycarbonyl)amino)methyl)benzoate | ESD-897513-250MG |
Cas.: 180863-55-2 | Purity: 97% | Methyl 3-(((tert-butoxycarbonyl)amino)methyl)benzoate | ESD-897513-1G |
Cas.: 59524-07-1 | Purity: ≥95% | Benzyl 2-(((benzyloxy)carbonyl)amino)acrylate | ESD-897514-100MG |
Cas.: 59524-07-1 | Purity: ≥95% | Benzyl 2-(((benzyloxy)carbonyl)amino)acrylate | ESD-897514-250MG |
Cas.: 59524-07-1 | Purity: ≥95% | Benzyl 2-(((benzyloxy)carbonyl)amino)acrylate | ESD-897514-1G |
Cas.: 1464137-23-2 | Purity: 97% | (S)-Benzyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-cyanopropanoate | ESD-897515-100MG |
Cas.: 1464137-23-2 | Purity: 97% | (S)-Benzyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-cyanopropanoate | ESD-897515-250MG |
Cas.: 1464137-23-2 | Purity: 97% | (S)-Benzyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-cyanopropanoate | ESD-897515-1G |
Cas.: 1195768-19-4 | Purity: 97% | Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate | ESD-897516-100MG |
Cas.: 1195768-19-4 | Purity: 97% | Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate | ESD-897516-250MG |
Cas.: 1195768-19-4 | Purity: 97% | Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate | ESD-897516-1G |
Cas.: 867164-54-3 | Purity: 97% | 2-Phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | ESD-897517-100MG |
Cas.: 867164-54-3 | Purity: 97% | 2-Phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | ESD-897517-250MG |
Cas.: 867164-54-3 | Purity: 97% | 2-Phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | ESD-897517-1G |
Cas.: 209336-49-2 | Purity: 97% | 1-Ethyl-6-fluoro-1,2,3,4-tetrahydroquinoline | ESD-897518-100MG |
Cas.: 209336-49-2 | Purity: 97% | 1-Ethyl-6-fluoro-1,2,3,4-tetrahydroquinoline | ESD-897518-250MG |
Cas.: 209336-49-2 | Purity: 97% | 1-Ethyl-6-fluoro-1,2,3,4-tetrahydroquinoline | ESD-897518-1G |
Cas.: 88486-72-0 | Purity: ≥95% | 2-(Benzyloxy)-1,3,5-tribromobenzene | ESD-897519-100MG |
Cas.: 88486-72-0 | Purity: ≥95% | 2-(Benzyloxy)-1,3,5-tribromobenzene | ESD-897519-250MG |
Cas.: 88486-72-0 | Purity: ≥95% | 2-(Benzyloxy)-1,3,5-tribromobenzene | ESD-897519-1G |
Cas.: 60640-17-7 | Purity: 95% | 7-Phenyl-1,2,3,4-tetrahydroquinoline | ESD-897520-100MG |
Cas.: 60640-17-7 | Purity: 95% | 7-Phenyl-1,2,3,4-tetrahydroquinoline | ESD-897520-250MG |
Cas.: 60640-17-7 | Purity: 95% | 7-Phenyl-1,2,3,4-tetrahydroquinoline | ESD-897520-1G |
Cas.: 444308-32-1 | Purity: 96% | 1-(4-Fluorophenyl)propan-2-ol | ESD-897521-100MG |
Cas.: 444308-32-1 | Purity: 96% | 1-(4-Fluorophenyl)propan-2-ol | ESD-897521-250MG |
Cas.: 444308-32-1 | Purity: 96% | 1-(4-Fluorophenyl)propan-2-ol | ESD-897521-1G |
Cas.: 16339-93-8 | Purity: ≥95% | 1-Bromoheptan-2-one | ESD-897522-100MG |
Cas.: 16339-93-8 | Purity: ≥95% | 1-Bromoheptan-2-one | ESD-897522-250MG |
Cas.: 16339-93-8 | Purity: ≥95% | 1-Bromoheptan-2-one | ESD-897522-1G |
Cas.: 1260862-43-8 | Purity: 97% | 4-(Difluoromethoxy)-2,6-difluorobenzonitrile | ESD-897523-100MG |
Cas.: 1260862-43-8 | Purity: 97% | 4-(Difluoromethoxy)-2,6-difluorobenzonitrile | ESD-897523-250MG |
Cas.: 1260862-43-8 | Purity: 97% | 4-(Difluoromethoxy)-2,6-difluorobenzonitrile | ESD-897523-1G |
Cas.: 76143-02-7 | Purity: 97% | Methyl 4-amino-3-(hydroxymethyl)benzoate | ESD-897524-100MG |
Cas.: 76143-02-7 | Purity: 97% | Methyl 4-amino-3-(hydroxymethyl)benzoate | ESD-897524-250MG |
Cas.: 76143-02-7 | Purity: 97% | Methyl 4-amino-3-(hydroxymethyl)benzoate | ESD-897524-1G |
Cas.: 1523618-36-1 | Purity: 97% | tert-Butyl 1,8-diazaspiro[4.5]decane-8-carboxylate oxalate (2:1) | ESD-897525-100MG |
Cas.: 1523618-36-1 | Purity: 97% | tert-Butyl 1,8-diazaspiro[4.5]decane-8-carboxylate oxalate (2:1) | ESD-897525-250MG |
Cas.: 1523618-36-1 | Purity: 97% | tert-Butyl 1,8-diazaspiro[4.5]decane-8-carboxylate oxalate (2:1) | ESD-897525-1G |
Cas.: 2061979-51-7 | Purity: 97% | Benzyl 4-((3-bromophenoxy)methyl)piperidine-1-carboxylate | ESD-897526-100MG |
Cas.: 2061979-51-7 | Purity: 97% | Benzyl 4-((3-bromophenoxy)methyl)piperidine-1-carboxylate | ESD-897526-250MG |
Cas.: 2061979-51-7 | Purity: 97% | Benzyl 4-((3-bromophenoxy)methyl)piperidine-1-carboxylate | ESD-897526-1G |
Cas.: 1345847-71-3 | Purity: 97% | Methyl 1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxylate | ESD-897527-100MG |
Cas.: 1345847-71-3 | Purity: 97% | Methyl 1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxylate | ESD-897527-250MG |
Cas.: 1345847-71-3 | Purity: 97% | Methyl 1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxylate | ESD-897527-1G |
Cas.: 856835-53-5 | Purity: ≥95% | 4-Methyl-3-nitropyridine hydrochloride | ESD-897528-100MG |
Cas.: 856835-53-5 | Purity: ≥95% | 4-Methyl-3-nitropyridine hydrochloride | ESD-897528-250MG |
Cas.: 856835-53-5 | Purity: ≥95% | 4-Methyl-3-nitropyridine hydrochloride | ESD-897528-1G |
Cas.: 87439-09-6 | Purity: ≥95% | 2-Morpholinobutanoic acid | ESD-897529-100MG |
Cas.: 87439-09-6 | Purity: ≥95% | 2-Morpholinobutanoic acid | ESD-897529-250MG |
Cas.: 87439-09-6 | Purity: ≥95% | 2-Morpholinobutanoic acid | ESD-897529-1G |
Cas.: 2097938-60-6 | Purity: 97% | N-(5-Iodo-4-oxo-7-tosyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-897530-100MG |
Cas.: 2097938-60-6 | Purity: 97% | N-(5-Iodo-4-oxo-7-tosyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-897530-250MG |
Cas.: 2097938-60-6 | Purity: 97% | N-(5-Iodo-4-oxo-7-tosyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-897530-1G |
Cas.: 2102451-30-7 | Purity: ≥95% | (1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid | ESD-897531-100MG |
Cas.: 2102451-30-7 | Purity: ≥95% | (1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid | ESD-897531-250MG |
Cas.: 2102451-30-7 | Purity: ≥95% | (1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid | ESD-897531-1G |
Cas.: 869494-15-5 | Purity: 97% | tert-Butyl 3-benzyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate | ESD-897532-100MG |
Cas.: 869494-15-5 | Purity: 97% | tert-Butyl 3-benzyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate | ESD-897532-250MG |
Cas.: 869494-15-5 | Purity: 97% | tert-Butyl 3-benzyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate | ESD-897532-1G |
Cas.: 51463-17-3 | Purity: ≥96% | 6-Chloroisoquinolin-3(2H)-one | ESD-897533-100MG |
Cas.: 51463-17-3 | Purity: ≥96% | 6-Chloroisoquinolin-3(2H)-one | ESD-897533-250MG |
Cas.: 51463-17-3 | Purity: ≥96% | 6-Chloroisoquinolin-3(2H)-one | ESD-897533-1G |
Cas.: 1217469-14-1 | Purity: ≥95% | (R)-tert-Butyl 3-isobutylpiperazine-1-carboxylate hydrochloride | ESD-897534-100MG |
Cas.: 1217469-14-1 | Purity: ≥95% | (R)-tert-Butyl 3-isobutylpiperazine-1-carboxylate hydrochloride | ESD-897534-250MG |
Cas.: 1217469-14-1 | Purity: ≥95% | (R)-tert-Butyl 3-isobutylpiperazine-1-carboxylate hydrochloride | ESD-897534-1G |
Cas.: 5446-17-3 | Purity: 97% | (5-Chloro-2-methylphenyl)hydrazine hydrochloride | ESD-897535-100MG |
Cas.: 5446-17-3 | Purity: 97% | (5-Chloro-2-methylphenyl)hydrazine hydrochloride | ESD-897535-250MG |
Cas.: 5446-17-3 | Purity: 97% | (5-Chloro-2-methylphenyl)hydrazine hydrochloride | ESD-897535-1G |
Cas.: 345967-22-8 | Purity: 97% | N,N-Dimethyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-897536-100MG |
Cas.: 345967-22-8 | Purity: 97% | N,N-Dimethyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-897536-250MG |
Cas.: 345967-22-8 | Purity: 97% | N,N-Dimethyldinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-amine | ESD-897536-1G |
Cas.: 60041-89-6 | Purity: 97% | 2-Amino-5-fluoro-N-phenylbenzamide | ESD-897537-100MG |
Cas.: 60041-89-6 | Purity: 97% | 2-Amino-5-fluoro-N-phenylbenzamide | ESD-897537-250MG |
Cas.: 60041-89-6 | Purity: 97% | 2-Amino-5-fluoro-N-phenylbenzamide | ESD-897537-1G |
Cas.: 6971-74-0 | Purity: ≥95% | N-Tosylbenzamide | ESD-897538-100MG |
Cas.: 6971-74-0 | Purity: ≥95% | N-Tosylbenzamide | ESD-897538-250MG |
Cas.: 6971-74-0 | Purity: ≥95% | N-Tosylbenzamide | ESD-897538-1G |
Cas.: 156496-39-8 | Purity: 97% | Methyl 2-(2-oxo-1,2-dihydroquinolin-3-yl)acetate | ESD-897539-100MG |
Cas.: 156496-39-8 | Purity: 97% | Methyl 2-(2-oxo-1,2-dihydroquinolin-3-yl)acetate | ESD-897539-250MG |
Cas.: 156496-39-8 | Purity: 97% | Methyl 2-(2-oxo-1,2-dihydroquinolin-3-yl)acetate | ESD-897539-1G |
Cas.: 400626-71-3 | Purity: ≥95% | (R)-2-Benzyl 1-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | ESD-897540-100MG |
Cas.: 400626-71-3 | Purity: ≥95% | (R)-2-Benzyl 1-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | ESD-897540-250MG |
Cas.: 400626-71-3 | Purity: ≥95% | (R)-2-Benzyl 1-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | ESD-897540-1G |
Cas.: 954371-46-1 | Purity: ≥95% | 5-Iodobenzo[d]isoxazole | ESD-897541-100MG |
Cas.: 954371-46-1 | Purity: ≥95% | 5-Iodobenzo[d]isoxazole | ESD-897541-250MG |
Cas.: 954371-46-1 | Purity: ≥95% | 5-Iodobenzo[d]isoxazole | ESD-897541-1G |
Cas.: 87362-30-9 | Purity: ≥95% | 5-Bromopyrimidine-2-carbohydrazide | ESD-897542-100MG |
Cas.: 87362-30-9 | Purity: ≥95% | 5-Bromopyrimidine-2-carbohydrazide | ESD-897542-250MG |
Cas.: 87362-30-9 | Purity: ≥95% | 5-Bromopyrimidine-2-carbohydrazide | ESD-897542-1G |
Cas.: 1956436-14-8 | Purity: 97% | (R)-tert-Butyl 2-amino-3-(3-bromophenyl)propanoate hydrochloride | ESD-897543-100MG |
Cas.: 1956436-14-8 | Purity: 97% | (R)-tert-Butyl 2-amino-3-(3-bromophenyl)propanoate hydrochloride | ESD-897543-250MG |
Cas.: 1956436-14-8 | Purity: 97% | (R)-tert-Butyl 2-amino-3-(3-bromophenyl)propanoate hydrochloride | ESD-897543-1G |
Cas.: 1416351-81-9 | Purity: ≥95% | 2,6-Dichloro-5-fluoropyridin-3-amine hydrochloride | ESD-897544-100MG |
Cas.: 1416351-81-9 | Purity: ≥95% | 2,6-Dichloro-5-fluoropyridin-3-amine hydrochloride | ESD-897544-250MG |
Cas.: 1416351-81-9 | Purity: ≥95% | 2,6-Dichloro-5-fluoropyridin-3-amine hydrochloride | ESD-897544-1G |
Cas.: 72954-91-7 | Purity: 95% | 1-(4-Chlorophenyl)-2-methylpropan-1-amine hydrochloride | ESD-897545-100MG |
Cas.: 72954-91-7 | Purity: 95% | 1-(4-Chlorophenyl)-2-methylpropan-1-amine hydrochloride | ESD-897545-250MG |
Cas.: 72954-91-7 | Purity: 95% | 1-(4-Chlorophenyl)-2-methylpropan-1-amine hydrochloride | ESD-897545-1G |
Cas.: 22245-86-9 | Purity: ≥95% | 5-(Trifluoromethyl)picolinamide | ESD-897546-100MG |
Cas.: 22245-86-9 | Purity: ≥95% | 5-(Trifluoromethyl)picolinamide | ESD-897546-250MG |
Cas.: 22245-86-9 | Purity: ≥95% | 5-(Trifluoromethyl)picolinamide | ESD-897546-1G |
Cas.: 30098-36-3 | Purity: 97% | 7-Bromo-5,8-dimethyl-3,4-dihydronaphthalen-1(2H)-one | ESD-897547-100MG |
Cas.: 30098-36-3 | Purity: 97% | 7-Bromo-5,8-dimethyl-3,4-dihydronaphthalen-1(2H)-one | ESD-897547-250MG |
Cas.: 30098-36-3 | Purity: 97% | 7-Bromo-5,8-dimethyl-3,4-dihydronaphthalen-1(2H)-one | ESD-897547-1G |
Cas.: 1416784-71-8 | Purity: 95% | 4-(3-Hydroxyazetidin-1-yl)benzoic acid | ESD-897548-100MG |
Cas.: 1416784-71-8 | Purity: 95% | 4-(3-Hydroxyazetidin-1-yl)benzoic acid | ESD-897548-250MG |
Cas.: 1416784-71-8 | Purity: 95% | 4-(3-Hydroxyazetidin-1-yl)benzoic acid | ESD-897548-1G |
Cas.: 50961-68-7 | Purity: 98% | (1S,2S)-2-Amino-1-(4-aminophenyl)propane-1,3-diol | ESD-897549-100MG |
Cas.: 50961-68-7 | Purity: 98% | (1S,2S)-2-Amino-1-(4-aminophenyl)propane-1,3-diol | ESD-897549-250MG |
Cas.: 50961-68-7 | Purity: 98% | (1S,2S)-2-Amino-1-(4-aminophenyl)propane-1,3-diol | ESD-897549-1G |
Cas.: 7295-50-3 | Purity: ≥95% | 1-(4-Chlorophenyl)hexan-1-one | ESD-897550-100MG |
Cas.: 7295-50-3 | Purity: ≥95% | 1-(4-Chlorophenyl)hexan-1-one | ESD-897550-250MG |
Cas.: 7295-50-3 | Purity: ≥95% | 1-(4-Chlorophenyl)hexan-1-one | ESD-897550-1G |
Cas.: 34990-61-9 | Purity: 97% | H-Leu-Lys(Z)-OH | ESD-897551-100MG |
Cas.: 34990-61-9 | Purity: 97% | H-Leu-Lys(Z)-OH | ESD-897551-250MG |
Cas.: 34990-61-9 | Purity: 97% | H-Leu-Lys(Z)-OH | ESD-897551-1G |
Cas.: 67058-77-9 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[2,3-c]pyridine | ESD-897552-100MG |
Cas.: 67058-77-9 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[2,3-c]pyridine | ESD-897552-250MG |
Cas.: 67058-77-9 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[2,3-c]pyridine | ESD-897552-1G |
Cas.: 162045-54-7 | Purity: ≥95% | 3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride | ESD-897553-100MG |
Cas.: 162045-54-7 | Purity: ≥95% | 3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride | ESD-897553-250MG |
Cas.: 162045-54-7 | Purity: ≥95% | 3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride | ESD-897553-1G |
Cas.: 1685-81-0 | Purity: 97% | 4,6-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-897554-100MG |
Cas.: 1685-81-0 | Purity: 97% | 4,6-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-897554-250MG |
Cas.: 1685-81-0 | Purity: 97% | 4,6-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-897554-1G |
Cas.: 1987286-78-1 | Purity: ≥95% | Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-897555-100MG |
Cas.: 1987286-78-1 | Purity: ≥95% | Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-897555-250MG |
Cas.: 1987286-78-1 | Purity: ≥95% | Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-897555-1G |
Cas.: 2068151-92-6 | Purity: 97% | 2-Bromo-1-(4-chloro-1-methyl-1H-pyrazol-3-yl)ethanone | ESD-897556-100MG |
Cas.: 2068151-92-6 | Purity: 97% | 2-Bromo-1-(4-chloro-1-methyl-1H-pyrazol-3-yl)ethanone | ESD-897556-250MG |
Cas.: 2068151-92-6 | Purity: 97% | 2-Bromo-1-(4-chloro-1-methyl-1H-pyrazol-3-yl)ethanone | ESD-897556-1G |
Cas.: 1290540-34-9 | Purity: 97% | 9-(tert-Butoxy)-9-oxononanoic acid | ESD-897557-100MG |
Cas.: 1290540-34-9 | Purity: 97% | 9-(tert-Butoxy)-9-oxononanoic acid | ESD-897557-250MG |
Cas.: 1290540-34-9 | Purity: 97% | 9-(tert-Butoxy)-9-oxononanoic acid | ESD-897557-1G |
Cas.: 118019-42-4 | Purity: ≥95% | Ethyl 5-amino-1H-imidazole-4-carboxylate hydrochloride | ESD-897558-100MG |
Cas.: 118019-42-4 | Purity: ≥95% | Ethyl 5-amino-1H-imidazole-4-carboxylate hydrochloride | ESD-897558-250MG |
Cas.: 118019-42-4 | Purity: ≥95% | Ethyl 5-amino-1H-imidazole-4-carboxylate hydrochloride | ESD-897558-1G |
Cas.: 3278-34-0 | Purity: 95% | Ethyl 2-((ethoxycarbonothioyl)thio)acetate | ESD-897559-100MG |
Cas.: 3278-34-0 | Purity: 95% | Ethyl 2-((ethoxycarbonothioyl)thio)acetate | ESD-897559-250MG |
Cas.: 3278-34-0 | Purity: 95% | Ethyl 2-((ethoxycarbonothioyl)thio)acetate | ESD-897559-1G |
Cas.: 242815-91-4 | Purity: ≥95% | 6-Chlorotetrazolo[1,5-a]pyridine | ESD-897560-100MG |
Cas.: 242815-91-4 | Purity: ≥95% | 6-Chlorotetrazolo[1,5-a]pyridine | ESD-897560-250MG |
Cas.: 242815-91-4 | Purity: ≥95% | 6-Chlorotetrazolo[1,5-a]pyridine | ESD-897560-1G |
Cas.: 177960-41-7 | Purity: 97% | 3,5-Diamino-2-hydroxybenzoic acid hydrochloride | ESD-897561-100MG |
Cas.: 177960-41-7 | Purity: 97% | 3,5-Diamino-2-hydroxybenzoic acid hydrochloride | ESD-897561-250MG |
Cas.: 177960-41-7 | Purity: 97% | 3,5-Diamino-2-hydroxybenzoic acid hydrochloride | ESD-897561-1G |
Cas.: 1346819-04-2 | Purity: ≥95% | 5-Bromo-N-methylpyrimidine-2-carboxamide | ESD-897562-100MG |
Cas.: 1346819-04-2 | Purity: ≥95% | 5-Bromo-N-methylpyrimidine-2-carboxamide | ESD-897562-250MG |
Cas.: 1346819-04-2 | Purity: ≥95% | 5-Bromo-N-methylpyrimidine-2-carboxamide | ESD-897562-1G |
Cas.: 82420-35-7 | Purity: ≥95% | 2-(Bromomethyl)-4-fluoro-1-nitrobenzene | ESD-897563-100MG |
Cas.: 82420-35-7 | Purity: ≥95% | 2-(Bromomethyl)-4-fluoro-1-nitrobenzene | ESD-897563-250MG |
Cas.: 82420-35-7 | Purity: ≥95% | 2-(Bromomethyl)-4-fluoro-1-nitrobenzene | ESD-897563-1G |
Cas.: 74440-82-7 | Purity: ≥95% | 3-Iodo-5-methoxybenzoic acid | ESD-897564-100MG |
Cas.: 74440-82-7 | Purity: ≥95% | 3-Iodo-5-methoxybenzoic acid | ESD-897564-250MG |
Cas.: 74440-82-7 | Purity: ≥95% | 3-Iodo-5-methoxybenzoic acid | ESD-897564-1G |
Cas.: 955887-09-9 | Purity: 97% | tert-Butyl 4-bromo-2,6-difluorobenzoate | ESD-897565-100MG |
Cas.: 955887-09-9 | Purity: 97% | tert-Butyl 4-bromo-2,6-difluorobenzoate | ESD-897565-250MG |
Cas.: 955887-09-9 | Purity: 97% | tert-Butyl 4-bromo-2,6-difluorobenzoate | ESD-897565-1G |
Cas.: 81316-36-1 | Purity: ≥95% | Methyl 2-(3-bromophenyl)-2-oxoacetate | ESD-897566-100MG |
Cas.: 81316-36-1 | Purity: ≥95% | Methyl 2-(3-bromophenyl)-2-oxoacetate | ESD-897566-250MG |
Cas.: 81316-36-1 | Purity: ≥95% | Methyl 2-(3-bromophenyl)-2-oxoacetate | ESD-897566-1G |
Cas.: 41960-44-5 | Purity: 97% | Methyl 5-iodopicolinate | ESD-897567-100MG |
Cas.: 41960-44-5 | Purity: 97% | Methyl 5-iodopicolinate | ESD-897567-250MG |
Cas.: 41960-44-5 | Purity: 97% | Methyl 5-iodopicolinate | ESD-897567-1G |
Cas.: 387824-78-4 | Purity: ≥98% | Fmoc-D-Dab(Aloc)-OH | ESD-897568-100MG |
Cas.: 387824-78-4 | Purity: ≥98% | Fmoc-D-Dab(Aloc)-OH | ESD-897568-250MG |
Cas.: 387824-78-4 | Purity: ≥98% | Fmoc-D-Dab(Aloc)-OH | ESD-897568-1G |
Cas.: 97986-08-8 | Purity: ≥95% | N,6-dimethylpyridin-2-amine | ESD-897569-100MG |
Cas.: 97986-08-8 | Purity: ≥95% | N,6-dimethylpyridin-2-amine | ESD-897569-250MG |
Cas.: 97986-08-8 | Purity: ≥95% | N,6-dimethylpyridin-2-amine | ESD-897569-1G |
Cas.: 773134-12-6 | Purity: ≥95% | Methyl 4-chloro-2,6-difluorobenzoate | ESD-897570-100MG |
Cas.: 773134-12-6 | Purity: ≥95% | Methyl 4-chloro-2,6-difluorobenzoate | ESD-897570-250MG |
Cas.: 773134-12-6 | Purity: ≥95% | Methyl 4-chloro-2,6-difluorobenzoate | ESD-897570-1G |
Cas.: 1335053-51-4 | Purity: ≥95% | 4-Amino-6-methoxypicolinonitrile | ESD-897571-100MG |
Cas.: 1335053-51-4 | Purity: ≥95% | 4-Amino-6-methoxypicolinonitrile | ESD-897571-250MG |
Cas.: 1335053-51-4 | Purity: ≥95% | 4-Amino-6-methoxypicolinonitrile | ESD-897571-1G |
Cas.: 658700-20-0 | Purity: ≥95% | 3-Fluoro-N-methyl-4-nitrobenzamide | ESD-897572-100MG |
Cas.: 658700-20-0 | Purity: ≥95% | 3-Fluoro-N-methyl-4-nitrobenzamide | ESD-897572-250MG |
Cas.: 658700-20-0 | Purity: ≥95% | 3-Fluoro-N-methyl-4-nitrobenzamide | ESD-897572-1G |
Cas.: 1187928-01-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride | ESD-897573-100MG |
Cas.: 1187928-01-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride | ESD-897573-250MG |
Cas.: 1187928-01-3 | Purity: ≥95% | 7-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride | ESD-897573-1G |
Cas.: 105532-25-0 | Purity: 97% | 1-Ethyl-6-methoxy-1,2,3,4-tetrahydroquinoline | ESD-897574-100MG |
Cas.: 105532-25-0 | Purity: 97% | 1-Ethyl-6-methoxy-1,2,3,4-tetrahydroquinoline | ESD-897574-250MG |
Cas.: 105532-25-0 | Purity: 97% | 1-Ethyl-6-methoxy-1,2,3,4-tetrahydroquinoline | ESD-897574-1G |
Cas.: 35982-55-9 | Purity: ≥95% | 6-Chloro-2-(trifluoromethyl)quinazolin-4(3H)-one | ESD-897575-100MG |
Cas.: 35982-55-9 | Purity: ≥95% | 6-Chloro-2-(trifluoromethyl)quinazolin-4(3H)-one | ESD-897575-250MG |
Cas.: 35982-55-9 | Purity: ≥95% | 6-Chloro-2-(trifluoromethyl)quinazolin-4(3H)-one | ESD-897575-1G |
Cas.: 67845-28-7 | Purity: ≥95% | 2-Methyl-6-propoxypyrazine | ESD-897576-100MG |
Cas.: 67845-28-7 | Purity: ≥95% | 2-Methyl-6-propoxypyrazine | ESD-897576-250MG |
Cas.: 67845-28-7 | Purity: ≥95% | 2-Methyl-6-propoxypyrazine | ESD-897576-1G |
Cas.: 391624-66-1 | Purity: ≥95% | (2S,3S)-2,3-Bis((2-methylbenzoyl)oxy)succinic acid | ESD-897577-100MG |
Cas.: 391624-66-1 | Purity: ≥95% | (2S,3S)-2,3-Bis((2-methylbenzoyl)oxy)succinic acid | ESD-897577-250MG |
Cas.: 391624-66-1 | Purity: ≥95% | (2S,3S)-2,3-Bis((2-methylbenzoyl)oxy)succinic acid | ESD-897577-1G |
Cas.: 85614-89-7 | Purity: ≥95% | Ethyl 5-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate | ESD-897578-100MG |
Cas.: 85614-89-7 | Purity: ≥95% | Ethyl 5-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate | ESD-897578-250MG |
Cas.: 85614-89-7 | Purity: ≥95% | Ethyl 5-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate | ESD-897578-1G |
Cas.: 1227694-88-3 | Purity: ≥95% | (E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-methylacetamide | ESD-897579-100MG |
Cas.: 1227694-88-3 | Purity: ≥95% | (E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-methylacetamide | ESD-897579-250MG |
Cas.: 1227694-88-3 | Purity: ≥95% | (E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-methylacetamide | ESD-897579-1G |
Cas.: 218938-55-7 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-6-(isopropylamino)hexanoic acid | ESD-897580-100MG |
Cas.: 218938-55-7 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-6-(isopropylamino)hexanoic acid | ESD-897580-250MG |
Cas.: 218938-55-7 | Purity: 97% | (S)-2-(((Benzyloxy)carbonyl)amino)-6-(isopropylamino)hexanoic acid | ESD-897580-1G |
Cas.: 422324-39-8 | Purity: 95% | (R)-tert-Butyl 3-amino-4-phenylbutanoate hydrochloride | ESD-897581-100MG |
Cas.: 422324-39-8 | Purity: 95% | (R)-tert-Butyl 3-amino-4-phenylbutanoate hydrochloride | ESD-897581-250MG |
Cas.: 422324-39-8 | Purity: 95% | (R)-tert-Butyl 3-amino-4-phenylbutanoate hydrochloride | ESD-897581-1G |
Cas.: 78760-60-8 | Purity: ≥95% | 5-(Benzyloxy)picolinonitrile | ESD-897582-100MG |
Cas.: 78760-60-8 | Purity: ≥95% | 5-(Benzyloxy)picolinonitrile | ESD-897582-250MG |
Cas.: 78760-60-8 | Purity: ≥95% | 5-(Benzyloxy)picolinonitrile | ESD-897582-1G |
Cas.: 928658-23-5 | Purity: 97% | 4-(6-Bromopyridin-2-yl)benzoic acid | ESD-897583-100MG |
Cas.: 928658-23-5 | Purity: 97% | 4-(6-Bromopyridin-2-yl)benzoic acid | ESD-897583-250MG |
Cas.: 928658-23-5 | Purity: 97% | 4-(6-Bromopyridin-2-yl)benzoic acid | ESD-897583-1G |
Cas.: 2109805-74-3 | Purity: 97% | tert-Butyl 5,6-dihydro-1H-pyrazolo[3,4-b]pyridine-7(4H)-carboxylate | ESD-897584-100MG |
Cas.: 2109805-74-3 | Purity: 97% | tert-Butyl 5,6-dihydro-1H-pyrazolo[3,4-b]pyridine-7(4H)-carboxylate | ESD-897584-250MG |
Cas.: 2109805-74-3 | Purity: 97% | tert-Butyl 5,6-dihydro-1H-pyrazolo[3,4-b]pyridine-7(4H)-carboxylate | ESD-897584-1G |
Cas.: 57850-17-6 | Purity: 97% | Z-Trp-Trp-OH | ESD-897585-100MG |
Cas.: 57850-17-6 | Purity: 97% | Z-Trp-Trp-OH | ESD-897585-250MG |
Cas.: 57850-17-6 | Purity: 97% | Z-Trp-Trp-OH | ESD-897585-1G |
Cas.: 946161-16-6 | Purity: 97% | (R)-Methyl 2-((2-chloro-5-nitropyrimidin-4-yl)(isopropyl)amino)butanoate | ESD-897586-100MG |
Cas.: 946161-16-6 | Purity: 97% | (R)-Methyl 2-((2-chloro-5-nitropyrimidin-4-yl)(isopropyl)amino)butanoate | ESD-897586-250MG |
Cas.: 946161-16-6 | Purity: 97% | (R)-Methyl 2-((2-chloro-5-nitropyrimidin-4-yl)(isopropyl)amino)butanoate | ESD-897586-1G |
Cas.: 1369775-42-7 | Purity: 97% | 1-Fluoro-4-iodo-2-isopropylbenzene | ESD-897587-100MG |
Cas.: 1369775-42-7 | Purity: 97% | 1-Fluoro-4-iodo-2-isopropylbenzene | ESD-897587-250MG |
Cas.: 1369775-42-7 | Purity: 97% | 1-Fluoro-4-iodo-2-isopropylbenzene | ESD-897587-1G |
Cas.: 25070-73-9 | Purity: 97% | Benzyl morpholine-4-carboxylate | ESD-897588-100MG |
Cas.: 25070-73-9 | Purity: 97% | Benzyl morpholine-4-carboxylate | ESD-897588-250MG |
Cas.: 25070-73-9 | Purity: 97% | Benzyl morpholine-4-carboxylate | ESD-897588-1G |
Cas.: 956034-03-0 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)furan-2-carboxylate | ESD-897589-100MG |
Cas.: 956034-03-0 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)furan-2-carboxylate | ESD-897589-250MG |
Cas.: 956034-03-0 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)furan-2-carboxylate | ESD-897589-1G |
Cas.: 960510-36-5 | Purity: 97% | 5-Bromo-3,6-dichloropyrazin-2-amine | ESD-897590-100MG |
Cas.: 960510-36-5 | Purity: 97% | 5-Bromo-3,6-dichloropyrazin-2-amine | ESD-897590-250MG |
Cas.: 960510-36-5 | Purity: 97% | 5-Bromo-3,6-dichloropyrazin-2-amine | ESD-897590-1G |
Cas.: 1229006-21-6 | Purity: 97% | Methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | ESD-897591-100MG |
Cas.: 1229006-21-6 | Purity: 97% | Methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | ESD-897591-250MG |
Cas.: 1229006-21-6 | Purity: 97% | Methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | ESD-897591-1G |
Cas.: 29922-52-9 | Purity: ≥95% | 2-(Hydroxymethyl)-3-methylphenol | ESD-897592-100MG |
Cas.: 29922-52-9 | Purity: ≥95% | 2-(Hydroxymethyl)-3-methylphenol | ESD-897592-250MG |
Cas.: 29922-52-9 | Purity: ≥95% | 2-(Hydroxymethyl)-3-methylphenol | ESD-897592-1G |
Cas.: 111082-23-6 | Purity: 97% | [1,1′-Biphenyl]-4-carboximidamide hydrochloride | ESD-897593-100MG |
Cas.: 111082-23-6 | Purity: 97% | [1,1′-Biphenyl]-4-carboximidamide hydrochloride | ESD-897593-250MG |
Cas.: 111082-23-6 | Purity: 97% | [1,1′-Biphenyl]-4-carboximidamide hydrochloride | ESD-897593-1G |
Cas.: 1799792-28-1 | Purity: 97% | 2-Bromo-5-fluoroisonicotinamide | ESD-897594-100MG |
Cas.: 1799792-28-1 | Purity: 97% | 2-Bromo-5-fluoroisonicotinamide | ESD-897594-250MG |
Cas.: 1799792-28-1 | Purity: 97% | 2-Bromo-5-fluoroisonicotinamide | ESD-897594-1G |
Cas.: 1899922-76-9 | Purity: 97% | 3-(2-Chloropyrimdin-4-yl)-1-cyclopropyl-1H-indole | ESD-897595-100MG |
Cas.: 1899922-76-9 | Purity: 97% | 3-(2-Chloropyrimdin-4-yl)-1-cyclopropyl-1H-indole | ESD-897595-250MG |
Cas.: 1899922-76-9 | Purity: 97% | 3-(2-Chloropyrimdin-4-yl)-1-cyclopropyl-1H-indole | ESD-897595-1G |
Cas.: 18542-98-8 | Purity: 97% | 4-Fluoro-N,N-dimethyl-3-nitroaniline | ESD-897596-100MG |
Cas.: 18542-98-8 | Purity: 97% | 4-Fluoro-N,N-dimethyl-3-nitroaniline | ESD-897596-250MG |
Cas.: 18542-98-8 | Purity: 97% | 4-Fluoro-N,N-dimethyl-3-nitroaniline | ESD-897596-1G |
Cas.: 1820030-49-6 | Purity: 97% | (R,Z)-4-((tert-Butyldimethylsilyl)oxy)-N,N-diphenylpent-2-enamide | ESD-897597-100MG |
Cas.: 1820030-49-6 | Purity: 97% | (R,Z)-4-((tert-Butyldimethylsilyl)oxy)-N,N-diphenylpent-2-enamide | ESD-897597-250MG |
Cas.: 1820030-49-6 | Purity: 97% | (R,Z)-4-((tert-Butyldimethylsilyl)oxy)-N,N-diphenylpent-2-enamide | ESD-897597-1G |
Cas.: 1362243-52-4 | Purity: ≥95% | 2-Methyl-4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butan-2-ol | ESD-897598-100MG |
Cas.: 1362243-52-4 | Purity: ≥95% | 2-Methyl-4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butan-2-ol | ESD-897598-250MG |
Cas.: 1362243-52-4 | Purity: ≥95% | 2-Methyl-4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butan-2-ol | ESD-897598-1G |
Cas.: 1823954-54-6 | Purity: ≥95% | 5-Bromo-2-methylquinazolin-4-ol | ESD-897599-100MG |
Cas.: 1823954-54-6 | Purity: ≥95% | 5-Bromo-2-methylquinazolin-4-ol | ESD-897599-250MG |
Cas.: 1823954-54-6 | Purity: ≥95% | 5-Bromo-2-methylquinazolin-4-ol | ESD-897599-1G |
Cas.: 1217831-52-1 | Purity: ≥95% | (R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride | ESD-897600-100MG |
Cas.: 1217831-52-1 | Purity: ≥95% | (R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride | ESD-897600-250MG |
Cas.: 1217831-52-1 | Purity: ≥95% | (R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride | ESD-897600-1G |
Cas.: 923289-30-9 | Purity: ≥95% | 1-(2-Amino-3-bromo-4-methoxyphenyl)ethanone | ESD-897601-100MG |
Cas.: 923289-30-9 | Purity: ≥95% | 1-(2-Amino-3-bromo-4-methoxyphenyl)ethanone | ESD-897601-250MG |
Cas.: 923289-30-9 | Purity: ≥95% | 1-(2-Amino-3-bromo-4-methoxyphenyl)ethanone | ESD-897601-1G |
Cas.: 60682-95-3 | Purity: ≥95% | Diethyl [(4-methylbenzenesulfonyl)methyl]-phosphonate | ESD-897602-100MG |
Cas.: 60682-95-3 | Purity: ≥95% | Diethyl [(4-methylbenzenesulfonyl)methyl]-phosphonate | ESD-897602-250MG |
Cas.: 60682-95-3 | Purity: ≥95% | Diethyl [(4-methylbenzenesulfonyl)methyl]-phosphonate | ESD-897602-1G |
Cas.: 1956355-82-0 | Purity: ≥95% | Methyl 4-methyl-7-nitro-1H-indole-2-carboxylate | ESD-897603-100MG |
Cas.: 1956355-82-0 | Purity: ≥95% | Methyl 4-methyl-7-nitro-1H-indole-2-carboxylate | ESD-897603-250MG |
Cas.: 1956355-82-0 | Purity: ≥95% | Methyl 4-methyl-7-nitro-1H-indole-2-carboxylate | ESD-897603-1G |
Cas.: 701227-09-0 | Purity: 97% | 2-Methoxy-N-(5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl)benzamide | ESD-897604-100MG |
Cas.: 701227-09-0 | Purity: 97% | 2-Methoxy-N-(5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl)benzamide | ESD-897604-250MG |
Cas.: 701227-09-0 | Purity: 97% | 2-Methoxy-N-(5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl)benzamide | ESD-897604-1G |
Cas.: 519028-33-2 | Purity: 97% | Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate | ESD-897605-100MG |
Cas.: 519028-33-2 | Purity: 97% | Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate | ESD-897605-250MG |
Cas.: 519028-33-2 | Purity: 97% | Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate | ESD-897605-1G |
Cas.: 1914148-52-9 | Purity: 97% | 2-(Adamantan-1-yl)-4-methyl-1H-pyrrole | ESD-897606-100MG |
Cas.: 1914148-52-9 | Purity: 97% | 2-(Adamantan-1-yl)-4-methyl-1H-pyrrole | ESD-897606-250MG |
Cas.: 1914148-52-9 | Purity: 97% | 2-(Adamantan-1-yl)-4-methyl-1H-pyrrole | ESD-897606-1G |
Cas.: 773135-31-2 | Purity: 95% | Ethyl 3-fluoro-4-(trifluoromethyl)benzoate | ESD-897607-100MG |
Cas.: 773135-31-2 | Purity: 95% | Ethyl 3-fluoro-4-(trifluoromethyl)benzoate | ESD-897607-250MG |
Cas.: 773135-31-2 | Purity: 95% | Ethyl 3-fluoro-4-(trifluoromethyl)benzoate | ESD-897607-1G |
Cas.: 1883347-27-0 | Purity: ≥95% | 2-Methyloctahydro-1H-pyrazino[1,2-a]pyrazine trihydrochloride | ESD-897608-100MG |
Cas.: 1883347-27-0 | Purity: ≥95% | 2-Methyloctahydro-1H-pyrazino[1,2-a]pyrazine trihydrochloride | ESD-897608-250MG |
Cas.: 1883347-27-0 | Purity: ≥95% | 2-Methyloctahydro-1H-pyrazino[1,2-a]pyrazine trihydrochloride | ESD-897608-1G |
Cas.: 95939-10-9 | Purity: 97% | 8-Benzyl-1-cyclohexyl-1,3,8-triazaspiro[4.5]decan-4-one | ESD-897609-100MG |
Cas.: 95939-10-9 | Purity: 97% | 8-Benzyl-1-cyclohexyl-1,3,8-triazaspiro[4.5]decan-4-one | ESD-897609-250MG |
Cas.: 95939-10-9 | Purity: 97% | 8-Benzyl-1-cyclohexyl-1,3,8-triazaspiro[4.5]decan-4-one | ESD-897609-1G |
Cas.: 2044706-54-7 | Purity: 97% | 2-(Benzyloxy)-N-(5-fluoro-2-iodophenyl)acetamide | ESD-897610-100MG |
Cas.: 2044706-54-7 | Purity: 97% | 2-(Benzyloxy)-N-(5-fluoro-2-iodophenyl)acetamide | ESD-897610-250MG |
Cas.: 2044706-54-7 | Purity: 97% | 2-(Benzyloxy)-N-(5-fluoro-2-iodophenyl)acetamide | ESD-897610-1G |
Cas.: 73000-30-3 | Purity: 97% | 2-(Ethylthio)pyrimidine-4,5,6-triamine | ESD-897611-100MG |
Cas.: 73000-30-3 | Purity: 97% | 2-(Ethylthio)pyrimidine-4,5,6-triamine | ESD-897611-250MG |
Cas.: 73000-30-3 | Purity: 97% | 2-(Ethylthio)pyrimidine-4,5,6-triamine | ESD-897611-1G |
Cas.: 400607-47-8 | Purity: 97% | (10-([1,1′-Biphenyl]-4-yl)anthracen-9-yl)boronic acid | ESD-897612-100MG |
Cas.: 400607-47-8 | Purity: 97% | (10-([1,1′-Biphenyl]-4-yl)anthracen-9-yl)boronic acid | ESD-897612-250MG |
Cas.: 400607-47-8 | Purity: 97% | (10-([1,1′-Biphenyl]-4-yl)anthracen-9-yl)boronic acid | ESD-897612-1G |
Cas.: 394-02-5 | Purity: ≥95% | 5-Fluoro-2-Nitrobenzoyl chloride | ESD-897613-100MG |
Cas.: 394-02-5 | Purity: ≥95% | 5-Fluoro-2-Nitrobenzoyl chloride | ESD-897613-250MG |
Cas.: 394-02-5 | Purity: ≥95% | 5-Fluoro-2-Nitrobenzoyl chloride | ESD-897613-1G |
Cas.: 1499193-66-6 | Purity: 97% | (1R,3S,4S)-tert-Butyl 3-(6-(7-(2-((S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptan-6-yl)-1H- imidazol-5-yl)-9,9-difluoro-9H-fluoren-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate oxalate | ESD-897614-100MG |
Cas.: 1499193-66-6 | Purity: 97% | (1R,3S,4S)-tert-Butyl 3-(6-(7-(2-((S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptan-6-yl)-1H- imidazol-5-yl)-9,9-difluoro-9H-fluoren-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate oxalate | ESD-897614-250MG |
Cas.: 1499193-66-6 | Purity: 97% | (1R,3S,4S)-tert-Butyl 3-(6-(7-(2-((S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptan-6-yl)-1H- imidazol-5-yl)-9,9-difluoro-9H-fluoren-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate oxalate | ESD-897614-1G |
Cas.: 773-63-7 | Purity: ≥95% | 2,3,3-Trimethyl-3H-indol-5-amine | ESD-897615-100MG |
Cas.: 773-63-7 | Purity: ≥95% | 2,3,3-Trimethyl-3H-indol-5-amine | ESD-897615-250MG |
Cas.: 773-63-7 | Purity: ≥95% | 2,3,3-Trimethyl-3H-indol-5-amine | ESD-897615-1G |
Cas.: 90586-84-8 | Purity: ≥95% | N-Ethylthiazol-2-amine hydrochloride | ESD-897616-100MG |
Cas.: 90586-84-8 | Purity: ≥95% | N-Ethylthiazol-2-amine hydrochloride | ESD-897616-250MG |
Cas.: 90586-84-8 | Purity: ≥95% | N-Ethylthiazol-2-amine hydrochloride | ESD-897616-1G |
Cas.: 2044702-83-0 | Purity: 97% | tert-Butyl (4-(4-bromophenylsulfonamido)-4-oxobutyl)carbamate | ESD-897617-100MG |
Cas.: 2044702-83-0 | Purity: 97% | tert-Butyl (4-(4-bromophenylsulfonamido)-4-oxobutyl)carbamate | ESD-897617-250MG |
Cas.: 2044702-83-0 | Purity: 97% | tert-Butyl (4-(4-bromophenylsulfonamido)-4-oxobutyl)carbamate | ESD-897617-1G |
Cas.: 406676-24-2 | Purity: ≥95% | 3,5-Dichloro-2-fluoro-4-iodopyridine | ESD-897618-100MG |
Cas.: 406676-24-2 | Purity: ≥95% | 3,5-Dichloro-2-fluoro-4-iodopyridine | ESD-897618-250MG |
Cas.: 406676-24-2 | Purity: ≥95% | 3,5-Dichloro-2-fluoro-4-iodopyridine | ESD-897618-1G |
Cas.: 46258-62-2 | Purity: ≥95% | 1-(4-Bromonaphthalen-1-yl)ethanone | ESD-897619-100MG |
Cas.: 46258-62-2 | Purity: ≥95% | 1-(4-Bromonaphthalen-1-yl)ethanone | ESD-897619-250MG |
Cas.: 46258-62-2 | Purity: ≥95% | 1-(4-Bromonaphthalen-1-yl)ethanone | ESD-897619-1G |
Cas.: 23676-63-3 | Purity: 97% | N-((4-Amino-2-methylpyrimidin-5-yl)methyl)acetamide | ESD-897620-100MG |
Cas.: 23676-63-3 | Purity: 97% | N-((4-Amino-2-methylpyrimidin-5-yl)methyl)acetamide | ESD-897620-250MG |
Cas.: 23676-63-3 | Purity: 97% | N-((4-Amino-2-methylpyrimidin-5-yl)methyl)acetamide | ESD-897620-1G |
Cas.: 50777-83-8 | Purity: 97% | 2,2′,2”-Phosphinetriyltribenzaldehyde | ESD-897621-100MG |
Cas.: 50777-83-8 | Purity: 97% | 2,2′,2”-Phosphinetriyltribenzaldehyde | ESD-897621-250MG |
Cas.: 50777-83-8 | Purity: 97% | 2,2′,2”-Phosphinetriyltribenzaldehyde | ESD-897621-1G |
Cas.: 1346691-33-5 | Purity: ≥95% | 3-Chloro-5-(2,2,2-trifluoroethoxy)pyridazine | ESD-897622-100MG |
Cas.: 1346691-33-5 | Purity: ≥95% | 3-Chloro-5-(2,2,2-trifluoroethoxy)pyridazine | ESD-897622-250MG |
Cas.: 1346691-33-5 | Purity: ≥95% | 3-Chloro-5-(2,2,2-trifluoroethoxy)pyridazine | ESD-897622-1G |
Cas.: 1369948-83-3 | Purity: 95% | 3-Amino-2-fluorobenzamide | ESD-897623-100MG |
Cas.: 1369948-83-3 | Purity: 95% | 3-Amino-2-fluorobenzamide | ESD-897623-250MG |
Cas.: 1369948-83-3 | Purity: 95% | 3-Amino-2-fluorobenzamide | ESD-897623-1G |
Cas.: 1357281-69-6 | Purity: 97% | 4-Ethynyl-3-methylbenzoic acid | ESD-897624-100MG |
Cas.: 1357281-69-6 | Purity: 97% | 4-Ethynyl-3-methylbenzoic acid | ESD-897624-250MG |
Cas.: 1357281-69-6 | Purity: 97% | 4-Ethynyl-3-methylbenzoic acid | ESD-897624-1G |
Cas.: 1260849-23-7 | Purity: ≥95% | Ethyl 2,6-difluoro-4-methoxybenzoate | ESD-897625-100MG |
Cas.: 1260849-23-7 | Purity: ≥95% | Ethyl 2,6-difluoro-4-methoxybenzoate | ESD-897625-250MG |
Cas.: 1260849-23-7 | Purity: ≥95% | Ethyl 2,6-difluoro-4-methoxybenzoate | ESD-897625-1G |
Cas.: 2153472-95-6 | Purity: 97% | Ethyl 6-(tert-butylamino)pyrimidine-4-carboxylate | ESD-897626-100MG |
Cas.: 2153472-95-6 | Purity: 97% | Ethyl 6-(tert-butylamino)pyrimidine-4-carboxylate | ESD-897626-250MG |
Cas.: 2153472-95-6 | Purity: 97% | Ethyl 6-(tert-butylamino)pyrimidine-4-carboxylate | ESD-897626-1G |
Cas.: 433336-90-4 | Purity: ≥95% | 2-(6-Chloropyridin-3-yl)acetamide | ESD-897627-100MG |
Cas.: 433336-90-4 | Purity: ≥95% | 2-(6-Chloropyridin-3-yl)acetamide | ESD-897627-250MG |
Cas.: 433336-90-4 | Purity: ≥95% | 2-(6-Chloropyridin-3-yl)acetamide | ESD-897627-1G |
Cas.: 2101207-00-3 | Purity: 97% | 7-tert-Butyl 2-methyl 5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate | ESD-897628-100MG |
Cas.: 2101207-00-3 | Purity: 97% | 7-tert-Butyl 2-methyl 5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate | ESD-897628-250MG |
Cas.: 2101207-00-3 | Purity: 97% | 7-tert-Butyl 2-methyl 5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate | ESD-897628-1G |
Cas.: 81660-73-3 | Purity: ≥97% | tert-Butyl isocotinate | ESD-897629-100MG |
Cas.: 81660-73-3 | Purity: ≥97% | tert-Butyl isocotinate | ESD-897629-250MG |
Cas.: 81660-73-3 | Purity: ≥97% | tert-Butyl isocotinate | ESD-897629-1G |
Cas.: 1805648-67-2 | Purity: 95% | Ethyl 6-chloro-3-nitropicolinate | ESD-897630-100MG |
Cas.: 1805648-67-2 | Purity: 95% | Ethyl 6-chloro-3-nitropicolinate | ESD-897630-250MG |
Cas.: 1805648-67-2 | Purity: 95% | Ethyl 6-chloro-3-nitropicolinate | ESD-897630-1G |
Cas.: 2909-84-4 | Purity: ≥95% | 2,4-Di-tert-butylaniline | ESD-897631-100MG |
Cas.: 2909-84-4 | Purity: ≥95% | 2,4-Di-tert-butylaniline | ESD-897631-250MG |
Cas.: 2909-84-4 | Purity: ≥95% | 2,4-Di-tert-butylaniline | ESD-897631-1G |
Cas.: 1884420-79-4 | Purity: 97% | 2,7-Bis(4-bromophenyl)-9-hexyl-9H-carbazole | ESD-897632-100MG |
Cas.: 1884420-79-4 | Purity: 97% | 2,7-Bis(4-bromophenyl)-9-hexyl-9H-carbazole | ESD-897632-250MG |
Cas.: 1884420-79-4 | Purity: 97% | 2,7-Bis(4-bromophenyl)-9-hexyl-9H-carbazole | ESD-897632-1G |
Cas.: 1445976-44-2 | Purity: 97% | (R)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-897633-100MG |
Cas.: 1445976-44-2 | Purity: 97% | (R)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-897633-250MG |
Cas.: 1445976-44-2 | Purity: 97% | (R)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-897633-1G |
Cas.: 65685-49-6 | Purity: ≥95% | 5-Methylbenzo[d]isoxazol-3(2H)-one | ESD-897634-100MG |
Cas.: 65685-49-6 | Purity: ≥95% | 5-Methylbenzo[d]isoxazol-3(2H)-one | ESD-897634-250MG |
Cas.: 65685-49-6 | Purity: ≥95% | 5-Methylbenzo[d]isoxazol-3(2H)-one | ESD-897634-1G |
Cas.: 137853-21-5 | Purity: 97% | 1-(5-Isopropylpyridin-2-yl)ethanone | ESD-897635-100MG |
Cas.: 137853-21-5 | Purity: 97% | 1-(5-Isopropylpyridin-2-yl)ethanone | ESD-897635-250MG |
Cas.: 137853-21-5 | Purity: 97% | 1-(5-Isopropylpyridin-2-yl)ethanone | ESD-897635-1G |
Cas.: 3108-23-4 | Purity: ≥95% | 4,4,4-Trifluoro-2-(4-fluorophenyl)-3-oxobutanenitrile | ESD-897636-100MG |
Cas.: 3108-23-4 | Purity: ≥95% | 4,4,4-Trifluoro-2-(4-fluorophenyl)-3-oxobutanenitrile | ESD-897636-250MG |
Cas.: 3108-23-4 | Purity: ≥95% | 4,4,4-Trifluoro-2-(4-fluorophenyl)-3-oxobutanenitrile | ESD-897636-1G |
Cas.: 1824142-81-5 | Purity: 97% | 4-Bromo-1-(fluoromethyl)-2-methylbenzene | ESD-897637-100MG |
Cas.: 1824142-81-5 | Purity: 97% | 4-Bromo-1-(fluoromethyl)-2-methylbenzene | ESD-897637-250MG |
Cas.: 1824142-81-5 | Purity: 97% | 4-Bromo-1-(fluoromethyl)-2-methylbenzene | ESD-897637-1G |
Cas.: 1565857-69-3 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(4-nitronaphthalen-1-yl)-1,3,2-dioxaborolane | ESD-897638-100MG |
Cas.: 1565857-69-3 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(4-nitronaphthalen-1-yl)-1,3,2-dioxaborolane | ESD-897638-250MG |
Cas.: 1565857-69-3 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(4-nitronaphthalen-1-yl)-1,3,2-dioxaborolane | ESD-897638-1G |
Cas.: 1258934-67-6 | Purity: ≥95% | tert-Butyl (2-chlorothiazol-4-yl)carbamate | ESD-897639-100MG |
Cas.: 1258934-67-6 | Purity: ≥95% | tert-Butyl (2-chlorothiazol-4-yl)carbamate | ESD-897639-250MG |
Cas.: 1258934-67-6 | Purity: ≥95% | tert-Butyl (2-chlorothiazol-4-yl)carbamate | ESD-897639-1G |
Cas.: 1260769-87-6 | Purity: ≥95% | 6-Methyl-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-897640-100MG |
Cas.: 1260769-87-6 | Purity: ≥95% | 6-Methyl-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-897640-250MG |
Cas.: 1260769-87-6 | Purity: ≥95% | 6-Methyl-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine | ESD-897640-1G |
Cas.: 408523-59-1 | Purity: 97% | 2,4-Dichloro-6-nitroquinoline | ESD-897641-100MG |
Cas.: 408523-59-1 | Purity: 97% | 2,4-Dichloro-6-nitroquinoline | ESD-897641-250MG |
Cas.: 408523-59-1 | Purity: 97% | 2,4-Dichloro-6-nitroquinoline | ESD-897641-1G |
Cas.: 1677681-05-8 | Purity: 97% | 1-(Benzo[b]thiophen-4-yl)piperazine dihydrochloride | ESD-897642-100MG |
Cas.: 1677681-05-8 | Purity: 97% | 1-(Benzo[b]thiophen-4-yl)piperazine dihydrochloride | ESD-897642-250MG |
Cas.: 1677681-05-8 | Purity: 97% | 1-(Benzo[b]thiophen-4-yl)piperazine dihydrochloride | ESD-897642-1G |
Cas.: 90035-20-4 | Purity: 95% | 4-(4-(Trifluoromethyl)phenoxy)benzaldehyde | ESD-897643-100MG |
Cas.: 90035-20-4 | Purity: 95% | 4-(4-(Trifluoromethyl)phenoxy)benzaldehyde | ESD-897643-250MG |
Cas.: 90035-20-4 | Purity: 95% | 4-(4-(Trifluoromethyl)phenoxy)benzaldehyde | ESD-897643-1G |
Cas.: 944900-09-8 | Purity: 95% | 2-Methoxy-6-(trifluoromethyl)pyridin-3-amine | ESD-897644-100MG |
Cas.: 944900-09-8 | Purity: 95% | 2-Methoxy-6-(trifluoromethyl)pyridin-3-amine | ESD-897644-250MG |
Cas.: 944900-09-8 | Purity: 95% | 2-Methoxy-6-(trifluoromethyl)pyridin-3-amine | ESD-897644-1G |
Cas.: 2061979-42-6 | Purity: 97% | Bis((6-bromopyridin-3-yl)methyl)amine | ESD-897645-100MG |
Cas.: 2061979-42-6 | Purity: 97% | Bis((6-bromopyridin-3-yl)methyl)amine | ESD-897645-250MG |
Cas.: 2061979-42-6 | Purity: 97% | Bis((6-bromopyridin-3-yl)methyl)amine | ESD-897645-1G |
Cas.: 153774-39-1 | Purity: 97% | Allyl 3-amino-4-fluorobenzoate | ESD-897646-100MG |
Cas.: 153774-39-1 | Purity: 97% | Allyl 3-amino-4-fluorobenzoate | ESD-897646-250MG |
Cas.: 153774-39-1 | Purity: 97% | Allyl 3-amino-4-fluorobenzoate | ESD-897646-1G |
Cas.: 1785566-87-1 | Purity: 97% | (1H-Pyrazolo[4,3-b]pyridin-3-yl)methanol | ESD-897647-100MG |
Cas.: 1785566-87-1 | Purity: 97% | (1H-Pyrazolo[4,3-b]pyridin-3-yl)methanol | ESD-897647-250MG |
Cas.: 1785566-87-1 | Purity: 97% | (1H-Pyrazolo[4,3-b]pyridin-3-yl)methanol | ESD-897647-1G |
Cas.: 92358-16-2 | Purity: 97% | Diethyl 3,3′-(5-oxopyrrolidine-2,2-diyl)dipropanoate | ESD-897648-100MG |
Cas.: 92358-16-2 | Purity: 97% | Diethyl 3,3′-(5-oxopyrrolidine-2,2-diyl)dipropanoate | ESD-897648-250MG |
Cas.: 92358-16-2 | Purity: 97% | Diethyl 3,3′-(5-oxopyrrolidine-2,2-diyl)dipropanoate | ESD-897648-1G |
Cas.: 930-73-4 | Purity: 95% | 1-Methylpyridin-1-ium iodide | ESD-897649-100MG |
Cas.: 930-73-4 | Purity: 95% | 1-Methylpyridin-1-ium iodide | ESD-897649-250MG |
Cas.: 930-73-4 | Purity: 95% | 1-Methylpyridin-1-ium iodide | ESD-897649-1G |
Cas.: 1445894-94-9 | Purity: 97% | 2-Chloro-4-isopropoxy-5-nitropyrimidine | ESD-897650-100MG |
Cas.: 1445894-94-9 | Purity: 97% | 2-Chloro-4-isopropoxy-5-nitropyrimidine | ESD-897650-250MG |
Cas.: 1445894-94-9 | Purity: 97% | 2-Chloro-4-isopropoxy-5-nitropyrimidine | ESD-897650-1G |
Cas.: 92248-06-1 | Purity: ≥95% | Bis(3-methoxyphenyl)amine | ESD-897651-100MG |
Cas.: 92248-06-1 | Purity: ≥95% | Bis(3-methoxyphenyl)amine | ESD-897651-250MG |
Cas.: 92248-06-1 | Purity: ≥95% | Bis(3-methoxyphenyl)amine | ESD-897651-1G |
Cas.: 1313753-02-4 | Purity: 97% | Methyl 5-acetoxy-2-methyl-1H-indole-3-carboxylate | ESD-897652-100MG |
Cas.: 1313753-02-4 | Purity: 97% | Methyl 5-acetoxy-2-methyl-1H-indole-3-carboxylate | ESD-897652-250MG |
Cas.: 1313753-02-4 | Purity: 97% | Methyl 5-acetoxy-2-methyl-1H-indole-3-carboxylate | ESD-897652-1G |
Cas.: 851211-74-0 | Purity: ≥95% | 1H-Indole-6-carbohydrazide | ESD-897653-100MG |
Cas.: 851211-74-0 | Purity: ≥95% | 1H-Indole-6-carbohydrazide | ESD-897653-250MG |
Cas.: 851211-74-0 | Purity: ≥95% | 1H-Indole-6-carbohydrazide | ESD-897653-1G |
Cas.: 1825394-89-5 | Purity: 97% | Bis(3-ethynylbenzyl)amine | ESD-897654-100MG |
Cas.: 1825394-89-5 | Purity: 97% | Bis(3-ethynylbenzyl)amine | ESD-897654-250MG |
Cas.: 1825394-89-5 | Purity: 97% | Bis(3-ethynylbenzyl)amine | ESD-897654-1G |
Cas.: 4102-60-7 | Purity: ≥95% | 18-Bromo-6,9-octadecadiene | ESD-897655-100MG |
Cas.: 4102-60-7 | Purity: ≥95% | 18-Bromo-6,9-octadecadiene | ESD-897655-250MG |
Cas.: 4102-60-7 | Purity: ≥95% | 18-Bromo-6,9-octadecadiene | ESD-897655-1G |
Cas.: 81937-39-5 | Purity: 98% | Diethyl 2-(1-(4-acetamidophenyl)-1-oxopropan-2-yl)malonate | ESD-897656-100MG |
Cas.: 81937-39-5 | Purity: 98% | Diethyl 2-(1-(4-acetamidophenyl)-1-oxopropan-2-yl)malonate | ESD-897656-250MG |
Cas.: 81937-39-5 | Purity: 98% | Diethyl 2-(1-(4-acetamidophenyl)-1-oxopropan-2-yl)malonate | ESD-897656-1G |
Cas.: 929252-65-3 | Purity: 97% | tert-Butyl 4-(((4-(4-amino-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)methyl)piperidine-1-carboxylate | ESD-897657-100MG |
Cas.: 929252-65-3 | Purity: 97% | tert-Butyl 4-(((4-(4-amino-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)methyl)piperidine-1-carboxylate | ESD-897657-250MG |
Cas.: 929252-65-3 | Purity: 97% | tert-Butyl 4-(((4-(4-amino-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)methyl)piperidine-1-carboxylate | ESD-897657-1G |
Cas.: 1820740-39-3 | Purity: 95% | 2-Chloro-4-morpholinopyrimidine-5-carbaldehyde | ESD-897658-100MG |
Cas.: 1820740-39-3 | Purity: 95% | 2-Chloro-4-morpholinopyrimidine-5-carbaldehyde | ESD-897658-250MG |
Cas.: 1820740-39-3 | Purity: 95% | 2-Chloro-4-morpholinopyrimidine-5-carbaldehyde | ESD-897658-1G |
Cas.: 135832-52-9 | Purity: ≥95% | 3-(5-Chloro-2-fluorophenyl)propanoic acid | ESD-897659-100MG |
Cas.: 135832-52-9 | Purity: ≥95% | 3-(5-Chloro-2-fluorophenyl)propanoic acid | ESD-897659-250MG |
Cas.: 135832-52-9 | Purity: ≥95% | 3-(5-Chloro-2-fluorophenyl)propanoic acid | ESD-897659-1G |
Cas.: 2101206-43-1 | Purity: 97% | 4-Ethyl-3-ethynylbenzoic acid | ESD-897660-100MG |
Cas.: 2101206-43-1 | Purity: 97% | 4-Ethyl-3-ethynylbenzoic acid | ESD-897660-250MG |
Cas.: 2101206-43-1 | Purity: 97% | 4-Ethyl-3-ethynylbenzoic acid | ESD-897660-1G |
Cas.: 121649-61-4 | Purity: 95% | Isopropyl 3,4-diaminobenzoate | ESD-897661-100MG |
Cas.: 121649-61-4 | Purity: 95% | Isopropyl 3,4-diaminobenzoate | ESD-897661-250MG |
Cas.: 121649-61-4 | Purity: 95% | Isopropyl 3,4-diaminobenzoate | ESD-897661-1G |
Cas.: 2197053-85-1 | Purity: 97% | 6-Chloro-2-(pipidin-3-yl)-1H-benzo[d]imidazole hydrochloride | ESD-897662-100MG |
Cas.: 2197053-85-1 | Purity: 97% | 6-Chloro-2-(pipidin-3-yl)-1H-benzo[d]imidazole hydrochloride | ESD-897662-250MG |
Cas.: 2197053-85-1 | Purity: 97% | 6-Chloro-2-(pipidin-3-yl)-1H-benzo[d]imidazole hydrochloride | ESD-897662-1G |
Cas.: 1914148-61-0 | Purity: ≥95% | 2-(4-Benzylmorpholin-2-yl)ethanamine dihydrochloride | ESD-897663-100MG |
Cas.: 1914148-61-0 | Purity: ≥95% | 2-(4-Benzylmorpholin-2-yl)ethanamine dihydrochloride | ESD-897663-250MG |
Cas.: 1914148-61-0 | Purity: ≥95% | 2-(4-Benzylmorpholin-2-yl)ethanamine dihydrochloride | ESD-897663-1G |
Cas.: 30098-34-1 | Purity: ≥95% | 4-(4-Bromo-2,5-dimethylphenyl)-4-oxobutanoic acid | ESD-897664-100MG |
Cas.: 30098-34-1 | Purity: ≥95% | 4-(4-Bromo-2,5-dimethylphenyl)-4-oxobutanoic acid | ESD-897664-250MG |
Cas.: 30098-34-1 | Purity: ≥95% | 4-(4-Bromo-2,5-dimethylphenyl)-4-oxobutanoic acid | ESD-897664-1G |
Cas.: 864292-48-8 | Purity: ≥95% | 4,6-Dichloro-1-ethyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-897665-100MG |
Cas.: 864292-48-8 | Purity: ≥95% | 4,6-Dichloro-1-ethyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-897665-250MG |
Cas.: 864292-48-8 | Purity: ≥95% | 4,6-Dichloro-1-ethyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-897665-1G |
Cas.: 1239786-71-0 | Purity: 97% | 5-Chloro-6-methyl-2-(pyridin-4-yl)pyrimidin-4-ol | ESD-897666-100MG |
Cas.: 1239786-71-0 | Purity: 97% | 5-Chloro-6-methyl-2-(pyridin-4-yl)pyrimidin-4-ol | ESD-897666-250MG |
Cas.: 1239786-71-0 | Purity: 97% | 5-Chloro-6-methyl-2-(pyridin-4-yl)pyrimidin-4-ol | ESD-897666-1G |
Cas.: 4319-83-9 | Purity: ≥95% | 5-Bromo-4,6-dimethoxy-2-methylpyrimidine | ESD-897667-100MG |
Cas.: 4319-83-9 | Purity: ≥95% | 5-Bromo-4,6-dimethoxy-2-methylpyrimidine | ESD-897667-250MG |
Cas.: 4319-83-9 | Purity: ≥95% | 5-Bromo-4,6-dimethoxy-2-methylpyrimidine | ESD-897667-1G |
Cas.: 1810715-04-8 | Purity: 95% | Methyl 2-(5-(trifluoromethyl)pyridin-2-yl)acetate | ESD-897668-100MG |
Cas.: 1810715-04-8 | Purity: 95% | Methyl 2-(5-(trifluoromethyl)pyridin-2-yl)acetate | ESD-897668-250MG |
Cas.: 1810715-04-8 | Purity: 95% | Methyl 2-(5-(trifluoromethyl)pyridin-2-yl)acetate | ESD-897668-1G |
Cas.: 914106-35-7 | Purity: 97% | 4-(Dibromomethyl)-3-methoxybenzonitrile | ESD-897669-100MG |
Cas.: 914106-35-7 | Purity: 97% | 4-(Dibromomethyl)-3-methoxybenzonitrile | ESD-897669-250MG |
Cas.: 914106-35-7 | Purity: 97% | 4-(Dibromomethyl)-3-methoxybenzonitrile | ESD-897669-1G |
Cas.: 61350-65-0 | Purity: ≥95% | (R)-2-(Pyrrolidin-2-yl)acetic acid | ESD-897670-100MG |
Cas.: 61350-65-0 | Purity: ≥95% | (R)-2-(Pyrrolidin-2-yl)acetic acid | ESD-897670-250MG |
Cas.: 61350-65-0 | Purity: ≥95% | (R)-2-(Pyrrolidin-2-yl)acetic acid | ESD-897670-1G |
Cas.: 1261566-52-2 | Purity: ≥95% | (3-Amino-5-methoxyphenyl)methanol | ESD-897671-100MG |
Cas.: 1261566-52-2 | Purity: ≥95% | (3-Amino-5-methoxyphenyl)methanol | ESD-897671-250MG |
Cas.: 1261566-52-2 | Purity: ≥95% | (3-Amino-5-methoxyphenyl)methanol | ESD-897671-1G |
Cas.: 136027-17-3 | Purity: 98% | Benzyl (2-sulfamoylethyl)carbamate | ESD-897672-100MG |
Cas.: 136027-17-3 | Purity: 98% | Benzyl (2-sulfamoylethyl)carbamate | ESD-897672-250MG |
Cas.: 136027-17-3 | Purity: 98% | Benzyl (2-sulfamoylethyl)carbamate | ESD-897672-1G |
Cas.: 67206-07-9 | Purity: 97% | 2-Acetamido-3-(thiophen-2-yl)propanoic acid | ESD-897673-100MG |
Cas.: 67206-07-9 | Purity: 97% | 2-Acetamido-3-(thiophen-2-yl)propanoic acid | ESD-897673-250MG |
Cas.: 67206-07-9 | Purity: 97% | 2-Acetamido-3-(thiophen-2-yl)propanoic acid | ESD-897673-1G |
Cas.: 52601-89-5 | Purity: ≥95% | 4-Aminopyrimidin-5-ol | ESD-897674-100MG |
Cas.: 52601-89-5 | Purity: ≥95% | 4-Aminopyrimidin-5-ol | ESD-897674-250MG |
Cas.: 52601-89-5 | Purity: ≥95% | 4-Aminopyrimidin-5-ol | ESD-897674-1G |
Cas.: 171263-26-6 | Purity: 95% | 2-((S)-1-((2S,5S,11S)-5,11-Diisopropyl-2-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctacosan-1- oyl)pyrrolidine-2-carboxamido)acetic acid | ESD-897675-100MG |
Cas.: 171263-26-6 | Purity: 95% | 2-((S)-1-((2S,5S,11S)-5,11-Diisopropyl-2-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctacosan-1- oyl)pyrrolidine-2-carboxamido)acetic acid | ESD-897675-250MG |
Cas.: 171263-26-6 | Purity: 95% | 2-((S)-1-((2S,5S,11S)-5,11-Diisopropyl-2-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctacosan-1- oyl)pyrrolidine-2-carboxamido)acetic acid | ESD-897675-1G |
Cas.: 1810069-91-0 | Purity: ≥95% | 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897676-100MG |
Cas.: 1810069-91-0 | Purity: ≥95% | 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897676-250MG |
Cas.: 1810069-91-0 | Purity: ≥95% | 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897676-1G |
Cas.: 204203-16-7 | Purity: ≥95% | N,N’-(Pyridine-2,6-diylbis(ethan-1-yl-1-ylidene))bis(2,6-dimethylaniline) | ESD-897677-100MG |
Cas.: 204203-16-7 | Purity: ≥95% | N,N’-(Pyridine-2,6-diylbis(ethan-1-yl-1-ylidene))bis(2,6-dimethylaniline) | ESD-897677-250MG |
Cas.: 204203-16-7 | Purity: ≥95% | N,N’-(Pyridine-2,6-diylbis(ethan-1-yl-1-ylidene))bis(2,6-dimethylaniline) | ESD-897677-1G |
Cas.: 61266-36-2 | Purity: ≥95% | Methyl 4-(3-hydroxyprop-1-yn-1-yl)benzoate | ESD-897678-100MG |
Cas.: 61266-36-2 | Purity: ≥95% | Methyl 4-(3-hydroxyprop-1-yn-1-yl)benzoate | ESD-897678-250MG |
Cas.: 61266-36-2 | Purity: ≥95% | Methyl 4-(3-hydroxyprop-1-yn-1-yl)benzoate | ESD-897678-1G |
Cas.: 90000-54-7 | Purity: 97% | 1H-Benzo[d]imidazole-5,6-diamine dihydrochloride | ESD-897679-100MG |
Cas.: 90000-54-7 | Purity: 97% | 1H-Benzo[d]imidazole-5,6-diamine dihydrochloride | ESD-897679-250MG |
Cas.: 90000-54-7 | Purity: 97% | 1H-Benzo[d]imidazole-5,6-diamine dihydrochloride | ESD-897679-1G |
Cas.: 857599-32-7 | Purity: 97% | 5-Methoxy-4-methyl-2-nitrobenzoic acid | ESD-897680-100MG |
Cas.: 857599-32-7 | Purity: 97% | 5-Methoxy-4-methyl-2-nitrobenzoic acid | ESD-897680-250MG |
Cas.: 857599-32-7 | Purity: 97% | 5-Methoxy-4-methyl-2-nitrobenzoic acid | ESD-897680-1G |
Cas.: 1571-85-3 | Purity: ≥95% | 6-Nitro-2-phenyl-1H-benzo[d]imidazole | ESD-897681-100MG |
Cas.: 1571-85-3 | Purity: ≥95% | 6-Nitro-2-phenyl-1H-benzo[d]imidazole | ESD-897681-250MG |
Cas.: 1571-85-3 | Purity: ≥95% | 6-Nitro-2-phenyl-1H-benzo[d]imidazole | ESD-897681-1G |
Cas.: 106047-17-0 | Purity: 97% | Methyl 4-(pyridin-4-yl)benzoate | ESD-897682-100MG |
Cas.: 106047-17-0 | Purity: 97% | Methyl 4-(pyridin-4-yl)benzoate | ESD-897682-250MG |
Cas.: 106047-17-0 | Purity: 97% | Methyl 4-(pyridin-4-yl)benzoate | ESD-897682-1G |
Cas.: 53976-65-1 | Purity: ≥95% | 2,3-Dichloropyridine1-oxide | ESD-897683-100MG |
Cas.: 53976-65-1 | Purity: ≥95% | 2,3-Dichloropyridine1-oxide | ESD-897683-250MG |
Cas.: 53976-65-1 | Purity: ≥95% | 2,3-Dichloropyridine1-oxide | ESD-897683-1G |
Cas.: 1686150-29-7 | Purity: 97% | Trifluoro(pyrrolidin-1-ium-1-ylmethyl)borate | ESD-897684-100MG |
Cas.: 1686150-29-7 | Purity: 97% | Trifluoro(pyrrolidin-1-ium-1-ylmethyl)borate | ESD-897684-250MG |
Cas.: 1686150-29-7 | Purity: 97% | Trifluoro(pyrrolidin-1-ium-1-ylmethyl)borate | ESD-897684-1G |
Cas.: 1222174-92-6 | Purity: 97% | Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-897685-100MG |
Cas.: 1222174-92-6 | Purity: 97% | Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-897685-250MG |
Cas.: 1222174-92-6 | Purity: 97% | Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate | ESD-897685-1G |
Cas.: 36728-89-9 | Purity: ≥95% | 1-Methyl-3-nitro-1H-indole | ESD-897686-100MG |
Cas.: 36728-89-9 | Purity: ≥95% | 1-Methyl-3-nitro-1H-indole | ESD-897686-250MG |
Cas.: 36728-89-9 | Purity: ≥95% | 1-Methyl-3-nitro-1H-indole | ESD-897686-1G |
Cas.: 1220036-23-6 | Purity: ≥95% | 1-(6-Chloropyridin-2-yl)piperidin-4-ol | ESD-897687-100MG |
Cas.: 1220036-23-6 | Purity: ≥95% | 1-(6-Chloropyridin-2-yl)piperidin-4-ol | ESD-897687-250MG |
Cas.: 1220036-23-6 | Purity: ≥95% | 1-(6-Chloropyridin-2-yl)piperidin-4-ol | ESD-897687-1G |
Cas.: 136117-71-0 | Purity: ≥95% | (6-Bromoimidazo[1,2-a]pyridin-2-yl)methanol | ESD-897688-100MG |
Cas.: 136117-71-0 | Purity: ≥95% | (6-Bromoimidazo[1,2-a]pyridin-2-yl)methanol | ESD-897688-250MG |
Cas.: 136117-71-0 | Purity: ≥95% | (6-Bromoimidazo[1,2-a]pyridin-2-yl)methanol | ESD-897688-1G |
Cas.: 499195-60-7 | Purity: 97% | Ethyl 4-(2-chloropyrimidin-4-yl)benzoate | ESD-897689-100MG |
Cas.: 499195-60-7 | Purity: 97% | Ethyl 4-(2-chloropyrimidin-4-yl)benzoate | ESD-897689-250MG |
Cas.: 499195-60-7 | Purity: 97% | Ethyl 4-(2-chloropyrimidin-4-yl)benzoate | ESD-897689-1G |
Cas.: 1914148-56-3 | Purity: 97% | Ethyl imidazo[1,5-a]pyridine-7-carboxylate hydrochloride | ESD-897690-100MG |
Cas.: 1914148-56-3 | Purity: 97% | Ethyl imidazo[1,5-a]pyridine-7-carboxylate hydrochloride | ESD-897690-250MG |
Cas.: 1914148-56-3 | Purity: 97% | Ethyl imidazo[1,5-a]pyridine-7-carboxylate hydrochloride | ESD-897690-1G |
Cas.: 77994-12-8 | Purity: ≥95% | 2,5-Diaminopyrimidin-4(3H)-one | ESD-897691-100MG |
Cas.: 77994-12-8 | Purity: ≥95% | 2,5-Diaminopyrimidin-4(3H)-one | ESD-897691-250MG |
Cas.: 77994-12-8 | Purity: ≥95% | 2,5-Diaminopyrimidin-4(3H)-one | ESD-897691-1G |
Cas.: 894804-42-3 | Purity: 98% | 2,6-Dichloro-4-ethoxypyridine | ESD-897692-100MG |
Cas.: 894804-42-3 | Purity: 98% | 2,6-Dichloro-4-ethoxypyridine | ESD-897692-250MG |
Cas.: 894804-42-3 | Purity: 98% | 2,6-Dichloro-4-ethoxypyridine | ESD-897692-1G |
Cas.: 1212977-59-7 | Purity: 97% | (S)-2-Amino-2-(3-ethoxy-4-methoxyphenyl)acetic acid | ESD-897693-100MG |
Cas.: 1212977-59-7 | Purity: 97% | (S)-2-Amino-2-(3-ethoxy-4-methoxyphenyl)acetic acid | ESD-897693-250MG |
Cas.: 1212977-59-7 | Purity: 97% | (S)-2-Amino-2-(3-ethoxy-4-methoxyphenyl)acetic acid | ESD-897693-1G |
Cas.: 122536-69-0 | Purity: ≥95% | (S)-Benzyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate | ESD-897694-100MG |
Cas.: 122536-69-0 | Purity: ≥95% | (S)-Benzyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate | ESD-897694-250MG |
Cas.: 122536-69-0 | Purity: ≥95% | (S)-Benzyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate | ESD-897694-1G |
Cas.: 62163-09-1 | Purity: ≥95% | 5-Chloroquinoxaline | ESD-897695-100MG |
Cas.: 62163-09-1 | Purity: ≥95% | 5-Chloroquinoxaline | ESD-897695-250MG |
Cas.: 62163-09-1 | Purity: ≥95% | 5-Chloroquinoxaline | ESD-897695-1G |
Cas.: 400827-64-7 | Purity: 97% | 4-(2-(((6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)thio)thiazol -4-yl)-1-methylpyridin-1-ium chloride hydrochloride | ESD-897696-100MG |
Cas.: 400827-64-7 | Purity: 97% | 4-(2-(((6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)thio)thiazol -4-yl)-1-methylpyridin-1-ium chloride hydrochloride | ESD-897696-250MG |
Cas.: 400827-64-7 | Purity: 97% | 4-(2-(((6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)thio)thiazol -4-yl)-1-methylpyridin-1-ium chloride hydrochloride | ESD-897696-1G |
Cas.: 1211496-23-9 | Purity: 97% | 1-(2-Amino-6-methylphenyl)piperidin-2-one | ESD-897697-100MG |
Cas.: 1211496-23-9 | Purity: 97% | 1-(2-Amino-6-methylphenyl)piperidin-2-one | ESD-897697-250MG |
Cas.: 1211496-23-9 | Purity: 97% | 1-(2-Amino-6-methylphenyl)piperidin-2-one | ESD-897697-1G |
Cas.: 262295-94-3 | Purity: ≥95% | tert-Butyl (2-cyanopyridin-4-yl)carbamate | ESD-897698-100MG |
Cas.: 262295-94-3 | Purity: ≥95% | tert-Butyl (2-cyanopyridin-4-yl)carbamate | ESD-897698-250MG |
Cas.: 262295-94-3 | Purity: ≥95% | tert-Butyl (2-cyanopyridin-4-yl)carbamate | ESD-897698-1G |
Cas.: 1239462-10-2 | Purity: ≥95% | 5-Iodo-2-(trifluoromethyl)pyridin-4-amine | ESD-897699-100MG |
Cas.: 1239462-10-2 | Purity: ≥95% | 5-Iodo-2-(trifluoromethyl)pyridin-4-amine | ESD-897699-250MG |
Cas.: 1239462-10-2 | Purity: ≥95% | 5-Iodo-2-(trifluoromethyl)pyridin-4-amine | ESD-897699-1G |
Cas.: 1258649-69-2 | Purity: 97% | 2-Amino-2-(4-methoxyphenyl)ethanol hydrochloride | ESD-897700-100MG |
Cas.: 1258649-69-2 | Purity: 97% | 2-Amino-2-(4-methoxyphenyl)ethanol hydrochloride | ESD-897700-250MG |
Cas.: 1258649-69-2 | Purity: 97% | 2-Amino-2-(4-methoxyphenyl)ethanol hydrochloride | ESD-897700-1G |
Cas.: 55150-07-7 | Purity: ≥95% | Methyl 5-chloro-2-(methylamino)benzoate | ESD-897701-100MG |
Cas.: 55150-07-7 | Purity: ≥95% | Methyl 5-chloro-2-(methylamino)benzoate | ESD-897701-250MG |
Cas.: 55150-07-7 | Purity: ≥95% | Methyl 5-chloro-2-(methylamino)benzoate | ESD-897701-1G |
Cas.: 90734-76-2 | Purity: 97% | Imidazo[1,2-a]pyrazin-3-yl(phenyl)methanone | ESD-897702-100MG |
Cas.: 90734-76-2 | Purity: 97% | Imidazo[1,2-a]pyrazin-3-yl(phenyl)methanone | ESD-897702-250MG |
Cas.: 90734-76-2 | Purity: 97% | Imidazo[1,2-a]pyrazin-3-yl(phenyl)methanone | ESD-897702-1G |
Cas.: 71309-43-8 | Purity: ≥95% | 1H-Thieno[2,3-d]imidazol-2(3H)-one | ESD-897703-100MG |
Cas.: 71309-43-8 | Purity: ≥95% | 1H-Thieno[2,3-d]imidazol-2(3H)-one | ESD-897703-250MG |
Cas.: 71309-43-8 | Purity: ≥95% | 1H-Thieno[2,3-d]imidazol-2(3H)-one | ESD-897703-1G |
Cas.: 2403-33-0 | Purity: ≥95% | 2-Bromopropan-1-amine hydrobromide | ESD-897704-100MG |
Cas.: 2403-33-0 | Purity: ≥95% | 2-Bromopropan-1-amine hydrobromide | ESD-897704-250MG |
Cas.: 2403-33-0 | Purity: ≥95% | 2-Bromopropan-1-amine hydrobromide | ESD-897704-1G |
Cas.: 39503-52-1 | Purity: ≥95% | Methyl 5-bromo-2-hydroxy-4-methoxybenzoate | ESD-897705-100MG |
Cas.: 39503-52-1 | Purity: ≥95% | Methyl 5-bromo-2-hydroxy-4-methoxybenzoate | ESD-897705-250MG |
Cas.: 39503-52-1 | Purity: ≥95% | Methyl 5-bromo-2-hydroxy-4-methoxybenzoate | ESD-897705-1G |
Cas.: 99451-55-5 | Purity: 97% | 8-Bromo-5-(methylthio)-[1,2,4]triazolo[4,3-c]pyrimidine | ESD-897706-100MG |
Cas.: 99451-55-5 | Purity: 97% | 8-Bromo-5-(methylthio)-[1,2,4]triazolo[4,3-c]pyrimidine | ESD-897706-250MG |
Cas.: 99451-55-5 | Purity: 97% | 8-Bromo-5-(methylthio)-[1,2,4]triazolo[4,3-c]pyrimidine | ESD-897706-1G |
Cas.: 101580-70-5 | Purity: 95% | 1,2-Dibromo-4-methyl-5-nitrobenzene | ESD-897707-100MG |
Cas.: 101580-70-5 | Purity: 95% | 1,2-Dibromo-4-methyl-5-nitrobenzene | ESD-897707-250MG |
Cas.: 101580-70-5 | Purity: 95% | 1,2-Dibromo-4-methyl-5-nitrobenzene | ESD-897707-1G |
Cas.: 945907-32-4 | Purity: 97% | 1-(3-Bromo-4-iodophenyl)ethanone | ESD-897708-100MG |
Cas.: 945907-32-4 | Purity: 97% | 1-(3-Bromo-4-iodophenyl)ethanone | ESD-897708-250MG |
Cas.: 945907-32-4 | Purity: 97% | 1-(3-Bromo-4-iodophenyl)ethanone | ESD-897708-1G |
Cas.: 84892-43-3 | Purity: ≥95% | 4-(4-Bromophenyl)cyclohexanone | ESD-897709-100MG |
Cas.: 84892-43-3 | Purity: ≥95% | 4-(4-Bromophenyl)cyclohexanone | ESD-897709-250MG |
Cas.: 84892-43-3 | Purity: ≥95% | 4-(4-Bromophenyl)cyclohexanone | ESD-897709-1G |
Cas.: 905807-66-1 | Purity: 97% | Methyl 6-(benzyloxy)-4-chloroquinoline-2-carboxylate | ESD-897710-100MG |
Cas.: 905807-66-1 | Purity: 97% | Methyl 6-(benzyloxy)-4-chloroquinoline-2-carboxylate | ESD-897710-250MG |
Cas.: 905807-66-1 | Purity: 97% | Methyl 6-(benzyloxy)-4-chloroquinoline-2-carboxylate | ESD-897710-1G |
Cas.: 230295-12-2 | Purity: ≥95% | 3-(2,3,6-Trifluorophenyl)acrylic acid | ESD-897711-100MG |
Cas.: 230295-12-2 | Purity: ≥95% | 3-(2,3,6-Trifluorophenyl)acrylic acid | ESD-897711-250MG |
Cas.: 230295-12-2 | Purity: ≥95% | 3-(2,3,6-Trifluorophenyl)acrylic acid | ESD-897711-1G |
Cas.: 59223-23-3 | Purity: 97% | 5-Hydroxy-1,2,3,3-tetramethyl-3H-indol-1-ium iodide | ESD-897712-100MG |
Cas.: 59223-23-3 | Purity: 97% | 5-Hydroxy-1,2,3,3-tetramethyl-3H-indol-1-ium iodide | ESD-897712-250MG |
Cas.: 59223-23-3 | Purity: 97% | 5-Hydroxy-1,2,3,3-tetramethyl-3H-indol-1-ium iodide | ESD-897712-1G |
Cas.: 890094-38-9 | Purity: 97% | 2-Chloro-N-isopropyl-5-nitropyrimidin-4-amine | ESD-897713-100MG |
Cas.: 890094-38-9 | Purity: 97% | 2-Chloro-N-isopropyl-5-nitropyrimidin-4-amine | ESD-897713-250MG |
Cas.: 890094-38-9 | Purity: 97% | 2-Chloro-N-isopropyl-5-nitropyrimidin-4-amine | ESD-897713-1G |
Cas.: 93465-26-0 | Purity: ≥95% | 2′-Methoxy-[1,1′-biphenyl]-2-carbaldehyde | ESD-897714-100MG |
Cas.: 93465-26-0 | Purity: ≥95% | 2′-Methoxy-[1,1′-biphenyl]-2-carbaldehyde | ESD-897714-250MG |
Cas.: 93465-26-0 | Purity: ≥95% | 2′-Methoxy-[1,1′-biphenyl]-2-carbaldehyde | ESD-897714-1G |
Cas.: 53965-69-8 | Purity: 97% | 4-Bromo-2,3,5,6-tetramethylaniline | ESD-897715-100MG |
Cas.: 53965-69-8 | Purity: 97% | 4-Bromo-2,3,5,6-tetramethylaniline | ESD-897715-250MG |
Cas.: 53965-69-8 | Purity: 97% | 4-Bromo-2,3,5,6-tetramethylaniline | ESD-897715-1G |
Cas.: 71845-20-0 | Purity: 97% | 4-Phenethylaniline hydrochloride | ESD-897716-100MG |
Cas.: 71845-20-0 | Purity: 97% | 4-Phenethylaniline hydrochloride | ESD-897716-250MG |
Cas.: 71845-20-0 | Purity: 97% | 4-Phenethylaniline hydrochloride | ESD-897716-1G |
Cas.: 785777-90-4 | Purity: ≥95% | 5-Bromo-4-(trifluoromethyl)pyrimidin-2(1H)-one | ESD-897718-100MG |
Cas.: 785777-90-4 | Purity: ≥95% | 5-Bromo-4-(trifluoromethyl)pyrimidin-2(1H)-one | ESD-897718-250MG |
Cas.: 785777-90-4 | Purity: ≥95% | 5-Bromo-4-(trifluoromethyl)pyrimidin-2(1H)-one | ESD-897718-1G |
Cas.: 1263045-28-8 | Purity: 97% | (R)-Benzyl tert-butyl (3-hydroxypropane-1,2-diyl)dicarbamate | ESD-897719-100MG |
Cas.: 1263045-28-8 | Purity: 97% | (R)-Benzyl tert-butyl (3-hydroxypropane-1,2-diyl)dicarbamate | ESD-897719-250MG |
Cas.: 1263045-28-8 | Purity: 97% | (R)-Benzyl tert-butyl (3-hydroxypropane-1,2-diyl)dicarbamate | ESD-897719-1G |
Cas.: 319442-19-8 | Purity: 98% | Ethyl 4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-2-carboxylate | ESD-897720-100MG |
Cas.: 319442-19-8 | Purity: 98% | Ethyl 4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-2-carboxylate | ESD-897720-250MG |
Cas.: 319442-19-8 | Purity: 98% | Ethyl 4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-2-carboxylate | ESD-897720-1G |
Cas.: 918524-07-9 | Purity: 97% | Benzyl (2,4-difluoro-3-formylphenyl)carbamate | ESD-897721-100MG |
Cas.: 918524-07-9 | Purity: 97% | Benzyl (2,4-difluoro-3-formylphenyl)carbamate | ESD-897721-250MG |
Cas.: 1820598-87-5 | Purity: 97% | Benzyl ((2S,3R)-3-hydroxy-1-oxo-1-(((tetrahydro-2H-pyran-2-yl)oxy)amino)butan-2-yl)carbamate | ESD-897722-100MG |
Cas.: 1820598-87-5 | Purity: 97% | Benzyl ((2S,3R)-3-hydroxy-1-oxo-1-(((tetrahydro-2H-pyran-2-yl)oxy)amino)butan-2-yl)carbamate | ESD-897722-250MG |
Cas.: 1820598-87-5 | Purity: 97% | Benzyl ((2S,3R)-3-hydroxy-1-oxo-1-(((tetrahydro-2H-pyran-2-yl)oxy)amino)butan-2-yl)carbamate | ESD-897722-1G |
Cas.: 887591-64-2 | Purity: ≥95% | 3-(3-Nitrophenyl)isoxazol-5-amine | ESD-897723-100MG |
Cas.: 887591-64-2 | Purity: ≥95% | 3-(3-Nitrophenyl)isoxazol-5-amine | ESD-897723-250MG |
Cas.: 887591-64-2 | Purity: ≥95% | 3-(3-Nitrophenyl)isoxazol-5-amine | ESD-897723-1G |
Cas.: 120277-01-2 | Purity: 97% | 4-(2-Bromoethyl)pyridine hydrobromide | ESD-897724-100MG |
Cas.: 120277-01-2 | Purity: 97% | 4-(2-Bromoethyl)pyridine hydrobromide | ESD-897724-250MG |
Cas.: 120277-01-2 | Purity: 97% | 4-(2-Bromoethyl)pyridine hydrobromide | ESD-897724-1G |
Cas.: 200353-65-7 | Purity: 97% | (S)-2-Amino-3-(tert-butylthio)propanoic acid hydrochloride | ESD-897725-100MG |
Cas.: 200353-65-7 | Purity: 97% | (S)-2-Amino-3-(tert-butylthio)propanoic acid hydrochloride | ESD-897725-250MG |
Cas.: 200353-65-7 | Purity: 97% | (S)-2-Amino-3-(tert-butylthio)propanoic acid hydrochloride | ESD-897725-1G |
Cas.: 932-93-4 | Purity: 95% | Thiophene-2,4-dicarbaldehyde | ESD-897726-100MG |
Cas.: 932-93-4 | Purity: 95% | Thiophene-2,4-dicarbaldehyde | ESD-897726-250MG |
Cas.: 932-93-4 | Purity: 95% | Thiophene-2,4-dicarbaldehyde | ESD-897726-1G |
Cas.: 97745-69-2 | Purity: ≥95% | (S)-5-(1,3-Bis(tert-butoxycarbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid | ESD-897727-100MG |
Cas.: 97745-69-2 | Purity: ≥95% | (S)-5-(1,3-Bis(tert-butoxycarbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid | ESD-897727-250MG |
Cas.: 97745-69-2 | Purity: ≥95% | (S)-5-(1,3-Bis(tert-butoxycarbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid | ESD-897727-1G |
Cas.: 218796-15-7 | Purity: ≥95% | N-(2-Chloro-6-fluoro-3-nitrophenyl)acetamide | ESD-897728-100MG |
Cas.: 218796-15-7 | Purity: ≥95% | N-(2-Chloro-6-fluoro-3-nitrophenyl)acetamide | ESD-897728-250MG |
Cas.: 218796-15-7 | Purity: ≥95% | N-(2-Chloro-6-fluoro-3-nitrophenyl)acetamide | ESD-897728-1G |
Cas.: 911297-02-4 | Purity: 97% | 4-(Boc-amino)-3-fluoro-phenol | ESD-897729-100MG |
Cas.: 911297-02-4 | Purity: 97% | 4-(Boc-amino)-3-fluoro-phenol | ESD-897729-250MG |
Cas.: 911297-02-4 | Purity: 97% | 4-(Boc-amino)-3-fluoro-phenol | ESD-897729-1G |
Cas.: 101498-55-9 | Purity: 95% | 1-(5,6,7,8-Tetrahydronaphthalen-2-yl)pentan-1-one | ESD-897730-100MG |
Cas.: 101498-55-9 | Purity: 95% | 1-(5,6,7,8-Tetrahydronaphthalen-2-yl)pentan-1-one | ESD-897730-250MG |
Cas.: 101498-55-9 | Purity: 95% | 1-(5,6,7,8-Tetrahydronaphthalen-2-yl)pentan-1-one | ESD-897730-1G |
Cas.: 22633-57-4 | Purity: 97% | 4-(2,2-Dimethoxyethyl)morpholine | ESD-897731-100MG |
Cas.: 22633-57-4 | Purity: 97% | 4-(2,2-Dimethoxyethyl)morpholine | ESD-897731-250MG |
Cas.: 22633-57-4 | Purity: 97% | 4-(2,2-Dimethoxyethyl)morpholine | ESD-897731-1G |
Cas.: 22245-84-7 | Purity: ≥95% | 6-(Trifluoromethyl)picolinamide | ESD-897732-100MG |
Cas.: 22245-84-7 | Purity: ≥95% | 6-(Trifluoromethyl)picolinamide | ESD-897732-250MG |
Cas.: 22245-84-7 | Purity: ≥95% | 6-(Trifluoromethyl)picolinamide | ESD-897732-1G |
Cas.: 82711-97-5 | Purity: 97% | 5-Fluoro-2-nitrobenzene-1-sulfonyl chloride | ESD-897733-100MG |
Cas.: 82711-97-5 | Purity: 97% | 5-Fluoro-2-nitrobenzene-1-sulfonyl chloride | ESD-897733-250MG |
Cas.: 82711-97-5 | Purity: 97% | 5-Fluoro-2-nitrobenzene-1-sulfonyl chloride | ESD-897733-1G |
Cas.: 823782-74-7 | Purity: 97% | 4-(2-(Trifluoromethyl)phenoxy)piperidine hydrochloride | ESD-897734-100MG |
Cas.: 823782-74-7 | Purity: 97% | 4-(2-(Trifluoromethyl)phenoxy)piperidine hydrochloride | ESD-897734-250MG |
Cas.: 823782-74-7 | Purity: 97% | 4-(2-(Trifluoromethyl)phenoxy)piperidine hydrochloride | ESD-897734-1G |
Cas.: 1231747-49-1 | Purity: 97% | 2-(Bromomethyl)-1-fluoro-3-iodobenzene | ESD-897735-100MG |
Cas.: 1231747-49-1 | Purity: 97% | 2-(Bromomethyl)-1-fluoro-3-iodobenzene | ESD-897735-250MG |
Cas.: 1231747-49-1 | Purity: 97% | 2-(Bromomethyl)-1-fluoro-3-iodobenzene | ESD-897735-1G |
Cas.: 888214-21-9 | Purity: 95% | 2-Bromo-1-iodo-3-methylbenzene | ESD-897736-100MG |
Cas.: 888214-21-9 | Purity: 95% | 2-Bromo-1-iodo-3-methylbenzene | ESD-897736-250MG |
Cas.: 888214-21-9 | Purity: 95% | 2-Bromo-1-iodo-3-methylbenzene | ESD-897736-1G |
Cas.: 379228-26-9 | Purity: ≥95% | Methyl 2-amino-4,6-dimethoxybenzoate | ESD-897737-100MG |
Cas.: 379228-26-9 | Purity: ≥95% | Methyl 2-amino-4,6-dimethoxybenzoate | ESD-897737-250MG |
Cas.: 379228-26-9 | Purity: ≥95% | Methyl 2-amino-4,6-dimethoxybenzoate | ESD-897737-1G |
Cas.: 1783512-25-3 | Purity: 97% | 5-Chloro-2,3-difluorobenzaldehyde | ESD-897738-100MG |
Cas.: 1783512-25-3 | Purity: 97% | 5-Chloro-2,3-difluorobenzaldehyde | ESD-897738-250MG |
Cas.: 1783512-25-3 | Purity: 97% | 5-Chloro-2,3-difluorobenzaldehyde | ESD-897738-1G |
Cas.: 187669-60-9 | Purity: 97% | 1-(4-(Methylsulfonyl)phenyl)piperazine | ESD-897739-100MG |
Cas.: 187669-60-9 | Purity: 97% | 1-(4-(Methylsulfonyl)phenyl)piperazine | ESD-897739-250MG |
Cas.: 187669-60-9 | Purity: 97% | 1-(4-(Methylsulfonyl)phenyl)piperazine | ESD-897739-1G |
Cas.: 5769-35-7 | Purity: ≥95% | 1,4-Ditosyl-1,4-diazepane | ESD-897740-100MG |
Cas.: 5769-35-7 | Purity: ≥95% | 1,4-Ditosyl-1,4-diazepane | ESD-897740-250MG |
Cas.: 5769-35-7 | Purity: ≥95% | 1,4-Ditosyl-1,4-diazepane | ESD-897740-1G |
Cas.: 57229-36-4 | Purity: 97% | 5,6-Dimethylpyrazin-2(1H)-one | ESD-897741-100MG |
Cas.: 57229-36-4 | Purity: 97% | 5,6-Dimethylpyrazin-2(1H)-one | ESD-897741-250MG |
Cas.: 57229-36-4 | Purity: 97% | 5,6-Dimethylpyrazin-2(1H)-one | ESD-897741-1G |
Cas.: 357287-88-8 | Purity: 97% | (4-Methylpyridin-2-yl)methanamine dihydrochloride | ESD-897742-100MG |
Cas.: 357287-88-8 | Purity: 97% | (4-Methylpyridin-2-yl)methanamine dihydrochloride | ESD-897742-250MG |
Cas.: 357287-88-8 | Purity: 97% | (4-Methylpyridin-2-yl)methanamine dihydrochloride | ESD-897742-1G |
Cas.: 1198283-55-4 | Purity: 98% | Imidazo[1,2-a]pyridine-5-carboxylic acid hydrochloride | ESD-897743-100MG |
Cas.: 1198283-55-4 | Purity: 98% | Imidazo[1,2-a]pyridine-5-carboxylic acid hydrochloride | ESD-897743-250MG |
Cas.: 1198283-55-4 | Purity: 98% | Imidazo[1,2-a]pyridine-5-carboxylic acid hydrochloride | ESD-897743-1G |
Cas.: 745011-75-0 | Purity: 97% | Boc-D-HoSer-OH | ESD-897744-100MG |
Cas.: 745011-75-0 | Purity: 97% | Boc-D-HoSer-OH | ESD-897744-250MG |
Cas.: 745011-75-0 | Purity: 97% | Boc-D-HoSer-OH | ESD-897744-1G |
Cas.: 2426-22-4 | Purity: 97% | N,N-Diisopropyl-2-(5-methoxy-1H-indol-3-yl)-2-oxoacetamide | ESD-897745-100MG |
Cas.: 2426-22-4 | Purity: 97% | N,N-Diisopropyl-2-(5-methoxy-1H-indol-3-yl)-2-oxoacetamide | ESD-897745-250MG |
Cas.: 2426-22-4 | Purity: 97% | N,N-Diisopropyl-2-(5-methoxy-1H-indol-3-yl)-2-oxoacetamide | ESD-897745-1G |
Cas.: 1000341-69-4 | Purity: ≥95% | 3,6-Dibromo-1H-pyrrolo[3,2-c]pyridine | ESD-897746-100MG |
Cas.: 1000341-69-4 | Purity: ≥95% | 3,6-Dibromo-1H-pyrrolo[3,2-c]pyridine | ESD-897746-250MG |
Cas.: 1000341-69-4 | Purity: ≥95% | 3,6-Dibromo-1H-pyrrolo[3,2-c]pyridine | ESD-897746-1G |
Cas.: 27783-55-7 | Purity: 98% | 5-Iodo-2-nitrophenol | ESD-897747-100MG |
Cas.: 27783-55-7 | Purity: 98% | 5-Iodo-2-nitrophenol | ESD-897747-250MG |
Cas.: 27783-55-7 | Purity: 98% | 5-Iodo-2-nitrophenol | ESD-897747-1G |
Cas.: 1229012-68-3 | Purity: ≥95% | 2,9-Dichloro-4,7-diphenyl-1,10-phenanthroline | ESD-897748-100MG |
Cas.: 1229012-68-3 | Purity: ≥95% | 2,9-Dichloro-4,7-diphenyl-1,10-phenanthroline | ESD-897748-250MG |
Cas.: 1229012-68-3 | Purity: ≥95% | 2,9-Dichloro-4,7-diphenyl-1,10-phenanthroline | ESD-897748-1G |
Cas.: 1256811-82-1 | Purity: ≥95% | 2-Chloro-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-897749-100MG |
Cas.: 1256811-82-1 | Purity: ≥95% | 2-Chloro-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-897749-250MG |
Cas.: 1256811-82-1 | Purity: ≥95% | 2-Chloro-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-897749-1G |
Cas.: 107583-37-9 | Purity: ≥95% | 5,6,7-Trifluoroindoline-2,3-dione | ESD-897750-100MG |
Cas.: 107583-37-9 | Purity: ≥95% | 5,6,7-Trifluoroindoline-2,3-dione | ESD-897750-250MG |
Cas.: 107583-37-9 | Purity: ≥95% | 5,6,7-Trifluoroindoline-2,3-dione | ESD-897750-1G |
Cas.: 79276-23-6 | Purity: 97% | (2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxoperazine-1-carboxamido)butanoic acid | ESD-897751-100MG |
Cas.: 79276-23-6 | Purity: 97% | (2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxoperazine-1-carboxamido)butanoic acid | ESD-897751-250MG |
Cas.: 79276-23-6 | Purity: 97% | (2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxoperazine-1-carboxamido)butanoic acid | ESD-897751-1G |
Cas.: 380610-92-4 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate | ESD-897752-100MG |
Cas.: 380610-92-4 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate | ESD-897752-250MG |
Cas.: 380610-92-4 | Purity: 97% | (R)-tert-Butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate | ESD-897752-1G |
Cas.: 1333316-35-0 | Purity: 97% | 2,7-Dibromo-9,9-dimethyl-9,10-dihydroacridine | ESD-897753-100MG |
Cas.: 1333316-35-0 | Purity: 97% | 2,7-Dibromo-9,9-dimethyl-9,10-dihydroacridine | ESD-897753-250MG |
Cas.: 1333316-35-0 | Purity: 97% | 2,7-Dibromo-9,9-dimethyl-9,10-dihydroacridine | ESD-897753-1G |
Cas.: 90562-34-8 | Purity: 97% | 7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-897754-100MG |
Cas.: 90562-34-8 | Purity: 97% | 7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-897754-250MG |
Cas.: 90562-34-8 | Purity: 97% | 7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-897754-1G |
Cas.: 1615-42-5 | Purity: 96% | 1-Methyl-5-nitro-1H-imidazole-2-carbonitrile | ESD-897755-100MG |
Cas.: 1615-42-5 | Purity: 96% | 1-Methyl-5-nitro-1H-imidazole-2-carbonitrile | ESD-897755-250MG |
Cas.: 1615-42-5 | Purity: 96% | 1-Methyl-5-nitro-1H-imidazole-2-carbonitrile | ESD-897755-1G |
Cas.: 1214741-14-6 | Purity: 97% | (S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate | ESD-897756-100MG |
Cas.: 1214741-14-6 | Purity: 97% | (S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate | ESD-897756-250MG |
Cas.: 1214741-14-6 | Purity: 97% | (S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate | ESD-897756-1G |
Cas.: 957513-70-1 | Purity: ≥95% | 5-(4-Chlorophenyl)-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-897757-100MG |
Cas.: 957513-70-1 | Purity: ≥95% | 5-(4-Chlorophenyl)-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-897757-250MG |
Cas.: 957513-70-1 | Purity: ≥95% | 5-(4-Chlorophenyl)-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-897757-1G |
Cas.: 269411-71-4 | Purity: 95% | 3-Amino-5-methoxybenzonitrile | ESD-897758-100MG |
Cas.: 269411-71-4 | Purity: 95% | 3-Amino-5-methoxybenzonitrile | ESD-897758-250MG |
Cas.: 269411-71-4 | Purity: 95% | 3-Amino-5-methoxybenzonitrile | ESD-897758-1G |
Cas.: 1402149-98-7 | Purity: 95% | Ethyl 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate oxalate | ESD-897759-100MG |
Cas.: 1402149-98-7 | Purity: 95% | Ethyl 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate oxalate | ESD-897759-250MG |
Cas.: 1402149-98-7 | Purity: 95% | Ethyl 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate oxalate | ESD-897759-1G |
Cas.: 854625-59-5 | Purity: 97% | 2-(3-Iodopropyl)thiophene | ESD-897760-100MG |
Cas.: 854625-59-5 | Purity: 97% | 2-(3-Iodopropyl)thiophene | ESD-897760-250MG |
Cas.: 854625-59-5 | Purity: 97% | 2-(3-Iodopropyl)thiophene | ESD-897760-1G |
Cas.: 17582-89-7 | Purity: 95% | 1,7-Dimethyl-1H-indazole | ESD-897761-100MG |
Cas.: 17582-89-7 | Purity: 95% | 1,7-Dimethyl-1H-indazole | ESD-897761-250MG |
Cas.: 17582-89-7 | Purity: 95% | 1,7-Dimethyl-1H-indazole | ESD-897761-1G |
Cas.: 868636-72-0 | Purity: ≥95% | 5-Fluoro-N-methylpyridin-2-amine | ESD-897762-100MG |
Cas.: 868636-72-0 | Purity: ≥95% | 5-Fluoro-N-methylpyridin-2-amine | ESD-897762-250MG |
Cas.: 868636-72-0 | Purity: ≥95% | 5-Fluoro-N-methylpyridin-2-amine | ESD-897762-1G |
Cas.: 1321963-79-4 | Purity: 95% | 2-(Methoxymethoxy)-4-(trifluoromethoxy)benzaldehyde | ESD-897763-100MG |
Cas.: 1321963-79-4 | Purity: 95% | 2-(Methoxymethoxy)-4-(trifluoromethoxy)benzaldehyde | ESD-897763-250MG |
Cas.: 1321963-79-4 | Purity: 95% | 2-(Methoxymethoxy)-4-(trifluoromethoxy)benzaldehyde | ESD-897763-1G |
Cas.: 1451215-02-3 | Purity: 95% | Imidazo[1,2-a]pyrazin-8(7H)-one hydrobromide | ESD-897764-100MG |
Cas.: 1451215-02-3 | Purity: 95% | Imidazo[1,2-a]pyrazin-8(7H)-one hydrobromide | ESD-897764-250MG |
Cas.: 1451215-02-3 | Purity: 95% | Imidazo[1,2-a]pyrazin-8(7H)-one hydrobromide | ESD-897764-1G |
Cas.: 1160573-63-6 | Purity: 97% | 1-Bromo-4-iodo-5-methyl-2-nitrobenzene | ESD-897765-100MG |
Cas.: 1160573-63-6 | Purity: 97% | 1-Bromo-4-iodo-5-methyl-2-nitrobenzene | ESD-897765-250MG |
Cas.: 1160573-63-6 | Purity: 97% | 1-Bromo-4-iodo-5-methyl-2-nitrobenzene | ESD-897765-1G |
Cas.: 286377-20-6 | Purity: 97% | Methyl 4-amino-5-bromo-2-hydroxybenzoate | ESD-897766-100MG |
Cas.: 286377-20-6 | Purity: 97% | Methyl 4-amino-5-bromo-2-hydroxybenzoate | ESD-897766-250MG |
Cas.: 286377-20-6 | Purity: 97% | Methyl 4-amino-5-bromo-2-hydroxybenzoate | ESD-897766-1G |
Cas.: 1147107-15-0 | Purity: 95% | Ethyl 2-amino-4,6-difluorobenzoate | ESD-897767-100MG |
Cas.: 1147107-15-0 | Purity: 95% | Ethyl 2-amino-4,6-difluorobenzoate | ESD-897767-250MG |
Cas.: 1147107-15-0 | Purity: 95% | Ethyl 2-amino-4,6-difluorobenzoate | ESD-897767-1G |
Cas.: 156817-73-1 | Purity: 97% | 2,3-Dibromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-897768-100MG |
Cas.: 156817-73-1 | Purity: 97% | 2,3-Dibromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-897768-250MG |
Cas.: 156817-73-1 | Purity: 97% | 2,3-Dibromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine | ESD-897768-1G |
Cas.: 1634647-80-5 | Purity: 97% | (6-Fluoroimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone | ESD-897769-100MG |
Cas.: 1634647-80-5 | Purity: 97% | (6-Fluoroimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone | ESD-897769-250MG |
Cas.: 1634647-80-5 | Purity: 97% | (6-Fluoroimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone | ESD-897769-1G |
Cas.: 36077-41-5 | Purity: 95% | H-Leu-Ile-OH | ESD-897770-100MG |
Cas.: 36077-41-5 | Purity: 95% | H-Leu-Ile-OH | ESD-897770-250MG |
Cas.: 36077-41-5 | Purity: 95% | H-Leu-Ile-OH | ESD-897770-1G |
Cas.: 1379337-73-1 | Purity: 97% | 2,4-Dichloro-6-nitropyridine | ESD-897771-100MG |
Cas.: 1379337-73-1 | Purity: 97% | 2,4-Dichloro-6-nitropyridine | ESD-897771-250MG |
Cas.: 1379337-73-1 | Purity: 97% | 2,4-Dichloro-6-nitropyridine | ESD-897771-1G |
Cas.: 74840-38-3 | Purity: ≥95% | Ethyl 5-bromo-2-(methylthio)pyrimidine-4-carboxylate | ESD-897772-100MG |
Cas.: 74840-38-3 | Purity: ≥95% | Ethyl 5-bromo-2-(methylthio)pyrimidine-4-carboxylate | ESD-897772-250MG |
Cas.: 74840-38-3 | Purity: ≥95% | Ethyl 5-bromo-2-(methylthio)pyrimidine-4-carboxylate | ESD-897772-1G |
Cas.: 198904-84-6 | Purity: 97% | tert-Butyl 2-(4-(pyridin-2-yl)benzylidene)hydrazinecarboxylate | ESD-897773-100MG |
Cas.: 198904-84-6 | Purity: 97% | tert-Butyl 2-(4-(pyridin-2-yl)benzylidene)hydrazinecarboxylate | ESD-897773-250MG |
Cas.: 198904-84-6 | Purity: 97% | tert-Butyl 2-(4-(pyridin-2-yl)benzylidene)hydrazinecarboxylate | ESD-897773-1G |
Cas.: 1510-25-4 | Purity: 97% | 3-Isothiocyanato-1,1′-biphenyl | ESD-897774-100MG |
Cas.: 1510-25-4 | Purity: 97% | 3-Isothiocyanato-1,1′-biphenyl | ESD-897774-250MG |
Cas.: 1510-25-4 | Purity: 97% | 3-Isothiocyanato-1,1′-biphenyl | ESD-897774-1G |
Cas.: 36556-33-9 | Purity: 97% | 1,3,5-Trichloro-2-fluorobenzene | ESD-897775-100MG |
Cas.: 36556-33-9 | Purity: 97% | 1,3,5-Trichloro-2-fluorobenzene | ESD-897775-250MG |
Cas.: 36556-33-9 | Purity: 97% | 1,3,5-Trichloro-2-fluorobenzene | ESD-897775-1G |
Cas.: 4071-22-1 | Purity: ≥95% | 2,2,4-Trimethyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-897776-100MG |
Cas.: 4071-22-1 | Purity: ≥95% | 2,2,4-Trimethyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-897776-250MG |
Cas.: 4071-22-1 | Purity: ≥95% | 2,2,4-Trimethyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-897776-1G |
Cas.: 210035-02-2 | Purity: 97% | Imidazo[1,2-a]pyridin-3-yl(phenyl)methanone | ESD-897777-100MG |
Cas.: 210035-02-2 | Purity: 97% | Imidazo[1,2-a]pyridin-3-yl(phenyl)methanone | ESD-897777-250MG |
Cas.: 210035-02-2 | Purity: 97% | Imidazo[1,2-a]pyridin-3-yl(phenyl)methanone | ESD-897777-1G |
Cas.: 1211589-24-0 | Purity: 95% | Methyl 4-amino-2-ethylbenzoate | ESD-897778-100MG |
Cas.: 1211589-24-0 | Purity: 95% | Methyl 4-amino-2-ethylbenzoate | ESD-897778-250MG |
Cas.: 1211589-24-0 | Purity: 95% | Methyl 4-amino-2-ethylbenzoate | ESD-897778-1G |
Cas.: 3993-79-1 | Purity: 97% | 2-Amino-5-iodopyrimidin-4(1H)-one | ESD-897779-100MG |
Cas.: 3993-79-1 | Purity: 97% | 2-Amino-5-iodopyrimidin-4(1H)-one | ESD-897779-250MG |
Cas.: 3993-79-1 | Purity: 97% | 2-Amino-5-iodopyrimidin-4(1H)-one | ESD-897779-1G |
Cas.: 174959-54-7 | Purity: ≥95% | tert-Butyl 4-aminobenzylcarbamate hydrochloride | ESD-897780-100MG |
Cas.: 174959-54-7 | Purity: ≥95% | tert-Butyl 4-aminobenzylcarbamate hydrochloride | ESD-897780-250MG |
Cas.: 174959-54-7 | Purity: ≥95% | tert-Butyl 4-aminobenzylcarbamate hydrochloride | ESD-897780-1G |
Cas.: 53316-51-1 | Purity: ≥95% | 4,5-Dimethyl-1H-imidazole hydrochloride | ESD-897781-100MG |
Cas.: 53316-51-1 | Purity: ≥95% | 4,5-Dimethyl-1H-imidazole hydrochloride | ESD-897781-250MG |
Cas.: 53316-51-1 | Purity: ≥95% | 4,5-Dimethyl-1H-imidazole hydrochloride | ESD-897781-1G |
Cas.: 32998-03-1 | Purity: ≥95% | 2,6-Dichloro-N-methylpyrimidin-4-amine | ESD-897782-100MG |
Cas.: 32998-03-1 | Purity: ≥95% | 2,6-Dichloro-N-methylpyrimidin-4-amine | ESD-897782-250MG |
Cas.: 32998-03-1 | Purity: ≥95% | 2,6-Dichloro-N-methylpyrimidin-4-amine | ESD-897782-1G |
Cas.: 21054-72-8 | Purity: 97% | 3-Benzyl-1-dodecyl-2-methyl-1H-imidazol-3-ium chloride | ESD-897783-100MG |
Cas.: 21054-72-8 | Purity: 97% | 3-Benzyl-1-dodecyl-2-methyl-1H-imidazol-3-ium chloride | ESD-897783-250MG |
Cas.: 21054-72-8 | Purity: 97% | 3-Benzyl-1-dodecyl-2-methyl-1H-imidazol-3-ium chloride | ESD-897783-1G |
Cas.: 201937-22-6 | Purity: ≥95% | 6-Methoxynicotimidamide hydrochloride | ESD-897784-100MG |
Cas.: 201937-22-6 | Purity: ≥95% | 6-Methoxynicotimidamide hydrochloride | ESD-897784-250MG |
Cas.: 201937-22-6 | Purity: ≥95% | 6-Methoxynicotimidamide hydrochloride | ESD-897784-1G |
Cas.: 1346691-32-4 | Purity: ≥95% | 5-(Benzyloxy)-3-chloropyridazine | ESD-897785-100MG |
Cas.: 1346691-32-4 | Purity: ≥95% | 5-(Benzyloxy)-3-chloropyridazine | ESD-897785-250MG |
Cas.: 1346691-32-4 | Purity: ≥95% | 5-(Benzyloxy)-3-chloropyridazine | ESD-897785-1G |
Cas.: 38067-29-7 | Purity: 97% | Ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)thiazole-5-carboxylate | ESD-897786-100MG |
Cas.: 38067-29-7 | Purity: 97% | Ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)thiazole-5-carboxylate | ESD-897786-250MG |
Cas.: 38067-29-7 | Purity: 97% | Ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)thiazole-5-carboxylate | ESD-897786-1G |
Cas.: 5985-89-7 | Purity: ≥95% | 4-Amino-2-hydroxybenzamide | ESD-897787-100MG |
Cas.: 5985-89-7 | Purity: ≥95% | 4-Amino-2-hydroxybenzamide | ESD-897787-250MG |
Cas.: 5985-89-7 | Purity: ≥95% | 4-Amino-2-hydroxybenzamide | ESD-897787-1G |
Cas.: 149436-41-9 | Purity: ≥95% | N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride | ESD-897788-100MG |
Cas.: 149436-41-9 | Purity: ≥95% | N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride | ESD-897788-250MG |
Cas.: 149436-41-9 | Purity: ≥95% | N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride | ESD-897788-1G |
Cas.: 98027-63-5 | Purity: 97% | 5-Sulfamoylfuran-2-carboxylic acid | ESD-897789-100MG |
Cas.: 98027-63-5 | Purity: 97% | 5-Sulfamoylfuran-2-carboxylic acid | ESD-897789-250MG |
Cas.: 98027-63-5 | Purity: 97% | 5-Sulfamoylfuran-2-carboxylic acid | ESD-897789-1G |
Cas.: 1065483-60-4 | Purity: ≥95% | 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole | ESD-897790-100MG |
Cas.: 1065483-60-4 | Purity: ≥95% | 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole | ESD-897790-250MG |
Cas.: 1065483-60-4 | Purity: ≥95% | 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole | ESD-897790-1G |
Cas.: 1250663-38-7 | Purity: ≥95% | Methyl 3-amino-4,5-dichlorobenzoate | ESD-897791-100MG |
Cas.: 1250663-38-7 | Purity: ≥95% | Methyl 3-amino-4,5-dichlorobenzoate | ESD-897791-250MG |
Cas.: 1250663-38-7 | Purity: ≥95% | Methyl 3-amino-4,5-dichlorobenzoate | ESD-897791-1G |
Cas.: 590424-04-7 | Purity: 97% | tert-Butyl 4-((2-(diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-897792-100MG |
Cas.: 590424-04-7 | Purity: 97% | tert-Butyl 4-((2-(diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-897792-250MG |
Cas.: 590424-04-7 | Purity: 97% | tert-Butyl 4-((2-(diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-897792-1G |
Cas.: 244014-85-5 | Purity: ≥95% | Methyl 7-aminothieno[2,3-b]pyrazine-6-carboxylate | ESD-897793-100MG |
Cas.: 244014-85-5 | Purity: ≥95% | Methyl 7-aminothieno[2,3-b]pyrazine-6-carboxylate | ESD-897793-250MG |
Cas.: 244014-85-5 | Purity: ≥95% | Methyl 7-aminothieno[2,3-b]pyrazine-6-carboxylate | ESD-897793-1G |
Cas.: 1260013-03-3 | Purity: 97% | 4-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-897794-100MG |
Cas.: 1260013-03-3 | Purity: 97% | 4-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-897794-250MG |
Cas.: 1260013-03-3 | Purity: 97% | 4-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-897794-1G |
Cas.: 1459-50-3 | Purity: 97% | N-(4-(Adamantan-1-yl)phenyl)acetamide | ESD-897795-100MG |
Cas.: 1459-50-3 | Purity: 97% | N-(4-(Adamantan-1-yl)phenyl)acetamide | ESD-897795-250MG |
Cas.: 1459-50-3 | Purity: 97% | N-(4-(Adamantan-1-yl)phenyl)acetamide | ESD-897795-1G |
Cas.: 5965-53-7 | Purity: ≥95% | Diethyl 2-oxopentanedioate | ESD-897796-100MG |
Cas.: 5965-53-7 | Purity: ≥95% | Diethyl 2-oxopentanedioate | ESD-897796-250MG |
Cas.: 5965-53-7 | Purity: ≥95% | Diethyl 2-oxopentanedioate | ESD-897796-1G |
Cas.: 1708974-12-2 | Purity: ≥95% | 4-Fluoro-5-iodopyridin-2-amine | ESD-897797-100MG |
Cas.: 1708974-12-2 | Purity: ≥95% | 4-Fluoro-5-iodopyridin-2-amine | ESD-897797-250MG |
Cas.: 1708974-12-2 | Purity: ≥95% | 4-Fluoro-5-iodopyridin-2-amine | ESD-897797-1G |
Cas.: 63615-95-2 | Purity: ≥95% | 5-Bromo-N-phenylthiazol-2-amine | ESD-897798-100MG |
Cas.: 63615-95-2 | Purity: ≥95% | 5-Bromo-N-phenylthiazol-2-amine | ESD-897798-250MG |
Cas.: 63615-95-2 | Purity: ≥95% | 5-Bromo-N-phenylthiazol-2-amine | ESD-897798-1G |
Cas.: 4853-52-5 | Purity: 95% | 3-Amino-5,6-dichloropyrazine-2-carboxylic acid | ESD-897799-100MG |
Cas.: 171230-81-2 | Purity: 97% | (R)-Methyl 2-((tert-butyldimethylsilyl)oxy)propanoate | ESD-897800-100MG |
Cas.: 171230-81-2 | Purity: 97% | (R)-Methyl 2-((tert-butyldimethylsilyl)oxy)propanoate | ESD-897800-250MG |
Cas.: 171230-81-2 | Purity: 97% | (R)-Methyl 2-((tert-butyldimethylsilyl)oxy)propanoate | ESD-897800-1G |
Cas.: 886502-14-3 | Purity: 97% | 2-Fluoro-6-methylbenzamide | ESD-897801-100MG |
Cas.: 886502-14-3 | Purity: 97% | 2-Fluoro-6-methylbenzamide | ESD-897801-250MG |
Cas.: 886502-14-3 | Purity: 97% | 2-Fluoro-6-methylbenzamide | ESD-897801-1G |
Cas.: 187731-65-3 | Purity: ≥95% | (2-Amino-4-methoxyphenyl)methanol | ESD-897802-100MG |
Cas.: 187731-65-3 | Purity: ≥95% | (2-Amino-4-methoxyphenyl)methanol | ESD-897802-250MG |
Cas.: 187731-65-3 | Purity: ≥95% | (2-Amino-4-methoxyphenyl)methanol | ESD-897802-1G |
Cas.: 344324-94-3 | Purity: 98% | 2-Bromo-3,5-dichloro-4-methylpyridine | ESD-897803-100MG |
Cas.: 344324-94-3 | Purity: 98% | 2-Bromo-3,5-dichloro-4-methylpyridine | ESD-897803-250MG |
Cas.: 344324-94-3 | Purity: 98% | 2-Bromo-3,5-dichloro-4-methylpyridine | ESD-897803-1G |
Cas.: 637348-81-3 | Purity: ≥95% | 3-Bromo-5-iodopyridin-2-ol | ESD-897804-100MG |
Cas.: 637348-81-3 | Purity: ≥95% | 3-Bromo-5-iodopyridin-2-ol | ESD-897804-250MG |
Cas.: 637348-81-3 | Purity: ≥95% | 3-Bromo-5-iodopyridin-2-ol | ESD-897804-1G |
Cas.: 288154-17-6 | Purity: 97% | tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-carbamoylpiperidine-1-carboxylate | ESD-897805-100MG |
Cas.: 288154-17-6 | Purity: 97% | tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-carbamoylpiperidine-1-carboxylate | ESD-897805-250MG |
Cas.: 288154-17-6 | Purity: 97% | tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-carbamoylpiperidine-1-carboxylate | ESD-897805-1G |
Cas.: 1020252-76-9 | Purity: 97% | N-Benzyl-4-bromo-3-methylbenzamide | ESD-897806-100MG |
Cas.: 1020252-76-9 | Purity: 97% | N-Benzyl-4-bromo-3-methylbenzamide | ESD-897806-250MG |
Cas.: 1020252-76-9 | Purity: 97% | N-Benzyl-4-bromo-3-methylbenzamide | ESD-897806-1G |
Cas.: 1445988-32-8 | Purity: 97% | Phenyl (3-methoxy-1,2,4-thiadiazol-5-yl)carbamate | ESD-897807-100MG |
Cas.: 1445988-32-8 | Purity: 97% | Phenyl (3-methoxy-1,2,4-thiadiazol-5-yl)carbamate | ESD-897807-250MG |
Cas.: 1445988-32-8 | Purity: 97% | Phenyl (3-methoxy-1,2,4-thiadiazol-5-yl)carbamate | ESD-897807-1G |
Cas.: 15809-19-5 | Purity: 98% | N-Benzyl-N,N-dimethyl-3-tetradecanamidopropan-1-aminium chloride | ESD-897808-100MG |
Cas.: 15809-19-5 | Purity: 98% | N-Benzyl-N,N-dimethyl-3-tetradecanamidopropan-1-aminium chloride | ESD-897808-250MG |
Cas.: 15809-19-5 | Purity: 98% | N-Benzyl-N,N-dimethyl-3-tetradecanamidopropan-1-aminium chloride | ESD-897808-1G |
Cas.: 1533519-85-5 | Purity: 97% | Methyl 2-((4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897809-100MG |
Cas.: 1533519-85-5 | Purity: 97% | Methyl 2-((4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897809-250MG |
Cas.: 1533519-85-5 | Purity: 97% | Methyl 2-((4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-897809-1G |
Cas.: 14394-57-1 | Purity: 97% | 6-Chloro-N,5-dimethylpyrimidin-4-amine | ESD-897810-100MG |
Cas.: 14394-57-1 | Purity: 97% | 6-Chloro-N,5-dimethylpyrimidin-4-amine | ESD-897810-250MG |
Cas.: 14394-57-1 | Purity: 97% | 6-Chloro-N,5-dimethylpyrimidin-4-amine | ESD-897810-1G |
Cas.: 72023-79-1 | Purity: ≥95% | 5-Bromo-4-nitrobenzo[c][1,2,5]thiadiazole | ESD-897811-100MG |
Cas.: 72023-79-1 | Purity: ≥95% | 5-Bromo-4-nitrobenzo[c][1,2,5]thiadiazole | ESD-897811-250MG |
Cas.: 72023-79-1 | Purity: ≥95% | 5-Bromo-4-nitrobenzo[c][1,2,5]thiadiazole | ESD-897811-1G |
Cas.: 10419-67-7 | Purity: 97% | (R)-2-Benzamido-2-phenylacetic acid | ESD-897812-100MG |
Cas.: 10419-67-7 | Purity: 97% | (R)-2-Benzamido-2-phenylacetic acid | ESD-897812-250MG |
Cas.: 10419-67-7 | Purity: 97% | (R)-2-Benzamido-2-phenylacetic acid | ESD-897812-1G |
Cas.: 41288-91-9 | Purity: 98% | 6-Chloro-N,N-dimethylpyridin-3-amine | ESD-897813-100MG |
Cas.: 41288-91-9 | Purity: 98% | 6-Chloro-N,N-dimethylpyridin-3-amine | ESD-897813-250MG |
Cas.: 41288-91-9 | Purity: 98% | 6-Chloro-N,N-dimethylpyridin-3-amine | ESD-897813-1G |
Cas.: 80087-70-3 | Purity: 98% | 5,6-Dimethylbenzo[d]thiazole-2-thiol | ESD-897814-100MG |
Cas.: 80087-70-3 | Purity: 98% | 5,6-Dimethylbenzo[d]thiazole-2-thiol | ESD-897814-250MG |
Cas.: 80087-70-3 | Purity: 98% | 5,6-Dimethylbenzo[d]thiazole-2-thiol | ESD-897814-1G |
Cas.: 6970-83-8 | Purity: ≥95% | Ethylphenethylcarbamate | ESD-897815-100MG |
Cas.: 6970-83-8 | Purity: ≥95% | Ethylphenethylcarbamate | ESD-897815-250MG |
Cas.: 6970-83-8 | Purity: ≥95% | Ethylphenethylcarbamate | ESD-897815-1G |
Cas.: 408352-58-9 | Purity: ≥95% | 2,6-Dibromoisonicotinonitrile | ESD-897816-100MG |
Cas.: 408352-58-9 | Purity: ≥95% | 2,6-Dibromoisonicotinonitrile | ESD-897816-250MG |
Cas.: 408352-58-9 | Purity: ≥95% | 2,6-Dibromoisonicotinonitrile | ESD-897816-1G |
Cas.: 1175835-99-0 | Purity: 97% | tert-Butyl 3-propoxypyrrolidine-1-carboxylate | ESD-897817-100MG |
Cas.: 1175835-99-0 | Purity: 97% | tert-Butyl 3-propoxypyrrolidine-1-carboxylate | ESD-897817-250MG |
Cas.: 1175835-99-0 | Purity: 97% | tert-Butyl 3-propoxypyrrolidine-1-carboxylate | ESD-897817-1G |
Cas.: 1934827-83-4 | Purity: 95% | tert-Butyl 3-fluoropicolinate | ESD-897818-100MG |
Cas.: 1934827-83-4 | Purity: 95% | tert-Butyl 3-fluoropicolinate | ESD-897818-250MG |
Cas.: 1934827-83-4 | Purity: 95% | tert-Butyl 3-fluoropicolinate | ESD-897818-1G |
Cas.: 191980-54-8 | Purity: ≥95% | 4-Iodo-1-trityl-1H-pyrazole | ESD-897819-100MG |
Cas.: 191980-54-8 | Purity: ≥95% | 4-Iodo-1-trityl-1H-pyrazole | ESD-897819-250MG |
Cas.: 191980-54-8 | Purity: ≥95% | 4-Iodo-1-trityl-1H-pyrazole | ESD-897819-1G |
Cas.: 1185064-24-7 | Purity: 97% | tert-Butyl 4-methyl-4-(piperazin-1-yl)piperidine-1-carboxylate | ESD-897820-100MG |
Cas.: 1185064-24-7 | Purity: 97% | tert-Butyl 4-methyl-4-(piperazin-1-yl)piperidine-1-carboxylate | ESD-897820-250MG |
Cas.: 1185064-24-7 | Purity: 97% | tert-Butyl 4-methyl-4-(piperazin-1-yl)piperidine-1-carboxylate | ESD-897820-1G |
Cas.: 891785-18-5 | Purity: 97% | 3-(Benzyloxy)-5-bromo-2-chloropyridine | ESD-897821-100MG |
Cas.: 891785-18-5 | Purity: 97% | 3-(Benzyloxy)-5-bromo-2-chloropyridine | ESD-897821-250MG |
Cas.: 891785-18-5 | Purity: 97% | 3-(Benzyloxy)-5-bromo-2-chloropyridine | ESD-897821-1G |
Cas.: 1012882-90-4 | Purity: ≥95% | Ethyl 5-chloro-2-iodobenzoate | ESD-897822-100MG |
Cas.: 1012882-90-4 | Purity: ≥95% | Ethyl 5-chloro-2-iodobenzoate | ESD-897822-250MG |
Cas.: 1012882-90-4 | Purity: ≥95% | Ethyl 5-chloro-2-iodobenzoate | ESD-897822-1G |
Cas.: 1800300-79-1 | Purity: ≥95% | (R)-Methyl 2-amino-3-methoxypropanoate hydrochloride | ESD-897823-100MG |
Cas.: 1800300-79-1 | Purity: ≥95% | (R)-Methyl 2-amino-3-methoxypropanoate hydrochloride | ESD-897823-250MG |
Cas.: 1800300-79-1 | Purity: ≥95% | (R)-Methyl 2-amino-3-methoxypropanoate hydrochloride | ESD-897823-1G |
Cas.: 127369-30-6 | Purity: ≥95% | (S)-Methyl 2-amino-2-(4-hydroxyphenyl)acetate hydrochloride | ESD-897824-100MG |
Cas.: 127369-30-6 | Purity: ≥95% | (S)-Methyl 2-amino-2-(4-hydroxyphenyl)acetate hydrochloride | ESD-897824-250MG |
Cas.: 127369-30-6 | Purity: ≥95% | (S)-Methyl 2-amino-2-(4-hydroxyphenyl)acetate hydrochloride | ESD-897824-1G |
Cas.: 58484-01-8 | Purity: ≥95% | 3-Amino-2,6-dichloroisonicotinic acid | ESD-897825-100MG |
Cas.: 58484-01-8 | Purity: ≥95% | 3-Amino-2,6-dichloroisonicotinic acid | ESD-897825-250MG |
Cas.: 58484-01-8 | Purity: ≥95% | 3-Amino-2,6-dichloroisonicotinic acid | ESD-897825-1G |
Cas.: 906673-45-8 | Purity: 97% | 4-(4-Bromo-3-(hydroxymethyl)phenoxy)benzonitrile | ESD-897826-100MG |
Cas.: 906673-45-8 | Purity: 97% | 4-(4-Bromo-3-(hydroxymethyl)phenoxy)benzonitrile | ESD-897826-250MG |
Cas.: 906673-45-8 | Purity: 97% | 4-(4-Bromo-3-(hydroxymethyl)phenoxy)benzonitrile | ESD-897826-1G |
Cas.: 2206320-30-9 | Purity: 95% | 2,4-Dichloro-6-ethoxyquinazoline | ESD-897827-100MG |
Cas.: 2206320-30-9 | Purity: 95% | 2,4-Dichloro-6-ethoxyquinazoline | ESD-897827-250MG |
Cas.: 2206320-30-9 | Purity: 95% | 2,4-Dichloro-6-ethoxyquinazoline | ESD-897827-1G |
Cas.: 1427409-40-2 | Purity: ≥95% | Methyl 4-bromo-2-fluoro-6-methylbenzoate | ESD-897828-100MG |
Cas.: 1427409-40-2 | Purity: ≥95% | Methyl 4-bromo-2-fluoro-6-methylbenzoate | ESD-897828-250MG |
Cas.: 1427409-40-2 | Purity: ≥95% | Methyl 4-bromo-2-fluoro-6-methylbenzoate | ESD-897828-1G |
Cas.: 22721-18-2 | Purity: 97% | 5-Bromo-2-(methylamino)benzamide | ESD-897829-100MG |
Cas.: 22721-18-2 | Purity: 97% | 5-Bromo-2-(methylamino)benzamide | ESD-897829-250MG |
Cas.: 22721-18-2 | Purity: 97% | 5-Bromo-2-(methylamino)benzamide | ESD-897829-1G |
Cas.: 2436-29-5 | Purity: 95% | 3-(1,3-Dioxoisoindolin-2-yl)propanal | ESD-897830-100MG |
Cas.: 2436-29-5 | Purity: 95% | 3-(1,3-Dioxoisoindolin-2-yl)propanal | ESD-897830-250MG |
Cas.: 2436-29-5 | Purity: 95% | 3-(1,3-Dioxoisoindolin-2-yl)propanal | ESD-897830-1G |
Cas.: 288385-98-8 | Purity: 97% | 1-(3-(benzyloxy)-2-fluoro-6-nitrophenyl)propan-2-one | ESD-897831-100MG |
Cas.: 288385-98-8 | Purity: 97% | 1-(3-(benzyloxy)-2-fluoro-6-nitrophenyl)propan-2-one | ESD-897831-250MG |
Cas.: 288385-98-8 | Purity: 97% | 1-(3-(benzyloxy)-2-fluoro-6-nitrophenyl)propan-2-one | ESD-897831-1G |
Cas.: 343269-52-3 | Purity: ≥95% | 2-Amino-4-bromo-6-methylphenol | ESD-897832-100MG |
Cas.: 343269-52-3 | Purity: ≥95% | 2-Amino-4-bromo-6-methylphenol | ESD-897832-250MG |
Cas.: 343269-52-3 | Purity: ≥95% | 2-Amino-4-bromo-6-methylphenol | ESD-897832-1G |
Cas.: 2096997-23-6 | Purity: 97% | 2-(3-Bromo-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-897833-100MG |
Cas.: 2096997-23-6 | Purity: 97% | 2-(3-Bromo-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-897833-250MG |
Cas.: 2096997-23-6 | Purity: 97% | 2-(3-Bromo-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-897833-1G |
Cas.: 906000-44-0 | Purity: ≥95% | 1H-Indazole-6-carboxamide | ESD-897834-100MG |
Cas.: 906000-44-0 | Purity: ≥95% | 1H-Indazole-6-carboxamide | ESD-897834-250MG |
Cas.: 906000-44-0 | Purity: ≥95% | 1H-Indazole-6-carboxamide | ESD-897834-1G |
Cas.: 697300-68-8 | Purity: 97% | 6-Bromo-5-iodopyridin-3-amine | ESD-897835-100MG |
Cas.: 697300-68-8 | Purity: 97% | 6-Bromo-5-iodopyridin-3-amine | ESD-897835-250MG |
Cas.: 697300-68-8 | Purity: 97% | 6-Bromo-5-iodopyridin-3-amine | ESD-897835-1G |
Cas.: 1159812-31-3 | Purity: 98% | 7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-897836-100MG |
Cas.: 1159812-31-3 | Purity: 98% | 7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-897836-250MG |
Cas.: 1159812-31-3 | Purity: 98% | 7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-897836-1G |
Cas.: 28217-95-0 | Purity: ≥95% | 2-Benzylpyrazine | ESD-897837-100MG |
Cas.: 28217-95-0 | Purity: ≥95% | 2-Benzylpyrazine | ESD-897837-250MG |
Cas.: 28217-95-0 | Purity: ≥95% | 2-Benzylpyrazine | ESD-897837-1G |
Cas.: 96938-51-1 | Purity: ≥95% | N-((6-Methylpyridin-2-yl)carbamothioyl)benzamide | ESD-897838-100MG |
Cas.: 96938-51-1 | Purity: ≥95% | N-((6-Methylpyridin-2-yl)carbamothioyl)benzamide | ESD-897838-250MG |
Cas.: 96938-51-1 | Purity: ≥95% | N-((6-Methylpyridin-2-yl)carbamothioyl)benzamide | ESD-897838-1G |
Cas.: 54631-37-7 | Purity: ≥95% | (S)-2-Amino-4-oxo-4-phenylbutanoic acid hydrochloride | ESD-897839-100MG |
Cas.: 54631-37-7 | Purity: ≥95% | (S)-2-Amino-4-oxo-4-phenylbutanoic acid hydrochloride | ESD-897839-250MG |
Cas.: 54631-37-7 | Purity: ≥95% | (S)-2-Amino-4-oxo-4-phenylbutanoic acid hydrochloride | ESD-897839-1G |
Cas.: 1093192-06-3 | Purity: ≥95% | (S)-Methyl 3-((tert-butoxycarbonyl)amino)-3-methyl-2-(((S)-1-phenylethyl)amino)butanoate | ESD-897840-100MG |
Cas.: 1093192-06-3 | Purity: ≥95% | (S)-Methyl 3-((tert-butoxycarbonyl)amino)-3-methyl-2-(((S)-1-phenylethyl)amino)butanoate | ESD-897840-250MG |
Cas.: 1093192-06-3 | Purity: ≥95% | (S)-Methyl 3-((tert-butoxycarbonyl)amino)-3-methyl-2-(((S)-1-phenylethyl)amino)butanoate | ESD-897840-1G |
Cas.: 1980063-54-4 | Purity: 95% | 4-(Difluoromethyl)aniline hydrochloride | ESD-897841-100MG |
Cas.: 1980063-54-4 | Purity: 95% | 4-(Difluoromethyl)aniline hydrochloride | ESD-897841-250MG |
Cas.: 1980063-54-4 | Purity: 95% | 4-(Difluoromethyl)aniline hydrochloride | ESD-897841-1G |
Cas.: 50651-75-7 | Purity: 97% | Silver(I) dibenzyl phosphate | ESD-897842-100MG |
Cas.: 50651-75-7 | Purity: 97% | Silver(I) dibenzyl phosphate | ESD-897842-250MG |
Cas.: 50651-75-7 | Purity: 97% | Silver(I) dibenzyl phosphate | ESD-897842-1G |
Cas.: 868736-61-2 | Purity: 97% | 6-((Trimethylsilyl)ethynyl)pyridin-3-amine | ESD-897843-100MG |
Cas.: 868736-61-2 | Purity: 97% | 6-((Trimethylsilyl)ethynyl)pyridin-3-amine | ESD-897843-250MG |
Cas.: 868736-61-2 | Purity: 97% | 6-((Trimethylsilyl)ethynyl)pyridin-3-amine | ESD-897843-1G |
Cas.: 215950-19-9 | Purity: ≥95% | N-Methoxy-N,1-dimethylpiperidine-4-carboxamide | ESD-897844-100MG |
Cas.: 215950-19-9 | Purity: ≥95% | N-Methoxy-N,1-dimethylpiperidine-4-carboxamide | ESD-897844-250MG |
Cas.: 215950-19-9 | Purity: ≥95% | N-Methoxy-N,1-dimethylpiperidine-4-carboxamide | ESD-897844-1G |
Cas.: 1115023-84-1 | Purity: ≥95% | 2-([1,1′:3′,1”-Terphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-897845-100MG |
Cas.: 1115023-84-1 | Purity: ≥95% | 2-([1,1′:3′,1”-Terphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-897845-250MG |
Cas.: 1115023-84-1 | Purity: ≥95% | 2-([1,1′:3′,1”-Terphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-897845-1G |
Cas.: 55747-84-7 | Purity: ≥95% | Boc-Asp(Ome)-Ome | ESD-897846-100MG |
Cas.: 55747-84-7 | Purity: ≥95% | Boc-Asp(Ome)-Ome | ESD-897846-250MG |
Cas.: 55747-84-7 | Purity: ≥95% | Boc-Asp(Ome)-Ome | ESD-897846-1G |
Cas.: 1332832-14-0 | Purity: 97% | (S)-1-(2-Fluorophenyl)ethanamine hydrochloride | ESD-897847-100MG |
Cas.: 1332832-14-0 | Purity: 97% | (S)-1-(2-Fluorophenyl)ethanamine hydrochloride | ESD-897847-250MG |
Cas.: 1332832-14-0 | Purity: 97% | (S)-1-(2-Fluorophenyl)ethanamine hydrochloride | ESD-897847-1G |
Cas.: 858238-17-2 | Purity: 95% | 7-Chloro-6-methoxyquinazolin-4(3H)-one | ESD-897848-100MG |
Cas.: 858238-17-2 | Purity: 95% | 7-Chloro-6-methoxyquinazolin-4(3H)-one | ESD-897848-250MG |
Cas.: 858238-17-2 | Purity: 95% | 7-Chloro-6-methoxyquinazolin-4(3H)-one | ESD-897848-1G |
Cas.: 14162-88-0 | Purity: 97% | 3-Hydroxy-6-methylpicolinic acid | ESD-897849-100MG |
Cas.: 14162-88-0 | Purity: 97% | 3-Hydroxy-6-methylpicolinic acid | ESD-897849-250MG |
Cas.: 14162-88-0 | Purity: 97% | 3-Hydroxy-6-methylpicolinic acid | ESD-897849-1G |
Cas.: 1214900-33-0 | Purity: 95% | tert-Butyl 6-bromo-1-oxo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-897850-100MG |
Cas.: 1214900-33-0 | Purity: 95% | tert-Butyl 6-bromo-1-oxo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-897850-250MG |
Cas.: 1214900-33-0 | Purity: 95% | tert-Butyl 6-bromo-1-oxo-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-897850-1G |
Cas.: 1229705-59-2 | Purity: ≥95% | Methyl 2-(azetidin-3-yl)acetate hydrochloride | ESD-897851-100MG |
Cas.: 1229705-59-2 | Purity: ≥95% | Methyl 2-(azetidin-3-yl)acetate hydrochloride | ESD-897851-250MG |
Cas.: 1229705-59-2 | Purity: ≥95% | Methyl 2-(azetidin-3-yl)acetate hydrochloride | ESD-897851-1G |
Cas.: 35143-75-0 | Purity: ≥95% | 4-Methylisoxazol-5-amine | ESD-897852-100MG |
Cas.: 35143-75-0 | Purity: ≥95% | 4-Methylisoxazol-5-amine | ESD-897852-250MG |
Cas.: 35143-75-0 | Purity: ≥95% | 4-Methylisoxazol-5-amine | ESD-897852-1G |
Cas.: 277328-34-4 | Purity: 97% | 1-Cbz-Amino-2-methylaminoethane hydrochloride | ESD-897853-100MG |
Cas.: 277328-34-4 | Purity: 97% | 1-Cbz-Amino-2-methylaminoethane hydrochloride | ESD-897853-250MG |
Cas.: 7181-87-5 | Purity: 97% | 1,3-Dimethyl-1H-benzo[d]imidazol-3-ium iodide | ESD-897854-100MG |
Cas.: 7181-87-5 | Purity: 97% | 1,3-Dimethyl-1H-benzo[d]imidazol-3-ium iodide | ESD-897854-250MG |
Cas.: 7181-87-5 | Purity: 97% | 1,3-Dimethyl-1H-benzo[d]imidazol-3-ium iodide | ESD-897854-1G |
Cas.: 1064677-18-4 | Purity: 97% | (3-Bromo-5-chloropyridin-4-yl)methanol | ESD-897855-100MG |
Cas.: 1064677-18-4 | Purity: 97% | (3-Bromo-5-chloropyridin-4-yl)methanol | ESD-897855-250MG |
Cas.: 1064677-18-4 | Purity: 97% | (3-Bromo-5-chloropyridin-4-yl)methanol | ESD-897855-1G |
Cas.: 1269773-21-8 | Purity: ≥95% | (S)-2-Amino-2-(4-fluorophenyl)ethanol hydrochloride | ESD-897856-100MG |
Cas.: 1269773-21-8 | Purity: ≥95% | (S)-2-Amino-2-(4-fluorophenyl)ethanol hydrochloride | ESD-897856-250MG |
Cas.: 1269773-21-8 | Purity: ≥95% | (S)-2-Amino-2-(4-fluorophenyl)ethanol hydrochloride | ESD-897856-1G |
Cas.: 1019442-22-8 | Purity: ≥95% | 5-Bromo-2-isopropoxyaniline | ESD-897857-100MG |
Cas.: 1019442-22-8 | Purity: ≥95% | 5-Bromo-2-isopropoxyaniline | ESD-897857-250MG |
Cas.: 1019442-22-8 | Purity: ≥95% | 5-Bromo-2-isopropoxyaniline | ESD-897857-1G |
Cas.: 1149587-02-9 | Purity: ≥95% | 3-Chloro-2-fluoroisonicotinaldehyde | ESD-897858-100MG |
Cas.: 1149587-02-9 | Purity: ≥95% | 3-Chloro-2-fluoroisonicotinaldehyde | ESD-897858-250MG |
Cas.: 1149587-02-9 | Purity: ≥95% | 3-Chloro-2-fluoroisonicotinaldehyde | ESD-897858-1G |
Cas.: 1841081-49-9 | Purity: ≥95% | tert-Butyl (1-(6-bromopyridin-2-yl)cyclobutyl)carbamate | ESD-897859-100MG |
Cas.: 1841081-49-9 | Purity: ≥95% | tert-Butyl (1-(6-bromopyridin-2-yl)cyclobutyl)carbamate | ESD-897859-250MG |
Cas.: 120422-90-4 | Purity: ≥95% | 4,6-Dichloro-3-methyl-1H-pyrazolo[4,3-c]pyridine | ESD-897860-100MG |
Cas.: 120422-90-4 | Purity: ≥95% | 4,6-Dichloro-3-methyl-1H-pyrazolo[4,3-c]pyridine | ESD-897860-250MG |
Cas.: 120422-90-4 | Purity: ≥95% | 4,6-Dichloro-3-methyl-1H-pyrazolo[4,3-c]pyridine | ESD-897860-1G |
Cas.: 1260018-10-7 | Purity: 97% | 5-Bromo-6-chloro-2,3-dihydro-1H-inden-1-one | ESD-897861-100MG |
Cas.: 1260018-10-7 | Purity: 97% | 5-Bromo-6-chloro-2,3-dihydro-1H-inden-1-one | ESD-897861-250MG |
Cas.: 1260018-10-7 | Purity: 97% | 5-Bromo-6-chloro-2,3-dihydro-1H-inden-1-one | ESD-897861-1G |
Cas.: 24124-59-2 | Purity: ≥95% | Methylene bis(4-methylbenzenesulfonate) | ESD-897862-100MG |
Cas.: 24124-59-2 | Purity: ≥95% | Methylene bis(4-methylbenzenesulfonate) | ESD-897862-250MG |
Cas.: 24124-59-2 | Purity: ≥95% | Methylene bis(4-methylbenzenesulfonate) | ESD-897862-1G |
Cas.: 1217680-27-7 | Purity: 97% | (S)-2-(2-Bromophenyl)pyrrolidine | ESD-897863-100MG |
Cas.: 1217680-27-7 | Purity: 97% | (S)-2-(2-Bromophenyl)pyrrolidine | ESD-897863-250MG |
Cas.: 1217680-27-7 | Purity: 97% | (S)-2-(2-Bromophenyl)pyrrolidine | ESD-897863-1G |
Cas.: 71670-70-7 | Purity: ≥95% | 2-(Chloromethyl)-5-methylpyridine hydrochloride | ESD-897864-100MG |
Cas.: 71670-70-7 | Purity: ≥95% | 2-(Chloromethyl)-5-methylpyridine hydrochloride | ESD-897864-250MG |
Cas.: 71670-70-7 | Purity: ≥95% | 2-(Chloromethyl)-5-methylpyridine hydrochloride | ESD-897864-1G |
Cas.: 1268246-12-3 | Purity: 97% | Methyl 4-(2-chloro-4-hydroxystyryl)benzoate | ESD-897865-100MG |
Cas.: 1268246-12-3 | Purity: 97% | Methyl 4-(2-chloro-4-hydroxystyryl)benzoate | ESD-897865-250MG |
Cas.: 1268246-12-3 | Purity: 97% | Methyl 4-(2-chloro-4-hydroxystyryl)benzoate | ESD-897865-1G |
Cas.: 327099-80-9 | Purity: 97% | 4-Bromo-1-methyl-1H-pyrazole-5-carbonitrile | ESD-897866-100MG |
Cas.: 327099-80-9 | Purity: 97% | 4-Bromo-1-methyl-1H-pyrazole-5-carbonitrile | ESD-897866-250MG |
Cas.: 327099-80-9 | Purity: 97% | 4-Bromo-1-methyl-1H-pyrazole-5-carbonitrile | ESD-897866-1G |
Cas.: 124491-42-5 | Purity: ≥95% | 1-(2-Aminopyrimidin-5-yl)ethanone | ESD-897867-100MG |
Cas.: 124491-42-5 | Purity: ≥95% | 1-(2-Aminopyrimidin-5-yl)ethanone | ESD-897867-250MG |
Cas.: 124491-42-5 | Purity: ≥95% | 1-(2-Aminopyrimidin-5-yl)ethanone | ESD-897867-1G |
Cas.: 1214367-20-0 | Purity: ≥95% | 3-(Difluoromethoxy)-4-fluorobenzaldehyde | ESD-897868-100MG |
Cas.: 1214367-20-0 | Purity: ≥95% | 3-(Difluoromethoxy)-4-fluorobenzaldehyde | ESD-897868-250MG |
Cas.: 1214367-20-0 | Purity: ≥95% | 3-(Difluoromethoxy)-4-fluorobenzaldehyde | ESD-897868-1G |
Cas.: 675606-20-9 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-1H-indole-3-carboxylic acid | ESD-897869-100MG |
Cas.: 675606-20-9 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-1H-indole-3-carboxylic acid | ESD-897869-250MG |
Cas.: 675606-20-9 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-1H-indole-3-carboxylic acid | ESD-897869-1G |
Cas.: 79128-78-2 | Purity: 97% | 2-Hydroxy-5-(methoxycarbonyl)benzoic acid | ESD-897870-100MG |
Cas.: 79128-78-2 | Purity: 97% | 2-Hydroxy-5-(methoxycarbonyl)benzoic acid | ESD-897870-250MG |
Cas.: 79128-78-2 | Purity: 97% | 2-Hydroxy-5-(methoxycarbonyl)benzoic acid | ESD-897870-1G |
Cas.: 59950-53-7 | Purity: 97% | 5-Aminopyrimidine-4-carboxylic acid | ESD-897871-100MG |
Cas.: 59950-53-7 | Purity: 97% | 5-Aminopyrimidine-4-carboxylic acid | ESD-897871-250MG |
Cas.: 59950-53-7 | Purity: 97% | 5-Aminopyrimidine-4-carboxylic acid | ESD-897871-1G |
Cas.: 15803-27-7 | Purity: ≥95% | Ethyl 4,5-dimethyl-1H-pyrazole-3-carboxylate | ESD-897872-100MG |
Cas.: 15803-27-7 | Purity: ≥95% | Ethyl 4,5-dimethyl-1H-pyrazole-3-carboxylate | ESD-897872-250MG |
Cas.: 15803-27-7 | Purity: ≥95% | Ethyl 4,5-dimethyl-1H-pyrazole-3-carboxylate | ESD-897872-1G |
Cas.: 1805578-52-2 | Purity: 95% | 2-Bromo-5-fluoro-4-nitropyridine | ESD-897873-100MG |
Cas.: 1805578-52-2 | Purity: 95% | 2-Bromo-5-fluoro-4-nitropyridine | ESD-897873-250MG |
Cas.: 1805578-52-2 | Purity: 95% | 2-Bromo-5-fluoro-4-nitropyridine | ESD-897873-1G |
Cas.: 123941-49-1 | Purity: 98% | Xylazole hydrochloride | ESD-897874-100MG |
Cas.: 123941-49-1 | Purity: 98% | Xylazole hydrochloride | ESD-897874-250MG |
Cas.: 123941-49-1 | Purity: 98% | Xylazole hydrochloride | ESD-897874-1G |
Cas.: 144870-96-2 | Purity: ≥95% | 4-Aminotetrahydrofuran-3-ol | ESD-897875-100MG |
Cas.: 144870-96-2 | Purity: ≥95% | 4-Aminotetrahydrofuran-3-ol | ESD-897875-250MG |
Cas.: 144870-96-2 | Purity: ≥95% | 4-Aminotetrahydrofuran-3-ol | ESD-897875-1G |
Cas.: 1218791-46-8 | Purity: ≥95% | N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-897876-100MG |
Cas.: 1218791-46-8 | Purity: ≥95% | N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-897876-250MG |
Cas.: 1218791-46-8 | Purity: ≥95% | N-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-897876-1G |
Cas.: 1000343-82-7 | Purity: ≥95% | 5-Bromo-3-iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897877-100MG |
Cas.: 1000343-82-7 | Purity: ≥95% | 5-Bromo-3-iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897877-250MG |
Cas.: 1000343-82-7 | Purity: ≥95% | 5-Bromo-3-iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-897877-1G |
Cas.: 1894988-20-5 | Purity: 97% | Ethyl 5-nitropyrimidine-2-carboxylate | ESD-897878-100MG |
Cas.: 1894988-20-5 | Purity: 97% | Ethyl 5-nitropyrimidine-2-carboxylate | ESD-897878-250MG |
Cas.: 1894988-20-5 | Purity: 97% | Ethyl 5-nitropyrimidine-2-carboxylate | ESD-897878-1G |
Cas.: 89181-79-3 | Purity: 95% | 3-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-897879-100MG |
Cas.: 89181-79-3 | Purity: 95% | 3-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-897879-250MG |
Cas.: 89181-79-3 | Purity: 95% | 3-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-897879-1G |
Cas.: 89985-86-4 | Purity: ≥95% | (R)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate | ESD-897880-100MG |
Cas.: 89985-86-4 | Purity: ≥95% | (R)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate | ESD-897880-250MG |
Cas.: 89985-86-4 | Purity: ≥95% | (R)-tert-Butyl (1-hydroxybut-3-en-2-yl)carbamate | ESD-897880-1G |
Cas.: 1044598-91-5 | Purity: 95% | 4-(4-((4′-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoic acid | ESD-897881-100MG |
Cas.: 1044598-91-5 | Purity: 95% | 4-(4-((4′-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoic acid | ESD-897881-250MG |
Cas.: 1044598-91-5 | Purity: 95% | 4-(4-((4′-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoic acid | ESD-897881-1G |
Cas.: 34595-33-0 | Purity: ≥95% | 5-Amino-2-(pipidin-1-yl)benzonitrile | ESD-897882-100MG |
Cas.: 34595-33-0 | Purity: ≥95% | 5-Amino-2-(pipidin-1-yl)benzonitrile | ESD-897882-250MG |
Cas.: 34595-33-0 | Purity: ≥95% | 5-Amino-2-(pipidin-1-yl)benzonitrile | ESD-897882-1G |
Cas.: 155790-01-5 | Purity: ≥95% | 5-Bromo-N,4-dimethyl-3-nitropyridin-2-amine | ESD-897883-100MG |
Cas.: 155790-01-5 | Purity: ≥95% | 5-Bromo-N,4-dimethyl-3-nitropyridin-2-amine | ESD-897883-250MG |
Cas.: 155790-01-5 | Purity: ≥95% | 5-Bromo-N,4-dimethyl-3-nitropyridin-2-amine | ESD-897883-1G |
Cas.: 1207894-59-4 | Purity: ≥95% | 7-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | ESD-897884-100MG |
Cas.: 1207894-59-4 | Purity: ≥95% | 7-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | ESD-897884-250MG |
Cas.: 1207894-59-4 | Purity: ≥95% | 7-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | ESD-897884-1G |
Cas.: 1391436-37-5 | Purity: 97% | (S)-2,2,2-Trifluoro-1-(3-fluorophenyl)ethanamine hydrochloride | ESD-897885-100MG |
Cas.: 1391436-37-5 | Purity: 97% | (S)-2,2,2-Trifluoro-1-(3-fluorophenyl)ethanamine hydrochloride | ESD-897885-250MG |
Cas.: 1391436-37-5 | Purity: 97% | (S)-2,2,2-Trifluoro-1-(3-fluorophenyl)ethanamine hydrochloride | ESD-897885-1G |
Cas.: 58781-08-1 | Purity: ≥95% | 4-Oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylic acid | ESD-897886-100MG |
Cas.: 58781-08-1 | Purity: ≥95% | 4-Oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylic acid | ESD-897886-250MG |
Cas.: 58781-08-1 | Purity: ≥95% | 4-Oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylic acid | ESD-897886-1G |
Cas.: 1036755-95-9 | Purity: 97% | Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate | ESD-897887-100MG |
Cas.: 1036755-95-9 | Purity: 97% | Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate | ESD-897887-250MG |
Cas.: 1036755-95-9 | Purity: 97% | Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate | ESD-897887-1G |
Cas.: 200283-08-5 | Purity: 97% | tert-Butyl (2-((tert-butoxycarbonyl)amino)ethyl)(2-hydroxyethyl)carbamate | ESD-897888-100MG |
Cas.: 200283-08-5 | Purity: 97% | tert-Butyl (2-((tert-butoxycarbonyl)amino)ethyl)(2-hydroxyethyl)carbamate | ESD-897888-250MG |
Cas.: 888968-67-0 | Purity: ≥95% | 4-(3-Bromophenyl)pyrimidin-2-ol | ESD-897889-100MG |
Cas.: 888968-67-0 | Purity: ≥95% | 4-(3-Bromophenyl)pyrimidin-2-ol | ESD-897889-250MG |
Cas.: 888968-67-0 | Purity: ≥95% | 4-(3-Bromophenyl)pyrimidin-2-ol | ESD-897889-1G |
Cas.: 51135-70-7 | Purity: ≥95% | Ethyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate | ESD-897890-100MG |
Cas.: 51135-70-7 | Purity: ≥95% | Ethyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate | ESD-897890-250MG |
Cas.: 51135-70-7 | Purity: ≥95% | Ethyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate | ESD-897890-1G |
Cas.: 90253-21-7 | Purity: ≥95% | 4-Cyclopropyl-1H-pyrazole | ESD-897891-100MG |
Cas.: 90253-21-7 | Purity: ≥95% | 4-Cyclopropyl-1H-pyrazole | ESD-897891-250MG |
Cas.: 90253-21-7 | Purity: ≥95% | 4-Cyclopropyl-1H-pyrazole | ESD-897891-1G |
Cas.: 69716-28-5 | Purity: ≥95% | N-Hydroxypicolinimidoyl chloride | ESD-897892-100MG |
Cas.: 69716-28-5 | Purity: ≥95% | N-Hydroxypicolinimidoyl chloride | ESD-897892-250MG |
Cas.: 69716-28-5 | Purity: ≥95% | N-Hydroxypicolinimidoyl chloride | ESD-897892-1G |
Cas.: 438450-39-6 | Purity: ≥95% | 1-(3-Chloropyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid | ESD-897893-100MG |
Cas.: 438450-39-6 | Purity: ≥95% | 1-(3-Chloropyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid | ESD-897893-250MG |
Cas.: 438450-39-6 | Purity: ≥95% | 1-(3-Chloropyridin-2-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid | ESD-897893-1G |
Cas.: 64376-18-7 | Purity: 97% | 6-Amino-2-chloropyrimidine-4-carbonitrile | ESD-897894-100MG |
Cas.: 64376-18-7 | Purity: 97% | 6-Amino-2-chloropyrimidine-4-carbonitrile | ESD-897894-250MG |
Cas.: 64376-18-7 | Purity: 97% | 6-Amino-2-chloropyrimidine-4-carbonitrile | ESD-897894-1G |
Cas.: 26371-48-2 | Purity: 95% | 6-Chlorochroman-3-one | ESD-897895-250MG |
Cas.: 26371-48-2 | Purity: 95% | 6-Chlorochroman-3-one | ESD-897895-1G |
Cas.: 1310384-07-6 | Purity: ≥95% | 2-Fluoro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897896-100MG |
Cas.: 1310384-07-6 | Purity: ≥95% | 2-Fluoro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897896-250MG |
Cas.: 1310384-07-6 | Purity: ≥95% | 2-Fluoro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-897896-1G |
Cas.: 1260383-49-0 | Purity: ≥95% | Methyl 4-bromo-2-methyl-1H-indole-6-carboxylate | ESD-897897-100MG |
Cas.: 1260383-49-0 | Purity: ≥95% | Methyl 4-bromo-2-methyl-1H-indole-6-carboxylate | ESD-897897-250MG |
Cas.: 1260383-49-0 | Purity: ≥95% | Methyl 4-bromo-2-methyl-1H-indole-6-carboxylate | ESD-897897-1G |
Cas.: 210345-89-4 | Purity: 97% | (R)-2-(Aminomethyl)-4-methylpentanoic acid | ESD-897898-100MG |
Cas.: 210345-89-4 | Purity: 97% | (R)-2-(Aminomethyl)-4-methylpentanoic acid | ESD-897898-250MG |
Cas.: 210345-89-4 | Purity: 97% | (R)-2-(Aminomethyl)-4-methylpentanoic acid | ESD-897898-1G |
Cas.: 88511-37-9 | Purity: ≥95% | 1-(Isoxazol-3-yl)ethanone | ESD-897899-100MG |
Cas.: 88511-37-9 | Purity: ≥95% | 1-(Isoxazol-3-yl)ethanone | ESD-897899-250MG |
Cas.: 88511-37-9 | Purity: ≥95% | 1-(Isoxazol-3-yl)ethanone | ESD-897899-1G |
Cas.: 1256834-13-5 | Purity: ≥95% | 4-Bromo-6-chloronicotinic acid | ESD-897900-100MG |
Cas.: 1256834-13-5 | Purity: ≥95% | 4-Bromo-6-chloronicotinic acid | ESD-897900-250MG |
Cas.: 1256834-13-5 | Purity: ≥95% | 4-Bromo-6-chloronicotinic acid | ESD-897900-1G |
Cas.: 1685-84-3 | Purity: ≥95% | 7-Methoxy-6-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-897901-100MG |
Cas.: 1685-84-3 | Purity: ≥95% | 7-Methoxy-6-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-897901-250MG |
Cas.: 1685-84-3 | Purity: ≥95% | 7-Methoxy-6-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-897901-1G |
Cas.: 39959-66-5 | Purity: 97% | LY 78335 hydrochloride | ESD-897902-100MG |
Cas.: 39959-66-5 | Purity: 97% | LY 78335 hydrochloride | ESD-897902-250MG |
Cas.: 39959-66-5 | Purity: 97% | LY 78335 hydrochloride | ESD-897902-1G |
Cas.: 111992-61-1 | Purity: ≥95% | 2-(3-Bromo-2,2-dimethylpropyl)isoindoline-1,3-dione | ESD-897903-100MG |
Cas.: 111992-61-1 | Purity: ≥95% | 2-(3-Bromo-2,2-dimethylpropyl)isoindoline-1,3-dione | ESD-897903-250MG |
Cas.: 111992-61-1 | Purity: ≥95% | 2-(3-Bromo-2,2-dimethylpropyl)isoindoline-1,3-dione | ESD-897903-1G |
Cas.: 1391540-47-8 | Purity: ≥95% | (S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride | ESD-897904-100MG |
Cas.: 1391540-47-8 | Purity: ≥95% | (S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride | ESD-897904-250MG |
Cas.: 1391540-47-8 | Purity: ≥95% | (S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride | ESD-897904-1G |
Cas.: 911372-79-7 | Purity: 97% | (S)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897905-100MG |
Cas.: 911372-79-7 | Purity: 97% | (S)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897905-250MG |
Cas.: 911372-79-7 | Purity: 97% | (S)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897905-1G |
Cas.: 502509-20-8 | Purity: ≥95% | 4-Bromo-2-vinylpyridine | ESD-897906-100MG |
Cas.: 502509-20-8 | Purity: ≥95% | 4-Bromo-2-vinylpyridine | ESD-897906-250MG |
Cas.: 502509-20-8 | Purity: ≥95% | 4-Bromo-2-vinylpyridine | ESD-897906-1G |
Cas.: 60713-78-2 | Purity: 97% | 5-Chloro-6-nitro-1H-benzo[d]imidazol-2(3H)-one | ESD-897907-100MG |
Cas.: 60713-78-2 | Purity: 97% | 5-Chloro-6-nitro-1H-benzo[d]imidazol-2(3H)-one | ESD-897907-250MG |
Cas.: 60713-78-2 | Purity: 97% | 5-Chloro-6-nitro-1H-benzo[d]imidazol-2(3H)-one | ESD-897907-1G |
Cas.: 924818-17-7 | Purity: 95% | 3-Bromo-2-(trifluoromethyl)thiophene | ESD-897908-100MG |
Cas.: 924818-17-7 | Purity: 95% | 3-Bromo-2-(trifluoromethyl)thiophene | ESD-897908-250MG |
Cas.: 924818-17-7 | Purity: 95% | 3-Bromo-2-(trifluoromethyl)thiophene | ESD-897908-1G |
Cas.: 1196074-43-7 | Purity: 97% | 4-Amino-2-methoxy-5-nitrobenzonitrile | ESD-897909-100MG |
Cas.: 1196074-43-7 | Purity: 97% | 4-Amino-2-methoxy-5-nitrobenzonitrile | ESD-897909-250MG |
Cas.: 1196074-43-7 | Purity: 97% | 4-Amino-2-methoxy-5-nitrobenzonitrile | ESD-897909-1G |
Cas.: 1807503-92-9 | Purity: 97% | 3-(2-(2-Bromoethoxy)ethoxy)propanoic acid | ESD-897910-100MG |
Cas.: 1807503-92-9 | Purity: 97% | 3-(2-(2-Bromoethoxy)ethoxy)propanoic acid | ESD-897910-250MG |
Cas.: 1807503-92-9 | Purity: 97% | 3-(2-(2-Bromoethoxy)ethoxy)propanoic acid | ESD-897910-1G |
Cas.: 99363-25-4 | Purity: 97% | trans-Cyclopentane-1,2-diamine dihydrochloride | ESD-897911-100MG |
Cas.: 99363-25-4 | Purity: 97% | trans-Cyclopentane-1,2-diamine dihydrochloride | ESD-897911-250MG |
Cas.: 99363-25-4 | Purity: 97% | trans-Cyclopentane-1,2-diamine dihydrochloride | ESD-897911-1G |
Cas.: 1233244-78-4 | Purity: ≥95% | 3-Hydroxyquinoline-6-carboxylic acid | ESD-897912-100MG |
Cas.: 1233244-78-4 | Purity: ≥95% | 3-Hydroxyquinoline-6-carboxylic acid | ESD-897912-250MG |
Cas.: 1233244-78-4 | Purity: ≥95% | 3-Hydroxyquinoline-6-carboxylic acid | ESD-897912-1G |
Cas.: 91131-72-5 | Purity: 97% | 4-(tert-Butyl)-3-iodobenzoic acid | ESD-897913-100MG |
Cas.: 91131-72-5 | Purity: 97% | 4-(tert-Butyl)-3-iodobenzoic acid | ESD-897913-250MG |
Cas.: 91131-72-5 | Purity: 97% | 4-(tert-Butyl)-3-iodobenzoic acid | ESD-897913-1G |
Cas.: 1567373-49-2 | Purity: 97% | (4-Chloro-2-methoxyphenyl)hydrazine hydrochloride | ESD-897914-100MG |
Cas.: 1567373-49-2 | Purity: 97% | (4-Chloro-2-methoxyphenyl)hydrazine hydrochloride | ESD-897914-250MG |
Cas.: 1567373-49-2 | Purity: 97% | (4-Chloro-2-methoxyphenyl)hydrazine hydrochloride | ESD-897914-1G |
Cas.: 215589-37-0 | Purity: ≥95% | 2-Ethynyl-4-methylaniline | ESD-897915-100MG |
Cas.: 215589-37-0 | Purity: ≥95% | 2-Ethynyl-4-methylaniline | ESD-897915-250MG |
Cas.: 215589-37-0 | Purity: ≥95% | 2-Ethynyl-4-methylaniline | ESD-897915-1G |
Cas.: 212327-11-2 | Purity: 97% | 7-Bromoquinoxalin-2-amine | ESD-897916-100MG |
Cas.: 212327-11-2 | Purity: 97% | 7-Bromoquinoxalin-2-amine | ESD-897916-250MG |
Cas.: 212327-11-2 | Purity: 97% | 7-Bromoquinoxalin-2-amine | ESD-897916-1G |
Cas.: 5247-86-9 | Purity: 97% | Methyl 8-hydroxy-1-naphthoate | ESD-897917-100MG |
Cas.: 5247-86-9 | Purity: 97% | Methyl 8-hydroxy-1-naphthoate | ESD-897917-250MG |
Cas.: 5247-86-9 | Purity: 97% | Methyl 8-hydroxy-1-naphthoate | ESD-897917-1G |
Cas.: 6647-98-9 | Purity: ≥95% | 4-Iodo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-897918-100MG |
Cas.: 6647-98-9 | Purity: ≥95% | 4-Iodo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-897918-250MG |
Cas.: 6647-98-9 | Purity: ≥95% | 4-Iodo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-897918-1G |
Cas.: 67159-85-7 | Purity: 95% | 5-Bromo-3,3-dimethyl-2,3-dihydro-1H-inden-1-one | ESD-897919-100MG |
Cas.: 67159-85-7 | Purity: 95% | 5-Bromo-3,3-dimethyl-2,3-dihydro-1H-inden-1-one | ESD-897919-250MG |
Cas.: 67159-85-7 | Purity: 95% | 5-Bromo-3,3-dimethyl-2,3-dihydro-1H-inden-1-one | ESD-897919-1G |
Cas.: 52927-23-8 | Purity: ≥95% | 5-Bromonaphthalen-1-ol | ESD-897920-100MG |
Cas.: 52927-23-8 | Purity: ≥95% | 5-Bromonaphthalen-1-ol | ESD-897920-250MG |
Cas.: 52927-23-8 | Purity: ≥95% | 5-Bromonaphthalen-1-ol | ESD-897920-1G |
Cas.: 1251922-71-0 | Purity: ≥95% | 4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897921-100MG |
Cas.: 1251922-71-0 | Purity: ≥95% | 4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897921-250MG |
Cas.: 1251922-71-0 | Purity: ≥95% | 4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897921-1G |
Cas.: 1035226-84-6 | Purity: 97% | (S)-tert-Butyl 2-methyl-1,4-diazepane-1-carboxylate | ESD-897922-100MG |
Cas.: 1035226-84-6 | Purity: 97% | (S)-tert-Butyl 2-methyl-1,4-diazepane-1-carboxylate | ESD-897922-250MG |
Cas.: 1035226-84-6 | Purity: 97% | (S)-tert-Butyl 2-methyl-1,4-diazepane-1-carboxylate | ESD-897922-1G |
Cas.: 27079-29-4 | Purity: 97% | Methyl [(2-aminophenyl)carbamothioyl]carbamate | ESD-897923-100MG |
Cas.: 27079-29-4 | Purity: 97% | Methyl [(2-aminophenyl)carbamothioyl]carbamate | ESD-897923-250MG |
Cas.: 27079-29-4 | Purity: 97% | Methyl [(2-aminophenyl)carbamothioyl]carbamate | ESD-897923-1G |
Cas.: 5748-33-4 | Purity: ≥95% | 4-Chloro-N-ethyl-6-methylpyrimidin-2-amine | ESD-897924-100MG |
Cas.: 5748-33-4 | Purity: ≥95% | 4-Chloro-N-ethyl-6-methylpyrimidin-2-amine | ESD-897924-250MG |
Cas.: 5748-33-4 | Purity: ≥95% | 4-Chloro-N-ethyl-6-methylpyrimidin-2-amine | ESD-897924-1G |
Cas.: 1424352-59-9 | Purity: ≥95% | Methyl 2-(2-chlorothiazol-5-yl)acetate | ESD-897925-100MG |
Cas.: 1424352-59-9 | Purity: ≥95% | Methyl 2-(2-chlorothiazol-5-yl)acetate | ESD-897925-250MG |
Cas.: 1424352-59-9 | Purity: ≥95% | Methyl 2-(2-chlorothiazol-5-yl)acetate | ESD-897925-1G |
Cas.: 623564-43-2 | Purity: 95% | 6,8-Dihydro-5H-imidazo[2,1-c][1,4]oxazine-3-carbaldehyde | ESD-897926-100MG |
Cas.: 623564-43-2 | Purity: 95% | 6,8-Dihydro-5H-imidazo[2,1-c][1,4]oxazine-3-carbaldehyde | ESD-897926-250MG |
Cas.: 623564-43-2 | Purity: 95% | 6,8-Dihydro-5H-imidazo[2,1-c][1,4]oxazine-3-carbaldehyde | ESD-897926-1G |
Cas.: 169206-55-7 | Purity: ≥95% | tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate | ESD-897927-100MG |
Cas.: 169206-55-7 | Purity: ≥95% | tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate | ESD-897927-250MG |
Cas.: 169206-55-7 | Purity: ≥95% | tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate | ESD-897927-1G |
Cas.: 204067-34-5 | Purity: ≥95% | 2-(5-Methoxypyridin-2-yl)acetonitrile | ESD-897928-100MG |
Cas.: 204067-34-5 | Purity: ≥95% | 2-(5-Methoxypyridin-2-yl)acetonitrile | ESD-897928-250MG |
Cas.: 204067-34-5 | Purity: ≥95% | 2-(5-Methoxypyridin-2-yl)acetonitrile | ESD-897928-1G |
Cas.: 1082503-79-4 | Purity: ≥95% | 1-Ethyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897929-100MG |
Cas.: 1082503-79-4 | Purity: ≥95% | 1-Ethyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897929-250MG |
Cas.: 1082503-79-4 | Purity: ≥95% | 1-Ethyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-897929-1G |
Cas.: 162155-27-3 | Purity: 97% | 3-Amino-5-methoxyphenol | ESD-897930-100MG |
Cas.: 162155-27-3 | Purity: 97% | 3-Amino-5-methoxyphenol | ESD-897930-250MG |
Cas.: 162155-27-3 | Purity: 97% | 3-Amino-5-methoxyphenol | ESD-897930-1G |
Cas.: 70735-79-4 | Purity: ≥95% | 4-Acetylbenzo[d]oxazol-2(3H)-one | ESD-897931-100MG |
Cas.: 70735-79-4 | Purity: ≥95% | 4-Acetylbenzo[d]oxazol-2(3H)-one | ESD-897931-250MG |
Cas.: 70735-79-4 | Purity: ≥95% | 4-Acetylbenzo[d]oxazol-2(3H)-one | ESD-897931-1G |
Cas.: 1393576-38-9 | Purity: 95% | 2-Chlorobenzo[d]thiazole-5-carboxylic acid | ESD-897932-100MG |
Cas.: 1393576-38-9 | Purity: 95% | 2-Chlorobenzo[d]thiazole-5-carboxylic acid | ESD-897932-250MG |
Cas.: 1393576-38-9 | Purity: 95% | 2-Chlorobenzo[d]thiazole-5-carboxylic acid | ESD-897932-1G |
Cas.: 1211583-69-5 | Purity: ≥95% | 4-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-897933-100MG |
Cas.: 1211583-69-5 | Purity: ≥95% | 4-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-897933-250MG |
Cas.: 1211583-69-5 | Purity: ≥95% | 4-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-897933-1G |
Cas.: 1309598-72-8 | Purity: ≥95% | (R)-1-(2,6-Difluorophenyl)ethanamine hydrochloride | ESD-897934-100MG |
Cas.: 1309598-72-8 | Purity: ≥95% | (R)-1-(2,6-Difluorophenyl)ethanamine hydrochloride | ESD-897934-250MG |
Cas.: 1309598-72-8 | Purity: ≥95% | (R)-1-(2,6-Difluorophenyl)ethanamine hydrochloride | ESD-897934-1G |
Cas.: 1211520-71-6 | Purity: 97% | 2,5-Dibromo-4-methoxypyridine | ESD-897935-100MG |
Cas.: 1211520-71-6 | Purity: 97% | 2,5-Dibromo-4-methoxypyridine | ESD-897935-250MG |
Cas.: 1211520-71-6 | Purity: 97% | 2,5-Dibromo-4-methoxypyridine | ESD-897935-1G |
Cas.: 1202070-39-0 | Purity: ≥95% | (R)-1-(5-Fluoropyridin-2-yl)ethanamine hydrochloride | ESD-897936-100MG |
Cas.: 1202070-39-0 | Purity: ≥95% | (R)-1-(5-Fluoropyridin-2-yl)ethanamine hydrochloride | ESD-897936-250MG |
Cas.: 1202070-39-0 | Purity: ≥95% | (R)-1-(5-Fluoropyridin-2-yl)ethanamine hydrochloride | ESD-897936-1G |
Cas.: 633328-98-0 | Purity: 95% | 5-Chloro-1H-pyrazolo[4,3-d]pyrimidine | ESD-897937-100MG |
Cas.: 633328-98-0 | Purity: 95% | 5-Chloro-1H-pyrazolo[4,3-d]pyrimidine | ESD-897937-250MG |
Cas.: 633328-98-0 | Purity: 95% | 5-Chloro-1H-pyrazolo[4,3-d]pyrimidine | ESD-897937-1G |
Cas.: 1415303-43-3 | Purity: ≥95% | (S)-1-(2,3-Difluorophenyl)ethanamine hydrochloride | ESD-897938-100MG |
Cas.: 1415303-43-3 | Purity: ≥95% | (S)-1-(2,3-Difluorophenyl)ethanamine hydrochloride | ESD-897938-250MG |
Cas.: 1415303-43-3 | Purity: ≥95% | (S)-1-(2,3-Difluorophenyl)ethanamine hydrochloride | ESD-897938-1G |
Cas.: 764717-61-5 | Purity: ≥95% | 2-Chloro-6-methyl-1,5-naphthyridine | ESD-897939-100MG |
Cas.: 764717-61-5 | Purity: ≥95% | 2-Chloro-6-methyl-1,5-naphthyridine | ESD-897939-250MG |
Cas.: 764717-61-5 | Purity: ≥95% | 2-Chloro-6-methyl-1,5-naphthyridine | ESD-897939-1G |
Cas.: 852138-93-3 | Purity: ≥95% | 2,2′-Dibromo-4,4′-diiodo-1,1′-biphenyl | ESD-897940-100MG |
Cas.: 852138-93-3 | Purity: ≥95% | 2,2′-Dibromo-4,4′-diiodo-1,1′-biphenyl | ESD-897940-250MG |
Cas.: 852138-93-3 | Purity: ≥95% | 2,2′-Dibromo-4,4′-diiodo-1,1′-biphenyl | ESD-897940-1G |
Cas.: 824-22-6 | Purity: ≥95% | 4-Methyl-2,3-dihydro-1H-indene | ESD-897941-100MG |
Cas.: 824-22-6 | Purity: ≥95% | 4-Methyl-2,3-dihydro-1H-indene | ESD-897941-250MG |
Cas.: 191231-58-0 | Purity: ≥95% | (S)-tert-Butyl 2-((methylamino)methyl)pyrrolidine-1-carboxylate | ESD-897942-100MG |
Cas.: 191231-58-0 | Purity: ≥95% | (S)-tert-Butyl 2-((methylamino)methyl)pyrrolidine-1-carboxylate | ESD-897942-250MG |
Cas.: 191231-58-0 | Purity: ≥95% | (S)-tert-Butyl 2-((methylamino)methyl)pyrrolidine-1-carboxylate | ESD-897942-1G |
Cas.: 686747-14-8 | Purity: 96% | 2,5-Dimethylbenzo[d]thiazol-6-amine | ESD-897943-100MG |
Cas.: 686747-14-8 | Purity: 96% | 2,5-Dimethylbenzo[d]thiazol-6-amine | ESD-897943-250MG |
Cas.: 686747-14-8 | Purity: 96% | 2,5-Dimethylbenzo[d]thiazol-6-amine | ESD-897943-1G |
Cas.: 361990-21-8 | Purity: 97% | Ethyl 1-(4-bromophenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylate | ESD-897944-100MG |
Cas.: 361990-21-8 | Purity: 97% | Ethyl 1-(4-bromophenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylate | ESD-897944-250MG |
Cas.: 361990-21-8 | Purity: 97% | Ethyl 1-(4-bromophenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylate | ESD-897944-1G |
Cas.: 3308-01-8 | Purity: 97% | 5-Amino-6-methylnicotinonitrile | ESD-897945-100MG |
Cas.: 3308-01-8 | Purity: 97% | 5-Amino-6-methylnicotinonitrile | ESD-897945-250MG |
Cas.: 3308-01-8 | Purity: 97% | 5-Amino-6-methylnicotinonitrile | ESD-897945-1G |
Cas.: 36640-53-6 | Purity: 97% | 3-(Naphthalen-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde | ESD-897946-100MG |
Cas.: 36640-53-6 | Purity: 97% | 3-(Naphthalen-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde | ESD-897946-250MG |
Cas.: 36640-53-6 | Purity: 97% | 3-(Naphthalen-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde | ESD-897946-1G |
Cas.: 1261648-89-8 | Purity: 95% | 4-Hydroxy-2-(trifluoromethoxy)benzonitrile | ESD-897947-100MG |
Cas.: 1261648-89-8 | Purity: 95% | 4-Hydroxy-2-(trifluoromethoxy)benzonitrile | ESD-897947-250MG |
Cas.: 1261648-89-8 | Purity: 95% | 4-Hydroxy-2-(trifluoromethoxy)benzonitrile | ESD-897947-1G |
Cas.: 17274-64-5 | Purity: ≥95% | 1-(4-Aminoindolin-1-yl)ethanone | ESD-897948-100MG |
Cas.: 17274-64-5 | Purity: ≥95% | 1-(4-Aminoindolin-1-yl)ethanone | ESD-897948-250MG |
Cas.: 17274-64-5 | Purity: ≥95% | 1-(4-Aminoindolin-1-yl)ethanone | ESD-897948-1G |
Cas.: 64224-65-3 | Purity: ≥95% | 5-Chloropyrimidine-4-carboxylic acid | ESD-897949-100MG |
Cas.: 64224-65-3 | Purity: ≥95% | 5-Chloropyrimidine-4-carboxylic acid | ESD-897949-250MG |
Cas.: 64224-65-3 | Purity: ≥95% | 5-Chloropyrimidine-4-carboxylic acid | ESD-897949-1G |
Cas.: 1363405-41-7 | Purity: ≥95% | 2-(1-Aminocyclopentyl)acetonitrile hydrochloride | ESD-897950-100MG |
Cas.: 1363405-41-7 | Purity: ≥95% | 2-(1-Aminocyclopentyl)acetonitrile hydrochloride | ESD-897950-250MG |
Cas.: 1363405-41-7 | Purity: ≥95% | 2-(1-Aminocyclopentyl)acetonitrile hydrochloride | ESD-897950-1G |
Cas.: 112892-88-3 | Purity: 97% | Bicyclo[4.2.0]octa-1,3,5-triene-3-carbaldehyde | ESD-897951-100MG |
Cas.: 112892-88-3 | Purity: 97% | Bicyclo[4.2.0]octa-1,3,5-triene-3-carbaldehyde | ESD-897951-250MG |
Cas.: 112892-88-3 | Purity: 97% | Bicyclo[4.2.0]octa-1,3,5-triene-3-carbaldehyde | ESD-897951-1G |
Cas.: 1160994-87-5 | Purity: ≥95% | 4-Chloro-7-(trifluoromethoxy)quinazoline | ESD-897952-100MG |
Cas.: 1160994-87-5 | Purity: ≥95% | 4-Chloro-7-(trifluoromethoxy)quinazoline | ESD-897952-250MG |
Cas.: 1160994-87-5 | Purity: ≥95% | 4-Chloro-7-(trifluoromethoxy)quinazoline | ESD-897952-1G |
Cas.: 802598-74-9 | Purity: 95% | 3-Hydrazinyl-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine | ESD-897953-100MG |
Cas.: 802598-74-9 | Purity: 95% | 3-Hydrazinyl-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine | ESD-897953-250MG |
Cas.: 802598-74-9 | Purity: 95% | 3-Hydrazinyl-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine | ESD-897953-1G |
Cas.: 1453315-68-8 | Purity: 95% | tert-Butyl 7-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate | ESD-897954-100MG |
Cas.: 1453315-68-8 | Purity: 95% | tert-Butyl 7-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate | ESD-897954-250MG |
Cas.: 1453315-68-8 | Purity: 95% | tert-Butyl 7-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate | ESD-897954-1G |
Cas.: 114087-45-5 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)pyridine-2,3-diamine | ESD-897955-100MG |
Cas.: 114087-45-5 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)pyridine-2,3-diamine | ESD-897955-250MG |
Cas.: 114087-45-5 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)pyridine-2,3-diamine | ESD-897955-1G |
Cas.: 204003-85-0 | Purity: 97% | 3-((4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene)indolin-2-one | ESD-897956-100MG |
Cas.: 204003-85-0 | Purity: 97% | 3-((4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene)indolin-2-one | ESD-897956-250MG |
Cas.: 204003-85-0 | Purity: 97% | 3-((4,5,6,7-Tetrahydro-1H-indol-2-yl)methylene)indolin-2-one | ESD-897956-1G |
Cas.: 1374669-63-2 | Purity: 97% | (R)-1-Benzyl 4-tert-butyl 2-cyanopiperazine-1,4-dicarboxylate | ESD-897957-100MG |
Cas.: 1374669-63-2 | Purity: 97% | (R)-1-Benzyl 4-tert-butyl 2-cyanopiperazine-1,4-dicarboxylate | ESD-897957-250MG |
Cas.: 1374669-63-2 | Purity: 97% | (R)-1-Benzyl 4-tert-butyl 2-cyanopiperazine-1,4-dicarboxylate | ESD-897957-1G |
Cas.: 21254-15-9 | Purity: ≥95% | 4-Chloro-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-897958-100MG |
Cas.: 21254-15-9 | Purity: ≥95% | 4-Chloro-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-897958-250MG |
Cas.: 21254-15-9 | Purity: ≥95% | 4-Chloro-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine | ESD-897958-1G |
Cas.: 952345-00-5 | Purity: 97% | (R)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid | ESD-897959-100MG |
Cas.: 952345-00-5 | Purity: 97% | (R)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid | ESD-897959-250MG |
Cas.: 952345-00-5 | Purity: 97% | (R)-1-Methyl-5-oxopyrrolidine-2-carboxylic acid | ESD-897959-1G |
Cas.: 731859-02-2 | Purity: 97% | (R)-6-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897960-100MG |
Cas.: 731859-02-2 | Purity: 97% | (R)-6-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897960-250MG |
Cas.: 731859-02-2 | Purity: 97% | (R)-6-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897960-1G |
Cas.: 1114808-89-7 | Purity: ≥95% | 4-Bromo-2-ethylbenzaldehyde | ESD-897961-100MG |
Cas.: 1114808-89-7 | Purity: ≥95% | 4-Bromo-2-ethylbenzaldehyde | ESD-897961-250MG |
Cas.: 1114808-89-7 | Purity: ≥95% | 4-Bromo-2-ethylbenzaldehyde | ESD-897961-1G |
Cas.: 1251903-83-9 | Purity: ≥95% | (R)-1-tert-Butyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride | ESD-897962-100MG |
Cas.: 1251903-83-9 | Purity: ≥95% | (R)-1-tert-Butyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride | ESD-897962-250MG |
Cas.: 1251903-83-9 | Purity: ≥95% | (R)-1-tert-Butyl 3-methyl piperazine-1,3-dicarboxylate hydrochloride | ESD-897962-1G |
Cas.: 220107-65-3 | Purity: 97% | (2-Amino-5-(trifluoromethyl)phenyl)methanol | ESD-897963-100MG |
Cas.: 220107-65-3 | Purity: 97% | (2-Amino-5-(trifluoromethyl)phenyl)methanol | ESD-897963-250MG |
Cas.: 885321-46-0 | Purity: 97% | (R)-4-tert-Butyl 3-methyl morpholine-3,4-dicarboxylate | ESD-897964-100MG |
Cas.: 885321-46-0 | Purity: 97% | (R)-4-tert-Butyl 3-methyl morpholine-3,4-dicarboxylate | ESD-897964-250MG |
Cas.: 885321-46-0 | Purity: 97% | (R)-4-tert-Butyl 3-methyl morpholine-3,4-dicarboxylate | ESD-897964-1G |
Cas.: 1393330-33-0 | Purity: 97% | 3-(2-Bromoethoxy)propanoic acid | ESD-897965-100MG |
Cas.: 1393330-33-0 | Purity: 97% | 3-(2-Bromoethoxy)propanoic acid | ESD-897965-250MG |
Cas.: 1393330-33-0 | Purity: 97% | 3-(2-Bromoethoxy)propanoic acid | ESD-897965-1G |
Cas.: 131019-87-9 | Purity: 97% | N1,5-Dimethylbenzene-1,2-diamine | ESD-897966-100MG |
Cas.: 131019-87-9 | Purity: 97% | N1,5-Dimethylbenzene-1,2-diamine | ESD-897966-250MG |
Cas.: 131019-87-9 | Purity: 97% | N1,5-Dimethylbenzene-1,2-diamine | ESD-897966-1G |
Cas.: 1224194-44-8 | Purity: 97% | 2-(tert-Butoxycarbonyl)-6-chloronicotinic acid | ESD-897967-100MG |
Cas.: 1224194-44-8 | Purity: 97% | 2-(tert-Butoxycarbonyl)-6-chloronicotinic acid | ESD-897967-250MG |
Cas.: 1224194-44-8 | Purity: 97% | 2-(tert-Butoxycarbonyl)-6-chloronicotinic acid | ESD-897967-1G |
Cas.: 1196145-01-3 | Purity: ≥95% | Benzyl 3-amino-4-oxopiperidine-1-carboxylate hydrochloride | ESD-897968-100MG |
Cas.: 1196145-01-3 | Purity: ≥95% | Benzyl 3-amino-4-oxopiperidine-1-carboxylate hydrochloride | ESD-897968-250MG |
Cas.: 1196145-01-3 | Purity: ≥95% | Benzyl 3-amino-4-oxopiperidine-1-carboxylate hydrochloride | ESD-897968-1G |
Cas.: 22162-15-8 | Purity: 95% | (2-Methyl-4-nitrophenyl)methanol | ESD-897969-100MG |
Cas.: 22162-15-8 | Purity: 95% | (2-Methyl-4-nitrophenyl)methanol | ESD-897969-250MG |
Cas.: 22162-15-8 | Purity: 95% | (2-Methyl-4-nitrophenyl)methanol | ESD-897969-1G |
Cas.: 1245643-85-9 | Purity: 97% | 1-(5-Bromopyrimidin-4-yl)ethanone | ESD-897970-100MG |
Cas.: 1245643-85-9 | Purity: 97% | 1-(5-Bromopyrimidin-4-yl)ethanone | ESD-897970-250MG |
Cas.: 1245643-85-9 | Purity: 97% | 1-(5-Bromopyrimidin-4-yl)ethanone | ESD-897970-1G |
Cas.: 40154-84-5 | Purity: ≥95% | (S)-1-(Pyridin-3-yl)ethanamine dihydrochloride | ESD-897971-100MG |
Cas.: 40154-84-5 | Purity: ≥95% | (S)-1-(Pyridin-3-yl)ethanamine dihydrochloride | ESD-897971-250MG |
Cas.: 40154-84-5 | Purity: ≥95% | (S)-1-(Pyridin-3-yl)ethanamine dihydrochloride | ESD-897971-1G |
Cas.: 111841-05-5 | Purity: ≥95% | 2-Bromo-1-(5-chloro-2-methoxyphenyl)ethanone | ESD-897972-100MG |
Cas.: 111841-05-5 | Purity: ≥95% | 2-Bromo-1-(5-chloro-2-methoxyphenyl)ethanone | ESD-897972-250MG |
Cas.: 111841-05-5 | Purity: ≥95% | 2-Bromo-1-(5-chloro-2-methoxyphenyl)ethanone | ESD-897972-1G |
Cas.: 1965314-73-1 | Purity: 97% | (S)-Isoindoline-1-carboxylic acid hydrochloride | ESD-897973-100MG |
Cas.: 1965314-73-1 | Purity: 97% | (S)-Isoindoline-1-carboxylic acid hydrochloride | ESD-897973-250MG |
Cas.: 1965314-73-1 | Purity: 97% | (S)-Isoindoline-1-carboxylic acid hydrochloride | ESD-897973-1G |
Cas.: 1391452-66-6 | Purity: ≥95% | (S)-2-(3-Bromophenyl)pyrrolidine hydrochloride | ESD-897974-100MG |
Cas.: 1391452-66-6 | Purity: ≥95% | (S)-2-(3-Bromophenyl)pyrrolidine hydrochloride | ESD-897974-250MG |
Cas.: 1391452-66-6 | Purity: ≥95% | (S)-2-(3-Bromophenyl)pyrrolidine hydrochloride | ESD-897974-1G |
Cas.: 1443238-61-6 | Purity: 97% | (R)-5-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897975-100MG |
Cas.: 1443238-61-6 | Purity: 97% | (R)-5-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897975-250MG |
Cas.: 1443238-61-6 | Purity: 97% | (R)-5-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-897975-1G |
Cas.: 1092351-93-3 | Purity: ≥95% | Ethyl 4-aminobenzofuran-2-carboxylate | ESD-897976-100MG |
Cas.: 1092351-93-3 | Purity: ≥95% | Ethyl 4-aminobenzofuran-2-carboxylate | ESD-897976-250MG |
Cas.: 1092351-93-3 | Purity: ≥95% | Ethyl 4-aminobenzofuran-2-carboxylate | ESD-897976-1G |
Cas.: 856563-12-7 | Purity: ≥95% | (S)-1-(2,4-Dimethylphenyl)ethanamine | ESD-897977-100MG |
Cas.: 856563-12-7 | Purity: ≥95% | (S)-1-(2,4-Dimethylphenyl)ethanamine | ESD-897977-250MG |
Cas.: 856563-12-7 | Purity: ≥95% | (S)-1-(2,4-Dimethylphenyl)ethanamine | ESD-897977-1G |
Cas.: 90868-92-1 | Purity: 95% | (4-Bromophenyl)(cyclopropyl)methanamine | ESD-897978-100MG |
Cas.: 90868-92-1 | Purity: 95% | (4-Bromophenyl)(cyclopropyl)methanamine | ESD-897978-250MG |
Cas.: 90868-92-1 | Purity: 95% | (4-Bromophenyl)(cyclopropyl)methanamine | ESD-897978-1G |
Cas.: 959986-66-4 | Purity: 98% | 4-Iodo-1-methyl-1H-pyrazole-5-carbaldehyde | ESD-897979-100MG |
Cas.: 959986-66-4 | Purity: 98% | 4-Iodo-1-methyl-1H-pyrazole-5-carbaldehyde | ESD-897979-250MG |
Cas.: 959986-66-4 | Purity: 98% | 4-Iodo-1-methyl-1H-pyrazole-5-carbaldehyde | ESD-897979-1G |
Cas.: 121496-39-7 | Purity: ≥95% | tert-Butyl benzyl(2-hydroxyethyl)carbamate | ESD-897980-100MG |
Cas.: 121496-39-7 | Purity: ≥95% | tert-Butyl benzyl(2-hydroxyethyl)carbamate | ESD-897980-250MG |
Cas.: 121496-39-7 | Purity: ≥95% | tert-Butyl benzyl(2-hydroxyethyl)carbamate | ESD-897980-1G |
Cas.: 59394-30-8 | Purity: ≥95% | 6-Chloroquinoline-2-carboxylic acid | ESD-897981-100MG |
Cas.: 59394-30-8 | Purity: ≥95% | 6-Chloroquinoline-2-carboxylic acid | ESD-897981-250MG |
Cas.: 59394-30-8 | Purity: ≥95% | 6-Chloroquinoline-2-carboxylic acid | ESD-897981-1G |
Cas.: 1416445-02-7 | Purity: 97% | (R)-4-(tert-Butoxycarbonyl)-6,6-dimethylmorpholine-2-carboxylic acid | ESD-897982-100MG |
Cas.: 1416445-02-7 | Purity: 97% | (R)-4-(tert-Butoxycarbonyl)-6,6-dimethylmorpholine-2-carboxylic acid | ESD-897982-250MG |
Cas.: 1416445-02-7 | Purity: 97% | (R)-4-(tert-Butoxycarbonyl)-6,6-dimethylmorpholine-2-carboxylic acid | ESD-897982-1G |
Cas.: 5054-94-4 | Purity: 97% | (2,3-Dimethyl-1H-indol-5-yl)methanamine | ESD-897983-100MG |
Cas.: 5054-94-4 | Purity: 97% | (2,3-Dimethyl-1H-indol-5-yl)methanamine | ESD-897983-250MG |
Cas.: 5054-94-4 | Purity: 97% | (2,3-Dimethyl-1H-indol-5-yl)methanamine | ESD-897983-1G |
Cas.: 354795-62-3 | Purity: ≥95% | 3-Methylisoxazol-4-amine | ESD-897984-100MG |
Cas.: 354795-62-3 | Purity: ≥95% | 3-Methylisoxazol-4-amine | ESD-897984-250MG |
Cas.: 354795-62-3 | Purity: ≥95% | 3-Methylisoxazol-4-amine | ESD-897984-1G |
Cas.: 1890194-45-2 | Purity: 95% | 2-(Difluoromethyl)pyridin-4-amine hydrochloride | ESD-897985-100MG |
Cas.: 1890194-45-2 | Purity: 95% | 2-(Difluoromethyl)pyridin-4-amine hydrochloride | ESD-897985-250MG |
Cas.: 1890194-45-2 | Purity: 95% | 2-(Difluoromethyl)pyridin-4-amine hydrochloride | ESD-897985-1G |
Cas.: 57775-06-1 | Purity: 97% | 2-(2-Bromophenyl)-2-methylpropanenitrile | ESD-897986-100MG |
Cas.: 57775-06-1 | Purity: 97% | 2-(2-Bromophenyl)-2-methylpropanenitrile | ESD-897986-250MG |
Cas.: 57775-06-1 | Purity: 97% | 2-(2-Bromophenyl)-2-methylpropanenitrile | ESD-897986-1G |
Cas.: 163685-38-9 | Purity: ≥95% | 1-(Isopropylamino)-3-(2-(2-methoxyethyl)phenoxy)propan-2-ol | ESD-897987-100MG |
Cas.: 163685-38-9 | Purity: ≥95% | 1-(Isopropylamino)-3-(2-(2-methoxyethyl)phenoxy)propan-2-ol | ESD-897987-250MG |
Cas.: 163685-38-9 | Purity: ≥95% | 1-(Isopropylamino)-3-(2-(2-methoxyethyl)phenoxy)propan-2-ol | ESD-897987-1G |
Cas.: 172361-60-3 | Purity: 97% | DMT-DMF-dG | ESD-897988-100MG |
Cas.: 172361-60-3 | Purity: 97% | DMT-DMF-dG | ESD-897988-250MG |
Cas.: 172361-60-3 | Purity: 97% | DMT-DMF-dG | ESD-897988-1G |
Cas.: 184151-49-3 | Purity: 97% | Methyl 3-methyl-1H-indole-6-carboxylate | ESD-897989-100MG |
Cas.: 184151-49-3 | Purity: 97% | Methyl 3-methyl-1H-indole-6-carboxylate | ESD-897989-250MG |
Cas.: 184151-49-3 | Purity: 97% | Methyl 3-methyl-1H-indole-6-carboxylate | ESD-897989-1G |
Cas.: 950746-21-1 | Purity: 97% | 6,8-Dichloro-2,7-naphthyridin-1(2H)-one | ESD-897990-100MG |
Cas.: 950746-21-1 | Purity: 97% | 6,8-Dichloro-2,7-naphthyridin-1(2H)-one | ESD-897990-250MG |
Cas.: 950746-21-1 | Purity: 97% | 6,8-Dichloro-2,7-naphthyridin-1(2H)-one | ESD-897990-1G |
Cas.: 1161931-71-0 | Purity: 95% | (2R,4R)-1-Boc-2-Hydroxymethyl-4-aminopyrrolidine hydrochloride | ESD-897991-100MG |
Cas.: 1161931-71-0 | Purity: 95% | (2R,4R)-1-Boc-2-Hydroxymethyl-4-aminopyrrolidine hydrochloride | ESD-897991-250MG |
Cas.: 1161931-71-0 | Purity: 95% | (2R,4R)-1-Boc-2-Hydroxymethyl-4-aminopyrrolidine hydrochloride | ESD-897991-1G |
Cas.: 90326-61-7 | Purity: ≥95% | 5-Bromo-2-methoxy-4-methylbenzoic acid | ESD-897992-100MG |
Cas.: 90326-61-7 | Purity: ≥95% | 5-Bromo-2-methoxy-4-methylbenzoic acid | ESD-897992-250MG |
Cas.: 90326-61-7 | Purity: ≥95% | 5-Bromo-2-methoxy-4-methylbenzoic acid | ESD-897992-1G |
Cas.: 1315360-75-8 | Purity: 97% | 3-Bromoimidazo[1,2-a]pyridine-7-carboxylic acid | ESD-897993-100MG |
Cas.: 1315360-75-8 | Purity: 97% | 3-Bromoimidazo[1,2-a]pyridine-7-carboxylic acid | ESD-897993-250MG |
Cas.: 1315360-75-8 | Purity: 97% | 3-Bromoimidazo[1,2-a]pyridine-7-carboxylic acid | ESD-897993-1G |
Cas.: 73289-79-9 | Purity: 97% | 5-Formyl-2-hydroxybenzonitrile | ESD-897994-100MG |
Cas.: 73289-79-9 | Purity: 97% | 5-Formyl-2-hydroxybenzonitrile | ESD-897994-250MG |
Cas.: 73289-79-9 | Purity: 97% | 5-Formyl-2-hydroxybenzonitrile | ESD-897994-1G |
Cas.: 914802-11-2 | Purity: ≥95% | 4-((Benzyloxy)methyl)-6-chloropyrimidine | ESD-897995-100MG |
Cas.: 914802-11-2 | Purity: ≥95% | 4-((Benzyloxy)methyl)-6-chloropyrimidine | ESD-897995-250MG |
Cas.: 914802-11-2 | Purity: ≥95% | 4-((Benzyloxy)methyl)-6-chloropyrimidine | ESD-897995-1G |
Cas.: 1607469-49-7 | Purity: 97% | (Ir[Me(Me)ppy]2(dtbpy))PF6 | ESD-897996-100MG |
Cas.: 1607469-49-7 | Purity: 97% | (Ir[Me(Me)ppy]2(dtbpy))PF6 | ESD-897996-250MG |
Cas.: 1607469-49-7 | Purity: 97% | (Ir[Me(Me)ppy]2(dtbpy))PF6 | ESD-897996-1G |
Cas.: 1199782-93-8 | Purity: 97% | 7-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897997-100MG |
Cas.: 1199782-93-8 | Purity: 97% | 7-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897997-250MG |
Cas.: 1199782-93-8 | Purity: 97% | 7-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-897997-1G |
Cas.: 1379476-75-1 | Purity: ≥95% | (6-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-5-methylpyridin-3-yl)boronic acid | ESD-897998-100MG |
Cas.: 1379476-75-1 | Purity: ≥95% | (6-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-5-methylpyridin-3-yl)boronic acid | ESD-897998-250MG |
Cas.: 1379476-75-1 | Purity: ≥95% | (6-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-5-methylpyridin-3-yl)boronic acid | ESD-897998-1G |
Cas.: 790305-05-4 | Purity: 97% | ITMN 4077 | ESD-897999-100MG |
Cas.: 790305-05-4 | Purity: 97% | ITMN 4077 | ESD-897999-250MG |
Cas.: 790305-05-4 | Purity: 97% | ITMN 4077 | ESD-897999-1G |
Cas.: 18112-31-7 | Purity: 98% | 3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine | ESD-898000-100MG |
Cas.: 18112-31-7 | Purity: 98% | 3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine | ESD-898000-250MG |
Cas.: 18112-31-7 | Purity: 98% | 3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine | ESD-898000-1G |
Cas.: 69047-36-5 | Purity: 97% | 1-Methyl-1H-indole-7-carbaldehyde | ESD-898001-100MG |
Cas.: 69047-36-5 | Purity: 97% | 1-Methyl-1H-indole-7-carbaldehyde | ESD-898001-250MG |
Cas.: 69047-36-5 | Purity: 97% | 1-Methyl-1H-indole-7-carbaldehyde | ESD-898001-1G |
Cas.: 10133-22-9 | Purity: 97% | 5-(Bromomethyl)benzo[b]thiophene | ESD-898002-100MG |
Cas.: 10133-22-9 | Purity: 97% | 5-(Bromomethyl)benzo[b]thiophene | ESD-898002-250MG |
Cas.: 10133-22-9 | Purity: 97% | 5-(Bromomethyl)benzo[b]thiophene | ESD-898002-1G |
Cas.: 27385-45-1 | Purity: ≥95% | (Z)-3-(2-Phenylhydrazono)cyclohexanone | ESD-898003-100MG |
Cas.: 27385-45-1 | Purity: ≥95% | (Z)-3-(2-Phenylhydrazono)cyclohexanone | ESD-898003-250MG |
Cas.: 27385-45-1 | Purity: ≥95% | (Z)-3-(2-Phenylhydrazono)cyclohexanone | ESD-898003-1G |
Cas.: 1049978-93-9 | Purity: ≥95% | trans-4-(4-Methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride | ESD-898004-100MG |
Cas.: 1049978-93-9 | Purity: ≥95% | trans-4-(4-Methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride | ESD-898004-250MG |
Cas.: 1049978-93-9 | Purity: ≥95% | trans-4-(4-Methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride | ESD-898004-1G |
Cas.: 1427395-43-4 | Purity: 95% | 4-Chloro-2-fluoro-6-methylbenzoic acid | ESD-898005-100MG |
Cas.: 1427395-43-4 | Purity: 95% | 4-Chloro-2-fluoro-6-methylbenzoic acid | ESD-898005-250MG |
Cas.: 1427395-43-4 | Purity: 95% | 4-Chloro-2-fluoro-6-methylbenzoic acid | ESD-898005-1G |
Cas.: 889451-31-4 | Purity: 97% | 1-(1H-Pyrazolo[3,4-b]pyridin-3-yl)ethanone | ESD-898006-100MG |
Cas.: 889451-31-4 | Purity: 97% | 1-(1H-Pyrazolo[3,4-b]pyridin-3-yl)ethanone | ESD-898006-250MG |
Cas.: 889451-31-4 | Purity: 97% | 1-(1H-Pyrazolo[3,4-b]pyridin-3-yl)ethanone | ESD-898006-1G |
Cas.: 1012067-91-2 | Purity: 97% | (R)-1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-898007-100MG |
Cas.: 1012067-91-2 | Purity: 97% | (R)-1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-898007-250MG |
Cas.: 1012067-91-2 | Purity: 97% | (R)-1-(Pyridin-4-yl)ethanamine dihydrochloride | ESD-898007-1G |
Cas.: 1212202-62-4 | Purity: 97% | (S)-1-(4-(Methylsulfonyl)phenyl)ethanamine hydrochloride | ESD-898008-100MG |
Cas.: 1212202-62-4 | Purity: 97% | (S)-1-(4-(Methylsulfonyl)phenyl)ethanamine hydrochloride | ESD-898008-250MG |
Cas.: 1212202-62-4 | Purity: 97% | (S)-1-(4-(Methylsulfonyl)phenyl)ethanamine hydrochloride | ESD-898008-1G |
Cas.: 51463-15-1 | Purity: ≥95% | 6-Fluoroisoquinolin-3(2H)-one | ESD-898009-100MG |
Cas.: 51463-15-1 | Purity: ≥95% | 6-Fluoroisoquinolin-3(2H)-one | ESD-898009-250MG |
Cas.: 51463-15-1 | Purity: ≥95% | 6-Fluoroisoquinolin-3(2H)-one | ESD-898009-1G |
Cas.: 1504465-76-2 | Purity: ≥95% | (2-Amino-5-(trifluoromethyl)phenyl)(2-fluorophenyl)methanone | ESD-898010-100MG |
Cas.: 1504465-76-2 | Purity: ≥95% | (2-Amino-5-(trifluoromethyl)phenyl)(2-fluorophenyl)methanone | ESD-898010-250MG |
Cas.: 1504465-76-2 | Purity: ≥95% | (2-Amino-5-(trifluoromethyl)phenyl)(2-fluorophenyl)methanone | ESD-898010-1G |
Cas.: 29421-99-6 | Purity: 97% | 4-Bromo-5-methylthiophene-2-carboxylic acid | ESD-898011-100MG |
Cas.: 29421-99-6 | Purity: 97% | 4-Bromo-5-methylthiophene-2-carboxylic acid | ESD-898011-250MG |
Cas.: 29421-99-6 | Purity: 97% | 4-Bromo-5-methylthiophene-2-carboxylic acid | ESD-898011-1G |
Cas.: 1998216-51-5 | Purity: 97% | Methyl 3-amino-5,6-dihydro-4H-thieno[2,3-c]pyrrole-2-carboxylate dihydrochloride | ESD-898012-100MG |
Cas.: 1998216-51-5 | Purity: 97% | Methyl 3-amino-5,6-dihydro-4H-thieno[2,3-c]pyrrole-2-carboxylate dihydrochloride | ESD-898012-250MG |
Cas.: 1998216-51-5 | Purity: 97% | Methyl 3-amino-5,6-dihydro-4H-thieno[2,3-c]pyrrole-2-carboxylate dihydrochloride | ESD-898012-1G |
Cas.: 1260099-72-6 | Purity: 97% | tert-Butyl 4-((2-hydroxyethoxy)methyl)piperidine-1-carboxylate | ESD-898013-100MG |
Cas.: 1260099-72-6 | Purity: 97% | tert-Butyl 4-((2-hydroxyethoxy)methyl)piperidine-1-carboxylate | ESD-898013-250MG |
Cas.: 1260099-72-6 | Purity: 97% | tert-Butyl 4-((2-hydroxyethoxy)methyl)piperidine-1-carboxylate | ESD-898013-1G |
Cas.: 800401-70-1 | Purity: 98% | Ethyl 5-bromo-1H-pyrrolo-[2,3-c]-pyridine-2-carboxylate | ESD-898014-100MG |
Cas.: 800401-70-1 | Purity: 98% | Ethyl 5-bromo-1H-pyrrolo-[2,3-c]-pyridine-2-carboxylate | ESD-898014-250MG |
Cas.: 800401-70-1 | Purity: 98% | Ethyl 5-bromo-1H-pyrrolo-[2,3-c]-pyridine-2-carboxylate | ESD-898014-1G |
Cas.: 107484-69-5 | Purity: ≥95% | 5-Chloro-8-iodo-1,6-naphthyridine | ESD-898015-100MG |
Cas.: 107484-69-5 | Purity: ≥95% | 5-Chloro-8-iodo-1,6-naphthyridine | ESD-898015-250MG |
Cas.: 107484-69-5 | Purity: ≥95% | 5-Chloro-8-iodo-1,6-naphthyridine | ESD-898015-1G |
Cas.: 314298-13-0 | Purity: 98% | 1-Fluoro-5-methoxy-2-methyl-4-nitrobenzene | ESD-898016-100MG |
Cas.: 314298-13-0 | Purity: 98% | 1-Fluoro-5-methoxy-2-methyl-4-nitrobenzene | ESD-898016-250MG |
Cas.: 314298-13-0 | Purity: 98% | 1-Fluoro-5-methoxy-2-methyl-4-nitrobenzene | ESD-898016-1G |
Cas.: 86324-51-8 | Purity: 96% | 6-Fluoroquinoline-2-carboxylic acid | ESD-898017-100MG |
Cas.: 86324-51-8 | Purity: 96% | 6-Fluoroquinoline-2-carboxylic acid | ESD-898017-250MG |
Cas.: 86324-51-8 | Purity: 96% | 6-Fluoroquinoline-2-carboxylic acid | ESD-898017-1G |
Cas.: 1060817-54-0 | Purity: ≥95% | 5-(Chloromethyl)-4-isopropyl-1,2,3-thiadiazole | ESD-898018-100MG |
Cas.: 1060817-54-0 | Purity: ≥95% | 5-(Chloromethyl)-4-isopropyl-1,2,3-thiadiazole | ESD-898018-250MG |
Cas.: 1060817-54-0 | Purity: ≥95% | 5-(Chloromethyl)-4-isopropyl-1,2,3-thiadiazole | ESD-898018-1G |
Cas.: 67713-99-9 | Purity: 95% | 3-(Chloromethyl)benzofuran | ESD-898019-100MG |
Cas.: 67713-99-9 | Purity: 95% | 3-(Chloromethyl)benzofuran | ESD-898019-250MG |
Cas.: 67713-99-9 | Purity: 95% | 3-(Chloromethyl)benzofuran | ESD-898019-1G |
Cas.: 29850-85-9 | Purity: 97% | (R)-1-(4-Chlorophenyl)-N-methylethanamine hydrochloride | ESD-898020-100MG |
Cas.: 29850-85-9 | Purity: 97% | (R)-1-(4-Chlorophenyl)-N-methylethanamine hydrochloride | ESD-898020-250MG |
Cas.: 29850-85-9 | Purity: 97% | (R)-1-(4-Chlorophenyl)-N-methylethanamine hydrochloride | ESD-898020-1G |
Cas.: 1353973-60-0 | Purity: 97% | 6-Chloro-N-methyl-2-(methylsulfonyl)pyrimidin-4-amine | ESD-898021-100MG |
Cas.: 1353973-60-0 | Purity: 97% | 6-Chloro-N-methyl-2-(methylsulfonyl)pyrimidin-4-amine | ESD-898021-250MG |
Cas.: 1353973-60-0 | Purity: 97% | 6-Chloro-N-methyl-2-(methylsulfonyl)pyrimidin-4-amine | ESD-898021-1G |
Cas.: 1296225-26-7 | Purity: 95% | (1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-yl)methanol | ESD-898022-100MG |
Cas.: 1296225-26-7 | Purity: 95% | (1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-yl)methanol | ESD-898022-250MG |
Cas.: 1296225-26-7 | Purity: 95% | (1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-yl)methanol | ESD-898022-1G |
Cas.: 1147883-41-7 | Purity: 97% | (S)-2-Amino-2-(4-chlorophenyl)ethanol hydrochloride | ESD-898023-100MG |
Cas.: 1147883-41-7 | Purity: 97% | (S)-2-Amino-2-(4-chlorophenyl)ethanol hydrochloride | ESD-898023-250MG |
Cas.: 1147883-41-7 | Purity: 97% | (S)-2-Amino-2-(4-chlorophenyl)ethanol hydrochloride | ESD-898023-1G |
Cas.: 172216-98-7 | Purity: ≥95% | 7-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-898024-100MG |
Cas.: 172216-98-7 | Purity: ≥95% | 7-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-898024-250MG |
Cas.: 172216-98-7 | Purity: ≥95% | 7-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-898024-1G |
Cas.: 1081548-91-5 | Purity: ≥99% | (1R,2R)-2-(Methylamino)-1,2-diphenylethanol | ESD-898025-100MG |
Cas.: 1081548-91-5 | Purity: ≥99% | (1R,2R)-2-(Methylamino)-1,2-diphenylethanol | ESD-898025-250MG |
Cas.: 1000152-84-0 | Purity: ≥95% | 2,6-Dibromo-4-(trifluoromethyl)pyridine | ESD-898026-100MG |
Cas.: 1000152-84-0 | Purity: ≥95% | 2,6-Dibromo-4-(trifluoromethyl)pyridine | ESD-898026-250MG |
Cas.: 1000152-84-0 | Purity: ≥95% | 2,6-Dibromo-4-(trifluoromethyl)pyridine | ESD-898026-1G |
Cas.: 1373503-66-2 | Purity: ≥95% | 4-(3,3-Difluoroazetidin-1-yl)piperidine dihydrochloride | ESD-898027-100MG |
Cas.: 1373503-66-2 | Purity: ≥95% | 4-(3,3-Difluoroazetidin-1-yl)piperidine dihydrochloride | ESD-898027-250MG |
Cas.: 1373503-66-2 | Purity: ≥95% | 4-(3,3-Difluoroazetidin-1-yl)piperidine dihydrochloride | ESD-898027-1G |
Cas.: 114248-23-6 | Purity: 98% | 2′-Deoxy-2′,2′-difluorouridine | ESD-898028-100MG |
Cas.: 114248-23-6 | Purity: 98% | 2′-Deoxy-2′,2′-difluorouridine | ESD-898028-250MG |
Cas.: 114248-23-6 | Purity: 98% | 2′-Deoxy-2′,2′-difluorouridine | ESD-898028-1G |
Cas.: 1049733-10-9 | Purity: 97% | (R)-2-(Prop-2-yn-1-yl)pyrrolidine-2-carboxylic acid hydrochloride | ESD-898029-100MG |
Cas.: 1049733-10-9 | Purity: 97% | (R)-2-(Prop-2-yn-1-yl)pyrrolidine-2-carboxylic acid hydrochloride | ESD-898029-250MG |
Cas.: 1049733-10-9 | Purity: 97% | (R)-2-(Prop-2-yn-1-yl)pyrrolidine-2-carboxylic acid hydrochloride | ESD-898029-1G |
Cas.: 1266230-22-1 | Purity: ≥95% | (R)-7-Fluorochroman-4-amine hydrochloride | ESD-898030-100MG |
Cas.: 1266230-22-1 | Purity: ≥95% | (R)-7-Fluorochroman-4-amine hydrochloride | ESD-898030-250MG |
Cas.: 1266230-22-1 | Purity: ≥95% | (R)-7-Fluorochroman-4-amine hydrochloride | ESD-898030-1G |
Cas.: 668268-68-6 | Purity: ≥95% | 4,6-Dichloro-1H-imidazo[4,5-c]pyridin-2(3H)-one | ESD-898031-100MG |
Cas.: 668268-68-6 | Purity: ≥95% | 4,6-Dichloro-1H-imidazo[4,5-c]pyridin-2(3H)-one | ESD-898031-250MG |
Cas.: 668268-68-6 | Purity: ≥95% | 4,6-Dichloro-1H-imidazo[4,5-c]pyridin-2(3H)-one | ESD-898031-1G |
Cas.: 478968-48-8 | Purity: 96% | Ethyl 3-methoxy-1H-pyrazole-4-carboxylate | ESD-898032-100MG |
Cas.: 478968-48-8 | Purity: 96% | Ethyl 3-methoxy-1H-pyrazole-4-carboxylate | ESD-898032-250MG |
Cas.: 478968-48-8 | Purity: 96% | Ethyl 3-methoxy-1H-pyrazole-4-carboxylate | ESD-898032-1G |
Cas.: 1211518-35-2 | Purity: 97% | Methyl 6-chloro-5-(trifluoromethyl)picolinate | ESD-898033-100MG |
Cas.: 1211518-35-2 | Purity: 97% | Methyl 6-chloro-5-(trifluoromethyl)picolinate | ESD-898033-250MG |
Cas.: 1211518-35-2 | Purity: 97% | Methyl 6-chloro-5-(trifluoromethyl)picolinate | ESD-898033-1G |
Cas.: 185963-32-0 | Purity: 97% | 3,5-Bis(aminomethyl)benzoic acid dihydrochloride | ESD-898034-100MG |
Cas.: 185963-32-0 | Purity: 97% | 3,5-Bis(aminomethyl)benzoic acid dihydrochloride | ESD-898034-250MG |
Cas.: 185963-32-0 | Purity: 97% | 3,5-Bis(aminomethyl)benzoic acid dihydrochloride | ESD-898034-1G |
Cas.: 1019351-46-2 | Purity: ≥95% | Methyl 4-aminopiperidine-1-carboxylate | ESD-898035-100MG |
Cas.: 1019351-46-2 | Purity: ≥95% | Methyl 4-aminopiperidine-1-carboxylate | ESD-898035-250MG |
Cas.: 1019351-46-2 | Purity: ≥95% | Methyl 4-aminopiperidine-1-carboxylate | ESD-898035-1G |
Cas.: 192725-45-4 | Purity: ≥97% | tert-Butyl ((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-898036-100MG |
Cas.: 192725-45-4 | Purity: ≥97% | tert-Butyl ((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-898036-250MG |
Cas.: 192725-45-4 | Purity: ≥97% | tert-Butyl ((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-898036-1G |
Cas.: 1321963-74-9 | Purity: 95% | 2-Fluoro-1-iodo-4-(trifluoromethoxy)benzene | ESD-898037-100MG |
Cas.: 1321963-74-9 | Purity: 95% | 2-Fluoro-1-iodo-4-(trifluoromethoxy)benzene | ESD-898037-250MG |
Cas.: 1321963-74-9 | Purity: 95% | 2-Fluoro-1-iodo-4-(trifluoromethoxy)benzene | ESD-898037-1G |
Cas.: 1207557-47-8 | Purity: 97% | Methyl 4-bromo-5-(difluoromethyl)thiophene-2-carboxylate | ESD-898038-100MG |
Cas.: 1207557-47-8 | Purity: 97% | Methyl 4-bromo-5-(difluoromethyl)thiophene-2-carboxylate | ESD-898038-250MG |
Cas.: 1207557-47-8 | Purity: 97% | Methyl 4-bromo-5-(difluoromethyl)thiophene-2-carboxylate | ESD-898038-1G |
Cas.: 1449131-17-2 | Purity: ≥95% | (S)-2-(4-Chlorophenyl)-3-(isopropylamino)propanoic acid hydrochloride | ESD-898039-100MG |
Cas.: 1449131-17-2 | Purity: ≥95% | (S)-2-(4-Chlorophenyl)-3-(isopropylamino)propanoic acid hydrochloride | ESD-898039-250MG |
Cas.: 1449131-17-2 | Purity: ≥95% | (S)-2-(4-Chlorophenyl)-3-(isopropylamino)propanoic acid hydrochloride | ESD-898039-1G |
Cas.: 1431699-56-7 | Purity: ≥95% | (R)-1-(2-Nitrophenyl)ethanamine hydrochloride | ESD-898040-100MG |
Cas.: 1431699-56-7 | Purity: ≥95% | (R)-1-(2-Nitrophenyl)ethanamine hydrochloride | ESD-898040-250MG |
Cas.: 1431699-56-7 | Purity: ≥95% | (R)-1-(2-Nitrophenyl)ethanamine hydrochloride | ESD-898040-1G |
Cas.: 161957-47-7 | Purity: ≥95% | 2,2,2-Trifluoro-1-(1H-pyrazol-4-yl)ethanone | ESD-898041-100MG |
Cas.: 161957-47-7 | Purity: ≥95% | 2,2,2-Trifluoro-1-(1H-pyrazol-4-yl)ethanone | ESD-898041-250MG |
Cas.: 161957-47-7 | Purity: ≥95% | 2,2,2-Trifluoro-1-(1H-pyrazol-4-yl)ethanone | ESD-898041-1G |
Cas.: 1228560-90-4 | Purity: ≥95% | (R)-2-(4-Chlorophenyl)pyrrolidine hydrochloride | ESD-898042-100MG |
Cas.: 1228560-90-4 | Purity: ≥95% | (R)-2-(4-Chlorophenyl)pyrrolidine hydrochloride | ESD-898042-250MG |
Cas.: 1228560-90-4 | Purity: ≥95% | (R)-2-(4-Chlorophenyl)pyrrolidine hydrochloride | ESD-898042-1G |
Cas.: 125903-77-7 | Purity: ≥95% | 3-Methylpicolinimidamide hydrochloride | ESD-898043-100MG |
Cas.: 125903-77-7 | Purity: ≥95% | 3-Methylpicolinimidamide hydrochloride | ESD-898043-250MG |
Cas.: 125903-77-7 | Purity: ≥95% | 3-Methylpicolinimidamide hydrochloride | ESD-898043-1G |
Cas.: 71616-83-6 | Purity: 97% | Methyl 4-butyrylbenzoate | ESD-898044-100MG |
Cas.: 71616-83-6 | Purity: 97% | Methyl 4-butyrylbenzoate | ESD-898044-250MG |
Cas.: 71616-83-6 | Purity: 97% | Methyl 4-butyrylbenzoate | ESD-898044-1G |
Cas.: 1624260-16-7 | Purity: ≥95% | 7,7-Difluorotetrahydropyrrolo[1,2-a]pyrazine-1,3(2H,4H)-dione | ESD-898046-100MG |
Cas.: 1624260-16-7 | Purity: ≥95% | 7,7-Difluorotetrahydropyrrolo[1,2-a]pyrazine-1,3(2H,4H)-dione | ESD-898046-250MG |
Cas.: 1624260-16-7 | Purity: ≥95% | 7,7-Difluorotetrahydropyrrolo[1,2-a]pyrazine-1,3(2H,4H)-dione | ESD-898046-1G |
Cas.: 1048919-15-8 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-6-fluorobenzoic acid | ESD-898047-100MG |
Cas.: 1048919-15-8 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-6-fluorobenzoic acid | ESD-898047-250MG |
Cas.: 1048919-15-8 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-6-fluorobenzoic acid | ESD-898047-1G |
Cas.: 1329166-90-6 | Purity: 97% | 4,6-Difluoro-1-methyl-1H-indazole-5-carboxylic acid | ESD-898048-100MG |
Cas.: 1329166-90-6 | Purity: 97% | 4,6-Difluoro-1-methyl-1H-indazole-5-carboxylic acid | ESD-898048-250MG |
Cas.: 1329166-90-6 | Purity: 97% | 4,6-Difluoro-1-methyl-1H-indazole-5-carboxylic acid | ESD-898048-1G |
Cas.: 1092797-76-6 | Purity: 97% | 1-(4-Fluorophenyl)propan-1-amine hydrochloride | ESD-898049-100MG |
Cas.: 1092797-76-6 | Purity: 97% | 1-(4-Fluorophenyl)propan-1-amine hydrochloride | ESD-898049-250MG |
Cas.: 1092797-76-6 | Purity: 97% | 1-(4-Fluorophenyl)propan-1-amine hydrochloride | ESD-898049-1G |
Cas.: 486460-20-2 | Purity: 97% | 3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine | ESD-898050-100MG |
Cas.: 486460-20-2 | Purity: 97% | 3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine | ESD-898050-250MG |
Cas.: 486460-20-2 | Purity: 97% | 3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine | ESD-898050-1G |
Cas.: 51885-81-5 | Purity: 95% | Methyl 4-acetyl-3-nitrobenzoate | ESD-898051-100MG |
Cas.: 51885-81-5 | Purity: 95% | Methyl 4-acetyl-3-nitrobenzoate | ESD-898051-250MG |
Cas.: 51885-81-5 | Purity: 95% | Methyl 4-acetyl-3-nitrobenzoate | ESD-898051-1G |
Cas.: 1459205-36-7 | Purity: 97% | 1-(4-(Aminomethyl)phenyl)pyridin-1-ium chloride | ESD-898052-100MG |
Cas.: 1459205-36-7 | Purity: 97% | 1-(4-(Aminomethyl)phenyl)pyridin-1-ium chloride | ESD-898052-250MG |
Cas.: 1459205-36-7 | Purity: 97% | 1-(4-(Aminomethyl)phenyl)pyridin-1-ium chloride | ESD-898052-1G |
Cas.: 54325-28-9 | Purity: ≥95% | (2S,3R,4S,5S,6R)-6-((Trityloxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetraol | ESD-898053-100MG |
Cas.: 54325-28-9 | Purity: ≥95% | (2S,3R,4S,5S,6R)-6-((Trityloxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetraol | ESD-898053-250MG |
Cas.: 54325-28-9 | Purity: ≥95% | (2S,3R,4S,5S,6R)-6-((Trityloxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetraol | ESD-898053-1G |
Cas.: 1261516-26-0 | Purity: 97% | 2-Bromo-4-iodobenzamide | ESD-898054-100MG |
Cas.: 1261516-26-0 | Purity: 97% | 2-Bromo-4-iodobenzamide | ESD-898054-250MG |
Cas.: 1261516-26-0 | Purity: 97% | 2-Bromo-4-iodobenzamide | ESD-898054-1G |
Cas.: 5701-87-1 | Purity: 95% | 2-Amino-3,4-dimethoxybenzoic acid | ESD-898055-100MG |
Cas.: 5701-87-1 | Purity: 95% | 2-Amino-3,4-dimethoxybenzoic acid | ESD-898055-250MG |
Cas.: 5701-87-1 | Purity: 95% | 2-Amino-3,4-dimethoxybenzoic acid | ESD-898055-1G |
Cas.: 1309598-68-2 | Purity: 97% | (S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride | ESD-898056-100MG |
Cas.: 1309598-68-2 | Purity: 97% | (S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride | ESD-898056-250MG |
Cas.: 1309598-68-2 | Purity: 97% | (S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride | ESD-898056-1G |
Cas.: 1810070-15-5 | Purity: ≥95% | 5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898057-100MG |
Cas.: 1810070-15-5 | Purity: ≥95% | 5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898057-250MG |
Cas.: 1810070-15-5 | Purity: ≥95% | 5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898057-1G |
Cas.: 1137451-25-2 | Purity: ≥95% | 3-Amino-1H-indazole-7-carbonitrile | ESD-898058-100MG |
Cas.: 1137451-25-2 | Purity: ≥95% | 3-Amino-1H-indazole-7-carbonitrile | ESD-898058-250MG |
Cas.: 1137451-25-2 | Purity: ≥95% | 3-Amino-1H-indazole-7-carbonitrile | ESD-898058-1G |
Cas.: 1060811-24-6 | Purity: 95% | 6-Bromo-4-chloronicotinaldehyde | ESD-898059-100MG |
Cas.: 1060811-24-6 | Purity: 95% | 6-Bromo-4-chloronicotinaldehyde | ESD-898059-250MG |
Cas.: 1060811-24-6 | Purity: 95% | 6-Bromo-4-chloronicotinaldehyde | ESD-898059-1G |
Cas.: 28547-28-6 | Purity: ≥95% | 2-Bromo-4-hydroxybenzoic acid | ESD-898060-100MG |
Cas.: 28547-28-6 | Purity: ≥95% | 2-Bromo-4-hydroxybenzoic acid | ESD-898060-250MG |
Cas.: 28547-28-6 | Purity: ≥95% | 2-Bromo-4-hydroxybenzoic acid | ESD-898060-1G |
Cas.: 89057-44-3 | Purity: 98% | 5,5,10,10-Tetramethyl-5,10-dihydroindeno[2,1-a]indene | ESD-898061-100MG |
Cas.: 89057-44-3 | Purity: 98% | 5,5,10,10-Tetramethyl-5,10-dihydroindeno[2,1-a]indene | ESD-898061-250MG |
Cas.: 89057-44-3 | Purity: 98% | 5,5,10,10-Tetramethyl-5,10-dihydroindeno[2,1-a]indene | ESD-898061-1G |
Cas.: 149554-03-0 | Purity: 98% | tert-Butyl 2-(4-oxopiperidin-1-yl)acetate | ESD-898062-100MG |
Cas.: 149554-03-0 | Purity: 98% | tert-Butyl 2-(4-oxopiperidin-1-yl)acetate | ESD-898062-250MG |
Cas.: 149554-03-0 | Purity: 98% | tert-Butyl 2-(4-oxopiperidin-1-yl)acetate | ESD-898062-1G |
Cas.: 850090-09-4 | Purity: 95% | tert-Butyl 1-hydroxy-3,6,9,12,15-pentaoxaoctadecan-18-oate | ESD-898063-100MG |
Cas.: 850090-09-4 | Purity: 95% | tert-Butyl 1-hydroxy-3,6,9,12,15-pentaoxaoctadecan-18-oate | ESD-898063-250MG |
Cas.: 850090-09-4 | Purity: 95% | tert-Butyl 1-hydroxy-3,6,9,12,15-pentaoxaoctadecan-18-oate | ESD-898063-1G |
Cas.: 19943-95-4 | Purity: 97% | Imidazo[1,2-a]pyrazin-3-amine | ESD-898064-100MG |
Cas.: 19943-95-4 | Purity: 97% | Imidazo[1,2-a]pyrazin-3-amine | ESD-898064-250MG |
Cas.: 19943-95-4 | Purity: 97% | Imidazo[1,2-a]pyrazin-3-amine | ESD-898064-1G |
Cas.: 808142-80-5 | Purity: 97% | [4,4′-Di-t-butyl-2,2′-bipyridine][bis[5-(t-butyl)-2-[4-(t-butyl)-2-pyridinyl-kN]phenyl-kC ]iridium(III) hexafluorophosphate | ESD-898065-100MG |
Cas.: 808142-80-5 | Purity: 97% | [4,4′-Di-t-butyl-2,2′-bipyridine][bis[5-(t-butyl)-2-[4-(t-butyl)-2-pyridinyl-kN]phenyl-kC ]iridium(III) hexafluorophosphate | ESD-898065-250MG |
Cas.: 808142-80-5 | Purity: 97% | [4,4′-Di-t-butyl-2,2′-bipyridine][bis[5-(t-butyl)-2-[4-(t-butyl)-2-pyridinyl-kN]phenyl-kC ]iridium(III) hexafluorophosphate | ESD-898065-1G |
Cas.: 62005-48-5 | Purity: ≥95% | N-(2,2-Dimethoxyethyl)acetamide | ESD-898066-100MG |
Cas.: 62005-48-5 | Purity: ≥95% | N-(2,2-Dimethoxyethyl)acetamide | ESD-898066-250MG |
Cas.: 62005-48-5 | Purity: ≥95% | N-(2,2-Dimethoxyethyl)acetamide | ESD-898066-1G |
Cas.: 102971-73-3 | Purity: ≥95% | Fmoc-Cys(tert-butoxycarnylpropyl)-OH | ESD-898067-100MG |
Cas.: 102971-73-3 | Purity: ≥95% | Fmoc-Cys(tert-butoxycarnylpropyl)-OH | ESD-898067-250MG |
Cas.: 102971-73-3 | Purity: ≥95% | Fmoc-Cys(tert-butoxycarnylpropyl)-OH | ESD-898067-1G |
Cas.: 16655-90-6 | Purity: ≥95% | 2-Amino-2-(2,3-dihydro-1H-inden-2-yl)acetic acid | ESD-898068-100MG |
Cas.: 16655-90-6 | Purity: ≥95% | 2-Amino-2-(2,3-dihydro-1H-inden-2-yl)acetic acid | ESD-898068-250MG |
Cas.: 16655-90-6 | Purity: ≥95% | 2-Amino-2-(2,3-dihydro-1H-inden-2-yl)acetic acid | ESD-898068-1G |
Cas.: 115871-19-7 | Purity: 97% | Sodium 2-(3,3-bis(4-(dimethylamino)phenyl)ureido)acetate | ESD-898069-100MG |
Cas.: 115871-19-7 | Purity: 97% | Sodium 2-(3,3-bis(4-(dimethylamino)phenyl)ureido)acetate | ESD-898069-250MG |
Cas.: 115871-19-7 | Purity: 97% | Sodium 2-(3,3-bis(4-(dimethylamino)phenyl)ureido)acetate | ESD-898069-1G |
Cas.: 1251013-42-9 | Purity: 97% | Ethyl 6-bromoimidazo[1,2-a]pyrimidine-3-carboxylate | ESD-898070-100MG |
Cas.: 1251013-42-9 | Purity: 97% | Ethyl 6-bromoimidazo[1,2-a]pyrimidine-3-carboxylate | ESD-898070-250MG |
Cas.: 1251013-42-9 | Purity: 97% | Ethyl 6-bromoimidazo[1,2-a]pyrimidine-3-carboxylate | ESD-898070-1G |
Cas.: 1269233-00-2 | Purity: ≥95% | 2,5-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-898071-100MG |
Cas.: 1269233-00-2 | Purity: ≥95% | 2,5-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-898071-250MG |
Cas.: 1269233-00-2 | Purity: ≥95% | 2,5-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-898071-1G |
Cas.: 1010422-58-8 | Purity: 95% | 5-Ethynyl-2-fluoroaniline | ESD-898072-100MG |
Cas.: 1010422-58-8 | Purity: 95% | 5-Ethynyl-2-fluoroaniline | ESD-898072-250MG |
Cas.: 1010422-58-8 | Purity: 95% | 5-Ethynyl-2-fluoroaniline | ESD-898072-1G |
Cas.: 884340-91-4 | Purity: 97% | 4-Chloro-5,7-dimethoxyquinazoline | ESD-898073-100MG |
Cas.: 884340-91-4 | Purity: 97% | 4-Chloro-5,7-dimethoxyquinazoline | ESD-898073-250MG |
Cas.: 884340-91-4 | Purity: 97% | 4-Chloro-5,7-dimethoxyquinazoline | ESD-898073-1G |
Cas.: 1019016-66-0 | Purity: 97% | 6-Bromo-4-chloro-8-fluoroquinoline | ESD-898074-100MG |
Cas.: 1019016-66-0 | Purity: 97% | 6-Bromo-4-chloro-8-fluoroquinoline | ESD-898074-250MG |
Cas.: 1019016-66-0 | Purity: 97% | 6-Bromo-4-chloro-8-fluoroquinoline | ESD-898074-1G |
Cas.: 1071449-08-5 | Purity: 97% | 7-Bromo-2,3-dihydro-1H-inden-1-amine | ESD-898075-100MG |
Cas.: 1071449-08-5 | Purity: 97% | 7-Bromo-2,3-dihydro-1H-inden-1-amine | ESD-898075-250MG |
Cas.: 1071449-08-5 | Purity: 97% | 7-Bromo-2,3-dihydro-1H-inden-1-amine | ESD-898075-1G |
Cas.: 72407-17-1 | Purity: ≥95% | 2,4-Dichloro-6,7-dimethoxyquinoline | ESD-898076-100MG |
Cas.: 72407-17-1 | Purity: ≥95% | 2,4-Dichloro-6,7-dimethoxyquinoline | ESD-898076-250MG |
Cas.: 72407-17-1 | Purity: ≥95% | 2,4-Dichloro-6,7-dimethoxyquinoline | ESD-898076-1G |
Cas.: 2227206-68-8 | Purity: 97% | 5-Bromo-8-chloroquinoxaline | ESD-898077-100MG |
Cas.: 2227206-68-8 | Purity: 97% | 5-Bromo-8-chloroquinoxaline | ESD-898077-250MG |
Cas.: 2227206-68-8 | Purity: 97% | 5-Bromo-8-chloroquinoxaline | ESD-898077-1G |
Cas.: 1187928-99-9 | Purity: 97% | Imidazo[1,2-a]pyrimidin-2-ylmethanamine dihydrochloride | ESD-898078-100MG |
Cas.: 1187928-99-9 | Purity: 97% | Imidazo[1,2-a]pyrimidin-2-ylmethanamine dihydrochloride | ESD-898078-250MG |
Cas.: 1187928-99-9 | Purity: 97% | Imidazo[1,2-a]pyrimidin-2-ylmethanamine dihydrochloride | ESD-898078-1G |
Cas.: 28177-52-8 | Purity: ≥95% | 2-Chloro-6-iodophenol | ESD-898079-100MG |
Cas.: 28177-52-8 | Purity: ≥95% | 2-Chloro-6-iodophenol | ESD-898079-250MG |
Cas.: 28177-52-8 | Purity: ≥95% | 2-Chloro-6-iodophenol | ESD-898079-1G |
Cas.: 1253522-03-0 | Purity: 98% | 2,3-Dichloro-6-(trifluoromethoxy)quinoxaline | ESD-898080-100MG |
Cas.: 1253522-03-0 | Purity: 98% | 2,3-Dichloro-6-(trifluoromethoxy)quinoxaline | ESD-898080-250MG |
Cas.: 1253522-03-0 | Purity: 98% | 2,3-Dichloro-6-(trifluoromethoxy)quinoxaline | ESD-898080-1G |
Cas.: 1353087-61-2 | Purity: ≥95% | 2,6-Dichloro-5-iodonicotinonitrile | ESD-898081-100MG |
Cas.: 1353087-61-2 | Purity: ≥95% | 2,6-Dichloro-5-iodonicotinonitrile | ESD-898081-250MG |
Cas.: 1353087-61-2 | Purity: ≥95% | 2,6-Dichloro-5-iodonicotinonitrile | ESD-898081-1G |
Cas.: 1256824-94-8 | Purity: 97% | 6-Ethynylpyridin-3-amine | ESD-898082-100MG |
Cas.: 1256824-94-8 | Purity: 97% | 6-Ethynylpyridin-3-amine | ESD-898082-250MG |
Cas.: 1256824-94-8 | Purity: 97% | 6-Ethynylpyridin-3-amine | ESD-898082-1G |
Cas.: 66033-75-8 | Purity: 97% | 7-Bromo-3-methylbenzo[d]isoxazole | ESD-898083-100MG |
Cas.: 66033-75-8 | Purity: 97% | 7-Bromo-3-methylbenzo[d]isoxazole | ESD-898083-250MG |
Cas.: 66033-75-8 | Purity: 97% | 7-Bromo-3-methylbenzo[d]isoxazole | ESD-898083-1G |
Cas.: 1314401-24-5 | Purity: ≥95% | 4,5,6-Trichloro-2-(pyridin-3-yl)pyrimidine | ESD-898084-100MG |
Cas.: 1314401-24-5 | Purity: ≥95% | 4,5,6-Trichloro-2-(pyridin-3-yl)pyrimidine | ESD-898084-250MG |
Cas.: 1314401-24-5 | Purity: ≥95% | 4,5,6-Trichloro-2-(pyridin-3-yl)pyrimidine | ESD-898084-1G |
Cas.: 3543-46-2 | Purity: 98% | 5-Bromo-4-phenylpyrimidine | ESD-898085-100MG |
Cas.: 3543-46-2 | Purity: 98% | 5-Bromo-4-phenylpyrimidine | ESD-898085-250MG |
Cas.: 3543-46-2 | Purity: 98% | 5-Bromo-4-phenylpyrimidine | ESD-898085-1G |
Cas.: 1934574-07-8 | Purity: ≥95% | 6-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898086-100MG |
Cas.: 1934574-07-8 | Purity: ≥95% | 6-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898086-250MG |
Cas.: 1934574-07-8 | Purity: ≥95% | 6-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898086-1G |
Cas.: 586369-93-9 | Purity: 95% | 2-Methyl-1-(3-(trifluoromethyl)phenyl)propan-1-one | ESD-898087-100MG |
Cas.: 586369-93-9 | Purity: 95% | 2-Methyl-1-(3-(trifluoromethyl)phenyl)propan-1-one | ESD-898087-250MG |
Cas.: 586369-93-9 | Purity: 95% | 2-Methyl-1-(3-(trifluoromethyl)phenyl)propan-1-one | ESD-898087-1G |
Cas.: 889865-34-3 | Purity: 98% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine-1-carboxylate | ESD-898088-100MG |
Cas.: 889865-34-3 | Purity: 98% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine-1-carboxylate | ESD-898088-250MG |
Cas.: 889865-34-3 | Purity: 98% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine-1-carboxylate | ESD-898088-1G |
Cas.: 89583-90-4 | Purity: 97% | 7-Chlorobenzo[d]isothiazole | ESD-898089-100MG |
Cas.: 89583-90-4 | Purity: 97% | 7-Chlorobenzo[d]isothiazole | ESD-898089-250MG |
Cas.: 89583-90-4 | Purity: 97% | 7-Chlorobenzo[d]isothiazole | ESD-898089-1G |
Cas.: 1189996-39-1 | Purity: ≥95% | 2-(2,4-Difluorophenyl)pyrrolidine hydrochloride | ESD-898090-100MG |
Cas.: 1189996-39-1 | Purity: ≥95% | 2-(2,4-Difluorophenyl)pyrrolidine hydrochloride | ESD-898090-250MG |
Cas.: 1189996-39-1 | Purity: ≥95% | 2-(2,4-Difluorophenyl)pyrrolidine hydrochloride | ESD-898090-1G |
Cas.: 118970-95-9 | Purity: 97% | (S)-(1-Benzylpyrrolidin-2-yl)diphenylmethanol | ESD-898091-100MG |
Cas.: 118970-95-9 | Purity: 97% | (S)-(1-Benzylpyrrolidin-2-yl)diphenylmethanol | ESD-898091-250MG |
Cas.: 118970-95-9 | Purity: 97% | (S)-(1-Benzylpyrrolidin-2-yl)diphenylmethanol | ESD-898091-1G |
Cas.: 19840-46-1 | Purity: 97% | 5-Chloro-6-hydroxynicotinonitrile | ESD-898092-100MG |
Cas.: 19840-46-1 | Purity: 97% | 5-Chloro-6-hydroxynicotinonitrile | ESD-898092-250MG |
Cas.: 19840-46-1 | Purity: 97% | 5-Chloro-6-hydroxynicotinonitrile | ESD-898092-1G |
Cas.: 4296-15-5 | Purity: 95% | 1-Iodo-2-methoxyethane | ESD-898093-100MG |
Cas.: 4296-15-5 | Purity: 95% | 1-Iodo-2-methoxyethane | ESD-898093-250MG |
Cas.: 4296-15-5 | Purity: 95% | 1-Iodo-2-methoxyethane | ESD-898093-1G |
Cas.: 1211590-25-8 | Purity: ≥95% | 6-Chloro-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidine | ESD-898094-100MG |
Cas.: 1211590-25-8 | Purity: ≥95% | 6-Chloro-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidine | ESD-898094-250MG |
Cas.: 1211590-25-8 | Purity: ≥95% | 6-Chloro-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidine | ESD-898094-1G |
Cas.: 943320-53-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-a]pyridine | ESD-898095-100MG |
Cas.: 943320-53-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-a]pyridine | ESD-898095-250MG |
Cas.: 943320-53-4 | Purity: ≥95% | 3-Ethynylimidazo[1,2-a]pyridine | ESD-898095-1G |
Cas.: 957346-37-1 | Purity: 97% | 5-Bromo-7-fluoroisoindolin-1-one | ESD-898096-100MG |
Cas.: 957346-37-1 | Purity: 97% | 5-Bromo-7-fluoroisoindolin-1-one | ESD-898096-250MG |
Cas.: 957346-37-1 | Purity: 97% | 5-Bromo-7-fluoroisoindolin-1-one | ESD-898096-1G |
Cas.: 651558-51-9 | Purity: ≥95% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-898097-100MG |
Cas.: 651558-51-9 | Purity: ≥95% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-898097-250MG |
Cas.: 651558-51-9 | Purity: ≥95% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-898097-1G |
Cas.: 71935-33-6 | Purity: ≥95% | 4-(Chloromethyl)picolinonitrile | ESD-898098-100MG |
Cas.: 71935-33-6 | Purity: ≥95% | 4-(Chloromethyl)picolinonitrile | ESD-898098-250MG |
Cas.: 71935-33-6 | Purity: ≥95% | 4-(Chloromethyl)picolinonitrile | ESD-898098-1G |
Cas.: 162100-56-3 | Purity: ≥95% | 5-Chloro-6-methyl-1H-indole | ESD-898099-100MG |
Cas.: 162100-56-3 | Purity: ≥95% | 5-Chloro-6-methyl-1H-indole | ESD-898099-250MG |
Cas.: 162100-56-3 | Purity: ≥95% | 5-Chloro-6-methyl-1H-indole | ESD-898099-1G |
Cas.: 220032-26-8 | Purity: 97% | 4-Amino-5-chloro-2-methoxy-N-(pipidin-4-ylmethyl)benzamide | ESD-898100-100MG |
Cas.: 220032-26-8 | Purity: 97% | 4-Amino-5-chloro-2-methoxy-N-(pipidin-4-ylmethyl)benzamide | ESD-898100-250MG |
Cas.: 220032-26-8 | Purity: 97% | 4-Amino-5-chloro-2-methoxy-N-(pipidin-4-ylmethyl)benzamide | ESD-898100-1G |
Cas.: 1267904-60-8 | Purity: 98% | N-(5-Bromo-4-ethylthiazol-2-yl)acetamide | ESD-898101-100MG |
Cas.: 1267904-60-8 | Purity: 98% | N-(5-Bromo-4-ethylthiazol-2-yl)acetamide | ESD-898101-250MG |
Cas.: 1267904-60-8 | Purity: 98% | N-(5-Bromo-4-ethylthiazol-2-yl)acetamide | ESD-898101-1G |
Cas.: 1391026-59-7 | Purity: 97% | tert-Butyl (1-bromopropan-2-yl)carbamate | ESD-898102-100MG |
Cas.: 1391026-59-7 | Purity: 97% | tert-Butyl (1-bromopropan-2-yl)carbamate | ESD-898102-250MG |
Cas.: 1391026-59-7 | Purity: 97% | tert-Butyl (1-bromopropan-2-yl)carbamate | ESD-898102-1G |
Cas.: 1256811-26-3 | Purity: ≥95% | 4-Bromo-6-methylpyridin-3-ol | ESD-898103-100MG |
Cas.: 1256811-26-3 | Purity: ≥95% | 4-Bromo-6-methylpyridin-3-ol | ESD-898103-250MG |
Cas.: 1256811-26-3 | Purity: ≥95% | 4-Bromo-6-methylpyridin-3-ol | ESD-898103-1G |
Cas.: 90721-34-9 | Purity: ≥95% | 8-Bromoisoquinolin-5-amine | ESD-898104-100MG |
Cas.: 90721-34-9 | Purity: ≥95% | 8-Bromoisoquinolin-5-amine | ESD-898104-250MG |
Cas.: 90721-34-9 | Purity: ≥95% | 8-Bromoisoquinolin-5-amine | ESD-898104-1G |
Cas.: 1260671-35-9 | Purity: 97% | 5-Bromo-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine | ESD-898105-100MG |
Cas.: 1260671-35-9 | Purity: 97% | 5-Bromo-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine | ESD-898105-250MG |
Cas.: 1260671-35-9 | Purity: 97% | 5-Bromo-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine | ESD-898105-1G |
Cas.: 16879-53-1 | Purity: 97% | 2-Phenylpyrimidine-4-carboxylic acid | ESD-898106-100MG |
Cas.: 16879-53-1 | Purity: 97% | 2-Phenylpyrimidine-4-carboxylic acid | ESD-898106-250MG |
Cas.: 16879-53-1 | Purity: 97% | 2-Phenylpyrimidine-4-carboxylic acid | ESD-898106-1G |
Cas.: 70033-61-3 | Purity: 95% | 5-Hydroxy-2-(hydroxymethyl)-1-phenylpyridin-4(1H)-one | ESD-898107-100MG |
Cas.: 70033-61-3 | Purity: 95% | 5-Hydroxy-2-(hydroxymethyl)-1-phenylpyridin-4(1H)-one | ESD-898107-250MG |
Cas.: 70033-61-3 | Purity: 95% | 5-Hydroxy-2-(hydroxymethyl)-1-phenylpyridin-4(1H)-one | ESD-898107-1G |
Cas.: 89182-18-3 | Purity: ≥95% | 4-Chloro-6-methylpyrimidin-5-amine | ESD-898108-100MG |
Cas.: 89182-18-3 | Purity: ≥95% | 4-Chloro-6-methylpyrimidin-5-amine | ESD-898108-250MG |
Cas.: 89182-18-3 | Purity: ≥95% | 4-Chloro-6-methylpyrimidin-5-amine | ESD-898108-1G |
Cas.: 120739-89-1 | Purity: 97% | N,6-Dimethylpyridin-3-amine | ESD-898109-100MG |
Cas.: 120739-89-1 | Purity: 97% | N,6-Dimethylpyridin-3-amine | ESD-898109-250MG |
Cas.: 120739-89-1 | Purity: 97% | N,6-Dimethylpyridin-3-amine | ESD-898109-1G |
Cas.: 1513212-02-6 | Purity: 95% | 5-Aminobenzo[d]thiazole-2-carbonitrile | ESD-898110-100MG |
Cas.: 1513212-02-6 | Purity: 95% | 5-Aminobenzo[d]thiazole-2-carbonitrile | ESD-898110-250MG |
Cas.: 1513212-02-6 | Purity: 95% | 5-Aminobenzo[d]thiazole-2-carbonitrile | ESD-898110-1G |
Cas.: 22808-73-7 | Purity: 97% | Methyl 4-sulfamoylbenzoate | ESD-898111-100MG |
Cas.: 22808-73-7 | Purity: 97% | Methyl 4-sulfamoylbenzoate | ESD-898111-250MG |
Cas.: 22808-73-7 | Purity: 97% | Methyl 4-sulfamoylbenzoate | ESD-898111-1G |
Cas.: 7746-30-7 | Purity: 98% | 5,6-Dimethoxy-1H-indazole | ESD-898112-100MG |
Cas.: 7746-30-7 | Purity: 98% | 5,6-Dimethoxy-1H-indazole | ESD-898112-250MG |
Cas.: 7746-30-7 | Purity: 98% | 5,6-Dimethoxy-1H-indazole | ESD-898112-1G |
Cas.: 942199-59-9 | Purity: ≥95% | 4-Cyano-3-(trifluoromethyl)benzene-1-sulfonyl chloride | ESD-898113-100MG |
Cas.: 942199-59-9 | Purity: ≥95% | 4-Cyano-3-(trifluoromethyl)benzene-1-sulfonyl chloride | ESD-898113-250MG |
Cas.: 942199-59-9 | Purity: ≥95% | 4-Cyano-3-(trifluoromethyl)benzene-1-sulfonyl chloride | ESD-898113-1G |
Cas.: 2688-85-9 | Purity: 95% | 2-Phenoxybenzene sulfonyl chloride | ESD-898114-100MG |
Cas.: 2688-85-9 | Purity: 95% | 2-Phenoxybenzene sulfonyl chloride | ESD-898114-250MG |
Cas.: 2688-85-9 | Purity: 95% | 2-Phenoxybenzene sulfonyl chloride | ESD-898114-1G |
Cas.: 885271-84-1 | Purity: 97% | 2-(5-Bromo-1H-indazol-3-yl)acetic acid | ESD-898115-100MG |
Cas.: 885271-84-1 | Purity: 97% | 2-(5-Bromo-1H-indazol-3-yl)acetic acid | ESD-898115-250MG |
Cas.: 885271-84-1 | Purity: 97% | 2-(5-Bromo-1H-indazol-3-yl)acetic acid | ESD-898115-1G |
Cas.: 1011-27-4 | Purity: ≥95% | 3,5-Dimethoxy-4-methylbenzaldehyde | ESD-898116-100MG |
Cas.: 1011-27-4 | Purity: ≥95% | 3,5-Dimethoxy-4-methylbenzaldehyde | ESD-898116-250MG |
Cas.: 189936-27-4 | Purity: 97% | 5-(Chloromethyl)nicotinonitrile hydrochloride | ESD-898117-100MG |
Cas.: 189936-27-4 | Purity: 97% | 5-(Chloromethyl)nicotinonitrile hydrochloride | ESD-898117-250MG |
Cas.: 189936-27-4 | Purity: 97% | 5-(Chloromethyl)nicotinonitrile hydrochloride | ESD-898117-1G |
Cas.: 1207836-10-9 | Purity: 98% | 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile | ESD-898118-100MG |
Cas.: 1207836-10-9 | Purity: 98% | 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile | ESD-898118-250MG |
Cas.: 1207836-10-9 | Purity: 98% | 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile | ESD-898118-1G |
Cas.: 1447607-69-3 | Purity: 97% | Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate | ESD-898119-100MG |
Cas.: 1447607-69-3 | Purity: 97% | Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate | ESD-898119-250MG |
Cas.: 1447607-69-3 | Purity: 97% | Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate | ESD-898119-1G |
Cas.: 1082674-24-5 | Purity: 97% | 6-Bromoisoquinoline-1-carbonitrile | ESD-898120-100MG |
Cas.: 1082674-24-5 | Purity: 97% | 6-Bromoisoquinoline-1-carbonitrile | ESD-898120-250MG |
Cas.: 1082674-24-5 | Purity: 97% | 6-Bromoisoquinoline-1-carbonitrile | ESD-898120-1G |
Cas.: 854733-39-4 | Purity: ≥95% | 2-Bromo-6-methoxy-3-nitrophenol | ESD-898121-100MG |
Cas.: 854733-39-4 | Purity: ≥95% | 2-Bromo-6-methoxy-3-nitrophenol | ESD-898121-250MG |
Cas.: 854733-39-4 | Purity: ≥95% | 2-Bromo-6-methoxy-3-nitrophenol | ESD-898121-1G |
Cas.: 133773-29-2 | Purity: ≥95% | (R)-1-(2,4-Dichlorophenyl)ethanamine | ESD-898122-100MG |
Cas.: 133773-29-2 | Purity: ≥95% | (R)-1-(2,4-Dichlorophenyl)ethanamine | ESD-898122-250MG |
Cas.: 133773-29-2 | Purity: ≥95% | (R)-1-(2,4-Dichlorophenyl)ethanamine | ESD-898122-1G |
Cas.: 61948-59-2 | Purity: 97% | 2,4-Dichloro-5-methoxyquinazoline | ESD-898123-100MG |
Cas.: 61948-59-2 | Purity: 97% | 2,4-Dichloro-5-methoxyquinazoline | ESD-898123-250MG |
Cas.: 61948-59-2 | Purity: 97% | 2,4-Dichloro-5-methoxyquinazoline | ESD-898123-1G |
Cas.: 1212981-84-4 | Purity: 97% | (S)-2-Amino-2-(3-fluoro-5-methoxyphenyl)ethanol | ESD-898124-100MG |
Cas.: 1212981-84-4 | Purity: 97% | (S)-2-Amino-2-(3-fluoro-5-methoxyphenyl)ethanol | ESD-898124-250MG |
Cas.: 1212981-84-4 | Purity: 97% | (S)-2-Amino-2-(3-fluoro-5-methoxyphenyl)ethanol | ESD-898124-1G |
Cas.: 1256791-78-2 | Purity: ≥95% | Methyl 5-hydroxy-6-methoxypicolinate | ESD-898125-100MG |
Cas.: 1256791-78-2 | Purity: ≥95% | Methyl 5-hydroxy-6-methoxypicolinate | ESD-898125-250MG |
Cas.: 1256791-78-2 | Purity: ≥95% | Methyl 5-hydroxy-6-methoxypicolinate | ESD-898125-1G |
Cas.: 1227588-59-1 | Purity: 97% | 6-Bromo-5-fluoronicotinaldehyde | ESD-898126-100MG |
Cas.: 1227588-59-1 | Purity: 97% | 6-Bromo-5-fluoronicotinaldehyde | ESD-898126-250MG |
Cas.: 1227588-59-1 | Purity: 97% | 6-Bromo-5-fluoronicotinaldehyde | ESD-898126-1G |
Cas.: 150780-67-9 | Purity: ≥95% | 2′-OMe-ibu-G Phosphoramidite | ESD-898127-100MG |
Cas.: 150780-67-9 | Purity: ≥95% | 2′-OMe-ibu-G Phosphoramidite | ESD-898127-250MG |
Cas.: 150780-67-9 | Purity: ≥95% | 2′-OMe-ibu-G Phosphoramidite | ESD-898127-1G |
Cas.: 1805948-04-2 | Purity: 97% | Methyl 2-(4-bromo-5-methylpyridin-2-yl)acetate | ESD-898128-100MG |
Cas.: 1805948-04-2 | Purity: 97% | Methyl 2-(4-bromo-5-methylpyridin-2-yl)acetate | ESD-898128-250MG |
Cas.: 1805948-04-2 | Purity: 97% | Methyl 2-(4-bromo-5-methylpyridin-2-yl)acetate | ESD-898128-1G |
Cas.: 864264-99-3 | Purity: ≥95% | 2-(Chloromethyl)-6-methoxypyridine hydrochloride | ESD-898129-100MG |
Cas.: 864264-99-3 | Purity: ≥95% | 2-(Chloromethyl)-6-methoxypyridine hydrochloride | ESD-898129-250MG |
Cas.: 864264-99-3 | Purity: ≥95% | 2-(Chloromethyl)-6-methoxypyridine hydrochloride | ESD-898129-1G |
Cas.: 121103-15-9 | Purity: ≥95% | (S)-tert-Butyl (2-aminopropyl)carbamate | ESD-898130-100MG |
Cas.: 121103-15-9 | Purity: ≥95% | (S)-tert-Butyl (2-aminopropyl)carbamate | ESD-898130-250MG |
Cas.: 121103-15-9 | Purity: ≥95% | (S)-tert-Butyl (2-aminopropyl)carbamate | ESD-898130-1G |
Cas.: 49609-03-2 | Purity: 97% | 2-Chloro-7-nitroquinoline | ESD-898131-100MG |
Cas.: 49609-03-2 | Purity: 97% | 2-Chloro-7-nitroquinoline | ESD-898131-250MG |
Cas.: 49609-03-2 | Purity: 97% | 2-Chloro-7-nitroquinoline | ESD-898131-1G |
Cas.: 316810-90-9 | Purity: ≥95% | 3-Bromo-1H-indazol-7-amine | ESD-898132-100MG |
Cas.: 316810-90-9 | Purity: ≥95% | 3-Bromo-1H-indazol-7-amine | ESD-898132-250MG |
Cas.: 316810-90-9 | Purity: ≥95% | 3-Bromo-1H-indazol-7-amine | ESD-898132-1G |
Cas.: 625386-57-4 | Purity: ≥95% | 3-(Piperazin-1-ylmethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898133-100MG |
Cas.: 625386-57-4 | Purity: ≥95% | 3-(Piperazin-1-ylmethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898133-250MG |
Cas.: 625386-57-4 | Purity: ≥95% | 3-(Piperazin-1-ylmethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898133-1G |
Cas.: 1260811-82-2 | Purity: ≥95% | 4′-Cyano-3′-fluorobiphenyl-4-carboxylic acid | ESD-898134-100MG |
Cas.: 1260811-82-2 | Purity: ≥95% | 4′-Cyano-3′-fluorobiphenyl-4-carboxylic acid | ESD-898134-250MG |
Cas.: 1260811-82-2 | Purity: ≥95% | 4′-Cyano-3′-fluorobiphenyl-4-carboxylic acid | ESD-898134-1G |
Cas.: 126674-95-1 | Purity: ≥95% | 3-Methoxy-1-methyl-1H-pyrazole-5-carboxylic acid | ESD-898135-100MG |
Cas.: 126674-95-1 | Purity: ≥95% | 3-Methoxy-1-methyl-1H-pyrazole-5-carboxylic acid | ESD-898135-250MG |
Cas.: 126674-95-1 | Purity: ≥95% | 3-Methoxy-1-methyl-1H-pyrazole-5-carboxylic acid | ESD-898135-1G |
Cas.: 439146-20-0 | Purity: ≥95% | 6-Chloro-4-methoxypyridin-2-amine | ESD-898136-100MG |
Cas.: 439146-20-0 | Purity: ≥95% | 6-Chloro-4-methoxypyridin-2-amine | ESD-898136-250MG |
Cas.: 439146-20-0 | Purity: ≥95% | 6-Chloro-4-methoxypyridin-2-amine | ESD-898136-1G |
Cas.: 878158-18-0 | Purity: ≥95% | Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate | ESD-898137-100MG |
Cas.: 878158-18-0 | Purity: ≥95% | Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate | ESD-898137-250MG |
Cas.: 878158-18-0 | Purity: ≥95% | Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate | ESD-898137-1G |
Cas.: 1260879-61-5 | Purity: ≥95% | 7-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine | ESD-898138-100MG |
Cas.: 1260879-61-5 | Purity: ≥95% | 7-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine | ESD-898138-250MG |
Cas.: 1260879-61-5 | Purity: ≥95% | 7-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine | ESD-898138-1G |
Cas.: 99951-90-3 | Purity: ≥95% | Ethyl 5-chloro[1,2,4]triazolo[4,3-a]pyrimidine-7-carboxylate | ESD-898139-100MG |
Cas.: 99951-90-3 | Purity: ≥95% | Ethyl 5-chloro[1,2,4]triazolo[4,3-a]pyrimidine-7-carboxylate | ESD-898139-250MG |
Cas.: 99951-90-3 | Purity: ≥95% | Ethyl 5-chloro[1,2,4]triazolo[4,3-a]pyrimidine-7-carboxylate | ESD-898139-1G |
Cas.: 1256561-76-8 | Purity: 98% | 3-Chloro-2-formylbenzonitrile | ESD-898140-100MG |
Cas.: 1256561-76-8 | Purity: 98% | 3-Chloro-2-formylbenzonitrile | ESD-898140-250MG |
Cas.: 1256561-76-8 | Purity: 98% | 3-Chloro-2-formylbenzonitrile | ESD-898140-1G |
Cas.: 17257-96-4 | Purity: 97% | Pyrimido[4,5-d]pyridazine-2,4(1H,3H)-dione | ESD-898141-100MG |
Cas.: 17257-96-4 | Purity: 97% | Pyrimido[4,5-d]pyridazine-2,4(1H,3H)-dione | ESD-898141-250MG |
Cas.: 17257-96-4 | Purity: 97% | Pyrimido[4,5-d]pyridazine-2,4(1H,3H)-dione | ESD-898141-1G |
Cas.: 41684-07-5 | Purity: 97% | 4-Amino-3-(methoxycarbonyl)benzoic acid | ESD-898142-100MG |
Cas.: 41684-07-5 | Purity: 97% | 4-Amino-3-(methoxycarbonyl)benzoic acid | ESD-898142-250MG |
Cas.: 41684-07-5 | Purity: 97% | 4-Amino-3-(methoxycarbonyl)benzoic acid | ESD-898142-1G |
Cas.: 1089279-64-0 | Purity: ≥95% | 1-(2-Fluoroethyl)piperazine dihydrochloride | ESD-898143-100MG |
Cas.: 1089279-64-0 | Purity: ≥95% | 1-(2-Fluoroethyl)piperazine dihydrochloride | ESD-898143-250MG |
Cas.: 1089279-64-0 | Purity: ≥95% | 1-(2-Fluoroethyl)piperazine dihydrochloride | ESD-898143-1G |
Cas.: 70807-90-8 | Purity: ≥95% | 2-Methoxypropan-1-amine hydrochloride | ESD-898144-100MG |
Cas.: 70807-90-8 | Purity: ≥95% | 2-Methoxypropan-1-amine hydrochloride | ESD-898144-250MG |
Cas.: 70807-90-8 | Purity: ≥95% | 2-Methoxypropan-1-amine hydrochloride | ESD-898144-1G |
Cas.: 1286734-86-8 | Purity: 98% | 6-Bromo-5-fluoro-1-methyl-1H-indazole | ESD-898145-100MG |
Cas.: 1286734-86-8 | Purity: 98% | 6-Bromo-5-fluoro-1-methyl-1H-indazole | ESD-898145-250MG |
Cas.: 1286734-86-8 | Purity: 98% | 6-Bromo-5-fluoro-1-methyl-1H-indazole | ESD-898145-1G |
Cas.: 40314-06-5 | Purity: 97% | 5-Methylisoindoline-1,3-dione | ESD-898146-100MG |
Cas.: 40314-06-5 | Purity: 97% | 5-Methylisoindoline-1,3-dione | ESD-898146-250MG |
Cas.: 40314-06-5 | Purity: 97% | 5-Methylisoindoline-1,3-dione | ESD-898146-1G |
Cas.: 1965309-48-1 | Purity: 97% | 4-Hydroxypicolinaldehyde hydrochloride | ESD-898147-100MG |
Cas.: 1965309-48-1 | Purity: 97% | 4-Hydroxypicolinaldehyde hydrochloride | ESD-898147-250MG |
Cas.: 1965309-48-1 | Purity: 97% | 4-Hydroxypicolinaldehyde hydrochloride | ESD-898147-1G |
Cas.: 1373232-29-1 | Purity: 96% | (R)-1,3-Dimethylpiperazin-2-one hydrochloride | ESD-898148-100MG |
Cas.: 1373232-29-1 | Purity: 96% | (R)-1,3-Dimethylpiperazin-2-one hydrochloride | ESD-898148-250MG |
Cas.: 1373232-29-1 | Purity: 96% | (R)-1,3-Dimethylpiperazin-2-one hydrochloride | ESD-898148-1G |
Cas.: 1060805-66-4 | Purity: 97% | 4-Bromo-6-chloropicolinic acid | ESD-898149-100MG |
Cas.: 1060805-66-4 | Purity: 97% | 4-Bromo-6-chloropicolinic acid | ESD-898149-250MG |
Cas.: 1060805-66-4 | Purity: 97% | 4-Bromo-6-chloropicolinic acid | ESD-898149-1G |
Cas.: 1032758-99-8 | Purity: ≥95% | 3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | ESD-898150-100MG |
Cas.: 1032758-99-8 | Purity: ≥95% | 3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | ESD-898150-250MG |
Cas.: 1032758-99-8 | Purity: ≥95% | 3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | ESD-898150-1G |
Cas.: 89877-62-3 | Purity: 97% | 3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile | ESD-898151-100MG |
Cas.: 89877-62-3 | Purity: 97% | 3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile | ESD-898151-250MG |
Cas.: 89877-62-3 | Purity: 97% | 3-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile | ESD-898151-1G |
Cas.: 848141-14-0 | Purity: 97% | (5-(Methylsulfonyl)pyridin-2-yl)methanamine hydrochloride | ESD-898152-100MG |
Cas.: 848141-14-0 | Purity: 97% | (5-(Methylsulfonyl)pyridin-2-yl)methanamine hydrochloride | ESD-898152-250MG |
Cas.: 848141-14-0 | Purity: 97% | (5-(Methylsulfonyl)pyridin-2-yl)methanamine hydrochloride | ESD-898152-1G |
Cas.: 13521-25-0 | Purity: 95% | 1H-Pyrazolo[3,4-d]pyridazin-4(5H)-one | ESD-898153-100MG |
Cas.: 13521-25-0 | Purity: 95% | 1H-Pyrazolo[3,4-d]pyridazin-4(5H)-one | ESD-898153-250MG |
Cas.: 13521-25-0 | Purity: 95% | 1H-Pyrazolo[3,4-d]pyridazin-4(5H)-one | ESD-898153-1G |
Cas.: 33675-75-1 | Purity: ≥95% | 3-Phenethylphenol | ESD-898154-100MG |
Cas.: 33675-75-1 | Purity: ≥95% | 3-Phenethylphenol | ESD-898154-250MG |
Cas.: 33675-75-1 | Purity: ≥95% | 3-Phenethylphenol | ESD-898154-1G |
Cas.: 1185010-62-1 | Purity: 97% | 2-(2-Fluorophenyl)piperidine hydrochloride | ESD-898155-100MG |
Cas.: 1185010-62-1 | Purity: 97% | 2-(2-Fluorophenyl)piperidine hydrochloride | ESD-898155-250MG |
Cas.: 1185010-62-1 | Purity: 97% | 2-(2-Fluorophenyl)piperidine hydrochloride | ESD-898155-1G |
Cas.: 276702-53-5 | Purity: ≥95% | 2,6-Dichloro-3-nitrobenzene-1-sulfonyl chloride | ESD-898156-100MG |
Cas.: 276702-53-5 | Purity: ≥95% | 2,6-Dichloro-3-nitrobenzene-1-sulfonyl chloride | ESD-898156-250MG |
Cas.: 276702-53-5 | Purity: ≥95% | 2,6-Dichloro-3-nitrobenzene-1-sulfonyl chloride | ESD-898156-1G |
Cas.: 649550-97-0 | Purity: 97% | Methyl 6-fluoro-1H-indole-3-carboxylate | ESD-898157-100MG |
Cas.: 649550-97-0 | Purity: 97% | Methyl 6-fluoro-1H-indole-3-carboxylate | ESD-898157-250MG |
Cas.: 649550-97-0 | Purity: 97% | Methyl 6-fluoro-1H-indole-3-carboxylate | ESD-898157-1G |
Cas.: 1215860-20-0 | Purity: 97% | Methyl 5-bromo-6-methylpicolinate | ESD-898158-100MG |
Cas.: 1215860-20-0 | Purity: 97% | Methyl 5-bromo-6-methylpicolinate | ESD-898158-250MG |
Cas.: 1215860-20-0 | Purity: 97% | Methyl 5-bromo-6-methylpicolinate | ESD-898158-1G |
Cas.: 1213846-75-3 | Purity: ≥95% | (R)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride | ESD-898159-100MG |
Cas.: 1213846-75-3 | Purity: ≥95% | (R)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride | ESD-898159-250MG |
Cas.: 1213846-75-3 | Purity: ≥95% | (R)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride | ESD-898159-1G |
Cas.: 2044706-05-8 | Purity: 97% | (2-Methoxypyrimidin-4-yl)methanamine dihydrochloride | ESD-898160-100MG |
Cas.: 2044706-05-8 | Purity: 97% | (2-Methoxypyrimidin-4-yl)methanamine dihydrochloride | ESD-898160-250MG |
Cas.: 2044706-05-8 | Purity: 97% | (2-Methoxypyrimidin-4-yl)methanamine dihydrochloride | ESD-898160-1G |
Cas.: 58271-59-3 | Purity: ≥95% | Cyclopropyl(4-methoxyphenyl)methanamine hydrochloride | ESD-898161-100MG |
Cas.: 58271-59-3 | Purity: ≥95% | Cyclopropyl(4-methoxyphenyl)methanamine hydrochloride | ESD-898161-250MG |
Cas.: 58271-59-3 | Purity: ≥95% | Cyclopropyl(4-methoxyphenyl)methanamine hydrochloride | ESD-898161-1G |
Cas.: 441074-81-3 | Purity: ≥95% | (R)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-898162-100MG |
Cas.: 441074-81-3 | Purity: ≥95% | (R)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-898162-250MG |
Cas.: 441074-81-3 | Purity: ≥95% | (R)-1-(3,4-Difluorophenyl)ethanamine hydrochloride | ESD-898162-1G |
Cas.: 104618-31-7 | Purity: 97% | 2-(4-Hydroxycyclohexyl)isoindoline-1,3-dione | ESD-898163-100MG |
Cas.: 104618-31-7 | Purity: 97% | 2-(4-Hydroxycyclohexyl)isoindoline-1,3-dione | ESD-898163-250MG |
Cas.: 104618-31-7 | Purity: 97% | 2-(4-Hydroxycyclohexyl)isoindoline-1,3-dione | ESD-898163-1G |
Cas.: 1105187-44-7 | Purity: ≥95% | 4-(3-Bromophenyl)pyrrolidin-2-one | ESD-898164-100MG |
Cas.: 1105187-44-7 | Purity: ≥95% | 4-(3-Bromophenyl)pyrrolidin-2-one | ESD-898164-250MG |
Cas.: 1105187-44-7 | Purity: ≥95% | 4-(3-Bromophenyl)pyrrolidin-2-one | ESD-898164-1G |
Cas.: 74590-69-5 | Purity: ≥95% | 2-(4-Chlorophenyl)-2-fluoroacetic acid | ESD-898165-100MG |
Cas.: 74590-69-5 | Purity: ≥95% | 2-(4-Chlorophenyl)-2-fluoroacetic acid | ESD-898165-250MG |
Cas.: 74590-69-5 | Purity: ≥95% | 2-(4-Chlorophenyl)-2-fluoroacetic acid | ESD-898165-1G |
Cas.: 1214384-10-7 | Purity: ≥95% | 5-(3-Fluorophenyl)pyridin-3-amine | ESD-898166-100MG |
Cas.: 1214384-10-7 | Purity: ≥95% | 5-(3-Fluorophenyl)pyridin-3-amine | ESD-898166-250MG |
Cas.: 1214384-10-7 | Purity: ≥95% | 5-(3-Fluorophenyl)pyridin-3-amine | ESD-898166-1G |
Cas.: 114746-70-2 | Purity: 95% | (R)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid | ESD-898167-100MG |
Cas.: 114746-70-2 | Purity: 95% | (R)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid | ESD-898167-250MG |
Cas.: 114746-70-2 | Purity: 95% | (R)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid | ESD-898167-1G |
Cas.: 1187931-95-8 | Purity: ≥95% | 1-(5-Methylpyridin-2-yl)ethanamine dihydrochloride | ESD-898168-100MG |
Cas.: 1187931-95-8 | Purity: ≥95% | 1-(5-Methylpyridin-2-yl)ethanamine dihydrochloride | ESD-898168-250MG |
Cas.: 1187931-95-8 | Purity: ≥95% | 1-(5-Methylpyridin-2-yl)ethanamine dihydrochloride | ESD-898168-1G |
Cas.: 391906-83-5 | Purity: ≥95% | 3-Phenoxypyridin-2-amine | ESD-898169-100MG |
Cas.: 391906-83-5 | Purity: ≥95% | 3-Phenoxypyridin-2-amine | ESD-898169-250MG |
Cas.: 391906-83-5 | Purity: ≥95% | 3-Phenoxypyridin-2-amine | ESD-898169-1G |
Cas.: 421551-82-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-5-cyanobenzoate | ESD-898170-100MG |
Cas.: 421551-82-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-5-cyanobenzoate | ESD-898170-250MG |
Cas.: 421551-82-8 | Purity: ≥95% | Methyl 2-(bromomethyl)-5-cyanobenzoate | ESD-898170-1G |
Cas.: 483340-19-8 | Purity: ≥95% | (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanoic acid | ESD-898171-100MG |
Cas.: 483340-19-8 | Purity: ≥95% | (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanoic acid | ESD-898171-250MG |
Cas.: 483340-19-8 | Purity: ≥95% | (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanoic acid | ESD-898171-1G |
Cas.: 321429-49-6 | Purity: 97% | (R)-1-(3-Fluorophenyl)ethylamine hydrochloride | ESD-898172-100MG |
Cas.: 321429-49-6 | Purity: 97% | (R)-1-(3-Fluorophenyl)ethylamine hydrochloride | ESD-898172-250MG |
Cas.: 321429-49-6 | Purity: 97% | (R)-1-(3-Fluorophenyl)ethylamine hydrochloride | ESD-898172-1G |
Cas.: 916214-44-3 | Purity: 97% | Methyl 4-(aminomethyl)thiophene-2-carboxylate hydrochloride | ESD-898173-100MG |
Cas.: 916214-44-3 | Purity: 97% | Methyl 4-(aminomethyl)thiophene-2-carboxylate hydrochloride | ESD-898173-250MG |
Cas.: 916214-44-3 | Purity: 97% | Methyl 4-(aminomethyl)thiophene-2-carboxylate hydrochloride | ESD-898173-1G |
Cas.: 1379295-90-5 | Purity: ≥95% | 2-Bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-amine | ESD-898174-100MG |
Cas.: 1379295-90-5 | Purity: ≥95% | 2-Bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-amine | ESD-898174-250MG |
Cas.: 1379295-90-5 | Purity: ≥95% | 2-Bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-amine | ESD-898174-1G |
Cas.: 1166827-91-3 | Purity: 97% | Methyl 6-bromo-5-methylpyrazine-2-carboxylate | ESD-898175-100MG |
Cas.: 1166827-91-3 | Purity: 97% | Methyl 6-bromo-5-methylpyrazine-2-carboxylate | ESD-898175-250MG |
Cas.: 1166827-91-3 | Purity: 97% | Methyl 6-bromo-5-methylpyrazine-2-carboxylate | ESD-898175-1G |
Cas.: 1208893-73-5 | Purity: 97% | (S)-1-(5-Fluoropyridin-2-yl)ethanamine dihydrochloride | ESD-898176-100MG |
Cas.: 1208893-73-5 | Purity: 97% | (S)-1-(5-Fluoropyridin-2-yl)ethanamine dihydrochloride | ESD-898176-250MG |
Cas.: 1208893-73-5 | Purity: 97% | (S)-1-(5-Fluoropyridin-2-yl)ethanamine dihydrochloride | ESD-898176-1G |
Cas.: 1142197-16-7 | Purity: ≥95% | 2-Bromo-5-isopropylpyridine | ESD-898177-100MG |
Cas.: 1142197-16-7 | Purity: ≥95% | 2-Bromo-5-isopropylpyridine | ESD-898177-250MG |
Cas.: 1142197-16-7 | Purity: ≥95% | 2-Bromo-5-isopropylpyridine | ESD-898177-1G |
Cas.: 1228878-69-0 | Purity: ≥95% | 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine dihydrochloride | ESD-898178-100MG |
Cas.: 1228878-69-0 | Purity: ≥95% | 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine dihydrochloride | ESD-898178-250MG |
Cas.: 1228878-69-0 | Purity: ≥95% | 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine dihydrochloride | ESD-898178-1G |
Cas.: 153888-47-2 | Purity: ≥95% | Methyl 5-bromo-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate | ESD-898179-100MG |
Cas.: 153888-47-2 | Purity: ≥95% | Methyl 5-bromo-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate | ESD-898179-250MG |
Cas.: 153888-47-2 | Purity: ≥95% | Methyl 5-bromo-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate | ESD-898179-1G |
Cas.: 28648-86-4 | Purity: 95% | Pyrimidine-4-carboxamide | ESD-898180-100MG |
Cas.: 28648-86-4 | Purity: 95% | Pyrimidine-4-carboxamide | ESD-898180-250MG |
Cas.: 28648-86-4 | Purity: 95% | Pyrimidine-4-carboxamide | ESD-898180-1G |
Cas.: 1190317-09-9 | Purity: ≥95% | 2-oxo-2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-898181-100MG |
Cas.: 1190317-09-9 | Purity: ≥95% | 2-oxo-2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-898181-250MG |
Cas.: 1190317-09-9 | Purity: ≥95% | 2-oxo-2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-898181-1G |
Cas.: 845829-91-6 | Purity: 97% | (R)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride | ESD-898182-100MG |
Cas.: 845829-91-6 | Purity: 97% | (R)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride | ESD-898182-250MG |
Cas.: 845829-91-6 | Purity: 97% | (R)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride | ESD-898182-1G |
Cas.: 144836-90-8 | Purity: ≥95% | (R)-2-Amino-N-methyl-3-phenylpropanamide | ESD-898183-100MG |
Cas.: 144836-90-8 | Purity: ≥95% | (R)-2-Amino-N-methyl-3-phenylpropanamide | ESD-898183-250MG |
Cas.: 144836-90-8 | Purity: ≥95% | (R)-2-Amino-N-methyl-3-phenylpropanamide | ESD-898183-1G |
Cas.: 1256809-64-9 | Purity: 95% | 5-Bromo-2-chloro-6-methylnicotinic acid | ESD-898184-100MG |
Cas.: 1256809-64-9 | Purity: 95% | 5-Bromo-2-chloro-6-methylnicotinic acid | ESD-898184-250MG |
Cas.: 1256809-64-9 | Purity: 95% | 5-Bromo-2-chloro-6-methylnicotinic acid | ESD-898184-1G |
Cas.: 110505-76-5 | Purity: 97% | (2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-898185-100MG |
Cas.: 110505-76-5 | Purity: 97% | (2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-898185-250MG |
Cas.: 110505-76-5 | Purity: 97% | (2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-898185-1G |
Cas.: 185692-85-7 | Purity: ≥95% | (S)-tert-Butyl (1-((tert-butyldimethylsilyl)oxy)-3-hydroxypropan-2-yl)carbamate | ESD-898186-100MG |
Cas.: 185692-85-7 | Purity: ≥95% | (S)-tert-Butyl (1-((tert-butyldimethylsilyl)oxy)-3-hydroxypropan-2-yl)carbamate | ESD-898186-250MG |
Cas.: 185692-85-7 | Purity: ≥95% | (S)-tert-Butyl (1-((tert-butyldimethylsilyl)oxy)-3-hydroxypropan-2-yl)carbamate | ESD-898186-1G |
Cas.: 1000025-93-3 | Purity: ≥95% | 3,5-Bis(benzyloxy)picolinic acid | ESD-898187-100MG |
Cas.: 1000025-93-3 | Purity: ≥95% | 3,5-Bis(benzyloxy)picolinic acid | ESD-898187-250MG |
Cas.: 1000025-93-3 | Purity: ≥95% | 3,5-Bis(benzyloxy)picolinic acid | ESD-898187-1G |
Cas.: 1346808-91-0 | Purity: ≥95% | 1-(5-Bromopyrimidin-2-yl)propan-1-one | ESD-898188-100MG |
Cas.: 1346808-91-0 | Purity: ≥95% | 1-(5-Bromopyrimidin-2-yl)propan-1-one | ESD-898188-250MG |
Cas.: 1346808-91-0 | Purity: ≥95% | 1-(5-Bromopyrimidin-2-yl)propan-1-one | ESD-898188-1G |
Cas.: 1006599-54-7 | Purity: ≥95% | 5-(2-(Methylthio)ethoxy)pyrimidin-2-amine | ESD-898189-100MG |
Cas.: 1006599-54-7 | Purity: ≥95% | 5-(2-(Methylthio)ethoxy)pyrimidin-2-amine | ESD-898189-250MG |
Cas.: 1006599-54-7 | Purity: ≥95% | 5-(2-(Methylthio)ethoxy)pyrimidin-2-amine | ESD-898189-1G |
Cas.: 1260663-92-0 | Purity: 95% | Methyl 6-amino-5-hydroxynicotinate | ESD-898190-100MG |
Cas.: 1260663-92-0 | Purity: 95% | Methyl 6-amino-5-hydroxynicotinate | ESD-898190-250MG |
Cas.: 1260663-92-0 | Purity: 95% | Methyl 6-amino-5-hydroxynicotinate | ESD-898190-1G |
Cas.: 445490-61-9 | Purity: 97% | 5,6,7,8-Tetrahydro-1,8-naphthyridin-2-acetic acid | ESD-898191-100MG |
Cas.: 445490-61-9 | Purity: 97% | 5,6,7,8-Tetrahydro-1,8-naphthyridin-2-acetic acid | ESD-898191-250MG |
Cas.: 445490-61-9 | Purity: 97% | 5,6,7,8-Tetrahydro-1,8-naphthyridin-2-acetic acid | ESD-898191-1G |
Cas.: 83410-15-5 | Purity: ≥95% | 4-Chloro-5-iodo-6-methylpyrimidine | ESD-898192-100MG |
Cas.: 83410-15-5 | Purity: ≥95% | 4-Chloro-5-iodo-6-methylpyrimidine | ESD-898192-250MG |
Cas.: 83410-15-5 | Purity: ≥95% | 4-Chloro-5-iodo-6-methylpyrimidine | ESD-898192-1G |
Cas.: 911372-77-5 | Purity: 97% | (R)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898193-100MG |
Cas.: 911372-77-5 | Purity: 97% | (R)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898193-250MG |
Cas.: 911372-77-5 | Purity: 97% | (R)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898193-1G |
Cas.: 1196154-93-4 | Purity: ≥95% | 4-Bromo-5-methylpicolinic acid | ESD-898194-100MG |
Cas.: 1196154-93-4 | Purity: ≥95% | 4-Bromo-5-methylpicolinic acid | ESD-898194-250MG |
Cas.: 1196154-93-4 | Purity: ≥95% | 4-Bromo-5-methylpicolinic acid | ESD-898194-1G |
Cas.: 68755-44-2 | Purity: 97% | 4-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898195-100MG |
Cas.: 68755-44-2 | Purity: 97% | 4-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898195-250MG |
Cas.: 68755-44-2 | Purity: 97% | 4-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898195-1G |
Cas.: 203854-59-5 | Purity: 99% | (S)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | ESD-898196-100MG |
Cas.: 203854-59-5 | Purity: 99% | (S)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | ESD-898196-250MG |
Cas.: 203854-59-5 | Purity: 99% | (S)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | ESD-898196-1G |
Cas.: 67058-71-3 | Purity: 97% | 1-(1H-Pyrrolo[2,3-c]pyridin-3-yl)ethanone | ESD-898197-100MG |
Cas.: 67058-71-3 | Purity: 97% | 1-(1H-Pyrrolo[2,3-c]pyridin-3-yl)ethanone | ESD-898197-250MG |
Cas.: 67058-71-3 | Purity: 97% | 1-(1H-Pyrrolo[2,3-c]pyridin-3-yl)ethanone | ESD-898197-1G |
Cas.: 1033713-11-9 | Purity: ≥95% | (S)-1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid | ESD-898198-100MG |
Cas.: 1033713-11-9 | Purity: ≥95% | (S)-1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid | ESD-898198-250MG |
Cas.: 1033713-11-9 | Purity: ≥95% | (S)-1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid | ESD-898198-1G |
Cas.: 957204-30-7 | Purity: 97% | tert-Butyl 6-hydroxyindoline-1-carboxylate | ESD-898199-100MG |
Cas.: 957204-30-7 | Purity: 97% | tert-Butyl 6-hydroxyindoline-1-carboxylate | ESD-898199-250MG |
Cas.: 957204-30-7 | Purity: 97% | tert-Butyl 6-hydroxyindoline-1-carboxylate | ESD-898199-1G |
Cas.: 129150-68-1 | Purity: 97% | tert-Butyl 3-hydroxyphenethylcarbamate | ESD-898200-100MG |
Cas.: 129150-68-1 | Purity: 97% | tert-Butyl 3-hydroxyphenethylcarbamate | ESD-898200-250MG |
Cas.: 129150-68-1 | Purity: 97% | tert-Butyl 3-hydroxyphenethylcarbamate | ESD-898200-1G |
Cas.: 1431412-19-9 | Purity: ≥95% | 4-Methoxyfuro[3,2-d]pyrimidine-6-carboxylic acid | ESD-898201-100MG |
Cas.: 1431412-19-9 | Purity: ≥95% | 4-Methoxyfuro[3,2-d]pyrimidine-6-carboxylic acid | ESD-898201-250MG |
Cas.: 1431412-19-9 | Purity: ≥95% | 4-Methoxyfuro[3,2-d]pyrimidine-6-carboxylic acid | ESD-898201-1G |
Cas.: 127862-88-8 | Purity: ≥95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid | ESD-898202-100MG |
Cas.: 127862-88-8 | Purity: ≥95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid | ESD-898202-250MG |
Cas.: 127862-88-8 | Purity: ≥95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(2-fluorophenyl)propanoic acid | ESD-898202-1G |
Cas.: 84341-13-9 | Purity: 95% | 8-Chloropyrido[3,4-d]pyrimidin-4-ol | ESD-898203-100MG |
Cas.: 84341-13-9 | Purity: 95% | 8-Chloropyrido[3,4-d]pyrimidin-4-ol | ESD-898203-250MG |
Cas.: 84341-13-9 | Purity: 95% | 8-Chloropyrido[3,4-d]pyrimidin-4-ol | ESD-898203-1G |
Cas.: 60126-86-5 | Purity: ≥95% | 3-Ethyl-2-(2-(phenylamino)vinyl)benzo[d]thiazol-3-ium iodide | ESD-898204-100MG |
Cas.: 60126-86-5 | Purity: ≥95% | 3-Ethyl-2-(2-(phenylamino)vinyl)benzo[d]thiazol-3-ium iodide | ESD-898204-250MG |
Cas.: 60126-86-5 | Purity: ≥95% | 3-Ethyl-2-(2-(phenylamino)vinyl)benzo[d]thiazol-3-ium iodide | ESD-898204-1G |
Cas.: 31945-06-9 | Purity: 97% | (S)-3-(Piperidin-2-yl)pyridine dihydrochloride | ESD-898205-100MG |
Cas.: 31945-06-9 | Purity: 97% | (S)-3-(Piperidin-2-yl)pyridine dihydrochloride | ESD-898205-250MG |
Cas.: 31945-06-9 | Purity: 97% | (S)-3-(Piperidin-2-yl)pyridine dihydrochloride | ESD-898205-1G |
Cas.: 91344-89-7 | Purity: 97% | Methyl 4-oxochroman-8-carboxylate | ESD-898206-100MG |
Cas.: 91344-89-7 | Purity: 97% | Methyl 4-oxochroman-8-carboxylate | ESD-898206-250MG |
Cas.: 91344-89-7 | Purity: 97% | Methyl 4-oxochroman-8-carboxylate | ESD-898206-1G |
Cas.: 1149383-12-9 | Purity: 95% | (S)-1-(2-Fluoro-4-methoxyphenyl)ethanamine hydrochloride | ESD-898207-100MG |
Cas.: 1149383-12-9 | Purity: 95% | (S)-1-(2-Fluoro-4-methoxyphenyl)ethanamine hydrochloride | ESD-898207-250MG |
Cas.: 1149383-12-9 | Purity: 95% | (S)-1-(2-Fluoro-4-methoxyphenyl)ethanamine hydrochloride | ESD-898207-1G |
Cas.: 1425045-01-7 | Purity: 97% | 1,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-898208-100MG |
Cas.: 1425045-01-7 | Purity: 97% | 1,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-898208-250MG |
Cas.: 1425045-01-7 | Purity: 97% | 1,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-898208-1G |
Cas.: 1310350-99-2 | Purity: 97% | 4-Chloro-1-(difluoromethyl)-1H-pyrazole-3-carboxylic acid | ESD-898209-100MG |
Cas.: 1310350-99-2 | Purity: 97% | 4-Chloro-1-(difluoromethyl)-1H-pyrazole-3-carboxylic acid | ESD-898209-250MG |
Cas.: 1310350-99-2 | Purity: 97% | 4-Chloro-1-(difluoromethyl)-1H-pyrazole-3-carboxylic acid | ESD-898209-1G |
Cas.: 1159813-15-6 | Purity: 98% | 8-Bromo-6-chloro-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-898210-100MG |
Cas.: 1159813-15-6 | Purity: 98% | 8-Bromo-6-chloro-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-898210-250MG |
Cas.: 1159813-15-6 | Purity: 98% | 8-Bromo-6-chloro-2-methyl-[1,2,4]triazolo[1,5-a]pyridine | ESD-898210-1G |
Cas.: 61049-67-0 | Purity: 97% | 3-(Benzyloxy)-4H-pyran-4-one | ESD-898211-100MG |
Cas.: 61049-67-0 | Purity: 97% | 3-(Benzyloxy)-4H-pyran-4-one | ESD-898211-250MG |
Cas.: 61049-67-0 | Purity: 97% | 3-(Benzyloxy)-4H-pyran-4-one | ESD-898211-1G |
Cas.: 908562-24-3 | Purity: ≥95% | Methyl 2-(bromomethyl)-3-cyanobenzoate | ESD-898212-100MG |
Cas.: 908562-24-3 | Purity: ≥95% | Methyl 2-(bromomethyl)-3-cyanobenzoate | ESD-898212-250MG |
Cas.: 908562-24-3 | Purity: ≥95% | Methyl 2-(bromomethyl)-3-cyanobenzoate | ESD-898212-1G |
Cas.: 66999-59-5 | Purity: ≥95% | 5-Chloro-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-898213-100MG |
Cas.: 66999-59-5 | Purity: ≥95% | 5-Chloro-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-898213-250MG |
Cas.: 66999-59-5 | Purity: ≥95% | 5-Chloro-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-898213-1G |
Cas.: 13916-91-1 | Purity: ≥95% | 6-Fluoronaphthalen-2-amine | ESD-898214-100MG |
Cas.: 13916-91-1 | Purity: ≥95% | 6-Fluoronaphthalen-2-amine | ESD-898214-250MG |
Cas.: 13916-91-1 | Purity: ≥95% | 6-Fluoronaphthalen-2-amine | ESD-898214-1G |
Cas.: 1640848-71-0 | Purity: 97% | (R)-2-Amino-2-(6-methoxypyridin-3-yl)ethanol dihydrochloride | ESD-898215-100MG |
Cas.: 1640848-71-0 | Purity: 97% | (R)-2-Amino-2-(6-methoxypyridin-3-yl)ethanol dihydrochloride | ESD-898215-250MG |
Cas.: 1640848-71-0 | Purity: 97% | (R)-2-Amino-2-(6-methoxypyridin-3-yl)ethanol dihydrochloride | ESD-898215-1G |
Cas.: 18260-69-0 | Purity: ≥95% | 6-Fluoro-5-methylpyrimidin-4-amine | ESD-898216-100MG |
Cas.: 18260-69-0 | Purity: ≥95% | 6-Fluoro-5-methylpyrimidin-4-amine | ESD-898216-250MG |
Cas.: 18260-69-0 | Purity: ≥95% | 6-Fluoro-5-methylpyrimidin-4-amine | ESD-898216-1G |
Cas.: 158563-45-2 | Purity: 97% | H-Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 | ESD-898217-100MG |
Cas.: 158563-45-2 | Purity: 97% | H-Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 | ESD-898217-250MG |
Cas.: 158563-45-2 | Purity: 97% | H-Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 | ESD-898217-1G |
Cas.: 116854-10-5 | Purity: 98% | 5-Methoxy-2,3-dihydro-1H-indene-1-carboxylic acid | ESD-898218-100MG |
Cas.: 116854-10-5 | Purity: 98% | 5-Methoxy-2,3-dihydro-1H-indene-1-carboxylic acid | ESD-898218-250MG |
Cas.: 116854-10-5 | Purity: 98% | 5-Methoxy-2,3-dihydro-1H-indene-1-carboxylic acid | ESD-898218-1G |
Cas.: 779340-50-0 | Purity: ≥95% | (R)-1-(5-Methylfuran-2-yl)propan-1-amine hydrochloride | ESD-898219-100MG |
Cas.: 779340-50-0 | Purity: ≥95% | (R)-1-(5-Methylfuran-2-yl)propan-1-amine hydrochloride | ESD-898219-250MG |
Cas.: 779340-50-0 | Purity: ≥95% | (R)-1-(5-Methylfuran-2-yl)propan-1-amine hydrochloride | ESD-898219-1G |
Cas.: 364794-82-1 | Purity: ≥95% | 4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine | ESD-898220-100MG |
Cas.: 364794-82-1 | Purity: ≥95% | 4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine | ESD-898220-250MG |
Cas.: 364794-82-1 | Purity: ≥95% | 4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine | ESD-898220-1G |
Cas.: 610277-13-9 | Purity: 95% | 2-Bromo-3-chloropyridin-4-amine | ESD-898221-100MG |
Cas.: 610277-13-9 | Purity: 95% | 2-Bromo-3-chloropyridin-4-amine | ESD-898221-250MG |
Cas.: 610277-13-9 | Purity: 95% | 2-Bromo-3-chloropyridin-4-amine | ESD-898221-1G |
Cas.: 170492-30-5 | Purity: ≥95% | 2-Morpholinothiazol-4-amine hydrochloride | ESD-898222-100MG |
Cas.: 170492-30-5 | Purity: ≥95% | 2-Morpholinothiazol-4-amine hydrochloride | ESD-898222-250MG |
Cas.: 170492-30-5 | Purity: ≥95% | 2-Morpholinothiazol-4-amine hydrochloride | ESD-898222-1G |
Cas.: 801303-32-2 | Purity: ≥95% | 1-(4-Bromo-2-fluorophenyl)-2-methylpropan-1-one | ESD-898223-100MG |
Cas.: 801303-32-2 | Purity: ≥95% | 1-(4-Bromo-2-fluorophenyl)-2-methylpropan-1-one | ESD-898223-250MG |
Cas.: 801303-32-2 | Purity: ≥95% | 1-(4-Bromo-2-fluorophenyl)-2-methylpropan-1-one | ESD-898223-1G |
Cas.: 1189154-01-5 | Purity: 97% | (R)-tert-Butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate | ESD-898224-100MG |
Cas.: 1189154-01-5 | Purity: 97% | (R)-tert-Butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate | ESD-898224-250MG |
Cas.: 1189154-01-5 | Purity: 97% | (R)-tert-Butyl 2-(4-bromophenyl)pyrrolidine-1-carboxylate | ESD-898224-1G |
Cas.: 1217686-40-2 | Purity: ≥95% | (S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid | ESD-898225-100MG |
Cas.: 1217686-40-2 | Purity: ≥95% | (S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid | ESD-898225-250MG |
Cas.: 1217686-40-2 | Purity: ≥95% | (S)-1-(tert-Butoxycarbonyl)-2-(4-iodobenzyl)pyrrolidine-2-carboxylic acid | ESD-898225-1G |
Cas.: 59032-71-2 | Purity: ≥95% | Ethyl 1-ethyl-4-oxocyclohexanecarboxylate | ESD-898226-100MG |
Cas.: 59032-71-2 | Purity: ≥95% | Ethyl 1-ethyl-4-oxocyclohexanecarboxylate | ESD-898226-250MG |
Cas.: 59032-71-2 | Purity: ≥95% | Ethyl 1-ethyl-4-oxocyclohexanecarboxylate | ESD-898226-1G |
Cas.: 218594-84-4 | Purity: ≥95% | (S)-Ethyl morpholine-3-carboxylate hydrochloride | ESD-898227-100MG |
Cas.: 218594-84-4 | Purity: ≥95% | (S)-Ethyl morpholine-3-carboxylate hydrochloride | ESD-898227-250MG |
Cas.: 218594-84-4 | Purity: ≥95% | (S)-Ethyl morpholine-3-carboxylate hydrochloride | ESD-898227-1G |
Cas.: 68906-27-4 | Purity: 97% | (S)-2-Methyl-1-phenylpropan-1-amine hydrochloride | ESD-898228-100MG |
Cas.: 68906-27-4 | Purity: 97% | (S)-2-Methyl-1-phenylpropan-1-amine hydrochloride | ESD-898228-250MG |
Cas.: 68906-27-4 | Purity: 97% | (S)-2-Methyl-1-phenylpropan-1-amine hydrochloride | ESD-898228-1G |
Cas.: 2044711-48-8 | Purity: 97% | (S)-3-Aminoazetidin-2-one hydrochloride | ESD-898229-100MG |
Cas.: 2044711-48-8 | Purity: 97% | (S)-3-Aminoazetidin-2-one hydrochloride | ESD-898229-250MG |
Cas.: 2044711-48-8 | Purity: 97% | (S)-3-Aminoazetidin-2-one hydrochloride | ESD-898229-1G |
Cas.: 89284-26-4 | Purity: 97% | 3-Amino-6-chloropyrazine-2-carbaldehyde | ESD-898230-100MG |
Cas.: 89284-26-4 | Purity: 97% | 3-Amino-6-chloropyrazine-2-carbaldehyde | ESD-898230-250MG |
Cas.: 89284-26-4 | Purity: 97% | 3-Amino-6-chloropyrazine-2-carbaldehyde | ESD-898230-1G |
Cas.: 1072249-83-2 | Purity: 97% | tert-Butyl 3-methyl-1H-pyrazolo[4,3-c]pyridine-1-carboxylate | ESD-898231-100MG |
Cas.: 1072249-83-2 | Purity: 97% | tert-Butyl 3-methyl-1H-pyrazolo[4,3-c]pyridine-1-carboxylate | ESD-898231-250MG |
Cas.: 1072249-83-2 | Purity: 97% | tert-Butyl 3-methyl-1H-pyrazolo[4,3-c]pyridine-1-carboxylate | ESD-898231-1G |
Cas.: 1121585-15-6 | Purity: ≥95% | 5-Bromo-2-(trifluoromethyl)phenol | ESD-898232-100MG |
Cas.: 1121585-15-6 | Purity: ≥95% | 5-Bromo-2-(trifluoromethyl)phenol | ESD-898232-250MG |
Cas.: 1121585-15-6 | Purity: ≥95% | 5-Bromo-2-(trifluoromethyl)phenol | ESD-898232-1G |
Cas.: 879127-67-0 | Purity: ≥95% | Sodium 3,5-dioxotetrahydro-2H-pyran-4-ide | ESD-898233-100MG |
Cas.: 879127-67-0 | Purity: ≥95% | Sodium 3,5-dioxotetrahydro-2H-pyran-4-ide | ESD-898233-250MG |
Cas.: 879127-67-0 | Purity: ≥95% | Sodium 3,5-dioxotetrahydro-2H-pyran-4-ide | ESD-898233-1G |
Cas.: 860624-88-0 | Purity: ≥95% | Methyl 5-bromoindoline-7-carboxylate | ESD-898234-100MG |
Cas.: 860624-88-0 | Purity: ≥95% | Methyl 5-bromoindoline-7-carboxylate | ESD-898234-250MG |
Cas.: 860624-88-0 | Purity: ≥95% | Methyl 5-bromoindoline-7-carboxylate | ESD-898234-1G |
Cas.: 1214900-01-2 | Purity: 97% | 2-(Benzyloxy)pyridin-4-amine | ESD-898235-100MG |
Cas.: 1214900-01-2 | Purity: 97% | 2-(Benzyloxy)pyridin-4-amine | ESD-898235-250MG |
Cas.: 1214900-01-2 | Purity: 97% | 2-(Benzyloxy)pyridin-4-amine | ESD-898235-1G |
Cas.: 1550887-26-7 | Purity: 97% | 4-(Methoxymethyl)-1H-pyrrole-2-carboxylic acid | ESD-898236-100MG |
Cas.: 1550887-26-7 | Purity: 97% | 4-(Methoxymethyl)-1H-pyrrole-2-carboxylic acid | ESD-898236-250MG |
Cas.: 1550887-26-7 | Purity: 97% | 4-(Methoxymethyl)-1H-pyrrole-2-carboxylic acid | ESD-898236-1G |
Cas.: 1170830-85-9 | Purity: ≥95% | 5,6,7,8-Tetrahydro-2,6-naphthyridin-1(2H)-one | ESD-898237-100MG |
Cas.: 1170830-85-9 | Purity: ≥95% | 5,6,7,8-Tetrahydro-2,6-naphthyridin-1(2H)-one | ESD-898237-250MG |
Cas.: 1170830-85-9 | Purity: ≥95% | 5,6,7,8-Tetrahydro-2,6-naphthyridin-1(2H)-one | ESD-898237-1G |
Cas.: 365996-04-9 | Purity: ≥95% | tert-Butyl (3-mercaptopyridin-4-yl)carbamate | ESD-898238-100MG |
Cas.: 365996-04-9 | Purity: ≥95% | tert-Butyl (3-mercaptopyridin-4-yl)carbamate | ESD-898238-250MG |
Cas.: 365996-04-9 | Purity: ≥95% | tert-Butyl (3-mercaptopyridin-4-yl)carbamate | ESD-898238-1G |
Cas.: 1292369-21-1 | Purity: 97% | 4-Ethylpyridazin-3(2H)-one | ESD-898239-100MG |
Cas.: 1292369-21-1 | Purity: 97% | 4-Ethylpyridazin-3(2H)-one | ESD-898239-250MG |
Cas.: 1292369-21-1 | Purity: 97% | 4-Ethylpyridazin-3(2H)-one | ESD-898239-1G |
Cas.: 1314910-43-4 | Purity: 97% | 2-(Azetidin-3-ylidene)acetonitrile hydrochloride | ESD-898240-100MG |
Cas.: 1314910-43-4 | Purity: 97% | 2-(Azetidin-3-ylidene)acetonitrile hydrochloride | ESD-898240-250MG |
Cas.: 1314910-43-4 | Purity: 97% | 2-(Azetidin-3-ylidene)acetonitrile hydrochloride | ESD-898240-1G |
Cas.: 865887-07-6 | Purity: 97% | Methyl 4-methoxy-1H-indazole-3-carboxylate | ESD-898241-100MG |
Cas.: 865887-07-6 | Purity: 97% | Methyl 4-methoxy-1H-indazole-3-carboxylate | ESD-898241-250MG |
Cas.: 865887-07-6 | Purity: 97% | Methyl 4-methoxy-1H-indazole-3-carboxylate | ESD-898241-1G |
Cas.: 1251015-16-3 | Purity: ≥95% | tert-Butyl 5-bromo-2H-spiro[benzofuran-3,4′-piperidine]-1′-carboxylate | ESD-898242-100MG |
Cas.: 1251015-16-3 | Purity: ≥95% | tert-Butyl 5-bromo-2H-spiro[benzofuran-3,4′-piperidine]-1′-carboxylate | ESD-898242-250MG |
Cas.: 1251015-16-3 | Purity: ≥95% | tert-Butyl 5-bromo-2H-spiro[benzofuran-3,4′-piperidine]-1′-carboxylate | ESD-898242-1G |
Cas.: 1381928-19-3 | Purity: 97% | (R)-5-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898243-100MG |
Cas.: 1381928-19-3 | Purity: 97% | (R)-5-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898243-250MG |
Cas.: 1381928-19-3 | Purity: 97% | (R)-5-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898243-1G |
Cas.: 1169789-29-0 | Purity: ≥95% | tert-Butyl 6-bromo-4-methoxy-1H-indazole-1-carboxylate | ESD-898244-100MG |
Cas.: 1169789-29-0 | Purity: ≥95% | tert-Butyl 6-bromo-4-methoxy-1H-indazole-1-carboxylate | ESD-898244-250MG |
Cas.: 1169789-29-0 | Purity: ≥95% | tert-Butyl 6-bromo-4-methoxy-1H-indazole-1-carboxylate | ESD-898244-1G |
Cas.: 69075-42-9 | Purity: 98% | 5-Ethynyluridine | ESD-898245-100MG |
Cas.: 69075-42-9 | Purity: 98% | 5-Ethynyluridine | ESD-898245-250MG |
Cas.: 69075-42-9 | Purity: 98% | 5-Ethynyluridine | ESD-898245-1G |
Cas.: 918511-92-9 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-898246-100MG |
Cas.: 918511-92-9 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-898246-250MG |
Cas.: 918511-92-9 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine | ESD-898246-1G |
Cas.: 1221171-98-7 | Purity: ≥95% | 2-(Trifluoromethoxy)isonicotinic acid | ESD-898247-100MG |
Cas.: 1221171-98-7 | Purity: ≥95% | 2-(Trifluoromethoxy)isonicotinic acid | ESD-898247-250MG |
Cas.: 1221171-98-7 | Purity: ≥95% | 2-(Trifluoromethoxy)isonicotinic acid | ESD-898247-1G |
Cas.: 1137475-57-0 | Purity: ≥95% | 2-Bromo-4-chloro-5-nitropyridine | ESD-898248-100MG |
Cas.: 1137475-57-0 | Purity: ≥95% | 2-Bromo-4-chloro-5-nitropyridine | ESD-898248-250MG |
Cas.: 1137475-57-0 | Purity: ≥95% | 2-Bromo-4-chloro-5-nitropyridine | ESD-898248-1G |
Cas.: 953770-85-9 | Purity: ≥95% | N-Methyl-4-((2-(methylthio)benzo[d]thiazol-6-yl)oxy)picolinamide | ESD-898249-100MG |
Cas.: 953770-85-9 | Purity: ≥95% | N-Methyl-4-((2-(methylthio)benzo[d]thiazol-6-yl)oxy)picolinamide | ESD-898249-250MG |
Cas.: 953770-85-9 | Purity: ≥95% | N-Methyl-4-((2-(methylthio)benzo[d]thiazol-6-yl)oxy)picolinamide | ESD-898249-1G |
Cas.: 101417-40-7 | Purity: ≥95% | 4-(Bromomethyl)benzo[d][1,3]dioxole | ESD-898250-100MG |
Cas.: 101417-40-7 | Purity: ≥95% | 4-(Bromomethyl)benzo[d][1,3]dioxole | ESD-898250-250MG |
Cas.: 101417-40-7 | Purity: ≥95% | 4-(Bromomethyl)benzo[d][1,3]dioxole | ESD-898250-1G |
Cas.: 783349-78-0 | Purity: 97% | (S)-4-(tert-Butoxycarbonyl)-6,6-dimethylmorpholine-3-carboxylic acid | ESD-898251-100MG |
Cas.: 783349-78-0 | Purity: 97% | (S)-4-(tert-Butoxycarbonyl)-6,6-dimethylmorpholine-3-carboxylic acid | ESD-898251-250MG |
Cas.: 783349-78-0 | Purity: 97% | (S)-4-(tert-Butoxycarbonyl)-6,6-dimethylmorpholine-3-carboxylic acid | ESD-898251-1G |
Cas.: 70411-83-5 | Purity: ≥95% | 1-Methyl-2-oxo-1,2-dihydropyridine-4-carbonitrile | ESD-898252-100MG |
Cas.: 70411-83-5 | Purity: ≥95% | 1-Methyl-2-oxo-1,2-dihydropyridine-4-carbonitrile | ESD-898252-250MG |
Cas.: 70411-83-5 | Purity: ≥95% | 1-Methyl-2-oxo-1,2-dihydropyridine-4-carbonitrile | ESD-898252-1G |
Cas.: 1810074-88-4 | Purity: ≥95% | (S)-2-Amino-3-(2-hydroxyphenyl)propanoic acid hydrochloride | ESD-898253-100MG |
Cas.: 1810074-88-4 | Purity: ≥95% | (S)-2-Amino-3-(2-hydroxyphenyl)propanoic acid hydrochloride | ESD-898253-250MG |
Cas.: 1810074-88-4 | Purity: ≥95% | (S)-2-Amino-3-(2-hydroxyphenyl)propanoic acid hydrochloride | ESD-898253-1G |
Cas.: 1300750-50-8 | Purity: ≥95% | (2-(Difluoromethoxy)pyridin-3-yl)boronic acid | ESD-898254-100MG |
Cas.: 1300750-50-8 | Purity: ≥95% | (2-(Difluoromethoxy)pyridin-3-yl)boronic acid | ESD-898254-250MG |
Cas.: 1300750-50-8 | Purity: ≥95% | (2-(Difluoromethoxy)pyridin-3-yl)boronic acid | ESD-898254-1G |
Cas.: 791136-88-4 | Purity: ≥95% | 3-Bromo-2-methoxybenzamide | ESD-898255-100MG |
Cas.: 791136-88-4 | Purity: ≥95% | 3-Bromo-2-methoxybenzamide | ESD-898255-250MG |
Cas.: 791136-88-4 | Purity: ≥95% | 3-Bromo-2-methoxybenzamide | ESD-898255-1G |
Cas.: 1956322-51-2 | Purity: 97% | 6-oxa-2-Azaspiro[4.5]decane hydrochloride | ESD-898256-100MG |
Cas.: 1956322-51-2 | Purity: 97% | 6-oxa-2-Azaspiro[4.5]decane hydrochloride | ESD-898256-250MG |
Cas.: 1956322-51-2 | Purity: 97% | 6-oxa-2-Azaspiro[4.5]decane hydrochloride | ESD-898256-1G |
Cas.: 1261737-67-0 | Purity: 97% | 2-Chlorobenzo[d]thiazol-5-ol | ESD-898257-100MG |
Cas.: 1261737-67-0 | Purity: 97% | 2-Chlorobenzo[d]thiazol-5-ol | ESD-898257-250MG |
Cas.: 1261737-67-0 | Purity: 97% | 2-Chlorobenzo[d]thiazol-5-ol | ESD-898257-1G |
Cas.: 41270-74-0 | Purity: 98% | 5-Phenyl-1H-imidazole-2-carboxylic acid | ESD-898258-100MG |
Cas.: 41270-74-0 | Purity: 98% | 5-Phenyl-1H-imidazole-2-carboxylic acid | ESD-898258-250MG |
Cas.: 41270-74-0 | Purity: 98% | 5-Phenyl-1H-imidazole-2-carboxylic acid | ESD-898258-1G |
Cas.: 62077-28-5 | Purity: ≥95% | 3,5-Dichloro-2-methylaniline | ESD-898259-100MG |
Cas.: 62077-28-5 | Purity: ≥95% | 3,5-Dichloro-2-methylaniline | ESD-898259-250MG |
Cas.: 62077-28-5 | Purity: ≥95% | 3,5-Dichloro-2-methylaniline | ESD-898259-1G |
Cas.: 1161847-36-4 | Purity: ≥95% | 6-Chloroimidazo[1,2-b]pyridazin-8-amine | ESD-898260-100MG |
Cas.: 1161847-36-4 | Purity: ≥95% | 6-Chloroimidazo[1,2-b]pyridazin-8-amine | ESD-898260-250MG |
Cas.: 1161847-36-4 | Purity: ≥95% | 6-Chloroimidazo[1,2-b]pyridazin-8-amine | ESD-898260-1G |
Cas.: 1301198-65-1 | Purity: 95% | 1-(Methoxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-898261-100MG |
Cas.: 1301198-65-1 | Purity: 95% | 1-(Methoxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-898261-250MG |
Cas.: 1301198-65-1 | Purity: 95% | 1-(Methoxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-898261-1G |
Cas.: 1060806-62-3 | Purity: ≥95% | 6-Bromo-2-methoxynicotinic acid | ESD-898262-100MG |
Cas.: 1060806-62-3 | Purity: ≥95% | 6-Bromo-2-methoxynicotinic acid | ESD-898262-250MG |
Cas.: 1060806-62-3 | Purity: ≥95% | 6-Bromo-2-methoxynicotinic acid | ESD-898262-1G |
Cas.: 867065-85-8 | Purity: ≥95% | tert-Butyl tetrahydropyrimidine-1(2H)-carboxylate | ESD-898263-100MG |
Cas.: 867065-85-8 | Purity: ≥95% | tert-Butyl tetrahydropyrimidine-1(2H)-carboxylate | ESD-898263-250MG |
Cas.: 867065-85-8 | Purity: ≥95% | tert-Butyl tetrahydropyrimidine-1(2H)-carboxylate | ESD-898263-1G |
Cas.: 861545-83-7 | Purity: 98% | 4,6-Dichloro-5-cyanopicolinic acid | ESD-898264-100MG |
Cas.: 861545-83-7 | Purity: 98% | 4,6-Dichloro-5-cyanopicolinic acid | ESD-898264-250MG |
Cas.: 861545-83-7 | Purity: 98% | 4,6-Dichloro-5-cyanopicolinic acid | ESD-898264-1G |
Cas.: 1184181-48-3 | Purity: 97% | 2,4-Dihydroxy-5-isopropylbenzoic acid | ESD-898266-100MG |
Cas.: 1184181-48-3 | Purity: 97% | 2,4-Dihydroxy-5-isopropylbenzoic acid | ESD-898266-250MG |
Cas.: 1184181-48-3 | Purity: 97% | 2,4-Dihydroxy-5-isopropylbenzoic acid | ESD-898266-1G |
Cas.: 383132-25-0 | Purity: 97% | 7-Isopropyl-1H-indole-2-carboxylic acid | ESD-898267-100MG |
Cas.: 383132-25-0 | Purity: 97% | 7-Isopropyl-1H-indole-2-carboxylic acid | ESD-898267-250MG |
Cas.: 383132-25-0 | Purity: 97% | 7-Isopropyl-1H-indole-2-carboxylic acid | ESD-898267-1G |
Cas.: 1286734-90-4 | Purity: ≥95% | (S)-4-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898268-100MG |
Cas.: 1286734-90-4 | Purity: ≥95% | (S)-4-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898268-250MG |
Cas.: 1286734-90-4 | Purity: ≥95% | (S)-4-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898268-1G |
Cas.: 112734-21-1 | Purity: ≥95% | 4-Bromo-2-nitrobenzoyl chloride | ESD-898269-100MG |
Cas.: 112734-21-1 | Purity: ≥95% | 4-Bromo-2-nitrobenzoyl chloride | ESD-898269-250MG |
Cas.: 112734-21-1 | Purity: ≥95% | 4-Bromo-2-nitrobenzoyl chloride | ESD-898269-1G |
Cas.: 1236353-78-8 | Purity: 97% | (R)-Methyl 3-(1-aminoethyl)benzoate hydrochloride | ESD-898270-100MG |
Cas.: 1236353-78-8 | Purity: 97% | (R)-Methyl 3-(1-aminoethyl)benzoate hydrochloride | ESD-898270-250MG |
Cas.: 1236353-78-8 | Purity: 97% | (R)-Methyl 3-(1-aminoethyl)benzoate hydrochloride | ESD-898270-1G |
Cas.: 148893-34-9 | Purity: 97% | Fmoc-Arg(Alloc)2-OH | ESD-898271-100MG |
Cas.: 148893-34-9 | Purity: 97% | Fmoc-Arg(Alloc)2-OH | ESD-898271-250MG |
Cas.: 148893-34-9 | Purity: 97% | Fmoc-Arg(Alloc)2-OH | ESD-898271-1G |
Cas.: 263407-17-6 | Purity: 97% | (2R,4S)-4-Aminopyrrolidine-2-carboxylic acid dihydrochloride | ESD-898272-100MG |
Cas.: 263407-17-6 | Purity: 97% | (2R,4S)-4-Aminopyrrolidine-2-carboxylic acid dihydrochloride | ESD-898272-250MG |
Cas.: 263407-17-6 | Purity: 97% | (2R,4S)-4-Aminopyrrolidine-2-carboxylic acid dihydrochloride | ESD-898272-1G |
Cas.: 856562-93-1 | Purity: 97% | (R)-1-(o-Tolyl)propan-1-amine hydrochloride | ESD-898273-100MG |
Cas.: 856562-93-1 | Purity: 97% | (R)-1-(o-Tolyl)propan-1-amine hydrochloride | ESD-898273-250MG |
Cas.: 856562-93-1 | Purity: 97% | (R)-1-(o-Tolyl)propan-1-amine hydrochloride | ESD-898273-1G |
Cas.: 870235-46-4 | Purity: ≥95% | 4-Fluorothieno[2,3-c]pyridine-2-carboxylic acid | ESD-898274-100MG |
Cas.: 870235-46-4 | Purity: ≥95% | 4-Fluorothieno[2,3-c]pyridine-2-carboxylic acid | ESD-898274-250MG |
Cas.: 870235-46-4 | Purity: ≥95% | 4-Fluorothieno[2,3-c]pyridine-2-carboxylic acid | ESD-898274-1G |
Cas.: 41172-77-4 | Purity: ≥95% | Methyl 2-amino-3-oxobutanoate hydrochloride | ESD-898275-100MG |
Cas.: 41172-77-4 | Purity: ≥95% | Methyl 2-amino-3-oxobutanoate hydrochloride | ESD-898275-250MG |
Cas.: 41172-77-4 | Purity: ≥95% | Methyl 2-amino-3-oxobutanoate hydrochloride | ESD-898275-1G |
Cas.: 1227584-17-9 | Purity: 95% | 3-Bromo-5-(chloromethyl)-2-fluoropyridine | ESD-898276-100MG |
Cas.: 1227584-17-9 | Purity: 95% | 3-Bromo-5-(chloromethyl)-2-fluoropyridine | ESD-898276-250MG |
Cas.: 1227584-17-9 | Purity: 95% | 3-Bromo-5-(chloromethyl)-2-fluoropyridine | ESD-898276-1G |
Cas.: 2089325-75-5 | Purity: 97% | 7-Bromothieno[2,3-c]pyridine-2-carboxylic acid | ESD-898277-100MG |
Cas.: 2089325-75-5 | Purity: 97% | 7-Bromothieno[2,3-c]pyridine-2-carboxylic acid | ESD-898277-250MG |
Cas.: 2089325-75-5 | Purity: 97% | 7-Bromothieno[2,3-c]pyridine-2-carboxylic acid | ESD-898277-1G |
Cas.: 1408327-48-9 | Purity: ≥95% | 5-Methyl-2-nitro-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one | ESD-898278-100MG |
Cas.: 1408327-48-9 | Purity: ≥95% | 5-Methyl-2-nitro-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one | ESD-898278-250MG |
Cas.: 1408327-48-9 | Purity: ≥95% | 5-Methyl-2-nitro-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one | ESD-898278-1G |
Cas.: 1171898-22-8 | Purity: 97% | 2-(3-Bromophenyl)pyrrolidine hydrochloride | ESD-898279-100MG |
Cas.: 1171898-22-8 | Purity: 97% | 2-(3-Bromophenyl)pyrrolidine hydrochloride | ESD-898279-250MG |
Cas.: 1171898-22-8 | Purity: 97% | 2-(3-Bromophenyl)pyrrolidine hydrochloride | ESD-898279-1G |
Cas.: 551001-79-7 | Purity: 95% | (5-Methoxybenzofuran-2-yl)boronic acid | ESD-898280-100MG |
Cas.: 551001-79-7 | Purity: 95% | (5-Methoxybenzofuran-2-yl)boronic acid | ESD-898280-250MG |
Cas.: 551001-79-7 | Purity: 95% | (5-Methoxybenzofuran-2-yl)boronic acid | ESD-898280-1G |
Cas.: 895243-39-7 | Purity: 97% | trans-1-Benzyl-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid | ESD-898281-100MG |
Cas.: 895243-39-7 | Purity: 97% | trans-1-Benzyl-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid | ESD-898281-250MG |
Cas.: 895243-39-7 | Purity: 97% | trans-1-Benzyl-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid | ESD-898281-1G |
Cas.: 259685-49-9 | Purity: ≥95% | Dodecyl 2-(dimethylamino)propanoate hydrochloride | ESD-898282-100MG |
Cas.: 259685-49-9 | Purity: ≥95% | Dodecyl 2-(dimethylamino)propanoate hydrochloride | ESD-898282-250MG |
Cas.: 259685-49-9 | Purity: ≥95% | Dodecyl 2-(dimethylamino)propanoate hydrochloride | ESD-898282-1G |
Cas.: 1060801-92-4 | Purity: 95% | 3-(Trifluoromethyl)isonicotinaldehyde | ESD-898283-100MG |
Cas.: 1060801-92-4 | Purity: 95% | 3-(Trifluoromethyl)isonicotinaldehyde | ESD-898283-250MG |
Cas.: 1060801-92-4 | Purity: 95% | 3-(Trifluoromethyl)isonicotinaldehyde | ESD-898283-1G |
Cas.: 1374655-69-2 | Purity: 95% | 3-Bromo-4-ethyl-5-fluoropyridine | ESD-898284-100MG |
Cas.: 1374655-69-2 | Purity: 95% | 3-Bromo-4-ethyl-5-fluoropyridine | ESD-898284-250MG |
Cas.: 1374655-69-2 | Purity: 95% | 3-Bromo-4-ethyl-5-fluoropyridine | ESD-898284-1G |
Cas.: 1294518-25-4 | Purity: 97% | 2-Chloro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-898285-100MG |
Cas.: 1294518-25-4 | Purity: 97% | 2-Chloro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-898285-250MG |
Cas.: 1294518-25-4 | Purity: 97% | 2-Chloro-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-898285-1G |
Cas.: 1083169-00-9 | Purity: ≥95% | 4-Bromo-2-methoxy-6-methylpyridine | ESD-898286-100MG |
Cas.: 1083169-00-9 | Purity: ≥95% | 4-Bromo-2-methoxy-6-methylpyridine | ESD-898286-250MG |
Cas.: 1083169-00-9 | Purity: ≥95% | 4-Bromo-2-methoxy-6-methylpyridine | ESD-898286-1G |
Cas.: 1373232-27-9 | Purity: 97% | (S)-6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898287-100MG |
Cas.: 1373232-27-9 | Purity: 97% | (S)-6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898287-250MG |
Cas.: 1373232-27-9 | Purity: 97% | (S)-6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898287-1G |
Cas.: 19733-56-3 | Purity: ≥95% | 4-(Piperidin-3-yl)aniline | ESD-898288-100MG |
Cas.: 19733-56-3 | Purity: ≥95% | 4-(Piperidin-3-yl)aniline | ESD-898288-250MG |
Cas.: 19733-56-3 | Purity: ≥95% | 4-(Piperidin-3-yl)aniline | ESD-898288-1G |
Cas.: 172876-96-9 | Purity: ≥95% | 3-Oxo-1,2-benziodoxole-1-(3H)-carbonitrile | ESD-898289-100MG |
Cas.: 172876-96-9 | Purity: ≥95% | 3-Oxo-1,2-benziodoxole-1-(3H)-carbonitrile | ESD-898289-250MG |
Cas.: 172876-96-9 | Purity: ≥95% | 3-Oxo-1,2-benziodoxole-1-(3H)-carbonitrile | ESD-898289-1G |
Cas.: 364794-81-0 | Purity: ≥95% | 4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine | ESD-898290-100MG |
Cas.: 364794-81-0 | Purity: ≥95% | 4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine | ESD-898290-250MG |
Cas.: 364794-81-0 | Purity: ≥95% | 4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenethyl)morpholine | ESD-898290-1G |
Cas.: 1179369-48-2 | Purity: 97% | 1-(Pyrimidin-2-yl)piperidin-4-amine dihydrochloride | ESD-898291-100MG |
Cas.: 1179369-48-2 | Purity: 97% | 1-(Pyrimidin-2-yl)piperidin-4-amine dihydrochloride | ESD-898291-250MG |
Cas.: 1179369-48-2 | Purity: 97% | 1-(Pyrimidin-2-yl)piperidin-4-amine dihydrochloride | ESD-898291-1G |
Cas.: 324-32-3 | Purity: ≥98% | 2-Methyl-7-(trifluoromethyl)quinoline | ESD-898292-100MG |
Cas.: 324-32-3 | Purity: ≥98% | 2-Methyl-7-(trifluoromethyl)quinoline | ESD-898292-250MG |
Cas.: 324-32-3 | Purity: ≥98% | 2-Methyl-7-(trifluoromethyl)quinoline | ESD-898292-1G |
Cas.: 1211541-93-3 | Purity: 97% | 5-Fluoro-2-methoxypyridin-3-amine | ESD-898293-100MG |
Cas.: 1211541-93-3 | Purity: 97% | 5-Fluoro-2-methoxypyridin-3-amine | ESD-898293-250MG |
Cas.: 1211541-93-3 | Purity: 97% | 5-Fluoro-2-methoxypyridin-3-amine | ESD-898293-1G |
Cas.: 852821-06-8 | Purity: 97% | (4AS,8aS,9S)-3-(benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH ,8H)-dione | ESD-898294-100MG |
Cas.: 852821-06-8 | Purity: 97% | (4AS,8aS,9S)-3-(benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH ,8H)-dione | ESD-898294-250MG |
Cas.: 852821-06-8 | Purity: 97% | (4AS,8aS,9S)-3-(benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(dimethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH ,8H)-dione | ESD-898294-1G |
Cas.: 1276075-40-1 | Purity: ≥95% | 5-Bromo-3-isopropyl-1H-indazole | ESD-898295-100MG |
Cas.: 1276075-40-1 | Purity: ≥95% | 5-Bromo-3-isopropyl-1H-indazole | ESD-898295-250MG |
Cas.: 1276075-40-1 | Purity: ≥95% | 5-Bromo-3-isopropyl-1H-indazole | ESD-898295-1G |
Cas.: 1420859-80-8 | Purity: ≥95% | tert-Butyl 3-(2-bromoethyl)azetidine-1-carboxylate | ESD-898296-100MG |
Cas.: 1420859-80-8 | Purity: ≥95% | tert-Butyl 3-(2-bromoethyl)azetidine-1-carboxylate | ESD-898296-250MG |
Cas.: 1420859-80-8 | Purity: ≥95% | tert-Butyl 3-(2-bromoethyl)azetidine-1-carboxylate | ESD-898296-1G |
Cas.: 1187933-29-4 | Purity: ≥95% | 1-(4-Chlorophenyl)azetidine-3-carboxylic acid | ESD-898297-100MG |
Cas.: 1187933-29-4 | Purity: ≥95% | 1-(4-Chlorophenyl)azetidine-3-carboxylic acid | ESD-898297-250MG |
Cas.: 1187933-29-4 | Purity: ≥95% | 1-(4-Chlorophenyl)azetidine-3-carboxylic acid | ESD-898297-1G |
Cas.: 1443538-48-4 | Purity: 97% | (R)-2-(2-Chloro-5-fluorophenyl)pyrrolidine hydrochloride | ESD-898298-100MG |
Cas.: 1443538-48-4 | Purity: 97% | (R)-2-(2-Chloro-5-fluorophenyl)pyrrolidine hydrochloride | ESD-898298-250MG |
Cas.: 1443538-48-4 | Purity: 97% | (R)-2-(2-Chloro-5-fluorophenyl)pyrrolidine hydrochloride | ESD-898298-1G |
Cas.: 1001756-23-5 | Purity: 98% | Methyl 7-bromoquinoline-3-carboxylate | ESD-898299-100MG |
Cas.: 1001756-23-5 | Purity: 98% | Methyl 7-bromoquinoline-3-carboxylate | ESD-898299-250MG |
Cas.: 1001756-23-5 | Purity: 98% | Methyl 7-bromoquinoline-3-carboxylate | ESD-898299-1G |
Cas.: 51043-75-5 | Purity: 97% | 2,3-Bis(chloromethyl)pyrazine | ESD-898300-100MG |
Cas.: 51043-75-5 | Purity: 97% | 2,3-Bis(chloromethyl)pyrazine | ESD-898300-250MG |
Cas.: 51043-75-5 | Purity: 97% | 2,3-Bis(chloromethyl)pyrazine | ESD-898300-1G |
Cas.: 1306763-29-0 | Purity: 97% | (R)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride | ESD-898301-100MG |
Cas.: 1306763-29-0 | Purity: 97% | (R)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride | ESD-898301-250MG |
Cas.: 1306763-29-0 | Purity: 97% | (R)-1-Amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride | ESD-898301-1G |
Cas.: 1240480-36-7 | Purity: 97% | (S)-2-Amino-2-(3-fluorophenyl)ethanol hydrochloride | ESD-898302-100MG |
Cas.: 1240480-36-7 | Purity: 97% | (S)-2-Amino-2-(3-fluorophenyl)ethanol hydrochloride | ESD-898302-250MG |
Cas.: 1240480-36-7 | Purity: 97% | (S)-2-Amino-2-(3-fluorophenyl)ethanol hydrochloride | ESD-898302-1G |
Cas.: 289470-44-6 | Purity: ≥95% | Ethyl 2,5-dibromothiophene-3-carboxylate | ESD-898303-100MG |
Cas.: 289470-44-6 | Purity: ≥95% | Ethyl 2,5-dibromothiophene-3-carboxylate | ESD-898303-250MG |
Cas.: 289470-44-6 | Purity: ≥95% | Ethyl 2,5-dibromothiophene-3-carboxylate | ESD-898303-1G |
Cas.: 1260637-74-8 | Purity: 97% | 6-Fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid hydrochloride | ESD-898304-100MG |
Cas.: 1260637-74-8 | Purity: 97% | 6-Fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid hydrochloride | ESD-898304-250MG |
Cas.: 1260637-74-8 | Purity: 97% | 6-Fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid hydrochloride | ESD-898304-1G |
Cas.: 199678-06-3 | Purity: 97% | 4-(1-Methyl-1H-pyrazol-4-yl)benzoic acid | ESD-898305-100MG |
Cas.: 199678-06-3 | Purity: 97% | 4-(1-Methyl-1H-pyrazol-4-yl)benzoic acid | ESD-898305-250MG |
Cas.: 199678-06-3 | Purity: 97% | 4-(1-Methyl-1H-pyrazol-4-yl)benzoic acid | ESD-898305-1G |
Cas.: 124429-27-2 | Purity: 95% | 4-Chloro-8-fluoroquinazoline | ESD-898306-100MG |
Cas.: 124429-27-2 | Purity: 95% | 4-Chloro-8-fluoroquinazoline | ESD-898306-250MG |
Cas.: 124429-27-2 | Purity: 95% | 4-Chloro-8-fluoroquinazoline | ESD-898306-1G |
Cas.: 880874-38-4 | Purity: 97% | 2-Fluoro-N,4-dihydroxybenzimidamide | ESD-898307-100MG |
Cas.: 880874-38-4 | Purity: 97% | 2-Fluoro-N,4-dihydroxybenzimidamide | ESD-898307-250MG |
Cas.: 880874-38-4 | Purity: 97% | 2-Fluoro-N,4-dihydroxybenzimidamide | ESD-898307-1G |
Cas.: 98331-10-3 | Purity: 97% | N-(tert-Butyl)furan-2-carboxamide | ESD-898308-100MG |
Cas.: 98331-10-3 | Purity: 97% | N-(tert-Butyl)furan-2-carboxamide | ESD-898308-250MG |
Cas.: 98331-10-3 | Purity: 97% | N-(tert-Butyl)furan-2-carboxamide | ESD-898308-1G |
Cas.: 52448-15-4 | Purity: 95% | (S)-2-Amino-3-(5-chloro-1H-indol-3-yl)propanoic acid | ESD-898309-100MG |
Cas.: 52448-15-4 | Purity: 95% | (S)-2-Amino-3-(5-chloro-1H-indol-3-yl)propanoic acid | ESD-898309-250MG |
Cas.: 52448-15-4 | Purity: 95% | (S)-2-Amino-3-(5-chloro-1H-indol-3-yl)propanoic acid | ESD-898309-1G |
Cas.: 1588769-34-9 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridin-6-ylboronic acid | ESD-898310-100MG |
Cas.: 1588769-34-9 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridin-6-ylboronic acid | ESD-898310-250MG |
Cas.: 1588769-34-9 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridin-6-ylboronic acid | ESD-898310-1G |
Cas.: 1159511-40-6 | Purity: 97% | 2-Methyl-2H-indazol-4-ol | ESD-898311-100MG |
Cas.: 1159511-40-6 | Purity: 97% | 2-Methyl-2H-indazol-4-ol | ESD-898311-250MG |
Cas.: 1159511-40-6 | Purity: 97% | 2-Methyl-2H-indazol-4-ol | ESD-898311-1G |
Cas.: 933768-06-0 | Purity: 97% | 3-Ethynyl-2-fluoropyridine | ESD-898312-100MG |
Cas.: 933768-06-0 | Purity: 97% | 3-Ethynyl-2-fluoropyridine | ESD-898312-250MG |
Cas.: 933768-06-0 | Purity: 97% | 3-Ethynyl-2-fluoropyridine | ESD-898312-1G |
Cas.: 1171992-10-1 | Purity: 97% | 3-Phenoxypiperidine hydrochloride | ESD-898313-100MG |
Cas.: 1171992-10-1 | Purity: 97% | 3-Phenoxypiperidine hydrochloride | ESD-898313-250MG |
Cas.: 1171992-10-1 | Purity: 97% | 3-Phenoxypiperidine hydrochloride | ESD-898313-1G |
Cas.: 16499-63-1 | Purity: 97% | 4-Chloro-5-(trifluoromethyl)quinazoline | ESD-898314-100MG |
Cas.: 16499-63-1 | Purity: 97% | 4-Chloro-5-(trifluoromethyl)quinazoline | ESD-898314-250MG |
Cas.: 16499-63-1 | Purity: 97% | 4-Chloro-5-(trifluoromethyl)quinazoline | ESD-898314-1G |
Cas.: 72209-19-9 | Purity: 97% | (3aS,4S,6R,6aR)-6-(6-Amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4 -carboxylic acid | ESD-898315-100MG |
Cas.: 72209-19-9 | Purity: 97% | (3aS,4S,6R,6aR)-6-(6-Amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4 -carboxylic acid | ESD-898315-250MG |
Cas.: 72209-19-9 | Purity: 97% | (3aS,4S,6R,6aR)-6-(6-Amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4 -carboxylic acid | ESD-898315-1G |
Cas.: 1989558-84-0 | Purity: 97% | Ethyl 3-azabicyclo[3.1.0]hexane-1-carboxylate hydrochloride | ESD-898316-100MG |
Cas.: 1989558-84-0 | Purity: 97% | Ethyl 3-azabicyclo[3.1.0]hexane-1-carboxylate hydrochloride | ESD-898316-250MG |
Cas.: 1989558-84-0 | Purity: 97% | Ethyl 3-azabicyclo[3.1.0]hexane-1-carboxylate hydrochloride | ESD-898316-1G |
Cas.: 1838669-70-7 | Purity: 97% | 3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine hydrochloride | ESD-898317-100MG |
Cas.: 1838669-70-7 | Purity: 97% | 3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine hydrochloride | ESD-898317-250MG |
Cas.: 1838669-70-7 | Purity: 97% | 3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine hydrochloride | ESD-898317-1G |
Cas.: 121588-79-2 | Purity: ≥95% | trans-4-Methoxycyclohexanamine | ESD-898318-100MG |
Cas.: 121588-79-2 | Purity: ≥95% | trans-4-Methoxycyclohexanamine | ESD-898318-250MG |
Cas.: 121588-79-2 | Purity: ≥95% | trans-4-Methoxycyclohexanamine | ESD-898318-1G |
Cas.: 58347-48-1 | Purity: ≥95% | Ethyl 7-chloro-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-898319-100MG |
Cas.: 58347-48-1 | Purity: ≥95% | Ethyl 7-chloro-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-898319-250MG |
Cas.: 58347-48-1 | Purity: ≥95% | Ethyl 7-chloro-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-898319-1G |
Cas.: 856562-95-3 | Purity: ≥95% | (R)-1-(3-Methoxyphenyl)propan-1-amine hydrochloride | ESD-898320-100MG |
Cas.: 856562-95-3 | Purity: ≥95% | (R)-1-(3-Methoxyphenyl)propan-1-amine hydrochloride | ESD-898320-250MG |
Cas.: 856562-95-3 | Purity: ≥95% | (R)-1-(3-Methoxyphenyl)propan-1-amine hydrochloride | ESD-898320-1G |
Cas.: 112635-08-2 | Purity: ≥95% | 7-Chloro-1H-indazol-6-amine | ESD-898321-100MG |
Cas.: 112635-08-2 | Purity: ≥95% | 7-Chloro-1H-indazol-6-amine | ESD-898321-250MG |
Cas.: 112635-08-2 | Purity: ≥95% | 7-Chloro-1H-indazol-6-amine | ESD-898321-1G |
Cas.: 51600-25-0 | Purity: ≥95% | (R)-2-Methyl-1-phenylpropan-1-amine hydrochloride | ESD-898322-100MG |
Cas.: 51600-25-0 | Purity: ≥95% | (R)-2-Methyl-1-phenylpropan-1-amine hydrochloride | ESD-898322-250MG |
Cas.: 51600-25-0 | Purity: ≥95% | (R)-2-Methyl-1-phenylpropan-1-amine hydrochloride | ESD-898322-1G |
Cas.: 86117-53-5 | Purity: 97% | (R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoic acid | ESD-898323-100MG |
Cas.: 86117-53-5 | Purity: 97% | (R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoic acid | ESD-898323-250MG |
Cas.: 86117-53-5 | Purity: 97% | (R)-2-(4-Methylphenylsulfonamido)-3-phenylpropanoic acid | ESD-898323-1G |
Cas.: 24484-99-9 | Purity: ≥95% | 4,6-Dichloropyridine-2,3-diamine | ESD-898324-100MG |
Cas.: 24484-99-9 | Purity: ≥95% | 4,6-Dichloropyridine-2,3-diamine | ESD-898324-250MG |
Cas.: 24484-99-9 | Purity: ≥95% | 4,6-Dichloropyridine-2,3-diamine | ESD-898324-1G |
Cas.: 1034579-02-6 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[2,3-b]pyridine | ESD-898325-100MG |
Cas.: 1034579-02-6 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[2,3-b]pyridine | ESD-898325-250MG |
Cas.: 1034579-02-6 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[2,3-b]pyridine | ESD-898325-1G |
Cas.: 1020035-04-4 | Purity: ≥95% | 6-Methylimidazo[1,2-a]pyrimidine-3-carboxylic acid | ESD-898326-100MG |
Cas.: 1020035-04-4 | Purity: ≥95% | 6-Methylimidazo[1,2-a]pyrimidine-3-carboxylic acid | ESD-898326-250MG |
Cas.: 1020035-04-4 | Purity: ≥95% | 6-Methylimidazo[1,2-a]pyrimidine-3-carboxylic acid | ESD-898326-1G |
Cas.: 1193387-95-9 | Purity: 95% | (4-Bromophenyl)(cyclobutyl)methanamine hydrochloride | ESD-898327-100MG |
Cas.: 1193387-95-9 | Purity: 95% | (4-Bromophenyl)(cyclobutyl)methanamine hydrochloride | ESD-898327-250MG |
Cas.: 1193387-95-9 | Purity: 95% | (4-Bromophenyl)(cyclobutyl)methanamine hydrochloride | ESD-898327-1G |
Cas.: 325976-45-2 | Purity: 97% | 2-Chlorooxazolo[4,5-b]pyridine | ESD-898328-100MG |
Cas.: 325976-45-2 | Purity: 97% | 2-Chlorooxazolo[4,5-b]pyridine | ESD-898328-250MG |
Cas.: 325976-45-2 | Purity: 97% | 2-Chlorooxazolo[4,5-b]pyridine | ESD-898328-1G |
Cas.: 1217500-61-2 | Purity: 97% | (2-Oxoindolin-6-yl)boronic acid | ESD-898329-100MG |
Cas.: 1217500-61-2 | Purity: 97% | (2-Oxoindolin-6-yl)boronic acid | ESD-898329-250MG |
Cas.: 1217500-61-2 | Purity: 97% | (2-Oxoindolin-6-yl)boronic acid | ESD-898329-1G |
Cas.: 916211-64-8 | Purity: 97% | (S)-4-(1-Aminoethyl)benzoic acid hydrochloride | ESD-898330-100MG |
Cas.: 916211-64-8 | Purity: 97% | (S)-4-(1-Aminoethyl)benzoic acid hydrochloride | ESD-898330-250MG |
Cas.: 916211-64-8 | Purity: 97% | (S)-4-(1-Aminoethyl)benzoic acid hydrochloride | ESD-898330-1G |
Cas.: 64096-91-9 | Purity: 97% | 4H-Benzo[4,5]imidazo[1,2-b]pyrazole-3-carbonitrile | ESD-898331-100MG |
Cas.: 64096-91-9 | Purity: 97% | 4H-Benzo[4,5]imidazo[1,2-b]pyrazole-3-carbonitrile | ESD-898331-250MG |
Cas.: 64096-91-9 | Purity: 97% | 4H-Benzo[4,5]imidazo[1,2-b]pyrazole-3-carbonitrile | ESD-898331-1G |
Cas.: 127425-80-3 | Purity: 97% | 3-(4-Bromo-3-fluorophenyl)propanoic acid | ESD-898332-100MG |
Cas.: 127425-80-3 | Purity: 97% | 3-(4-Bromo-3-fluorophenyl)propanoic acid | ESD-898332-250MG |
Cas.: 127425-80-3 | Purity: 97% | 3-(4-Bromo-3-fluorophenyl)propanoic acid | ESD-898332-1G |
Cas.: 4044-54-6 | Purity: ≥95% | 2,3-Dihydro-1H-indene-4-carboxylic acid | ESD-898333-100MG |
Cas.: 4044-54-6 | Purity: ≥95% | 2,3-Dihydro-1H-indene-4-carboxylic acid | ESD-898333-250MG |
Cas.: 4044-54-6 | Purity: ≥95% | 2,3-Dihydro-1H-indene-4-carboxylic acid | ESD-898333-1G |
Cas.: 1800240-39-4 | Purity: ≥95% | (R)-1-(4-((Trifluoromethyl)thio)phenyl)ethanamine hydrochloride | ESD-898334-100MG |
Cas.: 1800240-39-4 | Purity: ≥95% | (R)-1-(4-((Trifluoromethyl)thio)phenyl)ethanamine hydrochloride | ESD-898334-250MG |
Cas.: 1800240-39-4 | Purity: ≥95% | (R)-1-(4-((Trifluoromethyl)thio)phenyl)ethanamine hydrochloride | ESD-898334-1G |
Cas.: 6179-28-8 | Purity: ≥95% | Benzo[b]thiophen-6-ylmethanol | ESD-898335-100MG |
Cas.: 6179-28-8 | Purity: ≥95% | Benzo[b]thiophen-6-ylmethanol | ESD-898335-250MG |
Cas.: 6179-28-8 | Purity: ≥95% | Benzo[b]thiophen-6-ylmethanol | ESD-898335-1G |
Cas.: 1956436-56-8 | Purity: 97% | (S)-3-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid | ESD-898336-100MG |
Cas.: 1956436-56-8 | Purity: 97% | (S)-3-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid | ESD-898336-250MG |
Cas.: 1956436-56-8 | Purity: 97% | (S)-3-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid | ESD-898336-1G |
Cas.: 115899-40-6 | Purity: 97% | TFA-ap-dU | ESD-898337-100MG |
Cas.: 115899-40-6 | Purity: 97% | TFA-ap-dU | ESD-898337-250MG |
Cas.: 115899-40-6 | Purity: 97% | TFA-ap-dU | ESD-898337-1G |
Cas.: 91063-23-9 | Purity: 97% | 5-(Benzyloxy)-4-chloropyrimidine | ESD-898338-100MG |
Cas.: 91063-23-9 | Purity: 97% | 5-(Benzyloxy)-4-chloropyrimidine | ESD-898338-250MG |
Cas.: 91063-23-9 | Purity: 97% | 5-(Benzyloxy)-4-chloropyrimidine | ESD-898338-1G |
Cas.: 2232877-36-8 | Purity: 95% | tert-Butyl 4-(difluoromethyl)-1H-pyrazole-1-carboxylate | ESD-898339-100MG |
Cas.: 2232877-36-8 | Purity: 95% | tert-Butyl 4-(difluoromethyl)-1H-pyrazole-1-carboxylate | ESD-898339-250MG |
Cas.: 2232877-36-8 | Purity: 95% | tert-Butyl 4-(difluoromethyl)-1H-pyrazole-1-carboxylate | ESD-898339-1G |
Cas.: 871101-87-0 | Purity: ≥95% | 1-(3-Amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone | ESD-898340-100MG |
Cas.: 871101-87-0 | Purity: ≥95% | 1-(3-Amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone | ESD-898340-250MG |
Cas.: 871101-87-0 | Purity: ≥95% | 1-(3-Amino-4-(benzyloxy)-2-hydroxyphenyl)ethanone | ESD-898340-1G |
Cas.: 1956356-28-7 | Purity: ≥95% | Pyrimidin-5-ylmethanamine dihydrochloride | ESD-898341-100MG |
Cas.: 1956356-28-7 | Purity: ≥95% | Pyrimidin-5-ylmethanamine dihydrochloride | ESD-898341-250MG |
Cas.: 1956356-28-7 | Purity: ≥95% | Pyrimidin-5-ylmethanamine dihydrochloride | ESD-898341-1G |
Cas.: 60518-41-4 | Purity: ≥95% | 7-Chloro-3,4-dihydroisoquinoline | ESD-898342-100MG |
Cas.: 60518-41-4 | Purity: ≥95% | 7-Chloro-3,4-dihydroisoquinoline | ESD-898342-250MG |
Cas.: 60518-41-4 | Purity: ≥95% | 7-Chloro-3,4-dihydroisoquinoline | ESD-898342-1G |
Cas.: 1256808-62-4 | Purity: 97% | Methyl 5-bromo-4-chloronicotinate | ESD-898343-100MG |
Cas.: 1256808-62-4 | Purity: 97% | Methyl 5-bromo-4-chloronicotinate | ESD-898343-250MG |
Cas.: 1256808-62-4 | Purity: 97% | Methyl 5-bromo-4-chloronicotinate | ESD-898343-1G |
Cas.: 1171560-33-0 | Purity: 97% | 3-(4-Methoxyphenyl)morpholine hydrochloride | ESD-898344-100MG |
Cas.: 1171560-33-0 | Purity: 97% | 3-(4-Methoxyphenyl)morpholine hydrochloride | ESD-898344-250MG |
Cas.: 1171560-33-0 | Purity: 97% | 3-(4-Methoxyphenyl)morpholine hydrochloride | ESD-898344-1G |
Cas.: 70662-93-0 | Purity: ≥95% | Methyl 5-chloro-2-oxo-2,3-dihydropyrimidine-4-carboxylate | ESD-898345-100MG |
Cas.: 70662-93-0 | Purity: ≥95% | Methyl 5-chloro-2-oxo-2,3-dihydropyrimidine-4-carboxylate | ESD-898345-250MG |
Cas.: 70662-93-0 | Purity: ≥95% | Methyl 5-chloro-2-oxo-2,3-dihydropyrimidine-4-carboxylate | ESD-898345-1G |
Cas.: 479353-60-1 | Purity: 95% | (4-Aminophenyl)dimethylphosphine oxide hydrochloride | ESD-898346-100MG |
Cas.: 479353-60-1 | Purity: 95% | (4-Aminophenyl)dimethylphosphine oxide hydrochloride | ESD-898346-250MG |
Cas.: 479353-60-1 | Purity: 95% | (4-Aminophenyl)dimethylphosphine oxide hydrochloride | ESD-898346-1G |
Cas.: 1187932-50-8 | Purity: ≥95% | 1-(Pyridin-3-yl)cyclopropanamine dihydrochloride | ESD-898347-100MG |
Cas.: 1187932-50-8 | Purity: ≥95% | 1-(Pyridin-3-yl)cyclopropanamine dihydrochloride | ESD-898347-250MG |
Cas.: 1187932-50-8 | Purity: ≥95% | 1-(Pyridin-3-yl)cyclopropanamine dihydrochloride | ESD-898347-1G |
Cas.: 1251903-93-1 | Purity: ≥95% | (S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride | ESD-898348-100MG |
Cas.: 1251903-93-1 | Purity: ≥95% | (S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride | ESD-898348-250MG |
Cas.: 1251903-93-1 | Purity: ≥95% | (S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride | ESD-898348-1G |
Cas.: 1089318-91-1 | Purity: 97% | Ethyl 10-bromoanthracene-9-carboxylate | ESD-898349-100MG |
Cas.: 1089318-91-1 | Purity: 97% | Ethyl 10-bromoanthracene-9-carboxylate | ESD-898349-250MG |
Cas.: 1089318-91-1 | Purity: 97% | Ethyl 10-bromoanthracene-9-carboxylate | ESD-898349-1G |
Cas.: 147353-95-5 | Purity: 97% | tert-Butyl (1-(4-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-898350-100MG |
Cas.: 147353-95-5 | Purity: 97% | tert-Butyl (1-(4-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-898350-250MG |
Cas.: 147353-95-5 | Purity: 97% | tert-Butyl (1-(4-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-898350-1G |
Cas.: 942189-39-1 | Purity: ≥95% | 3-Bromo-5-nitro-1-trityl-1H-indazole | ESD-898351-100MG |
Cas.: 942189-39-1 | Purity: ≥95% | 3-Bromo-5-nitro-1-trityl-1H-indazole | ESD-898351-250MG |
Cas.: 942189-39-1 | Purity: ≥95% | 3-Bromo-5-nitro-1-trityl-1H-indazole | ESD-898351-1G |
Cas.: 156761-88-5 | Purity: 98% | 4-Bromo-2-ethylpyridine | ESD-898352-100MG |
Cas.: 156761-88-5 | Purity: 98% | 4-Bromo-2-ethylpyridine | ESD-898352-250MG |
Cas.: 156761-88-5 | Purity: 98% | 4-Bromo-2-ethylpyridine | ESD-898352-1G |
Cas.: 885518-97-8 | Purity: 97% | 4-Bromo-6-iodo-1H-indazole | ESD-898353-100MG |
Cas.: 885518-97-8 | Purity: 97% | 4-Bromo-6-iodo-1H-indazole | ESD-898353-250MG |
Cas.: 885518-97-8 | Purity: 97% | 4-Bromo-6-iodo-1H-indazole | ESD-898353-1G |
Cas.: 92815-50-4 | Purity: 95% | Isothiazol-5-amine hydrochloride | ESD-898354-100MG |
Cas.: 92815-50-4 | Purity: 95% | Isothiazol-5-amine hydrochloride | ESD-898354-250MG |
Cas.: 92815-50-4 | Purity: 95% | Isothiazol-5-amine hydrochloride | ESD-898354-1G |
Cas.: 69385-85-9 | Purity: 97% | N-(Piperidin-4-yl)pyrimidin-2-amine | ESD-898355-100MG |
Cas.: 69385-85-9 | Purity: 97% | N-(Piperidin-4-yl)pyrimidin-2-amine | ESD-898355-250MG |
Cas.: 69385-85-9 | Purity: 97% | N-(Piperidin-4-yl)pyrimidin-2-amine | ESD-898355-1G |
Cas.: 13380-85-3 | Purity: ≥95% | Methyl 4-(hydroxymethyl)cyclohexanecarboxylate | ESD-898356-100MG |
Cas.: 13380-85-3 | Purity: ≥95% | Methyl 4-(hydroxymethyl)cyclohexanecarboxylate | ESD-898356-250MG |
Cas.: 13380-85-3 | Purity: ≥95% | Methyl 4-(hydroxymethyl)cyclohexanecarboxylate | ESD-898356-1G |
Cas.: 1246509-66-9 | Purity: 97% | (S)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride | ESD-898357-100MG |
Cas.: 1246509-66-9 | Purity: 97% | (S)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride | ESD-898357-250MG |
Cas.: 1246509-66-9 | Purity: 97% | (S)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride | ESD-898357-1G |
Cas.: 279255-90-2 | Purity: ≥95% | tert-Butyl 5-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-898358-100MG |
Cas.: 279255-90-2 | Purity: ≥95% | tert-Butyl 5-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-898358-250MG |
Cas.: 279255-90-2 | Purity: ≥95% | tert-Butyl 5-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-898358-1G |
Cas.: 1417789-39-9 | Purity: 97% | (S)-Morpholine-2-carbonitrile hydrochloride | ESD-898359-100MG |
Cas.: 1417789-39-9 | Purity: 97% | (S)-Morpholine-2-carbonitrile hydrochloride | ESD-898359-250MG |
Cas.: 1417789-39-9 | Purity: 97% | (S)-Morpholine-2-carbonitrile hydrochloride | ESD-898359-1G |
Cas.: 920274-04-0 | Purity: ≥95% | (S)-2-(3-Fluorophenyl)pyrrolidine | ESD-898360-100MG |
Cas.: 920274-04-0 | Purity: ≥95% | (S)-2-(3-Fluorophenyl)pyrrolidine | ESD-898360-250MG |
Cas.: 920274-04-0 | Purity: ≥95% | (S)-2-(3-Fluorophenyl)pyrrolidine | ESD-898360-1G |
Cas.: 869557-28-8 | Purity: ≥95% | 2-Amino-5-chloronicotinonitrile | ESD-898361-100MG |
Cas.: 869557-28-8 | Purity: ≥95% | 2-Amino-5-chloronicotinonitrile | ESD-898361-250MG |
Cas.: 869557-28-8 | Purity: ≥95% | 2-Amino-5-chloronicotinonitrile | ESD-898361-1G |
Cas.: 128272-29-7 | Purity: 95% | 3-(Adamantan-1-yl)-6-bromonaphthalen-2-ol | ESD-898362-100MG |
Cas.: 128272-29-7 | Purity: 95% | 3-(Adamantan-1-yl)-6-bromonaphthalen-2-ol | ESD-898362-250MG |
Cas.: 128272-29-7 | Purity: 95% | 3-(Adamantan-1-yl)-6-bromonaphthalen-2-ol | ESD-898362-1G |
Cas.: 133261-11-7 | Purity: ≥95% | Ethyl 3-cyclopropyl-1-methyl-1H-pyrazole-5-carboxylate | ESD-898363-100MG |
Cas.: 133261-11-7 | Purity: ≥95% | Ethyl 3-cyclopropyl-1-methyl-1H-pyrazole-5-carboxylate | ESD-898363-250MG |
Cas.: 133261-11-7 | Purity: ≥95% | Ethyl 3-cyclopropyl-1-methyl-1H-pyrazole-5-carboxylate | ESD-898363-1G |
Cas.: 855915-21-8 | Purity: 95% | 6-Chloro-5-(trifluoromethyl)picolinic acid | ESD-898364-100MG |
Cas.: 855915-21-8 | Purity: 95% | 6-Chloro-5-(trifluoromethyl)picolinic acid | ESD-898364-250MG |
Cas.: 855915-21-8 | Purity: 95% | 6-Chloro-5-(trifluoromethyl)picolinic acid | ESD-898364-1G |
Cas.: 938061-94-0 | Purity: 97% | 4-Bromo-3-methoxy-1H-indazole | ESD-898365-100MG |
Cas.: 938061-94-0 | Purity: 97% | 4-Bromo-3-methoxy-1H-indazole | ESD-898365-250MG |
Cas.: 938061-94-0 | Purity: 97% | 4-Bromo-3-methoxy-1H-indazole | ESD-898365-1G |
Cas.: 894074-82-9 | Purity: ≥95% | 3-Chloro-6-methylpicolinic acid | ESD-898366-100MG |
Cas.: 894074-82-9 | Purity: ≥95% | 3-Chloro-6-methylpicolinic acid | ESD-898366-250MG |
Cas.: 894074-82-9 | Purity: ≥95% | 3-Chloro-6-methylpicolinic acid | ESD-898366-1G |
Cas.: 1273602-53-1 | Purity: ≥95% | 3-Bromo-5-oxo-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid | ESD-898367-100MG |
Cas.: 1273602-53-1 | Purity: ≥95% | 3-Bromo-5-oxo-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid | ESD-898367-250MG |
Cas.: 1273602-53-1 | Purity: ≥95% | 3-Bromo-5-oxo-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid | ESD-898367-1G |
Cas.: 89283-33-0 | Purity: ≥95% | 3-Chloro-5-methylpyrazin-2(1H)-one | ESD-898368-100MG |
Cas.: 89283-33-0 | Purity: ≥95% | 3-Chloro-5-methylpyrazin-2(1H)-one | ESD-898368-250MG |
Cas.: 89283-33-0 | Purity: ≥95% | 3-Chloro-5-methylpyrazin-2(1H)-one | ESD-898368-1G |
Cas.: 1233318-23-4 | Purity: 97% | Methyl 2-(quinoxalin-6-yl)acetate | ESD-898369-100MG |
Cas.: 1233318-23-4 | Purity: 97% | Methyl 2-(quinoxalin-6-yl)acetate | ESD-898369-250MG |
Cas.: 1233318-23-4 | Purity: 97% | Methyl 2-(quinoxalin-6-yl)acetate | ESD-898369-1G |
Cas.: 112434-18-1 | Purity: 97% | Benzyl (2,4-difluorophenyl)carbamate | ESD-898370-100MG |
Cas.: 112434-18-1 | Purity: 97% | Benzyl (2,4-difluorophenyl)carbamate | ESD-898370-250MG |
Cas.: 112434-18-1 | Purity: 97% | Benzyl (2,4-difluorophenyl)carbamate | ESD-898370-1G |
Cas.: 825-70-7 | Purity: 95% | 5-Fluoro-2-methylindoline | ESD-898371-100MG |
Cas.: 825-70-7 | Purity: 95% | 5-Fluoro-2-methylindoline | ESD-898371-250MG |
Cas.: 825-70-7 | Purity: 95% | 5-Fluoro-2-methylindoline | ESD-898371-1G |
Cas.: 1106941-26-7 | Purity: ≥95% | 3-(2-Methoxyphenyl)pyrrolidine hydrochloride | ESD-898372-100MG |
Cas.: 1106941-26-7 | Purity: ≥95% | 3-(2-Methoxyphenyl)pyrrolidine hydrochloride | ESD-898372-250MG |
Cas.: 1106941-26-7 | Purity: ≥95% | 3-(2-Methoxyphenyl)pyrrolidine hydrochloride | ESD-898372-1G |
Cas.: 1310404-00-2 | Purity: ≥95% | tert-Butyl 4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine-1-carboxylate | ESD-898373-100MG |
Cas.: 1310404-00-2 | Purity: ≥95% | tert-Butyl 4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine-1-carboxylate | ESD-898373-250MG |
Cas.: 1310404-00-2 | Purity: ≥95% | tert-Butyl 4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine-1-carboxylate | ESD-898373-1G |
Cas.: 1261452-97-4 | Purity: 97% | 4-Chloro-3-methoxypyridin-2-amine | ESD-898374-100MG |
Cas.: 1261452-97-4 | Purity: 97% | 4-Chloro-3-methoxypyridin-2-amine | ESD-898374-250MG |
Cas.: 1261452-97-4 | Purity: 97% | 4-Chloro-3-methoxypyridin-2-amine | ESD-898374-1G |
Cas.: 1089212-38-3 | Purity: ≥95% | 4-Bromo-3-(difluoromethyl)-1-methyl-1H-pyrazole | ESD-898375-100MG |
Cas.: 1089212-38-3 | Purity: ≥95% | 4-Bromo-3-(difluoromethyl)-1-methyl-1H-pyrazole | ESD-898375-250MG |
Cas.: 1089212-38-3 | Purity: ≥95% | 4-Bromo-3-(difluoromethyl)-1-methyl-1H-pyrazole | ESD-898375-1G |
Cas.: 847361-67-5 | Purity: ≥95% | 1-(4-Bromophenyl)cyclopropanecarboxamide | ESD-898376-100MG |
Cas.: 847361-67-5 | Purity: ≥95% | 1-(4-Bromophenyl)cyclopropanecarboxamide | ESD-898376-250MG |
Cas.: 847361-67-5 | Purity: ≥95% | 1-(4-Bromophenyl)cyclopropanecarboxamide | ESD-898376-1G |
Cas.: 178747-83-6 | Purity: 98% | 4-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-898377-100MG |
Cas.: 178747-83-6 | Purity: 98% | 4-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-898377-250MG |
Cas.: 178747-83-6 | Purity: 98% | 4-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-898377-1G |
Cas.: 1146291-81-7 | Purity: 97% | 4-Fluoro-1-methyl-1H-indole-2-carboxylic acid | ESD-898378-100MG |
Cas.: 1146291-81-7 | Purity: 97% | 4-Fluoro-1-methyl-1H-indole-2-carboxylic acid | ESD-898378-250MG |
Cas.: 1146291-81-7 | Purity: 97% | 4-Fluoro-1-methyl-1H-indole-2-carboxylic acid | ESD-898378-1G |
Cas.: 1307873-37-5 | Purity: ≥95% | (S)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898379-100MG |
Cas.: 1307873-37-5 | Purity: ≥95% | (S)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898379-250MG |
Cas.: 1307873-37-5 | Purity: ≥95% | (S)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride | ESD-898379-1G |
Cas.: 58971-08-7 | Purity: ≥95% | 1-Phenylpiperidine-3-carboxamide | ESD-898380-100MG |
Cas.: 58971-08-7 | Purity: ≥95% | 1-Phenylpiperidine-3-carboxamide | ESD-898380-250MG |
Cas.: 58971-08-7 | Purity: ≥95% | 1-Phenylpiperidine-3-carboxamide | ESD-898380-1G |
Cas.: 1375068-54-4 | Purity: 95% | Oxazol-5-ylmethanamine dihydrochloride | ESD-898381-100MG |
Cas.: 1375068-54-4 | Purity: 95% | Oxazol-5-ylmethanamine dihydrochloride | ESD-898381-250MG |
Cas.: 1375068-54-4 | Purity: 95% | Oxazol-5-ylmethanamine dihydrochloride | ESD-898381-1G |
Cas.: 1179360-83-8 | Purity: ≥95% | 1-N-Boc-Butane-1,2-diamine hydrochloride | ESD-898382-100MG |
Cas.: 1179360-83-8 | Purity: ≥95% | 1-N-Boc-Butane-1,2-diamine hydrochloride | ESD-898382-250MG |
Cas.: 1179360-83-8 | Purity: ≥95% | 1-N-Boc-Butane-1,2-diamine hydrochloride | ESD-898382-1G |
Cas.: 816448-09-6 | Purity: ≥95% | 8-Methylquinoline-4-carboxylic acid | ESD-898383-100MG |
Cas.: 816448-09-6 | Purity: ≥95% | 8-Methylquinoline-4-carboxylic acid | ESD-898383-250MG |
Cas.: 816448-09-6 | Purity: ≥95% | 8-Methylquinoline-4-carboxylic acid | ESD-898383-1G |
Cas.: 1082066-29-2 | Purity: ≥95% | (2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol | ESD-898384-100MG |
Cas.: 1082066-29-2 | Purity: ≥95% | (2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol | ESD-898384-250MG |
Cas.: 1082066-29-2 | Purity: ≥95% | (2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol | ESD-898384-1G |
Cas.: 107407-80-7 | Purity: ≥95% | Ethyl pyrrolo[1,2-c]pyrimidine-3-carboxylate | ESD-898385-100MG |
Cas.: 107407-80-7 | Purity: ≥95% | Ethyl pyrrolo[1,2-c]pyrimidine-3-carboxylate | ESD-898385-250MG |
Cas.: 107407-80-7 | Purity: ≥95% | Ethyl pyrrolo[1,2-c]pyrimidine-3-carboxylate | ESD-898385-1G |
Cas.: 169376-35-6 | Purity: ≥95% | Ethyl 3-oxo-3-(1H-pyrrol-2-yl)propanoate | ESD-898386-100MG |
Cas.: 169376-35-6 | Purity: ≥95% | Ethyl 3-oxo-3-(1H-pyrrol-2-yl)propanoate | ESD-898386-250MG |
Cas.: 169376-35-6 | Purity: ≥95% | Ethyl 3-oxo-3-(1H-pyrrol-2-yl)propanoate | ESD-898386-1G |
Cas.: 440099-32-1 | Purity: ≥95% | Isoxazol-5-ylmethanamine hydrochloride | ESD-898387-100MG |
Cas.: 440099-32-1 | Purity: ≥95% | Isoxazol-5-ylmethanamine hydrochloride | ESD-898387-250MG |
Cas.: 440099-32-1 | Purity: ≥95% | Isoxazol-5-ylmethanamine hydrochloride | ESD-898387-1G |
Cas.: 109221-88-7 | Purity: ≥95% | [1,1′-Biphenyl]-3-ylhydrazine hydrochloride | ESD-898388-100MG |
Cas.: 109221-88-7 | Purity: ≥95% | [1,1′-Biphenyl]-3-ylhydrazine hydrochloride | ESD-898388-250MG |
Cas.: 109221-88-7 | Purity: ≥95% | [1,1′-Biphenyl]-3-ylhydrazine hydrochloride | ESD-898388-1G |
Cas.: 1211580-49-2 | Purity: ≥95% | 5-Bromo-2-chloro-4-fluoropyridine | ESD-898389-100MG |
Cas.: 1211580-49-2 | Purity: ≥95% | 5-Bromo-2-chloro-4-fluoropyridine | ESD-898389-250MG |
Cas.: 1211580-49-2 | Purity: ≥95% | 5-Bromo-2-chloro-4-fluoropyridine | ESD-898389-1G |
Cas.: 120097-65-6 | Purity: ≥95% | 2-Acetamido-4,4,4-trifluorobutanoic acid | ESD-898390-100MG |
Cas.: 120097-65-6 | Purity: ≥95% | 2-Acetamido-4,4,4-trifluorobutanoic acid | ESD-898390-250MG |
Cas.: 120097-65-6 | Purity: ≥95% | 2-Acetamido-4,4,4-trifluorobutanoic acid | ESD-898390-1G |
Cas.: 170353-34-1 | Purity: ≥95% | 1-Phenylpiperidine-4-carboxamide | ESD-898391-100MG |
Cas.: 170353-34-1 | Purity: ≥95% | 1-Phenylpiperidine-4-carboxamide | ESD-898391-250MG |
Cas.: 170353-34-1 | Purity: ≥95% | 1-Phenylpiperidine-4-carboxamide | ESD-898391-1G |
Cas.: 1810069-89-6 | Purity: ≥95% | 7-Methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898392-100MG |
Cas.: 1810069-89-6 | Purity: ≥95% | 7-Methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898392-250MG |
Cas.: 1810069-89-6 | Purity: ≥95% | 7-Methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | ESD-898392-1G |
Cas.: 887581-54-6 | Purity: 95% | 6-(tert-Butyl)-1H-indole | ESD-898393-100MG |
Cas.: 887581-54-6 | Purity: 95% | 6-(tert-Butyl)-1H-indole | ESD-898393-250MG |
Cas.: 887581-54-6 | Purity: 95% | 6-(tert-Butyl)-1H-indole | ESD-898393-1G |
Cas.: 1373338-09-0 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridine-2-carbaldehyde | ESD-898394-100MG |
Cas.: 1373338-09-0 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridine-2-carbaldehyde | ESD-898394-250MG |
Cas.: 1373338-09-0 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridine-2-carbaldehyde | ESD-898394-1G |
Cas.: 934660-16-9 | Purity: 97% | 5-Bromo-6-chloro-1H-indole-2-carboxylic acid | ESD-898395-100MG |
Cas.: 934660-16-9 | Purity: 97% | 5-Bromo-6-chloro-1H-indole-2-carboxylic acid | ESD-898395-250MG |
Cas.: 934660-16-9 | Purity: 97% | 5-Bromo-6-chloro-1H-indole-2-carboxylic acid | ESD-898395-1G |
Cas.: 1186195-01-6 | Purity: ≥95% | 2,2,2-Trifluoro-1-(p-tolyl)ethanamine hydrochloride | ESD-898396-100MG |
Cas.: 1186195-01-6 | Purity: ≥95% | 2,2,2-Trifluoro-1-(p-tolyl)ethanamine hydrochloride | ESD-898396-250MG |
Cas.: 1186195-01-6 | Purity: ≥95% | 2,2,2-Trifluoro-1-(p-tolyl)ethanamine hydrochloride | ESD-898396-1G |
Cas.: 191796-90-4 | Purity: 97% | Methyl 2-amino-2-phenylpropanoate hydrochloride | ESD-898397-100MG |
Cas.: 191796-90-4 | Purity: 97% | Methyl 2-amino-2-phenylpropanoate hydrochloride | ESD-898397-250MG |
Cas.: 191796-90-4 | Purity: 97% | Methyl 2-amino-2-phenylpropanoate hydrochloride | ESD-898397-1G |
Cas.: 960116-27-2 | Purity: ≥95% | Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate | ESD-898398-100MG |
Cas.: 960116-27-2 | Purity: ≥95% | Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate | ESD-898398-250MG |
Cas.: 960116-27-2 | Purity: ≥95% | Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate | ESD-898398-1G |
Cas.: 182181-42-6 | Purity: ≥95% | 2-(Chloromethyl)-8-methylimidazo[1,2-a]pyridine | ESD-898399-100MG |
Cas.: 182181-42-6 | Purity: ≥95% | 2-(Chloromethyl)-8-methylimidazo[1,2-a]pyridine | ESD-898399-250MG |
Cas.: 182181-42-6 | Purity: ≥95% | 2-(Chloromethyl)-8-methylimidazo[1,2-a]pyridine | ESD-898399-1G |
Cas.: 889858-09-7 | Purity: 97% | tert-Butyl 4-bromo-2-hydroxybenzoate | ESD-898400-100MG |
Cas.: 889858-09-7 | Purity: 97% | tert-Butyl 4-bromo-2-hydroxybenzoate | ESD-898400-250MG |
Cas.: 889858-09-7 | Purity: 97% | tert-Butyl 4-bromo-2-hydroxybenzoate | ESD-898400-1G |
Cas.: 57097-45-7 | Purity: 97% | 4-Chloro-1H-pyrrole-2-carbonitrile | ESD-898401-100MG |
Cas.: 57097-45-7 | Purity: 97% | 4-Chloro-1H-pyrrole-2-carbonitrile | ESD-898401-250MG |
Cas.: 57097-45-7 | Purity: 97% | 4-Chloro-1H-pyrrole-2-carbonitrile | ESD-898401-1G |
Cas.: 667932-40-3 | Purity: 97% | 5-Ethynylpyridin-3-amine | ESD-898402-100MG |
Cas.: 667932-40-3 | Purity: 97% | 5-Ethynylpyridin-3-amine | ESD-898402-250MG |
Cas.: 667932-40-3 | Purity: 97% | 5-Ethynylpyridin-3-amine | ESD-898402-1G |
Cas.: 945381-62-4 | Purity: ≥95% | 7-Amino-5-fluoroindolin-2-one | ESD-898403-100MG |
Cas.: 945381-62-4 | Purity: ≥95% | 7-Amino-5-fluoroindolin-2-one | ESD-898403-250MG |
Cas.: 945381-62-4 | Purity: ≥95% | 7-Amino-5-fluoroindolin-2-one | ESD-898403-1G |
Cas.: 659729-70-1 | Purity: ≥95% | 2-Chloro-8-methoxyquinoxaline | ESD-898404-100MG |
Cas.: 659729-70-1 | Purity: ≥95% | 2-Chloro-8-methoxyquinoxaline | ESD-898404-250MG |
Cas.: 659729-70-1 | Purity: ≥95% | 2-Chloro-8-methoxyquinoxaline | ESD-898404-1G |
Cas.: 1245808-01-8 | Purity: ≥95% | (S)-1-(4-Chloro-3-fluorophenyl)ethanamine hydrochloride | ESD-898405-100MG |
Cas.: 1245808-01-8 | Purity: ≥95% | (S)-1-(4-Chloro-3-fluorophenyl)ethanamine hydrochloride | ESD-898405-250MG |
Cas.: 1245808-01-8 | Purity: ≥95% | (S)-1-(4-Chloro-3-fluorophenyl)ethanamine hydrochloride | ESD-898405-1G |
Cas.: 1347750-78-0 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azatricosan-23-oic acid | ESD-898406-100MG |
Cas.: 1347750-78-0 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azatricosan-23-oic acid | ESD-898406-250MG |
Cas.: 1347750-78-0 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azatricosan-23-oic acid | ESD-898406-1G |
Cas.: 1942858-50-5 | Purity: 97% | Benzyl 2-methyl-2-(methylsulfonyl)pent-4-enoate | ESD-898407-100MG |
Cas.: 1942858-50-5 | Purity: 97% | Benzyl 2-methyl-2-(methylsulfonyl)pent-4-enoate | ESD-898407-250MG |
Cas.: 1942858-50-5 | Purity: 97% | Benzyl 2-methyl-2-(methylsulfonyl)pent-4-enoate | ESD-898407-1G |
Cas.: 1257877-12-5 | Purity: ≥95% | 5-(6-Methoxynaphthalen-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-898408-100MG |
Cas.: 1257877-12-5 | Purity: ≥95% | 5-(6-Methoxynaphthalen-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-898408-250MG |
Cas.: 1257877-12-5 | Purity: ≥95% | 5-(6-Methoxynaphthalen-2-yl)-1H-pyrazole-3-carboxylic acid | ESD-898408-1G |
Cas.: 1169576-95-7 | Purity: ≥95% | (R)-1-(4-Fluorophenyl)propan-1-amine hydrochloride | ESD-898409-100MG |
Cas.: 1169576-95-7 | Purity: ≥95% | (R)-1-(4-Fluorophenyl)propan-1-amine hydrochloride | ESD-898409-250MG |
Cas.: 1169576-95-7 | Purity: ≥95% | (R)-1-(4-Fluorophenyl)propan-1-amine hydrochloride | ESD-898409-1G |
Cas.: 70724-23-1 | Purity: 98% | 1-Chloro-6,7-dimethoxyphthalazine | ESD-898410-100MG |
Cas.: 70724-23-1 | Purity: 98% | 1-Chloro-6,7-dimethoxyphthalazine | ESD-898410-250MG |
Cas.: 70724-23-1 | Purity: 98% | 1-Chloro-6,7-dimethoxyphthalazine | ESD-898410-1G |
Cas.: 1339175-72-2 | Purity: 95% | 6-Fluoro-2-methoxynicotinonitrile | ESD-898411-100MG |
Cas.: 1339175-72-2 | Purity: 95% | 6-Fluoro-2-methoxynicotinonitrile | ESD-898411-250MG |
Cas.: 1339175-72-2 | Purity: 95% | 6-Fluoro-2-methoxynicotinonitrile | ESD-898411-1G |
Cas.: 83640-36-2 | Purity: ≥95% | 6-(Chloromethyl)nicotinonitrile | ESD-898412-100MG |
Cas.: 83640-36-2 | Purity: ≥95% | 6-(Chloromethyl)nicotinonitrile | ESD-898412-250MG |
Cas.: 83640-36-2 | Purity: ≥95% | 6-(Chloromethyl)nicotinonitrile | ESD-898412-1G |
Cas.: 877385-86-9 | Purity: ≥95% | 2-Cyclopropylthiazole-5-carbaldehyde | ESD-898413-100MG |
Cas.: 877385-86-9 | Purity: ≥95% | 2-Cyclopropylthiazole-5-carbaldehyde | ESD-898413-250MG |
Cas.: 877385-86-9 | Purity: ≥95% | 2-Cyclopropylthiazole-5-carbaldehyde | ESD-898413-1G |
Cas.: 1803601-85-5 | Purity: ≥95% | 4,6-Difluoroindoline hydrochloride | ESD-898414-100MG |
Cas.: 1803601-85-5 | Purity: ≥95% | 4,6-Difluoroindoline hydrochloride | ESD-898414-250MG |
Cas.: 1803601-85-5 | Purity: ≥95% | 4,6-Difluoroindoline hydrochloride | ESD-898414-1G |
Cas.: 1379324-91-0 | Purity: 97% | 8-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one | ESD-898415-100MG |
Cas.: 1379324-91-0 | Purity: 97% | 8-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one | ESD-898415-250MG |
Cas.: 1379324-91-0 | Purity: 97% | 8-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one | ESD-898415-1G |
Cas.: 90892-97-0 | Purity: ≥95% | 1-(4-Methyloxazol-2-yl)ethanone | ESD-898416-100MG |
Cas.: 90892-97-0 | Purity: ≥95% | 1-(4-Methyloxazol-2-yl)ethanone | ESD-898416-250MG |
Cas.: 90892-97-0 | Purity: ≥95% | 1-(4-Methyloxazol-2-yl)ethanone | ESD-898416-1G |
Cas.: 3289-19-8 | Purity: 97% | (2-Methyl-1,3-dioxolan-2-yl)methanamine | ESD-898417-100MG |
Cas.: 3289-19-8 | Purity: 97% | (2-Methyl-1,3-dioxolan-2-yl)methanamine | ESD-898417-250MG |
Cas.: 3289-19-8 | Purity: 97% | (2-Methyl-1,3-dioxolan-2-yl)methanamine | ESD-898417-1G |
Cas.: 76537-42-3 | Purity: 95% | 5,6-Dichloropyrazine-2-carboxylic acid | ESD-898418-100MG |
Cas.: 76537-42-3 | Purity: 95% | 5,6-Dichloropyrazine-2-carboxylic acid | ESD-898418-250MG |
Cas.: 76537-42-3 | Purity: 95% | 5,6-Dichloropyrazine-2-carboxylic acid | ESD-898418-1G |
Cas.: 1334488-49-1 | Purity: 97% | 1-(6-Methoxypyrimidin-4-yl)piperidine-4-carboxylic acid | ESD-898419-100MG |
Cas.: 1334488-49-1 | Purity: 97% | 1-(6-Methoxypyrimidin-4-yl)piperidine-4-carboxylic acid | ESD-898419-250MG |
Cas.: 1334488-49-1 | Purity: 97% | 1-(6-Methoxypyrimidin-4-yl)piperidine-4-carboxylic acid | ESD-898419-1G |
Cas.: 50615-66-2 | Purity: ≥95% | (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-mercaptotetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-898420-100MG |
Cas.: 50615-66-2 | Purity: ≥95% | (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-mercaptotetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-898420-250MG |
Cas.: 50615-66-2 | Purity: ≥95% | (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-mercaptotetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-898420-1G |
Cas.: 1807259-37-5 | Purity: 95% | (5-Bromo-2-methylpyridin-4-yl)methanol | ESD-898421-100MG |
Cas.: 1807259-37-5 | Purity: 95% | (5-Bromo-2-methylpyridin-4-yl)methanol | ESD-898421-250MG |
Cas.: 1807259-37-5 | Purity: 95% | (5-Bromo-2-methylpyridin-4-yl)methanol | ESD-898421-1G |
Cas.: 1207954-85-5 | Purity: ≥95% | Ethyl 2-bromopyrimidine-4-carboxylate | ESD-898422-100MG |
Cas.: 1207954-85-5 | Purity: ≥95% | Ethyl 2-bromopyrimidine-4-carboxylate | ESD-898422-250MG |
Cas.: 1207954-85-5 | Purity: ≥95% | Ethyl 2-bromopyrimidine-4-carboxylate | ESD-898422-1G |
Cas.: 1956435-19-0 | Purity: 97% | (R)-Cyclobutyl(phenyl)methanamine hydrochloride | ESD-898423-100MG |
Cas.: 1956435-19-0 | Purity: 97% | (R)-Cyclobutyl(phenyl)methanamine hydrochloride | ESD-898423-250MG |
Cas.: 1956435-19-0 | Purity: 97% | (R)-Cyclobutyl(phenyl)methanamine hydrochloride | ESD-898423-1G |
Cas.: 145783-13-7 | Purity: 97% | 5-Nitro-2-(propylthio)pyrimidine-4,6-diol | ESD-898424-100MG |
Cas.: 145783-13-7 | Purity: 97% | 5-Nitro-2-(propylthio)pyrimidine-4,6-diol | ESD-898424-250MG |
Cas.: 145783-13-7 | Purity: 97% | 5-Nitro-2-(propylthio)pyrimidine-4,6-diol | ESD-898424-1G |
Cas.: 144053-99-6 | Purity: 97% | 2-(Methoxymethyl)morpholine hydrochloride | ESD-898425-100MG |
Cas.: 144053-99-6 | Purity: 97% | 2-(Methoxymethyl)morpholine hydrochloride | ESD-898425-250MG |
Cas.: 144053-99-6 | Purity: 97% | 2-(Methoxymethyl)morpholine hydrochloride | ESD-898425-1G |
Cas.: 1203686-59-2 | Purity: ≥95% | 4-(Trifluoromethyl)isoindoline hydrochloride | ESD-898426-100MG |
Cas.: 1203686-59-2 | Purity: ≥95% | 4-(Trifluoromethyl)isoindoline hydrochloride | ESD-898426-250MG |
Cas.: 1203686-59-2 | Purity: ≥95% | 4-(Trifluoromethyl)isoindoline hydrochloride | ESD-898426-1G |
Cas.: 152213-63-3 | Purity: 97% | Methyl 2-(6-bromo-1H-indol-3-yl)acetate | ESD-898427-100MG |
Cas.: 152213-63-3 | Purity: 97% | Methyl 2-(6-bromo-1H-indol-3-yl)acetate | ESD-898427-250MG |
Cas.: 152213-63-3 | Purity: 97% | Methyl 2-(6-bromo-1H-indol-3-yl)acetate | ESD-898427-1G |
Cas.: 860232-96-8 | Purity: ≥95% | 6-Chloroquinolin-3-ol | ESD-898428-100MG |
Cas.: 860232-96-8 | Purity: ≥95% | 6-Chloroquinolin-3-ol | ESD-898428-250MG |
Cas.: 860232-96-8 | Purity: ≥95% | 6-Chloroquinolin-3-ol | ESD-898428-1G |
Cas.: 791602-75-0 | Purity: 97% | 4-Chloro-5,7-difluoroquinazoline | ESD-898429-100MG |
Cas.: 791602-75-0 | Purity: 97% | 4-Chloro-5,7-difluoroquinazoline | ESD-898429-250MG |
Cas.: 791602-75-0 | Purity: 97% | 4-Chloro-5,7-difluoroquinazoline | ESD-898429-1G |
Cas.: 957472-02-5 | Purity: ≥95% | (Z)-Ethyl 2-(pipidin-3-ylidene)acetate hydrochloride | ESD-898430-100MG |
Cas.: 957472-02-5 | Purity: ≥95% | (Z)-Ethyl 2-(pipidin-3-ylidene)acetate hydrochloride | ESD-898430-250MG |
Cas.: 957472-02-5 | Purity: ≥95% | (Z)-Ethyl 2-(pipidin-3-ylidene)acetate hydrochloride | ESD-898430-1G |
Cas.: 1159821-66-5 | Purity: 95% | 6-Cyclopropylpyridin-3-amine | ESD-898431-100MG |
Cas.: 1159821-66-5 | Purity: 95% | 6-Cyclopropylpyridin-3-amine | ESD-898431-250MG |
Cas.: 1159821-66-5 | Purity: 95% | 6-Cyclopropylpyridin-3-amine | ESD-898431-1G |
Cas.: 73220-41-4 | Purity: ≥95% | 3-Bromo-7-methoxy-4H-chromen-4-one | ESD-898432-100MG |
Cas.: 73220-41-4 | Purity: ≥95% | 3-Bromo-7-methoxy-4H-chromen-4-one | ESD-898432-250MG |
Cas.: 73220-41-4 | Purity: ≥95% | 3-Bromo-7-methoxy-4H-chromen-4-one | ESD-898432-1G |
Cas.: 1268522-00-4 | Purity: 95% | 4-Amino-6-methyl-2-(methylthio)pyrimidine-5-carbaldehyde | ESD-898433-100MG |
Cas.: 1268522-00-4 | Purity: 95% | 4-Amino-6-methyl-2-(methylthio)pyrimidine-5-carbaldehyde | ESD-898433-250MG |
Cas.: 1268522-00-4 | Purity: 95% | 4-Amino-6-methyl-2-(methylthio)pyrimidine-5-carbaldehyde | ESD-898433-1G |
Cas.: 1391469-10-5 | Purity: 97% | (S)-3-(4-Fluorophenyl)morpholine hydrochloride | ESD-898434-100MG |
Cas.: 1391469-10-5 | Purity: 97% | (S)-3-(4-Fluorophenyl)morpholine hydrochloride | ESD-898434-250MG |
Cas.: 1391469-10-5 | Purity: 97% | (S)-3-(4-Fluorophenyl)morpholine hydrochloride | ESD-898434-1G |
Cas.: 4373-61-9 | Purity: ≥95% | 2-(m-Tolyl)pyridine | ESD-898435-100MG |
Cas.: 4373-61-9 | Purity: ≥95% | 2-(m-Tolyl)pyridine | ESD-898435-250MG |
Cas.: 4373-61-9 | Purity: ≥95% | 2-(m-Tolyl)pyridine | ESD-898435-1G |
Cas.: 405142-63-4 | Purity: ≥95% | 5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898436-100MG |
Cas.: 405142-63-4 | Purity: ≥95% | 5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898436-250MG |
Cas.: 405142-63-4 | Purity: ≥95% | 5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898436-1G |
Cas.: 1244949-24-3 | Purity: ≥95% | 2-Bromo-4-chloro-6-(trifluoromethoxy)aniline | ESD-898437-100MG |
Cas.: 1244949-24-3 | Purity: ≥95% | 2-Bromo-4-chloro-6-(trifluoromethoxy)aniline | ESD-898437-250MG |
Cas.: 1244949-24-3 | Purity: ≥95% | 2-Bromo-4-chloro-6-(trifluoromethoxy)aniline | ESD-898437-1G |
Cas.: 23928-47-4 | Purity: ≥95% | 1,4-Dichloro-5-fluorophthalazine | ESD-898438-100MG |
Cas.: 23928-47-4 | Purity: ≥95% | 1,4-Dichloro-5-fluorophthalazine | ESD-898438-250MG |
Cas.: 23928-47-4 | Purity: ≥95% | 1,4-Dichloro-5-fluorophthalazine | ESD-898438-1G |
Cas.: 1060805-13-1 | Purity: ≥95% | 6-Bromo-4-methoxypicolinic acid | ESD-898439-100MG |
Cas.: 1060805-13-1 | Purity: ≥95% | 6-Bromo-4-methoxypicolinic acid | ESD-898439-250MG |
Cas.: 1060805-13-1 | Purity: ≥95% | 6-Bromo-4-methoxypicolinic acid | ESD-898439-1G |
Cas.: 1256791-13-5 | Purity: 97% | 1-(6-Chloro-5-methylpyridin-3-yl)ethanone | ESD-898440-100MG |
Cas.: 1256791-13-5 | Purity: 97% | 1-(6-Chloro-5-methylpyridin-3-yl)ethanone | ESD-898440-250MG |
Cas.: 1256791-13-5 | Purity: 97% | 1-(6-Chloro-5-methylpyridin-3-yl)ethanone | ESD-898440-1G |
Cas.: 91061-46-0 | Purity: ≥95% | 2-(2-Methoxyphenyl)propanoic acid | ESD-898441-100MG |
Cas.: 91061-46-0 | Purity: ≥95% | 2-(2-Methoxyphenyl)propanoic acid | ESD-898441-250MG |
Cas.: 91061-46-0 | Purity: ≥95% | 2-(2-Methoxyphenyl)propanoic acid | ESD-898441-1G |
Cas.: 74537-49-8 | Purity: ≥95% | 2-(Methylthio)benzo[d]thiazol-6-ol | ESD-898442-100MG |
Cas.: 74537-49-8 | Purity: ≥95% | 2-(Methylthio)benzo[d]thiazol-6-ol | ESD-898442-250MG |
Cas.: 74537-49-8 | Purity: ≥95% | 2-(Methylthio)benzo[d]thiazol-6-ol | ESD-898442-1G |
Cas.: 37481-69-9 | Purity: ≥95% | 2-Benzyl-2,3-dihydroisoquinolin-4(1H)-one hydrochloride | ESD-898443-100MG |
Cas.: 37481-69-9 | Purity: ≥95% | 2-Benzyl-2,3-dihydroisoquinolin-4(1H)-one hydrochloride | ESD-898443-250MG |
Cas.: 37481-69-9 | Purity: ≥95% | 2-Benzyl-2,3-dihydroisoquinolin-4(1H)-one hydrochloride | ESD-898443-1G |
Cas.: 1228631-54-6 | Purity: ≥95% | 1-(6-(Trifluoromethyl)pyridin-3-yl)ethanol | ESD-898444-100MG |
Cas.: 1228631-54-6 | Purity: ≥95% | 1-(6-(Trifluoromethyl)pyridin-3-yl)ethanol | ESD-898444-250MG |
Cas.: 1228631-54-6 | Purity: ≥95% | 1-(6-(Trifluoromethyl)pyridin-3-yl)ethanol | ESD-898444-1G |
Cas.: 1865786-36-2 | Purity: ≥95% | (2R,4S)-2-Hydroxymethyl-4-Boc-aminopyrrolidine hydrochloride | ESD-898445-100MG |
Cas.: 1865786-36-2 | Purity: ≥95% | (2R,4S)-2-Hydroxymethyl-4-Boc-aminopyrrolidine hydrochloride | ESD-898445-250MG |
Cas.: 1865786-36-2 | Purity: ≥95% | (2R,4S)-2-Hydroxymethyl-4-Boc-aminopyrrolidine hydrochloride | ESD-898445-1G |
Cas.: 1010086-31-3 | Purity: ≥95% | tert-Butyl 4-((tert-butyldiphenylsilyl)oxy)cyclohexanecarboxylate | ESD-898446-100MG |
Cas.: 1010086-31-3 | Purity: ≥95% | tert-Butyl 4-((tert-butyldiphenylsilyl)oxy)cyclohexanecarboxylate | ESD-898446-250MG |
Cas.: 1010086-31-3 | Purity: ≥95% | tert-Butyl 4-((tert-butyldiphenylsilyl)oxy)cyclohexanecarboxylate | ESD-898446-1G |
Cas.: 893731-12-9 | Purity: 97% | 6-Fluoro-1-methyl-1H-indole-2-carboxylic acid | ESD-898447-100MG |
Cas.: 893731-12-9 | Purity: 97% | 6-Fluoro-1-methyl-1H-indole-2-carboxylic acid | ESD-898447-250MG |
Cas.: 893731-12-9 | Purity: 97% | 6-Fluoro-1-methyl-1H-indole-2-carboxylic acid | ESD-898447-1G |
Cas.: 1159823-51-4 | Purity: 97% | Isoindoline-5-carbonitrile hydrochloride | ESD-898448-100MG |
Cas.: 1159823-51-4 | Purity: 97% | Isoindoline-5-carbonitrile hydrochloride | ESD-898448-250MG |
Cas.: 1159823-51-4 | Purity: 97% | Isoindoline-5-carbonitrile hydrochloride | ESD-898448-1G |
Cas.: 63591-57-1 | Purity: ≥95% | cis-Cyclopentane-1,3-diamine dihydrochloride | ESD-898449-100MG |
Cas.: 63591-57-1 | Purity: ≥95% | cis-Cyclopentane-1,3-diamine dihydrochloride | ESD-898449-250MG |
Cas.: 63591-57-1 | Purity: ≥95% | cis-Cyclopentane-1,3-diamine dihydrochloride | ESD-898449-1G |
Cas.: 791098-81-2 | Purity: 97% | (R)-1-(2,4-Difluorophenyl)ethanamine hydrochloride | ESD-898450-100MG |
Cas.: 791098-81-2 | Purity: 97% | (R)-1-(2,4-Difluorophenyl)ethanamine hydrochloride | ESD-898450-250MG |
Cas.: 791098-81-2 | Purity: 97% | (R)-1-(2,4-Difluorophenyl)ethanamine hydrochloride | ESD-898450-1G |
Cas.: 94994-15-7 | Purity: 97% | Methyl 4-(hydroxymethyl)bicyclo[2.2.2]octane-1-carboxylate | ESD-898451-100MG |
Cas.: 94994-15-7 | Purity: 97% | Methyl 4-(hydroxymethyl)bicyclo[2.2.2]octane-1-carboxylate | ESD-898451-250MG |
Cas.: 94994-15-7 | Purity: 97% | Methyl 4-(hydroxymethyl)bicyclo[2.2.2]octane-1-carboxylate | ESD-898451-1G |
Cas.: 2586-99-4 | Purity: ≥95% | 5-Nitropyridine-2,4-diamine | ESD-898452-100MG |
Cas.: 2586-99-4 | Purity: ≥95% | 5-Nitropyridine-2,4-diamine | ESD-898452-250MG |
Cas.: 2586-99-4 | Purity: ≥95% | 5-Nitropyridine-2,4-diamine | ESD-898452-1G |
Cas.: 205114-20-1 | Purity: 98% | 3-Bromo-6-iodoquinoline | ESD-898453-100MG |
Cas.: 205114-20-1 | Purity: 98% | 3-Bromo-6-iodoquinoline | ESD-898453-250MG |
Cas.: 205114-20-1 | Purity: 98% | 3-Bromo-6-iodoquinoline | ESD-898453-1G |
Cas.: 830346-47-9 | Purity: ≥95% | 1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione | ESD-898454-100MG |
Cas.: 830346-47-9 | Purity: ≥95% | 1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione | ESD-898454-250MG |
Cas.: 830346-47-9 | Purity: ≥95% | 1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione | ESD-898454-1G |
Cas.: 1965314-51-5 | Purity: 97% | (R)-Methyl 2-(pyrrolidin-3-yloxy)acetate 4-methylbenzenesulfonate | ESD-898455-100MG |
Cas.: 1965314-51-5 | Purity: 97% | (R)-Methyl 2-(pyrrolidin-3-yloxy)acetate 4-methylbenzenesulfonate | ESD-898455-250MG |
Cas.: 1965314-51-5 | Purity: 97% | (R)-Methyl 2-(pyrrolidin-3-yloxy)acetate 4-methylbenzenesulfonate | ESD-898455-1G |
Cas.: 68889-62-3 | Purity: 97% | (S)-3-Aminohexan-1-ol hydrochloride | ESD-898456-100MG |
Cas.: 68889-62-3 | Purity: 97% | (S)-3-Aminohexan-1-ol hydrochloride | ESD-898456-250MG |
Cas.: 68889-62-3 | Purity: 97% | (S)-3-Aminohexan-1-ol hydrochloride | ESD-898456-1G |
Cas.: 1375108-41-0 | Purity: 95% | 7-Bromo-3-methylquinoline | ESD-898457-100MG |
Cas.: 1375108-41-0 | Purity: 95% | 7-Bromo-3-methylquinoline | ESD-898457-250MG |
Cas.: 1375108-41-0 | Purity: 95% | 7-Bromo-3-methylquinoline | ESD-898457-1G |
Cas.: 203854-54-0 | Purity: 97% | (S)-2-(Aminomethyl)-3-methylbutanoic acid | ESD-898458-100MG |
Cas.: 203854-54-0 | Purity: 97% | (S)-2-(Aminomethyl)-3-methylbutanoic acid | ESD-898458-250MG |
Cas.: 203854-54-0 | Purity: 97% | (S)-2-(Aminomethyl)-3-methylbutanoic acid | ESD-898458-1G |
Cas.: 39674-99-2 | Purity: ≥95% | Piperidine-4-carboxamide hydrochloride | ESD-898459-100MG |
Cas.: 39674-99-2 | Purity: ≥95% | Piperidine-4-carboxamide hydrochloride | ESD-898459-250MG |
Cas.: 39674-99-2 | Purity: ≥95% | Piperidine-4-carboxamide hydrochloride | ESD-898459-1G |
Cas.: 844470-82-2 | Purity: 97% | (S)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride | ESD-898460-100MG |
Cas.: 844470-82-2 | Purity: 97% | (S)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride | ESD-898460-250MG |
Cas.: 844470-82-2 | Purity: 97% | (S)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride | ESD-898460-1G |
Cas.: 944905-12-8 | Purity: 97% | 1-(Imidazo[1,2-a]pyridin-6-yl)ethanone | ESD-898461-100MG |
Cas.: 944905-12-8 | Purity: 97% | 1-(Imidazo[1,2-a]pyridin-6-yl)ethanone | ESD-898461-250MG |
Cas.: 944905-12-8 | Purity: 97% | 1-(Imidazo[1,2-a]pyridin-6-yl)ethanone | ESD-898461-1G |
Cas.: 234108-58-8 | Purity: ≥95% | tert-Butyl 4-(2-aminoethyl)-3-oxopiperazine-1-carboxylate | ESD-898462-100MG |
Cas.: 234108-58-8 | Purity: ≥95% | tert-Butyl 4-(2-aminoethyl)-3-oxopiperazine-1-carboxylate | ESD-898462-250MG |
Cas.: 234108-58-8 | Purity: ≥95% | tert-Butyl 4-(2-aminoethyl)-3-oxopiperazine-1-carboxylate | ESD-898462-1G |
Cas.: 23536-76-7 | Purity: ≥95% | 7-Bromo-4H-pyrido[1,2-a]pyrimidin-4-one | ESD-898463-100MG |
Cas.: 23536-76-7 | Purity: ≥95% | 7-Bromo-4H-pyrido[1,2-a]pyrimidin-4-one | ESD-898463-250MG |
Cas.: 23536-76-7 | Purity: ≥95% | 7-Bromo-4H-pyrido[1,2-a]pyrimidin-4-one | ESD-898463-1G |
Cas.: 1211523-71-5 | Purity: ≥95% | 2-(2-Bromopyridin-3-yl)acetonitrile | ESD-898464-100MG |
Cas.: 1211523-71-5 | Purity: ≥95% | 2-(2-Bromopyridin-3-yl)acetonitrile | ESD-898464-250MG |
Cas.: 1211523-71-5 | Purity: ≥95% | 2-(2-Bromopyridin-3-yl)acetonitrile | ESD-898464-1G |
Cas.: 1211479-06-9 | Purity: ≥95% | Methyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-898465-100MG |
Cas.: 1211479-06-9 | Purity: ≥95% | Methyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-898465-250MG |
Cas.: 1211479-06-9 | Purity: ≥95% | Methyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | ESD-898465-1G |
Cas.: 180323-49-3 | Purity: 95% | (1S,3R)-Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-898466-100MG |
Cas.: 180323-49-3 | Purity: 95% | (1S,3R)-Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-898466-250MG |
Cas.: 180323-49-3 | Purity: 95% | (1S,3R)-Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-898466-1G |
Cas.: 914943-91-2 | Purity: 95% | tert-Butyl 3-ethynylbenzoate | ESD-898467-100MG |
Cas.: 914943-91-2 | Purity: 95% | tert-Butyl 3-ethynylbenzoate | ESD-898467-250MG |
Cas.: 914943-91-2 | Purity: 95% | tert-Butyl 3-ethynylbenzoate | ESD-898467-1G |
Cas.: 1393562-33-8 | Purity: 97% | 2-Bromo-5-methoxy-3-methylpyrazine | ESD-898468-100MG |
Cas.: 1393562-33-8 | Purity: 97% | 2-Bromo-5-methoxy-3-methylpyrazine | ESD-898468-250MG |
Cas.: 1393562-33-8 | Purity: 97% | 2-Bromo-5-methoxy-3-methylpyrazine | ESD-898468-1G |
Cas.: 14779-18-1 | Purity: ≥95% | 7-Methylbenzo[d]thiazol-2-amine | ESD-898469-100MG |
Cas.: 14779-18-1 | Purity: ≥95% | 7-Methylbenzo[d]thiazol-2-amine | ESD-898469-250MG |
Cas.: 14779-18-1 | Purity: ≥95% | 7-Methylbenzo[d]thiazol-2-amine | ESD-898469-1G |
Cas.: 1360950-40-8 | Purity: 97% | 2-(5-Borono-2-pyrimidinyl)imidodicarbonic acid 1,3-bis(tert-butyl) ester | ESD-898470-100MG |
Cas.: 1360950-40-8 | Purity: 97% | 2-(5-Borono-2-pyrimidinyl)imidodicarbonic acid 1,3-bis(tert-butyl) ester | ESD-898470-250MG |
Cas.: 1360950-40-8 | Purity: 97% | 2-(5-Borono-2-pyrimidinyl)imidodicarbonic acid 1,3-bis(tert-butyl) ester | ESD-898470-1G |
Cas.: 1190198-13-0 | Purity: ≥95% | Methyl 7-(benzyloxy)-1H-indole-5-carboxylate | ESD-898471-100MG |
Cas.: 1190198-13-0 | Purity: ≥95% | Methyl 7-(benzyloxy)-1H-indole-5-carboxylate | ESD-898471-250MG |
Cas.: 1190198-13-0 | Purity: ≥95% | Methyl 7-(benzyloxy)-1H-indole-5-carboxylate | ESD-898471-1G |
Cas.: 875573-66-3 | Purity: ≥95% | (7R,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17- decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate | ESD-898472-100MG |
Cas.: 875573-66-3 | Purity: ≥95% | (7R,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17- decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate | ESD-898472-250MG |
Cas.: 875573-66-3 | Purity: ≥95% | (7R,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17- decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate | ESD-898472-1G |
Cas.: 31502-87-1 | Purity: ≥95% | 1,4-Bis(7-chloroquinolin-4-yl)piperazine | ESD-898473-100MG |
Cas.: 31502-87-1 | Purity: ≥95% | 1,4-Bis(7-chloroquinolin-4-yl)piperazine | ESD-898473-250MG |
Cas.: 31502-87-1 | Purity: ≥95% | 1,4-Bis(7-chloroquinolin-4-yl)piperazine | ESD-898473-1G |
Cas.: 1122-70-9 | Purity: ≥95% | 6-Methyl-2-vinylpyridine | ESD-898474-100MG |
Cas.: 1122-70-9 | Purity: ≥95% | 6-Methyl-2-vinylpyridine | ESD-898474-250MG |
Cas.: 1122-70-9 | Purity: ≥95% | 6-Methyl-2-vinylpyridine | ESD-898474-1G |
Cas.: 1308650-40-9 | Purity: 97% | (S)-1-(4-Iodophenyl)ethanamine hydrochloride | ESD-898475-100MG |
Cas.: 1308650-40-9 | Purity: 97% | (S)-1-(4-Iodophenyl)ethanamine hydrochloride | ESD-898475-250MG |
Cas.: 1308650-40-9 | Purity: 97% | (S)-1-(4-Iodophenyl)ethanamine hydrochloride | ESD-898475-1G |
Cas.: 1246651-15-9 | Purity: ≥95% | (S)-2-(Piperazin-2-yl)ethanol dihydrochloride | ESD-898476-100MG |
Cas.: 1246651-15-9 | Purity: ≥95% | (S)-2-(Piperazin-2-yl)ethanol dihydrochloride | ESD-898476-250MG |
Cas.: 1246651-15-9 | Purity: ≥95% | (S)-2-(Piperazin-2-yl)ethanol dihydrochloride | ESD-898476-1G |
Cas.: 330793-85-6 | Purity: ≥95% | N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazol-2-amine | ESD-898477-100MG |
Cas.: 330793-85-6 | Purity: ≥95% | N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazol-2-amine | ESD-898477-250MG |
Cas.: 330793-85-6 | Purity: ≥95% | N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazol-2-amine | ESD-898477-1G |
Cas.: 1359658-32-4 | Purity: ≥95% | (R)-tert-Butyl 3-(methoxymethyl)piperazine-1-carboxylate | ESD-898478-100MG |
Cas.: 1359658-32-4 | Purity: ≥95% | (R)-tert-Butyl 3-(methoxymethyl)piperazine-1-carboxylate | ESD-898478-250MG |
Cas.: 1359658-32-4 | Purity: ≥95% | (R)-tert-Butyl 3-(methoxymethyl)piperazine-1-carboxylate | ESD-898478-1G |
Cas.: 85468-38-8 | Purity: ≥95% | 3-(Aminomethyl)pyridin-2(1H)-one hydrochloride | ESD-898479-100MG |
Cas.: 85468-38-8 | Purity: ≥95% | 3-(Aminomethyl)pyridin-2(1H)-one hydrochloride | ESD-898479-250MG |
Cas.: 85468-38-8 | Purity: ≥95% | 3-(Aminomethyl)pyridin-2(1H)-one hydrochloride | ESD-898479-1G |
Cas.: 637337-65-6 | Purity: 97% | (S)-3-(((Benzyloxy)carbonyl)amino)-2-methylpropanoic acid | ESD-898480-100MG |
Cas.: 637337-65-6 | Purity: 97% | (S)-3-(((Benzyloxy)carbonyl)amino)-2-methylpropanoic acid | ESD-898480-250MG |
Cas.: 637337-65-6 | Purity: 97% | (S)-3-(((Benzyloxy)carbonyl)amino)-2-methylpropanoic acid | ESD-898480-1G |
Cas.: 14676-03-0 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(furan-2-yl)propanoic acid | ESD-898481-100MG |
Cas.: 14676-03-0 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(furan-2-yl)propanoic acid | ESD-898481-250MG |
Cas.: 14676-03-0 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(furan-2-yl)propanoic acid | ESD-898481-1G |
Cas.: 921927-88-0 | Purity: 97% | Methyl 2-formylthiazole-4-carboxylate | ESD-898482-100MG |
Cas.: 921927-88-0 | Purity: 97% | Methyl 2-formylthiazole-4-carboxylate | ESD-898482-250MG |
Cas.: 921927-88-0 | Purity: 97% | Methyl 2-formylthiazole-4-carboxylate | ESD-898482-1G |
Cas.: 176389-60-9 | Purity: 97% | 3-(3-(Trifluoromethyl)-3H-diazirin-3-yl)benzoic acid | ESD-898483-100MG |
Cas.: 176389-60-9 | Purity: 97% | 3-(3-(Trifluoromethyl)-3H-diazirin-3-yl)benzoic acid | ESD-898483-250MG |
Cas.: 176389-60-9 | Purity: 97% | 3-(3-(Trifluoromethyl)-3H-diazirin-3-yl)benzoic acid | ESD-898483-1G |
Cas.: 10374-51-3 | Purity: ≥95% | 5-(Hydroxymethyl)dihydrofuran-2(3H)-one | ESD-898484-100MG |
Cas.: 10374-51-3 | Purity: ≥95% | 5-(Hydroxymethyl)dihydrofuran-2(3H)-one | ESD-898484-250MG |
Cas.: 10374-51-3 | Purity: ≥95% | 5-(Hydroxymethyl)dihydrofuran-2(3H)-one | ESD-898484-1G |
Cas.: 203314-33-4 | Purity: 98% | Methyl 2-(5-bromo-2-chlorophenyl)acetate | ESD-898485-100MG |
Cas.: 203314-33-4 | Purity: 98% | Methyl 2-(5-bromo-2-chlorophenyl)acetate | ESD-898485-250MG |
Cas.: 203314-33-4 | Purity: 98% | Methyl 2-(5-bromo-2-chlorophenyl)acetate | ESD-898485-1G |
Cas.: 852471-15-9 | Purity: 97% | 1-Acetyl-1H-pyrazol-3(2H)-one | ESD-898486-100MG |
Cas.: 852471-15-9 | Purity: 97% | 1-Acetyl-1H-pyrazol-3(2H)-one | ESD-898486-250MG |
Cas.: 852471-15-9 | Purity: 97% | 1-Acetyl-1H-pyrazol-3(2H)-one | ESD-898486-1G |
Cas.: 1542268-31-4 | Purity: ≥95% | (3R,5R)-3,5-Dimethylmorpholine hydrochloride | ESD-898487-100MG |
Cas.: 1542268-31-4 | Purity: ≥95% | (3R,5R)-3,5-Dimethylmorpholine hydrochloride | ESD-898487-250MG |
Cas.: 1542268-31-4 | Purity: ≥95% | (3R,5R)-3,5-Dimethylmorpholine hydrochloride | ESD-898487-1G |
Cas.: 1209646-17-2 | Purity: 98% | 5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid | ESD-898488-100MG |
Cas.: 1209646-17-2 | Purity: 98% | 5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid | ESD-898488-250MG |
Cas.: 1209646-17-2 | Purity: 98% | 5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid | ESD-898488-1G |
Cas.: 330794-31-5 | Purity: ≥95% | 1-Cyclopentyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-898489-100MG |
Cas.: 330794-31-5 | Purity: ≥95% | 1-Cyclopentyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-898489-250MG |
Cas.: 330794-31-5 | Purity: ≥95% | 1-Cyclopentyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-898489-1G |
Cas.: 1369959-12-5 | Purity: 97% | 3-Chloro-5-nitro-1H-pyrazole | ESD-898490-100MG |
Cas.: 1369959-12-5 | Purity: 97% | 3-Chloro-5-nitro-1H-pyrazole | ESD-898490-250MG |
Cas.: 1369959-12-5 | Purity: 97% | 3-Chloro-5-nitro-1H-pyrazole | ESD-898490-1G |
Cas.: 34839-14-0 | Purity: 97% | (R)-1-Amino-3-chloropropan-2-ol hydrochloride | ESD-898491-100MG |
Cas.: 34839-14-0 | Purity: 97% | (R)-1-Amino-3-chloropropan-2-ol hydrochloride | ESD-898491-250MG |
Cas.: 34839-14-0 | Purity: 97% | (R)-1-Amino-3-chloropropan-2-ol hydrochloride | ESD-898491-1G |
Cas.: 1187932-64-4 | Purity: 97% | tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-898492-100MG |
Cas.: 1187932-64-4 | Purity: 97% | tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-898492-250MG |
Cas.: 1187932-64-4 | Purity: 97% | tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate | ESD-898492-1G |
Cas.: 1334411-79-8 | Purity: 98% | 4-Bromo-2-(2,6-dichlorophenyl)-1H-imidazo[4,5-c]pyridine | ESD-898493-100MG |
Cas.: 1334411-79-8 | Purity: 98% | 4-Bromo-2-(2,6-dichlorophenyl)-1H-imidazo[4,5-c]pyridine | ESD-898493-250MG |
Cas.: 1334411-79-8 | Purity: 98% | 4-Bromo-2-(2,6-dichlorophenyl)-1H-imidazo[4,5-c]pyridine | ESD-898493-1G |
Cas.: 957035-17-5 | Purity: ≥95% | (3,4-Dichloro-2-methylphenyl)boronic acid | ESD-898494-100MG |
Cas.: 957035-17-5 | Purity: ≥95% | (3,4-Dichloro-2-methylphenyl)boronic acid | ESD-898494-250MG |
Cas.: 957035-17-5 | Purity: ≥95% | (3,4-Dichloro-2-methylphenyl)boronic acid | ESD-898494-1G |
Cas.: 1190198-24-3 | Purity: ≥95% | 6-Bromobenzo[b]thiophene-2-carbonitrile | ESD-898495-100MG |
Cas.: 1190198-24-3 | Purity: ≥95% | 6-Bromobenzo[b]thiophene-2-carbonitrile | ESD-898495-250MG |
Cas.: 1190198-24-3 | Purity: ≥95% | 6-Bromobenzo[b]thiophene-2-carbonitrile | ESD-898495-1G |
Cas.: 895134-29-9 | Purity: 97% | 3-(Benzyloxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)-4-oxo-4H-pyran-2-carboxylic acid | ESD-898496-100MG |
Cas.: 895134-29-9 | Purity: 97% | 3-(Benzyloxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)-4-oxo-4H-pyran-2-carboxylic acid | ESD-898496-250MG |
Cas.: 895134-29-9 | Purity: 97% | 3-(Benzyloxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)-4-oxo-4H-pyran-2-carboxylic acid | ESD-898496-1G |
Cas.: 1628794-75-1 | Purity: 95% | tert-Butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate | ESD-898497-100MG |
Cas.: 1628794-75-1 | Purity: 95% | tert-Butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate | ESD-898497-250MG |
Cas.: 1628794-75-1 | Purity: 95% | tert-Butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate | ESD-898497-1G |
Cas.: 184040-74-2 | Purity: 97% | 3-(N-(4-Chloro-3-methylisoxazol-5-yl)sulfamoyl)thiophene-2-carboxylic acid | ESD-898498-100MG |
Cas.: 184040-74-2 | Purity: 97% | 3-(N-(4-Chloro-3-methylisoxazol-5-yl)sulfamoyl)thiophene-2-carboxylic acid | ESD-898498-250MG |
Cas.: 184040-74-2 | Purity: 97% | 3-(N-(4-Chloro-3-methylisoxazol-5-yl)sulfamoyl)thiophene-2-carboxylic acid | ESD-898498-1G |
Cas.: 924817-68-5 | Purity: ≥95% | 6-(4-(Trifluoromethyl)phenyl)picolinic acid | ESD-898499-100MG |
Cas.: 924817-68-5 | Purity: ≥95% | 6-(4-(Trifluoromethyl)phenyl)picolinic acid | ESD-898499-250MG |
Cas.: 924817-68-5 | Purity: ≥95% | 6-(4-(Trifluoromethyl)phenyl)picolinic acid | ESD-898499-1G |
Cas.: 136818-64-9 | Purity: ≥95% | Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate | ESD-898500-100MG |
Cas.: 136818-64-9 | Purity: ≥95% | Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate | ESD-898500-250MG |
Cas.: 136818-64-9 | Purity: ≥95% | Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate | ESD-898500-1G |
Cas.: 1799612-11-5 | Purity: 97% | 1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine | ESD-898501-100MG |
Cas.: 1799612-11-5 | Purity: 97% | 1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine | ESD-898501-250MG |
Cas.: 1799612-11-5 | Purity: 97% | 1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine | ESD-898501-1G |
Cas.: 359849-58-4 | Purity: 97% | (1S,2S)-2-Aminocyclopentanecarboxylic acid hydrochloride | ESD-898502-100MG |
Cas.: 359849-58-4 | Purity: 97% | (1S,2S)-2-Aminocyclopentanecarboxylic acid hydrochloride | ESD-898502-250MG |
Cas.: 359849-58-4 | Purity: 97% | (1S,2S)-2-Aminocyclopentanecarboxylic acid hydrochloride | ESD-898502-1G |
Cas.: 117516-97-9 | Purity: ≥95% | 2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one | ESD-898503-100MG |
Cas.: 117516-97-9 | Purity: ≥95% | 2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one | ESD-898503-250MG |
Cas.: 117516-97-9 | Purity: ≥95% | 2-Thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one | ESD-898503-1G |
Cas.: 1780964-59-1 | Purity: 97% | 8,8-Difluoro-2-azaspiro[4.5]decane hydrochloride | ESD-898504-100MG |
Cas.: 1780964-59-1 | Purity: 97% | 8,8-Difluoro-2-azaspiro[4.5]decane hydrochloride | ESD-898504-250MG |
Cas.: 1780964-59-1 | Purity: 97% | 8,8-Difluoro-2-azaspiro[4.5]decane hydrochloride | ESD-898504-1G |
Cas.: 1256785-40-6 | Purity: ≥95% | Methyl 4-amino-6-chloronicotinate | ESD-898505-100MG |
Cas.: 1256785-40-6 | Purity: ≥95% | Methyl 4-amino-6-chloronicotinate | ESD-898505-250MG |
Cas.: 1256785-40-6 | Purity: ≥95% | Methyl 4-amino-6-chloronicotinate | ESD-898505-1G |
Cas.: 194032-17-2 | Purity: 98% | 4-Methyl-5-nitroisoquinoline | ESD-898506-100MG |
Cas.: 194032-17-2 | Purity: 98% | 4-Methyl-5-nitroisoquinoline | ESD-898506-250MG |
Cas.: 194032-17-2 | Purity: 98% | 4-Methyl-5-nitroisoquinoline | ESD-898506-1G |
Cas.: 877399-51-4 | Purity: 97% | (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl) piperidine-1-carboxylate | ESD-898507-100MG |
Cas.: 877399-51-4 | Purity: 97% | (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl) piperidine-1-carboxylate | ESD-898507-250MG |
Cas.: 877399-51-4 | Purity: 97% | (R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl) piperidine-1-carboxylate | ESD-898507-1G |
Cas.: 174886-03-4 | Purity: 97% | 5-(Trifluoromethyl)thiazol-2-amine hydrochloride | ESD-898508-100MG |
Cas.: 174886-03-4 | Purity: 97% | 5-(Trifluoromethyl)thiazol-2-amine hydrochloride | ESD-898508-250MG |
Cas.: 174886-03-4 | Purity: 97% | 5-(Trifluoromethyl)thiazol-2-amine hydrochloride | ESD-898508-1G |
Cas.: 1273315-11-9 | Purity: ≥95% | 2-Chloro-9-methyl-7H-purin-8(9H)-one | ESD-898509-100MG |
Cas.: 1273315-11-9 | Purity: ≥95% | 2-Chloro-9-methyl-7H-purin-8(9H)-one | ESD-898509-250MG |
Cas.: 1273315-11-9 | Purity: ≥95% | 2-Chloro-9-methyl-7H-purin-8(9H)-one | ESD-898509-1G |
Cas.: 1313519-78-6 | Purity: 97% | 2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-898510-100MG |
Cas.: 1313519-78-6 | Purity: 97% | 2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-898510-250MG |
Cas.: 1313519-78-6 | Purity: 97% | 2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-898510-1G |
Cas.: 1227586-39-1 | Purity: ≥95% | 2-Chloro-5-methoxypyridin-4-amine | ESD-898511-100MG |
Cas.: 1227586-39-1 | Purity: ≥95% | 2-Chloro-5-methoxypyridin-4-amine | ESD-898511-250MG |
Cas.: 1227586-39-1 | Purity: ≥95% | 2-Chloro-5-methoxypyridin-4-amine | ESD-898511-1G |
Cas.: 912284-82-3 | Purity: ≥95% | 6-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline | ESD-898512-100MG |
Cas.: 912284-82-3 | Purity: ≥95% | 6-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline | ESD-898512-250MG |
Cas.: 912284-82-3 | Purity: ≥95% | 6-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline | ESD-898512-1G |
Cas.: 137520-99-1 | Purity: 97% | Ethyl 2,6-dichloro-3-methylisonicotinate | ESD-898513-100MG |
Cas.: 137520-99-1 | Purity: 97% | Ethyl 2,6-dichloro-3-methylisonicotinate | ESD-898513-250MG |
Cas.: 137520-99-1 | Purity: 97% | Ethyl 2,6-dichloro-3-methylisonicotinate | ESD-898513-1G |
Cas.: 401567-00-8 | Purity: ≥95% | 2-Chloro-1H-benzo[d]imidazole-5-carbonitrile | ESD-898514-100MG |
Cas.: 401567-00-8 | Purity: ≥95% | 2-Chloro-1H-benzo[d]imidazole-5-carbonitrile | ESD-898514-250MG |
Cas.: 401567-00-8 | Purity: ≥95% | 2-Chloro-1H-benzo[d]imidazole-5-carbonitrile | ESD-898514-1G |
Cas.: 1103738-17-5 | Purity: 97% | (3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carboxylic acid | ESD-898515-100MG |
Cas.: 1103738-17-5 | Purity: 97% | (3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carboxylic acid | ESD-898515-250MG |
Cas.: 1103738-17-5 | Purity: 97% | (3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carboxylic acid | ESD-898515-1G |
Cas.: 943751-30-2 | Purity: ≥95% | 2-Methylisoindolin-5-amine dihydrochloride | ESD-898516-100MG |
Cas.: 943751-30-2 | Purity: ≥95% | 2-Methylisoindolin-5-amine dihydrochloride | ESD-898516-250MG |
Cas.: 943751-30-2 | Purity: ≥95% | 2-Methylisoindolin-5-amine dihydrochloride | ESD-898516-1G |
Cas.: 27383-92-2 | Purity: 97% | Methyl 5-chlorobenzo[d]oxazole-2-carboxylate | ESD-898517-100MG |
Cas.: 27383-92-2 | Purity: 97% | Methyl 5-chlorobenzo[d]oxazole-2-carboxylate | ESD-898517-250MG |
Cas.: 27383-92-2 | Purity: 97% | Methyl 5-chlorobenzo[d]oxazole-2-carboxylate | ESD-898517-1G |
Cas.: 955369-56-9 | Purity: ≥95% | 2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one | ESD-898518-100MG |
Cas.: 955369-56-9 | Purity: ≥95% | 2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one | ESD-898518-250MG |
Cas.: 955369-56-9 | Purity: ≥95% | 2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one | ESD-898518-1G |
Cas.: 83605-44-1 | Purity: 98% | Ru(DMB)3(PF6)2 | ESD-898519-100MG |
Cas.: 83605-44-1 | Purity: 98% | Ru(DMB)3(PF6)2 | ESD-898519-250MG |
Cas.: 83605-44-1 | Purity: 98% | Ru(DMB)3(PF6)2 | ESD-898519-1G |
Cas.: 945217-60-7 | Purity: ≥95% | (3R,4S)-rel-tert-Butyl 3,4-diaminopyrrolidine-1-carboxylate | ESD-898520-100MG |
Cas.: 945217-60-7 | Purity: ≥95% | (3R,4S)-rel-tert-Butyl 3,4-diaminopyrrolidine-1-carboxylate | ESD-898520-250MG |
Cas.: 945217-60-7 | Purity: ≥95% | (3R,4S)-rel-tert-Butyl 3,4-diaminopyrrolidine-1-carboxylate | ESD-898520-1G |
Cas.: 1351343-41-3 | Purity: ≥95% | 4,4-Dimethylpyrrolidine-3-carboxylic acid hydrochloride | ESD-898521-100MG |
Cas.: 1351343-41-3 | Purity: ≥95% | 4,4-Dimethylpyrrolidine-3-carboxylic acid hydrochloride | ESD-898521-250MG |
Cas.: 1351343-41-3 | Purity: ≥95% | 4,4-Dimethylpyrrolidine-3-carboxylic acid hydrochloride | ESD-898521-1G |
Cas.: 1394003-86-1 | Purity: ≥95% | 2-Aminopyrazolo[1,5-a]pyrimidine-3-carboxylic acid | ESD-898522-100MG |
Cas.: 1394003-86-1 | Purity: ≥95% | 2-Aminopyrazolo[1,5-a]pyrimidine-3-carboxylic acid | ESD-898522-250MG |
Cas.: 1394003-86-1 | Purity: ≥95% | 2-Aminopyrazolo[1,5-a]pyrimidine-3-carboxylic acid | ESD-898522-1G |
Cas.: 464152-38-3 | Purity: 97% | 2-(2-Methoxypyridin-4-yl)acetic acid | ESD-898523-100MG |
Cas.: 464152-38-3 | Purity: 97% | 2-(2-Methoxypyridin-4-yl)acetic acid | ESD-898523-250MG |
Cas.: 464152-38-3 | Purity: 97% | 2-(2-Methoxypyridin-4-yl)acetic acid | ESD-898523-1G |
Cas.: 74545-26-9 | Purity: 97% | 5,6-Dibromo-1H-benzo[d]imidazole | ESD-898524-100MG |
Cas.: 74545-26-9 | Purity: 97% | 5,6-Dibromo-1H-benzo[d]imidazole | ESD-898524-250MG |
Cas.: 74545-26-9 | Purity: 97% | 5,6-Dibromo-1H-benzo[d]imidazole | ESD-898524-1G |
Cas.: 862695-75-8 | Purity: ≥95% | 6-Chloro-2-cyclopropylnicotinic acid | ESD-898525-100MG |
Cas.: 862695-75-8 | Purity: ≥95% | 6-Chloro-2-cyclopropylnicotinic acid | ESD-898525-250MG |
Cas.: 862695-75-8 | Purity: ≥95% | 6-Chloro-2-cyclopropylnicotinic acid | ESD-898525-1G |
Cas.: 1261499-34-6 | Purity: ≥95% | 2-Chloro-3-cyanobenzoic acid | ESD-898526-100MG |
Cas.: 1261499-34-6 | Purity: ≥95% | 2-Chloro-3-cyanobenzoic acid | ESD-898526-250MG |
Cas.: 1261499-34-6 | Purity: ≥95% | 2-Chloro-3-cyanobenzoic acid | ESD-898526-1G |
Cas.: 885520-31-0 | Purity: 95% | 4-Fluoro-1H-indole-6-carboxylic acid | ESD-898527-100MG |
Cas.: 885520-31-0 | Purity: 95% | 4-Fluoro-1H-indole-6-carboxylic acid | ESD-898527-250MG |
Cas.: 885520-31-0 | Purity: 95% | 4-Fluoro-1H-indole-6-carboxylic acid | ESD-898527-1G |
Cas.: 335255-43-1 | Purity: ≥95% | tert-Butyl (2-amino-4-(thiophen-2-yl)phenyl)carbamate | ESD-898528-100MG |
Cas.: 335255-43-1 | Purity: ≥95% | tert-Butyl (2-amino-4-(thiophen-2-yl)phenyl)carbamate | ESD-898528-250MG |
Cas.: 335255-43-1 | Purity: ≥95% | tert-Butyl (2-amino-4-(thiophen-2-yl)phenyl)carbamate | ESD-898528-1G |
Cas.: 1465-19-6 | Purity: ≥95% | 3-(Chloromethyl)-4-methylpyridine hydrochloride | ESD-898529-100MG |
Cas.: 1465-19-6 | Purity: ≥95% | 3-(Chloromethyl)-4-methylpyridine hydrochloride | ESD-898529-250MG |
Cas.: 1465-19-6 | Purity: ≥95% | 3-(Chloromethyl)-4-methylpyridine hydrochloride | ESD-898529-1G |
Cas.: 116632-14-5 | Purity: 97% | 3-Iodonaphthalen-2-amine | ESD-898530-100MG |
Cas.: 116632-14-5 | Purity: 97% | 3-Iodonaphthalen-2-amine | ESD-898530-250MG |
Cas.: 116632-14-5 | Purity: 97% | 3-Iodonaphthalen-2-amine | ESD-898530-1G |
Cas.: 103030-09-7 | Purity: ≥95% | 1H-Indole-2,3-dicarboxylic acid | ESD-898531-100MG |
Cas.: 103030-09-7 | Purity: ≥95% | 1H-Indole-2,3-dicarboxylic acid | ESD-898531-250MG |
Cas.: 103030-09-7 | Purity: ≥95% | 1H-Indole-2,3-dicarboxylic acid | ESD-898531-1G |
Cas.: 869569-77-7 | Purity: 98% | 2-Bromo-1-(4-bromo-2-fluorophenyl)ethanone | ESD-898532-100MG |
Cas.: 869569-77-7 | Purity: 98% | 2-Bromo-1-(4-bromo-2-fluorophenyl)ethanone | ESD-898532-250MG |
Cas.: 869569-77-7 | Purity: 98% | 2-Bromo-1-(4-bromo-2-fluorophenyl)ethanone | ESD-898532-1G |
Cas.: 1086378-71-3 | Purity: ≥95% | tert-Butyl (3-hydroxy-2,3-dihydro-1H-inden-1-yl)carbamate | ESD-898533-100MG |
Cas.: 1086378-71-3 | Purity: ≥95% | tert-Butyl (3-hydroxy-2,3-dihydro-1H-inden-1-yl)carbamate | ESD-898533-250MG |
Cas.: 1086378-71-3 | Purity: ≥95% | tert-Butyl (3-hydroxy-2,3-dihydro-1H-inden-1-yl)carbamate | ESD-898533-1G |
Cas.: 50786-37-3 | Purity: ≥95% | 4,6-Dibromopyridin-3-amine | ESD-898534-100MG |
Cas.: 50786-37-3 | Purity: ≥95% | 4,6-Dibromopyridin-3-amine | ESD-898534-250MG |
Cas.: 50786-37-3 | Purity: ≥95% | 4,6-Dibromopyridin-3-amine | ESD-898534-1G |
Cas.: 1309788-50-8 | Purity: 97% | 3-Iodo-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole | ESD-898535-100MG |
Cas.: 1309788-50-8 | Purity: 97% | 3-Iodo-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole | ESD-898535-250MG |
Cas.: 1309788-50-8 | Purity: 97% | 3-Iodo-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole | ESD-898535-1G |
Cas.: 221227-05-0 | Purity: 97% | Pal-Gly-Gln-Pro-Arg-OH | ESD-898536-100MG |
Cas.: 221227-05-0 | Purity: 97% | Pal-Gly-Gln-Pro-Arg-OH | ESD-898536-250MG |
Cas.: 221227-05-0 | Purity: 97% | Pal-Gly-Gln-Pro-Arg-OH | ESD-898536-1G |
Cas.: 862729-13-3 | Purity: ≥95% | 5-Iodo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-898537-100MG |
Cas.: 862729-13-3 | Purity: ≥95% | 5-Iodo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-898537-250MG |
Cas.: 862729-13-3 | Purity: ≥95% | 5-Iodo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ESD-898537-1G |
Cas.: 496946-80-6 | Purity: 98% | 2-Methyl-1H-indole-5-carboxylic acid | ESD-898538-100MG |
Cas.: 496946-80-6 | Purity: 98% | 2-Methyl-1H-indole-5-carboxylic acid | ESD-898538-250MG |
Cas.: 496946-80-6 | Purity: 98% | 2-Methyl-1H-indole-5-carboxylic acid | ESD-898538-1G |
Cas.: 1198408-35-3 | Purity: ≥95% | tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate | ESD-898539-100MG |
Cas.: 1198408-35-3 | Purity: ≥95% | tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate | ESD-898539-250MG |
Cas.: 1198408-35-3 | Purity: ≥95% | tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate | ESD-898539-1G |
Cas.: 136992-95-5 | Purity: ≥95% | Benzo[d]oxazol-7-amine | ESD-898540-100MG |
Cas.: 136992-95-5 | Purity: ≥95% | Benzo[d]oxazol-7-amine | ESD-898540-250MG |
Cas.: 136992-95-5 | Purity: ≥95% | Benzo[d]oxazol-7-amine | ESD-898540-1G |
Cas.: 913090-41-2 | Purity: 97% | 6-(Difluoromethyl)pyridin-3-amine | ESD-898541-100MG |
Cas.: 913090-41-2 | Purity: 97% | 6-(Difluoromethyl)pyridin-3-amine | ESD-898541-250MG |
Cas.: 913090-41-2 | Purity: 97% | 6-(Difluoromethyl)pyridin-3-amine | ESD-898541-1G |
Cas.: 1021918-86-4 | Purity: 97% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate | ESD-898542-100MG |
Cas.: 1021918-86-4 | Purity: 97% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate | ESD-898542-250MG |
Cas.: 1021918-86-4 | Purity: 97% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate | ESD-898542-1G |
Cas.: 301221-57-8 | Purity: ≥95% | tert-Butyl 4-(2-amino-1-hydroxyethyl)piperidine-1-carboxylate | ESD-898543-100MG |
Cas.: 301221-57-8 | Purity: ≥95% | tert-Butyl 4-(2-amino-1-hydroxyethyl)piperidine-1-carboxylate | ESD-898543-250MG |
Cas.: 301221-57-8 | Purity: ≥95% | tert-Butyl 4-(2-amino-1-hydroxyethyl)piperidine-1-carboxylate | ESD-898543-1G |
Cas.: 221681-75-0 | Purity: 98% | 6-Chloro-1H-indazol-5-amine | ESD-898544-100MG |
Cas.: 221681-75-0 | Purity: 98% | 6-Chloro-1H-indazol-5-amine | ESD-898544-250MG |
Cas.: 221681-75-0 | Purity: 98% | 6-Chloro-1H-indazol-5-amine | ESD-898544-1G |
Cas.: 1260671-33-7 | Purity: 97% | Methyl 3-chloro-5-formylpicolinate | ESD-898545-100MG |
Cas.: 1260671-33-7 | Purity: 97% | Methyl 3-chloro-5-formylpicolinate | ESD-898545-250MG |
Cas.: 1260671-33-7 | Purity: 97% | Methyl 3-chloro-5-formylpicolinate | ESD-898545-1G |
Cas.: 100137-47-1 | Purity: 97% | 4-Aminopicolinamide | ESD-898546-100MG |
Cas.: 100137-47-1 | Purity: 97% | 4-Aminopicolinamide | ESD-898546-250MG |
Cas.: 100137-47-1 | Purity: 97% | 4-Aminopicolinamide | ESD-898546-1G |
Cas.: 1302580-98-8 | Purity: 97% | 1-(5-Fluoropyridin-2-yl)cyclopropanecarboxylic acid | ESD-898547-100MG |
Cas.: 1302580-98-8 | Purity: 97% | 1-(5-Fluoropyridin-2-yl)cyclopropanecarboxylic acid | ESD-898547-250MG |
Cas.: 1302580-98-8 | Purity: 97% | 1-(5-Fluoropyridin-2-yl)cyclopropanecarboxylic acid | ESD-898547-1G |
Cas.: 1184986-84-2 | Purity: ≥95% | C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride | ESD-898548-100MG |
Cas.: 1184986-84-2 | Purity: ≥95% | C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride | ESD-898548-250MG |
Cas.: 1184986-84-2 | Purity: ≥95% | C-(5-Methyl-[1,2,4]oxadiazol-3-yl)-methylaminehydrochloride | ESD-898548-1G |
Cas.: 87789-35-3 | Purity: ≥95% | 5,7-Dichloro-2-(methylthio)thiazolo[4,5-d]pyrimidine | ESD-898549-100MG |
Cas.: 87789-35-3 | Purity: ≥95% | 5,7-Dichloro-2-(methylthio)thiazolo[4,5-d]pyrimidine | ESD-898549-250MG |
Cas.: 87789-35-3 | Purity: ≥95% | 5,7-Dichloro-2-(methylthio)thiazolo[4,5-d]pyrimidine | ESD-898549-1G |
Cas.: 888721-65-1 | Purity: 97% | 1-(4-Fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-898550-100MG |
Cas.: 888721-65-1 | Purity: 97% | 1-(4-Fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-898550-250MG |
Cas.: 888721-65-1 | Purity: 97% | 1-(4-Fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-898550-1G |
Cas.: 855343-01-0 | Purity: ≥95% | 4-Bromo-7-chlorobenzofuran | ESD-898551-100MG |
Cas.: 855343-01-0 | Purity: ≥95% | 4-Bromo-7-chlorobenzofuran | ESD-898551-250MG |
Cas.: 855343-01-0 | Purity: ≥95% | 4-Bromo-7-chlorobenzofuran | ESD-898551-1G |
Cas.: 1251903-95-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | ESD-898552-100MG |
Cas.: 1251903-95-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | ESD-898552-250MG |
Cas.: 1251903-95-3 | Purity: ≥95% | (R)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | ESD-898552-1G |
Cas.: 1001109-50-7 | Purity: 97% | (2-Bromo-4-(trifluoromethyl)phenyl)methanamine | ESD-898553-100MG |
Cas.: 1001109-50-7 | Purity: 97% | (2-Bromo-4-(trifluoromethyl)phenyl)methanamine | ESD-898553-250MG |
Cas.: 1001109-50-7 | Purity: 97% | (2-Bromo-4-(trifluoromethyl)phenyl)methanamine | ESD-898553-1G |
Cas.: 1213939-94-6 | Purity: ≥95% | (S)-1-(3-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-898554-100MG |
Cas.: 1213939-94-6 | Purity: ≥95% | (S)-1-(3-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-898554-250MG |
Cas.: 1213939-94-6 | Purity: ≥95% | (S)-1-(3-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-898554-1G |
Cas.: 209542-49-4 | Purity: 97% | 3-(2-(2-Methoxyethoxy)ethoxy)propanoic acid | ESD-898555-100MG |
Cas.: 209542-49-4 | Purity: 97% | 3-(2-(2-Methoxyethoxy)ethoxy)propanoic acid | ESD-898555-250MG |
Cas.: 209542-49-4 | Purity: 97% | 3-(2-(2-Methoxyethoxy)ethoxy)propanoic acid | ESD-898555-1G |
Cas.: 1160949-99-4 | Purity: ≥95% | 3-Bromoquinolin-7-ol | ESD-898556-100MG |
Cas.: 1160949-99-4 | Purity: ≥95% | 3-Bromoquinolin-7-ol | ESD-898556-250MG |
Cas.: 1160949-99-4 | Purity: ≥95% | 3-Bromoquinolin-7-ol | ESD-898556-1G |
Cas.: 201419-16-1 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-4-(tritylthio)butanoic acid | ESD-898557-100MG |
Cas.: 201419-16-1 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-4-(tritylthio)butanoic acid | ESD-898557-250MG |
Cas.: 201419-16-1 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-4-(tritylthio)butanoic acid | ESD-898557-1G |
Cas.: 51660-11-8 | Purity: 97% | 4-Chloro-2-(methylthio)-5,6,7,8-tetrahydroquinazoline | ESD-898558-100MG |
Cas.: 51660-11-8 | Purity: 97% | 4-Chloro-2-(methylthio)-5,6,7,8-tetrahydroquinazoline | ESD-898558-250MG |
Cas.: 51660-11-8 | Purity: 97% | 4-Chloro-2-(methylthio)-5,6,7,8-tetrahydroquinazoline | ESD-898558-1G |
Cas.: 202857-89-4 | Purity: ≥95% | 2-(Benzyloxy)-4-fluorobenzaldehyde | ESD-898559-100MG |
Cas.: 202857-89-4 | Purity: ≥95% | 2-(Benzyloxy)-4-fluorobenzaldehyde | ESD-898559-250MG |
Cas.: 202857-89-4 | Purity: ≥95% | 2-(Benzyloxy)-4-fluorobenzaldehyde | ESD-898559-1G |
Cas.: 1353101-37-7 | Purity: 97% | 7-Chlorothiazolo[4,5-d]pyrimidine | ESD-898560-100MG |
Cas.: 1353101-37-7 | Purity: 97% | 7-Chlorothiazolo[4,5-d]pyrimidine | ESD-898560-250MG |
Cas.: 1353101-37-7 | Purity: 97% | 7-Chlorothiazolo[4,5-d]pyrimidine | ESD-898560-1G |
Cas.: 211172-52-0 | Purity: 97% | 2-Amino-3-hydroxybenzonitrile | ESD-898561-100MG |
Cas.: 211172-52-0 | Purity: 97% | 2-Amino-3-hydroxybenzonitrile | ESD-898561-250MG |
Cas.: 211172-52-0 | Purity: 97% | 2-Amino-3-hydroxybenzonitrile | ESD-898561-1G |
Cas.: 929632-63-3 | Purity: 97% | 1-Methylpiperidine-4-sulfonamide | ESD-898562-100MG |
Cas.: 929632-63-3 | Purity: 97% | 1-Methylpiperidine-4-sulfonamide | ESD-898562-250MG |
Cas.: 929632-63-3 | Purity: 97% | 1-Methylpiperidine-4-sulfonamide | ESD-898562-1G |
Cas.: 70665-05-3 | Purity: 97% | (S)-2-Phenylpiperidine | ESD-898563-100MG |
Cas.: 70665-05-3 | Purity: 97% | (S)-2-Phenylpiperidine | ESD-898563-250MG |
Cas.: 70665-05-3 | Purity: 97% | (S)-2-Phenylpiperidine | ESD-898563-1G |
Cas.: 929642-58-0 | Purity: ≥95% | (S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride | ESD-898564-100MG |
Cas.: 929642-58-0 | Purity: ≥95% | (S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride | ESD-898564-250MG |
Cas.: 929642-58-0 | Purity: ≥95% | (S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride | ESD-898564-1G |
Cas.: 318515-70-7 | Purity: 97% | Ethyl (4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonylcarbamate | ESD-898565-100MG |
Cas.: 318515-70-7 | Purity: 97% | Ethyl (4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonylcarbamate | ESD-898565-250MG |
Cas.: 318515-70-7 | Purity: 97% | Ethyl (4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonylcarbamate | ESD-898565-1G |
Cas.: 907973-43-7 | Purity: ≥95% | 5-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898566-100MG |
Cas.: 907973-43-7 | Purity: ≥95% | 5-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898566-250MG |
Cas.: 907973-43-7 | Purity: ≥95% | 5-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898566-1G |
Cas.: 102677-73-6 | Purity: ≥95% | 3-(Aminomethyl)-4-methoxyaniline dihydrochloride | ESD-898567-100MG |
Cas.: 102677-73-6 | Purity: ≥95% | 3-(Aminomethyl)-4-methoxyaniline dihydrochloride | ESD-898567-250MG |
Cas.: 102677-73-6 | Purity: ≥95% | 3-(Aminomethyl)-4-methoxyaniline dihydrochloride | ESD-898567-1G |
Cas.: 1581754-84-8 | Purity: 95% | 6-Chloro-3,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-898568-100MG |
Cas.: 1581754-84-8 | Purity: 95% | 6-Chloro-3,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-898568-250MG |
Cas.: 1581754-84-8 | Purity: 95% | 6-Chloro-3,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-898568-1G |
Cas.: 1211528-24-3 | Purity: ≥95% | 5-Fluoropyrimidine-4-carboxylic acid | ESD-898569-100MG |
Cas.: 1211528-24-3 | Purity: ≥95% | 5-Fluoropyrimidine-4-carboxylic acid | ESD-898569-250MG |
Cas.: 1211528-24-3 | Purity: ≥95% | 5-Fluoropyrimidine-4-carboxylic acid | ESD-898569-1G |
Cas.: 1093192-07-4 | Purity: ≥95% | (S)-Methyl 2-amino-3-((tert-butoxycarbonyl)amino)-3-methylbutanoate | ESD-898570-100MG |
Cas.: 1093192-07-4 | Purity: ≥95% | (S)-Methyl 2-amino-3-((tert-butoxycarbonyl)amino)-3-methylbutanoate | ESD-898570-250MG |
Cas.: 1093192-07-4 | Purity: ≥95% | (S)-Methyl 2-amino-3-((tert-butoxycarbonyl)amino)-3-methylbutanoate | ESD-898570-1G |
Cas.: 405230-90-2 | Purity: 97% | 2-Chloro-5-fluoro-3-nitropyridin-4-amine | ESD-898571-100MG |
Cas.: 405230-90-2 | Purity: 97% | 2-Chloro-5-fluoro-3-nitropyridin-4-amine | ESD-898571-250MG |
Cas.: 405230-90-2 | Purity: 97% | 2-Chloro-5-fluoro-3-nitropyridin-4-amine | ESD-898571-1G |
Cas.: 1044210-57-2 | Purity: ≥95% | 3-Bromo-5-cyclopropylpyridine | ESD-898572-100MG |
Cas.: 1044210-57-2 | Purity: ≥95% | 3-Bromo-5-cyclopropylpyridine | ESD-898572-250MG |
Cas.: 1044210-57-2 | Purity: ≥95% | 3-Bromo-5-cyclopropylpyridine | ESD-898572-1G |
Cas.: 1211516-18-5 | Purity: 97% | 6-Bromo-3-methylpicolinic acid | ESD-898573-100MG |
Cas.: 1211516-18-5 | Purity: 97% | 6-Bromo-3-methylpicolinic acid | ESD-898573-250MG |
Cas.: 1211516-18-5 | Purity: 97% | 6-Bromo-3-methylpicolinic acid | ESD-898573-1G |
Cas.: 952737-54-1 | Purity: 97% | (6-Methoxybenzofuran-2-yl)boronic acid | ESD-898574-100MG |
Cas.: 952737-54-1 | Purity: 97% | (6-Methoxybenzofuran-2-yl)boronic acid | ESD-898574-250MG |
Cas.: 952737-54-1 | Purity: 97% | (6-Methoxybenzofuran-2-yl)boronic acid | ESD-898574-1G |
Cas.: 289483-82-5 | Purity: ≥95% | 4-Methyl-7-nitro-1H-indole-3-carbonitrile | ESD-898575-100MG |
Cas.: 289483-82-5 | Purity: ≥95% | 4-Methyl-7-nitro-1H-indole-3-carbonitrile | ESD-898575-250MG |
Cas.: 289483-82-5 | Purity: ≥95% | 4-Methyl-7-nitro-1H-indole-3-carbonitrile | ESD-898575-1G |
Cas.: 1965310-19-3 | Purity: 97% | tert-Butyl (2-methyloxazol-5-yl)carbamate | ESD-898576-100MG |
Cas.: 1965310-19-3 | Purity: 97% | tert-Butyl (2-methyloxazol-5-yl)carbamate | ESD-898576-250MG |
Cas.: 1965310-19-3 | Purity: 97% | tert-Butyl (2-methyloxazol-5-yl)carbamate | ESD-898576-1G |
Cas.: 1266322-58-0 | Purity: 98% | 7-Bromoquinolin-3-amine | ESD-898577-100MG |
Cas.: 1266322-58-0 | Purity: 98% | 7-Bromoquinolin-3-amine | ESD-898577-250MG |
Cas.: 1266322-58-0 | Purity: 98% | 7-Bromoquinolin-3-amine | ESD-898577-1G |
Cas.: 873893-94-8 | Purity: ≥95% | (1S)-1-(2-Chlorophenyl)propylamine hydrochloride | ESD-898578-100MG |
Cas.: 873893-94-8 | Purity: ≥95% | (1S)-1-(2-Chlorophenyl)propylamine hydrochloride | ESD-898578-250MG |
Cas.: 873893-94-8 | Purity: ≥95% | (1S)-1-(2-Chlorophenyl)propylamine hydrochloride | ESD-898578-1G |
Cas.: 475272-62-9 | Purity: 97% | 6-Methoxy-5-nitropicolinic acid | ESD-898579-100MG |
Cas.: 475272-62-9 | Purity: 97% | 6-Methoxy-5-nitropicolinic acid | ESD-898579-250MG |
Cas.: 475272-62-9 | Purity: 97% | 6-Methoxy-5-nitropicolinic acid | ESD-898579-1G |
Cas.: 214973-83-8 | Purity: ≥95% | tert-Butyl 2-(4-bromophenyl)propan-2-ylcarbamate | ESD-898580-100MG |
Cas.: 139183-89-4 | Purity: ≥95% | Methyl imidazo[1,5-a]pyridine-6-carboxylate | ESD-898581-100MG |
Cas.: 139183-89-4 | Purity: ≥95% | Methyl imidazo[1,5-a]pyridine-6-carboxylate | ESD-898581-250MG |
Cas.: 139183-89-4 | Purity: ≥95% | Methyl imidazo[1,5-a]pyridine-6-carboxylate | ESD-898581-1G |
Cas.: 131665-94-6 | Purity: 95% | (2-Bromoethoxy)cyclohexane | ESD-898582-100MG |
Cas.: 131665-94-6 | Purity: 95% | (2-Bromoethoxy)cyclohexane | ESD-898582-250MG |
Cas.: 131665-94-6 | Purity: 95% | (2-Bromoethoxy)cyclohexane | ESD-898582-1G |
Cas.: 96-07-1 | Purity: 97% | 2-Isopropylcyclohexan-1-ol | ESD-898583-100MG |
Cas.: 96-07-1 | Purity: 97% | 2-Isopropylcyclohexan-1-ol | ESD-898583-250MG |
Cas.: 96-07-1 | Purity: 97% | 2-Isopropylcyclohexan-1-ol | ESD-898583-1G |
Cas.: 84639-84-9 | Purity: 97% | 7-Hydroxyindole-2-carboxylic acid | ESD-898584-100MG |
Cas.: 84639-84-9 | Purity: 97% | 7-Hydroxyindole-2-carboxylic acid | ESD-898584-250MG |
Cas.: 84639-84-9 | Purity: 97% | 7-Hydroxyindole-2-carboxylic acid | ESD-898584-1G |
Cas.: 181147-94-4 | Purity: 97% | 2-Bromo-7-fluoroquinoline | ESD-898585-100MG |
Cas.: 181147-94-4 | Purity: 97% | 2-Bromo-7-fluoroquinoline | ESD-898585-250MG |
Cas.: 181147-94-4 | Purity: 97% | 2-Bromo-7-fluoroquinoline | ESD-898585-1G |
Cas.: 42070-92-8 | Purity: 95% | (R)-1-(p-Tolyl)ethan-1-ol | ESD-898586-100MG |
Cas.: 42070-92-8 | Purity: 95% | (R)-1-(p-Tolyl)ethan-1-ol | ESD-898586-250MG |
Cas.: 42070-92-8 | Purity: 95% | (R)-1-(p-Tolyl)ethan-1-ol | ESD-898586-1G |
Cas.: 1220696-38-7 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | ESD-898587-100MG |
Cas.: 1220696-38-7 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | ESD-898587-250MG |
Cas.: 1220696-38-7 | Purity: ≥95% | 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | ESD-898587-1G |
Cas.: 1255095-03-4 | Purity: ≥95% | tert-Butyl (2-bromo-4-methylthiazol-5-yl)carbamate | ESD-898588-100MG |
Cas.: 1255095-03-4 | Purity: ≥95% | tert-Butyl (2-bromo-4-methylthiazol-5-yl)carbamate | ESD-898588-250MG |
Cas.: 1255095-03-4 | Purity: ≥95% | tert-Butyl (2-bromo-4-methylthiazol-5-yl)carbamate | ESD-898588-1G |
Cas.: 459448-06-7 | Purity: 97% | 6-Bromo-3-isopropyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-898589-100MG |
Cas.: 459448-06-7 | Purity: 97% | 6-Bromo-3-isopropyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-898589-250MG |
Cas.: 459448-06-7 | Purity: 97% | 6-Bromo-3-isopropyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-898589-1G |
Cas.: 1588441-15-9 | Purity: ≥95% | 1-Methyl-1H-imidazol-5-amine hydrochloride | ESD-898590-100MG |
Cas.: 1588441-15-9 | Purity: ≥95% | 1-Methyl-1H-imidazol-5-amine hydrochloride | ESD-898590-250MG |
Cas.: 1588441-15-9 | Purity: ≥95% | 1-Methyl-1H-imidazol-5-amine hydrochloride | ESD-898590-1G |
Cas.: 25412-53-7 | Purity: 95% | 4-Acetamidobenzylamine | ESD-898591-100MG |
Cas.: 25412-53-7 | Purity: 95% | 4-Acetamidobenzylamine | ESD-898591-250MG |
Cas.: 25412-53-7 | Purity: 95% | 4-Acetamidobenzylamine | ESD-898591-1G |
Cas.: 137102-30-8 | Purity: 95% | (S)-tert-Butyl (2-amino-1-phenylethyl)carbamate | ESD-898592-100MG |
Cas.: 137102-30-8 | Purity: 95% | (S)-tert-Butyl (2-amino-1-phenylethyl)carbamate | ESD-898592-250MG |
Cas.: 137102-30-8 | Purity: 95% | (S)-tert-Butyl (2-amino-1-phenylethyl)carbamate | ESD-898592-1G |
Cas.: 151899-62-6 | Purity: 97% | 3-Iodo-1-trityl-1H-1,2,4-triazole | ESD-898593-100MG |
Cas.: 151899-62-6 | Purity: 97% | 3-Iodo-1-trityl-1H-1,2,4-triazole | ESD-898593-250MG |
Cas.: 151899-62-6 | Purity: 97% | 3-Iodo-1-trityl-1H-1,2,4-triazole | ESD-898593-1G |
Cas.: 1072438-56-2 | Purity: 95% | Methyl 6-(aminomethyl)nicotinate hydrochloride | ESD-898594-100MG |
Cas.: 1072438-56-2 | Purity: 95% | Methyl 6-(aminomethyl)nicotinate hydrochloride | ESD-898594-250MG |
Cas.: 1072438-56-2 | Purity: 95% | Methyl 6-(aminomethyl)nicotinate hydrochloride | ESD-898594-1G |
Cas.: 1395281-64-7 | Purity: 97% | 3-(3,5-Difluorophenyl)oxetan-3-ol | ESD-898595-100MG |
Cas.: 1395281-64-7 | Purity: 97% | 3-(3,5-Difluorophenyl)oxetan-3-ol | ESD-898595-250MG |
Cas.: 1395281-64-7 | Purity: 97% | 3-(3,5-Difluorophenyl)oxetan-3-ol | ESD-898595-1G |
Cas.: 916421-36-8 | Purity: ≥95% | tert-Butyl 3-(4-aminophenyl)azetidine-1-carboxylate | ESD-898596-100MG |
Cas.: 916421-36-8 | Purity: ≥95% | tert-Butyl 3-(4-aminophenyl)azetidine-1-carboxylate | ESD-898596-250MG |
Cas.: 916421-36-8 | Purity: ≥95% | tert-Butyl 3-(4-aminophenyl)azetidine-1-carboxylate | ESD-898596-1G |
Cas.: 105684-53-5 | Purity: ≥95% | 4-(Piperazin-1-yl)-1H-indazole | ESD-898597-100MG |
Cas.: 105684-53-5 | Purity: ≥95% | 4-(Piperazin-1-yl)-1H-indazole | ESD-898597-250MG |
Cas.: 105684-53-5 | Purity: ≥95% | 4-(Piperazin-1-yl)-1H-indazole | ESD-898597-1G |
Cas.: 953411-16-0 | Purity: 96% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazol-3-amine | ESD-898599-100MG |
Cas.: 953411-16-0 | Purity: 96% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazol-3-amine | ESD-898599-250MG |
Cas.: 953411-16-0 | Purity: 96% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazol-3-amine | ESD-898599-1G |
Cas.: 1354893-21-2 | Purity: ≥95% | 6,7,8,9-Tetrahydro-5H-pyrrolo[2,3-b:5,4-c’]dipyridine | ESD-898600-100MG |
Cas.: 1354893-21-2 | Purity: ≥95% | 6,7,8,9-Tetrahydro-5H-pyrrolo[2,3-b:5,4-c’]dipyridine | ESD-898600-250MG |
Cas.: 1354893-21-2 | Purity: ≥95% | 6,7,8,9-Tetrahydro-5H-pyrrolo[2,3-b:5,4-c’]dipyridine | ESD-898600-1G |
Cas.: 527681-33-0 | Purity: ≥95% | Chroman-7-carboxylic acid | ESD-898601-100MG |
Cas.: 527681-33-0 | Purity: ≥95% | Chroman-7-carboxylic acid | ESD-898601-250MG |
Cas.: 527681-33-0 | Purity: ≥95% | Chroman-7-carboxylic acid | ESD-898601-1G |
Cas.: 1032528-06-5 | Purity: 97% | tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate | ESD-898602-100MG |
Cas.: 1032528-06-5 | Purity: 97% | tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate | ESD-898602-250MG |
Cas.: 1032528-06-5 | Purity: 97% | tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate | ESD-898602-1G |
Cas.: 1429056-39-2 | Purity: ≥95% | 5-(Piperazin-1-yl)pyrimidine hydrochloride | ESD-898603-100MG |
Cas.: 1429056-39-2 | Purity: ≥95% | 5-(Piperazin-1-yl)pyrimidine hydrochloride | ESD-898603-250MG |
Cas.: 1429056-39-2 | Purity: ≥95% | 5-(Piperazin-1-yl)pyrimidine hydrochloride | ESD-898603-1G |
Cas.: 1211534-27-8 | Purity: 96% | 5-Fluoro-2-methoxy-3-nitropyridine | ESD-898604-100MG |
Cas.: 1211534-27-8 | Purity: 96% | 5-Fluoro-2-methoxy-3-nitropyridine | ESD-898604-250MG |
Cas.: 1211534-27-8 | Purity: 96% | 5-Fluoro-2-methoxy-3-nitropyridine | ESD-898604-1G |
Cas.: 799274-06-9 | Purity: ≥95% | 7-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-898605-100MG |
Cas.: 799274-06-9 | Purity: ≥95% | 7-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-898605-250MG |
Cas.: 799274-06-9 | Purity: ≥95% | 7-Fluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-898605-1G |
Cas.: 10603-45-9 | Purity: ≥95% | 3-Bromo-1-methylpyrrolidine | ESD-898606-100MG |
Cas.: 10603-45-9 | Purity: ≥95% | 3-Bromo-1-methylpyrrolidine | ESD-898606-250MG |
Cas.: 10603-45-9 | Purity: ≥95% | 3-Bromo-1-methylpyrrolidine | ESD-898606-1G |
Cas.: 15128-89-9 | Purity: 97% | 3-Hydroxy-4-methyl-2-nitropyridine | ESD-898607-100MG |
Cas.: 15128-89-9 | Purity: 97% | 3-Hydroxy-4-methyl-2-nitropyridine | ESD-898607-250MG |
Cas.: 15128-89-9 | Purity: 97% | 3-Hydroxy-4-methyl-2-nitropyridine | ESD-898607-1G |
Cas.: 120003-75-0 | Purity: ≥95% | 2-Chloro-5,6-dimethylnicotinic acid | ESD-898608-100MG |
Cas.: 120003-75-0 | Purity: ≥95% | 2-Chloro-5,6-dimethylnicotinic acid | ESD-898608-250MG |
Cas.: 120003-75-0 | Purity: ≥95% | 2-Chloro-5,6-dimethylnicotinic acid | ESD-898608-1G |
Cas.: 1434126-96-1 | Purity: ≥95% | (3S,4S)-tert-Butyl 3-amino-4-methylpiperidine-1-carboxylate | ESD-898609-100MG |
Cas.: 1434126-96-1 | Purity: ≥95% | (3S,4S)-tert-Butyl 3-amino-4-methylpiperidine-1-carboxylate | ESD-898609-250MG |
Cas.: 1434126-96-1 | Purity: ≥95% | (3S,4S)-tert-Butyl 3-amino-4-methylpiperidine-1-carboxylate | ESD-898609-1G |
Cas.: 59347-91-0 | Purity: 97% | (S)-2-Phenylpyrrolidine | ESD-898610-100MG |
Cas.: 59347-91-0 | Purity: 97% | (S)-2-Phenylpyrrolidine | ESD-898610-250MG |
Cas.: 59347-91-0 | Purity: 97% | (S)-2-Phenylpyrrolidine | ESD-898610-1G |
Cas.: 56523-58-1 | Purity: ≥95% | (S)-2-Phenylpyrrolidine hydrochloride | ESD-898611-100MG |
Cas.: 56523-58-1 | Purity: ≥95% | (S)-2-Phenylpyrrolidine hydrochloride | ESD-898611-250MG |
Cas.: 56523-58-1 | Purity: ≥95% | (S)-2-Phenylpyrrolidine hydrochloride | ESD-898611-1G |
Cas.: 331763-75-8 | Purity: ≥95% | (R)-4-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-898612-100MG |
Cas.: 331763-75-8 | Purity: ≥95% | (R)-4-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-898612-250MG |
Cas.: 331763-75-8 | Purity: ≥95% | (R)-4-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-898612-1G |
Cas.: 162100-95-0 | Purity: 98% | 6-Fluoro-5-methyl-1H-indole | ESD-898613-100MG |
Cas.: 162100-95-0 | Purity: 98% | 6-Fluoro-5-methyl-1H-indole | ESD-898613-250MG |
Cas.: 162100-95-0 | Purity: 98% | 6-Fluoro-5-methyl-1H-indole | ESD-898613-1G |
Cas.: 1083326-75-3 | Purity: ≥95% | N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide | ESD-898614-100MG |
Cas.: 1083326-75-3 | Purity: ≥95% | N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide | ESD-898614-250MG |
Cas.: 1083326-75-3 | Purity: ≥95% | N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide | ESD-898614-1G |
Cas.: 1190320-20-7 | Purity: ≥95% | 6-Methoxy-3-nitro-1H-pyrrolo[3,2-c]pyridine | ESD-898615-100MG |
Cas.: 1190320-20-7 | Purity: ≥95% | 6-Methoxy-3-nitro-1H-pyrrolo[3,2-c]pyridine | ESD-898615-250MG |
Cas.: 1190320-20-7 | Purity: ≥95% | 6-Methoxy-3-nitro-1H-pyrrolo[3,2-c]pyridine | ESD-898615-1G |
Cas.: 1263281-14-6 | Purity: 95% | tert-Butyl 2-bromo-5-fluorobenzoate | ESD-898616-100MG |
Cas.: 1263281-14-6 | Purity: 95% | tert-Butyl 2-bromo-5-fluorobenzoate | ESD-898616-250MG |
Cas.: 1263281-14-6 | Purity: 95% | tert-Butyl 2-bromo-5-fluorobenzoate | ESD-898616-1G |
Cas.: 127724-75-8 | Purity: ≥95% | 3-Chloro-7,8-dihydroquinolin-5(6H)-one | ESD-898617-100MG |
Cas.: 127724-75-8 | Purity: ≥95% | 3-Chloro-7,8-dihydroquinolin-5(6H)-one | ESD-898617-250MG |
Cas.: 127724-75-8 | Purity: ≥95% | 3-Chloro-7,8-dihydroquinolin-5(6H)-one | ESD-898617-1G |
Cas.: 156001-49-9 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-methylbenzene | ESD-898618-100MG |
Cas.: 156001-49-9 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-methylbenzene | ESD-898618-250MG |
Cas.: 156001-49-9 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-methylbenzene | ESD-898618-1G |
Cas.: 156390-35-1 | Purity: 98% | Methyl 4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylate | ESD-898619-100MG |
Cas.: 156390-35-1 | Purity: 98% | Methyl 4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylate | ESD-898619-250MG |
Cas.: 156390-35-1 | Purity: 98% | Methyl 4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylate | ESD-898619-1G |
Cas.: 1131007-43-6 | Purity: 98% | 6-(Difluoromethoxy)pyridin-2-amine | ESD-898620-100MG |
Cas.: 1131007-43-6 | Purity: 98% | 6-(Difluoromethoxy)pyridin-2-amine | ESD-898620-250MG |
Cas.: 1131007-43-6 | Purity: 98% | 6-(Difluoromethoxy)pyridin-2-amine | ESD-898620-1G |
Cas.: 1416354-35-2 | Purity: 97% | (2-Amino-2,3-dihydro-1H-inden-2-yl)phosphonic acid hydrochloride | ESD-898621-100MG |
Cas.: 1416354-35-2 | Purity: 97% | (2-Amino-2,3-dihydro-1H-inden-2-yl)phosphonic acid hydrochloride | ESD-898621-250MG |
Cas.: 102153-48-0 | Purity: 96% | 6-Bromo-1-nitronaphthalene | ESD-898622-100MG |
Cas.: 102153-48-0 | Purity: 96% | 6-Bromo-1-nitronaphthalene | ESD-898622-250MG |
Cas.: 102153-48-0 | Purity: 96% | 6-Bromo-1-nitronaphthalene | ESD-898622-1G |
Cas.: 4926-54-9 | Purity: 97% | 5-Bromo-3-methylimidazo[1,2-a]pyridine | ESD-898623-100MG |
Cas.: 4926-54-9 | Purity: 97% | 5-Bromo-3-methylimidazo[1,2-a]pyridine | ESD-898623-250MG |
Cas.: 4926-54-9 | Purity: 97% | 5-Bromo-3-methylimidazo[1,2-a]pyridine | ESD-898623-1G |
Cas.: 1326714-93-5 | Purity: 97% | 3-Bromo-2,4-difluorobenzaldehyde | ESD-898624-100MG |
Cas.: 1326714-93-5 | Purity: 97% | 3-Bromo-2,4-difluorobenzaldehyde | ESD-898624-250MG |
Cas.: 1326714-93-5 | Purity: 97% | 3-Bromo-2,4-difluorobenzaldehyde | ESD-898624-1G |
Cas.: 53871-08-2 | Purity: 97% | tert-Butyl azetidine-3-carboxylate hydrochloride | ESD-898625-100MG |
Cas.: 53871-08-2 | Purity: 97% | tert-Butyl azetidine-3-carboxylate hydrochloride | ESD-898625-250MG |
Cas.: 53871-08-2 | Purity: 97% | tert-Butyl azetidine-3-carboxylate hydrochloride | ESD-898625-1G |
Cas.: 213990-48-8 | Purity: 97% | (S)-tert-Butyl azepan-3-ylcarbamate | ESD-898626-100MG |
Cas.: 213990-48-8 | Purity: 97% | (S)-tert-Butyl azepan-3-ylcarbamate | ESD-898626-250MG |
Cas.: 213990-48-8 | Purity: 97% | (S)-tert-Butyl azepan-3-ylcarbamate | ESD-898626-1G |
Cas.: 1260007-55-3 | Purity: ≥95% | 5-Bromo-6-fluoro-3,4-dihydronaphthalen-1(2H)-one | ESD-898627-100MG |
Cas.: 1260007-55-3 | Purity: ≥95% | 5-Bromo-6-fluoro-3,4-dihydronaphthalen-1(2H)-one | ESD-898627-250MG |
Cas.: 1260007-55-3 | Purity: ≥95% | 5-Bromo-6-fluoro-3,4-dihydronaphthalen-1(2H)-one | ESD-898627-1G |
Cas.: 1207839-86-8 | Purity: 98% | 4-Bromo-6-methoxypyrazolo[1,5-a]pyridine | ESD-898628-100MG |
Cas.: 1207839-86-8 | Purity: 98% | 4-Bromo-6-methoxypyrazolo[1,5-a]pyridine | ESD-898628-250MG |
Cas.: 1207839-86-8 | Purity: 98% | 4-Bromo-6-methoxypyrazolo[1,5-a]pyridine | ESD-898628-1G |
Cas.: 1029720-75-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrido[3,4-d]pyrimidine | ESD-898629-100MG |
Cas.: 1029720-75-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrido[3,4-d]pyrimidine | ESD-898629-250MG |
Cas.: 1029720-75-9 | Purity: 97% | 4,6-Dichloro-2-methylpyrido[3,4-d]pyrimidine | ESD-898629-1G |
Cas.: 1246765-28-5 | Purity: ≥95% | (3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)boronic acid | ESD-898630-100MG |
Cas.: 1246765-28-5 | Purity: ≥95% | (3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)boronic acid | ESD-898630-250MG |
Cas.: 1246765-28-5 | Purity: ≥95% | (3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)boronic acid | ESD-898630-1G |
Cas.: 59916-75-5 | Purity: 97% | Diethyl 2-isopropyl-3-oxosuccinate | ESD-898631-100MG |
Cas.: 59916-75-5 | Purity: 97% | Diethyl 2-isopropyl-3-oxosuccinate | ESD-898631-250MG |
Cas.: 59916-75-5 | Purity: 97% | Diethyl 2-isopropyl-3-oxosuccinate | ESD-898631-1G |
Cas.: 31040-15-0 | Purity: ≥95% | 6-Nitro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-898632-100MG |
Cas.: 31040-15-0 | Purity: ≥95% | 6-Nitro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-898632-250MG |
Cas.: 31040-15-0 | Purity: ≥95% | 6-Nitro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | ESD-898632-1G |
Cas.: 1001412-41-4 | Purity: ≥95% | 5,7-Dichloro-1H-pyrrolo[2,3-c]pyridine | ESD-898633-100MG |
Cas.: 1001412-41-4 | Purity: ≥95% | 5,7-Dichloro-1H-pyrrolo[2,3-c]pyridine | ESD-898633-250MG |
Cas.: 1001412-41-4 | Purity: ≥95% | 5,7-Dichloro-1H-pyrrolo[2,3-c]pyridine | ESD-898633-1G |
Cas.: 101252-84-0 | Purity: 97% | 4,6-Dichloro-2,3-dimethylpyridine | ESD-898634-100MG |
Cas.: 101252-84-0 | Purity: 97% | 4,6-Dichloro-2,3-dimethylpyridine | ESD-898634-250MG |
Cas.: 101252-84-0 | Purity: 97% | 4,6-Dichloro-2,3-dimethylpyridine | ESD-898634-1G |
Cas.: 1333319-76-8 | Purity: 97% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol | ESD-898635-100MG |
Cas.: 1333319-76-8 | Purity: 97% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol | ESD-898635-250MG |
Cas.: 1333319-76-8 | Purity: 97% | 3-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol | ESD-898635-1G |
Cas.: 1286693-23-9 | Purity: ≥95% | (R)-3-(1-Aminoethyl)benzonitrile hydrochloride | ESD-898636-100MG |
Cas.: 1286693-23-9 | Purity: ≥95% | (R)-3-(1-Aminoethyl)benzonitrile hydrochloride | ESD-898636-250MG |
Cas.: 1286693-23-9 | Purity: ≥95% | (R)-3-(1-Aminoethyl)benzonitrile hydrochloride | ESD-898636-1G |
Cas.: 1240583-48-5 | Purity: 95% | (S)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-898637-100MG |
Cas.: 1240583-48-5 | Purity: 95% | (S)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-898637-250MG |
Cas.: 1240583-48-5 | Purity: 95% | (S)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-898637-1G |
Cas.: 1160248-06-5 | Purity: ≥95% | Ethyl 8-chloroimidazo[1,5-a]pyrazine-1-carboxylate | ESD-898638-100MG |
Cas.: 1160248-06-5 | Purity: ≥95% | Ethyl 8-chloroimidazo[1,5-a]pyrazine-1-carboxylate | ESD-898638-250MG |
Cas.: 1160248-06-5 | Purity: ≥95% | Ethyl 8-chloroimidazo[1,5-a]pyrazine-1-carboxylate | ESD-898638-1G |
Cas.: 1416354-93-2 | Purity: 97% | (S)-2-Amino-1-(pyridin-3-yl)ethanol hydrochloride | ESD-898639-100MG |
Cas.: 1416354-93-2 | Purity: 97% | (S)-2-Amino-1-(pyridin-3-yl)ethanol hydrochloride | ESD-898639-250MG |
Cas.: 1416354-93-2 | Purity: 97% | (S)-2-Amino-1-(pyridin-3-yl)ethanol hydrochloride | ESD-898639-1G |
Cas.: 1260814-20-7 | Purity: 95% | 4-Cyano-2-iodobenzoic acid | ESD-898640-100MG |
Cas.: 1260814-20-7 | Purity: 95% | 4-Cyano-2-iodobenzoic acid | ESD-898640-250MG |
Cas.: 1260814-20-7 | Purity: 95% | 4-Cyano-2-iodobenzoic acid | ESD-898640-1G |
Cas.: 89796-22-5 | Purity: 97% | 1-(2-Bromoethyl)piperidine hydrobromide | ESD-898641-100MG |
Cas.: 89796-22-5 | Purity: 97% | 1-(2-Bromoethyl)piperidine hydrobromide | ESD-898641-250MG |
Cas.: 89796-22-5 | Purity: 97% | 1-(2-Bromoethyl)piperidine hydrobromide | ESD-898641-1G |
Cas.: 1294481-82-5 | Purity: 97% | (2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-(((4-chlorobenzoyl)oxy)methyl)-4-fluoro-4- methyltetrahydrofuran-3-yl 4-chlorobenzoate | ESD-898642-100MG |
Cas.: 1294481-82-5 | Purity: 97% | (2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-(((4-chlorobenzoyl)oxy)methyl)-4-fluoro-4- methyltetrahydrofuran-3-yl 4-chlorobenzoate | ESD-898642-250MG |
Cas.: 449175-43-3 | Purity: 97% | 1,2,3,4-Tetrahydro-2,6-naphthyridine dihydrochloride | ESD-898643-100MG |
Cas.: 449175-43-3 | Purity: 97% | 1,2,3,4-Tetrahydro-2,6-naphthyridine dihydrochloride | ESD-898643-250MG |
Cas.: 449175-43-3 | Purity: 97% | 1,2,3,4-Tetrahydro-2,6-naphthyridine dihydrochloride | ESD-898643-1G |
Cas.: 1093651-96-7 | Purity: ≥95% | (2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-phenylpyrrolidine-2-carboxylic acid | ESD-898644-100MG |
Cas.: 1093651-96-7 | Purity: ≥95% | (2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-phenylpyrrolidine-2-carboxylic acid | ESD-898644-250MG |
Cas.: 1093651-96-7 | Purity: ≥95% | (2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-phenylpyrrolidine-2-carboxylic acid | ESD-898644-1G |
Cas.: 933717-06-7 | Purity: ≥95% | 2-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-898645-100MG |
Cas.: 933717-06-7 | Purity: ≥95% | 2-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-898645-250MG |
Cas.: 933717-06-7 | Purity: ≥95% | 2-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-898645-1G |
Cas.: 1186608-83-2 | Purity: 97% | 3-Bromo-5-nitro-1H-pyrazolo[3,4-b]pyridine | ESD-898646-100MG |
Cas.: 1186608-83-2 | Purity: 97% | 3-Bromo-5-nitro-1H-pyrazolo[3,4-b]pyridine | ESD-898646-250MG |
Cas.: 1186608-83-2 | Purity: 97% | 3-Bromo-5-nitro-1H-pyrazolo[3,4-b]pyridine | ESD-898646-1G |
Cas.: 854214-59-8 | Purity: ≥95% | 4-Aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride | ESD-898647-100MG |
Cas.: 854214-59-8 | Purity: ≥95% | 4-Aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride | ESD-898647-250MG |
Cas.: 854214-59-8 | Purity: ≥95% | 4-Aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride | ESD-898647-1G |
Cas.: 882517-92-2 | Purity: ≥95% | 9-Bromo-[1,2,4]triazolo[1,5-c]quinazolin-5(6H)-one | ESD-898648-100MG |
Cas.: 882517-92-2 | Purity: ≥95% | 9-Bromo-[1,2,4]triazolo[1,5-c]quinazolin-5(6H)-one | ESD-898648-250MG |
Cas.: 882517-92-2 | Purity: ≥95% | 9-Bromo-[1,2,4]triazolo[1,5-c]quinazolin-5(6H)-one | ESD-898648-1G |
Cas.: 264122-82-9 | Purity: ≥95% | 4-(4-Fluorophenyl)pyrrolidin-2-one | ESD-898649-100MG |
Cas.: 264122-82-9 | Purity: ≥95% | 4-(4-Fluorophenyl)pyrrolidin-2-one | ESD-898649-250MG |
Cas.: 264122-82-9 | Purity: ≥95% | 4-(4-Fluorophenyl)pyrrolidin-2-one | ESD-898649-1G |
Cas.: 871254-62-5 | Purity: ≥95% | 1-(2,4-Dichloropyrimidin-5-yl)ethanone | ESD-898650-100MG |
Cas.: 871254-62-5 | Purity: ≥95% | 1-(2,4-Dichloropyrimidin-5-yl)ethanone | ESD-898650-250MG |
Cas.: 881205-08-9 | Purity: ≥95% | 1-(4-Chloropyridin-2-yl)-N-methylmethanamine | ESD-898651-100MG |
Cas.: 881205-08-9 | Purity: ≥95% | 1-(4-Chloropyridin-2-yl)-N-methylmethanamine | ESD-898651-250MG |
Cas.: 881205-08-9 | Purity: ≥95% | 1-(4-Chloropyridin-2-yl)-N-methylmethanamine | ESD-898651-1G |
Cas.: 1214344-15-6 | Purity: ≥95% | 2,6-Dibromo-4-fluoropyridine | ESD-898652-100MG |
Cas.: 1214344-15-6 | Purity: ≥95% | 2,6-Dibromo-4-fluoropyridine | ESD-898652-250MG |
Cas.: 1214344-15-6 | Purity: ≥95% | 2,6-Dibromo-4-fluoropyridine | ESD-898652-1G |
Cas.: 197844-23-8 | Purity: 95% | (4-Ethynylphenyl)methanamine | ESD-898653-100MG |
Cas.: 197844-23-8 | Purity: 95% | (4-Ethynylphenyl)methanamine | ESD-898653-250MG |
Cas.: 197844-23-8 | Purity: 95% | (4-Ethynylphenyl)methanamine | ESD-898653-1G |
Cas.: 78222-09-0 | Purity: 97% | 1,3,7-Triazaspiro[4.5]decane-2,4-dione | ESD-898654-100MG |
Cas.: 78222-09-0 | Purity: 97% | 1,3,7-Triazaspiro[4.5]decane-2,4-dione | ESD-898654-250MG |
Cas.: 78222-09-0 | Purity: 97% | 1,3,7-Triazaspiro[4.5]decane-2,4-dione | ESD-898654-1G |
Cas.: 17702-88-4 | Purity: ≥95% | 2-Aminodecanoic acid | ESD-898655-100MG |
Cas.: 17702-88-4 | Purity: ≥95% | 2-Aminodecanoic acid | ESD-898655-250MG |
Cas.: 17702-88-4 | Purity: ≥95% | 2-Aminodecanoic acid | ESD-898655-1G |
Cas.: 1310383-27-7 | Purity: 97% | (4-(1-Methyl-1H-imidazol-2-yl)phenyl)boronic acid | ESD-898656-100MG |
Cas.: 1310383-27-7 | Purity: 97% | (4-(1-Methyl-1H-imidazol-2-yl)phenyl)boronic acid | ESD-898656-250MG |
Cas.: 1310383-27-7 | Purity: 97% | (4-(1-Methyl-1H-imidazol-2-yl)phenyl)boronic acid | ESD-898656-1G |
Cas.: 13101-83-2 | Purity: ≥95% | 6-Fluoronaphthalen-2-ol | ESD-898657-100MG |
Cas.: 13101-83-2 | Purity: ≥95% | 6-Fluoronaphthalen-2-ol | ESD-898657-250MG |
Cas.: 13101-83-2 | Purity: ≥95% | 6-Fluoronaphthalen-2-ol | ESD-898657-1G |
Cas.: 187143-22-2 | Purity: ≥95% | 6-(Methylsulfonyl)pyridin-3-amine | ESD-898658-100MG |
Cas.: 187143-22-2 | Purity: ≥95% | 6-(Methylsulfonyl)pyridin-3-amine | ESD-898658-250MG |
Cas.: 187143-22-2 | Purity: ≥95% | 6-(Methylsulfonyl)pyridin-3-amine | ESD-898658-1G |
Cas.: 874302-76-8 | Purity: ≥95% | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate | ESD-898659-100MG |
Cas.: 874302-76-8 | Purity: ≥95% | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate | ESD-898659-250MG |
Cas.: 874302-76-8 | Purity: ≥95% | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate | ESD-898659-1G |
Cas.: 1250443-39-0 | Purity: 95% | 6-(Aminomethyl)isoindolin-1-one hydrochloride | ESD-898660-100MG |
Cas.: 1250443-39-0 | Purity: 95% | 6-(Aminomethyl)isoindolin-1-one hydrochloride | ESD-898660-250MG |
Cas.: 1250443-39-0 | Purity: 95% | 6-(Aminomethyl)isoindolin-1-one hydrochloride | ESD-898660-1G |
Cas.: 856965-53-2 | Purity: ≥95% | 3-Cyclopropylpyridin-2(1H)-one | ESD-898661-100MG |
Cas.: 856965-53-2 | Purity: ≥95% | 3-Cyclopropylpyridin-2(1H)-one | ESD-898661-250MG |
Cas.: 856965-53-2 | Purity: ≥95% | 3-Cyclopropylpyridin-2(1H)-one | ESD-898661-1G |
Cas.: 1082041-52-8 | Purity: 98% | 5-Fluoro-7-methyl-1H-indole | ESD-898662-100MG |
Cas.: 1082041-52-8 | Purity: 98% | 5-Fluoro-7-methyl-1H-indole | ESD-898662-250MG |
Cas.: 1082041-52-8 | Purity: 98% | 5-Fluoro-7-methyl-1H-indole | ESD-898662-1G |
Cas.: 1260011-83-3 | Purity: ≥95% | 7-Bromo-6-fluoro-2,3-dihydro-1H-inden-1-one | ESD-898663-100MG |
Cas.: 1260011-83-3 | Purity: ≥95% | 7-Bromo-6-fluoro-2,3-dihydro-1H-inden-1-one | ESD-898663-250MG |
Cas.: 1260011-83-3 | Purity: ≥95% | 7-Bromo-6-fluoro-2,3-dihydro-1H-inden-1-one | ESD-898663-1G |
Cas.: 58613-54-0 | Purity: 97% | (R)-2-Phenylpiperidine | ESD-898664-100MG |
Cas.: 58613-54-0 | Purity: 97% | (R)-2-Phenylpiperidine | ESD-898664-250MG |
Cas.: 58613-54-0 | Purity: 97% | (R)-2-Phenylpiperidine | ESD-898664-1G |
Cas.: 1220418-77-8 | Purity: 97% | Methyl 6-bromoquinoline-3-carboxylate | ESD-898665-100MG |
Cas.: 1220418-77-8 | Purity: 97% | Methyl 6-bromoquinoline-3-carboxylate | ESD-898665-250MG |
Cas.: 1220418-77-8 | Purity: 97% | Methyl 6-bromoquinoline-3-carboxylate | ESD-898665-1G |
Cas.: 1379324-66-9 | Purity: ≥95% | 2-Chlorobenzo[d]thiazole-7-carboxylic acid | ESD-898666-100MG |
Cas.: 1379324-66-9 | Purity: ≥95% | 2-Chlorobenzo[d]thiazole-7-carboxylic acid | ESD-898666-250MG |
Cas.: 1379324-66-9 | Purity: ≥95% | 2-Chlorobenzo[d]thiazole-7-carboxylic acid | ESD-898666-1G |
Cas.: 1167056-46-3 | Purity: 98% | 5-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid | ESD-898667-100MG |
Cas.: 1167056-46-3 | Purity: 98% | 5-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid | ESD-898667-250MG |
Cas.: 1167056-46-3 | Purity: 98% | 5-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid | ESD-898667-1G |
Cas.: 7439-33-0 | Purity: 95% | trans-Cyclobutane-1,3-dicarboxylic acid | ESD-898668-100MG |
Cas.: 7439-33-0 | Purity: 95% | trans-Cyclobutane-1,3-dicarboxylic acid | ESD-898668-250MG |
Cas.: 7439-33-0 | Purity: 95% | trans-Cyclobutane-1,3-dicarboxylic acid | ESD-898668-1G |
Cas.: 956109-56-1 | Purity: ≥95% | (S)-3-Amino-1-methylpiperidin-2-one hydrochloride | ESD-898669-100MG |
Cas.: 956109-56-1 | Purity: ≥95% | (S)-3-Amino-1-methylpiperidin-2-one hydrochloride | ESD-898669-250MG |
Cas.: 956109-56-1 | Purity: ≥95% | (S)-3-Amino-1-methylpiperidin-2-one hydrochloride | ESD-898669-1G |
Cas.: 1502162-73-3 | Purity: 97% | tert-Butyl 4-hydroxy-2,2-dimethylpiperidine-1-carboxylate | ESD-898670-100MG |
Cas.: 1502162-73-3 | Purity: 97% | tert-Butyl 4-hydroxy-2,2-dimethylpiperidine-1-carboxylate | ESD-898670-250MG |
Cas.: 1502162-73-3 | Purity: 97% | tert-Butyl 4-hydroxy-2,2-dimethylpiperidine-1-carboxylate | ESD-898670-1G |
Cas.: 1211519-08-2 | Purity: 97% | 3-Chloro-6-(1H-pyrazol-4-yl)pyridazine | ESD-898671-100MG |
Cas.: 1211519-08-2 | Purity: 97% | 3-Chloro-6-(1H-pyrazol-4-yl)pyridazine | ESD-898671-250MG |
Cas.: 1211519-08-2 | Purity: 97% | 3-Chloro-6-(1H-pyrazol-4-yl)pyridazine | ESD-898671-1G |
Cas.: 1638759-79-1 | Purity: 98% | Methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate | ESD-898672-100MG |
Cas.: 1638759-79-1 | Purity: 98% | Methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate | ESD-898672-250MG |
Cas.: 1638759-79-1 | Purity: 98% | Methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate | ESD-898672-1G |
Cas.: 1445860-57-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine | ESD-898673-100MG |
Cas.: 1445860-57-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine | ESD-898673-250MG |
Cas.: 1445860-57-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine | ESD-898673-1G |
Cas.: 1422057-35-9 | Purity: ≥95% | 5-(Aminomethyl)isoindolin-1-one hydrochloride | ESD-898674-100MG |
Cas.: 1422057-35-9 | Purity: ≥95% | 5-(Aminomethyl)isoindolin-1-one hydrochloride | ESD-898674-250MG |
Cas.: 1422057-35-9 | Purity: ≥95% | 5-(Aminomethyl)isoindolin-1-one hydrochloride | ESD-898674-1G |
Cas.: 350601-39-7 | Purity: 97% | Methyl 4-amino-3,6-dichloropicolinate | ESD-898675-100MG |
Cas.: 350601-39-7 | Purity: 97% | Methyl 4-amino-3,6-dichloropicolinate | ESD-898675-250MG |
Cas.: 350601-39-7 | Purity: 97% | Methyl 4-amino-3,6-dichloropicolinate | ESD-898675-1G |
Cas.: 1290191-71-7 | Purity: 97% | (3S,4S)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate | ESD-898676-100MG |
Cas.: 1290191-71-7 | Purity: 97% | (3S,4S)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate | ESD-898676-250MG |
Cas.: 1290191-71-7 | Purity: 97% | (3S,4S)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate | ESD-898676-1G |
Cas.: 67858-19-9 | Purity: 97% | 6-Methoxychroman-4-amine hydrochloride | ESD-898677-100MG |
Cas.: 67858-19-9 | Purity: 97% | 6-Methoxychroman-4-amine hydrochloride | ESD-898677-250MG |
Cas.: 67858-19-9 | Purity: 97% | 6-Methoxychroman-4-amine hydrochloride | ESD-898677-1G |
Cas.: 1779942-70-9 | Purity: 97% | 8,8-Difluoro-3-azabicyclo[3.2.1]octane hydrochloride | ESD-898678-100MG |
Cas.: 1779942-70-9 | Purity: 97% | 8,8-Difluoro-3-azabicyclo[3.2.1]octane hydrochloride | ESD-898678-250MG |
Cas.: 1779942-70-9 | Purity: 97% | 8,8-Difluoro-3-azabicyclo[3.2.1]octane hydrochloride | ESD-898678-1G |
Cas.: 89607-15-8 | Purity: 97% | 3-Bromo-1-methyl-4-nitro-1H-pyrazole | ESD-898679-100MG |
Cas.: 89607-15-8 | Purity: 97% | 3-Bromo-1-methyl-4-nitro-1H-pyrazole | ESD-898679-250MG |
Cas.: 89607-15-8 | Purity: 97% | 3-Bromo-1-methyl-4-nitro-1H-pyrazole | ESD-898679-1G |
Cas.: 1346599-08-3 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-cyclopropylpiperidine-4-carboxylic acid | ESD-898680-100MG |
Cas.: 1346599-08-3 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-cyclopropylpiperidine-4-carboxylic acid | ESD-898680-250MG |
Cas.: 1346599-08-3 | Purity: 97% | 1-(tert-Butoxycarbonyl)-4-cyclopropylpiperidine-4-carboxylic acid | ESD-898680-1G |
Cas.: 882670-89-5 | Purity: ≥95% | 6-Bromopyrido[2,3-d]pyrimidin-2-amine | ESD-898681-100MG |
Cas.: 882670-89-5 | Purity: ≥95% | 6-Bromopyrido[2,3-d]pyrimidin-2-amine | ESD-898681-250MG |
Cas.: 882670-89-5 | Purity: ≥95% | 6-Bromopyrido[2,3-d]pyrimidin-2-amine | ESD-898681-1G |
Cas.: 909854-16-6 | Purity: 97% | 3-Ethoxypyridin-2(1H)-one | ESD-898682-100MG |
Cas.: 909854-16-6 | Purity: 97% | 3-Ethoxypyridin-2(1H)-one | ESD-898682-250MG |
Cas.: 909854-16-6 | Purity: 97% | 3-Ethoxypyridin-2(1H)-one | ESD-898682-1G |
Cas.: 955400-18-7 | Purity: ≥95% | (R)-3-(Methoxymethyl)pyrrolidine hydrochloride | ESD-898683-100MG |
Cas.: 955400-18-7 | Purity: ≥95% | (R)-3-(Methoxymethyl)pyrrolidine hydrochloride | ESD-898683-250MG |
Cas.: 955400-18-7 | Purity: ≥95% | (R)-3-(Methoxymethyl)pyrrolidine hydrochloride | ESD-898683-1G |
Cas.: 234109-20-7 | Purity: ≥95% | Methyl 6-oxopiperazine-2-carboxylate | ESD-898684-100MG |
Cas.: 234109-20-7 | Purity: ≥95% | Methyl 6-oxopiperazine-2-carboxylate | ESD-898684-250MG |
Cas.: 234109-20-7 | Purity: ≥95% | Methyl 6-oxopiperazine-2-carboxylate | ESD-898684-1G |
Cas.: 1228689-61-9 | Purity: ≥95% | Methyl 5-(4-bromophenyl)-3-methylisoxazole-4-carboxylate | ESD-898685-100MG |
Cas.: 1228689-61-9 | Purity: ≥95% | Methyl 5-(4-bromophenyl)-3-methylisoxazole-4-carboxylate | ESD-898685-250MG |
Cas.: 1228689-61-9 | Purity: ≥95% | Methyl 5-(4-bromophenyl)-3-methylisoxazole-4-carboxylate | ESD-898685-1G |
Cas.: 904886-12-0 | Purity: ≥95% | Benzo[h]quinoline-2-carbaldehyde | ESD-898686-100MG |
Cas.: 904886-12-0 | Purity: ≥95% | Benzo[h]quinoline-2-carbaldehyde | ESD-898686-250MG |
Cas.: 904886-12-0 | Purity: ≥95% | Benzo[h]quinoline-2-carbaldehyde | ESD-898686-1G |
Cas.: 550-89-0 | Purity: 98% | Phenazine-1-carboxamide | ESD-898687-100MG |
Cas.: 550-89-0 | Purity: 98% | Phenazine-1-carboxamide | ESD-898687-250MG |
Cas.: 550-89-0 | Purity: 98% | Phenazine-1-carboxamide | ESD-898687-1G |
Cas.: 19301-35-0 | Purity: 97% | Benzo[b]thiophen-5-ol | ESD-898688-100MG |
Cas.: 19301-35-0 | Purity: 97% | Benzo[b]thiophen-5-ol | ESD-898688-250MG |
Cas.: 19301-35-0 | Purity: 97% | Benzo[b]thiophen-5-ol | ESD-898688-1G |
Cas.: 36369-34-3 | Purity: ≥95% | (R)-2-(((Benzyloxy)carbonyl)amino)-3-fluoropropanoic acid | ESD-898689-100MG |
Cas.: 36369-34-3 | Purity: ≥95% | (R)-2-(((Benzyloxy)carbonyl)amino)-3-fluoropropanoic acid | ESD-898689-250MG |
Cas.: 36369-34-3 | Purity: ≥95% | (R)-2-(((Benzyloxy)carbonyl)amino)-3-fluoropropanoic acid | ESD-898689-1G |
Cas.: 10148-70-6 | Purity: ≥95% | (2S,3S)-2-Amino-3-hydroxy-4-methylpentanoic acid | ESD-898690-100MG |
Cas.: 10148-70-6 | Purity: ≥95% | (2S,3S)-2-Amino-3-hydroxy-4-methylpentanoic acid | ESD-898690-250MG |
Cas.: 10148-70-6 | Purity: ≥95% | (2S,3S)-2-Amino-3-hydroxy-4-methylpentanoic acid | ESD-898690-1G |
Cas.: 944129-00-4 | Purity: ≥95% | Methyl 6-amino-2-chloropyrimidine-4-carboxylate | ESD-898691-100MG |
Cas.: 944129-00-4 | Purity: ≥95% | Methyl 6-amino-2-chloropyrimidine-4-carboxylate | ESD-898691-250MG |
Cas.: 944129-00-4 | Purity: ≥95% | Methyl 6-amino-2-chloropyrimidine-4-carboxylate | ESD-898691-1G |
Cas.: 802559-38-2 | Purity: ≥95% | 5-(Bromomethyl)-2-methylpyrimidine | ESD-898692-100MG |
Cas.: 802559-38-2 | Purity: ≥95% | 5-(Bromomethyl)-2-methylpyrimidine | ESD-898692-250MG |
Cas.: 802559-38-2 | Purity: ≥95% | 5-(Bromomethyl)-2-methylpyrimidine | ESD-898692-1G |
Cas.: 1965310-16-0 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride | ESD-898693-100MG |
Cas.: 1965310-16-0 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride | ESD-898693-250MG |
Cas.: 1965310-16-0 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride | ESD-898693-1G |
Cas.: 693248-55-4 | Purity: 97% | 3-Oxabicyclo[3.1.0]hexan-6-amine hydrochloride | ESD-898694-100MG |
Cas.: 693248-55-4 | Purity: 97% | 3-Oxabicyclo[3.1.0]hexan-6-amine hydrochloride | ESD-898694-250MG |
Cas.: 693248-55-4 | Purity: 97% | 3-Oxabicyclo[3.1.0]hexan-6-amine hydrochloride | ESD-898694-1G |
Cas.: 618061-76-0 | Purity: ≥95% | (S)-Diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate | ESD-898695-100MG |
Cas.: 618061-76-0 | Purity: ≥95% | (S)-Diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate | ESD-898695-250MG |
Cas.: 618061-76-0 | Purity: ≥95% | (S)-Diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxoethylphosphonate | ESD-898695-1G |
Cas.: 882679-14-3 | Purity: ≥95% | 4-Chloro-5-methylpicolinic acid | ESD-898696-100MG |
Cas.: 882679-14-3 | Purity: ≥95% | 4-Chloro-5-methylpicolinic acid | ESD-898696-250MG |
Cas.: 882679-14-3 | Purity: ≥95% | 4-Chloro-5-methylpicolinic acid | ESD-898696-1G |
Cas.: 2089292-64-6 | Purity: 97% | 2-Amino-3-(thiazol-5-yl)propanoic acid hydrochloride | ESD-898697-100MG |
Cas.: 2089292-64-6 | Purity: 97% | 2-Amino-3-(thiazol-5-yl)propanoic acid hydrochloride | ESD-898697-250MG |
Cas.: 2089292-64-6 | Purity: 97% | 2-Amino-3-(thiazol-5-yl)propanoic acid hydrochloride | ESD-898697-1G |
Cas.: 944124-72-5 | Purity: 98% | 2-Chlorothiazole-4-carbonitrile | ESD-898698-100MG |
Cas.: 944124-72-5 | Purity: 98% | 2-Chlorothiazole-4-carbonitrile | ESD-898698-250MG |
Cas.: 944124-72-5 | Purity: 98% | 2-Chlorothiazole-4-carbonitrile | ESD-898698-1G |
Cas.: 1019021-93-2 | Purity: 97% | 7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-898699-100MG |
Cas.: 1019021-93-2 | Purity: 97% | 7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-898699-250MG |
Cas.: 1019021-93-2 | Purity: 97% | 7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-898699-1G |
Cas.: 841253-81-4 | Purity: ≥95% | 2-(1-(2-(4-Chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)piperidin-2-yl)ethanol | ESD-898700-100MG |
Cas.: 841253-81-4 | Purity: ≥95% | 2-(1-(2-(4-Chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)piperidin-2-yl)ethanol | ESD-898700-250MG |
Cas.: 841253-81-4 | Purity: ≥95% | 2-(1-(2-(4-Chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)piperidin-2-yl)ethanol | ESD-898700-1G |
Cas.: 87687-75-0 | Purity: ≥95% | Methyl 4-(benzyloxy)-3-hydroxybenzoate | ESD-898701-100MG |
Cas.: 87687-75-0 | Purity: ≥95% | Methyl 4-(benzyloxy)-3-hydroxybenzoate | ESD-898701-250MG |
Cas.: 87687-75-0 | Purity: ≥95% | Methyl 4-(benzyloxy)-3-hydroxybenzoate | ESD-898701-1G |
Cas.: 1215264-39-3 | Purity: 97% | (S)-N-Methyl-N-(pyrrolidin-3-yl)acetamide hydrochloride | ESD-898702-100MG |
Cas.: 1215264-39-3 | Purity: 97% | (S)-N-Methyl-N-(pyrrolidin-3-yl)acetamide hydrochloride | ESD-898702-250MG |
Cas.: 1215264-39-3 | Purity: 97% | (S)-N-Methyl-N-(pyrrolidin-3-yl)acetamide hydrochloride | ESD-898702-1G |
Cas.: 1206249-65-1 | Purity: 95% | 6-Bromo-4-chloropyridin-2-amine | ESD-898703-100MG |
Cas.: 1206249-65-1 | Purity: 95% | 6-Bromo-4-chloropyridin-2-amine | ESD-898703-250MG |
Cas.: 1206249-65-1 | Purity: 95% | 6-Bromo-4-chloropyridin-2-amine | ESD-898703-1G |
Cas.: 1000341-36-5 | Purity: ≥95% | 3-Bromo-1H-indazole-4-carbonitrile | ESD-898704-100MG |
Cas.: 1000341-36-5 | Purity: ≥95% | 3-Bromo-1H-indazole-4-carbonitrile | ESD-898704-250MG |
Cas.: 1000341-36-5 | Purity: ≥95% | 3-Bromo-1H-indazole-4-carbonitrile | ESD-898704-1G |
Cas.: 1263094-16-1 | Purity: ≥95% | (S)-1-(5-Bromopyridin-2-yl)ethanamine hydrochloride | ESD-898705-100MG |
Cas.: 1263094-16-1 | Purity: ≥95% | (S)-1-(5-Bromopyridin-2-yl)ethanamine hydrochloride | ESD-898705-250MG |
Cas.: 1263094-16-1 | Purity: ≥95% | (S)-1-(5-Bromopyridin-2-yl)ethanamine hydrochloride | ESD-898705-1G |
Cas.: 1082041-87-9 | Purity: 97% | 4-Fluoro-5-iodo-1H-indazole | ESD-898706-100MG |
Cas.: 1082041-87-9 | Purity: 97% | 4-Fluoro-5-iodo-1H-indazole | ESD-898706-250MG |
Cas.: 1082041-87-9 | Purity: 97% | 4-Fluoro-5-iodo-1H-indazole | ESD-898706-1G |
Cas.: 1179362-50-5 | Purity: ≥95% | 5-Phenylpicolinimidamide hydrochloride | ESD-898707-100MG |
Cas.: 1179362-50-5 | Purity: ≥95% | 5-Phenylpicolinimidamide hydrochloride | ESD-898707-250MG |
Cas.: 1179362-50-5 | Purity: ≥95% | 5-Phenylpicolinimidamide hydrochloride | ESD-898707-1G |
Cas.: 2435-46-3 | Purity: 97% | 3,6-Dimethylpyrazine-2-carboxylic acid | ESD-898708-100MG |
Cas.: 2435-46-3 | Purity: 97% | 3,6-Dimethylpyrazine-2-carboxylic acid | ESD-898708-250MG |
Cas.: 2435-46-3 | Purity: 97% | 3,6-Dimethylpyrazine-2-carboxylic acid | ESD-898708-1G |
Cas.: 491595-36-9 | Purity: ≥95% | (2′-Methyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-898709-100MG |
Cas.: 491595-36-9 | Purity: ≥95% | (2′-Methyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-898709-250MG |
Cas.: 491595-36-9 | Purity: ≥95% | (2′-Methyl-[1,1′-biphenyl]-4-yl)boronic acid | ESD-898709-1G |
Cas.: 771465-40-8 | Purity: ≥95% | (R)-1-(3,5-Difluorophenyl)ethanamine | ESD-898710-100MG |
Cas.: 771465-40-8 | Purity: ≥95% | (R)-1-(3,5-Difluorophenyl)ethanamine | ESD-898710-250MG |
Cas.: 771465-40-8 | Purity: ≥95% | (R)-1-(3,5-Difluorophenyl)ethanamine | ESD-898710-1G |
Cas.: 1263198-96-4 | Purity: 97% | (R)-1-(Pyridin-2-yl)propan-1-amine dihydrochloride | ESD-898711-100MG |
Cas.: 1263198-96-4 | Purity: 97% | (R)-1-(Pyridin-2-yl)propan-1-amine dihydrochloride | ESD-898711-250MG |
Cas.: 1263198-96-4 | Purity: 97% | (R)-1-(Pyridin-2-yl)propan-1-amine dihydrochloride | ESD-898711-1G |
Cas.: 185388-85-6 | Purity: 97% | 6-(Trifluoromethoxy)-2,3-dihydro-1H-inden-1-one | ESD-898712-100MG |
Cas.: 185388-85-6 | Purity: 97% | 6-(Trifluoromethoxy)-2,3-dihydro-1H-inden-1-one | ESD-898712-250MG |
Cas.: 185388-85-6 | Purity: 97% | 6-(Trifluoromethoxy)-2,3-dihydro-1H-inden-1-one | ESD-898712-1G |
Cas.: 1072145-33-5 | Purity: 97% | N-(3-(4,5-Dihydrothiazol-2-yl)thiazolidin-2-ylidene)-5H-dibenzo[a,d][7]annulen-5-amine | ESD-898713-100MG |
Cas.: 1072145-33-5 | Purity: 97% | N-(3-(4,5-Dihydrothiazol-2-yl)thiazolidin-2-ylidene)-5H-dibenzo[a,d][7]annulen-5-amine | ESD-898713-250MG |
Cas.: 1072145-33-5 | Purity: 97% | N-(3-(4,5-Dihydrothiazol-2-yl)thiazolidin-2-ylidene)-5H-dibenzo[a,d][7]annulen-5-amine | ESD-898713-1G |
Cas.: 701232-69-1 | Purity: 97% | Methyl 2-(trans-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate | ESD-898714-100MG |
Cas.: 701232-69-1 | Purity: 97% | Methyl 2-(trans-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate | ESD-898714-250MG |
Cas.: 701232-69-1 | Purity: 97% | Methyl 2-(trans-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclohexyl)acetate | ESD-898714-1G |
Cas.: 885519-30-2 | Purity: ≥95% | 3-Bromo-5-methoxy-1H-indazole | ESD-898715-100MG |
Cas.: 885519-30-2 | Purity: ≥95% | 3-Bromo-5-methoxy-1H-indazole | ESD-898715-250MG |
Cas.: 885519-30-2 | Purity: ≥95% | 3-Bromo-5-methoxy-1H-indazole | ESD-898715-1G |
Cas.: 1370347-50-4 | Purity: 97% | (S)-1-(3,5-Dichloropyridin-4-yl)ethanol | ESD-898716-100MG |
Cas.: 1370347-50-4 | Purity: 97% | (S)-1-(3,5-Dichloropyridin-4-yl)ethanol | ESD-898716-250MG |
Cas.: 1370347-50-4 | Purity: 97% | (S)-1-(3,5-Dichloropyridin-4-yl)ethanol | ESD-898716-1G |
Cas.: 1269493-35-7 | Purity: 97% | (S)-tert-Butyl (2-aminopropyl)carbamate hydrochloride | ESD-898717-100MG |
Cas.: 1269493-35-7 | Purity: 97% | (S)-tert-Butyl (2-aminopropyl)carbamate hydrochloride | ESD-898717-250MG |
Cas.: 1269493-35-7 | Purity: 97% | (S)-tert-Butyl (2-aminopropyl)carbamate hydrochloride | ESD-898717-1G |
Cas.: 1257403-88-5 | Purity: 97% | 1-(tert-Butyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-4(5H)-one | ESD-898718-100MG |
Cas.: 1257403-88-5 | Purity: 97% | 1-(tert-Butyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-4(5H)-one | ESD-898718-250MG |
Cas.: 1257403-88-5 | Purity: 97% | 1-(tert-Butyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-4(5H)-one | ESD-898718-1G |
Cas.: 182344-21-4 | Purity: ≥95% | (4-Hydroxy-3-methoxyphenyl)boronic acid | ESD-898719-100MG |
Cas.: 182344-21-4 | Purity: ≥95% | (4-Hydroxy-3-methoxyphenyl)boronic acid | ESD-898719-250MG |
Cas.: 182344-21-4 | Purity: ≥95% | (4-Hydroxy-3-methoxyphenyl)boronic acid | ESD-898719-1G |
Cas.: 1246509-67-0 | Purity: 97% | (R)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride | ESD-898720-100MG |
Cas.: 1246509-67-0 | Purity: 97% | (R)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride | ESD-898720-250MG |
Cas.: 1246509-67-0 | Purity: 97% | (R)-Methyl 3-amino-2,3-dihydro-1H-indene-5-carboxylate hydrochloride | ESD-898720-1G |
Cas.: 1246277-44-0 | Purity: 97% | (S)-N-(Pyrrolidin-3-yl)acetamide hydrochloride | ESD-898721-100MG |
Cas.: 1246277-44-0 | Purity: 97% | (S)-N-(Pyrrolidin-3-yl)acetamide hydrochloride | ESD-898721-250MG |
Cas.: 1246277-44-0 | Purity: 97% | (S)-N-(Pyrrolidin-3-yl)acetamide hydrochloride | ESD-898721-1G |
Cas.: 907544-43-8 | Purity: 98% | (S)-2-Methoxypropan-1-amine hydrochloride | ESD-898722-100MG |
Cas.: 907544-43-8 | Purity: 98% | (S)-2-Methoxypropan-1-amine hydrochloride | ESD-898722-250MG |
Cas.: 907544-43-8 | Purity: 98% | (S)-2-Methoxypropan-1-amine hydrochloride | ESD-898722-1G |
Cas.: 138469-76-8 | Purity: 97% | 5-Methoxy-3-methyl-1H-pyrrolo[3,2-b]pyridine | ESD-898723-100MG |
Cas.: 138469-76-8 | Purity: 97% | 5-Methoxy-3-methyl-1H-pyrrolo[3,2-b]pyridine | ESD-898723-250MG |
Cas.: 138469-76-8 | Purity: 97% | 5-Methoxy-3-methyl-1H-pyrrolo[3,2-b]pyridine | ESD-898723-1G |
Cas.: 1355338-16-7 | Purity: 98% | 2-(4-Amino-3-fluorophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol | ESD-898724-100MG |
Cas.: 1355338-16-7 | Purity: 98% | 2-(4-Amino-3-fluorophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol | ESD-898724-250MG |
Cas.: 1355338-16-7 | Purity: 98% | 2-(4-Amino-3-fluorophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol | ESD-898724-1G |
Cas.: 1784463-68-8 | Purity: ≥95% | Methyl 5-chlorothiazole-4-carboxylate | ESD-898725-100MG |
Cas.: 1784463-68-8 | Purity: ≥95% | Methyl 5-chlorothiazole-4-carboxylate | ESD-898725-250MG |
Cas.: 1784463-68-8 | Purity: ≥95% | Methyl 5-chlorothiazole-4-carboxylate | ESD-898725-1G |
Cas.: 124915-06-6 | Purity: ≥95% | 4-(Ethoxycarbonyl)-N,N,N-trimethylbenzenaminium trifluoromethanesulfonate | ESD-898726-100MG |
Cas.: 124915-06-6 | Purity: ≥95% | 4-(Ethoxycarbonyl)-N,N,N-trimethylbenzenaminium trifluoromethanesulfonate | ESD-898726-250MG |
Cas.: 124915-06-6 | Purity: ≥95% | 4-(Ethoxycarbonyl)-N,N,N-trimethylbenzenaminium trifluoromethanesulfonate | ESD-898726-1G |
Cas.: 142733-65-1 | Purity: 97% | (cis-3-Aminocyclobutyl)methanol hydrochloride | ESD-898727-100MG |
Cas.: 142733-65-1 | Purity: 97% | (cis-3-Aminocyclobutyl)methanol hydrochloride | ESD-898727-250MG |
Cas.: 142733-65-1 | Purity: 97% | (cis-3-Aminocyclobutyl)methanol hydrochloride | ESD-898727-1G |
Cas.: 869335-75-1 | Purity: ≥95% | 4-Chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898728-100MG |
Cas.: 869335-75-1 | Purity: ≥95% | 4-Chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898728-250MG |
Cas.: 869335-75-1 | Purity: ≥95% | 4-Chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-898728-1G |
Cas.: 176447-94-2 | Purity: 95% | N-(4-(2-((4-(Methylsulfonamido)phenethyl)amino)ethoxy)phenyl)methanesulfonamide | ESD-898729-100MG |
Cas.: 176447-94-2 | Purity: 95% | N-(4-(2-((4-(Methylsulfonamido)phenethyl)amino)ethoxy)phenyl)methanesulfonamide | ESD-898729-250MG |
Cas.: 176447-94-2 | Purity: 95% | N-(4-(2-((4-(Methylsulfonamido)phenethyl)amino)ethoxy)phenyl)methanesulfonamide | ESD-898729-1G |
Cas.: 55745-97-6 | Purity: 97% | Chroman-6-carbaldehyde | ESD-898730-100MG |
Cas.: 55745-97-6 | Purity: 97% | Chroman-6-carbaldehyde | ESD-898730-250MG |
Cas.: 55745-97-6 | Purity: 97% | Chroman-6-carbaldehyde | ESD-898730-1G |
Cas.: 864274-04-4 | Purity: 97% | 2-Methylbenzo[d]oxazole-6-carbaldehyde | ESD-898731-100MG |
Cas.: 864274-04-4 | Purity: 97% | 2-Methylbenzo[d]oxazole-6-carbaldehyde | ESD-898731-250MG |
Cas.: 864274-04-4 | Purity: 97% | 2-Methylbenzo[d]oxazole-6-carbaldehyde | ESD-898731-1G |
Cas.: 1060815-08-8 | Purity: 97% | 2-Bromo-6-fluoroimidazo[1,2-a]pyridine | ESD-898732-100MG |
Cas.: 1060815-08-8 | Purity: 97% | 2-Bromo-6-fluoroimidazo[1,2-a]pyridine | ESD-898732-250MG |
Cas.: 1060815-08-8 | Purity: 97% | 2-Bromo-6-fluoroimidazo[1,2-a]pyridine | ESD-898732-1G |
Cas.: 1269652-47-2 | Purity: ≥95% | (S)-2-Amino-2-(3-chloro-4-fluorophenyl)ethanol hydrochloride | ESD-898733-100MG |
Cas.: 1269652-47-2 | Purity: ≥95% | (S)-2-Amino-2-(3-chloro-4-fluorophenyl)ethanol hydrochloride | ESD-898733-250MG |
Cas.: 1269652-47-2 | Purity: ≥95% | (S)-2-Amino-2-(3-chloro-4-fluorophenyl)ethanol hydrochloride | ESD-898733-1G |
Cas.: 426219-51-4 | Purity: ≥95% | 6,7-Dihydroimidazo[1,5-a]pyridin-8(5H)-one | ESD-898734-100MG |
Cas.: 426219-51-4 | Purity: ≥95% | 6,7-Dihydroimidazo[1,5-a]pyridin-8(5H)-one | ESD-898734-250MG |
Cas.: 426219-51-4 | Purity: ≥95% | 6,7-Dihydroimidazo[1,5-a]pyridin-8(5H)-one | ESD-898734-1G |
Cas.: 90690-91-8 | Purity: 97% | 5-Chloro-7-methoxythieno[3,2-b]pyridine | ESD-898735-100MG |
Cas.: 90690-91-8 | Purity: 97% | 5-Chloro-7-methoxythieno[3,2-b]pyridine | ESD-898735-250MG |
Cas.: 90690-91-8 | Purity: 97% | 5-Chloro-7-methoxythieno[3,2-b]pyridine | ESD-898735-1G |
Cas.: 134221-52-6 | Purity: 97% | 4-Chloro-2,6-dimethoxypyrimidine-5-carbaldehyde | ESD-898736-100MG |
Cas.: 134221-52-6 | Purity: 97% | 4-Chloro-2,6-dimethoxypyrimidine-5-carbaldehyde | ESD-898736-250MG |
Cas.: 134221-52-6 | Purity: 97% | 4-Chloro-2,6-dimethoxypyrimidine-5-carbaldehyde | ESD-898736-1G |
Cas.: 764-89-6 | Purity: 97% | 8-Hydroxyoctanoic acid | ESD-898737-100MG |
Cas.: 764-89-6 | Purity: 97% | 8-Hydroxyoctanoic acid | ESD-898737-250MG |
Cas.: 764-89-6 | Purity: 97% | 8-Hydroxyoctanoic acid | ESD-898737-1G |
Cas.: 216661-72-2 | Purity: 97% | 6-(4-Methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidine | ESD-898738-100MG |
Cas.: 216661-72-2 | Purity: 97% | 6-(4-Methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidine | ESD-898738-250MG |
Cas.: 216661-72-2 | Purity: 97% | 6-(4-Methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidine | ESD-898738-1G |
Cas.: 1261759-41-4 | Purity: 97% | 2-Chloro-5-formylbenzonitrile | ESD-898739-100MG |
Cas.: 1261759-41-4 | Purity: 97% | 2-Chloro-5-formylbenzonitrile | ESD-898739-250MG |
Cas.: 1261759-41-4 | Purity: 97% | 2-Chloro-5-formylbenzonitrile | ESD-898739-1G |
Cas.: 180196-56-9 | Purity: ≥95% | (1R,3S)-Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-898740-100MG |
Cas.: 180196-56-9 | Purity: ≥95% | (1R,3S)-Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-898740-250MG |
Cas.: 180196-56-9 | Purity: ≥95% | (1R,3S)-Methyl 3-aminocyclopentanecarboxylate hydrochloride | ESD-898740-1G |
Cas.: 956136-85-9 | Purity: 97% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate | ESD-898741-100MG |
Cas.: 956136-85-9 | Purity: 97% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate | ESD-898741-250MG |
Cas.: 956136-85-9 | Purity: 97% | tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate | ESD-898741-1G |
Cas.: 131748-97-5 | Purity: 97% | (2-(Trifluoromethyl)thiazol-5-yl)methanol | ESD-898742-100MG |
Cas.: 131748-97-5 | Purity: 97% | (2-(Trifluoromethyl)thiazol-5-yl)methanol | ESD-898742-250MG |
Cas.: 131748-97-5 | Purity: 97% | (2-(Trifluoromethyl)thiazol-5-yl)methanol | ESD-898742-1G |
Cas.: 1190319-63-1 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carboxylic acid | ESD-898743-100MG |
Cas.: 1190319-63-1 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carboxylic acid | ESD-898743-250MG |
Cas.: 1190319-63-1 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-4-carboxylic acid | ESD-898743-1G |
Cas.: 1256821-83-6 | Purity: 95% | 5-Bromo-2-fluoronicotinonitrile | ESD-898744-100MG |
Cas.: 1256821-83-6 | Purity: 95% | 5-Bromo-2-fluoronicotinonitrile | ESD-898744-250MG |
Cas.: 1256821-83-6 | Purity: 95% | 5-Bromo-2-fluoronicotinonitrile | ESD-898744-1G |
Cas.: 408359-07-9 | Purity: ≥95% | 3-Bromo-1H-pyrrole-2-carbaldehyde | ESD-898745-100MG |
Cas.: 408359-07-9 | Purity: ≥95% | 3-Bromo-1H-pyrrole-2-carbaldehyde | ESD-898745-250MG |
Cas.: 408359-07-9 | Purity: ≥95% | 3-Bromo-1H-pyrrole-2-carbaldehyde | ESD-898745-1G |
Cas.: 1092108-79-6 | Purity: ≥95% | 3-(3,4-Dichlorophenyl)pyrrolidine hydrochloride | ESD-898746-100MG |
Cas.: 1092108-79-6 | Purity: ≥95% | 3-(3,4-Dichlorophenyl)pyrrolidine hydrochloride | ESD-898746-250MG |
Cas.: 1092108-79-6 | Purity: ≥95% | 3-(3,4-Dichlorophenyl)pyrrolidine hydrochloride | ESD-898746-1G |
Cas.: 73075-49-7 | Purity: 97% | 6,7-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-898747-100MG |
Cas.: 73075-49-7 | Purity: 97% | 6,7-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-898747-250MG |
Cas.: 73075-49-7 | Purity: 97% | 6,7-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-898747-1G |
Cas.: 1196157-14-8 | Purity: 97% | 4-Bromo-5-methylpicolinaldehyde | ESD-898748-100MG |
Cas.: 1196157-14-8 | Purity: 97% | 4-Bromo-5-methylpicolinaldehyde | ESD-898748-250MG |
Cas.: 1196157-14-8 | Purity: 97% | 4-Bromo-5-methylpicolinaldehyde | ESD-898748-1G |
Cas.: 26732-04-7 | Purity: ≥95% | 5-Chloro-2-methylpyrimidin-4(3H)-one | ESD-898749-100MG |
Cas.: 26732-04-7 | Purity: ≥95% | 5-Chloro-2-methylpyrimidin-4(3H)-one | ESD-898749-250MG |
Cas.: 26732-04-7 | Purity: ≥95% | 5-Chloro-2-methylpyrimidin-4(3H)-one | ESD-898749-1G |
Cas.: 7730-82-7 | Purity: 98% | 2-(Thiazol-5-yl)ethanamine dihydrochloride | ESD-898750-100MG |
Cas.: 7730-82-7 | Purity: 98% | 2-(Thiazol-5-yl)ethanamine dihydrochloride | ESD-898750-250MG |
Cas.: 7730-82-7 | Purity: 98% | 2-(Thiazol-5-yl)ethanamine dihydrochloride | ESD-898750-1G |
Cas.: 1263283-20-0 | Purity: 97% | 3,3-Dimethoxypyrrolidine hydrochloride | ESD-898751-100MG |
Cas.: 1263283-20-0 | Purity: 97% | 3,3-Dimethoxypyrrolidine hydrochloride | ESD-898751-250MG |
Cas.: 1263283-20-0 | Purity: 97% | 3,3-Dimethoxypyrrolidine hydrochloride | ESD-898751-1G |
Cas.: 1250444-23-5 | Purity: 97% | 3-Bromo-2,6-difluorobenzonitrile | ESD-898752-100MG |
Cas.: 1250444-23-5 | Purity: 97% | 3-Bromo-2,6-difluorobenzonitrile | ESD-898752-250MG |
Cas.: 1250444-23-5 | Purity: 97% | 3-Bromo-2,6-difluorobenzonitrile | ESD-898752-1G |
Cas.: 1381929-21-0 | Purity: 97% | (R)-2-(5-Fluoro-2-methylphenyl)pyrrolidine hydrochloride | ESD-898753-100MG |
Cas.: 1381929-21-0 | Purity: 97% | (R)-2-(5-Fluoro-2-methylphenyl)pyrrolidine hydrochloride | ESD-898753-250MG |
Cas.: 1381929-21-0 | Purity: 97% | (R)-2-(5-Fluoro-2-methylphenyl)pyrrolidine hydrochloride | ESD-898753-1G |
Cas.: 127248-99-1 | Purity: ≥95% | 3-Aminobenzaldehyde hydrochloride | ESD-898754-100MG |
Cas.: 127248-99-1 | Purity: ≥95% | 3-Aminobenzaldehyde hydrochloride | ESD-898754-250MG |
Cas.: 127248-99-1 | Purity: ≥95% | 3-Aminobenzaldehyde hydrochloride | ESD-898754-1G |
Cas.: 1201694-15-6 | Purity: ≥95% | 1-(2-Fluoroethyl)piperidin-4-amine dihydrochloride | ESD-898755-100MG |
Cas.: 1201694-15-6 | Purity: ≥95% | 1-(2-Fluoroethyl)piperidin-4-amine dihydrochloride | ESD-898755-250MG |
Cas.: 1201694-15-6 | Purity: ≥95% | 1-(2-Fluoroethyl)piperidin-4-amine dihydrochloride | ESD-898755-1G |
Cas.: 203395-29-3 | Purity: ≥95% | 5-Bromo-2-(methylthio)benzo[d]thiazole | ESD-898756-100MG |
Cas.: 203395-29-3 | Purity: ≥95% | 5-Bromo-2-(methylthio)benzo[d]thiazole | ESD-898756-250MG |
Cas.: 203395-29-3 | Purity: ≥95% | 5-Bromo-2-(methylthio)benzo[d]thiazole | ESD-898756-1G |
Cas.: 38588-64-6 | Purity: ≥95% | 3,5-Bis(methoxycarbonyl)benzoic acid | ESD-898757-100MG |
Cas.: 38588-64-6 | Purity: ≥95% | 3,5-Bis(methoxycarbonyl)benzoic acid | ESD-898757-250MG |
Cas.: 38588-64-6 | Purity: ≥95% | 3,5-Bis(methoxycarbonyl)benzoic acid | ESD-898757-1G |
Cas.: 1784280-46-1 | Purity: 97% | 2-Bromothieno[3,2-c]pyridin-4-amine | ESD-898758-100MG |
Cas.: 1784280-46-1 | Purity: 97% | 2-Bromothieno[3,2-c]pyridin-4-amine | ESD-898758-250MG |
Cas.: 1784280-46-1 | Purity: 97% | 2-Bromothieno[3,2-c]pyridin-4-amine | ESD-898758-1G |
Cas.: 383865-57-4 | Purity: ≥95% | 4-Methoxy-7-morpholinobenzo[d]thiazol-2-amine | ESD-898759-100MG |
Cas.: 383865-57-4 | Purity: ≥95% | 4-Methoxy-7-morpholinobenzo[d]thiazol-2-amine | ESD-898759-250MG |
Cas.: 383865-57-4 | Purity: ≥95% | 4-Methoxy-7-morpholinobenzo[d]thiazol-2-amine | ESD-898759-1G |
Cas.: 865449-63-4 | Purity: ≥95% | 1-(4-Bromo-5-fluoro-2-hydroxyphenyl)ethanone | ESD-898760-100MG |
Cas.: 865449-63-4 | Purity: ≥95% | 1-(4-Bromo-5-fluoro-2-hydroxyphenyl)ethanone | ESD-898760-250MG |
Cas.: 865449-63-4 | Purity: ≥95% | 1-(4-Bromo-5-fluoro-2-hydroxyphenyl)ethanone | ESD-898760-1G |
Cas.: 1303974-46-0 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-fluoropiperidine-4-carboxylic acid | ESD-898761-100MG |
Cas.: 1303974-46-0 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-fluoropiperidine-4-carboxylic acid | ESD-898761-250MG |
Cas.: 1303974-46-0 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-fluoropiperidine-4-carboxylic acid | ESD-898761-1G |
Cas.: 919278-72-1 | Purity: 97% | 5-Methyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | ESD-898762-100MG |
Cas.: 919278-72-1 | Purity: 97% | 5-Methyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | ESD-898762-250MG |
Cas.: 919278-72-1 | Purity: 97% | 5-Methyl-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | ESD-898762-1G |
Cas.: 500295-52-3 | Purity: 97% | Ir(p-CF3-ppy)3 | ESD-898763-100MG |
Cas.: 500295-52-3 | Purity: 97% | Ir(p-CF3-ppy)3 | ESD-898763-250MG |
Cas.: 500295-52-3 | Purity: 97% | Ir(p-CF3-ppy)3 | ESD-898763-1G |
Cas.: 1232431-41-2 | Purity: 96% | 3-Bromo-6-fluoropyridin-2-amine | ESD-898764-100MG |
Cas.: 1232431-41-2 | Purity: 96% | 3-Bromo-6-fluoropyridin-2-amine | ESD-898764-250MG |
Cas.: 1232431-41-2 | Purity: 96% | 3-Bromo-6-fluoropyridin-2-amine | ESD-898764-1G |
Cas.: 99898-84-7 | Purity: ≥95% | 5-Chloropyrazolo[1,5-a]pyrimidin-7(1H)-one | ESD-898765-100MG |
Cas.: 99898-84-7 | Purity: ≥95% | 5-Chloropyrazolo[1,5-a]pyrimidin-7(1H)-one | ESD-898765-250MG |
Cas.: 99898-84-7 | Purity: ≥95% | 5-Chloropyrazolo[1,5-a]pyrimidin-7(1H)-one | ESD-898765-1G |
Cas.: 90196-32-0 | Purity: 97% | 2-Chloro-5-ethylpyridine | ESD-898766-100MG |
Cas.: 90196-32-0 | Purity: 97% | 2-Chloro-5-ethylpyridine | ESD-898766-250MG |
Cas.: 90196-32-0 | Purity: 97% | 2-Chloro-5-ethylpyridine | ESD-898766-1G |
Cas.: 869973-96-6 | Purity: 97% | (1-Methyl-1H-pyrazol-3-yl)boronic acid | ESD-898767-100MG |
Cas.: 869973-96-6 | Purity: 97% | (1-Methyl-1H-pyrazol-3-yl)boronic acid | ESD-898767-250MG |
Cas.: 869973-96-6 | Purity: 97% | (1-Methyl-1H-pyrazol-3-yl)boronic acid | ESD-898767-1G |
Cas.: 1227599-26-9 | Purity: ≥95% | (3-Bromo-5-chloropyridin-2-yl)methanol | ESD-898768-100MG |
Cas.: 1227599-26-9 | Purity: ≥95% | (3-Bromo-5-chloropyridin-2-yl)methanol | ESD-898768-250MG |
Cas.: 1227599-26-9 | Purity: ≥95% | (3-Bromo-5-chloropyridin-2-yl)methanol | ESD-898768-1G |
Cas.: 1354952-28-5 | Purity: 95% | 2-Oxa-5-azabicyclo[4.1.0]heptane hydrochloride | ESD-898769-100MG |
Cas.: 1354952-28-5 | Purity: 95% | 2-Oxa-5-azabicyclo[4.1.0]heptane hydrochloride | ESD-898769-250MG |
Cas.: 1354952-28-5 | Purity: 95% | 2-Oxa-5-azabicyclo[4.1.0]heptane hydrochloride | ESD-898769-1G |
Cas.: 1041481-59-7 | Purity: 97% | 4-Fluoro-1H-indazole-5-carboxylic acid | ESD-898770-100MG |
Cas.: 1041481-59-7 | Purity: 97% | 4-Fluoro-1H-indazole-5-carboxylic acid | ESD-898770-250MG |
Cas.: 1041481-59-7 | Purity: 97% | 4-Fluoro-1H-indazole-5-carboxylic acid | ESD-898770-1G |
Cas.: 1186334-61-1 | Purity: ≥95% | 4-Bromo-7-chloro-1H-indazole | ESD-898771-100MG |
Cas.: 1186334-61-1 | Purity: ≥95% | 4-Bromo-7-chloro-1H-indazole | ESD-898771-250MG |
Cas.: 1186334-61-1 | Purity: ≥95% | 4-Bromo-7-chloro-1H-indazole | ESD-898771-1G |
Cas.: 205043-09-0 | Purity: 98% | 2-(Difluoromethoxy)pyridin-4-ol | ESD-898772-100MG |
Cas.: 205043-09-0 | Purity: 98% | 2-(Difluoromethoxy)pyridin-4-ol | ESD-898772-250MG |
Cas.: 205043-09-0 | Purity: 98% | 2-(Difluoromethoxy)pyridin-4-ol | ESD-898772-1G |
Cas.: 1622883-44-6 | Purity: 97% | 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid | ESD-898773-100MG |
Cas.: 1622883-44-6 | Purity: 97% | 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid | ESD-898773-250MG |
Cas.: 1622883-44-6 | Purity: 97% | 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid | ESD-898773-1G |
Cas.: 70558-11-1 | Purity: ≥95% | 6-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-898774-100MG |
Cas.: 70558-11-1 | Purity: ≥95% | 6-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-898774-250MG |
Cas.: 70558-11-1 | Purity: ≥95% | 6-Chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine | ESD-898774-1G |
Cas.: 1257554-02-1 | Purity: 97% | 3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine | ESD-898775-100MG |
Cas.: 1257554-02-1 | Purity: 97% | 3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine | ESD-898775-250MG |
Cas.: 1257554-02-1 | Purity: 97% | 3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine | ESD-898775-1G |
Cas.: 28691-49-8 | Purity: 96% | 6-Chlorobenzo[d]isoxazole-3-carboxylic acid | ESD-898776-100MG |
Cas.: 28691-49-8 | Purity: 96% | 6-Chlorobenzo[d]isoxazole-3-carboxylic acid | ESD-898776-250MG |
Cas.: 28691-49-8 | Purity: 96% | 6-Chlorobenzo[d]isoxazole-3-carboxylic acid | ESD-898776-1G |
Cas.: 76044-36-5 | Purity: 97% | 5-Chloro-[1,2,4]triazolo[1,5-c]pyrimidine | ESD-898777-100MG |
Cas.: 76044-36-5 | Purity: 97% | 5-Chloro-[1,2,4]triazolo[1,5-c]pyrimidine | ESD-898777-250MG |
Cas.: 76044-36-5 | Purity: 97% | 5-Chloro-[1,2,4]triazolo[1,5-c]pyrimidine | ESD-898777-1G |
Cas.: 1082040-92-3 | Purity: 97% | 1H-Pyrrolo[3,2-c]pyridine-7-carboxylic acid | ESD-898778-100MG |
Cas.: 1082040-92-3 | Purity: 97% | 1H-Pyrrolo[3,2-c]pyridine-7-carboxylic acid | ESD-898778-250MG |
Cas.: 1082040-92-3 | Purity: 97% | 1H-Pyrrolo[3,2-c]pyridine-7-carboxylic acid | ESD-898778-1G |
Cas.: 886363-98-0 | Purity: ≥95% | 7-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-898779-100MG |
Cas.: 886363-98-0 | Purity: ≥95% | 7-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-898779-250MG |
Cas.: 886363-98-0 | Purity: ≥95% | 7-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-898779-1G |
Cas.: 89381-07-7 | Purity: 97% | 3-Methylcyclobutanamine hydrochloride | ESD-898780-100MG |
Cas.: 89381-07-7 | Purity: 97% | 3-Methylcyclobutanamine hydrochloride | ESD-898780-250MG |
Cas.: 89381-07-7 | Purity: 97% | 3-Methylcyclobutanamine hydrochloride | ESD-898780-1G |
Cas.: 1315365-54-8 | Purity: ≥95% | ((Tetrahydro-2H-pyran-4-yl)methyl)hydrazine dihydrochloride | ESD-898781-100MG |
Cas.: 1315365-54-8 | Purity: ≥95% | ((Tetrahydro-2H-pyran-4-yl)methyl)hydrazine dihydrochloride | ESD-898781-250MG |
Cas.: 1315365-54-8 | Purity: ≥95% | ((Tetrahydro-2H-pyran-4-yl)methyl)hydrazine dihydrochloride | ESD-898781-1G |
Cas.: 74478-93-6 | Purity: 98% | Ethyl 2-bromo-1H-imidazole-5-carboxylate | ESD-898782-100MG |
Cas.: 74478-93-6 | Purity: 98% | Ethyl 2-bromo-1H-imidazole-5-carboxylate | ESD-898782-250MG |
Cas.: 74478-93-6 | Purity: 98% | Ethyl 2-bromo-1H-imidazole-5-carboxylate | ESD-898782-1G |
Cas.: 130596-62-2 | Purity: ≥95% | 4,4-Dimethyl-1,4-azasilinane hydrochloride | ESD-898783-100MG |
Cas.: 130596-62-2 | Purity: ≥95% | 4,4-Dimethyl-1,4-azasilinane hydrochloride | ESD-898783-250MG |
Cas.: 130596-62-2 | Purity: ≥95% | 4,4-Dimethyl-1,4-azasilinane hydrochloride | ESD-898783-1G |
Cas.: 1208084-77-8 | Purity: ≥95% | 8-Bromo-[1,2,4]triazolo[4,3-c]pyrimidine | ESD-898784-100MG |
Cas.: 1208084-77-8 | Purity: ≥95% | 8-Bromo-[1,2,4]triazolo[4,3-c]pyrimidine | ESD-898784-250MG |
Cas.: 1208084-77-8 | Purity: ≥95% | 8-Bromo-[1,2,4]triazolo[4,3-c]pyrimidine | ESD-898784-1G |
Cas.: 494-97-3 | Purity: 95% | (S)-3-(Pyrrolidin-2-yl)pyridine | ESD-898785-100MG |
Cas.: 494-97-3 | Purity: 95% | (S)-3-(Pyrrolidin-2-yl)pyridine | ESD-898785-250MG |
Cas.: 494-97-3 | Purity: 95% | (S)-3-(Pyrrolidin-2-yl)pyridine | ESD-898785-1G |
Cas.: 285991-71-1 | Purity: 97% | 4-Chloro-1,1-dimethylfuro[3,4-c]pyridin-3(1H)-one | ESD-898786-100MG |
Cas.: 285991-71-1 | Purity: 97% | 4-Chloro-1,1-dimethylfuro[3,4-c]pyridin-3(1H)-one | ESD-898786-250MG |
Cas.: 285991-71-1 | Purity: 97% | 4-Chloro-1,1-dimethylfuro[3,4-c]pyridin-3(1H)-one | ESD-898786-1G |
Cas.: 1262407-18-0 | Purity: 97% | tert-Butyl 3,6-diazabicyclo[3.1.0]hexane-3-carboxylate | ESD-898787-100MG |
Cas.: 1262407-18-0 | Purity: 97% | tert-Butyl 3,6-diazabicyclo[3.1.0]hexane-3-carboxylate | ESD-898787-250MG |
Cas.: 1262407-18-0 | Purity: 97% | tert-Butyl 3,6-diazabicyclo[3.1.0]hexane-3-carboxylate | ESD-898787-1G |
Cas.: 144750-42-5 | Purity: ≥95% | (S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride | ESD-898788-100MG |
Cas.: 144750-42-5 | Purity: ≥95% | (S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride | ESD-898788-250MG |
Cas.: 144750-42-5 | Purity: ≥95% | (S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride | ESD-898788-1G |
Cas.: 1260773-60-1 | Purity: 95% | 3-Bromo-6-chloropyrazine-2-carboxylic acid | ESD-898789-100MG |
Cas.: 1260773-60-1 | Purity: 95% | 3-Bromo-6-chloropyrazine-2-carboxylic acid | ESD-898789-250MG |
Cas.: 1260773-60-1 | Purity: 95% | 3-Bromo-6-chloropyrazine-2-carboxylic acid | ESD-898789-1G |
Cas.: 850882-87-0 | Purity: ≥95% | 6-Bromo-3-methoxy-2-methylpyridine | ESD-898790-100MG |
Cas.: 850882-87-0 | Purity: ≥95% | 6-Bromo-3-methoxy-2-methylpyridine | ESD-898790-250MG |
Cas.: 850882-87-0 | Purity: ≥95% | 6-Bromo-3-methoxy-2-methylpyridine | ESD-898790-1G |
Cas.: 103119-78-4 | Purity: 97% | 5-Bromophthalazine | ESD-898791-100MG |
Cas.: 103119-78-4 | Purity: 97% | 5-Bromophthalazine | ESD-898791-250MG |
Cas.: 103119-78-4 | Purity: 97% | 5-Bromophthalazine | ESD-898791-1G |
Cas.: 6297-80-9 | Purity: 95% | 4,6-Dichloropyrimidin-2(1H)-one | ESD-898792-100MG |
Cas.: 6297-80-9 | Purity: 95% | 4,6-Dichloropyrimidin-2(1H)-one | ESD-898792-250MG |
Cas.: 6297-80-9 | Purity: 95% | 4,6-Dichloropyrimidin-2(1H)-one | ESD-898792-1G |
Cas.: 1178884-53-1 | Purity: ≥95% | 4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one | ESD-898793-100MG |
Cas.: 1178884-53-1 | Purity: ≥95% | 4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one | ESD-898793-250MG |
Cas.: 1178884-53-1 | Purity: ≥95% | 4-Bromo-6-chloro-2-methylpyridazin-3(2H)-one | ESD-898793-1G |
Cas.: 1035235-26-7 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-898794-100MG |
Cas.: 1035235-26-7 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-898794-250MG |
Cas.: 1035235-26-7 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-898794-1G |
Cas.: 19936-14-2 | Purity: ≥95% | 1-(4-Bromophenyl)cyclobutanol | ESD-898795-100MG |
Cas.: 19936-14-2 | Purity: ≥95% | 1-(4-Bromophenyl)cyclobutanol | ESD-898795-250MG |
Cas.: 19936-14-2 | Purity: ≥95% | 1-(4-Bromophenyl)cyclobutanol | ESD-898795-1G |
Cas.: 614750-81-1 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridine-6-carbaldehyde | ESD-898796-100MG |
Cas.: 614750-81-1 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridine-6-carbaldehyde | ESD-898796-250MG |
Cas.: 614750-81-1 | Purity: ≥95% | [1,2,4]Triazolo[1,5-a]pyridine-6-carbaldehyde | ESD-898796-1G |
Cas.: 1173003-61-6 | Purity: ≥95% | 6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxylic acid | ESD-898797-100MG |
Cas.: 1173003-61-6 | Purity: ≥95% | 6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxylic acid | ESD-898797-250MG |
Cas.: 1173003-61-6 | Purity: ≥95% | 6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-carboxylic acid | ESD-898797-1G |
Cas.: 929019-95-4 | Purity: ≥95% | 6-(Hydroxymethyl)morpholin-3-one | ESD-898798-100MG |
Cas.: 929019-95-4 | Purity: ≥95% | 6-(Hydroxymethyl)morpholin-3-one | ESD-898798-250MG |
Cas.: 929019-95-4 | Purity: ≥95% | 6-(Hydroxymethyl)morpholin-3-one | ESD-898798-1G |
Cas.: 1245794-60-8 | Purity: ≥95% | 3-Benzyl-3-azabicyclo[3.1.1]heptan-6-amine | ESD-898799-100MG |
Cas.: 1245794-60-8 | Purity: ≥95% | 3-Benzyl-3-azabicyclo[3.1.1]heptan-6-amine | ESD-898799-250MG |
Cas.: 1245794-60-8 | Purity: ≥95% | 3-Benzyl-3-azabicyclo[3.1.1]heptan-6-amine | ESD-898799-1G |
Cas.: 1211510-15-4 | Purity: ≥95% | Ethyl 3-azabicyclo[3.1.0]hexane-6-carboxylate hydrochloride | ESD-898800-100MG |
Cas.: 1211510-15-4 | Purity: ≥95% | Ethyl 3-azabicyclo[3.1.0]hexane-6-carboxylate hydrochloride | ESD-898800-250MG |
Cas.: 1211510-15-4 | Purity: ≥95% | Ethyl 3-azabicyclo[3.1.0]hexane-6-carboxylate hydrochloride | ESD-898800-1G |
Cas.: 139393-02-5 | Purity: 97% | (S)-2-Amino-3-(5-cyano-1H-indol-3-yl)propanoic acid | ESD-898801-100MG |
Cas.: 139393-02-5 | Purity: 97% | (S)-2-Amino-3-(5-cyano-1H-indol-3-yl)propanoic acid | ESD-898801-250MG |
Cas.: 139393-02-5 | Purity: 97% | (S)-2-Amino-3-(5-cyano-1H-indol-3-yl)propanoic acid | ESD-898801-1G |
Cas.: 136293-86-2 | Purity: 96% | N-Methylazetidin-3-amine dihydrochloride | ESD-898802-100MG |
Cas.: 136293-86-2 | Purity: 96% | N-Methylazetidin-3-amine dihydrochloride | ESD-898802-250MG |
Cas.: 136293-86-2 | Purity: 96% | N-Methylazetidin-3-amine dihydrochloride | ESD-898802-1G |
Cas.: 1260771-44-5 | Purity: ≥95% | 7-Chloro-1H-pyrrolo[3,2-c]pyridine | ESD-898803-100MG |
Cas.: 1260771-44-5 | Purity: ≥95% | 7-Chloro-1H-pyrrolo[3,2-c]pyridine | ESD-898803-250MG |
Cas.: 1260771-44-5 | Purity: ≥95% | 7-Chloro-1H-pyrrolo[3,2-c]pyridine | ESD-898803-1G |
Cas.: 1380575-45-0 | Purity: 97% | 2-Isopropoxy-5-methyl-4-(pipidin-4-yl)aniline dihydrochloride | ESD-898804-100MG |
Cas.: 1380575-45-0 | Purity: 97% | 2-Isopropoxy-5-methyl-4-(pipidin-4-yl)aniline dihydrochloride | ESD-898804-250MG |
Cas.: 1380575-45-0 | Purity: 97% | 2-Isopropoxy-5-methyl-4-(pipidin-4-yl)aniline dihydrochloride | ESD-898804-1G |
Cas.: 1124199-15-0 | Purity: ≥95% | (R)-N-Methylpiperidine-3-carboxamide | ESD-898805-100MG |
Cas.: 1124199-15-0 | Purity: ≥95% | (R)-N-Methylpiperidine-3-carboxamide | ESD-898805-250MG |
Cas.: 1124199-15-0 | Purity: ≥95% | (R)-N-Methylpiperidine-3-carboxamide | ESD-898805-1G |
Cas.: 202931-88-2 | Purity: ≥95% | 1-Methyl-1H-1,2,3-triazole-5-carbaldehyde | ESD-898806-100MG |
Cas.: 202931-88-2 | Purity: ≥95% | 1-Methyl-1H-1,2,3-triazole-5-carbaldehyde | ESD-898806-250MG |
Cas.: 202931-88-2 | Purity: ≥95% | 1-Methyl-1H-1,2,3-triazole-5-carbaldehyde | ESD-898806-1G |
Cas.: 191608-18-1 | Purity: 97% | 8-Fluorochroman-4-amine hydrochloride | ESD-898807-100MG |
Cas.: 191608-18-1 | Purity: 97% | 8-Fluorochroman-4-amine hydrochloride | ESD-898807-250MG |
Cas.: 191608-18-1 | Purity: 97% | 8-Fluorochroman-4-amine hydrochloride | ESD-898807-1G |
Cas.: 55899-13-3 | Purity: ≥95% | 1-Amino-3-bromopyridin-1-ium 2,4,6-trimethylbenzenesulfonate | ESD-898808-100MG |
Cas.: 55899-13-3 | Purity: ≥95% | 1-Amino-3-bromopyridin-1-ium 2,4,6-trimethylbenzenesulfonate | ESD-898808-250MG |
Cas.: 55899-13-3 | Purity: ≥95% | 1-Amino-3-bromopyridin-1-ium 2,4,6-trimethylbenzenesulfonate | ESD-898808-1G |
Cas.: 327183-32-4 | Purity: 97% | Chroman-8-carbaldehyde | ESD-898809-100MG |
Cas.: 327183-32-4 | Purity: 97% | Chroman-8-carbaldehyde | ESD-898809-250MG |
Cas.: 327183-32-4 | Purity: 97% | Chroman-8-carbaldehyde | ESD-898809-1G |
Cas.: 864770-82-1 | Purity: 97% | tert-Butyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-898810-100MG |
Cas.: 864770-82-1 | Purity: 97% | tert-Butyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-898810-250MG |
Cas.: 864770-82-1 | Purity: 97% | tert-Butyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-898810-1G |
Cas.: 291289-41-3 | Purity: 97% | 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | ESD-898811-100MG |
Cas.: 291289-41-3 | Purity: 97% | 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | ESD-898811-250MG |
Cas.: 291289-41-3 | Purity: 97% | 2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | ESD-898811-1G |
Cas.: 1035229-32-3 | Purity: 97% | 8-Acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-898812-100MG |
Cas.: 1035229-32-3 | Purity: 97% | 8-Acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-898812-250MG |
Cas.: 1035229-32-3 | Purity: 97% | 8-Acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-898812-1G |
Cas.: 1369512-65-1 | Purity: 97% | 4-(1-Aminocyclopropyl)benzonitrile hydrochloride | ESD-898813-100MG |
Cas.: 1369512-65-1 | Purity: 97% | 4-(1-Aminocyclopropyl)benzonitrile hydrochloride | ESD-898813-250MG |
Cas.: 1369512-65-1 | Purity: 97% | 4-(1-Aminocyclopropyl)benzonitrile hydrochloride | ESD-898813-1G |
Cas.: 442877-23-8 | Purity: 97% | rel-(3aR,5r,6aS)-2-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrole-5-carboxylic acid | ESD-898814-100MG |
Cas.: 442877-23-8 | Purity: 97% | rel-(3aR,5r,6aS)-2-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrole-5-carboxylic acid | ESD-898814-250MG |
Cas.: 442877-23-8 | Purity: 97% | rel-(3aR,5r,6aS)-2-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrole-5-carboxylic acid | ESD-898814-1G |
Cas.: 1013-04-3 | Purity: 98% | 4-Chloro-1-naphthoic acid | ESD-898815-100MG |
Cas.: 1013-04-3 | Purity: 98% | 4-Chloro-1-naphthoic acid | ESD-898815-250MG |
Cas.: 1013-04-3 | Purity: 98% | 4-Chloro-1-naphthoic acid | ESD-898815-1G |
Cas.: 1463053-93-1 | Purity: 97% | 2-Bromo-5-fluoro-3-methylaniline | ESD-898816-100MG |
Cas.: 1463053-93-1 | Purity: 97% | 2-Bromo-5-fluoro-3-methylaniline | ESD-898816-250MG |
Cas.: 1463053-93-1 | Purity: 97% | 2-Bromo-5-fluoro-3-methylaniline | ESD-898816-1G |
Cas.: 885522-12-3 | Purity: ≥95% | 6-Chloro-1H-indazole-4-carboxylic acid | ESD-898817-100MG |
Cas.: 885522-12-3 | Purity: ≥95% | 6-Chloro-1H-indazole-4-carboxylic acid | ESD-898817-250MG |
Cas.: 885522-12-3 | Purity: ≥95% | 6-Chloro-1H-indazole-4-carboxylic acid | ESD-898817-1G |
Cas.: 5984-56-5 | Purity: ≥95% | Piperidine-4-carboxylic acid hydrochloride | ESD-898818-100MG |
Cas.: 5984-56-5 | Purity: ≥95% | Piperidine-4-carboxylic acid hydrochloride | ESD-898818-250MG |
Cas.: 5984-56-5 | Purity: ≥95% | Piperidine-4-carboxylic acid hydrochloride | ESD-898818-1G |
Cas.: 412356-24-2 | Purity: ≥95% | (1r,4r)-4-Morpholinocyclohexanamine dihydrochloride | ESD-898819-100MG |
Cas.: 412356-24-2 | Purity: ≥95% | (1r,4r)-4-Morpholinocyclohexanamine dihydrochloride | ESD-898819-250MG |
Cas.: 951624-83-2 | Purity: ≥95% | 5-(Trifluoromethyl)nicotinonitrile | ESD-898820-100MG |
Cas.: 951624-83-2 | Purity: ≥95% | 5-(Trifluoromethyl)nicotinonitrile | ESD-898820-250MG |
Cas.: 951624-83-2 | Purity: ≥95% | 5-(Trifluoromethyl)nicotinonitrile | ESD-898820-1G |
Cas.: 1190317-11-3 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-898821-100MG |
Cas.: 1190317-11-3 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-898821-250MG |
Cas.: 1190317-11-3 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-898821-1G |
Cas.: 100047-56-1 | Purity: 97% | 5-Bromo-3-methylpyrazin-2-ol | ESD-898822-100MG |
Cas.: 100047-56-1 | Purity: 97% | 5-Bromo-3-methylpyrazin-2-ol | ESD-898822-250MG |
Cas.: 100047-56-1 | Purity: 97% | 5-Bromo-3-methylpyrazin-2-ol | ESD-898822-1G |
Cas.: 21801-80-9 | Purity: 97% | 7-Methylimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-898823-100MG |
Cas.: 21801-80-9 | Purity: 97% | 7-Methylimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-898823-250MG |
Cas.: 21801-80-9 | Purity: 97% | 7-Methylimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-898823-1G |
Cas.: 849067-97-6 | Purity: ≥95% | (1H-Pyrrolo[2,3-b]pyridin-5-yl)methanol | ESD-898824-100MG |
Cas.: 849067-97-6 | Purity: ≥95% | (1H-Pyrrolo[2,3-b]pyridin-5-yl)methanol | ESD-898824-250MG |
Cas.: 849067-97-6 | Purity: ≥95% | (1H-Pyrrolo[2,3-b]pyridin-5-yl)methanol | ESD-898824-1G |
Cas.: 6608-47-5 | Purity: ≥95% | Ethenesulfonyl chloride | ESD-898825-100MG |
Cas.: 6608-47-5 | Purity: ≥95% | Ethenesulfonyl chloride | ESD-898825-250MG |
Cas.: 6608-47-5 | Purity: ≥95% | Ethenesulfonyl chloride | ESD-898825-1G |
Cas.: 1638137-85-5 | Purity: ≥95% | (S)-1-(3-Methylpiperazin-1-yl)ethanone hydrochloride | ESD-898826-100MG |
Cas.: 1638137-85-5 | Purity: ≥95% | (S)-1-(3-Methylpiperazin-1-yl)ethanone hydrochloride | ESD-898826-250MG |
Cas.: 1638137-85-5 | Purity: ≥95% | (S)-1-(3-Methylpiperazin-1-yl)ethanone hydrochloride | ESD-898826-1G |
Cas.: 1556457-89-6 | Purity: 97% | 5-Bromo-7H-pyrrolo[2,3-d]pyrimidin-2-amine | ESD-898827-100MG |
Cas.: 1556457-89-6 | Purity: 97% | 5-Bromo-7H-pyrrolo[2,3-d]pyrimidin-2-amine | ESD-898827-250MG |
Cas.: 1556457-89-6 | Purity: 97% | 5-Bromo-7H-pyrrolo[2,3-d]pyrimidin-2-amine | ESD-898827-1G |
Cas.: 1206978-11-1 | Purity: 95% | 2-Bromo-3-(trifluoromethoxy)pyridine | ESD-898828-100MG |
Cas.: 1206978-11-1 | Purity: 95% | 2-Bromo-3-(trifluoromethoxy)pyridine | ESD-898828-250MG |
Cas.: 1206978-11-1 | Purity: 95% | 2-Bromo-3-(trifluoromethoxy)pyridine | ESD-898828-1G |
Cas.: 1062174-44-0 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indoline | ESD-898829-100MG |
Cas.: 1062174-44-0 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indoline | ESD-898829-250MG |
Cas.: 1062174-44-0 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indoline | ESD-898829-1G |
Cas.: 247564-59-6 | Purity: 98% | 5,7-Difluoroindolin-2-one | ESD-898830-100MG |
Cas.: 247564-59-6 | Purity: 98% | 5,7-Difluoroindolin-2-one | ESD-898830-250MG |
Cas.: 247564-59-6 | Purity: 98% | 5,7-Difluoroindolin-2-one | ESD-898830-1G |
Cas.: 1320266-92-9 | Purity: 95% | 8-Chloro-1-iodo-3-isopropylimidazo[1,5-a]pyrazine | ESD-898831-100MG |
Cas.: 1320266-92-9 | Purity: 95% | 8-Chloro-1-iodo-3-isopropylimidazo[1,5-a]pyrazine | ESD-898831-250MG |
Cas.: 1320266-92-9 | Purity: 95% | 8-Chloro-1-iodo-3-isopropylimidazo[1,5-a]pyrazine | ESD-898831-1G |
Cas.: 1403766-76-6 | Purity: ≥95% | 4-(Azetidin-3-yl)-1-methylpiperazin-2-one dihydrochloride | ESD-898832-100MG |
Cas.: 1403766-76-6 | Purity: ≥95% | 4-(Azetidin-3-yl)-1-methylpiperazin-2-one dihydrochloride | ESD-898832-250MG |
Cas.: 1403766-76-6 | Purity: ≥95% | 4-(Azetidin-3-yl)-1-methylpiperazin-2-one dihydrochloride | ESD-898832-1G |
Cas.: 35196-48-6 | Purity: 97% | Ethyl 2-hydrazinyl-2-oxoacetate | ESD-898833-100MG |
Cas.: 35196-48-6 | Purity: 97% | Ethyl 2-hydrazinyl-2-oxoacetate | ESD-898833-250MG |
Cas.: 35196-48-6 | Purity: 97% | Ethyl 2-hydrazinyl-2-oxoacetate | ESD-898833-1G |
Cas.: 1067230-65-2 | Purity: 96% | (R)-1-Boc-3-(Bromomethyl)pyrrolidine | ESD-898834-100MG |
Cas.: 1067230-65-2 | Purity: 96% | (R)-1-Boc-3-(Bromomethyl)pyrrolidine | ESD-898834-250MG |
Cas.: 1067230-65-2 | Purity: 96% | (R)-1-Boc-3-(Bromomethyl)pyrrolidine | ESD-898834-1G |
Cas.: 796090-23-8 | Purity: 96% | 2-Chloro-6-(trifluoromethyl)isonicotinic acid | ESD-898835-100MG |
Cas.: 796090-23-8 | Purity: 96% | 2-Chloro-6-(trifluoromethyl)isonicotinic acid | ESD-898835-250MG |
Cas.: 796090-23-8 | Purity: 96% | 2-Chloro-6-(trifluoromethyl)isonicotinic acid | ESD-898835-1G |
Cas.: 351005-12-4 | Purity: 97% | 5-Bromo-1,3-dihydrobenzo[c]thiophene 2,2-dioxide | ESD-898836-100MG |
Cas.: 351005-12-4 | Purity: 97% | 5-Bromo-1,3-dihydrobenzo[c]thiophene 2,2-dioxide | ESD-898836-250MG |
Cas.: 351005-12-4 | Purity: 97% | 5-Bromo-1,3-dihydrobenzo[c]thiophene 2,2-dioxide | ESD-898836-1G |
Cas.: 15224-11-0 | Purity: 96% | Ethyl 2-(hydroxymethyl)cyclopropanecarboxylate | ESD-898837-100MG |
Cas.: 15224-11-0 | Purity: 96% | Ethyl 2-(hydroxymethyl)cyclopropanecarboxylate | ESD-898837-250MG |
Cas.: 15224-11-0 | Purity: 96% | Ethyl 2-(hydroxymethyl)cyclopropanecarboxylate | ESD-898837-1G |
Cas.: 120258-69-7 | Purity: 98% | 2,8-Dichloroquinoxaline | ESD-898838-100MG |
Cas.: 120258-69-7 | Purity: 98% | 2,8-Dichloroquinoxaline | ESD-898838-250MG |
Cas.: 120258-69-7 | Purity: 98% | 2,8-Dichloroquinoxaline | ESD-898838-1G |
Cas.: 15400-58-5 | Purity: 98% | Methyl 2,4-dimethoxypyrimidine-5-carboxylate | ESD-898839-100MG |
Cas.: 15400-58-5 | Purity: 98% | Methyl 2,4-dimethoxypyrimidine-5-carboxylate | ESD-898839-250MG |
Cas.: 15400-58-5 | Purity: 98% | Methyl 2,4-dimethoxypyrimidine-5-carboxylate | ESD-898839-1G |
Cas.: 6760-99-2 | Purity: 97% | 8-Azabicyclo[3.2.1]octane hydrochloride | ESD-898840-100MG |
Cas.: 6760-99-2 | Purity: 97% | 8-Azabicyclo[3.2.1]octane hydrochloride | ESD-898840-250MG |
Cas.: 6760-99-2 | Purity: 97% | 8-Azabicyclo[3.2.1]octane hydrochloride | ESD-898840-1G |
Cas.: 867065-53-0 | Purity: 97% | Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate | ESD-898841-100MG |
Cas.: 867065-53-0 | Purity: 97% | Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate | ESD-898841-250MG |
Cas.: 867065-53-0 | Purity: 97% | Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate | ESD-898841-1G |
Cas.: 13196-11-7 | Purity: ≥95% | Benzofuran-6-ol | ESD-898842-100MG |
Cas.: 13196-11-7 | Purity: ≥95% | Benzofuran-6-ol | ESD-898842-250MG |
Cas.: 13196-11-7 | Purity: ≥95% | Benzofuran-6-ol | ESD-898842-1G |
Cas.: 1428234-73-4 | Purity: ≥95% | 4-Bromo-5-(trifluoromethyl)-1H-indazole | ESD-898843-100MG |
Cas.: 1428234-73-4 | Purity: ≥95% | 4-Bromo-5-(trifluoromethyl)-1H-indazole | ESD-898843-250MG |
Cas.: 1428234-73-4 | Purity: ≥95% | 4-Bromo-5-(trifluoromethyl)-1H-indazole | ESD-898843-1G |
Cas.: 56181-38-5 | Purity: ≥95% | 5-Bromo-N-methylpyrimidin-4-amine | ESD-898844-100MG |
Cas.: 56181-38-5 | Purity: ≥95% | 5-Bromo-N-methylpyrimidin-4-amine | ESD-898844-250MG |
Cas.: 56181-38-5 | Purity: ≥95% | 5-Bromo-N-methylpyrimidin-4-amine | ESD-898844-1G |
Cas.: 58249-61-9 | Purity: 97% | Benzo[d]thiazole-6-carbonitrile | ESD-898845-100MG |
Cas.: 58249-61-9 | Purity: 97% | Benzo[d]thiazole-6-carbonitrile | ESD-898845-250MG |
Cas.: 58249-61-9 | Purity: 97% | Benzo[d]thiazole-6-carbonitrile | ESD-898845-1G |
Cas.: 65977-55-1 | Purity: ≥95% | 5-Chlorothieno[3,2-b]pyridine | ESD-898846-100MG |
Cas.: 65977-55-1 | Purity: ≥95% | 5-Chlorothieno[3,2-b]pyridine | ESD-898846-250MG |
Cas.: 65977-55-1 | Purity: ≥95% | 5-Chlorothieno[3,2-b]pyridine | ESD-898846-1G |
Cas.: 1383056-73-2 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | ESD-898847-100MG |
Cas.: 1383056-73-2 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | ESD-898847-250MG |
Cas.: 1383056-73-2 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | ESD-898847-1G |
Cas.: 1063733-41-4 | Purity: 97% | N-(2,4-Dimethoxybenzyl)-1,2,4-thiadiazol-5-amine | ESD-898848-100MG |
Cas.: 1063733-41-4 | Purity: 97% | N-(2,4-Dimethoxybenzyl)-1,2,4-thiadiazol-5-amine | ESD-898848-250MG |
Cas.: 1063733-41-4 | Purity: 97% | N-(2,4-Dimethoxybenzyl)-1,2,4-thiadiazol-5-amine | ESD-898848-1G |
Cas.: 784150-41-0 | Purity: ≥95% | 6-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-898849-100MG |
Cas.: 784150-41-0 | Purity: ≥95% | 6-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-898849-250MG |
Cas.: 784150-41-0 | Purity: ≥95% | 6-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-898849-1G |
Cas.: 204136-88-9 | Purity: 97% | 4-Oxocyclohexanecarboxamide | ESD-898850-100MG |
Cas.: 204136-88-9 | Purity: 97% | 4-Oxocyclohexanecarboxamide | ESD-898850-250MG |
Cas.: 204136-88-9 | Purity: 97% | 4-Oxocyclohexanecarboxamide | ESD-898850-1G |
Cas.: 655255-08-6 | Purity: 96% | Furo[3,2-d]pyrimidin-4(3H)-one | ESD-898851-100MG |
Cas.: 655255-08-6 | Purity: 96% | Furo[3,2-d]pyrimidin-4(3H)-one | ESD-898851-250MG |
Cas.: 655255-08-6 | Purity: 96% | Furo[3,2-d]pyrimidin-4(3H)-one | ESD-898851-1G |
Cas.: 845267-80-3 | Purity: 95% | 1-Boc-5-Ethyl-2,4-dioxopiperidine | ESD-898852-100MG |
Cas.: 845267-80-3 | Purity: 95% | 1-Boc-5-Ethyl-2,4-dioxopiperidine | ESD-898852-250MG |
Cas.: 845267-80-3 | Purity: 95% | 1-Boc-5-Ethyl-2,4-dioxopiperidine | ESD-898852-1G |
Cas.: 915394-29-5 | Purity: ≥95% | 2-(3-Aminophenyl)-2-methylpropanenitrile | ESD-898853-100MG |
Cas.: 915394-29-5 | Purity: ≥95% | 2-(3-Aminophenyl)-2-methylpropanenitrile | ESD-898853-250MG |
Cas.: 915394-29-5 | Purity: ≥95% | 2-(3-Aminophenyl)-2-methylpropanenitrile | ESD-898853-1G |
Cas.: 1256823-05-8 | Purity: 97% | 6-Chloro-4-methoxynicotinaldehyde | ESD-898854-100MG |
Cas.: 1256823-05-8 | Purity: 97% | 6-Chloro-4-methoxynicotinaldehyde | ESD-898854-250MG |
Cas.: 1256823-05-8 | Purity: 97% | 6-Chloro-4-methoxynicotinaldehyde | ESD-898854-1G |
Cas.: 1217474-04-8 | Purity: ≥95% | (2R,4R)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride | ESD-898855-100MG |
Cas.: 1217474-04-8 | Purity: ≥95% | (2R,4R)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride | ESD-898855-250MG |
Cas.: 1217474-04-8 | Purity: ≥95% | (2R,4R)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate hydrochloride | ESD-898855-1G |
Cas.: 81115-60-8 | Purity: ≥95% | 5-Methyl-1H-indazol-4-amine | ESD-898856-100MG |
Cas.: 81115-60-8 | Purity: ≥95% | 5-Methyl-1H-indazol-4-amine | ESD-898856-250MG |
Cas.: 81115-60-8 | Purity: ≥95% | 5-Methyl-1H-indazol-4-amine | ESD-898856-1G |
Cas.: 331833-83-1 | Purity: 98% | (5-Cyanobenzofuran-2-yl)boronic acid | ESD-898857-100MG |
Cas.: 331833-83-1 | Purity: 98% | (5-Cyanobenzofuran-2-yl)boronic acid | ESD-898857-250MG |
Cas.: 331833-83-1 | Purity: 98% | (5-Cyanobenzofuran-2-yl)boronic acid | ESD-898857-1G |
Cas.: 1171124-65-4 | Purity: ≥95% | Ethyl 5-ethyl-1H-imidazole-2-carboxylate | ESD-898858-100MG |
Cas.: 1171124-65-4 | Purity: ≥95% | Ethyl 5-ethyl-1H-imidazole-2-carboxylate | ESD-898858-250MG |
Cas.: 1171124-65-4 | Purity: ≥95% | Ethyl 5-ethyl-1H-imidazole-2-carboxylate | ESD-898858-1G |
Cas.: 885520-48-9 | Purity: 98% | 4-Bromo-6-methyl-1H-indole | ESD-898859-100MG |
Cas.: 885520-48-9 | Purity: 98% | 4-Bromo-6-methyl-1H-indole | ESD-898859-250MG |
Cas.: 885520-48-9 | Purity: 98% | 4-Bromo-6-methyl-1H-indole | ESD-898859-1G |
Cas.: 114097-17-5 | Purity: 97% | Ethyl 3-oxo-3,4-dihydropyrido[2,3-b]pyrazine-2-carboxylate | ESD-898860-100MG |
Cas.: 114097-17-5 | Purity: 97% | Ethyl 3-oxo-3,4-dihydropyrido[2,3-b]pyrazine-2-carboxylate | ESD-898860-250MG |
Cas.: 114097-17-5 | Purity: 97% | Ethyl 3-oxo-3,4-dihydropyrido[2,3-b]pyrazine-2-carboxylate | ESD-898860-1G |
Cas.: 1234616-83-1 | Purity: ≥95% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-898861-100MG |
Cas.: 1234616-83-1 | Purity: ≥95% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-898861-250MG |
Cas.: 1234616-83-1 | Purity: ≥95% | Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | ESD-898861-1G |
Cas.: 1351586-91-8 | Purity: 97% | Methyl 2-amino-2-(3-chlorophenyl)acetate hydrochloride | ESD-898862-100MG |
Cas.: 1351586-91-8 | Purity: 97% | Methyl 2-amino-2-(3-chlorophenyl)acetate hydrochloride | ESD-898862-250MG |
Cas.: 1351586-91-8 | Purity: 97% | Methyl 2-amino-2-(3-chlorophenyl)acetate hydrochloride | ESD-898862-1G |
Cas.: 1190318-63-8 | Purity: 95% | 7-Bromo-4-azindole | ESD-898863-100MG |
Cas.: 1190318-63-8 | Purity: 95% | 7-Bromo-4-azindole | ESD-898863-250MG |
Cas.: 1190318-63-8 | Purity: 95% | 7-Bromo-4-azindole | ESD-898863-1G |
Cas.: 1363381-07-0 | Purity: ≥95% | Ethyl 7-bromoimidazo[1,5-a]pyridine-1-carboxylate | ESD-898864-100MG |
Cas.: 1363381-07-0 | Purity: ≥95% | Ethyl 7-bromoimidazo[1,5-a]pyridine-1-carboxylate | ESD-898864-250MG |
Cas.: 1363381-07-0 | Purity: ≥95% | Ethyl 7-bromoimidazo[1,5-a]pyridine-1-carboxylate | ESD-898864-1G |
Cas.: 14252-05-2 | Purity: 97% | Bicyclo[3.2.1]octan-3-one | ESD-898865-100MG |
Cas.: 14252-05-2 | Purity: 97% | Bicyclo[3.2.1]octan-3-one | ESD-898865-250MG |
Cas.: 14252-05-2 | Purity: 97% | Bicyclo[3.2.1]octan-3-one | ESD-898865-1G |
Cas.: 1357354-49-4 | Purity: ≥95% | 2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate | ESD-898866-100MG |
Cas.: 1357354-49-4 | Purity: ≥95% | 2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate | ESD-898866-250MG |
Cas.: 1357354-49-4 | Purity: ≥95% | 2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate | ESD-898866-1G |
Cas.: 113118-84-6 | Purity: 98% | 5-Phenylnicotinaldehyde | ESD-898867-100MG |
Cas.: 113118-84-6 | Purity: 98% | 5-Phenylnicotinaldehyde | ESD-898867-250MG |
Cas.: 113118-84-6 | Purity: 98% | 5-Phenylnicotinaldehyde | ESD-898867-1G |
Cas.: 1151802-02-6 | Purity: 97% | 8-Chloro-3-fluoro-1,5-naphthyridine | ESD-898868-100MG |
Cas.: 1151802-02-6 | Purity: 97% | 8-Chloro-3-fluoro-1,5-naphthyridine | ESD-898868-250MG |
Cas.: 1151802-02-6 | Purity: 97% | 8-Chloro-3-fluoro-1,5-naphthyridine | ESD-898868-1G |
Cas.: 412327-07-2 | Purity: ≥95% | (4-Methoxybenzyl)hydrazine dihydrochloride | ESD-898869-100MG |
Cas.: 412327-07-2 | Purity: ≥95% | (4-Methoxybenzyl)hydrazine dihydrochloride | ESD-898869-250MG |
Cas.: 412327-07-2 | Purity: ≥95% | (4-Methoxybenzyl)hydrazine dihydrochloride | ESD-898869-1G |
Cas.: 1198-46-5 | Purity: ≥95% | 2-Chloro-6-methoxypurine | ESD-898870-100MG |
Cas.: 1198-46-5 | Purity: ≥95% | 2-Chloro-6-methoxypurine | ESD-898870-250MG |
Cas.: 1198-46-5 | Purity: ≥95% | 2-Chloro-6-methoxypurine | ESD-898870-1G |
Cas.: 73873-61-7 | Purity: 97% | trans-4-Methoxycyclohexanecarboxylic acid | ESD-898871-100MG |
Cas.: 73873-61-7 | Purity: 97% | trans-4-Methoxycyclohexanecarboxylic acid | ESD-898871-250MG |
Cas.: 73873-61-7 | Purity: 97% | trans-4-Methoxycyclohexanecarboxylic acid | ESD-898871-1G |
Cas.: 443955-90-6 | Purity: 97% | 2,3-Dihydro-[1,4]dioxino[2,3-c]pyridine-7-carbaldehyde | ESD-898872-100MG |
Cas.: 443955-90-6 | Purity: 97% | 2,3-Dihydro-[1,4]dioxino[2,3-c]pyridine-7-carbaldehyde | ESD-898872-250MG |
Cas.: 443955-90-6 | Purity: 97% | 2,3-Dihydro-[1,4]dioxino[2,3-c]pyridine-7-carbaldehyde | ESD-898872-1G |
Cas.: 1404373-78-9 | Purity: 97% | 4-Amino-1-methylpyridin-2(1H)-one hydrochloride | ESD-898873-100MG |
Cas.: 1404373-78-9 | Purity: 97% | 4-Amino-1-methylpyridin-2(1H)-one hydrochloride | ESD-898873-250MG |
Cas.: 1404373-78-9 | Purity: 97% | 4-Amino-1-methylpyridin-2(1H)-one hydrochloride | ESD-898873-1G |
Cas.: 301666-62-6 | Purity: 97% | Ethyl 3-(cyanomethyl)picolinate | ESD-898874-100MG |
Cas.: 301666-62-6 | Purity: 97% | Ethyl 3-(cyanomethyl)picolinate | ESD-898874-250MG |
Cas.: 301666-62-6 | Purity: 97% | Ethyl 3-(cyanomethyl)picolinate | ESD-898874-1G |
Cas.: 143469-22-1 | Purity: ≥95% | 2-Bromo-5-(trifluoromethyl)thiophene | ESD-898875-100MG |
Cas.: 143469-22-1 | Purity: ≥95% | 2-Bromo-5-(trifluoromethyl)thiophene | ESD-898875-250MG |
Cas.: 143469-22-1 | Purity: ≥95% | 2-Bromo-5-(trifluoromethyl)thiophene | ESD-898875-1G |
Cas.: 944903-06-4 | Purity: ≥95% | 3-Bromo-6-chloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-898876-100MG |
Cas.: 944903-06-4 | Purity: ≥95% | 3-Bromo-6-chloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-898876-250MG |
Cas.: 944903-06-4 | Purity: ≥95% | 3-Bromo-6-chloro-1H-pyrazolo[3,4-d]pyrimidine | ESD-898876-1G |
Cas.: 1224844-66-9 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2-amine | ESD-898877-100MG |
Cas.: 1224844-66-9 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2-amine | ESD-898877-250MG |
Cas.: 1224844-66-9 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2-amine | ESD-898877-1G |
Cas.: 885102-33-0 | Purity: 97% | (3R,4S)-rel-tert-Butyl 3-hydroxy-4-methylpyrrolidine-1-carboxylate | ESD-898878-100MG |
Cas.: 885102-33-0 | Purity: 97% | (3R,4S)-rel-tert-Butyl 3-hydroxy-4-methylpyrrolidine-1-carboxylate | ESD-898878-250MG |
Cas.: 885102-33-0 | Purity: 97% | (3R,4S)-rel-tert-Butyl 3-hydroxy-4-methylpyrrolidine-1-carboxylate | ESD-898878-1G |
Cas.: 1171891-35-2 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ol | ESD-898879-100MG |
Cas.: 1171891-35-2 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ol | ESD-898879-250MG |
Cas.: 1171891-35-2 | Purity: ≥95% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ol | ESD-898879-1G |
Cas.: 52651-15-7 | Purity: ≥95% | 6-Chloro-2,3-dihydro-1H-indene-1-carboxylic acid | ESD-898880-100MG |
Cas.: 52651-15-7 | Purity: ≥95% | 6-Chloro-2,3-dihydro-1H-indene-1-carboxylic acid | ESD-898880-250MG |
Cas.: 52651-15-7 | Purity: ≥95% | 6-Chloro-2,3-dihydro-1H-indene-1-carboxylic acid | ESD-898880-1G |
Cas.: 152265-57-1 | Purity: 95% | 7-Bromophthalazin-1(2H)-one | ESD-898881-100MG |
Cas.: 152265-57-1 | Purity: 95% | 7-Bromophthalazin-1(2H)-one | ESD-898881-250MG |
Cas.: 152265-57-1 | Purity: 95% | 7-Bromophthalazin-1(2H)-one | ESD-898881-1G |
Cas.: 1807882-36-5 | Purity: ≥95% | trans-2-Methylmorpholine-3-carboxylic acid hydrochloride | ESD-898882-100MG |
Cas.: 1807882-36-5 | Purity: ≥95% | trans-2-Methylmorpholine-3-carboxylic acid hydrochloride | ESD-898882-250MG |
Cas.: 1807882-36-5 | Purity: ≥95% | trans-2-Methylmorpholine-3-carboxylic acid hydrochloride | ESD-898882-1G |
Cas.: 49851-36-7 | Purity: 97% | Methyl 2-(2-aminophenyl)acetate hydrochloride | ESD-898883-100MG |
Cas.: 49851-36-7 | Purity: 97% | Methyl 2-(2-aminophenyl)acetate hydrochloride | ESD-898883-250MG |
Cas.: 49851-36-7 | Purity: 97% | Methyl 2-(2-aminophenyl)acetate hydrochloride | ESD-898883-1G |
Cas.: 1211533-26-4 | Purity: ≥95% | 2-Chloro-6-fluoronicotinic acid | ESD-898884-100MG |
Cas.: 1211533-26-4 | Purity: ≥95% | 2-Chloro-6-fluoronicotinic acid | ESD-898884-250MG |
Cas.: 1211533-26-4 | Purity: ≥95% | 2-Chloro-6-fluoronicotinic acid | ESD-898884-1G |
Cas.: 1160246-75-2 | Purity: 95% | tert-Butyl 3-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-898885-100MG |
Cas.: 1160246-75-2 | Purity: 95% | tert-Butyl 3-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-898885-250MG |
Cas.: 1160246-75-2 | Purity: 95% | tert-Butyl 3-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-898885-1G |
Cas.: 1189434-55-6 | Purity: ≥95% | Ethyl 6-(aminomethyl)nicotinate hydrochloride | ESD-898886-100MG |
Cas.: 1189434-55-6 | Purity: ≥95% | Ethyl 6-(aminomethyl)nicotinate hydrochloride | ESD-898886-250MG |
Cas.: 1189434-55-6 | Purity: ≥95% | Ethyl 6-(aminomethyl)nicotinate hydrochloride | ESD-898886-1G |
Cas.: 117738-76-8 | Purity: 97% | 4-Chloro-3-cyanobenzoic acid | ESD-898887-100MG |
Cas.: 117738-76-8 | Purity: 97% | 4-Chloro-3-cyanobenzoic acid | ESD-898887-250MG |
Cas.: 117738-76-8 | Purity: 97% | 4-Chloro-3-cyanobenzoic acid | ESD-898887-1G |
Cas.: 318951-60-9 | Purity: ≥95% | 3-(Trifluoromethyl)-1H-pyrazole-4-carbonitrile | ESD-898888-100MG |
Cas.: 318951-60-9 | Purity: ≥95% | 3-(Trifluoromethyl)-1H-pyrazole-4-carbonitrile | ESD-898888-250MG |
Cas.: 318951-60-9 | Purity: ≥95% | 3-(Trifluoromethyl)-1H-pyrazole-4-carbonitrile | ESD-898888-1G |
Cas.: 1260779-19-8 | Purity: ≥95% | (1-Methylcyclopropyl)methanamine hydrochloride | ESD-898889-100MG |
Cas.: 1260779-19-8 | Purity: ≥95% | (1-Methylcyclopropyl)methanamine hydrochloride | ESD-898889-250MG |
Cas.: 1260779-19-8 | Purity: ≥95% | (1-Methylcyclopropyl)methanamine hydrochloride | ESD-898889-1G |
Cas.: 1190322-18-9 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-898890-100MG |
Cas.: 1190322-18-9 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-898890-250MG |
Cas.: 1190322-18-9 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine | ESD-898890-1G |
Cas.: 865156-48-5 | Purity: 97% | 7-Bromoimidazo[1,5-a]pyridine | ESD-898891-100MG |
Cas.: 865156-48-5 | Purity: 97% | 7-Bromoimidazo[1,5-a]pyridine | ESD-898891-250MG |
Cas.: 865156-48-5 | Purity: 97% | 7-Bromoimidazo[1,5-a]pyridine | ESD-898891-1G |
Cas.: 19910-33-9 | Purity: ≥95% | 2-(4-Nitrophenyl)propanoic acid | ESD-898892-100MG |
Cas.: 19910-33-9 | Purity: ≥95% | 2-(4-Nitrophenyl)propanoic acid | ESD-898892-250MG |
Cas.: 19910-33-9 | Purity: ≥95% | 2-(4-Nitrophenyl)propanoic acid | ESD-898892-1G |
Cas.: 1360952-20-0 | Purity: ≥95% | 5-Fluoro-6-nitro-1H-indazole | ESD-898893-100MG |
Cas.: 1360952-20-0 | Purity: ≥95% | 5-Fluoro-6-nitro-1H-indazole | ESD-898893-250MG |
Cas.: 1360952-20-0 | Purity: ≥95% | 5-Fluoro-6-nitro-1H-indazole | ESD-898893-1G |
Cas.: 1092394-16-5 | Purity: ≥95% | 2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-ol hydrobromide | ESD-898894-100MG |
Cas.: 1092394-16-5 | Purity: ≥95% | 2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-ol hydrobromide | ESD-898894-250MG |
Cas.: 1092394-16-5 | Purity: ≥95% | 2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-ol hydrobromide | ESD-898894-1G |
Cas.: 1799612-10-4 | Purity: 97% | 2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-898895-100MG |
Cas.: 1799612-10-4 | Purity: 97% | 2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-898895-250MG |
Cas.: 1799612-10-4 | Purity: 97% | 2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-898895-1G |
Cas.: 94994-25-9 | Purity: ≥95% | Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate | ESD-898896-100MG |
Cas.: 94994-25-9 | Purity: ≥95% | Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate | ESD-898896-250MG |
Cas.: 94994-25-9 | Purity: ≥95% | Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate | ESD-898896-1G |
Cas.: 22364-29-0 | Purity: 97% | 2-Bromo-4,5-dimethylaniline | ESD-898897-100MG |
Cas.: 22364-29-0 | Purity: 97% | 2-Bromo-4,5-dimethylaniline | ESD-898897-250MG |
Cas.: 22364-29-0 | Purity: 97% | 2-Bromo-4,5-dimethylaniline | ESD-898897-1G |
Cas.: 1223748-35-3 | Purity: ≥95% | 5-Bromo-6-iodopyridin-2-amine | ESD-898898-100MG |
Cas.: 1223748-35-3 | Purity: ≥95% | 5-Bromo-6-iodopyridin-2-amine | ESD-898898-250MG |
Cas.: 1223748-35-3 | Purity: ≥95% | 5-Bromo-6-iodopyridin-2-amine | ESD-898898-1G |
Cas.: 1215504-30-5 | Purity: 97% | Ethyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-898899-100MG |
Cas.: 1215504-30-5 | Purity: 97% | Ethyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-898899-250MG |
Cas.: 1215504-30-5 | Purity: 97% | Ethyl 3-bromoimidazo[1,2-a]pyridine-6-carboxylate | ESD-898899-1G |
Cas.: 321890-22-6 | Purity: 97% | 1-(Azetidin-3-yl)-N,N-dimethylmethanamine dihydrochloride | ESD-898900-100MG |
Cas.: 321890-22-6 | Purity: 97% | 1-(Azetidin-3-yl)-N,N-dimethylmethanamine dihydrochloride | ESD-898900-250MG |
Cas.: 321890-22-6 | Purity: 97% | 1-(Azetidin-3-yl)-N,N-dimethylmethanamine dihydrochloride | ESD-898900-1G |
Cas.: 15910-91-5 | Purity: 98% | 1-Methylcyclopropanecarboxamide | ESD-898901-100MG |
Cas.: 15910-91-5 | Purity: 98% | 1-Methylcyclopropanecarboxamide | ESD-898901-250MG |
Cas.: 15910-91-5 | Purity: 98% | 1-Methylcyclopropanecarboxamide | ESD-898901-1G |
Cas.: 1378695-64-7 | Purity: 97% | 4-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid | ESD-898902-100MG |
Cas.: 1378695-64-7 | Purity: 97% | 4-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid | ESD-898902-250MG |
Cas.: 1378695-64-7 | Purity: 97% | 4-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid | ESD-898902-1G |
Cas.: 1190314-85-2 | Purity: 98% | 5-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-898903-100MG |
Cas.: 1190314-85-2 | Purity: 98% | 5-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-898903-250MG |
Cas.: 1190314-85-2 | Purity: 98% | 5-Fluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-898903-1G |
Cas.: 877399-31-0 | Purity: ≥95% | tert-Butyl 3-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)azetidine-1-carboxylate | ESD-898904-100MG |
Cas.: 877399-31-0 | Purity: ≥95% | tert-Butyl 3-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)azetidine-1-carboxylate | ESD-898904-250MG |
Cas.: 877399-31-0 | Purity: ≥95% | tert-Butyl 3-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)azetidine-1-carboxylate | ESD-898904-1G |
Cas.: 535924-74-4 | Purity: ≥95% | (S)-3-(Methoxymethyl)pyrrolidine | ESD-898905-100MG |
Cas.: 535924-74-4 | Purity: ≥95% | (S)-3-(Methoxymethyl)pyrrolidine | ESD-898905-250MG |
Cas.: 535924-74-4 | Purity: ≥95% | (S)-3-(Methoxymethyl)pyrrolidine | ESD-898905-1G |
Cas.: 57473-32-2 | Purity: 97% | 5,7-Dichloroimidazo[1,2-a]pyrimidine | ESD-898906-100MG |
Cas.: 57473-32-2 | Purity: 97% | 5,7-Dichloroimidazo[1,2-a]pyrimidine | ESD-898906-250MG |
Cas.: 57473-32-2 | Purity: 97% | 5,7-Dichloroimidazo[1,2-a]pyrimidine | ESD-898906-1G |
Cas.: 54732-89-7 | Purity: 97% | 5-Amino-1-methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-898907-100MG |
Cas.: 54732-89-7 | Purity: 97% | 5-Amino-1-methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-898907-250MG |
Cas.: 54732-89-7 | Purity: 97% | 5-Amino-1-methyl-1H-benzo[d]imidazol-2(3H)-one | ESD-898907-1G |
Cas.: 199330-64-8 | Purity: ≥95% | Methyl 2-amino-2,3-dihydro-1H-indene-2-carboxylate hydrochloride | ESD-898908-100MG |
Cas.: 199330-64-8 | Purity: ≥95% | Methyl 2-amino-2,3-dihydro-1H-indene-2-carboxylate hydrochloride | ESD-898908-250MG |
Cas.: 199330-64-8 | Purity: ≥95% | Methyl 2-amino-2,3-dihydro-1H-indene-2-carboxylate hydrochloride | ESD-898908-1G |
Cas.: 203663-25-6 | Purity: ≥95% | tert-Butyl 5-hydroxyhexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate | ESD-898909-100MG |
Cas.: 203663-25-6 | Purity: ≥95% | tert-Butyl 5-hydroxyhexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate | ESD-898909-250MG |
Cas.: 203663-25-6 | Purity: ≥95% | tert-Butyl 5-hydroxyhexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate | ESD-898909-1G |
Cas.: 1015868-48-0 | Purity: 95% | 3-(4-Chlorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid | ESD-898910-100MG |
Cas.: 1015868-48-0 | Purity: 95% | 3-(4-Chlorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid | ESD-898910-250MG |
Cas.: 1015868-48-0 | Purity: 95% | 3-(4-Chlorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid | ESD-898910-1G |
Cas.: 1071973-95-9 | Purity: 98% | 6-Methoxy-5-methyl-1H-indole | ESD-898911-100MG |
Cas.: 1071973-95-9 | Purity: 98% | 6-Methoxy-5-methyl-1H-indole | ESD-898911-250MG |
Cas.: 1071973-95-9 | Purity: 98% | 6-Methoxy-5-methyl-1H-indole | ESD-898911-1G |
Cas.: 1239355-46-4 | Purity: 97% | (R)-1-tert-Butyl 2-methyl aziridine-1,2-dicarboxylate | ESD-898912-100MG |
Cas.: 1239355-46-4 | Purity: 97% | (R)-1-tert-Butyl 2-methyl aziridine-1,2-dicarboxylate | ESD-898912-250MG |
Cas.: 1239355-46-4 | Purity: 97% | (R)-1-tert-Butyl 2-methyl aziridine-1,2-dicarboxylate | ESD-898912-1G |
Cas.: 191664-14-9 | Purity: 97% | (R)-2-(((tert-Butoxycarbonyl)amino)methyl)-3-methylbutanoic acid | ESD-898913-100MG |
Cas.: 191664-14-9 | Purity: 97% | (R)-2-(((tert-Butoxycarbonyl)amino)methyl)-3-methylbutanoic acid | ESD-898913-250MG |
Cas.: 191664-14-9 | Purity: 97% | (R)-2-(((tert-Butoxycarbonyl)amino)methyl)-3-methylbutanoic acid | ESD-898913-1G |
Cas.: 1057216-55-3 | Purity: 95% | 2-Chloro-5-iodopyrazine | ESD-898914-100MG |
Cas.: 1057216-55-3 | Purity: 95% | 2-Chloro-5-iodopyrazine | ESD-898914-250MG |
Cas.: 1057216-55-3 | Purity: 95% | 2-Chloro-5-iodopyrazine | ESD-898914-1G |
Cas.: 40261-59-4 | Purity: ≥95% | 1-Phenyl-1H-pyrazole-3-carbaldehyde | ESD-898915-100MG |
Cas.: 40261-59-4 | Purity: ≥95% | 1-Phenyl-1H-pyrazole-3-carbaldehyde | ESD-898915-250MG |
Cas.: 40261-59-4 | Purity: ≥95% | 1-Phenyl-1H-pyrazole-3-carbaldehyde | ESD-898915-1G |
Cas.: 194278-44-9 | Purity: ≥95% | 1-(3-Nitropyridin-2-yl)ethanone | ESD-898916-100MG |
Cas.: 194278-44-9 | Purity: ≥95% | 1-(3-Nitropyridin-2-yl)ethanone | ESD-898916-250MG |
Cas.: 194278-44-9 | Purity: ≥95% | 1-(3-Nitropyridin-2-yl)ethanone | ESD-898916-1G |
Cas.: 1150271-44-5 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | ESD-898917-100MG |
Cas.: 1150271-44-5 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | ESD-898917-250MG |
Cas.: 1150271-44-5 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | ESD-898917-1G |
Cas.: 17366-48-2 | Purity: 97% | exo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride | ESD-898918-100MG |
Cas.: 17366-48-2 | Purity: 97% | exo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride | ESD-898918-250MG |
Cas.: 17366-48-2 | Purity: 97% | exo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride | ESD-898918-1G |
Cas.: 351439-07-1 | Purity: ≥97% | Methyl 1H-pyrrolo[2,3-b]pyridine-4-carboxylate | ESD-898919-100MG |
Cas.: 351439-07-1 | Purity: ≥97% | Methyl 1H-pyrrolo[2,3-b]pyridine-4-carboxylate | ESD-898919-250MG |
Cas.: 351439-07-1 | Purity: ≥97% | Methyl 1H-pyrrolo[2,3-b]pyridine-4-carboxylate | ESD-898919-1G |
Cas.: 1000896-40-1 | Purity: ≥95% | 5-(Benzyloxy)-1H-pyrazol-3-amine | ESD-898920-100MG |
Cas.: 1000896-40-1 | Purity: ≥95% | 5-(Benzyloxy)-1H-pyrazol-3-amine | ESD-898920-250MG |
Cas.: 1000896-40-1 | Purity: ≥95% | 5-(Benzyloxy)-1H-pyrazol-3-amine | ESD-898920-1G |
Cas.: 885519-41-5 | Purity: 98% | 6-Bromo-4-iodo-1H-indazole | ESD-898921-100MG |
Cas.: 885519-41-5 | Purity: 98% | 6-Bromo-4-iodo-1H-indazole | ESD-898921-250MG |
Cas.: 885519-41-5 | Purity: 98% | 6-Bromo-4-iodo-1H-indazole | ESD-898921-1G |
Cas.: 89089-19-0 | Purity: ≥95% | 5-Bromo-6-chloro-4(3H)-pyrimidinone | ESD-898922-100MG |
Cas.: 89089-19-0 | Purity: ≥95% | 5-Bromo-6-chloro-4(3H)-pyrimidinone | ESD-898922-250MG |
Cas.: 89089-19-0 | Purity: ≥95% | 5-Bromo-6-chloro-4(3H)-pyrimidinone | ESD-898922-1G |
Cas.: 233276-35-2 | Purity: 98% | cis-3-(Benzyloxy)cyclobutanol | ESD-898923-100MG |
Cas.: 233276-35-2 | Purity: 98% | cis-3-(Benzyloxy)cyclobutanol | ESD-898923-250MG |
Cas.: 233276-35-2 | Purity: 98% | cis-3-(Benzyloxy)cyclobutanol | ESD-898923-1G |
Cas.: 1481631-51-9 | Purity: 97% | tert-Butyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate | ESD-898924-100MG |
Cas.: 1481631-51-9 | Purity: 97% | tert-Butyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate | ESD-898924-250MG |
Cas.: 1481631-51-9 | Purity: 97% | tert-Butyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate | ESD-898924-1G |
Cas.: 383132-39-6 | Purity: 97% | 5-Isopropyl-1H-indole-2-carboxylic acid | ESD-898925-100MG |
Cas.: 383132-39-6 | Purity: 97% | 5-Isopropyl-1H-indole-2-carboxylic acid | ESD-898925-250MG |
Cas.: 383132-39-6 | Purity: 97% | 5-Isopropyl-1H-indole-2-carboxylic acid | ESD-898925-1G |
Cas.: 1187931-39-0 | Purity: ≥95% | 3-(4-Bromophenyl)pyrrolidine hydrochloride | ESD-898926-100MG |
Cas.: 1187931-39-0 | Purity: ≥95% | 3-(4-Bromophenyl)pyrrolidine hydrochloride | ESD-898926-250MG |
Cas.: 1187931-39-0 | Purity: ≥95% | 3-(4-Bromophenyl)pyrrolidine hydrochloride | ESD-898926-1G |
Cas.: 1254473-66-9 | Purity: 97% | 1-(3,5-Dichloropyridin-4-yl)ethanol | ESD-898927-100MG |
Cas.: 1254473-66-9 | Purity: 97% | 1-(3,5-Dichloropyridin-4-yl)ethanol | ESD-898927-250MG |
Cas.: 1254473-66-9 | Purity: 97% | 1-(3,5-Dichloropyridin-4-yl)ethanol | ESD-898927-1G |
Cas.: 1082042-15-6 | Purity: 98% | 5-Methyl-1H-indazol-6-ol | ESD-898928-100MG |
Cas.: 1082042-15-6 | Purity: 98% | 5-Methyl-1H-indazol-6-ol | ESD-898928-250MG |
Cas.: 1082042-15-6 | Purity: 98% | 5-Methyl-1H-indazol-6-ol | ESD-898928-1G |
Cas.: 558479-16-6 | Purity: 97% | (S)-2-Ethylpiperidine hydrochloride | ESD-898929-100MG |
Cas.: 558479-16-6 | Purity: 97% | (S)-2-Ethylpiperidine hydrochloride | ESD-898929-250MG |
Cas.: 558479-16-6 | Purity: 97% | (S)-2-Ethylpiperidine hydrochloride | ESD-898929-1G |
Cas.: 440644-06-4 | Purity: ≥95% | Methyl 3-amino-2-(aminomethyl)propanoate dihydrochloride | ESD-898930-100MG |
Cas.: 440644-06-4 | Purity: ≥95% | Methyl 3-amino-2-(aminomethyl)propanoate dihydrochloride | ESD-898930-250MG |
Cas.: 440644-06-4 | Purity: ≥95% | Methyl 3-amino-2-(aminomethyl)propanoate dihydrochloride | ESD-898930-1G |
Cas.: 1421252-92-7 | Purity: 97% | 4-Chloro-3,5-dimethyl-1-tosyl-1H-indazole | ESD-898931-100MG |
Cas.: 1421252-92-7 | Purity: 97% | 4-Chloro-3,5-dimethyl-1-tosyl-1H-indazole | ESD-898931-250MG |
Cas.: 1421252-92-7 | Purity: 97% | 4-Chloro-3,5-dimethyl-1-tosyl-1H-indazole | ESD-898931-1G |
Cas.: 1337523-99-5 | Purity: ≥95% | 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898932-100MG |
Cas.: 1337523-99-5 | Purity: ≥95% | 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898932-250MG |
Cas.: 1337523-99-5 | Purity: ≥95% | 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine | ESD-898932-1G |
Cas.: 1314137-24-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine | ESD-898933-100MG |
Cas.: 1314137-24-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine | ESD-898933-250MG |
Cas.: 1314137-24-0 | Purity: 97% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine | ESD-898933-1G |
Cas.: 933683-35-3 | Purity: 98% | 5-Methylpyrimidine-4-carboxylic acid | ESD-898934-100MG |
Cas.: 933683-35-3 | Purity: 98% | 5-Methylpyrimidine-4-carboxylic acid | ESD-898934-250MG |
Cas.: 933683-35-3 | Purity: 98% | 5-Methylpyrimidine-4-carboxylic acid | ESD-898934-1G |
Cas.: 500904-61-0 | Purity: 97% | 5-(2,5-Dimethyl-4-(prop-1-en-1-yl)phenoxy)-2,2-dimethylpentanoic acid | ESD-898935-100MG |
Cas.: 500904-61-0 | Purity: 97% | 5-(2,5-Dimethyl-4-(prop-1-en-1-yl)phenoxy)-2,2-dimethylpentanoic acid | ESD-898935-250MG |
Cas.: 1363383-17-8 | Purity: 95% | tert-Butyl 4-ethynyl-4-methylpiperidine-1-carboxylate | ESD-898936-100MG |
Cas.: 1363383-17-8 | Purity: 95% | tert-Butyl 4-ethynyl-4-methylpiperidine-1-carboxylate | ESD-898936-250MG |
Cas.: 1363383-17-8 | Purity: 95% | tert-Butyl 4-ethynyl-4-methylpiperidine-1-carboxylate | ESD-898936-1G |
Cas.: 1105187-36-7 | Purity: ≥95% | Methyl 3-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-898937-100MG |
Cas.: 1105187-36-7 | Purity: ≥95% | Methyl 3-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-898937-250MG |
Cas.: 1105187-36-7 | Purity: ≥95% | Methyl 3-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate | ESD-898937-1G |
Cas.: 101820-69-3 | Purity: 97% | Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate | ESD-898938-100MG |
Cas.: 101820-69-3 | Purity: 97% | Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate | ESD-898938-250MG |
Cas.: 101820-69-3 | Purity: 97% | Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate | ESD-898938-1G |
Cas.: 177595-28-7 | Purity: 97% | (4-(2H-Tetrazol-5-yl)phenyl)methanamine hydrochloride | ESD-898939-100MG |
Cas.: 177595-28-7 | Purity: 97% | (4-(2H-Tetrazol-5-yl)phenyl)methanamine hydrochloride | ESD-898939-250MG |
Cas.: 177595-28-7 | Purity: 97% | (4-(2H-Tetrazol-5-yl)phenyl)methanamine hydrochloride | ESD-898939-1G |
Cas.: 184150-96-7 | Purity: ≥95% | Methyl 2-methyl-1H-indole-6-carboxylate | ESD-898940-100MG |
Cas.: 184150-96-7 | Purity: ≥95% | Methyl 2-methyl-1H-indole-6-carboxylate | ESD-898940-250MG |
Cas.: 184150-96-7 | Purity: ≥95% | Methyl 2-methyl-1H-indole-6-carboxylate | ESD-898940-1G |
Cas.: 1208090-98-5 | Purity: 97% | 4-(4-Methylpiperidin-4-yl)morpholine dihydrochloride | ESD-898941-100MG |
Cas.: 1208090-98-5 | Purity: 97% | 4-(4-Methylpiperidin-4-yl)morpholine dihydrochloride | ESD-898941-250MG |
Cas.: 1208090-98-5 | Purity: 97% | 4-(4-Methylpiperidin-4-yl)morpholine dihydrochloride | ESD-898941-1G |
Cas.: 91270-68-7 | Purity: ≥95% | 6-Bromo-1-hydroxynaphthalene | ESD-898942-100MG |
Cas.: 91270-68-7 | Purity: ≥95% | 6-Bromo-1-hydroxynaphthalene | ESD-898942-250MG |
Cas.: 91270-68-7 | Purity: ≥95% | 6-Bromo-1-hydroxynaphthalene | ESD-898942-1G |
Cas.: 1218790-38-5 | Purity: 98% | 2-Fluoro-6-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-898943-100MG |
Cas.: 1218790-38-5 | Purity: 98% | 2-Fluoro-6-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-898943-250MG |
Cas.: 1218790-38-5 | Purity: 98% | 2-Fluoro-6-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-898943-1G |
Cas.: 1159010-96-4 | Purity: ≥95% | 3-Bromo-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | ESD-898944-100MG |
Cas.: 1159010-96-4 | Purity: ≥95% | 3-Bromo-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | ESD-898944-250MG |
Cas.: 1159010-96-4 | Purity: ≥95% | 3-Bromo-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | ESD-898944-1G |
Cas.: 144750-52-7 | Purity: ≥95% | Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate hydrochloride | ESD-898945-100MG |
Cas.: 144750-52-7 | Purity: ≥95% | Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate hydrochloride | ESD-898945-250MG |
Cas.: 144750-52-7 | Purity: ≥95% | Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate hydrochloride | ESD-898945-1G |
Cas.: 114435-86-8 | Purity: 97% | Fluoromethyl 4-methylbenzenesulfonate | ESD-898946-100MG |
Cas.: 114435-86-8 | Purity: 97% | Fluoromethyl 4-methylbenzenesulfonate | ESD-898946-250MG |
Cas.: 114435-86-8 | Purity: 97% | Fluoromethyl 4-methylbenzenesulfonate | ESD-898946-1G |
Cas.: 885518-39-8 | Purity: 98% | 4-Amino-1H-indole-6-carbonitrile | ESD-898947-100MG |
Cas.: 885518-39-8 | Purity: 98% | 4-Amino-1H-indole-6-carbonitrile | ESD-898947-250MG |
Cas.: 885518-39-8 | Purity: 98% | 4-Amino-1H-indole-6-carbonitrile | ESD-898947-1G |
Cas.: 1346697-39-9 | Purity: 98% | 5-Bromo-4-cyclopropylpyrimidine | ESD-898948-100MG |
Cas.: 1346697-39-9 | Purity: 98% | 5-Bromo-4-cyclopropylpyrimidine | ESD-898948-250MG |
Cas.: 1346697-39-9 | Purity: 98% | 5-Bromo-4-cyclopropylpyrimidine | ESD-898948-1G |
Cas.: 19677-37-3 | Purity: 97% | Diethyl 2-(4-chlorophenyl)malonate | ESD-898949-100MG |
Cas.: 19677-37-3 | Purity: 97% | Diethyl 2-(4-chlorophenyl)malonate | ESD-898949-250MG |
Cas.: 19677-37-3 | Purity: 97% | Diethyl 2-(4-chlorophenyl)malonate | ESD-898949-1G |
Cas.: 55580-08-0 | Purity: ≥95% | 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-898950-100MG |
Cas.: 55580-08-0 | Purity: ≥95% | 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-898950-250MG |
Cas.: 55580-08-0 | Purity: ≥95% | 7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-898950-1G |
Cas.: 1408074-49-6 | Purity: 97% | trans-3-Methoxycyclobutanamine hydrochloride | ESD-898951-100MG |
Cas.: 1408074-49-6 | Purity: 97% | trans-3-Methoxycyclobutanamine hydrochloride | ESD-898951-250MG |
Cas.: 1408074-49-6 | Purity: 97% | trans-3-Methoxycyclobutanamine hydrochloride | ESD-898951-1G |
Cas.: 2164-66-1 | Purity: 97% | Methyl 2-aminopyrimidine-4-carboxylate | ESD-898952-100MG |
Cas.: 2164-66-1 | Purity: 97% | Methyl 2-aminopyrimidine-4-carboxylate | ESD-898952-250MG |
Cas.: 2164-66-1 | Purity: 97% | Methyl 2-aminopyrimidine-4-carboxylate | ESD-898952-1G |
Cas.: 1161763-15-0 | Purity: 97% | 4-Amino-6-bromo-2-methylpyrimidine | ESD-898953-100MG |
Cas.: 1161763-15-0 | Purity: 97% | 4-Amino-6-bromo-2-methylpyrimidine | ESD-898953-250MG |
Cas.: 1161763-15-0 | Purity: 97% | 4-Amino-6-bromo-2-methylpyrimidine | ESD-898953-1G |
Cas.: 1258298-05-3 | Purity: 97% | 2,6-Dichloro-4-cyanobenzoic acid | ESD-898954-100MG |
Cas.: 1258298-05-3 | Purity: 97% | 2,6-Dichloro-4-cyanobenzoic acid | ESD-898954-250MG |
Cas.: 1258298-05-3 | Purity: 97% | 2,6-Dichloro-4-cyanobenzoic acid | ESD-898954-1G |
Cas.: 1286754-14-0 | Purity: 97% | Ethyl imidazo[1,2-a]pyrazine-3-carboxylate | ESD-898955-100MG |
Cas.: 1286754-14-0 | Purity: 97% | Ethyl imidazo[1,2-a]pyrazine-3-carboxylate | ESD-898955-250MG |
Cas.: 1286754-14-0 | Purity: 97% | Ethyl imidazo[1,2-a]pyrazine-3-carboxylate | ESD-898955-1G |
Cas.: 120202-71-3 | Purity: ≥95% | (R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate | ESD-898956-100MG |
Cas.: 120202-71-3 | Purity: ≥95% | (R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate | ESD-898956-250MG |
Cas.: 120202-71-3 | Purity: ≥95% | (R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate | ESD-898956-1G |
Cas.: 498532-32-4 | Purity: ≥95% | (1R,3S)-rel-Cyclohexane-1,3-diamine dihydrochloride | ESD-898957-100MG |
Cas.: 498532-32-4 | Purity: ≥95% | (1R,3S)-rel-Cyclohexane-1,3-diamine dihydrochloride | ESD-898957-250MG |
Cas.: 498532-32-4 | Purity: ≥95% | (1R,3S)-rel-Cyclohexane-1,3-diamine dihydrochloride | ESD-898957-1G |
Cas.: 13031-62-4 | Purity: ≥95% | 4-Aminobutanamide hydrochloride | ESD-898958-100MG |
Cas.: 13031-62-4 | Purity: ≥95% | 4-Aminobutanamide hydrochloride | ESD-898958-250MG |
Cas.: 13031-62-4 | Purity: ≥95% | 4-Aminobutanamide hydrochloride | ESD-898958-1G |
Cas.: 81224-16-0 | Purity: 95% | 7-Bromo-4-methoxy-1H-indole | ESD-898959-100MG |
Cas.: 81224-16-0 | Purity: 95% | 7-Bromo-4-methoxy-1H-indole | ESD-898959-250MG |
Cas.: 81224-16-0 | Purity: 95% | 7-Bromo-4-methoxy-1H-indole | ESD-898959-1G |
Cas.: 1357172-39-4 | Purity: 95% | 3,6-Dichloropyrazine-2-carbaldehyde | ESD-898960-100MG |
Cas.: 1357172-39-4 | Purity: 95% | 3,6-Dichloropyrazine-2-carbaldehyde | ESD-898960-250MG |
Cas.: 1357172-39-4 | Purity: 95% | 3,6-Dichloropyrazine-2-carbaldehyde | ESD-898960-1G |
Cas.: 129295-32-5 | Purity: ≥95% | 7-Chloro-1H-indazole-3-carboxylic acid | ESD-898961-100MG |
Cas.: 129295-32-5 | Purity: ≥95% | 7-Chloro-1H-indazole-3-carboxylic acid | ESD-898961-250MG |
Cas.: 129295-32-5 | Purity: ≥95% | 7-Chloro-1H-indazole-3-carboxylic acid | ESD-898961-1G |
Cas.: 1313738-91-8 | Purity: 97% | N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide | ESD-898962-100MG |
Cas.: 1313738-91-8 | Purity: 97% | N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide | ESD-898962-250MG |
Cas.: 1313738-91-8 | Purity: 97% | N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide | ESD-898962-1G |
Cas.: 1033203-32-5 | Purity: ≥95% | 4-Bromo-5-methylpyridin-2-amine | ESD-898963-100MG |
Cas.: 1033203-32-5 | Purity: ≥95% | 4-Bromo-5-methylpyridin-2-amine | ESD-898963-250MG |
Cas.: 1033203-32-5 | Purity: ≥95% | 4-Bromo-5-methylpyridin-2-amine | ESD-898963-1G |
Cas.: 351038-62-5 | Purity: 97% | 5,6,7,8-Tetrahydro-1,7-naphthyridine dihydrochloride | ESD-898964-100MG |
Cas.: 351038-62-5 | Purity: 97% | 5,6,7,8-Tetrahydro-1,7-naphthyridine dihydrochloride | ESD-898964-250MG |
Cas.: 351038-62-5 | Purity: 97% | 5,6,7,8-Tetrahydro-1,7-naphthyridine dihydrochloride | ESD-898964-1G |
Cas.: 178268-92-3 | Purity: ≥95% | 4-Chloro-6-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-898965-100MG |
Cas.: 178268-92-3 | Purity: ≥95% | 4-Chloro-6-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-898965-250MG |
Cas.: 178268-92-3 | Purity: ≥95% | 4-Chloro-6-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-898965-1G |
Cas.: 800401-63-2 | Purity: ≥95% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid | ESD-898966-100MG |
Cas.: 800401-63-2 | Purity: ≥95% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid | ESD-898966-250MG |
Cas.: 800401-63-2 | Purity: ≥95% | 5-Chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid | ESD-898966-1G |
Cas.: 1363382-19-7 | Purity: ≥95% | tert-Butyl 7-amino-2-azaspiro[4.5]decane-2-carboxylate | ESD-898967-100MG |
Cas.: 1363382-19-7 | Purity: ≥95% | tert-Butyl 7-amino-2-azaspiro[4.5]decane-2-carboxylate | ESD-898967-250MG |
Cas.: 1363382-19-7 | Purity: ≥95% | tert-Butyl 7-amino-2-azaspiro[4.5]decane-2-carboxylate | ESD-898967-1G |
Cas.: 19012-02-3 | Purity: 97% | 3-Acetyl-1-methylindole | ESD-898968-100MG |
Cas.: 19012-02-3 | Purity: 97% | 3-Acetyl-1-methylindole | ESD-898968-250MG |
Cas.: 19012-02-3 | Purity: 97% | 3-Acetyl-1-methylindole | ESD-898968-1G |
Cas.: 34433-86-8 | Purity: ≥95% | 3-Bromopipidin-2-one | ESD-898969-100MG |
Cas.: 34433-86-8 | Purity: ≥95% | 3-Bromopipidin-2-one | ESD-898969-250MG |
Cas.: 34433-86-8 | Purity: ≥95% | 3-Bromopipidin-2-one | ESD-898969-1G |
Cas.: 7606-30-6 | Purity: ≥95% | 3-Phenylazetidine hydrochloride | ESD-898970-100MG |
Cas.: 7606-30-6 | Purity: ≥95% | 3-Phenylazetidine hydrochloride | ESD-898970-250MG |
Cas.: 7606-30-6 | Purity: ≥95% | 3-Phenylazetidine hydrochloride | ESD-898970-1G |
Cas.: 1374014-30-8 | Purity: ≥95% | 3-(Bromomethyl)oxetane | ESD-898971-100MG |
Cas.: 1374014-30-8 | Purity: ≥95% | 3-(Bromomethyl)oxetane | ESD-898971-250MG |
Cas.: 1374014-30-8 | Purity: ≥95% | 3-(Bromomethyl)oxetane | ESD-898971-1G |
Cas.: 208772-23-0 | Purity: 97% | Benzo[d]oxazole-4-carboxylic acid | ESD-898972-100MG |
Cas.: 208772-23-0 | Purity: 97% | Benzo[d]oxazole-4-carboxylic acid | ESD-898972-250MG |
Cas.: 208772-23-0 | Purity: 97% | Benzo[d]oxazole-4-carboxylic acid | ESD-898972-1G |
Cas.: 603130-13-8 | Purity: ≥95% | (2S,5R)-5-((tert-Butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic acid | ESD-898973-100MG |
Cas.: 603130-13-8 | Purity: ≥95% | (2S,5R)-5-((tert-Butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic acid | ESD-898973-250MG |
Cas.: 603130-13-8 | Purity: ≥95% | (2S,5R)-5-((tert-Butoxycarbonyl)amino)tetrahydro-2H-pyran-2-carboxylic acid | ESD-898973-1G |
Cas.: 256518-81-7 | Purity: ≥95% | 3,5-Dimethylmorpholine hydrochloride | ESD-898974-100MG |
Cas.: 256518-81-7 | Purity: ≥95% | 3,5-Dimethylmorpholine hydrochloride | ESD-898974-250MG |
Cas.: 256518-81-7 | Purity: ≥95% | 3,5-Dimethylmorpholine hydrochloride | ESD-898974-1G |
Cas.: 171879-99-5 | Purity: 95% | 4-Chloro-6-methyl-7-azaindole | ESD-898975-100MG |
Cas.: 171879-99-5 | Purity: 95% | 4-Chloro-6-methyl-7-azaindole | ESD-898975-250MG |
Cas.: 171879-99-5 | Purity: 95% | 4-Chloro-6-methyl-7-azaindole | ESD-898975-1G |
Cas.: 69042-30-4 | Purity: 95% | 1-Chloro-2,7-naphthyridine | ESD-898976-100MG |
Cas.: 69042-30-4 | Purity: 95% | 1-Chloro-2,7-naphthyridine | ESD-898976-250MG |
Cas.: 69042-30-4 | Purity: 95% | 1-Chloro-2,7-naphthyridine | ESD-898976-1G |
Cas.: 14521-81-4 | Purity: ≥98% | 3-Fluoro-1H-pyrazole | ESD-898977-100MG |
Cas.: 14521-81-4 | Purity: ≥98% | 3-Fluoro-1H-pyrazole | ESD-898977-250MG |
Cas.: 14521-81-4 | Purity: ≥98% | 3-Fluoro-1H-pyrazole | ESD-898977-1G |
Cas.: 1208901-69-2 | Purity: ≥95% | 2,4-Dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine hydrochloride | ESD-898978-100MG |
Cas.: 1208901-69-2 | Purity: ≥95% | 2,4-Dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine hydrochloride | ESD-898978-250MG |
Cas.: 1208901-69-2 | Purity: ≥95% | 2,4-Dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine hydrochloride | ESD-898978-1G |
Cas.: 1207625-29-3 | Purity: ≥95% | 5-Bromo-6-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-898979-100MG |
Cas.: 1207625-29-3 | Purity: ≥95% | 5-Bromo-6-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-898979-250MG |
Cas.: 1207625-29-3 | Purity: ≥95% | 5-Bromo-6-fluoro-1H-pyrrolo[2,3-b]pyridine | ESD-898979-1G |
Cas.: 295327-22-9 | Purity: 95% | 1H-Pyrrolo[2,3-c]pyridin-2(3H)-one hydrochloride | ESD-898980-100MG |
Cas.: 295327-22-9 | Purity: 95% | 1H-Pyrrolo[2,3-c]pyridin-2(3H)-one hydrochloride | ESD-898980-250MG |
Cas.: 295327-22-9 | Purity: 95% | 1H-Pyrrolo[2,3-c]pyridin-2(3H)-one hydrochloride | ESD-898980-1G |
Cas.: 530116-33-7 | Purity: 97% | tert-Butyl 4-(2-aminopropan-2-yl)piperidine-1-carboxylate | ESD-898981-100MG |
Cas.: 530116-33-7 | Purity: 97% | tert-Butyl 4-(2-aminopropan-2-yl)piperidine-1-carboxylate | ESD-898981-250MG |
Cas.: 530116-33-7 | Purity: 97% | tert-Butyl 4-(2-aminopropan-2-yl)piperidine-1-carboxylate | ESD-898981-1G |
Cas.: 136834-20-3 | Purity: 97% | Bz-2′-F-dA | ESD-898982-100MG |
Cas.: 136834-20-3 | Purity: 97% | Bz-2′-F-dA | ESD-898982-250MG |
Cas.: 136834-20-3 | Purity: 97% | Bz-2′-F-dA | ESD-898982-1G |
Cas.: 480449-99-8 | Purity: 97% | Benzyl 3-hydroxycyclobutanecarboxylate | ESD-898983-100MG |
Cas.: 480449-99-8 | Purity: 97% | Benzyl 3-hydroxycyclobutanecarboxylate | ESD-898983-250MG |
Cas.: 480449-99-8 | Purity: 97% | Benzyl 3-hydroxycyclobutanecarboxylate | ESD-898983-1G |
Cas.: 1373223-45-0 | Purity: ≥95% | 4-Amino-1-methylpiperidin-2-one hydrochloride | ESD-898984-100MG |
Cas.: 1373223-45-0 | Purity: ≥95% | 4-Amino-1-methylpiperidin-2-one hydrochloride | ESD-898984-250MG |
Cas.: 1373223-45-0 | Purity: ≥95% | 4-Amino-1-methylpiperidin-2-one hydrochloride | ESD-898984-1G |
Cas.: 151213-15-9 | Purity: ≥95% | 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline -3-carboxylic acid | ESD-898985-100MG |
Cas.: 151213-15-9 | Purity: ≥95% | 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline -3-carboxylic acid | ESD-898985-250MG |
Cas.: 151213-15-9 | Purity: ≥95% | 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline -3-carboxylic acid | ESD-898985-1G |
Cas.: 1060805-64-2 | Purity: 98% | 4-Bromo-6-chloronicotinaldehyde | ESD-898986-100MG |
Cas.: 1060805-64-2 | Purity: 98% | 4-Bromo-6-chloronicotinaldehyde | ESD-898986-250MG |
Cas.: 1060805-64-2 | Purity: 98% | 4-Bromo-6-chloronicotinaldehyde | ESD-898986-1G |
Cas.: 1217002-90-8 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-c]pyridin-2(3H)-one | ESD-898987-100MG |
Cas.: 1217002-90-8 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-c]pyridin-2(3H)-one | ESD-898987-250MG |
Cas.: 1217002-90-8 | Purity: ≥95% | 5-Bromo-1H-pyrrolo[2,3-c]pyridin-2(3H)-one | ESD-898987-1G |
Cas.: 1355196-92-7 | Purity: 97% | 6-Hydroxy-4-methylnicotinonitrile | ESD-898988-100MG |
Cas.: 1355196-92-7 | Purity: 97% | 6-Hydroxy-4-methylnicotinonitrile | ESD-898988-250MG |
Cas.: 1355196-92-7 | Purity: 97% | 6-Hydroxy-4-methylnicotinonitrile | ESD-898988-1G |
Cas.: 1175298-09-5 | Purity: ≥95% | tert-Butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate | ESD-898989-100MG |
Cas.: 1175298-09-5 | Purity: ≥95% | tert-Butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate | ESD-898989-250MG |
Cas.: 1175298-09-5 | Purity: ≥95% | tert-Butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)carbamate | ESD-898989-1G |
Cas.: 1396215-84-1 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane | ESD-898990-100MG |
Cas.: 1396215-84-1 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane | ESD-898990-250MG |
Cas.: 1396215-84-1 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane | ESD-898990-1G |
Cas.: 935269-27-5 | Purity: 97% | 3-Oxoisoindoline-4-carboxylic acid | ESD-898991-100MG |
Cas.: 935269-27-5 | Purity: 97% | 3-Oxoisoindoline-4-carboxylic acid | ESD-898991-250MG |
Cas.: 935269-27-5 | Purity: 97% | 3-Oxoisoindoline-4-carboxylic acid | ESD-898991-1G |
Cas.: 51739-61-8 | Purity: ≥95% | 3-Amino-N-methylpropanamide hydrochloride | ESD-898992-100MG |
Cas.: 51739-61-8 | Purity: ≥95% | 3-Amino-N-methylpropanamide hydrochloride | ESD-898992-250MG |
Cas.: 51739-61-8 | Purity: ≥95% | 3-Amino-N-methylpropanamide hydrochloride | ESD-898992-1G |
Cas.: 944896-64-4 | Purity: ≥95% | Imidazo[1,2-a]pyrimidine-6-carboxylic acid | ESD-898993-100MG |
Cas.: 944896-64-4 | Purity: ≥95% | Imidazo[1,2-a]pyrimidine-6-carboxylic acid | ESD-898993-250MG |
Cas.: 944896-64-4 | Purity: ≥95% | Imidazo[1,2-a]pyrimidine-6-carboxylic acid | ESD-898993-1G |
Cas.: 1023305-87-4 | Purity: 97% | 4-Fluoro-4-methylpiperidine hydrochloride | ESD-898994-100MG |
Cas.: 1023305-87-4 | Purity: 97% | 4-Fluoro-4-methylpiperidine hydrochloride | ESD-898994-250MG |
Cas.: 1023305-87-4 | Purity: 97% | 4-Fluoro-4-methylpiperidine hydrochloride | ESD-898994-1G |
Cas.: 942308-06-7 | Purity: ≥95% | 3-(Methoxymethyl)azetidine hydrochloride | ESD-898995-100MG |
Cas.: 942308-06-7 | Purity: ≥95% | 3-(Methoxymethyl)azetidine hydrochloride | ESD-898995-250MG |
Cas.: 942308-06-7 | Purity: ≥95% | 3-(Methoxymethyl)azetidine hydrochloride | ESD-898995-1G |
Cas.: 1260384-77-7 | Purity: 97% | 6-Fluoro-5-iodo-1H-indazole | ESD-898996-100MG |
Cas.: 1260384-77-7 | Purity: 97% | 6-Fluoro-5-iodo-1H-indazole | ESD-898996-250MG |
Cas.: 1260384-77-7 | Purity: 97% | 6-Fluoro-5-iodo-1H-indazole | ESD-898996-1G |
Cas.: 1209573-86-3 | Purity: 97% | 5-Bromo-2-methyloxazole-4-carboxylic acid | ESD-898997-100MG |
Cas.: 1209573-86-3 | Purity: 97% | 5-Bromo-2-methyloxazole-4-carboxylic acid | ESD-898997-250MG |
Cas.: 1209573-86-3 | Purity: 97% | 5-Bromo-2-methyloxazole-4-carboxylic acid | ESD-898997-1G |
Cas.: 1208084-53-0 | Purity: ≥95% | 6-Chloroimidazo[1,2-b]pyridazine-3-carboxylic acid | ESD-898998-100MG |
Cas.: 1208084-53-0 | Purity: ≥95% | 6-Chloroimidazo[1,2-b]pyridazine-3-carboxylic acid | ESD-898998-250MG |
Cas.: 1208084-53-0 | Purity: ≥95% | 6-Chloroimidazo[1,2-b]pyridazine-3-carboxylic acid | ESD-898998-1G |
Cas.: 1334416-77-1 | Purity: ≥95% | 3,3-Difluoropiperidin-4-ol hydrochloride | ESD-898999-100MG |
Cas.: 1334416-77-1 | Purity: ≥95% | 3,3-Difluoropiperidin-4-ol hydrochloride | ESD-898999-250MG |
Cas.: 1334416-77-1 | Purity: ≥95% | 3,3-Difluoropiperidin-4-ol hydrochloride | ESD-898999-1G |
Cas.: 16767-40-1 | Purity: ≥95% | 7H-Pyrrolo[2,3-c]pyridazine | ESD-899000-100MG |
Cas.: 16767-40-1 | Purity: ≥95% | 7H-Pyrrolo[2,3-c]pyridazine | ESD-899000-250MG |
Cas.: 16767-40-1 | Purity: ≥95% | 7H-Pyrrolo[2,3-c]pyridazine | ESD-899000-1G |
Cas.: 635712-49-1 | Purity: ≥95% | 5-Bromo-7-ethyl-1H-indazole | ESD-899001-100MG |
Cas.: 635712-49-1 | Purity: ≥95% | 5-Bromo-7-ethyl-1H-indazole | ESD-899001-250MG |
Cas.: 635712-49-1 | Purity: ≥95% | 5-Bromo-7-ethyl-1H-indazole | ESD-899001-1G |
Cas.: 53491-80-8 | Purity: ≥95% | 1-Chloroisoquinoline-4-carbonitrile | ESD-899002-100MG |
Cas.: 53491-80-8 | Purity: ≥95% | 1-Chloroisoquinoline-4-carbonitrile | ESD-899002-250MG |
Cas.: 53491-80-8 | Purity: ≥95% | 1-Chloroisoquinoline-4-carbonitrile | ESD-899002-1G |
Cas.: 1016241-64-7 | Purity: ≥95% | 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-899003-100MG |
Cas.: 1016241-64-7 | Purity: ≥95% | 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-899003-250MG |
Cas.: 1016241-64-7 | Purity: ≥95% | 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid | ESD-899003-1G |
Cas.: 85989-61-3 | Purity: 97% | 5,7-Dichloroimidazo[1,2-c]pyrimidine | ESD-899004-100MG |
Cas.: 85989-61-3 | Purity: 97% | 5,7-Dichloroimidazo[1,2-c]pyrimidine | ESD-899004-250MG |
Cas.: 85989-61-3 | Purity: 97% | 5,7-Dichloroimidazo[1,2-c]pyrimidine | ESD-899004-1G |
Cas.: 289483-87-0 | Purity: 95% | 7-Amino-4-methyl-1H-indole-3-carbonitrile | ESD-899005-100MG |
Cas.: 289483-87-0 | Purity: 95% | 7-Amino-4-methyl-1H-indole-3-carbonitrile | ESD-899005-250MG |
Cas.: 289483-87-0 | Purity: 95% | 7-Amino-4-methyl-1H-indole-3-carbonitrile | ESD-899005-1G |
Cas.: 1221819-46-0 | Purity: 97% | 3-((Phenylsulfonyl)methylene)oxetane | ESD-899006-100MG |
Cas.: 1221819-46-0 | Purity: 97% | 3-((Phenylsulfonyl)methylene)oxetane | ESD-899006-250MG |
Cas.: 1221819-46-0 | Purity: 97% | 3-((Phenylsulfonyl)methylene)oxetane | ESD-899006-1G |
Cas.: 36131-43-8 | Purity: 98% | Ethyl 3-formyl-1H-pyrrole-2-carboxylate | ESD-899007-100MG |
Cas.: 36131-43-8 | Purity: 98% | Ethyl 3-formyl-1H-pyrrole-2-carboxylate | ESD-899007-250MG |
Cas.: 36131-43-8 | Purity: 98% | Ethyl 3-formyl-1H-pyrrole-2-carboxylate | ESD-899007-1G |
Cas.: 850197-67-0 | Purity: ≥95% | 1-Chloroisoquinolin-6-ol | ESD-899008-100MG |
Cas.: 850197-67-0 | Purity: ≥95% | 1-Chloroisoquinolin-6-ol | ESD-899008-250MG |
Cas.: 850197-67-0 | Purity: ≥95% | 1-Chloroisoquinolin-6-ol | ESD-899008-1G |
Cas.: 1212304-86-3 | Purity: 97% | cis-Methyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-899009-100MG |
Cas.: 1212304-86-3 | Purity: 97% | cis-Methyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-899009-250MG |
Cas.: 1212304-86-3 | Purity: 97% | cis-Methyl 3-aminocyclobutanecarboxylate hydrochloride | ESD-899009-1G |
Cas.: 180854-44-8 | Purity: ≥95% | (S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate | ESD-899010-100MG |
Cas.: 180854-44-8 | Purity: ≥95% | (S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate | ESD-899010-250MG |
Cas.: 180854-44-8 | Purity: ≥95% | (S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate | ESD-899010-1G |
Cas.: 1422772-78-8 | Purity: ≥95% | 2-Bromo-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid | ESD-899011-100MG |
Cas.: 1422772-78-8 | Purity: ≥95% | 2-Bromo-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid | ESD-899011-250MG |
Cas.: 1422772-78-8 | Purity: ≥95% | 2-Bromo-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid | ESD-899011-1G |
Cas.: 207405-60-5 | Purity: 97% | tert-Butyl 5-hydroxy-2-aza-bicyclo[2.2.1]heptane-2-carboxylate | ESD-899012-100MG |
Cas.: 207405-60-5 | Purity: 97% | tert-Butyl 5-hydroxy-2-aza-bicyclo[2.2.1]heptane-2-carboxylate | ESD-899012-250MG |
Cas.: 207405-60-5 | Purity: 97% | tert-Butyl 5-hydroxy-2-aza-bicyclo[2.2.1]heptane-2-carboxylate | ESD-899012-1G |
Cas.: 1206981-49-8 | Purity: 95% | 3-(Trifluoromethoxy)pyridin-2-amine | ESD-899013-100MG |
Cas.: 1206981-49-8 | Purity: 95% | 3-(Trifluoromethoxy)pyridin-2-amine | ESD-899013-250MG |
Cas.: 1206981-49-8 | Purity: 95% | 3-(Trifluoromethoxy)pyridin-2-amine | ESD-899013-1G |
Cas.: 1159817-16-9 | Purity: 97% | 2-Bromo-5-isopropylthiazole | ESD-899014-100MG |
Cas.: 1159817-16-9 | Purity: 97% | 2-Bromo-5-isopropylthiazole | ESD-899014-250MG |
Cas.: 1159817-16-9 | Purity: 97% | 2-Bromo-5-isopropylthiazole | ESD-899014-1G |
Cas.: 324769-03-1 | Purity: ≥95% | (3S,5R)-1-Benzyl-3,5-dimethylpiperidin-4-one | ESD-899015-100MG |
Cas.: 324769-03-1 | Purity: ≥95% | (3S,5R)-1-Benzyl-3,5-dimethylpiperidin-4-one | ESD-899015-250MG |
Cas.: 324769-03-1 | Purity: ≥95% | (3S,5R)-1-Benzyl-3,5-dimethylpiperidin-4-one | ESD-899015-1G |
Cas.: 645400-44-8 | Purity: ≥95% | tert-Butyl ((1S,3S)-3-aminocyclopentyl)carbamate | ESD-899016-100MG |
Cas.: 645400-44-8 | Purity: ≥95% | tert-Butyl ((1S,3S)-3-aminocyclopentyl)carbamate | ESD-899016-250MG |
Cas.: 645400-44-8 | Purity: ≥95% | tert-Butyl ((1S,3S)-3-aminocyclopentyl)carbamate | ESD-899016-1G |
Cas.: 869335-48-8 | Purity: 97% | 1-Methyl-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-899017-100MG |
Cas.: 869335-48-8 | Purity: 97% | 1-Methyl-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-899017-250MG |
Cas.: 869335-48-8 | Purity: 97% | 1-Methyl-1H-pyrrolo[2,3-b]pyridin-4-amine | ESD-899017-1G |
Cas.: 221698-39-1 | Purity: 98% | 4-Chloro-6,7-dimethoxyquinazolin-2-amine | ESD-899018-100MG |
Cas.: 221698-39-1 | Purity: 98% | 4-Chloro-6,7-dimethoxyquinazolin-2-amine | ESD-899018-250MG |
Cas.: 221698-39-1 | Purity: 98% | 4-Chloro-6,7-dimethoxyquinazolin-2-amine | ESD-899018-1G |
Cas.: 1179362-15-2 | Purity: ≥95% | 5-Fluoropicolinimidamide hydrochloride | ESD-899019-100MG |
Cas.: 1179362-15-2 | Purity: ≥95% | 5-Fluoropicolinimidamide hydrochloride | ESD-899019-250MG |
Cas.: 1179362-15-2 | Purity: ≥95% | 5-Fluoropicolinimidamide hydrochloride | ESD-899019-1G |
Cas.: 1260670-03-8 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-5-carboxylic acid | ESD-899020-100MG |
Cas.: 1260670-03-8 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-5-carboxylic acid | ESD-899020-250MG |
Cas.: 1260670-03-8 | Purity: 97% | 1H-Pyrazolo[4,3-b]pyridine-5-carboxylic acid | ESD-899020-1G |
Cas.: 40117-63-3 | Purity: 98% | Quinuclidine-4-carboxylic acid hydrochloride | ESD-899021-100MG |
Cas.: 40117-63-3 | Purity: 98% | Quinuclidine-4-carboxylic acid hydrochloride | ESD-899021-250MG |
Cas.: 40117-63-3 | Purity: 98% | Quinuclidine-4-carboxylic acid hydrochloride | ESD-899021-1G |
Cas.: 220437-83-2 | Purity: 97% | 3,4-Dimethoxypicolinic acid | ESD-899022-100MG |
Cas.: 220437-83-2 | Purity: 97% | 3,4-Dimethoxypicolinic acid | ESD-899022-250MG |
Cas.: 220437-83-2 | Purity: 97% | 3,4-Dimethoxypicolinic acid | ESD-899022-1G |
Cas.: 1082503-77-2 | Purity: 97% | 2-Methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol | ESD-899023-100MG |
Cas.: 1082503-77-2 | Purity: 97% | 2-Methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol | ESD-899023-250MG |
Cas.: 1082503-77-2 | Purity: 97% | 2-Methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol | ESD-899023-1G |
Cas.: 633327-22-7 | Purity: 95% | 5-Bromo-2,3-difluorobenzaldehyde | ESD-899024-100MG |
Cas.: 633327-22-7 | Purity: 95% | 5-Bromo-2,3-difluorobenzaldehyde | ESD-899024-250MG |
Cas.: 633327-22-7 | Purity: 95% | 5-Bromo-2,3-difluorobenzaldehyde | ESD-899024-1G |
Cas.: 1053657-15-0 | Purity: 97% | tert-Butyl 4-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-899025-100MG |
Cas.: 1053657-15-0 | Purity: 97% | tert-Butyl 4-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-899025-250MG |
Cas.: 1053657-15-0 | Purity: 97% | tert-Butyl 4-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | ESD-899025-1G |
Cas.: 945863-21-8 | Purity: 95% | N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | ESD-899026-100MG |
Cas.: 945863-21-8 | Purity: 95% | N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | ESD-899026-250MG |
Cas.: 945863-21-8 | Purity: 95% | N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | ESD-899026-1G |
Cas.: 1363383-31-6 | Purity: 97% | Methyl 3-aminooxetane-3-carboxylate | ESD-899027-100MG |
Cas.: 1363383-31-6 | Purity: 97% | Methyl 3-aminooxetane-3-carboxylate | ESD-899027-250MG |
Cas.: 1363383-31-6 | Purity: 97% | Methyl 3-aminooxetane-3-carboxylate | ESD-899027-1G |
Cas.: 1394117-24-8 | Purity: ≥95% | 3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-899028-100MG |
Cas.: 1394117-24-8 | Purity: ≥95% | 3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-899028-250MG |
Cas.: 1394117-24-8 | Purity: ≥95% | 3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine hydrochloride | ESD-899028-1G |
Cas.: 244268-34-6 | Purity: 95% | 5-(Trifluoromethyl)pyridazin-3(2H)-one | ESD-899029-100MG |
Cas.: 244268-34-6 | Purity: 95% | 5-(Trifluoromethyl)pyridazin-3(2H)-one | ESD-899029-250MG |
Cas.: 244268-34-6 | Purity: 95% | 5-(Trifluoromethyl)pyridazin-3(2H)-one | ESD-899029-1G |
Cas.: 29096-64-8 | Purity: 98% | 1-(Imidazo[1,2-a]pyridin-3-yl)ethanone | ESD-899030-100MG |
Cas.: 29096-64-8 | Purity: 98% | 1-(Imidazo[1,2-a]pyridin-3-yl)ethanone | ESD-899030-250MG |
Cas.: 29096-64-8 | Purity: 98% | 1-(Imidazo[1,2-a]pyridin-3-yl)ethanone | ESD-899030-1G |
Cas.: 1263180-22-8 | Purity: ≥95% | tert-Butyl (3,3-difluoropipidin-4-yl)carbamate | ESD-899031-100MG |
Cas.: 1263180-22-8 | Purity: ≥95% | tert-Butyl (3,3-difluoropipidin-4-yl)carbamate | ESD-899031-250MG |
Cas.: 1263180-22-8 | Purity: ≥95% | tert-Butyl (3,3-difluoropipidin-4-yl)carbamate | ESD-899031-1G |
Cas.: 885518-26-3 | Purity: 97% | 4-Fluoro-1H-indol-6-amine | ESD-899032-100MG |
Cas.: 885518-26-3 | Purity: 97% | 4-Fluoro-1H-indol-6-amine | ESD-899032-250MG |
Cas.: 885518-26-3 | Purity: 97% | 4-Fluoro-1H-indol-6-amine | ESD-899032-1G |
Cas.: 955368-90-8 | Purity: ≥95% | 2-Allyl-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one | ESD-899033-100MG |
Cas.: 955368-90-8 | Purity: ≥95% | 2-Allyl-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one | ESD-899033-250MG |
Cas.: 955368-90-8 | Purity: ≥95% | 2-Allyl-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one | ESD-899033-1G |
Cas.: 1620569-19-8 | Purity: 98% | 7-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-899034-100MG |
Cas.: 1620569-19-8 | Purity: 98% | 7-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-899034-250MG |
Cas.: 1620569-19-8 | Purity: 98% | 7-(Trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid | ESD-899034-1G |
Cas.: 20780-77-2 | Purity: ≥95% | 6-Iodoindoline-2,3-dione | ESD-899035-100MG |
Cas.: 20780-77-2 | Purity: ≥95% | 6-Iodoindoline-2,3-dione | ESD-899035-250MG |
Cas.: 20780-77-2 | Purity: ≥95% | 6-Iodoindoline-2,3-dione | ESD-899035-1G |
Cas.: 1092352-55-0 | Purity: ≥95% | tert-Butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-899036-100MG |
Cas.: 1092352-55-0 | Purity: ≥95% | tert-Butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-899036-250MG |
Cas.: 1092352-55-0 | Purity: ≥95% | tert-Butyl 2-chloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | ESD-899036-1G |
Cas.: 1206641-26-0 | Purity: 97% | 3-(Methylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899037-100MG |
Cas.: 1206641-26-0 | Purity: 97% | 3-(Methylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899037-250MG |
Cas.: 1206641-26-0 | Purity: 97% | 3-(Methylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899037-1G |
Cas.: 1036260-25-9 | Purity: 98% | 3-Aminocyclobutanol hydrochloride | ESD-899038-100MG |
Cas.: 1036260-25-9 | Purity: 98% | 3-Aminocyclobutanol hydrochloride | ESD-899038-250MG |
Cas.: 1036260-25-9 | Purity: 98% | 3-Aminocyclobutanol hydrochloride | ESD-899038-1G |
Cas.: 101420-67-1 | Purity: ≥95% | 4-Methyl-5-nitro-1H-indazole | ESD-899039-100MG |
Cas.: 101420-67-1 | Purity: ≥95% | 4-Methyl-5-nitro-1H-indazole | ESD-899039-250MG |
Cas.: 101420-67-1 | Purity: ≥95% | 4-Methyl-5-nitro-1H-indazole | ESD-899039-1G |
Cas.: 944937-30-8 | Purity: 97% | Methyl 3-iodo-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-899040-100MG |
Cas.: 944937-30-8 | Purity: 97% | Methyl 3-iodo-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-899040-250MG |
Cas.: 944937-30-8 | Purity: 97% | Methyl 3-iodo-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | ESD-899040-1G |
Cas.: 163513-98-2 | Purity: 95% | (1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane | ESD-899041-100MG |
Cas.: 163513-98-2 | Purity: 95% | (1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane | ESD-899041-250MG |
Cas.: 163513-98-2 | Purity: 95% | (1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane | ESD-899041-1G |
Cas.: 4249-19-8 | Purity: ≥95% | (S)-3-Amino-2-methylpropanoic acid | ESD-899042-100MG |
Cas.: 4249-19-8 | Purity: ≥95% | (S)-3-Amino-2-methylpropanoic acid | ESD-899042-250MG |
Cas.: 4249-19-8 | Purity: ≥95% | (S)-3-Amino-2-methylpropanoic acid | ESD-899042-1G |
Cas.: 1150617-94-9 | Purity: 98% | 5-Iodo-2-methyl-2H-indazole | ESD-899043-100MG |
Cas.: 1150617-94-9 | Purity: 98% | 5-Iodo-2-methyl-2H-indazole | ESD-899043-250MG |
Cas.: 1150617-94-9 | Purity: 98% | 5-Iodo-2-methyl-2H-indazole | ESD-899043-1G |
Cas.: 1254115-16-6 | Purity: 97% | (4-Fluoropiperidin-4-yl)methanol hydrochloride | ESD-899044-100MG |
Cas.: 1254115-16-6 | Purity: 97% | (4-Fluoropiperidin-4-yl)methanol hydrochloride | ESD-899044-250MG |
Cas.: 1254115-16-6 | Purity: 97% | (4-Fluoropiperidin-4-yl)methanol hydrochloride | ESD-899044-1G |
Cas.: 1111637-94-5 | Purity: 97% | 5-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-899045-100MG |
Cas.: 1111637-94-5 | Purity: 97% | 5-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-899045-250MG |
Cas.: 1111637-94-5 | Purity: 97% | 5-Bromo-3-methyl-1H-pyrrolo[2,3-b]pyridine | ESD-899045-1G |
Cas.: 1000931-04-3 | Purity: ≥95% | 1-Boc-3-Hydroxy-4-phenylpiperidine | ESD-899046-100MG |
Cas.: 1000931-04-3 | Purity: ≥95% | 1-Boc-3-Hydroxy-4-phenylpiperidine | ESD-899046-250MG |
Cas.: 1000931-04-3 | Purity: ≥95% | 1-Boc-3-Hydroxy-4-phenylpiperidine | ESD-899046-1G |
Cas.: 1029689-82-4 | Purity: ≥95% | Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride | ESD-899047-100MG |
Cas.: 1029689-82-4 | Purity: ≥95% | Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride | ESD-899047-250MG |
Cas.: 1029689-82-4 | Purity: ≥95% | Methyl 1,2,3,4-tetrahydroisoquinoline-8-carboxylate hydrochloride | ESD-899047-1G |
Cas.: 864293-50-5 | Purity: ≥95% | 4-Fluoro-5-methoxy-2-nitrobenzoic acid | ESD-899048-100MG |
Cas.: 864293-50-5 | Purity: ≥95% | 4-Fluoro-5-methoxy-2-nitrobenzoic acid | ESD-899048-250MG |
Cas.: 864293-50-5 | Purity: ≥95% | 4-Fluoro-5-methoxy-2-nitrobenzoic acid | ESD-899048-1G |
Cas.: 67247-13-6 | Purity: 98% | 7-Methoxynaphthalen-1-ol | ESD-899049-100MG |
Cas.: 67247-13-6 | Purity: 98% | 7-Methoxynaphthalen-1-ol | ESD-899049-250MG |
Cas.: 67247-13-6 | Purity: 98% | 7-Methoxynaphthalen-1-ol | ESD-899049-1G |
Cas.: 109229-22-3 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one | ESD-899050-100MG |
Cas.: 109229-22-3 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one | ESD-899050-250MG |
Cas.: 109229-22-3 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one | ESD-899050-1G |
Cas.: 1375302-99-0 | Purity: ≥95% | 3-(Benzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899051-100MG |
Cas.: 1375302-99-0 | Purity: ≥95% | 3-(Benzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899051-250MG |
Cas.: 1375302-99-0 | Purity: ≥95% | 3-(Benzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899051-1G |
Cas.: 1150271-61-6 | Purity: 98% | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzoate | ESD-899052-100MG |
Cas.: 1150271-61-6 | Purity: 98% | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzoate | ESD-899052-250MG |
Cas.: 1150271-61-6 | Purity: 98% | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzoate | ESD-899052-1G |
Cas.: 692737-66-9 | Purity: 90% | 1-(3-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-899053-100MG |
Cas.: 692737-66-9 | Purity: 90% | 1-(3-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-899053-250MG |
Cas.: 692737-66-9 | Purity: 90% | 1-(3-fluorophenyl)cyclopropan-1-amine hydrochloride | ESD-899053-1G |
Cas.: 94170-15-7 | Purity: ≥95% | 1-Methyl-2-oxo-1,2-dihydropyridine-4-carbaldehyde | ESD-899054-100MG |
Cas.: 94170-15-7 | Purity: ≥95% | 1-Methyl-2-oxo-1,2-dihydropyridine-4-carbaldehyde | ESD-899054-250MG |
Cas.: 94170-15-7 | Purity: ≥95% | 1-Methyl-2-oxo-1,2-dihydropyridine-4-carbaldehyde | ESD-899054-1G |
Cas.: 13129-21-0 | Purity: 95% | Thietane-3-carboxylic acid 1,1-dioxide | ESD-899055-100MG |
Cas.: 13129-21-0 | Purity: 95% | Thietane-3-carboxylic acid 1,1-dioxide | ESD-899055-250MG |
Cas.: 13129-21-0 | Purity: 95% | Thietane-3-carboxylic acid 1,1-dioxide | ESD-899055-1G |
Cas.: 24391-41-1 | Purity: 95% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | ESD-899056-100MG |
Cas.: 24391-41-1 | Purity: 95% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | ESD-899056-250MG |
Cas.: 24391-41-1 | Purity: 95% | 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | ESD-899056-1G |
Cas.: 944709-69-7 | Purity: ≥95% | Methyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-899057-100MG |
Cas.: 944709-69-7 | Purity: ≥95% | Methyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-899057-250MG |
Cas.: 944709-69-7 | Purity: ≥95% | Methyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | ESD-899057-1G |
Cas.: 89167-24-8 | Purity: 97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-899058-100MG |
Cas.: 89167-24-8 | Purity: 97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-899058-250MG |
Cas.: 89167-24-8 | Purity: 97% | 6-Bromo-[1,2,4]triazolo[1,5-a]pyrimidine | ESD-899058-1G |
Cas.: 139022-27-8 | Purity: ≥95% | 6-Fluoroimidazo[1,2-a]pyridine | ESD-899059-100MG |
Cas.: 139022-27-8 | Purity: ≥95% | 6-Fluoroimidazo[1,2-a]pyridine | ESD-899059-250MG |
Cas.: 139022-27-8 | Purity: ≥95% | 6-Fluoroimidazo[1,2-a]pyridine | ESD-899059-1G |
Cas.: 940284-98-0 | Purity: 98% | tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate | ESD-899060-100MG |
Cas.: 940284-98-0 | Purity: 98% | tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate | ESD-899060-250MG |
Cas.: 940284-98-0 | Purity: 98% | tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate | ESD-899060-1G |
Cas.: 1119455-04-7 | Purity: 96% | 2,3-Difluoro-5-nitrophenol | ESD-899061-100MG |
Cas.: 1119455-04-7 | Purity: 96% | 2,3-Difluoro-5-nitrophenol | ESD-899061-250MG |
Cas.: 1119455-04-7 | Purity: 96% | 2,3-Difluoro-5-nitrophenol | ESD-899061-1G |
Cas.: 1255666-86-4 | Purity: 97% | 1-(tert-Butoxycarbonyl)-5,5-difluoropiperidine-3-carboxylic acid | ESD-899062-100MG |
Cas.: 1255666-86-4 | Purity: 97% | 1-(tert-Butoxycarbonyl)-5,5-difluoropiperidine-3-carboxylic acid | ESD-899062-250MG |
Cas.: 1255666-86-4 | Purity: 97% | 1-(tert-Butoxycarbonyl)-5,5-difluoropiperidine-3-carboxylic acid | ESD-899062-1G |
Cas.: 1205544-78-0 | Purity: ≥95% | 1-(Aminomethyl)cyclopropanecarbonitrile hydrochloride | ESD-899063-100MG |
Cas.: 1205544-78-0 | Purity: ≥95% | 1-(Aminomethyl)cyclopropanecarbonitrile hydrochloride | ESD-899063-250MG |
Cas.: 1205544-78-0 | Purity: ≥95% | 1-(Aminomethyl)cyclopropanecarbonitrile hydrochloride | ESD-899063-1G |
Cas.: 1072806-60-0 | Purity: ≥95% | 4-Oxazolemethanamine hydrochloride | ESD-899064-100MG |
Cas.: 1072806-60-0 | Purity: ≥95% | 4-Oxazolemethanamine hydrochloride | ESD-899064-250MG |
Cas.: 1072806-60-0 | Purity: ≥95% | 4-Oxazolemethanamine hydrochloride | ESD-899064-1G |
Cas.: 1160790-84-0 | Purity: 97% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-899065-100MG |
Cas.: 1160790-84-0 | Purity: 97% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-899065-250MG |
Cas.: 1160790-84-0 | Purity: 97% | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | ESD-899065-1G |
Cas.: 197142-34-0 | Purity: 97% | (1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid | ESD-899066-100MG |
Cas.: 197142-34-0 | Purity: 97% | (1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid | ESD-899066-250MG |
Cas.: 197142-34-0 | Purity: 97% | (1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid | ESD-899066-1G |
Cas.: 1303973-22-9 | Purity: ≥95% | tert-Butyl 4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | ESD-899067-100MG |
Cas.: 1303973-22-9 | Purity: ≥95% | tert-Butyl 4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | ESD-899067-250MG |
Cas.: 1303973-22-9 | Purity: ≥95% | tert-Butyl 4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | ESD-899067-1G |
Cas.: 1638767-25-5 | Purity: 97% | tert-Butyl (3-aminobicyclo[1.1.1]pentan-1-yl)carbamate | ESD-899068-100MG |
Cas.: 1638767-25-5 | Purity: 97% | tert-Butyl (3-aminobicyclo[1.1.1]pentan-1-yl)carbamate | ESD-899068-250MG |
Cas.: 1638767-25-5 | Purity: 97% | tert-Butyl (3-aminobicyclo[1.1.1]pentan-1-yl)carbamate | ESD-899068-1G |
Cas.: 204196-80-5 | Purity: ≥95% | 3-(1H-Tetrazol-1-yl)benzoic acid | ESD-899069-250MG |
Cas.: 204196-80-5 | Purity: ≥95% | 3-(1H-Tetrazol-1-yl)benzoic acid | ESD-899069-1G |
Cas.: 204196-80-5 | Purity: ≥95% | 3-(1H-Tetrazol-1-yl)benzoic acid | ESD-899069-5G |
Cas.: 43068-41-3 | Purity: 95% | 4-Bromopyridazine-3,6-diol | ESD-899070-250MG |
Cas.: 43068-41-3 | Purity: 95% | 4-Bromopyridazine-3,6-diol | ESD-899070-1G |
Cas.: 43068-41-3 | Purity: 95% | 4-Bromopyridazine-3,6-diol | ESD-899070-5G |
Cas.: 202460-56-8 | Purity: 97% | Tris(dinaphthoylmethane) mono(phenathroline)europium (III) | ESD-899071-250MG |
Cas.: 202460-56-8 | Purity: 97% | Tris(dinaphthoylmethane) mono(phenathroline)europium (III) | ESD-899071-1G |
Cas.: 202460-56-8 | Purity: 97% | Tris(dinaphthoylmethane) mono(phenathroline)europium (III) | ESD-899071-5G |
Cas.: 845751-59-9 | Purity: 97% | 7-Bromo-2H-indazole | ESD-899072-250MG |
Cas.: 845751-59-9 | Purity: 97% | 7-Bromo-2H-indazole | ESD-899072-1G |
Cas.: 845751-59-9 | Purity: 97% | 7-Bromo-2H-indazole | ESD-899072-5G |
Cas.: 877309-59-6 | Purity: 98% | Methyl 2H-1,2,3-triazole-4-carboxylate | ESD-899073-250MG |
Cas.: 877309-59-6 | Purity: 98% | Methyl 2H-1,2,3-triazole-4-carboxylate | ESD-899073-1G |
Cas.: 877309-59-6 | Purity: 98% | Methyl 2H-1,2,3-triazole-4-carboxylate | ESD-899073-5G |
Cas.: 1173999-43-3 | Purity: 95% | 5-Fluoro-2H-indazole | ESD-899074-250MG |
Cas.: 1173999-43-3 | Purity: 95% | 5-Fluoro-2H-indazole | ESD-899074-1G |
Cas.: 1173999-43-3 | Purity: 95% | 5-Fluoro-2H-indazole | ESD-899074-5G |
Cas.: 121239-75-6 | Purity: 97% | (4-(Octyloxy)phenyl)(phenyl)iodonium hexafluorostibate(V) | ESD-899075-250MG |
Cas.: 121239-75-6 | Purity: 97% | (4-(Octyloxy)phenyl)(phenyl)iodonium hexafluorostibate(V) | ESD-899075-1G |
Cas.: 121239-75-6 | Purity: 97% | (4-(Octyloxy)phenyl)(phenyl)iodonium hexafluorostibate(V) | ESD-899075-5G |
Cas.: 910656-00-7 | Purity: ≥95% | 4-Amino-N-methylnicotinamide | ESD-899076-250MG |
Cas.: 910656-00-7 | Purity: ≥95% | 4-Amino-N-methylnicotinamide | ESD-899076-1G |
Cas.: 910656-00-7 | Purity: ≥95% | 4-Amino-N-methylnicotinamide | ESD-899076-5G |
Cas.: 861114-47-8 | Purity: 97% | Allyl 2-((2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)amino)acetate hydrochloride | ESD-899077-250MG |
Cas.: 861114-47-8 | Purity: 97% | Allyl 2-((2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)amino)acetate hydrochloride | ESD-899077-1G |
Cas.: 861114-47-8 | Purity: 97% | Allyl 2-((2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)amino)acetate hydrochloride | ESD-899077-5G |
Cas.: 876378-16-4 | Purity: 97% | (S)-Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-899078-250MG |
Cas.: 876378-16-4 | Purity: 97% | (S)-Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-899078-1G |
Cas.: 876378-16-4 | Purity: 97% | (S)-Benzyl 3-aminopiperidine-1-carboxylate hydrochloride | ESD-899078-5G |
Cas.: 1342707-37-2 | Purity: 95% | Ethyl 2-amino-3-bromobenzoate | ESD-899079-250MG |
Cas.: 1342707-37-2 | Purity: 95% | Ethyl 2-amino-3-bromobenzoate | ESD-899079-1G |
Cas.: 1342707-37-2 | Purity: 95% | Ethyl 2-amino-3-bromobenzoate | ESD-899079-5G |
Cas.: 140480-93-9 | Purity: 95% | 1-(2-Bromobenzyl)-1H-pyrrole-2,5-dione | ESD-899080-250MG |
Cas.: 140480-93-9 | Purity: 95% | 1-(2-Bromobenzyl)-1H-pyrrole-2,5-dione | ESD-899080-1G |
Cas.: 140480-93-9 | Purity: 95% | 1-(2-Bromobenzyl)-1H-pyrrole-2,5-dione | ESD-899080-5G |
Cas.: 82200-53-1 | Purity: 97% | 4-Methoxyphenyl 4-((6-(acryloyloxy)hexyl)oxy)benzoate | ESD-899081-250MG |
Cas.: 82200-53-1 | Purity: 97% | 4-Methoxyphenyl 4-((6-(acryloyloxy)hexyl)oxy)benzoate | ESD-899081-1G |
Cas.: 82200-53-1 | Purity: 97% | 4-Methoxyphenyl 4-((6-(acryloyloxy)hexyl)oxy)benzoate | ESD-899081-5G |
Cas.: 1137129-05-5 | Purity: 97% | 2-Bromo-5-(4-fluorophenyl)thiazole-4-carboxylic acid | ESD-899082-250MG |
Cas.: 1137129-05-5 | Purity: 97% | 2-Bromo-5-(4-fluorophenyl)thiazole-4-carboxylic acid | ESD-899082-1G |
Cas.: 1137129-05-5 | Purity: 97% | 2-Bromo-5-(4-fluorophenyl)thiazole-4-carboxylic acid | ESD-899082-5G |
Cas.: 16440-97-4 | Purity: 96% | 5,6-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-899083-250MG |
Cas.: 16440-97-4 | Purity: 96% | 5,6-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-899083-1G |
Cas.: 16440-97-4 | Purity: 96% | 5,6-Dimethyl-2,3-dihydro-1H-inden-1-one | ESD-899083-5G |
Cas.: 133170-57-7 | Purity: 97% | (S)-Benzyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate hydrochloride | ESD-899084-250MG |
Cas.: 133170-57-7 | Purity: 97% | (S)-Benzyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate hydrochloride | ESD-899084-1G |
Cas.: 133170-57-7 | Purity: 97% | (S)-Benzyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate hydrochloride | ESD-899084-5G |
Cas.: 2048273-58-9 | Purity: 96% | 6,7-Dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-899085-250MG |
Cas.: 2048273-58-9 | Purity: 96% | 6,7-Dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-899085-1G |
Cas.: 2048273-58-9 | Purity: 96% | 6,7-Dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | ESD-899085-5G |
Cas.: 1027534-43-5 | Purity: ≥95% | Pyrazolo[1,5-a]pyrimidin-5(1H)-one | ESD-899086-250MG |
Cas.: 1027534-43-5 | Purity: ≥95% | Pyrazolo[1,5-a]pyrimidin-5(1H)-one | ESD-899086-1G |
Cas.: 1027534-43-5 | Purity: ≥95% | Pyrazolo[1,5-a]pyrimidin-5(1H)-one | ESD-899086-5G |
Cas.: 69627-02-7 | Purity: 95% | Thieno[3,2-b]pyridin-7(4H)-one | ESD-899087-250MG |
Cas.: 69627-02-7 | Purity: 95% | Thieno[3,2-b]pyridin-7(4H)-one | ESD-899087-1G |
Cas.: 69627-02-7 | Purity: 95% | Thieno[3,2-b]pyridin-7(4H)-one | ESD-899087-5G |
Cas.: 52084-84-1 | Purity: 97% | 2-Amino-5-(aminomethyl)naphthalene-1-sulfonic acid | ESD-899088-250MG |
Cas.: 52084-84-1 | Purity: 97% | 2-Amino-5-(aminomethyl)naphthalene-1-sulfonic acid | ESD-899088-1G |
Cas.: 52084-84-1 | Purity: 97% | 2-Amino-5-(aminomethyl)naphthalene-1-sulfonic acid | ESD-899088-5G |
Cas.: 167216-17-3 | Purity: ≥95% | (R)-tert-Butyl (4-hydroxybutan-2-yl)carbamate | ESD-899089-250MG |
Cas.: 167216-17-3 | Purity: ≥95% | (R)-tert-Butyl (4-hydroxybutan-2-yl)carbamate | ESD-899089-1G |
Cas.: 167216-17-3 | Purity: ≥95% | (R)-tert-Butyl (4-hydroxybutan-2-yl)carbamate | ESD-899089-5G |
Cas.: 1196073-28-5 | Purity: 97% | Methyl 4,6-dichloro-2-methylnicotinate | ESD-899090-250MG |
Cas.: 1196073-28-5 | Purity: 97% | Methyl 4,6-dichloro-2-methylnicotinate | ESD-899090-1G |
Cas.: 1196073-28-5 | Purity: 97% | Methyl 4,6-dichloro-2-methylnicotinate | ESD-899090-5G |
Cas.: 2216751-08-3 | Purity: 95% | (S)-2-Amino-3-guanidinopropanoic acid dihydrochloride | ESD-899091-250MG |
Cas.: 2216751-08-3 | Purity: 95% | (S)-2-Amino-3-guanidinopropanoic acid dihydrochloride | ESD-899091-1G |
Cas.: 2216751-08-3 | Purity: 95% | (S)-2-Amino-3-guanidinopropanoic acid dihydrochloride | ESD-899091-5G |
Cas.: 42965-55-9 | Purity: ≥95% | 5,6-Diaminopyrimidine-2,4(1H,3H)-dione sulfate | ESD-899092-250MG |
Cas.: 42965-55-9 | Purity: ≥95% | 5,6-Diaminopyrimidine-2,4(1H,3H)-dione sulfate | ESD-899092-1G |
Cas.: 42965-55-9 | Purity: ≥95% | 5,6-Diaminopyrimidine-2,4(1H,3H)-dione sulfate | ESD-899092-5G |
Cas.: 94787-97-0 | Purity: 97% | H-Nle-NH2.HCl | ESD-899093-250MG |
Cas.: 94787-97-0 | Purity: 97% | H-Nle-NH2.HCl | ESD-899093-1G |
Cas.: 94787-97-0 | Purity: 97% | H-Nle-NH2.HCl | ESD-899093-5G |
Cas.: 18464-23-8 | Purity: 97% | N1,N2-Didodecyl-N1,N1,N2,N2-tetramethylethane-1,2-diaminium bromide | ESD-899094-250MG |
Cas.: 18464-23-8 | Purity: 97% | N1,N2-Didodecyl-N1,N1,N2,N2-tetramethylethane-1,2-diaminium bromide | ESD-899094-1G |
Cas.: 1992989-11-3 | Purity: 95% | Methyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate hydrochloride | ESD-899095-250MG |
Cas.: 1992989-11-3 | Purity: 95% | Methyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate hydrochloride | ESD-899095-1G |
Cas.: 1992989-11-3 | Purity: 95% | Methyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate hydrochloride | ESD-899095-5G |
Cas.: 6268-43-5 | Purity: 97% | 1,3-Di(pyridin-2-yl)urea | ESD-899096-250MG |
Cas.: 6268-43-5 | Purity: 97% | 1,3-Di(pyridin-2-yl)urea | ESD-899096-1G |
Cas.: 90221-46-8 | Purity: 97% | 6-Bromo-3-methyl-2H-indazole | ESD-899097-250MG |
Cas.: 90221-46-8 | Purity: 97% | 6-Bromo-3-methyl-2H-indazole | ESD-899097-1G |
Cas.: 90221-46-8 | Purity: 97% | 6-Bromo-3-methyl-2H-indazole | ESD-899097-5G |
Cas.: 1195677-97-4 | Purity: 97% | 4-Iodo-2-(trifluoromethyl)benzamide | ESD-899098-250MG |
Cas.: 1195677-97-4 | Purity: 97% | 4-Iodo-2-(trifluoromethyl)benzamide | ESD-899098-1G |
Cas.: 1195677-97-4 | Purity: 97% | 4-Iodo-2-(trifluoromethyl)benzamide | ESD-899098-5G |
Cas.: 29636-94-0 | Purity: 97% | 1-(2-Hydroxyethyl)-2,3,3-trimethyl-3H-indol-1-ium bromide | ESD-899099-250MG |
Cas.: 29636-94-0 | Purity: 97% | 1-(2-Hydroxyethyl)-2,3,3-trimethyl-3H-indol-1-ium bromide | ESD-899099-1G |
Cas.: 29636-94-0 | Purity: 97% | 1-(2-Hydroxyethyl)-2,3,3-trimethyl-3H-indol-1-ium bromide | ESD-899099-5G |
Cas.: 125982-23-2 | Purity: 97% | (S)-tert-Butyl (6-oxotetrahydro-2H-pyran-3-yl)carbamate | ESD-899100-250MG |
Cas.: 125982-23-2 | Purity: 97% | (S)-tert-Butyl (6-oxotetrahydro-2H-pyran-3-yl)carbamate | ESD-899100-1G |
Cas.: 125982-23-2 | Purity: 97% | (S)-tert-Butyl (6-oxotetrahydro-2H-pyran-3-yl)carbamate | ESD-899100-5G |
Cas.: 634468-72-7 | Purity: ≥95% | 4-(Piperazin-1-yl)pyrimidine dihydrochloride | ESD-899101-250MG |
Cas.: 634468-72-7 | Purity: ≥95% | 4-(Piperazin-1-yl)pyrimidine dihydrochloride | ESD-899101-1G |
Cas.: 634468-72-7 | Purity: ≥95% | 4-(Piperazin-1-yl)pyrimidine dihydrochloride | ESD-899101-5G |
Cas.: 78910-06-2 | Purity: 97% | 1-Ethyl-1H-1,2,3-triazole | ESD-899102-250MG |
Cas.: 78910-06-2 | Purity: 97% | 1-Ethyl-1H-1,2,3-triazole | ESD-899102-1G |
Cas.: 78910-06-2 | Purity: 97% | 1-Ethyl-1H-1,2,3-triazole | ESD-899102-5G |
Cas.: 71133-20-5 | Purity: ≥95% | Ethyl 4-hydroxypyrimidine-5-carboxylate | ESD-899103-250MG |
Cas.: 71133-20-5 | Purity: ≥95% | Ethyl 4-hydroxypyrimidine-5-carboxylate | ESD-899103-1G |
Cas.: 71133-20-5 | Purity: ≥95% | Ethyl 4-hydroxypyrimidine-5-carboxylate | ESD-899103-5G |
Cas.: 86246-71-1 | Purity: 97% | Methyl 3-bromo-2,6-dimethylbenzoate | ESD-899104-250MG |
Cas.: 86246-71-1 | Purity: 97% | Methyl 3-bromo-2,6-dimethylbenzoate | ESD-899104-1G |
Cas.: 86246-71-1 | Purity: 97% | Methyl 3-bromo-2,6-dimethylbenzoate | ESD-899104-5G |
Cas.: 367453-05-2 | Purity: ≥95% | H-Hyp(tBu)-OtBu.HCl | ESD-899105-250MG |
Cas.: 367453-05-2 | Purity: ≥95% | H-Hyp(tBu)-OtBu.HCl | ESD-899105-1G |
Cas.: 367453-05-2 | Purity: ≥95% | H-Hyp(tBu)-OtBu.HCl | ESD-899105-5G |
Cas.: 75179-29-2 | Purity: 96% | Boc-Cys(Trt)-OSu | ESD-899106-250MG |
Cas.: 75179-29-2 | Purity: 96% | Boc-Cys(Trt)-OSu | ESD-899106-1G |
Cas.: 75179-29-2 | Purity: 96% | Boc-Cys(Trt)-OSu | ESD-899106-5G |
Cas.: 1998701-25-9 | Purity: 97% | (R)-Benzyl 2-amino-3-(tert-butoxy)propanoate hydrochloride | ESD-899107-250MG |
Cas.: 1998701-25-9 | Purity: 97% | (R)-Benzyl 2-amino-3-(tert-butoxy)propanoate hydrochloride | ESD-899107-1G |
Cas.: 1998701-25-9 | Purity: 97% | (R)-Benzyl 2-amino-3-(tert-butoxy)propanoate hydrochloride | ESD-899107-5G |
Cas.: 39602-93-2 | Purity: 97% | 4-Amino-1-methyl-4H-1,2,4-triazol-1-ium iodide | ESD-899108-250MG |
Cas.: 39602-93-2 | Purity: 97% | 4-Amino-1-methyl-4H-1,2,4-triazol-1-ium iodide | ESD-899108-1G |
Cas.: 39602-93-2 | Purity: 97% | 4-Amino-1-methyl-4H-1,2,4-triazol-1-ium iodide | ESD-899108-5G |
Cas.: 69887-15-6 | Purity: 97% | Adamantane-1,3-diyldimethanamine dihydrochloride | ESD-899109-250MG |
Cas.: 69887-15-6 | Purity: 97% | Adamantane-1,3-diyldimethanamine dihydrochloride | ESD-899109-1G |
Cas.: 69887-15-6 | Purity: 97% | Adamantane-1,3-diyldimethanamine dihydrochloride | ESD-899109-5G |
Cas.: 98102-32-0 | Purity: 97% | H-Glu(OtBu)-OBzl.HCl | ESD-899110-250MG |
Cas.: 98102-32-0 | Purity: 97% | H-Glu(OtBu)-OBzl.HCl | ESD-899110-1G |
Cas.: 98102-32-0 | Purity: 97% | H-Glu(OtBu)-OBzl.HCl | ESD-899110-5G |
Cas.: 78981-25-6 | Purity: 97% | Boc-D-Ala-NH2 | ESD-899111-250MG |
Cas.: 78981-25-6 | Purity: 97% | Boc-D-Ala-NH2 | ESD-899111-1G |
Cas.: 78981-25-6 | Purity: 97% | Boc-D-Ala-NH2 | ESD-899111-5G |
Cas.: 611-92-7 | Purity: ≥95% | 1,3-Dimethyl-1,3-diphenylurea | ESD-899112-250MG |
Cas.: 611-92-7 | Purity: ≥95% | 1,3-Dimethyl-1,3-diphenylurea | ESD-899112-1G |
Cas.: 611-92-7 | Purity: ≥95% | 1,3-Dimethyl-1,3-diphenylurea | ESD-899112-5G |
Cas.: 82586-60-5 | Purity: 97% | (S)-tert-Butyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride | ESD-899113-250MG |
Cas.: 82586-60-5 | Purity: 97% | (S)-tert-Butyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride | ESD-899113-1G |
Cas.: 82586-60-5 | Purity: 97% | (S)-tert-Butyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride | ESD-899113-5G |
Cas.: 58607-69-5 | Purity: 95% | (R)-2-((R)-2-Amino-3-phenylpropanamido)-3-phenylpropanoic acid | ESD-899114-250MG |
Cas.: 58607-69-5 | Purity: 95% | (R)-2-((R)-2-Amino-3-phenylpropanamido)-3-phenylpropanoic acid | ESD-899114-1G |
Cas.: 58607-69-5 | Purity: 95% | (R)-2-((R)-2-Amino-3-phenylpropanamido)-3-phenylpropanoic acid | ESD-899114-5G |
Cas.: 1242056-42-3 | Purity: 96% | N-([1,1′-Biphenyl]-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2- amine | ESD-899115-250MG |
Cas.: 1242056-42-3 | Purity: 96% | N-([1,1′-Biphenyl]-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2- amine | ESD-899115-1G |
Cas.: 1242056-42-3 | Purity: 96% | N-([1,1′-Biphenyl]-4-yl)-9,9-dimethyl-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-9H-fluoren-2- amine | ESD-899115-5G |
Cas.: 499132-20-6 | Purity: 97% | 1-Isopropyl-1H-1,2,3-triazole | ESD-899116-250MG |
Cas.: 499132-20-6 | Purity: 97% | 1-Isopropyl-1H-1,2,3-triazole | ESD-899116-1G |
Cas.: 499132-20-6 | Purity: 97% | 1-Isopropyl-1H-1,2,3-triazole | ESD-899116-5G |
Cas.: 1261686-95-6 | Purity: 97% | 2-(Bromomethyl)-6-fluorobenzonitrile | ESD-899117-250MG |
Cas.: 1261686-95-6 | Purity: 97% | 2-(Bromomethyl)-6-fluorobenzonitrile | ESD-899117-1G |
Cas.: 1261686-95-6 | Purity: 97% | 2-(Bromomethyl)-6-fluorobenzonitrile | ESD-899117-5G |
Cas.: 2061979-87-9 | Purity: 97% | tert-Butyl 5-aminoisoindoline-2-carboxylate oxalate (2:1) | ESD-899118-250MG |
Cas.: 2061979-87-9 | Purity: 97% | tert-Butyl 5-aminoisoindoline-2-carboxylate oxalate (2:1) | ESD-899118-1G |
Cas.: 2061979-87-9 | Purity: 97% | tert-Butyl 5-aminoisoindoline-2-carboxylate oxalate (2:1) | ESD-899118-5G |
Cas.: 1360438-72-7 | Purity: ≥95% | 1,2-Dichloro-4-fluoro-3-nitrobenzene | ESD-899119-250MG |
Cas.: 1360438-72-7 | Purity: ≥95% | 1,2-Dichloro-4-fluoro-3-nitrobenzene | ESD-899119-1G |
Cas.: 1360438-72-7 | Purity: ≥95% | 1,2-Dichloro-4-fluoro-3-nitrobenzene | ESD-899119-5G |
Cas.: 63619-51-2 | Purity: 97% | 4-Bromo-4′-(pentyloxy)-1,1′-biphenyl | ESD-899120-250MG |
Cas.: 63619-51-2 | Purity: 97% | 4-Bromo-4′-(pentyloxy)-1,1′-biphenyl | ESD-899120-1G |
Cas.: 63619-51-2 | Purity: 97% | 4-Bromo-4′-(pentyloxy)-1,1′-biphenyl | ESD-899120-5G |
Cas.: 110990-08-4 | Purity: 95% | Fmoc-D-Lys-OH | ESD-899121-250MG |
Cas.: 273920-24-4 | Purity: ≥95% | Methyl 3-amino-3-(4-nitrophenyl)propanoate | ESD-899122-250MG |
Cas.: 273920-24-4 | Purity: ≥95% | Methyl 3-amino-3-(4-nitrophenyl)propanoate | ESD-899122-1G |
Cas.: 273920-24-4 | Purity: ≥95% | Methyl 3-amino-3-(4-nitrophenyl)propanoate | ESD-899122-5G |
Cas.: 1841081-54-6 | Purity: 97% | (Perfluoro-1,4-phenylene)dimethanamine acetate | ESD-899123-250MG |
Cas.: 1841081-54-6 | Purity: 97% | (Perfluoro-1,4-phenylene)dimethanamine acetate | ESD-899123-1G |
Cas.: 1841081-54-6 | Purity: 97% | (Perfluoro-1,4-phenylene)dimethanamine acetate | ESD-899123-5G |
Cas.: 131257-07-3 | Purity: 97% | Sodium (6R,7R)-7-amino-3-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | ESD-899124-250MG |
Cas.: 131257-07-3 | Purity: 97% | Sodium (6R,7R)-7-amino-3-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | ESD-899124-1G |
Cas.: 131257-07-3 | Purity: 97% | Sodium (6R,7R)-7-amino-3-(((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio)methyl) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | ESD-899124-5G |
Cas.: 1869912-48-0 | Purity: 97% | 4-(Piperidin-4-yl)phenol hydrobromide | ESD-899125-250MG |
Cas.: 1869912-48-0 | Purity: 97% | 4-(Piperidin-4-yl)phenol hydrobromide | ESD-899125-1G |
Cas.: 1869912-48-0 | Purity: 97% | 4-(Piperidin-4-yl)phenol hydrobromide | ESD-899125-5G |
Cas.: 90458-75-6 | Purity: 97% | Sodium ((1,4-phenylenebis(methanylylidene))bis(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl-3-ylidene))dimethanesulfonate | ESD-899126-250MG |
Cas.: 90458-75-6 | Purity: 97% | Sodium ((1,4-phenylenebis(methanylylidene))bis(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl-3-ylidene))dimethanesulfonate | ESD-899126-1G |
Cas.: 90458-75-6 | Purity: 97% | Sodium ((1,4-phenylenebis(methanylylidene))bis(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl-3-ylidene))dimethanesulfonate | ESD-899126-5G |
Cas.: 2061980-39-8 | Purity: 95% | Benzyl 3-acetoxyazetidine-1-carboxylate | ESD-899127-250MG |
Cas.: 2061980-39-8 | Purity: 95% | Benzyl 3-acetoxyazetidine-1-carboxylate | ESD-899127-1G |
Cas.: 2061980-39-8 | Purity: 95% | Benzyl 3-acetoxyazetidine-1-carboxylate | ESD-899127-5G |
Cas.: 5744-68-3 | Purity: 98% | 5-Bromo-3-methyl-1H-pyrazole | ESD-899128-250MG |
Cas.: 5744-68-3 | Purity: 98% | 5-Bromo-3-methyl-1H-pyrazole | ESD-899128-1G |
Cas.: 5744-68-3 | Purity: 98% | 5-Bromo-3-methyl-1H-pyrazole | ESD-899128-5G |
Cas.: 32938-44-6 | Purity: ≥95% | 2-Bromo-4-(bromomethyl)pyridine hydrobromide | ESD-899129-250MG |
Cas.: 32938-44-6 | Purity: ≥95% | 2-Bromo-4-(bromomethyl)pyridine hydrobromide | ESD-899129-1G |
Cas.: 32938-44-6 | Purity: ≥95% | 2-Bromo-4-(bromomethyl)pyridine hydrobromide | ESD-899129-5G |
Cas.: 13392-26-2 | Purity: ≥95% | 2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol | ESD-899130-250MG |
Cas.: 13392-26-2 | Purity: ≥95% | 2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol | ESD-899130-1G |
Cas.: 174518-82-2 | Purity: ≥95% | 1-Bromo-2,5-dimethoxy-4-iodobenzene | ESD-899131-250MG |
Cas.: 174518-82-2 | Purity: ≥95% | 1-Bromo-2,5-dimethoxy-4-iodobenzene | ESD-899131-1G |
Cas.: 174518-82-2 | Purity: ≥95% | 1-Bromo-2,5-dimethoxy-4-iodobenzene | ESD-899131-5G |
Cas.: 25503-87-1 | Purity: ≥95% | Phenyl(pyrrolidin-3-yl)methanone hydrochloride | ESD-899132-250MG |
Cas.: 25503-87-1 | Purity: ≥95% | Phenyl(pyrrolidin-3-yl)methanone hydrochloride | ESD-899132-1G |
Cas.: 25503-87-1 | Purity: ≥95% | Phenyl(pyrrolidin-3-yl)methanone hydrochloride | ESD-899132-5G |
Cas.: 66831-16-1 | Purity: 97% | H-Hyp(Bzl)-OH.HCl | ESD-899133-250MG |
Cas.: 66831-16-1 | Purity: 97% | H-Hyp(Bzl)-OH.HCl | ESD-899133-1G |
Cas.: 1315342-15-4 | Purity: 97% | (4-Ethoxy-2,6-dimethylphenyl)boronic acid | ESD-899134-250MG |
Cas.: 1315342-15-4 | Purity: 97% | (4-Ethoxy-2,6-dimethylphenyl)boronic acid | ESD-899134-1G |
Cas.: 1315342-15-4 | Purity: 97% | (4-Ethoxy-2,6-dimethylphenyl)boronic acid | ESD-899134-5G |
Cas.: 361441-96-5 | Purity: 97% | (S)-2-(Adamantan-1-yl)-2-(((R)-2-hydroxy-1-phenylethyl)amino)acetic acid hydrochloride | ESD-899135-250MG |
Cas.: 361441-96-5 | Purity: 97% | (S)-2-(Adamantan-1-yl)-2-(((R)-2-hydroxy-1-phenylethyl)amino)acetic acid hydrochloride | ESD-899135-1G |
Cas.: 361441-96-5 | Purity: 97% | (S)-2-(Adamantan-1-yl)-2-(((R)-2-hydroxy-1-phenylethyl)amino)acetic acid hydrochloride | ESD-899135-5G |
Cas.: 86161-49-1 | Purity: ≥95% | LZ-Isoleucinamide | ESD-899136-250MG |
Cas.: 86161-49-1 | Purity: ≥95% | LZ-Isoleucinamide | ESD-899136-1G |
Cas.: 86161-49-1 | Purity: ≥95% | LZ-Isoleucinamide | ESD-899136-5G |
Cas.: 157662-77-6 | Purity: 95% | 4-Fluoro-3-nitrophenylacetonitrile | ESD-899137-250MG |
Cas.: 157662-77-6 | Purity: 95% | 4-Fluoro-3-nitrophenylacetonitrile | ESD-899137-1G |
Cas.: 157662-77-6 | Purity: 95% | 4-Fluoro-3-nitrophenylacetonitrile | ESD-899137-5G |
Cas.: 75898-47-4 | Purity: ≥95% | H-DL-Phe-OtBu.HCl | ESD-899138-250MG |
Cas.: 75898-47-4 | Purity: ≥95% | H-DL-Phe-OtBu.HCl | ESD-899138-1G |
Cas.: 75898-47-4 | Purity: ≥95% | H-DL-Phe-OtBu.HCl | ESD-899138-5G |
Cas.: 50509-09-6 | Purity: 97% | 2-Amino-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide | ESD-899139-250MG |
Cas.: 50509-09-6 | Purity: 97% | 2-Amino-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide | ESD-899139-1G |
Cas.: 50509-09-6 | Purity: 97% | 2-Amino-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide | ESD-899139-5G |
Cas.: 597562-39-5 | Purity: ≥95% | Methyl 4-amino-3-(butylamino)benzoate | ESD-899140-250MG |
Cas.: 597562-39-5 | Purity: ≥95% | Methyl 4-amino-3-(butylamino)benzoate | ESD-899140-1G |
Cas.: 597562-39-5 | Purity: ≥95% | Methyl 4-amino-3-(butylamino)benzoate | ESD-899140-5G |
Cas.: 454170-16-2 | Purity: ≥95% | tert-Butyl ((1R,2R)-2-hydroxycyclopentyl)carbamate | ESD-899141-250MG |
Cas.: 454170-16-2 | Purity: ≥95% | tert-Butyl ((1R,2R)-2-hydroxycyclopentyl)carbamate | ESD-899141-1G |
Cas.: 454170-16-2 | Purity: ≥95% | tert-Butyl ((1R,2R)-2-hydroxycyclopentyl)carbamate | ESD-899141-5G |
Cas.: 6278-90-6 | Purity: ≥95% | Octyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride | ESD-899142-250MG |
Cas.: 6278-90-6 | Purity: ≥95% | Octyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride | ESD-899142-1G |
Cas.: 6278-90-6 | Purity: ≥95% | Octyl 2-amino-3-(1H-indol-3-yl)propanoate hydrochloride | ESD-899142-5G |
Cas.: 13382-61-1 | Purity: ≥95% | 4-(4-Nitrophenyl)oxazole | ESD-899143-250MG |
Cas.: 13382-61-1 | Purity: ≥95% | 4-(4-Nitrophenyl)oxazole | ESD-899143-1G |
Cas.: 13382-61-1 | Purity: ≥95% | 4-(4-Nitrophenyl)oxazole | ESD-899143-5G |
Cas.: 1588441-19-3 | Purity: 97% | 2-Aminopyrimidine-5-carbaldehyde hydrate | ESD-899144-250MG |
Cas.: 1588441-19-3 | Purity: 97% | 2-Aminopyrimidine-5-carbaldehyde hydrate | ESD-899144-1G |
Cas.: 1588441-19-3 | Purity: 97% | 2-Aminopyrimidine-5-carbaldehyde hydrate | ESD-899144-5G |
Cas.: 4630-95-9 | Purity: 97% | 3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide | ESD-899145-250MG |
Cas.: 4630-95-9 | Purity: 97% | 3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide | ESD-899145-1G |
Cas.: 4630-95-9 | Purity: 97% | 3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide | ESD-899145-5G |
Cas.: 32327-46-1 | Purity: 95% | 5-Methoxynaphthalene-1-sulfonamide | ESD-899146-250MG |
Cas.: 32327-46-1 | Purity: 95% | 5-Methoxynaphthalene-1-sulfonamide | ESD-899146-1G |
Cas.: 32327-46-1 | Purity: 95% | 5-Methoxynaphthalene-1-sulfonamide | ESD-899146-5G |
Cas.: 14685-90-6 | Purity: ≥95% | Ethyl 4-hydrazinylbenzoate | ESD-899147-250MG |
Cas.: 14685-90-6 | Purity: ≥95% | Ethyl 4-hydrazinylbenzoate | ESD-899147-1G |
Cas.: 14685-90-6 | Purity: ≥95% | Ethyl 4-hydrazinylbenzoate | ESD-899147-5G |
Cas.: 352220-15-6 | Purity: ≥95% | 3-(Piperidin-2-yl)pyridine hydrochloride | ESD-899148-250MG |
Cas.: 352220-15-6 | Purity: ≥95% | 3-(Piperidin-2-yl)pyridine hydrochloride | ESD-899148-1G |
Cas.: 352220-15-6 | Purity: ≥95% | 3-(Piperidin-2-yl)pyridine hydrochloride | ESD-899148-5G |
Cas.: 53956-05-1 | Purity: 98% | H-Abu-OtBu.HCl | ESD-899149-250MG |
Cas.: 53956-05-1 | Purity: 98% | H-Abu-OtBu.HCl | ESD-899149-1G |
Cas.: 53956-05-1 | Purity: 98% | H-Abu-OtBu.HCl | ESD-899149-5G |
Cas.: 5906-98-9 | Purity: ≥95% | 2-Chlorobenzenesulfonohydrazide | ESD-899150-250MG |
Cas.: 5906-98-9 | Purity: ≥95% | 2-Chlorobenzenesulfonohydrazide | ESD-899150-1G |
Cas.: 5906-98-9 | Purity: ≥95% | 2-Chlorobenzenesulfonohydrazide | ESD-899150-5G |
Cas.: 61788-27-0 | Purity: 97% | N-(2-Chlorophenyl)-1H-indole-3-carboxamide | ESD-899151-250MG |
Cas.: 16255-90-6 | Purity: 97% | 2-((2-Chloro-5-fluoropyrimidin-4-yl)amino)ethanol | ESD-899152-250MG |
Cas.: 16255-90-6 | Purity: 97% | 2-((2-Chloro-5-fluoropyrimidin-4-yl)amino)ethanol | ESD-899152-1G |
Cas.: 16255-90-6 | Purity: 97% | 2-((2-Chloro-5-fluoropyrimidin-4-yl)amino)ethanol | ESD-899152-5G |
Cas.: 16948-36-0 | Purity: 97% | HD-Glu(OtBu)-OMe.HCl | ESD-899153-250MG |
Cas.: 16948-36-0 | Purity: 97% | HD-Glu(OtBu)-OMe.HCl | ESD-899153-1G |
Cas.: 16948-36-0 | Purity: 97% | HD-Glu(OtBu)-OMe.HCl | ESD-899153-5G |
Cas.: 87579-78-0 | Purity: ≥95% | (2S,5R)-Benzhydryl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide | ESD-899154-250MG |
Cas.: 87579-78-0 | Purity: ≥95% | (2S,5R)-Benzhydryl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide | ESD-899154-1G |
Cas.: 87579-78-0 | Purity: ≥95% | (2S,5R)-Benzhydryl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide | ESD-899154-5G |
Cas.: 88704-72-7 | Purity: 97% | 2-(1H-Benzo[d]imidazol-2-yl)ethanamine hydrochloride | ESD-899155-250MG |
Cas.: 88704-72-7 | Purity: 97% | 2-(1H-Benzo[d]imidazol-2-yl)ethanamine hydrochloride | ESD-899155-1G |
Cas.: 88704-72-7 | Purity: 97% | 2-(1H-Benzo[d]imidazol-2-yl)ethanamine hydrochloride | ESD-899155-5G |
Cas.: 1956325-54-4 | Purity: ≥95% | N1,N2-Dimethylcyclohexane-1,2-diamine hydrochloride | ESD-899156-250MG |
Cas.: 1956325-54-4 | Purity: ≥95% | N1,N2-Dimethylcyclohexane-1,2-diamine hydrochloride | ESD-899156-1G |
Cas.: 1956325-54-4 | Purity: ≥95% | N1,N2-Dimethylcyclohexane-1,2-diamine hydrochloride | ESD-899156-5G |
Cas.: 123280-64-8 | Purity: 98% | 3,6-Dichloro-2-methylpyridine | ESD-899157-250MG |
Cas.: 123280-64-8 | Purity: 98% | 3,6-Dichloro-2-methylpyridine | ESD-899157-1G |
Cas.: 123280-64-8 | Purity: 98% | 3,6-Dichloro-2-methylpyridine | ESD-899157-5G |
Cas.: 692058-21-2 | Purity: 97% | 1-Boc-4-(2,2,2-trifluoroethyl)piperazine | ESD-899158-250MG |
Cas.: 692058-21-2 | Purity: 97% | 1-Boc-4-(2,2,2-trifluoroethyl)piperazine | ESD-899158-1G |
Cas.: 692058-21-2 | Purity: 97% | 1-Boc-4-(2,2,2-trifluoroethyl)piperazine | ESD-899158-5G |
Cas.: 350797-56-7 | Purity: ≥97% | 3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate | ESD-899159-250MG |
Cas.: 350797-56-7 | Purity: ≥97% | 3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate | ESD-899159-1G |
Cas.: 350797-56-7 | Purity: ≥97% | 3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate | ESD-899159-5G |
Cas.: 84787-81-5 | Purity: ≥95% | (S)-Ethyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-899160-250MG |
Cas.: 84787-81-5 | Purity: ≥95% | (S)-Ethyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-899160-1G |
Cas.: 84787-81-5 | Purity: ≥95% | (S)-Ethyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-899160-5G |
Cas.: 1260834-31-8 | Purity: 97% | 2-Cyano-3-nitrobenzoic acid | ESD-899161-250MG |
Cas.: 1260834-31-8 | Purity: 97% | 2-Cyano-3-nitrobenzoic acid | ESD-899161-1G |
Cas.: 1260834-31-8 | Purity: 97% | 2-Cyano-3-nitrobenzoic acid | ESD-899161-5G |
Cas.: 2717-76-2 | Purity: ≥95% | Z-Trp-OMe | ESD-899162-250MG |
Cas.: 2717-76-2 | Purity: ≥95% | Z-Trp-OMe | ESD-899162-1G |
Cas.: 2717-76-2 | Purity: ≥95% | Z-Trp-OMe | ESD-899162-5G |
Cas.: 2096342-38-8 | Purity: 97% | (3-Chloro-2-fluoro-5-(trifluoromethyl)phenyl)boronic acid | ESD-899163-250MG |
Cas.: 2096342-38-8 | Purity: 97% | (3-Chloro-2-fluoro-5-(trifluoromethyl)phenyl)boronic acid | ESD-899163-1G |
Cas.: 2096342-38-8 | Purity: 97% | (3-Chloro-2-fluoro-5-(trifluoromethyl)phenyl)boronic acid | ESD-899163-5G |
Cas.: 15459-51-5 | Purity: 97% | 4-Bromo-2,6-diiodophenol | ESD-899164-250MG |
Cas.: 15459-51-5 | Purity: 97% | 4-Bromo-2,6-diiodophenol | ESD-899164-1G |
Cas.: 15459-51-5 | Purity: 97% | 4-Bromo-2,6-diiodophenol | ESD-899164-5G |
Cas.: 177352-26-0 | Purity: 95% | Cycloheptylmethanamine hydrochloride | ESD-899165-250MG |
Cas.: 177352-26-0 | Purity: 95% | Cycloheptylmethanamine hydrochloride | ESD-899165-1G |
Cas.: 177352-26-0 | Purity: 95% | Cycloheptylmethanamine hydrochloride | ESD-899165-5G |
Cas.: 1820580-34-4 | Purity: ≥95% | 2′-Deoxy-2′-fluorocytidine hydrate | ESD-899166-250MG |
Cas.: 1820580-34-4 | Purity: ≥95% | 2′-Deoxy-2′-fluorocytidine hydrate | ESD-899166-1G |
Cas.: 1820580-34-4 | Purity: ≥95% | 2′-Deoxy-2′-fluorocytidine hydrate | ESD-899166-5G |
Cas.: 60154-05-4 | Purity: 95% | 5-Iodo-1-methylpyridin-2(1H)-one | ESD-899167-250MG |
Cas.: 60154-05-4 | Purity: 95% | 5-Iodo-1-methylpyridin-2(1H)-one | ESD-899167-1G |
Cas.: 60154-05-4 | Purity: 95% | 5-Iodo-1-methylpyridin-2(1H)-one | ESD-899167-5G |
Cas.: 849751-48-0 | Purity: 95% | tert-Butyl (2-chloropyrimidin-4-yl)carbamate | ESD-899168-250MG |
Cas.: 849751-48-0 | Purity: 95% | tert-Butyl (2-chloropyrimidin-4-yl)carbamate | ESD-899168-1G |
Cas.: 849751-48-0 | Purity: 95% | tert-Butyl (2-chloropyrimidin-4-yl)carbamate | ESD-899168-5G |
Cas.: 87205-47-8 | Purity: ≥95% | (R)-2-Aminopent-4-ynoic acid hydrochloride | ESD-899169-250MG |
Cas.: 87205-47-8 | Purity: ≥95% | (R)-2-Aminopent-4-ynoic acid hydrochloride | ESD-899169-1G |
Cas.: 87205-47-8 | Purity: ≥95% | (R)-2-Aminopent-4-ynoic acid hydrochloride | ESD-899169-5G |
Cas.: 58117-53-6 | Purity: 96% | H-Lys(Z)-NH2.HCl | ESD-899170-250MG |
Cas.: 58117-53-6 | Purity: 96% | H-Lys(Z)-NH2.HCl | ESD-899170-1G |
Cas.: 58117-53-6 | Purity: 96% | H-Lys(Z)-NH2.HCl | ESD-899170-5G |
Cas.: 854778-42-0 | Purity: 95% | 4-Bromo-1-(bromomethyl)-2-methoxybenzene | ESD-899171-250MG |
Cas.: 854778-42-0 | Purity: 95% | 4-Bromo-1-(bromomethyl)-2-methoxybenzene | ESD-899171-1G |
Cas.: 854778-42-0 | Purity: 95% | 4-Bromo-1-(bromomethyl)-2-methoxybenzene | ESD-899171-5G |
Cas.: 20651-30-3 | Purity: 97% | 5-Methyl-2-(methylthio)pyrimidin-4(3H)-one | ESD-899172-250MG |
Cas.: 20651-30-3 | Purity: 97% | 5-Methyl-2-(methylthio)pyrimidin-4(3H)-one | ESD-899172-1G |
Cas.: 20651-30-3 | Purity: 97% | 5-Methyl-2-(methylthio)pyrimidin-4(3H)-one | ESD-899172-5G |
Cas.: 63619-54-5 | Purity: 98% | 4-Bromo-4′-butyl-1,1′-biphenyl | ESD-899173-250MG |
Cas.: 63619-54-5 | Purity: 98% | 4-Bromo-4′-butyl-1,1′-biphenyl | ESD-899173-1G |
Cas.: 63619-54-5 | Purity: 98% | 4-Bromo-4′-butyl-1,1′-biphenyl | ESD-899173-5G |
Cas.: 195053-92-0 | Purity: 97% | 2-(1-Trityl-1H-imidazol-4-yl)ethanamine | ESD-899174-250MG |
Cas.: 195053-92-0 | Purity: 97% | 2-(1-Trityl-1H-imidazol-4-yl)ethanamine | ESD-899174-1G |
Cas.: 195053-92-0 | Purity: 97% | 2-(1-Trityl-1H-imidazol-4-yl)ethanamine | ESD-899174-5G |
Cas.: 216961-61-4 | Purity: 95% | tert-Butyl (10-aminodecyl)carbamate | ESD-899175-250MG |
Cas.: 216961-61-4 | Purity: 95% | tert-Butyl (10-aminodecyl)carbamate | ESD-899175-1G |
Cas.: 216961-61-4 | Purity: 95% | tert-Butyl (10-aminodecyl)carbamate | ESD-899175-5G |
Cas.: 147065-06-3 | Purity: 97% | HD-Phe(4-NO2)-OH.HCl | ESD-899176-250MG |
Cas.: 147065-06-3 | Purity: 97% | HD-Phe(4-NO2)-OH.HCl | ESD-899176-1G |
Cas.: 147065-06-3 | Purity: 97% | HD-Phe(4-NO2)-OH.HCl | ESD-899176-5G |
Cas.: 38484-94-5 | Purity: ≥95% | 2,5-Dichlorobenzenesulfonic acid dihydrate | ESD-899177-250MG |
Cas.: 38484-94-5 | Purity: ≥95% | 2,5-Dichlorobenzenesulfonic acid dihydrate | ESD-899177-1G |
Cas.: 38484-94-5 | Purity: ≥95% | 2,5-Dichlorobenzenesulfonic acid dihydrate | ESD-899177-5G |
Cas.: 173999-22-9 | Purity: 97% | 5-Bromo-2-(bromomethyl)pyridine hydrobromide | ESD-899178-250MG |
Cas.: 173999-22-9 | Purity: 97% | 5-Bromo-2-(bromomethyl)pyridine hydrobromide | ESD-899178-1G |
Cas.: 173999-22-9 | Purity: 97% | 5-Bromo-2-(bromomethyl)pyridine hydrobromide | ESD-899178-5G |
Cas.: 108321-83-1 | Purity: ≥99% | H-DL-Phe-NH2.HCl | ESD-899179-250MG |
Cas.: 108321-83-1 | Purity: ≥99% | H-DL-Phe-NH2.HCl | ESD-899179-1G |
Cas.: 108321-83-1 | Purity: ≥99% | H-DL-Phe-NH2.HCl | ESD-899179-5G |
Cas.: 23377-40-4 | Purity: 98% | 3-(Hexadecyloxy)propan-1-ol | ESD-899180-250MG |
Cas.: 23377-40-4 | Purity: 98% | 3-(Hexadecyloxy)propan-1-ol | ESD-899180-1G |
Cas.: 23377-40-4 | Purity: 98% | 3-(Hexadecyloxy)propan-1-ol | ESD-899180-5G |
Cas.: 66494-53-9 | Purity: ≥95% | HD-Lys(Boc)-OMe.HCl | ESD-899181-250MG |
Cas.: 66494-53-9 | Purity: ≥95% | HD-Lys(Boc)-OMe.HCl | ESD-899181-1G |
Cas.: 66494-53-9 | Purity: ≥95% | HD-Lys(Boc)-OMe.HCl | ESD-899181-5G |
Cas.: 112575-13-0 | Purity: 98% | 6-Bromo-N,N-dimethylpyridin-2-amine | ESD-899182-250MG |
Cas.: 112575-13-0 | Purity: 98% | 6-Bromo-N,N-dimethylpyridin-2-amine | ESD-899182-1G |
Cas.: 112575-13-0 | Purity: 98% | 6-Bromo-N,N-dimethylpyridin-2-amine | ESD-899182-5G |
Cas.: 98136-42-6 | Purity: 96% | 2,6-Dichloropyrimidine-4-carboxamide | ESD-899183-250MG |
Cas.: 98136-42-6 | Purity: 96% | 2,6-Dichloropyrimidine-4-carboxamide | ESD-899183-1G |
Cas.: 98136-42-6 | Purity: 96% | 2,6-Dichloropyrimidine-4-carboxamide | ESD-899183-5G |
Cas.: 179559-35-4 | Purity: 97% | HD-Ser(tBu)-OtBu.HCl | ESD-899184-250MG |
Cas.: 179559-35-4 | Purity: 97% | HD-Ser(tBu)-OtBu.HCl | ESD-899184-1G |
Cas.: 179559-35-4 | Purity: 97% | HD-Ser(tBu)-OtBu.HCl | ESD-899184-5G |
Cas.: 1260903-17-0 | Purity: 97% | 7-Fluoroimidazo[1,2-a]pyridine | ESD-899185-250MG |
Cas.: 1260903-17-0 | Purity: 97% | 7-Fluoroimidazo[1,2-a]pyridine | ESD-899185-1G |
Cas.: 1260903-17-0 | Purity: 97% | 7-Fluoroimidazo[1,2-a]pyridine | ESD-899185-5G |
Cas.: 7139-02-8 | Purity: 97% | 2,6-Dichloro-4,8-di(pipidin-1-yl)pyrimido[5,4-d]pyrimidine | ESD-899186-250MG |
Cas.: 7139-02-8 | Purity: 97% | 2,6-Dichloro-4,8-di(pipidin-1-yl)pyrimido[5,4-d]pyrimidine | ESD-899186-1G |
Cas.: 7139-02-8 | Purity: 97% | 2,6-Dichloro-4,8-di(pipidin-1-yl)pyrimido[5,4-d]pyrimidine | ESD-899186-5G |
Cas.: 1642873-03-7 | Purity: 97% | N-Propyl-sulfamide sodium salt | ESD-899187-250MG |
Cas.: 1642873-03-7 | Purity: 97% | N-Propyl-sulfamide sodium salt | ESD-899187-1G |
Cas.: 1642873-03-7 | Purity: 97% | N-Propyl-sulfamide sodium salt | ESD-899187-5G |
Cas.: 654056-82-3 | Purity: ≥95% | N-BOC-4-bromo-3-methylaniline | ESD-899188-250MG |
Cas.: 654056-82-3 | Purity: ≥95% | N-BOC-4-bromo-3-methylaniline | ESD-899188-1G |
Cas.: 654056-82-3 | Purity: ≥95% | N-BOC-4-bromo-3-methylaniline | ESD-899188-5G |
Cas.: 115141-43-0 | Purity: 97% | HD-Thr(tBu)-OMe.HCl | ESD-899189-250MG |
Cas.: 115141-43-0 | Purity: 97% | HD-Thr(tBu)-OMe.HCl | ESD-899189-1G |
Cas.: 115141-43-0 | Purity: 97% | HD-Thr(tBu)-OMe.HCl | ESD-899189-5G |
Cas.: 2044703-04-8 | Purity: 97% | 4-Amino-1-benzylpyrrolidin-2-one dihydrochloride | ESD-899190-250MG |
Cas.: 2044703-04-8 | Purity: 97% | 4-Amino-1-benzylpyrrolidin-2-one dihydrochloride | ESD-899190-1G |
Cas.: 2044703-04-8 | Purity: 97% | 4-Amino-1-benzylpyrrolidin-2-one dihydrochloride | ESD-899190-5G |
Cas.: 2096998-40-0 | Purity: 97% | 2-(4-Chloro-3-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899191-250MG |
Cas.: 2096998-40-0 | Purity: 97% | 2-(4-Chloro-3-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899191-1G |
Cas.: 2096998-40-0 | Purity: 97% | 2-(4-Chloro-3-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899191-5G |
Cas.: 147359-76-0 | Purity: ≥95% | Flibanserin Hydrochloride | ESD-899192-250MG |
Cas.: 147359-76-0 | Purity: ≥95% | Flibanserin Hydrochloride | ESD-899192-1G |
Cas.: 147359-76-0 | Purity: ≥95% | Flibanserin Hydrochloride | ESD-899192-5G |
Cas.: 21943-17-9 | Purity: 97% | 5-Bromo-3-chloropyrazin-2(1H)-one | ESD-899193-250MG |
Cas.: 21943-17-9 | Purity: 97% | 5-Bromo-3-chloropyrazin-2(1H)-one | ESD-899193-1G |
Cas.: 21943-17-9 | Purity: 97% | 5-Bromo-3-chloropyrazin-2(1H)-one | ESD-899193-5G |
Cas.: 859877-49-9 | Purity: 97% | 4-Chloro-2-methoxy-6-nitroaniline | ESD-899194-250MG |
Cas.: 859877-49-9 | Purity: 97% | 4-Chloro-2-methoxy-6-nitroaniline | ESD-899194-1G |
Cas.: 859877-49-9 | Purity: 97% | 4-Chloro-2-methoxy-6-nitroaniline | ESD-899194-5G |
Cas.: 855207-59-9 | Purity: ≥95% | 4-Chloro-[1,1′-biphenyl]-3-carboxylic acid | ESD-899195-250MG |
Cas.: 855207-59-9 | Purity: ≥95% | 4-Chloro-[1,1′-biphenyl]-3-carboxylic acid | ESD-899195-1G |
Cas.: 855207-59-9 | Purity: ≥95% | 4-Chloro-[1,1′-biphenyl]-3-carboxylic acid | ESD-899195-5G |
Cas.: 144494-72-4 | Purity: 97% | (S)-Methyl 3-amino-3-phenylpropanoate hydrochloride | ESD-899196-250MG |
Cas.: 144494-72-4 | Purity: 97% | (S)-Methyl 3-amino-3-phenylpropanoate hydrochloride | ESD-899196-1G |
Cas.: 144494-72-4 | Purity: 97% | (S)-Methyl 3-amino-3-phenylpropanoate hydrochloride | ESD-899196-5G |
Cas.: 55660-73-6 | Purity: ≥95% | 2-Fluorobenzene-1,4-diol | ESD-899197-250MG |
Cas.: 55660-73-6 | Purity: ≥95% | 2-Fluorobenzene-1,4-diol | ESD-899197-1G |
Cas.: 55660-73-6 | Purity: ≥95% | 2-Fluorobenzene-1,4-diol | ESD-899197-5G |
Cas.: 864076-05-1 | Purity: ≥95% | Methyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate | ESD-899198-250MG |
Cas.: 864076-05-1 | Purity: ≥95% | Methyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate | ESD-899198-1G |
Cas.: 864076-05-1 | Purity: ≥95% | Methyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate | ESD-899198-5G |
Cas.: 1049744-89-9 | Purity: ≥95% | 2-Hydrazino-5-(trifluoromethyl)pyridine, HCl | ESD-899199-250MG |
Cas.: 1049744-89-9 | Purity: ≥95% | 2-Hydrazino-5-(trifluoromethyl)pyridine, HCl | ESD-899199-1G |
Cas.: 1049744-89-9 | Purity: ≥95% | 2-Hydrazino-5-(trifluoromethyl)pyridine, HCl | ESD-899199-5G |
Cas.: 1260807-49-5 | Purity: 97% | tert-Butyl 3-bromopicolinate | ESD-899200-250MG |
Cas.: 1260807-49-5 | Purity: 97% | tert-Butyl 3-bromopicolinate | ESD-899200-1G |
Cas.: 1260807-49-5 | Purity: 97% | tert-Butyl 3-bromopicolinate | ESD-899200-5G |
Cas.: 390360-97-1 | Purity: ≥95% | 2-Hydroxy-5-iodonicotinic acid | ESD-899201-250MG |
Cas.: 390360-97-1 | Purity: ≥95% | 2-Hydroxy-5-iodonicotinic acid | ESD-899201-1G |
Cas.: 390360-97-1 | Purity: ≥95% | 2-Hydroxy-5-iodonicotinic acid | ESD-899201-5G |
Cas.: 173522-95-7 | Purity: 97% | H-Phe(3,4-DiCl)-OMe.HCl | ESD-899202-250MG |
Cas.: 173522-95-7 | Purity: 97% | H-Phe(3,4-DiCl)-OMe.HCl | ESD-899202-1G |
Cas.: 173522-95-7 | Purity: 97% | H-Phe(3,4-DiCl)-OMe.HCl | ESD-899202-5G |
Cas.: 1588440-96-3 | Purity: ≥95% | tert-Butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate oxalate | ESD-899203-250MG |
Cas.: 1588440-96-3 | Purity: ≥95% | tert-Butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate oxalate | ESD-899203-1G |
Cas.: 1588440-96-3 | Purity: ≥95% | tert-Butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate oxalate | ESD-899203-5G |
Cas.: 87004-78-2 | Purity: 97% | (R)-Benzyl 2-amino-3-phenylpropanoate hydrochloride | ESD-899204-250MG |
Cas.: 87004-78-2 | Purity: 97% | (R)-Benzyl 2-amino-3-phenylpropanoate hydrochloride | ESD-899204-1G |
Cas.: 87004-78-2 | Purity: 97% | (R)-Benzyl 2-amino-3-phenylpropanoate hydrochloride | ESD-899204-5G |
Cas.: 43024-61-9 | Purity: ≥95% | Ethyl 7-hydroxypyrazolo[1,5-a]pyrimidine-6-carboxylate | ESD-899205-250MG |
Cas.: 43024-61-9 | Purity: ≥95% | Ethyl 7-hydroxypyrazolo[1,5-a]pyrimidine-6-carboxylate | ESD-899205-1G |
Cas.: 43024-61-9 | Purity: ≥95% | Ethyl 7-hydroxypyrazolo[1,5-a]pyrimidine-6-carboxylate | ESD-899205-5G |
Cas.: 1029691-06-2 | Purity: ≥95% | 2-(3-Oxocyclopentyl)isoindoline-1,3-dione | ESD-899206-250MG |
Cas.: 1029691-06-2 | Purity: ≥95% | 2-(3-Oxocyclopentyl)isoindoline-1,3-dione | ESD-899206-1G |
Cas.: 1029691-06-2 | Purity: ≥95% | 2-(3-Oxocyclopentyl)isoindoline-1,3-dione | ESD-899206-5G |
Cas.: 1217478-55-1 | Purity: ≥95% | (S)-tert-Butyl 2-propylpiperazine-1-carboxylate hydrochloride | ESD-899207-250MG |
Cas.: 1217478-55-1 | Purity: ≥95% | (S)-tert-Butyl 2-propylpiperazine-1-carboxylate hydrochloride | ESD-899207-1G |
Cas.: 1217478-55-1 | Purity: ≥95% | (S)-tert-Butyl 2-propylpiperazine-1-carboxylate hydrochloride | ESD-899207-5G |
Cas.: 22680-44-0 | Purity: 97% | (2-Chlorophenyl)methanamine hydrochloride | ESD-899208-250MG |
Cas.: 22680-44-0 | Purity: 97% | (2-Chlorophenyl)methanamine hydrochloride | ESD-899208-1G |
Cas.: 22680-44-0 | Purity: 97% | (2-Chlorophenyl)methanamine hydrochloride | ESD-899208-5G |
Cas.: 60076-09-7 | Purity: ≥95% | 1-(Chloromethyl)-3-iodobenzene | ESD-899209-250MG |
Cas.: 60076-09-7 | Purity: ≥95% | 1-(Chloromethyl)-3-iodobenzene | ESD-899209-1G |
Cas.: 60076-09-7 | Purity: ≥95% | 1-(Chloromethyl)-3-iodobenzene | ESD-899209-5G |
Cas.: 51248-35-2 | Purity: ≥97% | Isobutyloxazolidine-2,5-dione | ESD-899210-250MG |
Cas.: 51248-35-2 | Purity: ≥97% | Isobutyloxazolidine-2,5-dione | ESD-899210-1G |
Cas.: 51248-35-2 | Purity: ≥97% | Isobutyloxazolidine-2,5-dione | ESD-899210-5G |
Cas.: 288251-87-6 | Purity: 97% | tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate | ESD-899211-250MG |
Cas.: 288251-87-6 | Purity: 97% | tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate | ESD-899211-1G |
Cas.: 288251-87-6 | Purity: 97% | tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate | ESD-899211-5G |
Cas.: 2153472-89-8 | Purity: 97% | (2-Aminopyridin-3-yl)methyl tert-butyl carbonate | ESD-899212-250MG |
Cas.: 2153472-89-8 | Purity: 97% | (2-Aminopyridin-3-yl)methyl tert-butyl carbonate | ESD-899212-1G |
Cas.: 2153472-89-8 | Purity: 97% | (2-Aminopyridin-3-yl)methyl tert-butyl carbonate | ESD-899212-5G |
Cas.: 58107-62-3 | Purity: 97% | H-Pro-NHEt.HCl | ESD-899213-250MG |
Cas.: 58107-62-3 | Purity: 97% | H-Pro-NHEt.HCl | ESD-899213-1G |
Cas.: 58107-62-3 | Purity: 97% | H-Pro-NHEt.HCl | ESD-899213-5G |
Cas.: 170230-27-0 | Purity: 98% | (4-(Pyridin-2-yl)phenyl)boronic acid | ESD-899214-250MG |
Cas.: 170230-27-0 | Purity: 98% | (4-(Pyridin-2-yl)phenyl)boronic acid | ESD-899214-1G |
Cas.: 170230-27-0 | Purity: 98% | (4-(Pyridin-2-yl)phenyl)boronic acid | ESD-899214-5G |
Cas.: 1027512-98-6 | Purity: 97% | 4-Amino-3-bromo-5-fluorobenzoic acid | ESD-899215-250MG |
Cas.: 1027512-98-6 | Purity: 97% | 4-Amino-3-bromo-5-fluorobenzoic acid | ESD-899215-1G |
Cas.: 1027512-98-6 | Purity: 97% | 4-Amino-3-bromo-5-fluorobenzoic acid | ESD-899215-5G |
Cas.: 210830-32-3 | Purity: 97% | HN-Me-D-Val-OH.HCl | ESD-899216-250MG |
Cas.: 210830-32-3 | Purity: 97% | HN-Me-D-Val-OH.HCl | ESD-899216-1G |
Cas.: 210830-32-3 | Purity: 97% | HN-Me-D-Val-OH.HCl | ESD-899216-5G |
Cas.: 4044-98-8 | Purity: 97% | 6-Bromo-2-phenylimidazo[1,2-a]pyridine | ESD-899217-250MG |
Cas.: 4044-98-8 | Purity: 97% | 6-Bromo-2-phenylimidazo[1,2-a]pyridine | ESD-899217-1G |
Cas.: 4044-98-8 | Purity: 97% | 6-Bromo-2-phenylimidazo[1,2-a]pyridine | ESD-899217-5G |
Cas.: 128917-74-8 | Purity: 97% | Fmoc-12-Ado-OH | ESD-899218-250MG |
Cas.: 128917-74-8 | Purity: 97% | Fmoc-12-Ado-OH | ESD-899218-1G |
Cas.: 128917-74-8 | Purity: 97% | Fmoc-12-Ado-OH | ESD-899218-5G |
Cas.: 1027-14-1 | Purity: 97% | Trimecaine HCl | ESD-899219-250MG |
Cas.: 114080-95-4 | Purity: 95% | 3-Chloropicolinamide | ESD-899220-250MG |
Cas.: 114080-95-4 | Purity: 95% | 3-Chloropicolinamide | ESD-899220-1G |
Cas.: 114080-95-4 | Purity: 95% | 3-Chloropicolinamide | ESD-899220-5G |
Cas.: 154093-72-8 | Purity: 97% | 1-Cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-899221-250MG |
Cas.: 154093-72-8 | Purity: 97% | 1-Cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-899221-1G |
Cas.: 154093-72-8 | Purity: 97% | 1-Cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-899221-5G |
Cas.: 1308814-98-3 | Purity: 95% | Ethyl 1-(4-nitrophenyl)cyclopropanecarboxylate | ESD-899222-250MG |
Cas.: 1308814-98-3 | Purity: 95% | Ethyl 1-(4-nitrophenyl)cyclopropanecarboxylate | ESD-899222-1G |
Cas.: 1308814-98-3 | Purity: 95% | Ethyl 1-(4-nitrophenyl)cyclopropanecarboxylate | ESD-899222-5G |
Cas.: 42116-55-2 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)propanoate | ESD-899223-250MG |
Cas.: 42116-55-2 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)propanoate | ESD-899223-1G |
Cas.: 42116-55-2 | Purity: ≥95% | Methyl 3-((tert-butoxycarbonyl)amino)propanoate | ESD-899223-5G |
Cas.: 252554-79-3 | Purity: ≥95% | Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH | ESD-899224-250MG |
Cas.: 252554-79-3 | Purity: ≥95% | Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH | ESD-899224-1G |
Cas.: 252554-79-3 | Purity: ≥95% | Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH | ESD-899224-5G |
Cas.: 33628-84-1 | Purity: ≥95% | Methyl ZL-Alaninamide | ESD-899225-250MG |
Cas.: 33628-84-1 | Purity: ≥95% | Methyl ZL-Alaninamide | ESD-899225-1G |
Cas.: 33628-84-1 | Purity: ≥95% | Methyl ZL-Alaninamide | ESD-899225-5G |
Cas.: 90159-60-7 | Purity: 97% | (R)-5-Benzyl 1-tert-butyl 2-aminopentanedioate hydrochloride | ESD-899226-250MG |
Cas.: 90159-60-7 | Purity: 97% | (R)-5-Benzyl 1-tert-butyl 2-aminopentanedioate hydrochloride | ESD-899226-1G |
Cas.: 90159-60-7 | Purity: 97% | (R)-5-Benzyl 1-tert-butyl 2-aminopentanedioate hydrochloride | ESD-899226-5G |
Cas.: 233770-05-3 | Purity: ≥95% | 5-Bromo-6-chlorobenzo[d][1,3]dioxole | ESD-899227-250MG |
Cas.: 233770-05-3 | Purity: ≥95% | 5-Bromo-6-chlorobenzo[d][1,3]dioxole | ESD-899227-1G |
Cas.: 233770-05-3 | Purity: ≥95% | 5-Bromo-6-chlorobenzo[d][1,3]dioxole | ESD-899227-5G |
Cas.: 54535-00-1 | Purity: ≥95% | (5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol | ESD-899228-250MG |
Cas.: 54535-00-1 | Purity: ≥95% | (5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol | ESD-899228-1G |
Cas.: 54535-00-1 | Purity: ≥95% | (5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol | ESD-899228-5G |
Cas.: 180628-74-4 | Purity: ≥95% | 3-(Hydroxymethyl)-5-nitrophenol | ESD-899229-250MG |
Cas.: 180628-74-4 | Purity: ≥95% | 3-(Hydroxymethyl)-5-nitrophenol | ESD-899229-1G |
Cas.: 180628-74-4 | Purity: ≥95% | 3-(Hydroxymethyl)-5-nitrophenol | ESD-899229-5G |
Cas.: 84661-56-3 | Purity: 97% | Di(1H-imidazol-1-yl)methane | ESD-899230-250MG |
Cas.: 84661-56-3 | Purity: 97% | Di(1H-imidazol-1-yl)methane | ESD-899230-1G |
Cas.: 84661-56-3 | Purity: 97% | Di(1H-imidazol-1-yl)methane | ESD-899230-5G |
Cas.: 884494-70-6 | Purity: 97% | 2-Chloro-4-methylpyridin-3-ol | ESD-899231-250MG |
Cas.: 884494-70-6 | Purity: 97% | 2-Chloro-4-methylpyridin-3-ol | ESD-899231-1G |
Cas.: 884494-70-6 | Purity: 97% | 2-Chloro-4-methylpyridin-3-ol | ESD-899231-5G |
Cas.: 167834-24-4 | Purity: ≥95% | (S)-Ethyl 3-amino-3-phenylpropanoate hydrochloride | ESD-899232-250MG |
Cas.: 167834-24-4 | Purity: ≥95% | (S)-Ethyl 3-amino-3-phenylpropanoate hydrochloride | ESD-899232-1G |
Cas.: 167834-24-4 | Purity: ≥95% | (S)-Ethyl 3-amino-3-phenylpropanoate hydrochloride | ESD-899232-5G |
Cas.: 21957-58-4 | Purity: 97% | (S)-2-(4-Methylphenylsulfonamido)propanoic acid | ESD-899233-250MG |
Cas.: 21957-58-4 | Purity: 97% | (S)-2-(4-Methylphenylsulfonamido)propanoic acid | ESD-899233-1G |
Cas.: 21957-58-4 | Purity: 97% | (S)-2-(4-Methylphenylsulfonamido)propanoic acid | ESD-899233-5G |
Cas.: 7099-87-8 | Purity: ≥95% | 2-(4-Bromophenyl)-2-oxoacetic acid | ESD-899234-250MG |
Cas.: 7099-87-8 | Purity: ≥95% | 2-(4-Bromophenyl)-2-oxoacetic acid | ESD-899234-1G |
Cas.: 7099-87-8 | Purity: ≥95% | 2-(4-Bromophenyl)-2-oxoacetic acid | ESD-899234-5G |
Cas.: 2230901-24-1 | Purity: 97% | (3-Amino-2-methylphenyl)boronic acid hydrochloride | ESD-899235-250MG |
Cas.: 2230901-24-1 | Purity: 97% | (3-Amino-2-methylphenyl)boronic acid hydrochloride | ESD-899235-1G |
Cas.: 2230901-24-1 | Purity: 97% | (3-Amino-2-methylphenyl)boronic acid hydrochloride | ESD-899235-5G |
Cas.: 59772-48-4 | Purity: ≥95% | 1-Bromo-3-chloro-2-nitrobenzene | ESD-899236-250MG |
Cas.: 59772-48-4 | Purity: ≥95% | 1-Bromo-3-chloro-2-nitrobenzene | ESD-899236-1G |
Cas.: 59772-48-4 | Purity: ≥95% | 1-Bromo-3-chloro-2-nitrobenzene | ESD-899236-5G |
Cas.: 198544-94-4 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((diphenyl(p-tolyl)methyl)amino)hexanoic acid | ESD-899237-250MG |
Cas.: 198544-94-4 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((diphenyl(p-tolyl)methyl)amino)hexanoic acid | ESD-899237-1G |
Cas.: 198544-94-4 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((diphenyl(p-tolyl)methyl)amino)hexanoic acid | ESD-899237-5G |
Cas.: 116-71-2 | Purity: Strength ≥290% | Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione | ESD-899238-250MG |
Cas.: 116-71-2 | Purity: Strength ≥290% | Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione | ESD-899238-1G |
Cas.: 116-71-2 | Purity: Strength ≥290% | Anthra[9,1,2-cde]benzo[rst]pentaphene-5,10-dione | ESD-899238-5G |
Cas.: 4761-93-7 | Purity: 97% | Biguanidehydrochloride | ESD-899239-250MG |
Cas.: 4761-93-7 | Purity: 97% | Biguanidehydrochloride | ESD-899239-1G |
Cas.: 4761-93-7 | Purity: 97% | Biguanidehydrochloride | ESD-899239-5G |
Cas.: 139301-16-9 | Purity: 97% | [4-[(2-Hydroxytetradecyl)oxy]phenyl]phenyliodonium hexafluoroantimonate | ESD-899240-250MG |
Cas.: 139301-16-9 | Purity: 97% | [4-[(2-Hydroxytetradecyl)oxy]phenyl]phenyliodonium hexafluoroantimonate | ESD-899240-1G |
Cas.: 1214386-97-6 | Purity: ≥95% | Ethyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-899241-250MG |
Cas.: 1214386-97-6 | Purity: ≥95% | Ethyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-899241-1G |
Cas.: 1214386-97-6 | Purity: ≥95% | Ethyl 3-bromo-4-(trifluoromethyl)benzoate | ESD-899241-5G |
Cas.: 936342-91-5 | Purity: 97% | 5-Bromo-2-(chloromethyl)pyridine hydrochloride | ESD-899242-250MG |
Cas.: 936342-91-5 | Purity: 97% | 5-Bromo-2-(chloromethyl)pyridine hydrochloride | ESD-899242-1G |
Cas.: 936342-91-5 | Purity: 97% | 5-Bromo-2-(chloromethyl)pyridine hydrochloride | ESD-899242-5G |
Cas.: 923023-08-9 | Purity: 97% | trans-4-(Methylamino)cyclohexanol hydrochloride | ESD-899243-250MG |
Cas.: 923023-08-9 | Purity: 97% | trans-4-(Methylamino)cyclohexanol hydrochloride | ESD-899243-1G |
Cas.: 923023-08-9 | Purity: 97% | trans-4-(Methylamino)cyclohexanol hydrochloride | ESD-899243-5G |
Cas.: 142217-77-4 | Purity: 97% | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | ESD-899244-250MG |
Cas.: 142217-77-4 | Purity: 97% | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | ESD-899244-1G |
Cas.: 142217-77-4 | Purity: 97% | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | ESD-899244-5G |
Cas.: 20299-31-4 | Purity: ≥95% | 4-Acetyl-L-phenylalanine Hydrochloride | ESD-899245-250MG |
Cas.: 20299-31-4 | Purity: ≥95% | 4-Acetyl-L-phenylalanine Hydrochloride | ESD-899245-1G |
Cas.: 20299-31-4 | Purity: ≥95% | 4-Acetyl-L-phenylalanine Hydrochloride | ESD-899245-5G |
Cas.: 1313012-28-0 | Purity: 97% | 4-((Trifluoromethyl)thio)benzene-1,2-diamine dihydrochloride | ESD-899246-250MG |
Cas.: 1313012-28-0 | Purity: 97% | 4-((Trifluoromethyl)thio)benzene-1,2-diamine dihydrochloride | ESD-899246-1G |
Cas.: 1313012-28-0 | Purity: 97% | 4-((Trifluoromethyl)thio)benzene-1,2-diamine dihydrochloride | ESD-899246-5G |
Cas.: 334-18-9 | Purity: ≥95% | Agmatine dihydrochloride | ESD-899247-250MG |
Cas.: 334-18-9 | Purity: ≥95% | Agmatine dihydrochloride | ESD-899247-1G |
Cas.: 334-18-9 | Purity: ≥95% | Agmatine dihydrochloride | ESD-899247-5G |
Cas.: 486-52-2 | Purity: 97% | 6,12-Dihydroindeno[1,2-b]fluorene | ESD-899248-250MG |
Cas.: 486-52-2 | Purity: 97% | 6,12-Dihydroindeno[1,2-b]fluorene | ESD-899248-1G |
Cas.: 486-52-2 | Purity: 97% | 6,12-Dihydroindeno[1,2-b]fluorene | ESD-899248-5G |
Cas.: 127132-32-5 | Purity: 97% | (S)-Ethyl 3-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoate | ESD-899249-250MG |
Cas.: 127132-32-5 | Purity: 97% | (S)-Ethyl 3-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoate | ESD-899249-1G |
Cas.: 127132-32-5 | Purity: 97% | (S)-Ethyl 3-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoate | ESD-899249-5G |
Cas.: 259750-61-3 | Purity: ≥95% | 1-(4-Bromo-2-fluorophenyl)propan-1-one | ESD-899250-250MG |
Cas.: 259750-61-3 | Purity: ≥95% | 1-(4-Bromo-2-fluorophenyl)propan-1-one | ESD-899250-1G |
Cas.: 259750-61-3 | Purity: ≥95% | 1-(4-Bromo-2-fluorophenyl)propan-1-one | ESD-899250-5G |
Cas.: 79326-96-8 | Purity: 97% | 3-Nitrobenzenesulfonic acid hydrate | ESD-899251-250MG |
Cas.: 79326-96-8 | Purity: 97% | 3-Nitrobenzenesulfonic acid hydrate | ESD-899251-1G |
Cas.: 79326-96-8 | Purity: 97% | 3-Nitrobenzenesulfonic acid hydrate | ESD-899251-5G |
Cas.: 1256360-63-0 | Purity: 97% | N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-899252-250MG |
Cas.: 1256360-63-0 | Purity: 97% | N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-899252-1G |
Cas.: 1256360-63-0 | Purity: 97% | N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-899252-5G |
Cas.: 1015939-24-8 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-3-carboxylic acid | ESD-899253-250MG |
Cas.: 1015939-24-8 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-3-carboxylic acid | ESD-899253-1G |
Cas.: 1015939-24-8 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-3-carboxylic acid | ESD-899253-5G |
Cas.: 80466-51-9 | Purity: ≥95% | 1-(Benzylamino)-2-methylpropan-2-ol | ESD-899254-250MG |
Cas.: 80466-51-9 | Purity: ≥95% | 1-(Benzylamino)-2-methylpropan-2-ol | ESD-899254-1G |
Cas.: 80466-51-9 | Purity: ≥95% | 1-(Benzylamino)-2-methylpropan-2-ol | ESD-899254-5G |
Cas.: 1350475-36-3 | Purity: ≥95% | N-(2-Chloro-4-formyl-5-hydroxyphenyl)acetamide | ESD-899255-250MG |
Cas.: 1350475-36-3 | Purity: ≥95% | N-(2-Chloro-4-formyl-5-hydroxyphenyl)acetamide | ESD-899255-1G |
Cas.: 1350475-36-3 | Purity: ≥95% | N-(2-Chloro-4-formyl-5-hydroxyphenyl)acetamide | ESD-899255-5G |
Cas.: 51761-16-1 | Purity: 97% | 7-Aminonaphthalen-2-ol hydrochloride | ESD-899256-250MG |
Cas.: 51761-16-1 | Purity: 97% | 7-Aminonaphthalen-2-ol hydrochloride | ESD-899256-1G |
Cas.: 51761-16-1 | Purity: 97% | 7-Aminonaphthalen-2-ol hydrochloride | ESD-899256-5G |
Cas.: 1016530-98-5 | Purity: ≥95% | 2-Chloro-6-(2,2,2-trifluoroethoxy)pyrazine | ESD-899257-250MG |
Cas.: 1016530-98-5 | Purity: ≥95% | 2-Chloro-6-(2,2,2-trifluoroethoxy)pyrazine | ESD-899257-1G |
Cas.: 1016530-98-5 | Purity: ≥95% | 2-Chloro-6-(2,2,2-trifluoroethoxy)pyrazine | ESD-899257-5G |
Cas.: 864369-95-9 | Purity: ≥95% | tert-Butyl 4-methyl-4-morpholinopiperidine-1-carboxylate | ESD-899258-250MG |
Cas.: 864369-95-9 | Purity: ≥95% | tert-Butyl 4-methyl-4-morpholinopiperidine-1-carboxylate | ESD-899258-1G |
Cas.: 864369-95-9 | Purity: ≥95% | tert-Butyl 4-methyl-4-morpholinopiperidine-1-carboxylate | ESD-899258-5G |
Cas.: 850568-25-1 | Purity: 97% | (4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid | ESD-899259-250MG |
Cas.: 850568-25-1 | Purity: 97% | (4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid | ESD-899259-1G |
Cas.: 850568-25-1 | Purity: 97% | (4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid | ESD-899259-5G |
Cas.: 223127-24-0 | Purity: ≥95% | 6-(4-Fluorophenyl)nicotinic acid | ESD-899260-250MG |
Cas.: 223127-24-0 | Purity: ≥95% | 6-(4-Fluorophenyl)nicotinic acid | ESD-899260-1G |
Cas.: 223127-24-0 | Purity: ≥95% | 6-(4-Fluorophenyl)nicotinic acid | ESD-899260-5G |
Cas.: 91219-90-8 | Purity: ≥95% | (4-Methoxy-3,5-dimethylpyridin-2-yl)methyl acetate | ESD-899261-250MG |
Cas.: 91219-90-8 | Purity: ≥95% | (4-Methoxy-3,5-dimethylpyridin-2-yl)methyl acetate | ESD-899261-1G |
Cas.: 91219-90-8 | Purity: ≥95% | (4-Methoxy-3,5-dimethylpyridin-2-yl)methyl acetate | ESD-899261-5G |
Cas.: 1450-86-8 | Purity: 96% | Pyrimidine-4(3H)-thione | ESD-899262-250MG |
Cas.: 1450-86-8 | Purity: 96% | Pyrimidine-4(3H)-thione | ESD-899262-1G |
Cas.: 1450-86-8 | Purity: 96% | Pyrimidine-4(3H)-thione | ESD-899262-5G |
Cas.: 1196-07-2 | Purity: 97% | Methyl 5-bromo-1-methyl-1H-pyrrole-2-carboxylate | ESD-899263-250MG |
Cas.: 1196-07-2 | Purity: 97% | Methyl 5-bromo-1-methyl-1H-pyrrole-2-carboxylate | ESD-899263-1G |
Cas.: 1196-07-2 | Purity: 97% | Methyl 5-bromo-1-methyl-1H-pyrrole-2-carboxylate | ESD-899263-5G |
Cas.: 65464-00-8 | Purity: 97% | 4-Ethylpiperazin-2-one hydrochloride | ESD-899264-250MG |
Cas.: 65464-00-8 | Purity: 97% | 4-Ethylpiperazin-2-one hydrochloride | ESD-899264-1G |
Cas.: 65464-00-8 | Purity: 97% | 4-Ethylpiperazin-2-one hydrochloride | ESD-899264-5G |
Cas.: 1159822-61-3 | Purity: 95% | 5-Methoxyisoindoline hydrochloride | ESD-899265-250MG |
Cas.: 1159822-61-3 | Purity: 95% | 5-Methoxyisoindoline hydrochloride | ESD-899265-1G |
Cas.: 1159822-61-3 | Purity: 95% | 5-Methoxyisoindoline hydrochloride | ESD-899265-5G |
Cas.: 875664-25-8 | Purity: 98% | 4-Bromo-2-phenoxybenzonitrile | ESD-899266-250MG |
Cas.: 875664-25-8 | Purity: 98% | 4-Bromo-2-phenoxybenzonitrile | ESD-899266-1G |
Cas.: 875664-25-8 | Purity: 98% | 4-Bromo-2-phenoxybenzonitrile | ESD-899266-5G |
Cas.: 1394291-59-8 | Purity: 97% | (5-Bromo-4-methylpyridin-2-yl)methanol | ESD-899267-250MG |
Cas.: 1394291-59-8 | Purity: 97% | (5-Bromo-4-methylpyridin-2-yl)methanol | ESD-899267-1G |
Cas.: 1394291-59-8 | Purity: 97% | (5-Bromo-4-methylpyridin-2-yl)methanol | ESD-899267-5G |
Cas.: 58083-59-3 | Purity: 96% | 6-Chloroisoindolin-1-one | ESD-899268-250MG |
Cas.: 58083-59-3 | Purity: 96% | 6-Chloroisoindolin-1-one | ESD-899268-1G |
Cas.: 58083-59-3 | Purity: 96% | 6-Chloroisoindolin-1-one | ESD-899268-5G |
Cas.: 943751-21-1 | Purity: 97% | 4-(Aminomethyl)pyridin-2(1H)-one hydrochloride | ESD-899269-100MG |
Cas.: 943751-21-1 | Purity: 97% | 4-(Aminomethyl)pyridin-2(1H)-one hydrochloride | ESD-899269-1G |
Cas.: 943751-21-1 | Purity: 97% | 4-(Aminomethyl)pyridin-2(1H)-one hydrochloride | ESD-899269-5G |
Cas.: 1201644-47-4 | Purity: ≥95% | Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone | ESD-899270-250MG |
Cas.: 1201644-47-4 | Purity: ≥95% | Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone | ESD-899270-1G |
Cas.: 1201644-47-4 | Purity: ≥95% | Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone | ESD-899270-5G |
Cas.: 176097-24-8 | Purity: ≥96% | 1,4-Bis[[(8α,9R)-10,11-dihydro-6′-methoxycinchonan-9-yl]oxy]-9,10-anthracenedione | ESD-899271-250MG |
Cas.: 176097-24-8 | Purity: ≥96% | 1,4-Bis[[(8α,9R)-10,11-dihydro-6′-methoxycinchonan-9-yl]oxy]-9,10-anthracenedione | ESD-899271-1G |
Cas.: 176097-24-8 | Purity: ≥96% | 1,4-Bis[[(8α,9R)-10,11-dihydro-6′-methoxycinchonan-9-yl]oxy]-9,10-anthracenedione | ESD-899271-5G |
Cas.: 1379325-36-6 | Purity: ≥95% | 1,3-Dichloro-2-(chloromethyl)-4-methylbenzene | ESD-899272-250MG |
Cas.: 1379325-36-6 | Purity: ≥95% | 1,3-Dichloro-2-(chloromethyl)-4-methylbenzene | ESD-899272-1G |
Cas.: 1379325-36-6 | Purity: ≥95% | 1,3-Dichloro-2-(chloromethyl)-4-methylbenzene | ESD-899272-5G |
Cas.: 87674-15-5 | Purity: ≥95% | 1-(3-Fluoropyridin-4-yl)ethanol | ESD-899273-250MG |
Cas.: 87674-15-5 | Purity: ≥95% | 1-(3-Fluoropyridin-4-yl)ethanol | ESD-899273-1G |
Cas.: 87674-15-5 | Purity: ≥95% | 1-(3-Fluoropyridin-4-yl)ethanol | ESD-899273-5G |
Cas.: 27144-54-3 | Purity: 97% | N,5-Dimethylisoxazole-3-carboxamide | ESD-899274-250MG |
Cas.: 27144-54-3 | Purity: 97% | N,5-Dimethylisoxazole-3-carboxamide | ESD-899274-1G |
Cas.: 27144-54-3 | Purity: 97% | N,5-Dimethylisoxazole-3-carboxamide | ESD-899274-5G |
Cas.: 847818-68-2 | Purity: ≥95% | (1,3-Dimethyl-1H-pyrazol-5-yl)boronic acid | ESD-899275-250MG |
Cas.: 847818-68-2 | Purity: ≥95% | (1,3-Dimethyl-1H-pyrazol-5-yl)boronic acid | ESD-899275-1G |
Cas.: 847818-68-2 | Purity: ≥95% | (1,3-Dimethyl-1H-pyrazol-5-yl)boronic acid | ESD-899275-5G |
Cas.: 1190235-39-2 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)benzyl)-1,3,2-dioxaborolane | ESD-899276-250MG |
Cas.: 1190235-39-2 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)benzyl)-1,3,2-dioxaborolane | ESD-899276-1G |
Cas.: 1190235-39-2 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)benzyl)-1,3,2-dioxaborolane | ESD-899276-5G |
Cas.: 34837-88-2 | Purity: ≥98% | Methyl 2-(4-methoxy-3-nitrophenyl)acetate | ESD-899277-250MG |
Cas.: 34837-88-2 | Purity: ≥98% | Methyl 2-(4-methoxy-3-nitrophenyl)acetate | ESD-899277-1G |
Cas.: 34837-88-2 | Purity: ≥98% | Methyl 2-(4-methoxy-3-nitrophenyl)acetate | ESD-899277-5G |
Cas.: 848308-47-4 | Purity: 98% | 5-((tert-Butoxycarbonyl)amino)picolinic acid | ESD-899278-250MG |
Cas.: 848308-47-4 | Purity: 98% | 5-((tert-Butoxycarbonyl)amino)picolinic acid | ESD-899278-1G |
Cas.: 848308-47-4 | Purity: 98% | 5-((tert-Butoxycarbonyl)amino)picolinic acid | ESD-899278-5G |
Cas.: 1269449-40-2 | Purity: ≥95% | 1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride | ESD-899279-250MG |
Cas.: 1269449-40-2 | Purity: ≥95% | 1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride | ESD-899279-1G |
Cas.: 1269449-40-2 | Purity: ≥95% | 1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride | ESD-899279-5G |
Cas.: 1211540-92-9 | Purity: 97% | 3-Bromo-4-chloro-5-fluoropyridine | ESD-899280-250MG |
Cas.: 1211540-92-9 | Purity: 97% | 3-Bromo-4-chloro-5-fluoropyridine | ESD-899280-1G |
Cas.: 1211540-92-9 | Purity: 97% | 3-Bromo-4-chloro-5-fluoropyridine | ESD-899280-5G |
Cas.: 1504965-88-1 | Purity: 95% | Methyl 5-amino-2-fluoro-4-methylbenzoate | ESD-899281-250MG |
Cas.: 1504965-88-1 | Purity: 95% | Methyl 5-amino-2-fluoro-4-methylbenzoate | ESD-899281-1G |
Cas.: 1504965-88-1 | Purity: 95% | Methyl 5-amino-2-fluoro-4-methylbenzoate | ESD-899281-5G |
Cas.: 21483-64-7 | Purity: 97% | tert-Butyl (2-bromothiophen-3-yl)carbamate | ESD-899282-250MG |
Cas.: 21483-64-7 | Purity: 97% | tert-Butyl (2-bromothiophen-3-yl)carbamate | ESD-899282-1G |
Cas.: 21483-64-7 | Purity: 97% | tert-Butyl (2-bromothiophen-3-yl)carbamate | ESD-899282-5G |
Cas.: 3213-79-4 | Purity: ≥98% | N1,N2-Dimethylbenzene-1,2-diamine | ESD-899283-250MG |
Cas.: 3213-79-4 | Purity: ≥98% | N1,N2-Dimethylbenzene-1,2-diamine | ESD-899283-1G |
Cas.: 3213-79-4 | Purity: ≥98% | N1,N2-Dimethylbenzene-1,2-diamine | ESD-899283-5G |
Cas.: 6003-05-0 | Purity: 97% | (S)-2-Aminopropanoic acid hydrochloride | ESD-899284-250MG |
Cas.: 6003-05-0 | Purity: 97% | (S)-2-Aminopropanoic acid hydrochloride | ESD-899284-1G |
Cas.: 6003-05-0 | Purity: 97% | (S)-2-Aminopropanoic acid hydrochloride | ESD-899284-5G |
Cas.: 509142-74-9 | Purity: 99% | 2-(4-Bromo-2-(trifluoromethoxy)phenyl)acetic acid | ESD-899285-250MG |
Cas.: 509142-74-9 | Purity: 99% | 2-(4-Bromo-2-(trifluoromethoxy)phenyl)acetic acid | ESD-899285-1G |
Cas.: 509142-74-9 | Purity: 99% | 2-(4-Bromo-2-(trifluoromethoxy)phenyl)acetic acid | ESD-899285-5G |
Cas.: 1393574-54-3 | Purity: 97% | 5-Chloro-4-fluoropyridin-2-amine | ESD-899286-250MG |
Cas.: 1393574-54-3 | Purity: 97% | 5-Chloro-4-fluoropyridin-2-amine | ESD-899286-1G |
Cas.: 1393574-54-3 | Purity: 97% | 5-Chloro-4-fluoropyridin-2-amine | ESD-899286-5G |
Cas.: 95092-10-7 | Purity: 95% | N-Methoxy-N-methyl-2-phenylacetamide | ESD-899287-250MG |
Cas.: 95092-10-7 | Purity: 95% | N-Methoxy-N-methyl-2-phenylacetamide | ESD-899287-1G |
Cas.: 95092-10-7 | Purity: 95% | N-Methoxy-N-methyl-2-phenylacetamide | ESD-899287-5G |
Cas.: 1187928-88-6 | Purity: 98% | (R)-Morpholine-3-carboxylic acid hydrochloride | ESD-899288-250MG |
Cas.: 1187928-88-6 | Purity: 98% | (R)-Morpholine-3-carboxylic acid hydrochloride | ESD-899288-1G |
Cas.: 1187928-88-6 | Purity: 98% | (R)-Morpholine-3-carboxylic acid hydrochloride | ESD-899288-5G |
Cas.: 287944-05-2 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(1,2,3,6-tetrahydro-[1,1′-biphenyl]-4-yl)-1,3,2-dioxaborolane | ESD-899289-250MG |
Cas.: 287944-05-2 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(1,2,3,6-tetrahydro-[1,1′-biphenyl]-4-yl)-1,3,2-dioxaborolane | ESD-899289-1G |
Cas.: 287944-05-2 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(1,2,3,6-tetrahydro-[1,1′-biphenyl]-4-yl)-1,3,2-dioxaborolane | ESD-899289-5G |
Cas.: 5216-31-9 | Purity: 97% | 1,2-Bis(4-fluorophenyl)ethyne | ESD-899290-250MG |
Cas.: 5216-31-9 | Purity: 97% | 1,2-Bis(4-fluorophenyl)ethyne | ESD-899290-1G |
Cas.: 5216-31-9 | Purity: 97% | 1,2-Bis(4-fluorophenyl)ethyne | ESD-899290-5G |
Cas.: 1214345-25-1 | Purity: 97% | 1-Bromo-3-methoxy-2-(trifluoromethyl)benzene | ESD-899291-250MG |
Cas.: 1214345-25-1 | Purity: 97% | 1-Bromo-3-methoxy-2-(trifluoromethyl)benzene | ESD-899291-1G |
Cas.: 1214345-25-1 | Purity: 97% | 1-Bromo-3-methoxy-2-(trifluoromethyl)benzene | ESD-899291-5G |
Cas.: 916078-39-2 | Purity: 97% | Methyl 4-(hydroxymethyl)piperidine-1-carboxylate | ESD-899292-250MG |
Cas.: 916078-39-2 | Purity: 97% | Methyl 4-(hydroxymethyl)piperidine-1-carboxylate | ESD-899292-1G |
Cas.: 916078-39-2 | Purity: 97% | Methyl 4-(hydroxymethyl)piperidine-1-carboxylate | ESD-899292-5G |
Cas.: 105985-21-5 | Purity: ≥95% | 2-Chloro-5-(chloromethyl)pyrazine | ESD-899293-100MG |
Cas.: 105985-21-5 | Purity: ≥95% | 2-Chloro-5-(chloromethyl)pyrazine | ESD-899293-1G |
Cas.: 105985-21-5 | Purity: ≥95% | 2-Chloro-5-(chloromethyl)pyrazine | ESD-899293-5G |
Cas.: 67815-54-7 | Purity: ≥95% | 3,4,5-Trifluoropyridine | ESD-899294-250MG |
Cas.: 67815-54-7 | Purity: ≥95% | 3,4,5-Trifluoropyridine | ESD-899294-1G |
Cas.: 80099-98-5 | Purity: 95% | 6-Chloropicolinoyl chloride | ESD-899295-250MG |
Cas.: 80099-98-5 | Purity: 95% | 6-Chloropicolinoyl chloride | ESD-899295-1G |
Cas.: 217656-69-4 | Purity: 97% | 5-Bromo-4-chloro-1H-indole | ESD-899296-250MG |
Cas.: 217656-69-4 | Purity: 97% | 5-Bromo-4-chloro-1H-indole | ESD-899296-1G |
Cas.: 217656-69-4 | Purity: 97% | 5-Bromo-4-chloro-1H-indole | ESD-899296-5G |
Cas.: 50551-17-2 | Purity: ≥95% | 4-Nitro-2-(trifluoromethyl)benzaldehyde | ESD-899297-250MG |
Cas.: 50551-17-2 | Purity: ≥95% | 4-Nitro-2-(trifluoromethyl)benzaldehyde | ESD-899297-1G |
Cas.: 50551-17-2 | Purity: ≥95% | 4-Nitro-2-(trifluoromethyl)benzaldehyde | ESD-899297-5G |
Cas.: 82454-61-3 | Purity: 97% | 5-Ethynylpyridin-2-amine | ESD-899298-250MG |
Cas.: 82454-61-3 | Purity: 97% | 5-Ethynylpyridin-2-amine | ESD-899298-1G |
Cas.: 82454-61-3 | Purity: 97% | 5-Ethynylpyridin-2-amine | ESD-899298-5G |
Cas.: 586409-05-4 | Purity: 98% | 6-Methylthiazolo[4,5-b]pyridine-2-thiol | ESD-899299-250MG |
Cas.: 586409-05-4 | Purity: 98% | 6-Methylthiazolo[4,5-b]pyridine-2-thiol | ESD-899299-1G |
Cas.: 586409-05-4 | Purity: 98% | 6-Methylthiazolo[4,5-b]pyridine-2-thiol | ESD-899299-5G |
Cas.: 202348-55-8 | Purity: ≥95% | 6-Methylimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-899300-250MG |
Cas.: 202348-55-8 | Purity: ≥95% | 6-Methylimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-899300-1G |
Cas.: 202348-55-8 | Purity: ≥95% | 6-Methylimidazo[1,2-a]pyridine-2-carbaldehyde | ESD-899300-5G |
Cas.: 713-21-3 | Purity: 95% | 2-Fluoro-5-nitrobenzenesulfonyl chloride | ESD-899302-250MG |
Cas.: 713-21-3 | Purity: 95% | 2-Fluoro-5-nitrobenzenesulfonyl chloride | ESD-899302-1G |
Cas.: 713-21-3 | Purity: 95% | 2-Fluoro-5-nitrobenzenesulfonyl chloride | ESD-899302-5G |
Cas.: 18841-64-0 | Purity: ≥95% | Methyl 2-Chloro-3-phenylpropionate | ESD-899303-250MG |
Cas.: 18841-64-0 | Purity: ≥95% | Methyl 2-Chloro-3-phenylpropionate | ESD-899303-1G |
Cas.: 18841-64-0 | Purity: ≥95% | Methyl 2-Chloro-3-phenylpropionate | ESD-899303-5G |
Cas.: 77302-72-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)hexanedioic acid | ESD-899304-250MG |
Cas.: 77302-72-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)hexanedioic acid | ESD-899304-1G |
Cas.: 77302-72-8 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)hexanedioic acid | ESD-899304-5G |
Cas.: 187876-47-7 | Purity: 95% | (S)-Ethyl 3-aminobutanoate hydrochloride | ESD-899305-250MG |
Cas.: 187876-47-7 | Purity: 95% | (S)-Ethyl 3-aminobutanoate hydrochloride | ESD-899305-1G |
Cas.: 187876-47-7 | Purity: 95% | (S)-Ethyl 3-aminobutanoate hydrochloride | ESD-899305-5G |
Cas.: 1250113-83-7 | Purity: 97% | 1-(2,4,6-Trifluorophenyl)ethanol | ESD-899306-250MG |
Cas.: 1250113-83-7 | Purity: 97% | 1-(2,4,6-Trifluorophenyl)ethanol | ESD-899306-1G |
Cas.: 1250113-83-7 | Purity: 97% | 1-(2,4,6-Trifluorophenyl)ethanol | ESD-899306-5G |
Cas.: 49721-45-1 | Purity: 97% | Pyrimidine-4,5,6-triamine sulfate | ESD-899307-250MG |
Cas.: 49721-45-1 | Purity: 97% | Pyrimidine-4,5,6-triamine sulfate | ESD-899307-1G |
Cas.: 49721-45-1 | Purity: 97% | Pyrimidine-4,5,6-triamine sulfate | ESD-899307-5G |
Cas.: 773874-16-1 | Purity: 98% | Methyl 2,4-difluoro-6-hydroxybenzoate | ESD-899308-250MG |
Cas.: 773874-16-1 | Purity: 98% | Methyl 2,4-difluoro-6-hydroxybenzoate | ESD-899308-1G |
Cas.: 773874-16-1 | Purity: 98% | Methyl 2,4-difluoro-6-hydroxybenzoate | ESD-899308-5G |
Cas.: 209733-13-1 | Purity: 97% | 2-(Piperazin-1-yl)thiazole hydrochloride | ESD-899309-250MG |
Cas.: 209733-13-1 | Purity: 97% | 2-(Piperazin-1-yl)thiazole hydrochloride | ESD-899309-1G |
Cas.: 209733-13-1 | Purity: 97% | 2-(Piperazin-1-yl)thiazole hydrochloride | ESD-899309-5G |
Cas.: 67455-41-8 | Purity: 96% | 4-(Piperazin-1-yl)aniline | ESD-899310-250MG |
Cas.: 67455-41-8 | Purity: 96% | 4-(Piperazin-1-yl)aniline | ESD-899310-1G |
Cas.: 67455-41-8 | Purity: 96% | 4-(Piperazin-1-yl)aniline | ESD-899310-5G |
Cas.: 1416440-23-7 | Purity: ≥95% | 6-Bromo-3-iodoquinoline | ESD-899311-250MG |
Cas.: 1416440-23-7 | Purity: ≥95% | 6-Bromo-3-iodoquinoline | ESD-899311-1G |
Cas.: 1416440-23-7 | Purity: ≥95% | 6-Bromo-3-iodoquinoline | ESD-899311-5G |
Cas.: 882238-14-4 | Purity: ≥95% | 5-(2,5-Dimethoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-899312-250MG |
Cas.: 882238-14-4 | Purity: ≥95% | 5-(2,5-Dimethoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-899312-1G |
Cas.: 882238-14-4 | Purity: ≥95% | 5-(2,5-Dimethoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-899312-5G |
Cas.: 860187-45-7 | Purity: 95% | Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate | ESD-899313-250MG |
Cas.: 860187-45-7 | Purity: 95% | Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate | ESD-899313-1G |
Cas.: 860187-45-7 | Purity: 95% | Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate | ESD-899313-5G |
Cas.: 193693-95-7 | Purity: 95% | 3-Hydroxy-5-nitrobenzaldehyde | ESD-899314-250MG |
Cas.: 193693-95-7 | Purity: 95% | 3-Hydroxy-5-nitrobenzaldehyde | ESD-899314-1G |
Cas.: 193693-95-7 | Purity: 95% | 3-Hydroxy-5-nitrobenzaldehyde | ESD-899314-5G |
Cas.: 514209-40-6 | Purity: ≥95% | 2-(4-Methylpiperazin-1-ylmethyl)benzoic acid | ESD-899315-250MG |
Cas.: 514209-40-6 | Purity: ≥95% | 2-(4-Methylpiperazin-1-ylmethyl)benzoic acid | ESD-899315-1G |
Cas.: 514209-40-6 | Purity: ≥95% | 2-(4-Methylpiperazin-1-ylmethyl)benzoic acid | ESD-899315-5G |
Cas.: 486415-29-6 | Purity: ≥95% | tert-Butyl 3-carbamoylazetidine-1-carboxylate | ESD-899316-250MG |
Cas.: 486415-29-6 | Purity: ≥95% | tert-Butyl 3-carbamoylazetidine-1-carboxylate | ESD-899316-1G |
Cas.: 486415-29-6 | Purity: ≥95% | tert-Butyl 3-carbamoylazetidine-1-carboxylate | ESD-899316-5G |
Cas.: 72005-84-6 | Purity: 95% | 2-Methyl-4-nitrobenzaldehyde | ESD-899317-250MG |
Cas.: 72005-84-6 | Purity: 95% | 2-Methyl-4-nitrobenzaldehyde | ESD-899317-1G |
Cas.: 72005-84-6 | Purity: 95% | 2-Methyl-4-nitrobenzaldehyde | ESD-899317-5G |
Cas.: 1094107-41-1 | Purity: 95% | Methyl 2-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate | ESD-899318-250MG |
Cas.: 1094107-41-1 | Purity: 95% | Methyl 2-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate | ESD-899318-1G |
Cas.: 1094107-41-1 | Purity: 95% | Methyl 2-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate | ESD-899318-5G |
Cas.: 99822-23-8 | Purity: 97% | 5-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-899319-250MG |
Cas.: 99822-23-8 | Purity: 97% | 5-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-899319-1G |
Cas.: 99822-23-8 | Purity: 97% | 5-Fluorobenzo[d]isoxazol-3(2H)-one | ESD-899319-5G |
Cas.: 160989-35-5 | Purity: ≥95% | 3,4-Dibromo-1-trityl-1H-pyrrole-2,5-dione | ESD-899320-250MG |
Cas.: 160989-35-5 | Purity: ≥95% | 3,4-Dibromo-1-trityl-1H-pyrrole-2,5-dione | ESD-899320-1G |
Cas.: 160989-35-5 | Purity: ≥95% | 3,4-Dibromo-1-trityl-1H-pyrrole-2,5-dione | ESD-899320-5G |
Cas.: 1063712-34-4 | Purity: 98% | 2-Chloro-4-formylphenylboronic Acid | ESD-899321-250MG |
Cas.: 1063712-34-4 | Purity: 98% | 2-Chloro-4-formylphenylboronic Acid | ESD-899321-1G |
Cas.: 1063712-34-4 | Purity: 98% | 2-Chloro-4-formylphenylboronic Acid | ESD-899321-5G |
Cas.: 1010133-97-7 | Purity: ≥95% | 1-(Pyridin-3-yl)piperazine hydrochloride | ESD-899322-250MG |
Cas.: 1010133-97-7 | Purity: ≥95% | 1-(Pyridin-3-yl)piperazine hydrochloride | ESD-899322-1G |
Cas.: 1010133-97-7 | Purity: ≥95% | 1-(Pyridin-3-yl)piperazine hydrochloride | ESD-899322-5G |
Cas.: 1328640-39-6 | Purity: ≥95% | Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate | ESD-899323-250MG |
Cas.: 1328640-39-6 | Purity: ≥95% | Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate | ESD-899323-1G |
Cas.: 1328640-39-6 | Purity: ≥95% | Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate | ESD-899323-5G |
Cas.: 672324-87-7 | Purity: ≥95% | [4-(1,3-Thiazol-2-yl)phenyl]methylamine | ESD-899324-250MG |
Cas.: 672324-87-7 | Purity: ≥95% | [4-(1,3-Thiazol-2-yl)phenyl]methylamine | ESD-899324-1G |
Cas.: 672324-87-7 | Purity: ≥95% | [4-(1,3-Thiazol-2-yl)phenyl]methylamine | ESD-899324-5G |
Cas.: 1208542-95-3 | Purity: 98% | tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate | ESD-899325-250MG |
Cas.: 1208542-95-3 | Purity: 98% | tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate | ESD-899325-1G |
Cas.: 1208542-95-3 | Purity: 98% | tert-Butyl 4-(3-aminopyrazin-2-yl)piperazine-1-carboxylate | ESD-899325-5G |
Cas.: 174500-88-0 | Purity: ≥95% | 6-Cyano-1H-indole-3-carboxylic acid | ESD-899326-250MG |
Cas.: 174500-88-0 | Purity: ≥95% | 6-Cyano-1H-indole-3-carboxylic acid | ESD-899326-1G |
Cas.: 174500-88-0 | Purity: ≥95% | 6-Cyano-1H-indole-3-carboxylic acid | ESD-899326-5G |
Cas.: 1189106-78-2 | Purity: ≥95% | 6-Bromo-2,8-dimethylquinoline | ESD-899327-250MG |
Cas.: 1189106-78-2 | Purity: ≥95% | 6-Bromo-2,8-dimethylquinoline | ESD-899327-1G |
Cas.: 1189106-78-2 | Purity: ≥95% | 6-Bromo-2,8-dimethylquinoline | ESD-899327-5G |
Cas.: 130046-91-2 | Purity: 97% | 5-Fluoro-2-hydroxy-3-nitrobenzoic acid | ESD-899328-250MG |
Cas.: 130046-91-2 | Purity: 97% | 5-Fluoro-2-hydroxy-3-nitrobenzoic acid | ESD-899328-1G |
Cas.: 130046-91-2 | Purity: 97% | 5-Fluoro-2-hydroxy-3-nitrobenzoic acid | ESD-899328-5G |
Cas.: 4751-61-5 | Purity: 98% | 7,8-Dihydro-4H-thieno[3,2-b]azepin-5(6H)-one | ESD-899329-250MG |
Cas.: 4751-61-5 | Purity: 98% | 7,8-Dihydro-4H-thieno[3,2-b]azepin-5(6H)-one | ESD-899329-1G |
Cas.: 4751-61-5 | Purity: 98% | 7,8-Dihydro-4H-thieno[3,2-b]azepin-5(6H)-one | ESD-899329-5G |
Cas.: 1154310-76-5 | Purity: ≥95% | 2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol | ESD-899330-250MG |
Cas.: 1154310-76-5 | Purity: ≥95% | 2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol | ESD-899330-1G |
Cas.: 1154310-76-5 | Purity: ≥95% | 2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol | ESD-899330-5G |
Cas.: 1677-42-5 | Purity: 98% | 4-Hydroxy-8-methylquinolin-2(1H)-one | ESD-899331-250MG |
Cas.: 1677-42-5 | Purity: 98% | 4-Hydroxy-8-methylquinolin-2(1H)-one | ESD-899331-1G |
Cas.: 1677-42-5 | Purity: 98% | 4-Hydroxy-8-methylquinolin-2(1H)-one | ESD-899331-5G |
Cas.: 532965-74-5 | Purity: 98% | 4-Ethoxy-2-fluorobenzaldehyde | ESD-899332-250MG |
Cas.: 532965-74-5 | Purity: 98% | 4-Ethoxy-2-fluorobenzaldehyde | ESD-899332-1G |
Cas.: 532965-74-5 | Purity: 98% | 4-Ethoxy-2-fluorobenzaldehyde | ESD-899332-5G |
Cas.: 70918-54-6 | Purity: 97% | (S)-1,4-Benzodioxane-2-carboxylic acid | ESD-899333-250MG |
Cas.: 70918-54-6 | Purity: 97% | (S)-1,4-Benzodioxane-2-carboxylic acid | ESD-899333-1G |
Cas.: 70918-54-6 | Purity: 97% | (S)-1,4-Benzodioxane-2-carboxylic acid | ESD-899333-5G |
Cas.: 321596-58-1 | Purity: 95% | 6-Bromo-3-hydroxypicolinic acid | ESD-899334-250MG |
Cas.: 321596-58-1 | Purity: 95% | 6-Bromo-3-hydroxypicolinic acid | ESD-899334-1G |
Cas.: 321596-58-1 | Purity: 95% | 6-Bromo-3-hydroxypicolinic acid | ESD-899334-5G |
Cas.: 1071455-14-5 | Purity: 97% | (3-Methyl-1H-pyrazol-4-yl)boronic acid | ESD-899335-250MG |
Cas.: 1071455-14-5 | Purity: 97% | (3-Methyl-1H-pyrazol-4-yl)boronic acid | ESD-899335-1G |
Cas.: 1071455-14-5 | Purity: 97% | (3-Methyl-1H-pyrazol-4-yl)boronic acid | ESD-899335-5G |
Cas.: 5081-87-8 | Purity: 97% | 3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione | ESD-899336-250MG |
Cas.: 5081-87-8 | Purity: 97% | 3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione | ESD-899336-1G |
Cas.: 5081-87-8 | Purity: 97% | 3-(2-Chloroethyl)quinazoline-2,4(1H,3H)-dione | ESD-899336-5G |
Cas.: 1107632-13-2 | Purity: 97% | (4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride | ESD-899337-250MG |
Cas.: 1107632-13-2 | Purity: 97% | (4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride | ESD-899337-1G |
Cas.: 1107632-13-2 | Purity: 97% | (4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride | ESD-899337-5G |
Cas.: 1187931-26-5 | Purity: 97% | (S)-1-(2-Bromophenyl)ethanamine hydrochloride | ESD-899338-250MG |
Cas.: 1187931-26-5 | Purity: 97% | (S)-1-(2-Bromophenyl)ethanamine hydrochloride | ESD-899338-1G |
Cas.: 1187931-26-5 | Purity: 97% | (S)-1-(2-Bromophenyl)ethanamine hydrochloride | ESD-899338-5G |
Cas.: 146954-75-8 | Purity: ≥95% | 2′-F-dU Phosphoramidite | ESD-899339-250MG |
Cas.: 146954-75-8 | Purity: ≥95% | 2′-F-dU Phosphoramidite | ESD-899339-1G |
Cas.: 146954-75-8 | Purity: ≥95% | 2′-F-dU Phosphoramidite | ESD-899339-5G |
Cas.: 910308-92-8 | Purity: 97% | (S)-tert-Butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate | ESD-899340-250MG |
Cas.: 910308-92-8 | Purity: 97% | (S)-tert-Butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate | ESD-899340-1G |
Cas.: 910308-92-8 | Purity: 97% | (S)-tert-Butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate | ESD-899340-5G |
Cas.: 92821-92-6 | Purity: ≥95% | 1-(3,5-Dichlorophenyl)propan-1-one | ESD-899341-250MG |
Cas.: 92821-92-6 | Purity: ≥95% | 1-(3,5-Dichlorophenyl)propan-1-one | ESD-899341-1G |
Cas.: 92821-92-6 | Purity: ≥95% | 1-(3,5-Dichlorophenyl)propan-1-one | ESD-899341-5G |
Cas.: 1253789-47-7 | Purity: ≥95% | 6-Bromo-3-ethyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-899342-250MG |
Cas.: 1253789-47-7 | Purity: ≥95% | 6-Bromo-3-ethyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-899342-1G |
Cas.: 1253789-47-7 | Purity: ≥95% | 6-Bromo-3-ethyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-899342-5G |
Cas.: 6274-82-4 | Purity: 98% | 2,6-Dimethoxyisonicotinic acid | ESD-899343-250MG |
Cas.: 6274-82-4 | Purity: 98% | 2,6-Dimethoxyisonicotinic acid | ESD-899343-1G |
Cas.: 6274-82-4 | Purity: 98% | 2,6-Dimethoxyisonicotinic acid | ESD-899343-5G |
Cas.: 127544-88-1 | Purity: 97% | Sodium 4,4′-(m-tolylazanediyl)bis(butane-1-sulfonate) | ESD-899344-250MG |
Cas.: 127544-88-1 | Purity: 97% | Sodium 4,4′-(m-tolylazanediyl)bis(butane-1-sulfonate) | ESD-899344-1G |
Cas.: 127544-88-1 | Purity: 97% | Sodium 4,4′-(m-tolylazanediyl)bis(butane-1-sulfonate) | ESD-899344-5G |
Cas.: 7719-08-6 | Purity: 95% | 2-(Methoxycarbonyl)cyclohexanecarboxylic acid | ESD-899345-250MG |
Cas.: 7719-08-6 | Purity: 95% | 2-(Methoxycarbonyl)cyclohexanecarboxylic acid | ESD-899345-1G |
Cas.: 7719-08-6 | Purity: 95% | 2-(Methoxycarbonyl)cyclohexanecarboxylic acid | ESD-899345-5G |
Cas.: 1388032-50-5 | Purity: 97% | 5-Chloro-2-iodo-1H-indole | ESD-899346-250MG |
Cas.: 1388032-50-5 | Purity: 97% | 5-Chloro-2-iodo-1H-indole | ESD-899346-1G |
Cas.: 1388032-50-5 | Purity: 97% | 5-Chloro-2-iodo-1H-indole | ESD-899346-5G |
Cas.: 3597-63-5 | Purity: ≥95% | 3-Hydroxy-2H-benzo[b][1,4]oxazin-2-one | ESD-899347-250MG |
Cas.: 3597-63-5 | Purity: ≥95% | 3-Hydroxy-2H-benzo[b][1,4]oxazin-2-one | ESD-899347-1G |
Cas.: 3597-63-5 | Purity: ≥95% | 3-Hydroxy-2H-benzo[b][1,4]oxazin-2-one | ESD-899347-5G |
Cas.: 56059-30-4 | Purity: 97% | 2-(5-Fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid | ESD-899348-250MG |
Cas.: 56059-30-4 | Purity: 97% | 2-(5-Fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid | ESD-899348-1G |
Cas.: 56059-30-4 | Purity: 97% | 2-(5-Fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid | ESD-899348-5G |
Cas.: 1184-90-3 | Purity: ≥95% | Amino(imino)methanesulfonic acid | ESD-899350-250MG |
Cas.: 1184-90-3 | Purity: ≥95% | Amino(imino)methanesulfonic acid | ESD-899350-1G |
Cas.: 1184-90-3 | Purity: ≥95% | Amino(imino)methanesulfonic acid | ESD-899350-5G |
Cas.: 51264-76-7 | Purity: 97% | 2-(2-Ethoxy-4-formylphenoxy)acetic acid | ESD-899351-250MG |
Cas.: 51264-76-7 | Purity: 97% | 2-(2-Ethoxy-4-formylphenoxy)acetic acid | ESD-899351-1G |
Cas.: 51264-76-7 | Purity: 97% | 2-(2-Ethoxy-4-formylphenoxy)acetic acid | ESD-899351-5G |
Cas.: 23669-79-6 | Purity: 98% | 5′-O-(4,4′-Dimethoxytrityl)-2′-deoxyuridine | ESD-899352-250MG |
Cas.: 23669-79-6 | Purity: 98% | 5′-O-(4,4′-Dimethoxytrityl)-2′-deoxyuridine | ESD-899352-1G |
Cas.: 23669-79-6 | Purity: 98% | 5′-O-(4,4′-Dimethoxytrityl)-2′-deoxyuridine | ESD-899352-5G |
Cas.: 1172057-73-6 | Purity: 96% | 3-Bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | ESD-899353-250MG |
Cas.: 1172057-73-6 | Purity: 96% | 3-Bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | ESD-899353-1G |
Cas.: 1172057-73-6 | Purity: 96% | 3-Bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | ESD-899353-5G |
Cas.: 1201643-73-3 | Purity: ≥95% | 2-(4-(Bromomethyl)phenyl)-2-methylpropanenitrile | ESD-899354-250MG |
Cas.: 1201643-73-3 | Purity: ≥95% | 2-(4-(Bromomethyl)phenyl)-2-methylpropanenitrile | ESD-899354-1G |
Cas.: 1201643-73-3 | Purity: ≥95% | 2-(4-(Bromomethyl)phenyl)-2-methylpropanenitrile | ESD-899354-5G |
Cas.: 33630-25-0 | Purity: 97% | 2-Phenylpyrimidin-4-amine | ESD-899355-250MG |
Cas.: 33630-25-0 | Purity: 97% | 2-Phenylpyrimidin-4-amine | ESD-899355-1G |
Cas.: 33630-25-0 | Purity: 97% | 2-Phenylpyrimidin-4-amine | ESD-899355-5G |
Cas.: 886364-92-7 | Purity: ≥95% | 5-Chloro-4-methylpyridin-2-ol | ESD-899356-250MG |
Cas.: 886364-92-7 | Purity: ≥95% | 5-Chloro-4-methylpyridin-2-ol | ESD-899356-1G |
Cas.: 886364-92-7 | Purity: ≥95% | 5-Chloro-4-methylpyridin-2-ol | ESD-899356-5G |
Cas.: 206996-51-2 | Purity: ≥95% | (R)-tert-Butyl 2-hydroxybutanoate | ESD-899357-250MG |
Cas.: 206996-51-2 | Purity: ≥95% | (R)-tert-Butyl 2-hydroxybutanoate | ESD-899357-1G |
Cas.: 206996-51-2 | Purity: ≥95% | (R)-tert-Butyl 2-hydroxybutanoate | ESD-899357-5G |
Cas.: 1033265-51-8 | Purity: 97% | tert-Butyl 5-bromo-1H-indole-3-carboxylate | ESD-899358-250MG |
Cas.: 1033265-51-8 | Purity: 97% | tert-Butyl 5-bromo-1H-indole-3-carboxylate | ESD-899358-1G |
Cas.: 1033265-51-8 | Purity: 97% | tert-Butyl 5-bromo-1H-indole-3-carboxylate | ESD-899358-5G |
Cas.: 1116099-07-0 | Purity: 95% | 3,5-Difluoro-4-iodopyridine | ESD-899359-250MG |
Cas.: 1116099-07-0 | Purity: 95% | 3,5-Difluoro-4-iodopyridine | ESD-899359-1G |
Cas.: 1116099-07-0 | Purity: 95% | 3,5-Difluoro-4-iodopyridine | ESD-899359-5G |
Cas.: 14318-64-0 | Purity: 95% | Ethyl 2-(3-nitrophenyl)acetate | ESD-899360-250MG |
Cas.: 14318-64-0 | Purity: 95% | Ethyl 2-(3-nitrophenyl)acetate | ESD-899360-1G |
Cas.: 14318-64-0 | Purity: 95% | Ethyl 2-(3-nitrophenyl)acetate | ESD-899360-5G |
Cas.: 1110767-89-9 | Purity: 97% | (E)-3,5-Dichloro-4-(3-ethoxy-2-methyl-3-oxoprop-1-en-1-yl)benzoic acid | ESD-899361-250MG |
Cas.: 1110767-89-9 | Purity: 97% | (E)-3,5-Dichloro-4-(3-ethoxy-2-methyl-3-oxoprop-1-en-1-yl)benzoic acid | ESD-899361-1G |
Cas.: 1110767-89-9 | Purity: 97% | (E)-3,5-Dichloro-4-(3-ethoxy-2-methyl-3-oxoprop-1-en-1-yl)benzoic acid | ESD-899361-5G |
Cas.: 54568-12-6 | Purity: ≥95% | 5,6-Dimethylpyrimidin-4-amine | ESD-899362-250MG |
Cas.: 54568-12-6 | Purity: ≥95% | 5,6-Dimethylpyrimidin-4-amine | ESD-899362-1G |
Cas.: 54568-12-6 | Purity: ≥95% | 5,6-Dimethylpyrimidin-4-amine | ESD-899362-5G |
Cas.: 1220021-56-6 | Purity: ≥95% | Piperidin-4-ylmethyl benzoate hydrochloride | ESD-899363-250MG |
Cas.: 1220021-56-6 | Purity: ≥95% | Piperidin-4-ylmethyl benzoate hydrochloride | ESD-899363-1G |
Cas.: 1220021-56-6 | Purity: ≥95% | Piperidin-4-ylmethyl benzoate hydrochloride | ESD-899363-5G |
Cas.: 1598-42-1 | Purity: ≥95% | 2,4-Dichloro-5-(trifluoromethoxy)aniline | ESD-899364-250MG |
Cas.: 1598-42-1 | Purity: ≥95% | 2,4-Dichloro-5-(trifluoromethoxy)aniline | ESD-899364-1G |
Cas.: 1598-42-1 | Purity: ≥95% | 2,4-Dichloro-5-(trifluoromethoxy)aniline | ESD-899364-5G |
Cas.: 1357942-79-0 | Purity: 97% | 4-Amino-2-fluoro-5-methylbenzonitrile | ESD-899365-250MG |
Cas.: 1357942-79-0 | Purity: 97% | 4-Amino-2-fluoro-5-methylbenzonitrile | ESD-899365-1G |
Cas.: 1357942-79-0 | Purity: 97% | 4-Amino-2-fluoro-5-methylbenzonitrile | ESD-899365-5G |
Cas.: 1021298-68-9 | Purity: 97% | 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile | ESD-899366-250MG |
Cas.: 1021298-68-9 | Purity: 97% | 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile | ESD-899366-1G |
Cas.: 1021298-68-9 | Purity: 97% | 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile | ESD-899366-5G |
Cas.: 65845-56-9 | Purity: ≥95% | 3-(Methylamino)propanoic acid hydrochloride | ESD-899367-250MG |
Cas.: 65845-56-9 | Purity: ≥95% | 3-(Methylamino)propanoic acid hydrochloride | ESD-899367-1G |
Cas.: 65845-56-9 | Purity: ≥95% | 3-(Methylamino)propanoic acid hydrochloride | ESD-899367-5G |
Cas.: 90721-58-7 | Purity: 95% | Methyl 2-bromo-5-(bromomethyl)benzoate | ESD-899368-250MG |
Cas.: 90721-58-7 | Purity: 95% | Methyl 2-bromo-5-(bromomethyl)benzoate | ESD-899368-1G |
Cas.: 90721-58-7 | Purity: 95% | Methyl 2-bromo-5-(bromomethyl)benzoate | ESD-899368-5G |
Cas.: 167884-17-5 | Purity: ≥95% | Imidazo[1,2-a]pyridin-5-ylmethanol | ESD-899369-250MG |
Cas.: 167884-17-5 | Purity: ≥95% | Imidazo[1,2-a]pyridin-5-ylmethanol | ESD-899369-1G |
Cas.: 167884-17-5 | Purity: ≥95% | Imidazo[1,2-a]pyridin-5-ylmethanol | ESD-899369-5G |
Cas.: 105107-84-4 | Purity: ≥95% | cis-4-Phenylthio-L-proline hydrochloride | ESD-899370-250MG |
Cas.: 105107-84-4 | Purity: ≥95% | cis-4-Phenylthio-L-proline hydrochloride | ESD-899370-1G |
Cas.: 105107-84-4 | Purity: ≥95% | cis-4-Phenylthio-L-proline hydrochloride | ESD-899370-5G |
Cas.: 7146-68-1 | Purity: 97% | 4-((4-Chlorophenyl)sulfonyl)aniline | ESD-899371-250MG |
Cas.: 7146-68-1 | Purity: 97% | 4-((4-Chlorophenyl)sulfonyl)aniline | ESD-899371-1G |
Cas.: 7146-68-1 | Purity: 97% | 4-((4-Chlorophenyl)sulfonyl)aniline | ESD-899371-5G |
Cas.: 191340-85-9 | Purity: 97% | 2-Chloro-3-iodopyrazine | ESD-899372-250MG |
Cas.: 191340-85-9 | Purity: 97% | 2-Chloro-3-iodopyrazine | ESD-899372-1G |
Cas.: 191340-85-9 | Purity: 97% | 2-Chloro-3-iodopyrazine | ESD-899372-5G |
Cas.: 156899-02-4 | Purity: 97% | 3-(2-(tert-Butoxycarbonyl)hydrazinyl)benzoic acid | ESD-899373-250MG |
Cas.: 156899-02-4 | Purity: 97% | 3-(2-(tert-Butoxycarbonyl)hydrazinyl)benzoic acid | ESD-899373-1G |
Cas.: 156899-02-4 | Purity: 97% | 3-(2-(tert-Butoxycarbonyl)hydrazinyl)benzoic acid | ESD-899373-5G |
Cas.: 1450-94-8 | Purity: ≥95% | 1-Methyl-1H-imidazol-2-amine hydrochloride | ESD-899374-250MG |
Cas.: 1450-94-8 | Purity: ≥95% | 1-Methyl-1H-imidazol-2-amine hydrochloride | ESD-899374-1G |
Cas.: 1450-94-8 | Purity: ≥95% | 1-Methyl-1H-imidazol-2-amine hydrochloride | ESD-899374-5G |
Cas.: 83304-59-0 | Purity: 97% | N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride | ESD-899375-250MG |
Cas.: 83304-59-0 | Purity: 97% | N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride | ESD-899375-1G |
Cas.: 83304-59-0 | Purity: 97% | N-Benzyl-1-(2,4-dimethoxyphenyl)methanamine hydrochloride | ESD-899375-5G |
Cas.: 159990-12-2 | Purity: ≥95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoic acid | ESD-899376-250MG |
Cas.: 159990-12-2 | Purity: ≥95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoic acid | ESD-899376-1G |
Cas.: 159990-12-2 | Purity: ≥95% | (S)-3-((tert-Butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoic acid | ESD-899376-5G |
Cas.: 112006-57-2 | Purity: 97% | 2-(Benzylthio)-N,N-dimethylnicotinamide | ESD-899377-250MG |
Cas.: 112006-57-2 | Purity: 97% | 2-(Benzylthio)-N,N-dimethylnicotinamide | ESD-899377-1G |
Cas.: 112006-57-2 | Purity: 97% | 2-(Benzylthio)-N,N-dimethylnicotinamide | ESD-899377-5G |
Cas.: 23956-12-9 | Purity: ≥95% | 5-(2-Hydroxyethyl)pyrimidine-2,4(1H,3H)-dione | ESD-899378-250MG |
Cas.: 23956-12-9 | Purity: ≥95% | 5-(2-Hydroxyethyl)pyrimidine-2,4(1H,3H)-dione | ESD-899378-1G |
Cas.: 23956-12-9 | Purity: ≥95% | 5-(2-Hydroxyethyl)pyrimidine-2,4(1H,3H)-dione | ESD-899378-5G |
Cas.: 505082-91-7 | Purity: ≥95% | 6-(2-Fluorophenyl)nicotinic acid | ESD-899379-250MG |
Cas.: 505082-91-7 | Purity: ≥95% | 6-(2-Fluorophenyl)nicotinic acid | ESD-899379-1G |
Cas.: 505082-91-7 | Purity: ≥95% | 6-(2-Fluorophenyl)nicotinic acid | ESD-899379-5G |
Cas.: 340040-67-7 | Purity: ≥95% | (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride | ESD-899380-250MG |
Cas.: 340040-67-7 | Purity: ≥95% | (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride | ESD-899380-1G |
Cas.: 340040-67-7 | Purity: ≥95% | (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride | ESD-899380-5G |
Cas.: 1214372-82-3 | Purity: ≥95% | 1-(Difluoromethyl)-4-iodobenzene | ESD-899381-250MG |
Cas.: 1214372-82-3 | Purity: ≥95% | 1-(Difluoromethyl)-4-iodobenzene | ESD-899381-1G |
Cas.: 1214372-82-3 | Purity: ≥95% | 1-(Difluoromethyl)-4-iodobenzene | ESD-899381-5G |
Cas.: 73502-04-2 | Purity: ≥95% | (5-Methoxy-2-methylphenyl)methanol | ESD-899382-250MG |
Cas.: 73502-04-2 | Purity: ≥95% | (5-Methoxy-2-methylphenyl)methanol | ESD-899382-1G |
Cas.: 73502-04-2 | Purity: ≥95% | (5-Methoxy-2-methylphenyl)methanol | ESD-899382-5G |
Cas.: 184163-56-2 | Purity: 97% | 4-Hydrazinyl-3-(trifluoromethyl)benzonitrile | ESD-899383-250MG |
Cas.: 184163-56-2 | Purity: 97% | 4-Hydrazinyl-3-(trifluoromethyl)benzonitrile | ESD-899383-1G |
Cas.: 184163-56-2 | Purity: 97% | 4-Hydrazinyl-3-(trifluoromethyl)benzonitrile | ESD-899383-5G |
Cas.: 1998701-09-9 | Purity: 97% | (R)-tert-Butyl 2-(aminomethyl)morpholine-4-carboxylate acetate | ESD-899384-250MG |
Cas.: 1998701-09-9 | Purity: 97% | (R)-tert-Butyl 2-(aminomethyl)morpholine-4-carboxylate acetate | ESD-899384-1G |
Cas.: 1998701-09-9 | Purity: 97% | (R)-tert-Butyl 2-(aminomethyl)morpholine-4-carboxylate acetate | ESD-899384-5G |
Cas.: 15837-41-9 | Purity: 98% | 5-Hydroxypyrimidin-4(3H)-one | ESD-899385-250MG |
Cas.: 15837-41-9 | Purity: 98% | 5-Hydroxypyrimidin-4(3H)-one | ESD-899385-1G |
Cas.: 15837-41-9 | Purity: 98% | 5-Hydroxypyrimidin-4(3H)-one | ESD-899385-5G |
Cas.: 1400764-35-3 | Purity: ≥95% | Pyridazin-4-amine hydrochloride | ESD-899386-250MG |
Cas.: 1400764-35-3 | Purity: ≥95% | Pyridazin-4-amine hydrochloride | ESD-899386-1G |
Cas.: 1400764-35-3 | Purity: ≥95% | Pyridazin-4-amine hydrochloride | ESD-899386-5G |
Cas.: 57772-57-3 | Purity: ≥95% | 5-Hydroxy-2-iodobenzoic acid | ESD-899387-250MG |
Cas.: 57772-57-3 | Purity: ≥95% | 5-Hydroxy-2-iodobenzoic acid | ESD-899387-1G |
Cas.: 57772-57-3 | Purity: ≥95% | 5-Hydroxy-2-iodobenzoic acid | ESD-899387-5G |
Cas.: 1217482-47-7 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid | ESD-899388-250MG |
Cas.: 1217482-47-7 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid | ESD-899388-1G |
Cas.: 1217482-47-7 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid | ESD-899388-5G |
Cas.: 176523-95-8 | Purity: 97% | Ethyl 3-methylpiperidine-3-carboxylate hydrochloride | ESD-899389-250MG |
Cas.: 176523-95-8 | Purity: 97% | Ethyl 3-methylpiperidine-3-carboxylate hydrochloride | ESD-899389-1G |
Cas.: 176523-95-8 | Purity: 97% | Ethyl 3-methylpiperidine-3-carboxylate hydrochloride | ESD-899389-5G |
Cas.: 83515-06-4 | Purity: 97% | 5-Bromo-2-phenyl-1H-indole | ESD-899390-250MG |
Cas.: 83515-06-4 | Purity: 97% | 5-Bromo-2-phenyl-1H-indole | ESD-899390-1G |
Cas.: 83515-06-4 | Purity: 97% | 5-Bromo-2-phenyl-1H-indole | ESD-899390-5G |
Cas.: 1314216-33-5 | Purity: 97% | (1H-Pyrazol-3-yl)boronic acid hydrochloride | ESD-899391-250MG |
Cas.: 1314216-33-5 | Purity: 97% | (1H-Pyrazol-3-yl)boronic acid hydrochloride | ESD-899391-1G |
Cas.: 1314216-33-5 | Purity: 97% | (1H-Pyrazol-3-yl)boronic acid hydrochloride | ESD-899391-5G |
Cas.: 25813-24-5 | Purity: 98% | 3,5-Dibromo-4-methoxypyridine | ESD-899392-250MG |
Cas.: 25813-24-5 | Purity: 98% | 3,5-Dibromo-4-methoxypyridine | ESD-899392-1G |
Cas.: 25813-24-5 | Purity: 98% | 3,5-Dibromo-4-methoxypyridine | ESD-899392-5G |
Cas.: 874823-37-7 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate hydrochloride | ESD-899393-250MG |
Cas.: 874823-37-7 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate hydrochloride | ESD-899393-1G |
Cas.: 874823-37-7 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate hydrochloride | ESD-899393-5G |
Cas.: 54042-47-6 | Purity: 95% | (4-Chlorophenyl)(piperazin-1-yl)methanone | ESD-899394-250MG |
Cas.: 54042-47-6 | Purity: 95% | (4-Chlorophenyl)(piperazin-1-yl)methanone | ESD-899394-1G |
Cas.: 54042-47-6 | Purity: 95% | (4-Chlorophenyl)(piperazin-1-yl)methanone | ESD-899394-5G |
Cas.: 634468-96-5 | Purity: 98% | tert-Butyl 4-(pyrimidin-5-yl)piperazine-1-carboxylate | ESD-899395-250MG |
Cas.: 634468-96-5 | Purity: 98% | tert-Butyl 4-(pyrimidin-5-yl)piperazine-1-carboxylate | ESD-899395-1G |
Cas.: 634468-96-5 | Purity: 98% | tert-Butyl 4-(pyrimidin-5-yl)piperazine-1-carboxylate | ESD-899395-5G |
Cas.: 1029413-53-3 | Purity: 97% | tert-Butyl 3-(4-amino-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-899396-250MG |
Cas.: 1029413-53-3 | Purity: 97% | tert-Butyl 3-(4-amino-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-899396-1G |
Cas.: 1029413-53-3 | Purity: 97% | tert-Butyl 3-(4-amino-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate | ESD-899396-5G |
Cas.: 78016-98-5 | Purity: 96% | 2-(Trifluoromethyl)-1H-imidazole-5-carboxylic acid | ESD-899397-250MG |
Cas.: 78016-98-5 | Purity: 96% | 2-(Trifluoromethyl)-1H-imidazole-5-carboxylic acid | ESD-899397-1G |
Cas.: 78016-98-5 | Purity: 96% | 2-(Trifluoromethyl)-1H-imidazole-5-carboxylic acid | ESD-899397-5G |
Cas.: 1374639-77-6 | Purity: 97% | (2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol | ESD-899398-250MG |
Cas.: 1374639-77-6 | Purity: 97% | (2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol | ESD-899398-1G |
Cas.: 1374639-77-6 | Purity: 97% | (2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol | ESD-899398-5G |
Cas.: 1093656-34-8 | Purity: 97% | 2-Ethoxy-1-fluoro-4-nitrobenzene | ESD-899399-250MG |
Cas.: 1093656-34-8 | Purity: 97% | 2-Ethoxy-1-fluoro-4-nitrobenzene | ESD-899399-1G |
Cas.: 1093656-34-8 | Purity: 97% | 2-Ethoxy-1-fluoro-4-nitrobenzene | ESD-899399-5G |
Cas.: 103261-70-7 | Purity: 97% | Ethyl benzo[d]thiazole-5-carboxylate | ESD-899400-250MG |
Cas.: 103261-70-7 | Purity: 97% | Ethyl benzo[d]thiazole-5-carboxylate | ESD-899400-1G |
Cas.: 103261-70-7 | Purity: 97% | Ethyl benzo[d]thiazole-5-carboxylate | ESD-899400-5G |
Cas.: 64080-15-5 | Purity: ≥95% | 2-Bromo-4-ethylphenol | ESD-899401-250MG |
Cas.: 64080-15-5 | Purity: ≥95% | 2-Bromo-4-ethylphenol | ESD-899401-1G |
Cas.: 64080-15-5 | Purity: ≥95% | 2-Bromo-4-ethylphenol | ESD-899401-5G |
Cas.: 736991-39-2 | Purity: ≥95% | 4-(4-Bromophenethyl)morpholine | ESD-899402-250MG |
Cas.: 736991-39-2 | Purity: ≥95% | 4-(4-Bromophenethyl)morpholine | ESD-899402-1G |
Cas.: 736991-39-2 | Purity: ≥95% | 4-(4-Bromophenethyl)morpholine | ESD-899402-5G |
Cas.: 1998216-00-4 | Purity: 97% | 3-(Piperazin-1-yl)benzoic acid hydrochloride | ESD-899403-250MG |
Cas.: 1998216-00-4 | Purity: 97% | 3-(Piperazin-1-yl)benzoic acid hydrochloride | ESD-899403-1G |
Cas.: 1998216-00-4 | Purity: 97% | 3-(Piperazin-1-yl)benzoic acid hydrochloride | ESD-899403-5G |
Cas.: 323578-38-7 | Purity: 95% | tert-Butyl (6-(hydroxymethyl)pyridin-3-yl)carbamate | ESD-899404-250MG |
Cas.: 323578-38-7 | Purity: 95% | tert-Butyl (6-(hydroxymethyl)pyridin-3-yl)carbamate | ESD-899404-1G |
Cas.: 323578-38-7 | Purity: 95% | tert-Butyl (6-(hydroxymethyl)pyridin-3-yl)carbamate | ESD-899404-5G |
Cas.: 40925-69-7 | Purity: 97% | 2-Amino-3-methoxyphenol | ESD-899405-250MG |
Cas.: 40925-69-7 | Purity: 97% | 2-Amino-3-methoxyphenol | ESD-899405-1G |
Cas.: 40925-69-7 | Purity: 97% | 2-Amino-3-methoxyphenol | ESD-899405-5G |
Cas.: 458532-92-8 | Purity: 97% | 3-Bromo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899406-250MG |
Cas.: 458532-92-8 | Purity: 97% | 3-Bromo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899406-1G |
Cas.: 458532-92-8 | Purity: 97% | 3-Bromo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-899406-5G |
Cas.: 84378-94-9 | Purity: 97% | 4-Chloro-5-fluoroindoline-2,3-dione | ESD-899407-250MG |
Cas.: 84378-94-9 | Purity: 97% | 4-Chloro-5-fluoroindoline-2,3-dione | ESD-899407-1G |
Cas.: 84378-94-9 | Purity: 97% | 4-Chloro-5-fluoroindoline-2,3-dione | ESD-899407-5G |
Cas.: 133092-34-9 | Purity: ≥95% | 4-Chloro-5,6,7,8-tetrahydroquinoline | ESD-899408-250MG |
Cas.: 133092-34-9 | Purity: ≥95% | 4-Chloro-5,6,7,8-tetrahydroquinoline | ESD-899408-1G |
Cas.: 133092-34-9 | Purity: ≥95% | 4-Chloro-5,6,7,8-tetrahydroquinoline | ESD-899408-5G |
Cas.: 1441670-89-8 | Purity: 97% | (S)-tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5 -carboxylate | ESD-899409-250MG |
Cas.: 1441670-89-8 | Purity: 97% | (S)-tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5 -carboxylate | ESD-899409-1G |
Cas.: 1441670-89-8 | Purity: 97% | (S)-tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5 -carboxylate | ESD-899409-5G |
Cas.: 19396-06-6 | Purity: 70% | Polyoxin B | ESD-899410-250MG |
Cas.: 19396-06-6 | Purity: 70% | Polyoxin B | ESD-899410-1G |
Cas.: 19396-06-6 | Purity: 70% | Polyoxin B | ESD-899410-5G |
Cas.: 891494-65-8 | Purity: ≥95% | tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate | ESD-899411-250MG |
Cas.: 891494-65-8 | Purity: ≥95% | tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate | ESD-899411-1G |
Cas.: 891494-65-8 | Purity: ≥95% | tert-Butyl 3-(3-methoxy-3-oxopropanoyl)-piperidine-1-carboxylate | ESD-899411-5G |
Cas.: 54903-16-1 | Purity: ≥95% | 2-Oxo-2,3-dihydrobenzo[d]oxazole-6-carboxylic acid | ESD-899412-250MG |
Cas.: 54903-16-1 | Purity: ≥95% | 2-Oxo-2,3-dihydrobenzo[d]oxazole-6-carboxylic acid | ESD-899412-1G |
Cas.: 54903-16-1 | Purity: ≥95% | 2-Oxo-2,3-dihydrobenzo[d]oxazole-6-carboxylic acid | ESD-899412-5G |
Cas.: 205055-10-3 | Purity: ≥95% | 6-Fluorobenzo[b]thiophene | ESD-899413-250MG |
Cas.: 205055-10-3 | Purity: ≥95% | 6-Fluorobenzo[b]thiophene | ESD-899413-1G |
Cas.: 205055-10-3 | Purity: ≥95% | 6-Fluorobenzo[b]thiophene | ESD-899413-5G |
Cas.: 130599-34-7 | Purity: ≥95% | 3-(4-(Trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-899414-250MG |
Cas.: 130599-34-7 | Purity: ≥95% | 3-(4-(Trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-899414-1G |
Cas.: 130599-34-7 | Purity: ≥95% | 3-(4-(Trifluoromethyl)phenyl)-1H-pyrazol-5-amine | ESD-899414-5G |
Cas.: 7385-87-7 | Purity: ≥95% | 8-Bromonaphthalen-2-ol | ESD-899415-250MG |
Cas.: 7385-87-7 | Purity: ≥95% | 8-Bromonaphthalen-2-ol | ESD-899415-1G |
Cas.: 7385-87-7 | Purity: ≥95% | 8-Bromonaphthalen-2-ol | ESD-899415-5G |
Cas.: 154820-99-2 | Purity: 95% | 2-(3,3-Dimethylbut-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899416-250MG |
Cas.: 154820-99-2 | Purity: 95% | 2-(3,3-Dimethylbut-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899416-1G |
Cas.: 154820-99-2 | Purity: 95% | 2-(3,3-Dimethylbut-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899416-5G |
Cas.: 69595-02-4 | Purity: 95% | Tetrahydrofuran-3-carbonyl chloride | ESD-899417-250MG |
Cas.: 69595-02-4 | Purity: 95% | Tetrahydrofuran-3-carbonyl chloride | ESD-899417-1G |
Cas.: 69595-02-4 | Purity: 95% | Tetrahydrofuran-3-carbonyl chloride | ESD-899417-5G |
Cas.: 71925-11-6 | Purity: ≥95% | 1-Ethyl-1H-imidazole-5-carboxylic acid | ESD-899418-250MG |
Cas.: 71925-11-6 | Purity: ≥95% | 1-Ethyl-1H-imidazole-5-carboxylic acid | ESD-899418-1G |
Cas.: 71925-11-6 | Purity: ≥95% | 1-Ethyl-1H-imidazole-5-carboxylic acid | ESD-899418-5G |
Cas.: 1142192-57-1 | Purity: ≥95% | 3-Iodo-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-899419-250MG |
Cas.: 1142192-57-1 | Purity: ≥95% | 3-Iodo-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-899419-1G |
Cas.: 1142192-57-1 | Purity: ≥95% | 3-Iodo-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine | ESD-899419-5G |
Cas.: 927800-38-2 | Purity: ≥95% | 4-Bromo-8-fluoroquinoline | ESD-899420-250MG |
Cas.: 927800-38-2 | Purity: ≥95% | 4-Bromo-8-fluoroquinoline | ESD-899420-1G |
Cas.: 927800-38-2 | Purity: ≥95% | 4-Bromo-8-fluoroquinoline | ESD-899420-5G |
Cas.: 885275-59-2 | Purity: ≥95% | 6-Chloro-3-iodoimidazo[1,2-a]pyridine | ESD-899421-250MG |
Cas.: 885275-59-2 | Purity: ≥95% | 6-Chloro-3-iodoimidazo[1,2-a]pyridine | ESD-899421-1G |
Cas.: 885275-59-2 | Purity: ≥95% | 6-Chloro-3-iodoimidazo[1,2-a]pyridine | ESD-899421-5G |
Cas.: 51169-05-2 | Purity: 97% | 2-Hydrazinylpyridine hydrochloride | ESD-899422-250MG |
Cas.: 51169-05-2 | Purity: 97% | 2-Hydrazinylpyridine hydrochloride | ESD-899422-1G |
Cas.: 51169-05-2 | Purity: 97% | 2-Hydrazinylpyridine hydrochloride | ESD-899422-5G |
Cas.: 76660-37-2 | Purity: 98% | 4-((5-Bromopyrimidin-2-yl)oxy)aniline | ESD-899423-250MG |
Cas.: 76660-37-2 | Purity: 98% | 4-((5-Bromopyrimidin-2-yl)oxy)aniline | ESD-899423-1G |
Cas.: 76660-37-2 | Purity: 98% | 4-((5-Bromopyrimidin-2-yl)oxy)aniline | ESD-899423-5G |
Cas.: 189442-92-0 | Purity: 98% | 1-Boc-4-Formyl-4-methylpiperidine | ESD-899424-250MG |
Cas.: 189442-92-0 | Purity: 98% | 1-Boc-4-Formyl-4-methylpiperidine | ESD-899424-1G |
Cas.: 189442-92-0 | Purity: 98% | 1-Boc-4-Formyl-4-methylpiperidine | ESD-899424-5G |
Cas.: 854923-38-9 | Purity: 98% | 5,6-Dibromo-1H-indole | ESD-899425-250MG |
Cas.: 854923-38-9 | Purity: 98% | 5,6-Dibromo-1H-indole | ESD-899425-1G |
Cas.: 854923-38-9 | Purity: 98% | 5,6-Dibromo-1H-indole | ESD-899425-5G |
Cas.: 914348-97-3 | Purity: ≥95% | tert-Butyl 3-formyl-7-nitro-1H-indole-1-carboxylate | ESD-899426-250MG |
Cas.: 914348-97-3 | Purity: ≥95% | tert-Butyl 3-formyl-7-nitro-1H-indole-1-carboxylate | ESD-899426-1G |
Cas.: 914348-97-3 | Purity: ≥95% | tert-Butyl 3-formyl-7-nitro-1H-indole-1-carboxylate | ESD-899426-5G |
Cas.: 957207-58-8 | Purity: 98% | Methyl 4-bromo-2-(trifluoromethyl)benzoate | ESD-899427-250MG |
Cas.: 957207-58-8 | Purity: 98% | Methyl 4-bromo-2-(trifluoromethyl)benzoate | ESD-899427-1G |
Cas.: 957207-58-8 | Purity: 98% | Methyl 4-bromo-2-(trifluoromethyl)benzoate | ESD-899427-5G |
Cas.: 651341-54-7 | Purity: ≥95% | (R)-3-Methoxypiperidine | ESD-899428-250MG |
Cas.: 651341-54-7 | Purity: ≥95% | (R)-3-Methoxypiperidine | ESD-899428-1G |
Cas.: 651341-54-7 | Purity: ≥95% | (R)-3-Methoxypiperidine | ESD-899428-5G |
Cas.: 178876-86-3 | Purity: 98% | Methyl 5-bromo-6-oxo-1,6-dihydropyridine-2-carboxylate | ESD-899429-250MG |
Cas.: 178876-86-3 | Purity: 98% | Methyl 5-bromo-6-oxo-1,6-dihydropyridine-2-carboxylate | ESD-899429-1G |
Cas.: 178876-86-3 | Purity: 98% | Methyl 5-bromo-6-oxo-1,6-dihydropyridine-2-carboxylate | ESD-899429-5G |
Cas.: 163808-09-1 | Purity: 98% | 4-Aminobenzoxazole | ESD-899430-250MG |
Cas.: 163808-09-1 | Purity: 98% | 4-Aminobenzoxazole | ESD-899430-1G |
Cas.: 163808-09-1 | Purity: 98% | 4-Aminobenzoxazole | ESD-899430-5G |
Cas.: 914347-52-7 | Purity: 97% | 5-Bromo-4-(dimethoxymethyl)pyrimidin-2-amine | ESD-899431-250MG |
Cas.: 914347-52-7 | Purity: 97% | 5-Bromo-4-(dimethoxymethyl)pyrimidin-2-amine | ESD-899431-1G |
Cas.: 914347-52-7 | Purity: 97% | 5-Bromo-4-(dimethoxymethyl)pyrimidin-2-amine | ESD-899431-5G |
Cas.: 1018446-95-1 | Purity: ≥95% | tert-Butyl 4-amino-1H-pyrazole-1-carboxylate | ESD-899432-250MG |
Cas.: 1018446-95-1 | Purity: ≥95% | tert-Butyl 4-amino-1H-pyrazole-1-carboxylate | ESD-899432-1G |
Cas.: 1018446-95-1 | Purity: ≥95% | tert-Butyl 4-amino-1H-pyrazole-1-carboxylate | ESD-899432-5G |
Cas.: 1289168-19-9 | Purity: 97% | 3-Amino-5-bromopicolinaldehyde | ESD-899433-250MG |
Cas.: 1289168-19-9 | Purity: 97% | 3-Amino-5-bromopicolinaldehyde | ESD-899433-1G |
Cas.: 1289168-19-9 | Purity: 97% | 3-Amino-5-bromopicolinaldehyde | ESD-899433-5G |
Cas.: 84539-07-1 | Purity: ≥95% | 3,5-Dibromo-N,N-dimethylpyrazin-2-amine | ESD-899434-250MG |
Cas.: 84539-07-1 | Purity: ≥95% | 3,5-Dibromo-N,N-dimethylpyrazin-2-amine | ESD-899434-1G |
Cas.: 84539-07-1 | Purity: ≥95% | 3,5-Dibromo-N,N-dimethylpyrazin-2-amine | ESD-899434-5G |
Cas.: 202217-19-4 | Purity: 97% | 6-Chloro-5-methyl-3-nitropyridin-2-amine | ESD-899435-250MG |
Cas.: 202217-19-4 | Purity: 97% | 6-Chloro-5-methyl-3-nitropyridin-2-amine | ESD-899435-1G |
Cas.: 202217-19-4 | Purity: 97% | 6-Chloro-5-methyl-3-nitropyridin-2-amine | ESD-899435-5G |
Cas.: 148890-63-5 | Purity: 95% | 5-Amino-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-899436-250MG |
Cas.: 148890-63-5 | Purity: 95% | 5-Amino-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-899436-1G |
Cas.: 148890-63-5 | Purity: 95% | 5-Amino-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-899436-5G |
Cas.: 138904-35-5 | Purity: 97% | 7-Amino-4,5-dihydro-5-oxo-pyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-899437-250MG |
Cas.: 138904-35-5 | Purity: 97% | 7-Amino-4,5-dihydro-5-oxo-pyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-899437-1G |
Cas.: 138904-35-5 | Purity: 97% | 7-Amino-4,5-dihydro-5-oxo-pyrazolo[1,5-a]pyrimidine-3-carbonitrile | ESD-899437-5G |
Cas.: 625099-31-2 | Purity: 97% | 3,3-Dimethyldihydro-2H-pyran-4(3H)-one | ESD-899438-250MG |
Cas.: 625099-31-2 | Purity: 97% | 3,3-Dimethyldihydro-2H-pyran-4(3H)-one | ESD-899438-1G |
Cas.: 625099-31-2 | Purity: 97% | 3,3-Dimethyldihydro-2H-pyran-4(3H)-one | ESD-899438-5G |
Cas.: 178546-34-4 | Purity: ≥95% | 3-Bromo-5-fluoro-2-hydroxybenzaldehyde | ESD-899439-250MG |
Cas.: 178546-34-4 | Purity: ≥95% | 3-Bromo-5-fluoro-2-hydroxybenzaldehyde | ESD-899439-1G |
Cas.: 178546-34-4 | Purity: ≥95% | 3-Bromo-5-fluoro-2-hydroxybenzaldehyde | ESD-899439-5G |
Cas.: 935547-73-2 | Purity: 98% | 5-(1H-Imidazol-1-yl)pyridin-2-amine | ESD-899440-250MG |
Cas.: 935547-73-2 | Purity: 98% | 5-(1H-Imidazol-1-yl)pyridin-2-amine | ESD-899440-1G |
Cas.: 935547-73-2 | Purity: 98% | 5-(1H-Imidazol-1-yl)pyridin-2-amine | ESD-899440-5G |
Cas.: 23683-68-3 | Purity: ≥95% | 3-Bromoperylene | ESD-899441-250MG |
Cas.: 23683-68-3 | Purity: ≥95% | 3-Bromoperylene | ESD-899441-1G |
Cas.: 23683-68-3 | Purity: ≥95% | 3-Bromoperylene | ESD-899441-5G |
Cas.: 269747-25-3 | Purity: 98% | tert-Butyl (4-(chlorosulfonyl)phenyl)carbamate | ESD-899442-250MG |
Cas.: 269747-25-3 | Purity: 98% | tert-Butyl (4-(chlorosulfonyl)phenyl)carbamate | ESD-899442-1G |
Cas.: 269747-25-3 | Purity: 98% | tert-Butyl (4-(chlorosulfonyl)phenyl)carbamate | ESD-899442-5G |
Cas.: 1217631-74-7 | Purity: 97% | (S)-Benzyl pyrrolidin-3-ylcarbamate hydrochloride | ESD-899443-250MG |
Cas.: 1217631-74-7 | Purity: 97% | (S)-Benzyl pyrrolidin-3-ylcarbamate hydrochloride | ESD-899443-1G |
Cas.: 1217631-74-7 | Purity: 97% | (S)-Benzyl pyrrolidin-3-ylcarbamate hydrochloride | ESD-899443-5G |
Cas.: 123158-75-8 | Purity: ≥95% | 4-Chloro-2-iodo-6-nitroaniline | ESD-899444-250MG |
Cas.: 123158-75-8 | Purity: ≥95% | 4-Chloro-2-iodo-6-nitroaniline | ESD-899444-1G |
Cas.: 123158-75-8 | Purity: ≥95% | 4-Chloro-2-iodo-6-nitroaniline | ESD-899444-5G |
Cas.: 219310-09-5 | Purity: 97% | (R)-3-Amino-4-methylpentanoic acid hydrochloride | ESD-899445-250MG |
Cas.: 219310-09-5 | Purity: 97% | (R)-3-Amino-4-methylpentanoic acid hydrochloride | ESD-899445-1G |
Cas.: 219310-09-5 | Purity: 97% | (R)-3-Amino-4-methylpentanoic acid hydrochloride | ESD-899445-5G |
Cas.: 77893-68-6 | Purity: 95% | 2-Bromo-3-chlorothiophene | ESD-899446-250MG |
Cas.: 77893-68-6 | Purity: 95% | 2-Bromo-3-chlorothiophene | ESD-899446-1G |
Cas.: 77893-68-6 | Purity: 95% | 2-Bromo-3-chlorothiophene | ESD-899446-5G |
Cas.: 502496-21-1 | Purity: ≥95% | (4-Fluoro-2-(trifluoromethyl)phenyl)hydrazine hydrochloride | ESD-899447-250MG |
Cas.: 502496-21-1 | Purity: ≥95% | (4-Fluoro-2-(trifluoromethyl)phenyl)hydrazine hydrochloride | ESD-899447-1G |
Cas.: 502496-21-1 | Purity: ≥95% | (4-Fluoro-2-(trifluoromethyl)phenyl)hydrazine hydrochloride | ESD-899447-5G |
Cas.: 1210838-82-6 | Purity: 97% | 5-Bromo-3-ethynylpyridin-2-ylamine | ESD-899448-250MG |
Cas.: 1210838-82-6 | Purity: 97% | 5-Bromo-3-ethynylpyridin-2-ylamine | ESD-899448-1G |
Cas.: 1210838-82-6 | Purity: 97% | 5-Bromo-3-ethynylpyridin-2-ylamine | ESD-899448-5G |
Cas.: 53525-60-3 | Purity: 97% | Ethyl 1-trityl-1H-imidazole-4-carboxylate | ESD-899449-250MG |
Cas.: 53525-60-3 | Purity: 97% | Ethyl 1-trityl-1H-imidazole-4-carboxylate | ESD-899449-1G |
Cas.: 53525-60-3 | Purity: 97% | Ethyl 1-trityl-1H-imidazole-4-carboxylate | ESD-899449-5G |
Cas.: 1177559-63-5 | Purity: ≥95% | (3-Bromo-2-fluorophenyl)methanamine hydrochloride | ESD-899450-250MG |
Cas.: 1177559-63-5 | Purity: ≥95% | (3-Bromo-2-fluorophenyl)methanamine hydrochloride | ESD-899450-1G |
Cas.: 1177559-63-5 | Purity: ≥95% | (3-Bromo-2-fluorophenyl)methanamine hydrochloride | ESD-899450-5G |
Cas.: 871035-64-2 | Purity: 98% | 2-(4-Bromo-2,5-difluorophenyl)acetic acid | ESD-899451-250MG |
Cas.: 871035-64-2 | Purity: 98% | 2-(4-Bromo-2,5-difluorophenyl)acetic acid | ESD-899451-1G |
Cas.: 871035-64-2 | Purity: 98% | 2-(4-Bromo-2,5-difluorophenyl)acetic acid | ESD-899451-5G |
Cas.: 1245906-64-2 | Purity: ≥95% | Potassium (5-bromo-2-fluoropyridin-3-yl)trifluoroborate | ESD-899452-250MG |
Cas.: 1245906-64-2 | Purity: ≥95% | Potassium (5-bromo-2-fluoropyridin-3-yl)trifluoroborate | ESD-899452-1G |
Cas.: 1245906-64-2 | Purity: ≥95% | Potassium (5-bromo-2-fluoropyridin-3-yl)trifluoroborate | ESD-899452-5G |
Cas.: 651058-97-8 | Purity: ≥95% | 2-Chloro-5-(methoxycarbonyl)benzoic acid | ESD-899453-250MG |
Cas.: 651058-97-8 | Purity: ≥95% | 2-Chloro-5-(methoxycarbonyl)benzoic acid | ESD-899453-1G |
Cas.: 651058-97-8 | Purity: ≥95% | 2-Chloro-5-(methoxycarbonyl)benzoic acid | ESD-899453-5G |
Cas.: 336182-14-0 | Purity: ≥95% | (3R,4R)-3-Amino-4-hydroxypentanoic acid hydrochloride | ESD-899454-250MG |
Cas.: 336182-14-0 | Purity: ≥95% | (3R,4R)-3-Amino-4-hydroxypentanoic acid hydrochloride | ESD-899454-1G |
Cas.: 336182-14-0 | Purity: ≥95% | (3R,4R)-3-Amino-4-hydroxypentanoic acid hydrochloride | ESD-899454-5G |
Cas.: 1159825-25-8 | Purity: ≥95% | 4-(3-Bromophenyl)piperidine hydrochloride | ESD-899455-250MG |
Cas.: 1159825-25-8 | Purity: ≥95% | 4-(3-Bromophenyl)piperidine hydrochloride | ESD-899455-1G |
Cas.: 1159825-25-8 | Purity: ≥95% | 4-(3-Bromophenyl)piperidine hydrochloride | ESD-899455-5G |
Cas.: 13490-69-2 | Purity: 98% | (S)-3-Methyl-2-phenylbutanoic acid | ESD-899456-250MG |
Cas.: 13490-69-2 | Purity: 98% | (S)-3-Methyl-2-phenylbutanoic acid | ESD-899456-1G |
Cas.: 13490-69-2 | Purity: 98% | (S)-3-Methyl-2-phenylbutanoic acid | ESD-899456-5G |
Cas.: 702700-79-6 | Purity: 95% | (R)-5-(Pyrrolidin-2-yl)-1H-tetrazole | ESD-899457-250MG |
Cas.: 702700-79-6 | Purity: 95% | (R)-5-(Pyrrolidin-2-yl)-1H-tetrazole | ESD-899457-1G |
Cas.: 702700-79-6 | Purity: 95% | (R)-5-(Pyrrolidin-2-yl)-1H-tetrazole | ESD-899457-5G |
Cas.: 290353-57-0 | Purity: ≥95% | 1-Bromo-2-methyl-3,4-dinitrobenzene | ESD-899458-250MG |
Cas.: 290353-57-0 | Purity: ≥95% | 1-Bromo-2-methyl-3,4-dinitrobenzene | ESD-899458-1G |
Cas.: 290353-57-0 | Purity: ≥95% | 1-Bromo-2-methyl-3,4-dinitrobenzene | ESD-899458-5G |
Cas.: 220798-39-0 | Purity: 96% | (3-(Methylsulfonyl)phenyl)methanol | ESD-899459-250MG |
Cas.: 220798-39-0 | Purity: 96% | (3-(Methylsulfonyl)phenyl)methanol | ESD-899459-1G |
Cas.: 220798-39-0 | Purity: 96% | (3-(Methylsulfonyl)phenyl)methanol | ESD-899459-5G |
Cas.: 163706-58-9 | Purity: 97% | (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H- purin-9-yl)tetrahydrofuran-3,4-diol | ESD-899460-250MG |
Cas.: 163706-58-9 | Purity: 97% | (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H- purin-9-yl)tetrahydrofuran-3,4-diol | ESD-899460-1G |
Cas.: 163706-58-9 | Purity: 97% | (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H- purin-9-yl)tetrahydrofuran-3,4-diol | ESD-899460-5G |
Cas.: 1187931-81-2 | Purity: ≥95% | 1-Quinolin-5-yl-methylamine hydrochloride | ESD-899461-250MG |
Cas.: 1187931-81-2 | Purity: ≥95% | 1-Quinolin-5-yl-methylamine hydrochloride | ESD-899461-1G |
Cas.: 1187931-81-2 | Purity: ≥95% | 1-Quinolin-5-yl-methylamine hydrochloride | ESD-899461-5G |
Cas.: 1571-93-3 | Purity: 97% | 2-Methyl-1H-benzo[d]imidazol-5-amine hydrochloride | ESD-899462-250MG |
Cas.: 1571-93-3 | Purity: 97% | 2-Methyl-1H-benzo[d]imidazol-5-amine hydrochloride | ESD-899462-1G |
Cas.: 1571-93-3 | Purity: 97% | 2-Methyl-1H-benzo[d]imidazol-5-amine hydrochloride | ESD-899462-5G |
Cas.: 359586-64-4 | Purity: ≥95% | (1S,2S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid | ESD-899463-250MG |
Cas.: 42417-39-0 | Purity: 97% | 3-Aminodihydrofuran-2(3H)-one hydrochloride | ESD-899464-250MG |
Cas.: 42417-39-0 | Purity: 97% | 3-Aminodihydrofuran-2(3H)-one hydrochloride | ESD-899464-1G |
Cas.: 42417-39-0 | Purity: 97% | 3-Aminodihydrofuran-2(3H)-one hydrochloride | ESD-899464-5G |
Cas.: 163487-10-3 | Purity: 97% | Methyl (E)-3-(3-aminophenyl)acrylate | ESD-899465-250MG |
Cas.: 163487-10-3 | Purity: 97% | Methyl (E)-3-(3-aminophenyl)acrylate | ESD-899465-1G |
Cas.: 163487-10-3 | Purity: 97% | Methyl (E)-3-(3-aminophenyl)acrylate | ESD-899465-5G |
Cas.: 218609-00-8 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic acid | ESD-899466-250MG |
Cas.: 218609-00-8 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic acid | ESD-899466-1G |
Cas.: 218609-00-8 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-fluorophenyl)butanoic acid | ESD-899466-5G |
Cas.: 423165-07-5 | Purity: ≥95% | exo-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane | ESD-899467-250MG |
Cas.: 423165-07-5 | Purity: ≥95% | exo-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane | ESD-899467-1G |
Cas.: 423165-07-5 | Purity: ≥95% | exo-3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane | ESD-899467-5G |
Cas.: 1023357-63-2 | Purity: ≥95% | Potassium trifluoro(3-methoxy-3-oxopropyl)borate | ESD-899468-250MG |
Cas.: 1023357-63-2 | Purity: ≥95% | Potassium trifluoro(3-methoxy-3-oxopropyl)borate | ESD-899468-1G |
Cas.: 1023357-63-2 | Purity: ≥95% | Potassium trifluoro(3-methoxy-3-oxopropyl)borate | ESD-899468-5G |
Cas.: 220497-67-6 | Purity: ≥95% | (1R,3S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid | ESD-899469-250MG |
Cas.: 133256-51-6 | Purity: 97% | 4-(4-Chlorophenyl)pyrimidin-2-amine | ESD-899470-250MG |
Cas.: 133256-51-6 | Purity: 97% | 4-(4-Chlorophenyl)pyrimidin-2-amine | ESD-899470-1G |
Cas.: 133256-51-6 | Purity: 97% | 4-(4-Chlorophenyl)pyrimidin-2-amine | ESD-899470-5G |
Cas.: 210992-56-6 | Purity: 95% | 2-Fluoro-3-(methylthio)pyridine | ESD-899471-250MG |
Cas.: 210992-56-6 | Purity: 95% | 2-Fluoro-3-(methylthio)pyridine | ESD-899471-1G |
Cas.: 210992-56-6 | Purity: 95% | 2-Fluoro-3-(methylthio)pyridine | ESD-899471-5G |
Cas.: 203186-56-5 | Purity: 97% | (E)-Methyl 2-((dimethylamino)methylene)-3-oxobutanoate | ESD-899472-250MG |
Cas.: 203186-56-5 | Purity: 97% | (E)-Methyl 2-((dimethylamino)methylene)-3-oxobutanoate | ESD-899472-1G |
Cas.: 203186-56-5 | Purity: 97% | (E)-Methyl 2-((dimethylamino)methylene)-3-oxobutanoate | ESD-899472-5G |
Cas.: 1000341-02-5 | Purity: 98% | 6-Chloro-5-methyl-1H-indazole | ESD-899473-250MG |
Cas.: 1000341-02-5 | Purity: 98% | 6-Chloro-5-methyl-1H-indazole | ESD-899473-1G |
Cas.: 1000341-02-5 | Purity: 98% | 6-Chloro-5-methyl-1H-indazole | ESD-899473-5G |
Cas.: 206564-00-3 | Purity: ≥95% | 4-(2-Furyl)pyrimidin-2-amine | ESD-899474-250MG |
Cas.: 206564-00-3 | Purity: ≥95% | 4-(2-Furyl)pyrimidin-2-amine | ESD-899474-1G |
Cas.: 206564-00-3 | Purity: ≥95% | 4-(2-Furyl)pyrimidin-2-amine | ESD-899474-5G |
Cas.: 876617-06-0 | Purity: 97% | (R)-tert-Butyl 2-ethylpyrrolidine-1-carboxylate | ESD-899475-250MG |
Cas.: 876617-06-0 | Purity: 97% | (R)-tert-Butyl 2-ethylpyrrolidine-1-carboxylate | ESD-899475-1G |
Cas.: 876617-06-0 | Purity: 97% | (R)-tert-Butyl 2-ethylpyrrolidine-1-carboxylate | ESD-899475-5G |
Cas.: 116106-16-2 | Purity: 97% | 5-Bromo-6-methyl-1H-benzo[d]imidazole | ESD-899476-250MG |
Cas.: 116106-16-2 | Purity: 97% | 5-Bromo-6-methyl-1H-benzo[d]imidazole | ESD-899476-1G |
Cas.: 116106-16-2 | Purity: 97% | 5-Bromo-6-methyl-1H-benzo[d]imidazole | ESD-899476-5G |
Cas.: 785777-92-6 | Purity: 97% | 5-Bromo-2-chloro-4-(trifluoromethyl)pyrimidine | ESD-899477-250MG |
Cas.: 785777-92-6 | Purity: 97% | 5-Bromo-2-chloro-4-(trifluoromethyl)pyrimidine | ESD-899477-1G |
Cas.: 785777-92-6 | Purity: 97% | 5-Bromo-2-chloro-4-(trifluoromethyl)pyrimidine | ESD-899477-5G |
Cas.: 1026796-81-5 | Purity: ≥95% | N-(4-Bromopyridin-2-yl)acetamide | ESD-899478-250MG |
Cas.: 1026796-81-5 | Purity: ≥95% | N-(4-Bromopyridin-2-yl)acetamide | ESD-899478-1G |
Cas.: 1026796-81-5 | Purity: ≥95% | N-(4-Bromopyridin-2-yl)acetamide | ESD-899478-5G |
Cas.: 848952-83-0 | Purity: 98% | 5-Chloropyrazine-2-carboxylic acid hydrazide | ESD-899479-250MG |
Cas.: 848952-83-0 | Purity: 98% | 5-Chloropyrazine-2-carboxylic acid hydrazide | ESD-899479-1G |
Cas.: 848952-83-0 | Purity: 98% | 5-Chloropyrazine-2-carboxylic acid hydrazide | ESD-899479-5G |
Cas.: 103275-21-4 | Purity: ≥95% | 3-Bromo-4-(tert-butyl)aniline | ESD-899480-250MG |
Cas.: 103275-21-4 | Purity: ≥95% | 3-Bromo-4-(tert-butyl)aniline | ESD-899480-1G |
Cas.: 103275-21-4 | Purity: ≥95% | 3-Bromo-4-(tert-butyl)aniline | ESD-899480-5G |
Cas.: 270063-51-9 | Purity: 97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(3,4-dichlorophenyl)butanoic acid | ESD-899481-250MG |
Cas.: 270063-51-9 | Purity: 97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(3,4-dichlorophenyl)butanoic acid | ESD-899481-1G |
Cas.: 270063-51-9 | Purity: 97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(3,4-dichlorophenyl)butanoic acid | ESD-899481-5G |
Cas.: 861368-85-6 | Purity: 97% | 5-Methyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-899482-250MG |
Cas.: 861368-85-6 | Purity: 97% | 5-Methyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-899482-1G |
Cas.: 861368-85-6 | Purity: 97% | 5-Methyl-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-899482-5G |
Cas.: 1170936-92-1 | Purity: ≥95% | 3-(Pyridin-2-yl)aniline dihydrochloride | ESD-899483-250MG |
Cas.: 1170936-92-1 | Purity: ≥95% | 3-(Pyridin-2-yl)aniline dihydrochloride | ESD-899483-1G |
Cas.: 1170936-92-1 | Purity: ≥95% | 3-(Pyridin-2-yl)aniline dihydrochloride | ESD-899483-5G |
Cas.: 110782-31-5 | Purity: 97% | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3- yl (2-cyanoethyl) diisopropylphosphoramidite | ESD-899484-250MG |
Cas.: 110782-31-5 | Purity: 97% | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3- yl (2-cyanoethyl) diisopropylphosphoramidite | ESD-899484-1G |
Cas.: 110782-31-5 | Purity: 97% | (2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3- yl (2-cyanoethyl) diisopropylphosphoramidite | ESD-899484-5G |
Cas.: 902772-13-8 | Purity: 95% | 5-Bromo-1H-indole-2-carbonitrile | ESD-899485-250MG |
Cas.: 902772-13-8 | Purity: 95% | 5-Bromo-1H-indole-2-carbonitrile | ESD-899485-1G |
Cas.: 902772-13-8 | Purity: 95% | 5-Bromo-1H-indole-2-carbonitrile | ESD-899485-5G |
Cas.: 1093759-80-8 | Purity: 95% | tert-Butyl 4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate | ESD-899486-250MG |
Cas.: 1093759-80-8 | Purity: 95% | tert-Butyl 4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate | ESD-899486-1G |
Cas.: 1093759-80-8 | Purity: 95% | tert-Butyl 4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate | ESD-899486-5G |
Cas.: 66016-28-2 | Purity: 97% | 3-Phenylcyclobutanecarboxylic acid | ESD-899487-250MG |
Cas.: 66016-28-2 | Purity: 97% | 3-Phenylcyclobutanecarboxylic acid | ESD-899487-1G |
Cas.: 66016-28-2 | Purity: 97% | 3-Phenylcyclobutanecarboxylic acid | ESD-899487-5G |
Cas.: 5835-79-0 | Purity: ≥95% | 4-Morpholinobutan-1-ol | ESD-899488-250MG |
Cas.: 5835-79-0 | Purity: ≥95% | 4-Morpholinobutan-1-ol | ESD-899488-1G |
Cas.: 5835-79-0 | Purity: ≥95% | 4-Morpholinobutan-1-ol | ESD-899488-5G |
Cas.: 135355-96-3 | Purity: ≥95% | (E)-4-(tert-Butoxy)-4-oxobut-2-enoic acid | ESD-899489-250MG |
Cas.: 135355-96-3 | Purity: ≥95% | (E)-4-(tert-Butoxy)-4-oxobut-2-enoic acid | ESD-899489-1G |
Cas.: 135355-96-3 | Purity: ≥95% | (E)-4-(tert-Butoxy)-4-oxobut-2-enoic acid | ESD-899489-5G |
Cas.: 149978-43-8 | Purity: 95% | 2-Methyl-5-trifluoromethyl-2H-pyrazol-3-ylamine | ESD-899490-250MG |
Cas.: 149978-43-8 | Purity: 95% | 2-Methyl-5-trifluoromethyl-2H-pyrazol-3-ylamine | ESD-899490-1G |
Cas.: 149978-43-8 | Purity: 95% | 2-Methyl-5-trifluoromethyl-2H-pyrazol-3-ylamine | ESD-899490-5G |
Cas.: 135248-89-4 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-mercaptopropanoic acid | ESD-899491-250MG |
Cas.: 135248-89-4 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-mercaptopropanoic acid | ESD-899491-1G |
Cas.: 135248-89-4 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-mercaptopropanoic acid | ESD-899491-5G |
Cas.: 174913-20-3 | Purity: 98% | 2-Bromo-1,3-dichloro-5-methoxybenzene | ESD-899492-250MG |
Cas.: 174913-20-3 | Purity: 98% | 2-Bromo-1,3-dichloro-5-methoxybenzene | ESD-899492-1G |
Cas.: 174913-20-3 | Purity: 98% | 2-Bromo-1,3-dichloro-5-methoxybenzene | ESD-899492-5G |
Cas.: 879648-22-3 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane | ESD-899493-250MG |
Cas.: 879648-22-3 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane | ESD-899493-1G |
Cas.: 879648-22-3 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane | ESD-899493-5G |
Cas.: 13019-32-4 | Purity: ≥95% | 7-Bromoquinolin-8-ol | ESD-899494-250MG |
Cas.: 13019-32-4 | Purity: ≥95% | 7-Bromoquinolin-8-ol | ESD-899494-1G |
Cas.: 13019-32-4 | Purity: ≥95% | 7-Bromoquinolin-8-ol | ESD-899494-5G |
Cas.: 61098-37-1 | Purity: ≥95% | Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-5-carboxylate | ESD-899495-250MG |
Cas.: 61098-37-1 | Purity: ≥95% | Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-5-carboxylate | ESD-899495-1G |
Cas.: 61098-37-1 | Purity: ≥95% | Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-5-carboxylate | ESD-899495-5G |
Cas.: 131109-75-6 | Purity: ≥95% | 1-(3-Chloropyridin-2-yl)ethanone | ESD-899496-250MG |
Cas.: 131109-75-6 | Purity: ≥95% | 1-(3-Chloropyridin-2-yl)ethanone | ESD-899496-1G |
Cas.: 131109-75-6 | Purity: ≥95% | 1-(3-Chloropyridin-2-yl)ethanone | ESD-899496-5G |
Cas.: 136516-64-8 | Purity: 97% | 2,4-Difluoro-6-hydroxybenzaldehyde | ESD-899497-250MG |
Cas.: 136516-64-8 | Purity: 97% | 2,4-Difluoro-6-hydroxybenzaldehyde | ESD-899497-1G |
Cas.: 136516-64-8 | Purity: 97% | 2,4-Difluoro-6-hydroxybenzaldehyde | ESD-899497-5G |
Cas.: 1260850-70-1 | Purity: ≥95% | 3-Bromoimidazo[1,2-b]pyridazin-6-ylamine | ESD-899498-250MG |
Cas.: 1260850-70-1 | Purity: ≥95% | 3-Bromoimidazo[1,2-b]pyridazin-6-ylamine | ESD-899498-1G |
Cas.: 1260850-70-1 | Purity: ≥95% | 3-Bromoimidazo[1,2-b]pyridazin-6-ylamine | ESD-899498-5G |
Cas.: 149765-16-2 | Purity: ≥95% | N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-899499-250MG |
Cas.: 149765-16-2 | Purity: ≥95% | N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-899499-1G |
Cas.: 149765-16-2 | Purity: ≥95% | N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | ESD-899499-5G |
Cas.: 1153950-49-2 | Purity: ≥95% | (S)-Pyrrolidine-3-carbonitrile hydrochloride | ESD-899500-250MG |
Cas.: 1153950-49-2 | Purity: ≥95% | (S)-Pyrrolidine-3-carbonitrile hydrochloride | ESD-899500-1G |
Cas.: 1153950-49-2 | Purity: ≥95% | (S)-Pyrrolidine-3-carbonitrile hydrochloride | ESD-899500-5G |
Cas.: 28036-31-9 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-3-amine | ESD-899501-250MG |
Cas.: 28036-31-9 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-3-amine | ESD-899501-1G |
Cas.: 28036-31-9 | Purity: 95% | 2-Methylimidazo[1,2-a]pyridin-3-amine | ESD-899501-5G |
Cas.: 189089-90-5 | Purity: 97% | 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | ESD-899502-250MG |
Cas.: 189089-90-5 | Purity: 97% | 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | ESD-899502-1G |
Cas.: 189089-90-5 | Purity: 97% | 1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | ESD-899502-5G |
Cas.: 98592-34-8 | Purity: 95% | Methyl 2-chloro-4-cyanobenzoate | ESD-899503-250MG |
Cas.: 98592-34-8 | Purity: 95% | Methyl 2-chloro-4-cyanobenzoate | ESD-899503-1G |
Cas.: 98592-34-8 | Purity: 95% | Methyl 2-chloro-4-cyanobenzoate | ESD-899503-5G |
Cas.: 914222-86-9 | Purity: 97% | 6-Chloro-2-methoxypyridin-3-amine | ESD-899504-250MG |
Cas.: 914222-86-9 | Purity: 97% | 6-Chloro-2-methoxypyridin-3-amine | ESD-899504-1G |
Cas.: 914222-86-9 | Purity: 97% | 6-Chloro-2-methoxypyridin-3-amine | ESD-899504-5G |
Cas.: 10397-15-6 | Purity: ≥95% | 4,6-Dichloro-N-methylpyrimidin-2-amine | ESD-899505-250MG |
Cas.: 10397-15-6 | Purity: ≥95% | 4,6-Dichloro-N-methylpyrimidin-2-amine | ESD-899505-1G |
Cas.: 10397-15-6 | Purity: ≥95% | 4,6-Dichloro-N-methylpyrimidin-2-amine | ESD-899505-5G |
Cas.: 2346-73-8 | Purity: ≥95% | 2-Chloro-9-methyl-9H-purine | ESD-899506-250MG |
Cas.: 2346-73-8 | Purity: ≥95% | 2-Chloro-9-methyl-9H-purine | ESD-899506-1G |
Cas.: 2346-73-8 | Purity: ≥95% | 2-Chloro-9-methyl-9H-purine | ESD-899506-5G |
Cas.: 1171381-49-9 | Purity: 97% | (4-Bromo-2-methylphenyl)methanamine hydrochloride | ESD-899507-250MG |
Cas.: 1171381-49-9 | Purity: 97% | (4-Bromo-2-methylphenyl)methanamine hydrochloride | ESD-899507-1G |
Cas.: 1171381-49-9 | Purity: 97% | (4-Bromo-2-methylphenyl)methanamine hydrochloride | ESD-899507-5G |
Cas.: 1288978-82-4 | Purity: 97% | 2-(4-Fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899508-250MG |
Cas.: 1288978-82-4 | Purity: 97% | 2-(4-Fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899508-1G |
Cas.: 1288978-82-4 | Purity: 97% | 2-(4-Fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899508-5G |
Cas.: 1167055-55-1 | Purity: 97% | 4-Bromo-1H-indazole-3-carbonitrile | ESD-899509-250MG |
Cas.: 1167055-55-1 | Purity: 97% | 4-Bromo-1H-indazole-3-carbonitrile | ESD-899509-1G |
Cas.: 54781-93-0 | Purity: ≥95% | Dimethyl 1H-indole-2,3-dicarboxylate | ESD-899510-250MG |
Cas.: 54781-93-0 | Purity: ≥95% | Dimethyl 1H-indole-2,3-dicarboxylate | ESD-899510-1G |
Cas.: 54781-93-0 | Purity: ≥95% | Dimethyl 1H-indole-2,3-dicarboxylate | ESD-899510-5G |
Cas.: 87720-55-6 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpent-4-enoic acid | ESD-899511-250MG |
Cas.: 87720-55-6 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpent-4-enoic acid | ESD-899511-1G |
Cas.: 87720-55-6 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpent-4-enoic acid | ESD-899511-5G |
Cas.: 64214-66-0 | Purity: ≥95% | 4-Chloro-N-methoxy-N-methylbutanamide | ESD-899512-250MG |
Cas.: 64214-66-0 | Purity: ≥95% | 4-Chloro-N-methoxy-N-methylbutanamide | ESD-899512-1G |
Cas.: 64214-66-0 | Purity: ≥95% | 4-Chloro-N-methoxy-N-methylbutanamide | ESD-899512-5G |
Cas.: 1016258-69-7 | Purity: 97% | 1-tert-Butyl 4-ethyl 4-(aminomethyl)piperidine-1,4-dicarboxylate | ESD-899513-250MG |
Cas.: 1016258-69-7 | Purity: 97% | 1-tert-Butyl 4-ethyl 4-(aminomethyl)piperidine-1,4-dicarboxylate | ESD-899513-1G |
Cas.: 1016258-69-7 | Purity: 97% | 1-tert-Butyl 4-ethyl 4-(aminomethyl)piperidine-1,4-dicarboxylate | ESD-899513-5G |
Cas.: 496031-57-3 | Purity: ≥95% | (R)-5-(Chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | ESD-899514-250MG |
Cas.: 496031-57-3 | Purity: ≥95% | (R)-5-(Chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | ESD-899514-1G |
Cas.: 58914-40-2 | Purity: 95% | 4-(Bromomethyl)benzamide | ESD-899515-250MG |
Cas.: 58914-40-2 | Purity: 95% | 4-(Bromomethyl)benzamide | ESD-899515-1G |
Cas.: 58914-40-2 | Purity: 95% | 4-(Bromomethyl)benzamide | ESD-899515-5G |
Cas.: 1150271-74-1 | Purity: ≥95% | 2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899516-250MG |
Cas.: 1150271-74-1 | Purity: ≥95% | 2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899516-1G |
Cas.: 1150271-74-1 | Purity: ≥95% | 2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-899516-5G |
Cas.: 1234616-67-1 | Purity: ≥95% | 1H-Pyrazolo[3,4-b]pyridine-5-carbonitrile | ESD-899517-250MG |
Cas.: 1234616-67-1 | Purity: ≥95% | 1H-Pyrazolo[3,4-b]pyridine-5-carbonitrile | ESD-899517-1G |
Cas.: 1234616-67-1 | Purity: ≥95% | 1H-Pyrazolo[3,4-b]pyridine-5-carbonitrile | ESD-899517-5G |
Cas.: 112342-72-0 | Purity: 97% | 6-Bromothiazolo[4,5-b]pyrazin-2-amine | ESD-899518-250MG |
Cas.: 112342-72-0 | Purity: 97% | 6-Bromothiazolo[4,5-b]pyrazin-2-amine | ESD-899518-1G |
Cas.: 112342-72-0 | Purity: 97% | 6-Bromothiazolo[4,5-b]pyrazin-2-amine | ESD-899518-5G |
Cas.: 121507-34-4 | Purity: 97% | 5-Isopropoxy-1H-pyrazol-3-amine | ESD-899519-250MG |
Cas.: 121507-34-4 | Purity: 97% | 5-Isopropoxy-1H-pyrazol-3-amine | ESD-899519-1G |
Cas.: 121507-34-4 | Purity: 97% | 5-Isopropoxy-1H-pyrazol-3-amine | ESD-899519-5G |
Cas.: 130754-19-7 | Purity: 95% | Ethyl 2-(4-Chlorophenyl)-2,2-difluoroacetate | ESD-899520-250MG |
Cas.: 130754-19-7 | Purity: 95% | Ethyl 2-(4-Chlorophenyl)-2,2-difluoroacetate | ESD-899520-1G |
Cas.: 130754-19-7 | Purity: 95% | Ethyl 2-(4-Chlorophenyl)-2,2-difluoroacetate | ESD-899520-5G |
Cas.: 943442-96-4 | Purity: ≥95% | (R)-(4-Benzylmorpholin-2-yl)methanol | ESD-899521-250MG |
Cas.: 943442-96-4 | Purity: ≥95% | (R)-(4-Benzylmorpholin-2-yl)methanol | ESD-899521-1G |
Cas.: 943442-96-4 | Purity: ≥95% | (R)-(4-Benzylmorpholin-2-yl)methanol | ESD-899521-5G |
Cas.: 6850-65-3 | Purity: ≥98%, cis-trans mixed isomerism | 4-Aminocyclohexan-1-ol | ESD-899522-250MG |
Cas.: 6850-65-3 | Purity: ≥98%, cis-trans mixed isomerism | 4-Aminocyclohexan-1-ol | ESD-899522-1G |
Cas.: 6850-65-3 | Purity: ≥98%, cis-trans mixed isomerism | 4-Aminocyclohexan-1-ol | ESD-899522-5G |
Cas.: 134856-58-9 | Purity: ≥95% | ((4-Iodophenyl)ethynyl)trimethylsilane | ESD-899523-250MG |
Cas.: 134856-58-9 | Purity: ≥95% | ((4-Iodophenyl)ethynyl)trimethylsilane | ESD-899523-1G |
Cas.: 134856-58-9 | Purity: ≥95% | ((4-Iodophenyl)ethynyl)trimethylsilane | ESD-899523-5G |
Cas.: 99767-45-0 | Purity: 97% | 2-Amino-5-cyanobenzoic acid | ESD-899524-250MG |
Cas.: 99767-45-0 | Purity: 97% | 2-Amino-5-cyanobenzoic acid | ESD-899524-1G |
Cas.: 99767-45-0 | Purity: 97% | 2-Amino-5-cyanobenzoic acid | ESD-899524-5G |
Cas.: 741737-30-4 | Purity: 95% | tert-Butyl 2-methyl-3-oxopiperidine-1-carboxylate | ESD-899525-250MG |
Cas.: 741737-30-4 | Purity: 95% | tert-Butyl 2-methyl-3-oxopiperidine-1-carboxylate | ESD-899525-1G |
Cas.: 741737-30-4 | Purity: 95% | tert-Butyl 2-methyl-3-oxopiperidine-1-carboxylate | ESD-899525-5G |
Cas.: 110256-15-0 | Purity: ≥95% | 5-Cyclopropylisoxazole-3-carboxylic acid | ESD-899526-250MG |
Cas.: 110256-15-0 | Purity: ≥95% | 5-Cyclopropylisoxazole-3-carboxylic acid | ESD-899526-1G |
Cas.: 110256-15-0 | Purity: ≥95% | 5-Cyclopropylisoxazole-3-carboxylic acid | ESD-899526-5G |
Cas.: 385432-46-2 | Purity: 97% | 2-Chlorobenzo[d]thiazole-5-carbonitrile | ESD-899527-250MG |
Cas.: 385432-46-2 | Purity: 97% | 2-Chlorobenzo[d]thiazole-5-carbonitrile | ESD-899527-1G |
Cas.: 385432-46-2 | Purity: 97% | 2-Chlorobenzo[d]thiazole-5-carbonitrile | ESD-899527-5G |
Cas.: 75291-85-9 | Purity: ≥95% | 5-Bromo-2-chloronicotinamide | ESD-899528-250MG |
Cas.: 75291-85-9 | Purity: ≥95% | 5-Bromo-2-chloronicotinamide | ESD-899528-1G |
Cas.: 75291-85-9 | Purity: ≥95% | 5-Bromo-2-chloronicotinamide | ESD-899528-5G |
Cas.: 1246471-38-4 | Purity: 95% | Ethyl 3-Cyclopropylpyrazole-4-carboxylate | ESD-899529-250MG |
Cas.: 1246471-38-4 | Purity: 95% | Ethyl 3-Cyclopropylpyrazole-4-carboxylate | ESD-899529-1G |
Cas.: 1246471-38-4 | Purity: 95% | Ethyl 3-Cyclopropylpyrazole-4-carboxylate | ESD-899529-5G |
Cas.: 25090-33-9 | Purity: 98% | 3,4-Dihydro-2H-pyran-5-carbaldehyde | ESD-899530-250MG |
Cas.: 25090-33-9 | Purity: 98% | 3,4-Dihydro-2H-pyran-5-carbaldehyde | ESD-899530-1G |
Cas.: 25090-33-9 | Purity: 98% | 3,4-Dihydro-2H-pyran-5-carbaldehyde | ESD-899530-5G |
Cas.: 56440-28-9 | Purity: 98% | (S)-3-Amino-2-pyrrolidinone Hydrochloride | ESD-899531-250MG |
Cas.: 56440-28-9 | Purity: 98% | (S)-3-Amino-2-pyrrolidinone Hydrochloride | ESD-899531-1G |
Cas.: 56440-28-9 | Purity: 98% | (S)-3-Amino-2-pyrrolidinone Hydrochloride | ESD-899531-5G |
Cas.: 205059-24-1 | Purity: 95% | tert-Butyl 4-(piperidin-4-yl)piperazine-1-carboxylate | ESD-899532-250MG |
Cas.: 205059-24-1 | Purity: 95% | tert-Butyl 4-(piperidin-4-yl)piperazine-1-carboxylate | ESD-899532-1G |
Cas.: 205059-24-1 | Purity: 95% | tert-Butyl 4-(piperidin-4-yl)piperazine-1-carboxylate | ESD-899532-5G |
Cas.: 138500-88-6 | Purity: 95% | (4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-899533-250MG |
Cas.: 138500-88-6 | Purity: 95% | (4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-899533-1G |
Cas.: 138500-88-6 | Purity: 95% | (4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-899533-5G |
Cas.: 178813-78-0 | Purity: 97% | 2,6-Dichloro-3-fluorobenzoic acid | ESD-899534-250MG |
Cas.: 178813-78-0 | Purity: 97% | 2,6-Dichloro-3-fluorobenzoic acid | ESD-899534-1G |
Cas.: 178813-78-0 | Purity: 97% | 2,6-Dichloro-3-fluorobenzoic acid | ESD-899534-5G |
Cas.: 943541-20-6 | Purity: ≥95% | 3-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyridazine | ESD-899535-250MG |
Cas.: 943541-20-6 | Purity: ≥95% | 3-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyridazine | ESD-899535-1G |
Cas.: 943541-20-6 | Purity: ≥95% | 3-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyridazine | ESD-899535-5G |
Cas.: 171919-37-2 | Purity: ≥95% | 1-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-899536-250MG |
Cas.: 171919-37-2 | Purity: ≥95% | 1-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-899536-1G |
Cas.: 171919-37-2 | Purity: ≥95% | 1-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | ESD-899536-5G |
Cas.: 20254-76-6 | Purity: 98% | 3-Chloroquinoxaline-2-carboxylic acid | ESD-899537-250MG |
Cas.: 20254-76-6 | Purity: 98% | 3-Chloroquinoxaline-2-carboxylic acid | ESD-899537-1G |
Cas.: 20254-76-6 | Purity: 98% | 3-Chloroquinoxaline-2-carboxylic acid | ESD-899537-5G |
Cas.: 220060-08-2 | Purity: 97% | (S)-Methyl 2-methylpyrrolidine-2-carboxylate hydrochloride | ESD-899538-250MG |
Cas.: 220060-08-2 | Purity: 97% | (S)-Methyl 2-methylpyrrolidine-2-carboxylate hydrochloride | ESD-899538-1G |
Cas.: 220060-08-2 | Purity: 97% | (S)-Methyl 2-methylpyrrolidine-2-carboxylate hydrochloride | ESD-899538-5G |
Cas.: 186393-21-5 | Purity: 98% | cis-Pyrrolidine-3,4-diol hydrochloride | ESD-899539-250MG |
Cas.: 186393-21-5 | Purity: 98% | cis-Pyrrolidine-3,4-diol hydrochloride | ESD-899539-1G |
Cas.: 186393-21-5 | Purity: 98% | cis-Pyrrolidine-3,4-diol hydrochloride | ESD-899539-5G |
Cas.: 1190927-76-4 | Purity: 98% | 7-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-899540-250MG |
Cas.: 1190927-76-4 | Purity: 98% | 7-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-899540-1G |
Cas.: 1190927-76-4 | Purity: 98% | 7-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine | ESD-899540-5G |
Cas.: 1195901-53-1 | Purity: 96% | 7-Bromo-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-899541-250MG |
Cas.: 1195901-53-1 | Purity: 96% | 7-Bromo-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-899541-1G |
Cas.: 1195901-53-1 | Purity: 96% | 7-Bromo-1,2,3,4-tetrahydroquinoline hydrochloride | ESD-899541-5G |
Cas.: 1245906-70-0 | Purity: 97% | Potassium (2-chloropyrimidin-5-yl)trifluoroborate | ESD-899542-250MG |
Cas.: 1245906-70-0 | Purity: 97% | Potassium (2-chloropyrimidin-5-yl)trifluoroborate | ESD-899542-1G |
Cas.: 1245906-70-0 | Purity: 97% | Potassium (2-chloropyrimidin-5-yl)trifluoroborate | ESD-899542-5G |
Cas.: 150192-39-5 | Purity: 95% | (2-Bromo-5-methoxyphenyl)methanol | ESD-899543-250MG |
Cas.: 150192-39-5 | Purity: 95% | (2-Bromo-5-methoxyphenyl)methanol | ESD-899543-1G |
Cas.: 150192-39-5 | Purity: 95% | (2-Bromo-5-methoxyphenyl)methanol | ESD-899543-5G |
Cas.: 274-85-1 | Purity: 97% | [1,2,4]Triazolo[1,5-a]pyridine | ESD-899544-250MG |
Cas.: 274-85-1 | Purity: 97% | [1,2,4]Triazolo[1,5-a]pyridine | ESD-899544-1G |
Cas.: 274-85-1 | Purity: 97% | [1,2,4]Triazolo[1,5-a]pyridine | ESD-899544-5G |
Cas.: 325486-45-1 | Purity: 96% | tert-Butyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-899545-250MG |
Cas.: 325486-45-1 | Purity: 96% | tert-Butyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-899545-1G |
Cas.: 325486-45-1 | Purity: 96% | tert-Butyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-899545-5G |
Cas.: 78155-76-7 | Purity: 95% | 5-Nitro-1H-indazole-3-carboxylic acid | ESD-899546-250MG |
Cas.: 78155-76-7 | Purity: 95% | 5-Nitro-1H-indazole-3-carboxylic acid | ESD-899546-1G |
Cas.: 78155-76-7 | Purity: 95% | 5-Nitro-1H-indazole-3-carboxylic acid | ESD-899546-5G |
Cas.: 1207174-85-3 | Purity: ≥95% | 7-Bromo-3H-imidazo[4,5-b]pyridine | ESD-899547-250MG |
Cas.: 1207174-85-3 | Purity: ≥95% | 7-Bromo-3H-imidazo[4,5-b]pyridine | ESD-899547-1G |
Cas.: 1207174-85-3 | Purity: ≥95% | 7-Bromo-3H-imidazo[4,5-b]pyridine | ESD-899547-5G |
Cas.: 861928-26-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzaldehyde | ESD-899548-250MG |
Cas.: 861928-26-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzaldehyde | ESD-899548-1G |
Cas.: 861928-26-9 | Purity: 97% | 4-Bromo-5-fluoro-2-methylbenzaldehyde | ESD-899548-5G |
Cas.: 187949-90-2 | Purity: ≥95% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carboxylic acid | ESD-899549-250MG |
Cas.: 187949-90-2 | Purity: ≥95% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carboxylic acid | ESD-899549-1G |
Cas.: 187949-90-2 | Purity: ≥95% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carboxylic acid | ESD-899549-5G |
Cas.: 141106-23-2 | Purity: 97% | 8-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-899550-250MG |
Cas.: 141106-23-2 | Purity: 97% | 8-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-899550-1G |
Cas.: 141106-23-2 | Purity: 97% | 8-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-899550-5G |
Cas.: 178033-78-8 | Purity: ≥95% | (S)-1-Cyclopropylethanamine hydrochloride | ESD-899551-250MG |
Cas.: 178033-78-8 | Purity: ≥95% | (S)-1-Cyclopropylethanamine hydrochloride | ESD-899551-1G |
Cas.: 178033-78-8 | Purity: ≥95% | (S)-1-Cyclopropylethanamine hydrochloride | ESD-899551-5G |
Cas.: 916210-98-5 | Purity: ≥95% | (2-Chloropyridin-4-yl)methanamine hydrochloride | ESD-899552-250MG |
Cas.: 916210-98-5 | Purity: ≥95% | (2-Chloropyridin-4-yl)methanamine hydrochloride | ESD-899552-1G |
Cas.: 916210-98-5 | Purity: ≥95% | (2-Chloropyridin-4-yl)methanamine hydrochloride | ESD-899552-5G |
Cas.: 40019-21-4 | Purity: 95% | Ethyl 3-methyl-1,2,4-oxadiazole-5-carboxylate | ESD-899553-250MG |
Cas.: 40019-21-4 | Purity: 95% | Ethyl 3-methyl-1,2,4-oxadiazole-5-carboxylate | ESD-899553-1G |
Cas.: 40019-21-4 | Purity: 95% | Ethyl 3-methyl-1,2,4-oxadiazole-5-carboxylate | ESD-899553-5G |
Cas.: 1122-63-0 | Purity: 97% | 1-(Pyridazin-3-yl)ethanone | ESD-899554-250MG |
Cas.: 1122-63-0 | Purity: 97% | 1-(Pyridazin-3-yl)ethanone | ESD-899554-1G |
Cas.: 1122-63-0 | Purity: 97% | 1-(Pyridazin-3-yl)ethanone | ESD-899554-5G |
Cas.: 134575-07-8 | Purity: ≥95% | ((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol | ESD-899555-250MG |
Cas.: 134575-07-8 | Purity: ≥95% | ((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol | ESD-899555-1G |
Cas.: 134575-07-8 | Purity: ≥95% | ((1R,5S,6R)-3-Benzyl-3-azabicyclo[3.1.0]hexan-6-yl)methanol | ESD-899555-5G |
Cas.: 87029-84-3 | Purity: 95% | 5-Amino-2-hydroxybenzonitrile | ESD-899556-250MG |
Cas.: 87029-84-3 | Purity: 95% | 5-Amino-2-hydroxybenzonitrile | ESD-899556-1G |
Cas.: 87029-84-3 | Purity: 95% | 5-Amino-2-hydroxybenzonitrile | ESD-899556-5G |
Cas.: 6027-15-2 | Purity: 96% | (2R,2’R)-4,4′-Disulfanediylbis(2-aminobutanoic acid) | ESD-899557-250MG |
Cas.: 6027-15-2 | Purity: 96% | (2R,2’R)-4,4′-Disulfanediylbis(2-aminobutanoic acid) | ESD-899557-1G |
Cas.: 6027-15-2 | Purity: 96% | (2R,2’R)-4,4′-Disulfanediylbis(2-aminobutanoic acid) | ESD-899557-5G |
Cas.: 103382-84-9 | Purity: 97% | (S)-Pyrrolidin-2-ylmethanamine dihydrochloride | ESD-899558-250MG |
Cas.: 103382-84-9 | Purity: 97% | (S)-Pyrrolidin-2-ylmethanamine dihydrochloride | ESD-899558-1G |
Cas.: 103382-84-9 | Purity: 97% | (S)-Pyrrolidin-2-ylmethanamine dihydrochloride | ESD-899558-5G |
Cas.: 57224-50-7 | Purity: ≥95% | (S)-2-Amino-4,4-dimethylpentanoic acid | ESD-899559-250MG |
Cas.: 57224-50-7 | Purity: ≥95% | (S)-2-Amino-4,4-dimethylpentanoic acid | ESD-899559-1G |
Cas.: 57224-50-7 | Purity: ≥95% | (S)-2-Amino-4,4-dimethylpentanoic acid | ESD-899559-5G |
Cas.: 909186-56-7 | Purity: 97% | 2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride | ESD-899560-250MG |
Cas.: 909186-56-7 | Purity: 97% | 2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride | ESD-899560-1G |
Cas.: 909186-56-7 | Purity: 97% | 2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride | ESD-899560-5G |
Cas.: 683233-14-9 | Purity: 95% | (R)-tert-Butyl 2-(aminomethyl)piperidine-1-carboxylate | ESD-899561-250MG |
Cas.: 683233-14-9 | Purity: 95% | (R)-tert-Butyl 2-(aminomethyl)piperidine-1-carboxylate | ESD-899561-1G |
Cas.: 683233-14-9 | Purity: 95% | (R)-tert-Butyl 2-(aminomethyl)piperidine-1-carboxylate | ESD-899561-5G |
Cas.: 489446-42-6 | Purity: 95% | (4-(((tert-Butoxycarbonyl)amino)methyl)phenyl)boronic acid | ESD-899562-250MG |
Cas.: 489446-42-6 | Purity: 95% | (4-(((tert-Butoxycarbonyl)amino)methyl)phenyl)boronic acid | ESD-899562-1G |
Cas.: 489446-42-6 | Purity: 95% | (4-(((tert-Butoxycarbonyl)amino)methyl)phenyl)boronic acid | ESD-899562-5G |
Cas.: 913835-63-9 | Purity: 97% | Imidazo[1,2-a]pyridine-6-boronic acid | ESD-899563-100MG |
Cas.: 913835-63-9 | Purity: 97% | Imidazo[1,2-a]pyridine-6-boronic acid | ESD-899563-1G |
Cas.: 913835-63-9 | Purity: 97% | Imidazo[1,2-a]pyridine-6-boronic acid | ESD-899563-5G |
Cas.: 89719-92-6 | Purity: 96% | 2,5-Dichloro-4-(trifluoromethyl)pyridine | ESD-899564-250MG |
Cas.: 89719-92-6 | Purity: 96% | 2,5-Dichloro-4-(trifluoromethyl)pyridine | ESD-899564-1G |
Cas.: 89719-92-6 | Purity: 96% | 2,5-Dichloro-4-(trifluoromethyl)pyridine | ESD-899564-5G |
Cas.: 1228014-35-4 | Purity: 96% | tert-Butyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-899565-250MG |
Cas.: 1228014-35-4 | Purity: 96% | tert-Butyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-899565-1G |
Cas.: 1228014-35-4 | Purity: 96% | tert-Butyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-899565-5G |
Cas.: 4774-34-9 | Purity: 98% | 4-Hydroxypyrimidine-5-carbonitrile | ESD-899566-250MG |
Cas.: 4774-34-9 | Purity: 98% | 4-Hydroxypyrimidine-5-carbonitrile | ESD-899566-1G |
Cas.: 4774-34-9 | Purity: 98% | 4-Hydroxypyrimidine-5-carbonitrile | ESD-899566-5G |
Cas.: 177966-60-8 | Purity: 97% | Fmoc-3-Ala(3-benzothienyl)-OH | ESD-899567-250MG |
Cas.: 177966-60-8 | Purity: 97% | Fmoc-3-Ala(3-benzothienyl)-OH | ESD-899567-1G |
Cas.: 177966-60-8 | Purity: 97% | Fmoc-3-Ala(3-benzothienyl)-OH | ESD-899567-5G |
Cas.: 98548-01-7 | Purity: 95% | Ethyl 6-aminopyridazine-3-carboxylate | ESD-899568-250MG |
Cas.: 98548-01-7 | Purity: 95% | Ethyl 6-aminopyridazine-3-carboxylate | ESD-899568-1G |
Cas.: 98548-01-7 | Purity: 95% | Ethyl 6-aminopyridazine-3-carboxylate | ESD-899568-5G |
Cas.: 76066-27-8 | Purity: ≥95% | 1-(Aminomethyl)cyclopentanol hydrochloride | ESD-899569-250MG |
Cas.: 76066-27-8 | Purity: ≥95% | 1-(Aminomethyl)cyclopentanol hydrochloride | ESD-899569-1G |
Cas.: 76066-27-8 | Purity: ≥95% | 1-(Aminomethyl)cyclopentanol hydrochloride | ESD-899569-5G |
Cas.: 138642-97-4 | Purity: 97% | 6-Chloroimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-899570-250MG |
Cas.: 138642-97-4 | Purity: 97% | 6-Chloroimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-899570-1G |
Cas.: 138642-97-4 | Purity: 97% | 6-Chloroimidazo[1,2-a]pyridine-3-carboxylic acid | ESD-899570-5G |
Cas.: 54404-06-7 | Purity: 98% | 3-Oxo-2,3-dihydropyridazine-4-carboxylic acid | ESD-899571-250MG |
Cas.: 54404-06-7 | Purity: 98% | 3-Oxo-2,3-dihydropyridazine-4-carboxylic acid | ESD-899571-1G |
Cas.: 54404-06-7 | Purity: 98% | 3-Oxo-2,3-dihydropyridazine-4-carboxylic acid | ESD-899571-5G |
Cas.: 121058-88-6 | Purity: ≥95% | Ac-rC Phosphoramidite | ESD-899572-250MG |
Cas.: 121058-88-6 | Purity: ≥95% | Ac-rC Phosphoramidite | ESD-899572-1G |
Cas.: 121058-88-6 | Purity: ≥95% | Ac-rC Phosphoramidite | ESD-899572-5G |
Cas.: 937046-96-3 | Purity: 97% | tert-Butyl (2-cyano-1H-pyrrol-1-yl)carbamate | ESD-899573-250MG |
Cas.: 937046-96-3 | Purity: 97% | tert-Butyl (2-cyano-1H-pyrrol-1-yl)carbamate | ESD-899573-1G |
Cas.: 937046-96-3 | Purity: 97% | tert-Butyl (2-cyano-1H-pyrrol-1-yl)carbamate | ESD-899573-5G |
Cas.: 1053656-37-3 | Purity: ≥95% | Methyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-899574-250MG |
Cas.: 1053656-37-3 | Purity: ≥95% | Methyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-899574-1G |
Cas.: 1053656-37-3 | Purity: ≥95% | Methyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-899574-5G |
Cas.: 1072448-08-8 | Purity: ≥95% | Methyl 3-amino-5-bromopicolinate | ESD-899575-250MG |
Cas.: 1072448-08-8 | Purity: ≥95% | Methyl 3-amino-5-bromopicolinate | ESD-899575-1G |
Cas.: 1072448-08-8 | Purity: ≥95% | Methyl 3-amino-5-bromopicolinate | ESD-899575-5G |
Cas.: 90322-37-5 | Purity: 96% | 2-Oxoindoline-4-carboxylic acid | ESD-899576-250MG |
Cas.: 90322-37-5 | Purity: 96% | 2-Oxoindoline-4-carboxylic acid | ESD-899576-1G |
Cas.: 90322-37-5 | Purity: 96% | 2-Oxoindoline-4-carboxylic acid | ESD-899576-5G |
Cas.: 1072952-34-1 | Purity: 97% | (2-Methylpyridin-3-yl)boronic acid hydrochloride | ESD-899577-250MG |
Cas.: 1072952-34-1 | Purity: 97% | (2-Methylpyridin-3-yl)boronic acid hydrochloride | ESD-899577-1G |
Cas.: 1072952-34-1 | Purity: 97% | (2-Methylpyridin-3-yl)boronic acid hydrochloride | ESD-899577-5G |
Cas.: 885518-50-3 | Purity: 96% | 6-Bromo-1H-indazol-4-amine | ESD-899578-250MG |
Cas.: 885518-50-3 | Purity: 96% | 6-Bromo-1H-indazol-4-amine | ESD-899578-1G |
Cas.: 885518-50-3 | Purity: 96% | 6-Bromo-1H-indazol-4-amine | ESD-899578-5G |
Cas.: 474707-30-7 | Purity: 95% | (R)-3-Methoxypyrrolidine hydrochloride | ESD-899579-250MG |
Cas.: 474707-30-7 | Purity: 95% | (R)-3-Methoxypyrrolidine hydrochloride | ESD-899579-1G |
Cas.: 474707-30-7 | Purity: 95% | (R)-3-Methoxypyrrolidine hydrochloride | ESD-899579-5G |
Cas.: 1357923-33-1 | Purity: ≥95% | 2-(Azetidin-3-yl)propan-2-ol hydrochloride | ESD-899580-250MG |
Cas.: 1357923-33-1 | Purity: ≥95% | 2-(Azetidin-3-yl)propan-2-ol hydrochloride | ESD-899580-1G |
Cas.: 1357923-33-1 | Purity: ≥95% | 2-(Azetidin-3-yl)propan-2-ol hydrochloride | ESD-899580-5G |
Cas.: 89381-08-8 | Purity: 95% | 2-Cyclopropylethanamine hydrochloride | ESD-899581-250MG |
Cas.: 89381-08-8 | Purity: 95% | 2-Cyclopropylethanamine hydrochloride | ESD-899581-1G |
Cas.: 89381-08-8 | Purity: 95% | 2-Cyclopropylethanamine hydrochloride | ESD-899581-5G |
Cas.: 1279032-31-3 | Purity: 97% | (1R,3S)-3-Aminocyclopentanol hydrochloride | ESD-899582-250MG |
Cas.: 1279032-31-3 | Purity: 97% | (1R,3S)-3-Aminocyclopentanol hydrochloride | ESD-899582-1G |
Cas.: 1279032-31-3 | Purity: 97% | (1R,3S)-3-Aminocyclopentanol hydrochloride | ESD-899582-5G |
Cas.: 883738-27-0 | Purity: 96% | 1-Methyl-4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine | ESD-899583-250MG |
Cas.: 883738-27-0 | Purity: 96% | 1-Methyl-4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine | ESD-899583-1G |
Cas.: 883738-27-0 | Purity: 96% | 1-Methyl-4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine | ESD-899583-5G |
Cas.: 180975-66-0 | Purity: 97% | tert-Butyl cis-2,6-dimethylpiperazine-1-carboxylate | ESD-899584-250MG |
Cas.: 180975-66-0 | Purity: 97% | tert-Butyl cis-2,6-dimethylpiperazine-1-carboxylate | ESD-899584-1G |
Cas.: 180975-66-0 | Purity: 97% | tert-Butyl cis-2,6-dimethylpiperazine-1-carboxylate | ESD-899584-5G |
Cas.: 40547-58-8 | Purity: ≥95% | N-(4-Acetyl-3-hydroxyphenyl)acetamide | ESD-899585-250MG |
Cas.: 40547-58-8 | Purity: ≥95% | N-(4-Acetyl-3-hydroxyphenyl)acetamide | ESD-899585-1G |
Cas.: 1095539-84-6 | Purity: 97% | 6-Bromo-1,3-dimethyl-1H-indazole | ESD-899586-250MG |
Cas.: 1095539-84-6 | Purity: 97% | 6-Bromo-1,3-dimethyl-1H-indazole | ESD-899586-1G |
Cas.: 1095539-84-6 | Purity: 97% | 6-Bromo-1,3-dimethyl-1H-indazole | ESD-899586-5G |
Cas.: 934536-10-4 | Purity: ≥95% | tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate | ESD-899587-250MG |
Cas.: 934536-10-4 | Purity: ≥95% | tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate | ESD-899587-1G |
Cas.: 934536-10-4 | Purity: ≥95% | tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate | ESD-899587-5G |
Cas.: 25742-12-5 | Purity: 98% | Thiazole-5-carbonitrile | ESD-899588-250MG |
Cas.: 25742-12-5 | Purity: 98% | Thiazole-5-carbonitrile | ESD-899588-1G |
Cas.: 25742-12-5 | Purity: 98% | Thiazole-5-carbonitrile | ESD-899588-5G |
Cas.: 1054483-78-1 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol | ESD-899589-250MG |
Cas.: 1054483-78-1 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol | ESD-899589-1G |
Cas.: 1167418-13-4 | Purity: ≥95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline | ESD-899590-250MG |
Cas.: 1167418-13-4 | Purity: ≥95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline | ESD-899590-1G |
Cas.: 1167418-13-4 | Purity: ≥95% | 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline | ESD-899590-5G |
Cas.: 13517-31-2 | Purity: 97% | 5-Iodopyridin-2-ol | ESD-899592-1G |
Cas.: 13517-31-2 | Purity: 97% | 5-Iodopyridin-2-ol | ESD-899592-5G |
Cas.: 13517-31-2 | Purity: 97% | 5-Iodopyridin-2-ol | ESD-899592-10G |
Cas.: 1449693-24-6 | Purity: ≥95% | 5-Bromo-2H-pyrazolo[3,4-b]pyridine | ESD-899593-1G |
Cas.: 1449693-24-6 | Purity: ≥95% | 5-Bromo-2H-pyrazolo[3,4-b]pyridine | ESD-899593-5G |
Cas.: 1449693-24-6 | Purity: ≥95% | 5-Bromo-2H-pyrazolo[3,4-b]pyridine | ESD-899593-10G |
Cas.: 1171916-79-2 | Purity: 95% | 5-(Trifluoromethyl)pyrimidine-2,4(3H,5H)-dione | ESD-899594-1G |
Cas.: 1171916-79-2 | Purity: 95% | 5-(Trifluoromethyl)pyrimidine-2,4(3H,5H)-dione | ESD-899594-5G |
Cas.: 1171916-79-2 | Purity: 95% | 5-(Trifluoromethyl)pyrimidine-2,4(3H,5H)-dione | ESD-899594-10G |
Cas.: 15182-40-8 | Purity: 98% | 3-Bromo-1H-1,2,4-triazole | ESD-899595-1G |
Cas.: 15182-40-8 | Purity: 98% | 3-Bromo-1H-1,2,4-triazole | ESD-899595-5G |
Cas.: 15182-40-8 | Purity: 98% | 3-Bromo-1H-1,2,4-triazole | ESD-899595-10G |
Cas.: 13060-24-7 | Purity: 97% | 2-Octylbenzimidazole | ESD-899596-1G |
Cas.: 13060-24-7 | Purity: 97% | 2-Octylbenzimidazole | ESD-899596-5G |
Cas.: 13060-24-7 | Purity: 97% | 2-Octylbenzimidazole | ESD-899596-10G |
Cas.: 98548-81-3 | Purity: 98% (only trans) | 4-(Dimethylamino)but-2-enoic acid hydrochloride | ESD-899597-1G |
Cas.: 98548-81-3 | Purity: 98% (only trans) | 4-(Dimethylamino)but-2-enoic acid hydrochloride | ESD-899597-5G |
Cas.: 98548-81-3 | Purity: 98% (only trans) | 4-(Dimethylamino)but-2-enoic acid hydrochloride | ESD-899597-10G |
Cas.: 83345-46-4 | Purity: 97% | Boc-L-Tyr-ol | ESD-899598-1G |
Cas.: 83345-46-4 | Purity: 97% | Boc-L-Tyr-ol | ESD-899598-5G |
Cas.: 83345-46-4 | Purity: 97% | Boc-L-Tyr-ol | ESD-899598-10G |
Cas.: 402846-49-5 | Purity: ≥95% | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate hydrate | ESD-899599-1G |
Cas.: 402846-49-5 | Purity: ≥95% | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate hydrate | ESD-899599-5G |
Cas.: 402846-49-5 | Purity: ≥95% | Sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate hydrate | ESD-899599-10G |
Cas.: 849725-39-9 | Purity: ≥98% | Inosine-5′-monophosphate Disodium Salt heptahydrate | ESD-899600-1G |
Cas.: 849725-39-9 | Purity: ≥98% | Inosine-5′-monophosphate Disodium Salt heptahydrate | ESD-899600-5G |
Cas.: 849725-39-9 | Purity: ≥98% | Inosine-5′-monophosphate Disodium Salt heptahydrate | ESD-899600-10G |
Cas.: 47729-63-5 | Purity: 98% | (E)-5,6-Dichloro-2-(3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)prop-1- en-1-yl)-1,3-diethyl-1H-benzo[d]imidazol-3-ium iodide | ESD-899601-1MG |
Cas.: 47729-63-5 | Purity: 98% | (E)-5,6-Dichloro-2-(3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)prop-1- en-1-yl)-1,3-diethyl-1H-benzo[d]imidazol-3-ium iodide | ESD-899601-5MG |
Cas.: 47729-63-5 | Purity: 98% | (E)-5,6-Dichloro-2-(3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)prop-1- en-1-yl)-1,3-diethyl-1H-benzo[d]imidazol-3-ium iodide | ESD-899601-10MG |
Cas.: 72797-17-2 | Purity: 98% (mix) | 2-Acetyl-3,5(6)-dimethylpyrazine, mixture of isomers | ESD-899602-1G |
Cas.: 72797-17-2 | Purity: 98% (mix) | 2-Acetyl-3,5(6)-dimethylpyrazine, mixture of isomers | ESD-899602-5G |
Cas.: 72797-17-2 | Purity: 98% (mix) | 2-Acetyl-3,5(6)-dimethylpyrazine, mixture of isomers | ESD-899602-10G |
Cas.: 59315-47-8 | Purity: ≥98% | 6-Aminopyridin-2-ol | ESD-899603-1G |
Cas.: 59315-47-8 | Purity: ≥98% | 6-Aminopyridin-2-ol | ESD-899603-5G |
Cas.: 59315-47-8 | Purity: ≥98% | 6-Aminopyridin-2-ol | ESD-899603-10G |
Cas.: 34176-31-3 | Purity: 97% | 5-Methyl-4-phenylthiazol-2-amine hydrobromide | ESD-899604-1G |
Cas.: 34176-31-3 | Purity: 97% | 5-Methyl-4-phenylthiazol-2-amine hydrobromide | ESD-899604-5G |
Cas.: 34176-31-3 | Purity: 97% | 5-Methyl-4-phenylthiazol-2-amine hydrobromide | ESD-899604-10G |
Cas.: 1821798-25-7 | Purity: ≥98% | GSK-LSD1 Dihydrochloride | ESD-899605-1MG |
Cas.: 1821798-25-7 | Purity: ≥98% | GSK-LSD1 Dihydrochloride | ESD-899605-5MG |
Cas.: 1821798-25-7 | Purity: ≥98% | GSK-LSD1 Dihydrochloride | ESD-899605-10MG |
Cas.: 333326-97-9 | Purity: 97% | N-(4-(2-(3,5-Diamino-4H-pyrazol-4-ylidene)hydrazinyl)phenyl)acetamide | ESD-899606-1G |
Cas.: 333326-97-9 | Purity: 97% | N-(4-(2-(3,5-Diamino-4H-pyrazol-4-ylidene)hydrazinyl)phenyl)acetamide | ESD-899606-5G |
Cas.: 333326-97-9 | Purity: 97% | N-(4-(2-(3,5-Diamino-4H-pyrazol-4-ylidene)hydrazinyl)phenyl)acetamide | ESD-899606-10G |
Cas.: 10007-84-8 | Purity: 97% | Sodium 2,6-dichlorobenzoate | ESD-899607-1G |
Cas.: 10007-84-8 | Purity: 97% | Sodium 2,6-dichlorobenzoate | ESD-899607-5G |
Cas.: 10007-84-8 | Purity: 97% | Sodium 2,6-dichlorobenzoate | ESD-899607-10G |
Cas.: 174603-37-3 | Purity: 98% | (E)-3-(2-Chloro-4-fluorophenyl)acrylic acid | ESD-899608-1G |
Cas.: 174603-37-3 | Purity: 98% | (E)-3-(2-Chloro-4-fluorophenyl)acrylic acid | ESD-899608-5G |
Cas.: 174603-37-3 | Purity: 98% | (E)-3-(2-Chloro-4-fluorophenyl)acrylic acid | ESD-899608-10G |
Cas.: 13185-09-6 | Purity: 97% | Sodium 1-benzyl-1H-indazol-3-olate | ESD-899609-1G |
Cas.: 13185-09-6 | Purity: 97% | Sodium 1-benzyl-1H-indazol-3-olate | ESD-899609-5G |
Cas.: 13185-09-6 | Purity: 97% | Sodium 1-benzyl-1H-indazol-3-olate | ESD-899609-10G |
Cas.: 2095432-28-1 | Purity: ≥98% | 6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile hydrochloride | ESD-899610-1MG |
Cas.: 2095432-28-1 | Purity: ≥98% | 6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile hydrochloride | ESD-899610-5MG |
Cas.: 2095432-28-1 | Purity: ≥98% | 6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile hydrochloride | ESD-899610-10MG |
Cas.: 2095433-94-4 | Purity: ≥98% | THZ1 Dihydrochloride | ESD-899611-1MG |
Cas.: 2095433-94-4 | Purity: ≥98% | THZ1 Dihydrochloride | ESD-899611-5MG |
Cas.: 2095433-94-4 | Purity: ≥98% | THZ1 Dihydrochloride | ESD-899611-10MG |
Cas.: 391624-46-7 | Purity: 95% | (9H-Fluoren-9-yl)methyl (2-aminoethyl)carbamate hydrochloride | ESD-899612-1G |
Cas.: 391624-46-7 | Purity: 95% | (9H-Fluoren-9-yl)methyl (2-aminoethyl)carbamate hydrochloride | ESD-899612-5G |
Cas.: 391624-46-7 | Purity: 95% | (9H-Fluoren-9-yl)methyl (2-aminoethyl)carbamate hydrochloride | ESD-899612-10G |
Cas.: 1472611-44-1 | Purity: ≥98% | Pyridostatin Trifluoroacetate | ESD-899613-1MG |
Cas.: 1472611-44-1 | Purity: ≥98% | Pyridostatin Trifluoroacetate | ESD-899613-5MG |
Cas.: 1472611-44-1 | Purity: ≥98% | Pyridostatin Trifluoroacetate | ESD-899613-10MG |
Cas.: 1096105-18-8 | Purity: ≥95% | (R)-N-Methyl-1-phenylethanamine hydrochloride | ESD-899614-1G |
Cas.: 1096105-18-8 | Purity: ≥95% | (R)-N-Methyl-1-phenylethanamine hydrochloride | ESD-899614-5G |
Cas.: 1096105-18-8 | Purity: ≥95% | (R)-N-Methyl-1-phenylethanamine hydrochloride | ESD-899614-10G |
Cas.: 1204918-72-8 | Purity: ≥98% | TG02 (Double bond E) | ESD-899615-1MG |
Cas.: 1204918-72-8 | Purity: ≥98% | TG02 (Double bond E) | ESD-899615-5MG |
Cas.: 1204918-72-8 | Purity: ≥98% | TG02 (Double bond E) | ESD-899615-10MG |
Cas.: 111359-62-7 | Purity: 97% | 2-Bromo-6-(methoxymethoxy)naphthalene | ESD-899616-1G |
Cas.: 111359-62-7 | Purity: 97% | 2-Bromo-6-(methoxymethoxy)naphthalene | ESD-899616-5G |
Cas.: 111359-62-7 | Purity: 97% | 2-Bromo-6-(methoxymethoxy)naphthalene | ESD-899616-10G |
Cas.: 2044704-44-9 | Purity: 97% | N,N-Dimethyl-2-(perfluorophenoxy)ethanamine | ESD-899617-1G |
Cas.: 2044704-44-9 | Purity: 97% | N,N-Dimethyl-2-(perfluorophenoxy)ethanamine | ESD-899617-5G |
Cas.: 2044704-44-9 | Purity: 97% | N,N-Dimethyl-2-(perfluorophenoxy)ethanamine | ESD-899617-10G |
Cas.: 2070014-87-6 | Purity: 99% | MRT68921 hydrochloride | ESD-899618-1MG |
Cas.: 2070014-87-6 | Purity: 99% | MRT68921 hydrochloride | ESD-899618-5MG |
Cas.: 2070014-87-6 | Purity: 99% | MRT68921 hydrochloride | ESD-899618-10MG |
Cas.: 21296-93-5 | Purity: ≥95% | 5-Chloro-2,3-dimethyl-1H-indole | ESD-899619-1G |
Cas.: 21296-93-5 | Purity: ≥95% | 5-Chloro-2,3-dimethyl-1H-indole | ESD-899619-5G |
Cas.: 21296-93-5 | Purity: ≥95% | 5-Chloro-2,3-dimethyl-1H-indole | ESD-899619-10G |
Cas.: 861905-97-7 | Purity: ≥95% | (2-Methylpyridin-4-yl)boronic acid hydrochloride | ESD-899620-1G |
Cas.: 861905-97-7 | Purity: ≥95% | (2-Methylpyridin-4-yl)boronic acid hydrochloride | ESD-899620-5G |
Cas.: 861905-97-7 | Purity: ≥95% | (2-Methylpyridin-4-yl)boronic acid hydrochloride | ESD-899620-10G |
Cas.: 1973401-99-8 | Purity: 97% | 5-(Benzyloxy)-1-(2,2-dimethoxyethyl)-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | ESD-899621-1G |
Cas.: 1973401-99-8 | Purity: 97% | 5-(Benzyloxy)-1-(2,2-dimethoxyethyl)-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | ESD-899621-5G |
Cas.: 1973401-99-8 | Purity: 97% | 5-(Benzyloxy)-1-(2,2-dimethoxyethyl)-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | ESD-899621-10G |
Cas.: 947667-22-3 | Purity: 97% | (R)-Methyl 2-(isopropylamino)butanoate | ESD-899622-1G |
Cas.: 947667-22-3 | Purity: 97% | (R)-Methyl 2-(isopropylamino)butanoate | ESD-899622-5G |
Cas.: 947667-22-3 | Purity: 97% | (R)-Methyl 2-(isopropylamino)butanoate | ESD-899622-10G |
Cas.: 1973503-49-9 | Purity: 97% | 5,7-Dibromo-6-methyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole | ESD-899623-1G |
Cas.: 1973503-49-9 | Purity: 97% | 5,7-Dibromo-6-methyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole | ESD-899623-5G |
Cas.: 1973503-49-9 | Purity: 97% | 5,7-Dibromo-6-methyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole | ESD-899623-10G |
Cas.: 3555-41-7 | Purity: 95% | 6,8-Dibromo-3,4-dihydroquinolin-2(1H)-one | ESD-899624-1G |
Cas.: 3555-41-7 | Purity: 95% | 6,8-Dibromo-3,4-dihydroquinolin-2(1H)-one | ESD-899624-5G |
Cas.: 3555-41-7 | Purity: 95% | 6,8-Dibromo-3,4-dihydroquinolin-2(1H)-one | ESD-899624-10G |
Cas.: 57229-67-1 | Purity: 97% | Boc-Trp-OBzl | ESD-899625-1G |
Cas.: 57229-67-1 | Purity: 97% | Boc-Trp-OBzl | ESD-899625-5G |
Cas.: 57229-67-1 | Purity: 97% | Boc-Trp-OBzl | ESD-899625-10G |
Cas.: 63196-11-2 | Purity: ≥95% | 5-(4-Methoxyphenoxy)isobenzofuran-1,3-dione | ESD-899626-1G |
Cas.: 63196-11-2 | Purity: ≥95% | 5-(4-Methoxyphenoxy)isobenzofuran-1,3-dione | ESD-899626-5G |
Cas.: 63196-11-2 | Purity: ≥95% | 5-(4-Methoxyphenoxy)isobenzofuran-1,3-dione | ESD-899626-10G |
Cas.: 18464-25-0 | Purity: 97% | N1,N5-Didodecyl-N1,N1,N5,N5-tetramethylpentane-1,5-diaminium bromide | ESD-899627-1G |
Cas.: 18464-25-0 | Purity: 97% | N1,N5-Didodecyl-N1,N1,N5,N5-tetramethylpentane-1,5-diaminium bromide | ESD-899627-5G |
Cas.: 18464-25-0 | Purity: 97% | N1,N5-Didodecyl-N1,N1,N5,N5-tetramethylpentane-1,5-diaminium bromide | ESD-899627-10G |
Cas.: 34004-36-9 | Purity: 95% | 2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-899628-1G |
Cas.: 34004-36-9 | Purity: 95% | 2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-899628-5G |
Cas.: 34004-36-9 | Purity: 95% | 2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride | ESD-899628-10G |
Cas.: 18944-00-8 | Purity: 97% | N-Me-Val-OH.HCl | ESD-899629-1G |
Cas.: 18944-00-8 | Purity: 97% | N-Me-Val-OH.HCl | ESD-899629-5G |
Cas.: 18944-00-8 | Purity: 97% | N-Me-Val-OH.HCl | ESD-899629-10G |
Cas.: 854828-86-7 | Purity: 97% | 1-Benzyl-1,4-diazepan-5-one hydrochloride | ESD-899630-1G |
Cas.: 854828-86-7 | Purity: 97% | 1-Benzyl-1,4-diazepan-5-one hydrochloride | ESD-899630-5G |
Cas.: 854828-86-7 | Purity: 97% | 1-Benzyl-1,4-diazepan-5-one hydrochloride | ESD-899630-10G |
Cas.: 2444-90-8 | Purity: ≥95% | Sodium 4,4′-(propane-2,2-diyl)diphenolate | ESD-899631-1G |
Cas.: 2444-90-8 | Purity: ≥95% | Sodium 4,4′-(propane-2,2-diyl)diphenolate | ESD-899631-5G |
Cas.: 2444-90-8 | Purity: ≥95% | Sodium 4,4′-(propane-2,2-diyl)diphenolate | ESD-899631-10G |
Cas.: 360067-61-4 | Purity: 97% | 1,3-Dicyclohexyl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-899632-1G |
Cas.: 360067-61-4 | Purity: 97% | 1,3-Dicyclohexyl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-899632-5G |
Cas.: 360067-61-4 | Purity: 97% | 1,3-Dicyclohexyl-4,5-dihydro-1H-imidazol-3-ium chloride | ESD-899632-10G |
Cas.: 58287-18-6 | Purity: ≥95% | (R)-1-(4-Nitrophenyl)ethanol | ESD-899633-1G |
Cas.: 58287-18-6 | Purity: ≥95% | (R)-1-(4-Nitrophenyl)ethanol | ESD-899633-5G |
Cas.: 58287-18-6 | Purity: ≥95% | (R)-1-(4-Nitrophenyl)ethanol | ESD-899633-10G |
Cas.: 344-95-6 | Purity: 95% | 2-(Trifluoromethyl)benzohydrazide | ESD-899634-1G |
Cas.: 344-95-6 | Purity: 95% | 2-(Trifluoromethyl)benzohydrazide | ESD-899634-5G |
Cas.: 344-95-6 | Purity: 95% | 2-(Trifluoromethyl)benzohydrazide | ESD-899634-10G |
Cas.: 76379-02-7 | Purity: ≥95% | Boc-D-Glu(Ome)-OH.DCHA | ESD-899635-1G |
Cas.: 76379-02-7 | Purity: ≥95% | Boc-D-Glu(Ome)-OH.DCHA | ESD-899635-5G |
Cas.: 76379-02-7 | Purity: ≥95% | Boc-D-Glu(Ome)-OH.DCHA | ESD-899635-10G |
Cas.: 49855-91-6 | Purity: ≥95% | Z-Dab(Boc)-OH | ESD-899636-1G |
Cas.: 49855-91-6 | Purity: ≥95% | Z-Dab(Boc)-OH | ESD-899636-5G |
Cas.: 49855-91-6 | Purity: ≥95% | Z-Dab(Boc)-OH | ESD-899636-10G |
Cas.: 1049780-58-6 | Purity: ≥98% | 2-([1,1′-Biphenyl]-4-yl)-5,6-dihydroimidazo[2,1-b]thiazole hydrobromide | ESD-899637-1MG |
Cas.: 1049780-58-6 | Purity: ≥98% | 2-([1,1′-Biphenyl]-4-yl)-5,6-dihydroimidazo[2,1-b]thiazole hydrobromide | ESD-899637-5MG |
Cas.: 1049780-58-6 | Purity: ≥98% | 2-([1,1′-Biphenyl]-4-yl)-5,6-dihydroimidazo[2,1-b]thiazole hydrobromide | ESD-899637-10MG |
Cas.: 1998701-21-5 | Purity: 97% | (R)-2-Amino-4-oxo-4-(tritylamino)butanoic acid hydrate | ESD-899638-1G |
Cas.: 1998701-21-5 | Purity: 97% | (R)-2-Amino-4-oxo-4-(tritylamino)butanoic acid hydrate | ESD-899638-5G |
Cas.: 1998701-21-5 | Purity: 97% | (R)-2-Amino-4-oxo-4-(tritylamino)butanoic acid hydrate | ESD-899638-10G |
Cas.: 201472-66-4 | Purity: ≥95% | Boc-Dab(Boc)-OH.DCHA | ESD-899639-1G |
Cas.: 201472-66-4 | Purity: ≥95% | Boc-Dab(Boc)-OH.DCHA | ESD-899639-5G |
Cas.: 201472-66-4 | Purity: ≥95% | Boc-Dab(Boc)-OH.DCHA | ESD-899639-10G |
Cas.: 773134-65-9 | Purity: 97% | Ethyl 2,3-difluorobenzoate | ESD-899640-1G |
Cas.: 773134-65-9 | Purity: 97% | Ethyl 2,3-difluorobenzoate | ESD-899640-5G |
Cas.: 773134-65-9 | Purity: 97% | Ethyl 2,3-difluorobenzoate | ESD-899640-10G |
Cas.: 873837-23-1 | Purity: ≥98% | BMS-599626 Hydrochloride | ESD-899641-1MG |
Cas.: 873837-23-1 | Purity: ≥98% | BMS-599626 Hydrochloride | ESD-899641-5MG |
Cas.: 873837-23-1 | Purity: ≥98% | BMS-599626 Hydrochloride | ESD-899641-10MG |
Cas.: 22454-86-0 | Purity: ≥95% | Calcium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate | ESD-899642-1G |
Cas.: 22454-86-0 | Purity: ≥95% | Calcium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate | ESD-899642-5G |
Cas.: 22454-86-0 | Purity: ≥95% | Calcium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate | ESD-899642-10G |
Cas.: 2036044-77-4 | Purity: 97% | Porcupine-IN-1 | ESD-899643-1MG |
Cas.: 2036044-77-4 | Purity: 97% | Porcupine-IN-1 | ESD-899643-5MG |
Cas.: 2036044-77-4 | Purity: 97% | Porcupine-IN-1 | ESD-899643-10MG |
Cas.: 38862-65-6 | Purity: ≥95% | Ethyl 2,4-dihydroxy-6-pentylbenzoate | ESD-899644-1G |
Cas.: 38862-65-6 | Purity: ≥95% | Ethyl 2,4-dihydroxy-6-pentylbenzoate | ESD-899644-5G |
Cas.: 38862-65-6 | Purity: ≥95% | Ethyl 2,4-dihydroxy-6-pentylbenzoate | ESD-899644-10G |
Cas.: 76614-98-7 | Purity: 97% | H-Ser(Bzl)-OH.HCl | ESD-899645-1G |
Cas.: 76614-98-7 | Purity: 97% | H-Ser(Bzl)-OH.HCl | ESD-899645-5G |
Cas.: 76614-98-7 | Purity: 97% | H-Ser(Bzl)-OH.HCl | ESD-899645-10G |
Cas.: 350228-35-2 | Purity: ≥95% | H-3-D-Pal-OH.HCl | ESD-899646-1G |
Cas.: 350228-35-2 | Purity: ≥95% | H-3-D-Pal-OH.HCl | ESD-899646-5G |
Cas.: 350228-35-2 | Purity: ≥95% | H-3-D-Pal-OH.HCl | ESD-899646-10G |
Cas.: 1621085-33-3 | Purity: 97% | Propan-2-amine (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoate | ESD-899647-1G |
Cas.: 1621085-33-3 | Purity: 97% | Propan-2-amine (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoate | ESD-899647-5G |
Cas.: 1621085-33-3 | Purity: 97% | Propan-2-amine (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoate | ESD-899647-10G |
Cas.: 872365-14-5 | Purity: ≥99% | Fevipiprant | ESD-899648-1MG |
Cas.: 872365-14-5 | Purity: ≥99% | Fevipiprant | ESD-899648-5MG |
Cas.: 872365-14-5 | Purity: ≥99% | Fevipiprant | ESD-899648-10MG |
Cas.: 74450-59-2 | Purity: 98% | Ethyl 4-amino-2-methylbenzoate | ESD-899649-1G |
Cas.: 74450-59-2 | Purity: 98% | Ethyl 4-amino-2-methylbenzoate | ESD-899649-5G |
Cas.: 74450-59-2 | Purity: 98% | Ethyl 4-amino-2-methylbenzoate | ESD-899649-10G |
Cas.: 135273-01-7 | Purity: 96% | (2R,2’R)-3,3′-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid) | ESD-899650-1G |
Cas.: 135273-01-7 | Purity: 96% | (2R,2’R)-3,3′-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid) | ESD-899650-5G |
Cas.: 135273-01-7 | Purity: 96% | (2R,2’R)-3,3′-Disulfanediylbis(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid) | ESD-899650-10G |
Cas.: 2095432-75-8 | Purity: ≥98% | Wnt Agonist 1 | ESD-899651-1MG |
Cas.: 2095432-75-8 | Purity: ≥98% | Wnt Agonist 1 | ESD-899651-5MG |
Cas.: 2095432-75-8 | Purity: ≥98% | Wnt Agonist 1 | ESD-899651-10MG |
Cas.: 1450824-22-2 | Purity: ≥95% | TD 139 | ESD-899652-1MG |
Cas.: 1450824-22-2 | Purity: ≥95% | TD 139 | ESD-899652-5MG |
Cas.: 1450824-22-2 | Purity: ≥95% | TD 139 | ESD-899652-10MG |
Cas.: 200625-96-3 | Purity: 97% | (R)-5-Amino-2-(((benzyloxy)carbonyl)(trityl)amino)-5-oxopentanoic acid | ESD-899653-1G |
Cas.: 200625-96-3 | Purity: 97% | (R)-5-Amino-2-(((benzyloxy)carbonyl)(trityl)amino)-5-oxopentanoic acid | ESD-899653-5G |
Cas.: 200625-96-3 | Purity: 97% | (R)-5-Amino-2-(((benzyloxy)carbonyl)(trityl)amino)-5-oxopentanoic acid | ESD-899653-10G |
Cas.: 4801-79-0 | Purity: 97% | (S)-Benzyl (1-amino-4-methyl-1-oxopentan-2-yl)carbamate | ESD-899654-1G |
Cas.: 4801-79-0 | Purity: 97% | (S)-Benzyl (1-amino-4-methyl-1-oxopentan-2-yl)carbamate | ESD-899654-5G |
Cas.: 4801-79-0 | Purity: 97% | (S)-Benzyl (1-amino-4-methyl-1-oxopentan-2-yl)carbamate | ESD-899654-10G |
Cas.: 4071-36-7 | Purity: ≥95% | (S)-Ethyl 2-acetamido-4-methylpentanoate | ESD-899655-1G |
Cas.: 4071-36-7 | Purity: ≥95% | (S)-Ethyl 2-acetamido-4-methylpentanoate | ESD-899655-5G |
Cas.: 4071-36-7 | Purity: ≥95% | (S)-Ethyl 2-acetamido-4-methylpentanoate | ESD-899655-10G |
Cas.: 194154-40-0 | Purity: 97% | CBZ-Vaganciclovir | ESD-899656-1G |
Cas.: 194154-40-0 | Purity: 97% | CBZ-Vaganciclovir | ESD-899656-5G |
Cas.: 194154-40-0 | Purity: 97% | CBZ-Vaganciclovir | ESD-899656-10G |
Cas.: 73913-64-1 | Purity: 97% | (R)-Ethyl 2-amino-3-methylbutanoate hydrochloride | ESD-899657-1G |
Cas.: 73913-64-1 | Purity: 97% | (R)-Ethyl 2-amino-3-methylbutanoate hydrochloride | ESD-899657-5G |
Cas.: 73913-64-1 | Purity: 97% | (R)-Ethyl 2-amino-3-methylbutanoate hydrochloride | ESD-899657-10G |
Cas.: 126401-22-7 | Purity: 97% | 1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate | ESD-899658-1G |
Cas.: 126401-22-7 | Purity: 97% | 1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate | ESD-899658-5G |
Cas.: 126401-22-7 | Purity: 97% | 1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate | ESD-899658-10G |
Cas.: 1004538-34-4 | Purity: ≥95% | (R)-tert-Butyl 3-aminopyrrolidine-1-carboxylate hydrochloride | ESD-899659-1G |
Cas.: 1004538-34-4 | Purity: ≥95% | (R)-tert-Butyl 3-aminopyrrolidine-1-carboxylate hydrochloride | ESD-899659-5G |
Cas.: 1004538-34-4 | Purity: ≥95% | (R)-tert-Butyl 3-aminopyrrolidine-1-carboxylate hydrochloride | ESD-899659-10G |
Cas.: 23994-93-6 | Purity: 97% | 2-(Ethylthio)pyrimidine-4,6-diamine | ESD-899660-1G |
Cas.: 23994-93-6 | Purity: 97% | 2-(Ethylthio)pyrimidine-4,6-diamine | ESD-899660-5G |
Cas.: 23994-93-6 | Purity: 97% | 2-(Ethylthio)pyrimidine-4,6-diamine | ESD-899660-10G |
Cas.: 1588440-88-3 | Purity: ≥95% | 1,2,4-Thiadiazol-5-amine dihydrochloride | ESD-899661-1G |
Cas.: 1588440-88-3 | Purity: ≥95% | 1,2,4-Thiadiazol-5-amine dihydrochloride | ESD-899661-5G |
Cas.: 1588440-88-3 | Purity: ≥95% | 1,2,4-Thiadiazol-5-amine dihydrochloride | ESD-899661-10G |
Cas.: 146844-02-2 | Purity: 97% | (R)-Dibenzyl 2-aminopentanedioate hydrochloride | ESD-899662-1G |
Cas.: 146844-02-2 | Purity: 97% | (R)-Dibenzyl 2-aminopentanedioate hydrochloride | ESD-899662-5G |
Cas.: 146844-02-2 | Purity: 97% | (R)-Dibenzyl 2-aminopentanedioate hydrochloride | ESD-899662-10G |
Cas.: 90802-45-2 | Purity: 97% | 3-Aminopiperidine-2,6-dione hydrobromide | ESD-899663-1G |
Cas.: 90802-45-2 | Purity: 97% | 3-Aminopiperidine-2,6-dione hydrobromide | ESD-899663-5G |
Cas.: 90802-45-2 | Purity: 97% | 3-Aminopiperidine-2,6-dione hydrobromide | ESD-899663-10G |
Cas.: 2070014-90-1 | Purity: ≥98% | LY303511 Hydrochloride | ESD-899664-1MG |
Cas.: 2070014-90-1 | Purity: ≥98% | LY303511 Hydrochloride | ESD-899664-5MG |
Cas.: 2070014-90-1 | Purity: ≥98% | LY303511 Hydrochloride | ESD-899664-10MG |
Cas.: 1333327-56-2 | Purity: ≥98% | TRC051384 Hydrochloride | ESD-899665-1MG |
Cas.: 1333327-56-2 | Purity: ≥98% | TRC051384 Hydrochloride | ESD-899665-5MG |
Cas.: 1333327-56-2 | Purity: ≥98% | TRC051384 Hydrochloride | ESD-899665-10MG |
Cas.: 1308061-19-9 | Purity: 97% | 2-Amino-6-chloro-N-(2,4-dimethylphenyl)benzenesulfonamide | ESD-899666-1G |
Cas.: 1308061-19-9 | Purity: 97% | 2-Amino-6-chloro-N-(2,4-dimethylphenyl)benzenesulfonamide | ESD-899666-5G |
Cas.: 1308061-19-9 | Purity: 97% | 2-Amino-6-chloro-N-(2,4-dimethylphenyl)benzenesulfonamide | ESD-899666-10G |
Cas.: 874-10-2 | Purity: ≥95% | 8-Methylimidazo[1,2-a]pyridine | ESD-899667-1G |
Cas.: 874-10-2 | Purity: ≥95% | 8-Methylimidazo[1,2-a]pyridine | ESD-899667-5G |
Cas.: 874-10-2 | Purity: ≥95% | 8-Methylimidazo[1,2-a]pyridine | ESD-899667-10G |
Cas.: 159847-83-3 | Purity: 98% | Methyl 2-amino-4-cyanobenzoate | ESD-899668-1G |
Cas.: 915759-45-4 | Purity: ≥98% | WAY-316606 | ESD-899669-1MG |
Cas.: 915759-45-4 | Purity: ≥98% | WAY-316606 | ESD-899669-5MG |
Cas.: 915759-45-4 | Purity: ≥98% | WAY-316606 | ESD-899669-10MG |
Cas.: 116795-47-2 | Purity: ≥95% | 3-Bromo-5-chloro-2-hydroxybenzyl alcohol | ESD-899670-1G |
Cas.: 116795-47-2 | Purity: ≥95% | 3-Bromo-5-chloro-2-hydroxybenzyl alcohol | ESD-899670-5G |
Cas.: 116795-47-2 | Purity: ≥95% | 3-Bromo-5-chloro-2-hydroxybenzyl alcohol | ESD-899670-10G |
Cas.: 1393822-96-2 | Purity: 95% | Lithium trihydroxy(pyridin-2-yl)borate | ESD-899671-1G |
Cas.: 1393822-96-2 | Purity: 95% | Lithium trihydroxy(pyridin-2-yl)borate | ESD-899671-5G |
Cas.: 1393822-96-2 | Purity: 95% | Lithium trihydroxy(pyridin-2-yl)borate | ESD-899671-10G |
Cas.: 850363-42-7 | Purity: ≥95% | tert-Butyl (1-(4-bromophenyl)ethyl)carbamate | ESD-899672-1G |
Cas.: 850363-42-7 | Purity: ≥95% | tert-Butyl (1-(4-bromophenyl)ethyl)carbamate | ESD-899672-5G |
Cas.: 850363-42-7 | Purity: ≥95% | tert-Butyl (1-(4-bromophenyl)ethyl)carbamate | ESD-899672-10G |
Cas.: 155694-84-1 | Purity: 97% | 1-(4-Methyl-2-nitrophenyl)ethanone | ESD-899673-1G |
Cas.: 155694-84-1 | Purity: 97% | 1-(4-Methyl-2-nitrophenyl)ethanone | ESD-899673-5G |
Cas.: 155694-84-1 | Purity: 97% | 1-(4-Methyl-2-nitrophenyl)ethanone | ESD-899673-10G |
Cas.: 177259-98-2 | Purity: ≥95% | 2-(3-(Benzyloxy)phenyl)ethanol | ESD-899674-1G |
Cas.: 177259-98-2 | Purity: ≥95% | 2-(3-(Benzyloxy)phenyl)ethanol | ESD-899674-5G |
Cas.: 177259-98-2 | Purity: ≥95% | 2-(3-(Benzyloxy)phenyl)ethanol | ESD-899674-10G |
Cas.: 953778-58-0 | Purity: ≥98% | MK-8998 | ESD-899675-1MG |
Cas.: 953778-58-0 | Purity: ≥98% | MK-8998 | ESD-899675-5MG |
Cas.: 953778-58-0 | Purity: ≥98% | MK-8998 | ESD-899675-10MG |
Cas.: 6343-93-7 | Purity: 98% | 2-(4-Methoxyphenyl)acetamide | ESD-899676-1G |
Cas.: 6343-93-7 | Purity: 98% | 2-(4-Methoxyphenyl)acetamide | ESD-899676-5G |
Cas.: 6343-93-7 | Purity: 98% | 2-(4-Methoxyphenyl)acetamide | ESD-899676-10G |
Cas.: 58377-44-9 | Purity: 98% | tert-Butyl-methoxycarbamate | ESD-899677-1G |
Cas.: 483282-25-3 | Purity: ≥95% | 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carboxylic acid | ESD-899678-1G |
Cas.: 483282-25-3 | Purity: ≥95% | 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carboxylic acid | ESD-899678-5G |
Cas.: 483282-25-3 | Purity: ≥95% | 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carboxylic acid | ESD-899678-10G |
Cas.: 4746-61-6 | Purity: 95% | 2-Hydroxy-N-phenylacetamide | ESD-899679-1G |
Cas.: 4746-61-6 | Purity: 95% | 2-Hydroxy-N-phenylacetamide | ESD-899679-5G |
Cas.: 4746-61-6 | Purity: 95% | 2-Hydroxy-N-phenylacetamide | ESD-899679-10G |
Cas.: 907545-64-6 | Purity: 97% | Ethyl 2-chloro-5-nitroisonicotinate | ESD-899680-1G |
Cas.: 907545-64-6 | Purity: 97% | Ethyl 2-chloro-5-nitroisonicotinate | ESD-899680-5G |
Cas.: 907545-64-6 | Purity: 97% | Ethyl 2-chloro-5-nitroisonicotinate | ESD-899680-10G |
Cas.: 1682-04-8 | Purity: 97% | 1-Bromo-2,3,5,6-tetrafluoro-4-methoxybenzene | ESD-899681-1G |
Cas.: 1682-04-8 | Purity: 97% | 1-Bromo-2,3,5,6-tetrafluoro-4-methoxybenzene | ESD-899681-5G |
Cas.: 1682-04-8 | Purity: 97% | 1-Bromo-2,3,5,6-tetrafluoro-4-methoxybenzene | ESD-899681-10G |
Cas.: 2251-76-5 | Purity: 95% | 2-(4-Fluorophenyl)-2-oxoacetic acid | ESD-899682-1G |
Cas.: 2251-76-5 | Purity: 95% | 2-(4-Fluorophenyl)-2-oxoacetic acid | ESD-899682-5G |
Cas.: 2251-76-5 | Purity: 95% | 2-(4-Fluorophenyl)-2-oxoacetic acid | ESD-899682-10G |
Cas.: 55863-02-0 | Purity: ≥95% | N-Methylhex-5-en-1-amine | ESD-899683-1G |
Cas.: 55863-02-0 | Purity: ≥95% | N-Methylhex-5-en-1-amine | ESD-899683-5G |
Cas.: 55863-02-0 | Purity: ≥95% | N-Methylhex-5-en-1-amine | ESD-899683-10G |
Cas.: 21109-01-3 | Purity: 97% | 5-Chloro-1H-indole-2-carboxamide | ESD-899684-1G |
Cas.: 21109-01-3 | Purity: 97% | 5-Chloro-1H-indole-2-carboxamide | ESD-899684-5G |
Cas.: 21109-01-3 | Purity: 97% | 5-Chloro-1H-indole-2-carboxamide | ESD-899684-10G |
Cas.: 849898-48-2 | Purity: 98% | 5-Bromo-2-chloro-N-isopropylbenzamide | ESD-899685-1G |
Cas.: 849898-48-2 | Purity: 98% | 5-Bromo-2-chloro-N-isopropylbenzamide | ESD-899685-5G |
Cas.: 849898-48-2 | Purity: 98% | 5-Bromo-2-chloro-N-isopropylbenzamide | ESD-899685-10G |
Cas.: 16606-61-4 | Purity: 98% | 2,4-Dichlorobenzene-1,3-diol | ESD-899686-1G |
Cas.: 16606-61-4 | Purity: 98% | 2,4-Dichlorobenzene-1,3-diol | ESD-899686-5G |
Cas.: 16606-61-4 | Purity: 98% | 2,4-Dichlorobenzene-1,3-diol | ESD-899686-10G |
Cas.: 887707-21-3 | Purity: ≥95% | (6-Chloro-5-methylpyridin-3-yl)methanol | ESD-899687-1G |
Cas.: 887707-21-3 | Purity: ≥95% | (6-Chloro-5-methylpyridin-3-yl)methanol | ESD-899687-5G |
Cas.: 887707-21-3 | Purity: ≥95% | (6-Chloro-5-methylpyridin-3-yl)methanol | ESD-899687-10G |
Cas.: 873697-78-0 | Purity: 98% | 1-(2-Fluoro-3-nitrophenyl)ethanone | ESD-899688-1G |
Cas.: 1560648-02-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-ol | ESD-899689-1G |
Cas.: 1560648-02-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-ol | ESD-899689-5G |
Cas.: 1560648-02-3 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-ol | ESD-899689-10G |
Cas.: 1189973-29-2 | Purity: 97% | (1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol | ESD-899690-1G |
Cas.: 1189973-29-2 | Purity: 97% | (1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol | ESD-899690-5G |
Cas.: 1189973-29-2 | Purity: 97% | (1-(5-Bromopyrimidin-2-yl)piperidin-3-yl)methanol | ESD-899690-10G |
Cas.: 903131-13-5 | Purity: ≥95% | 4-Bromo-1H-indole-3-carbonitrile | ESD-899691-1G |
Cas.: 903131-13-5 | Purity: ≥95% | 4-Bromo-1H-indole-3-carbonitrile | ESD-899691-5G |
Cas.: 903131-13-5 | Purity: ≥95% | 4-Bromo-1H-indole-3-carbonitrile | ESD-899691-10G |
Cas.: 1086838-13-2 | Purity: ≥95% | 5-Chloro-3-nitropicolinaldehyde | ESD-899692-1G |
Cas.: 1086838-13-2 | Purity: ≥95% | 5-Chloro-3-nitropicolinaldehyde | ESD-899692-5G |
Cas.: 1086838-13-2 | Purity: ≥95% | 5-Chloro-3-nitropicolinaldehyde | ESD-899692-10G |
Cas.: 933585-44-5 | Purity: 97% | Ethyl 2-iodo-5-methylbenzoate | ESD-899693-1G |
Cas.: 933585-44-5 | Purity: 97% | Ethyl 2-iodo-5-methylbenzoate | ESD-899693-5G |
Cas.: 933585-44-5 | Purity: 97% | Ethyl 2-iodo-5-methylbenzoate | ESD-899693-10G |
Cas.: 719282-11-8 | Purity: ≥95% | 5-Acetamido-2-chlorobenzoic acid | ESD-899694-1G |
Cas.: 719282-11-8 | Purity: ≥95% | 5-Acetamido-2-chlorobenzoic acid | ESD-899694-5G |
Cas.: 155382-86-8 | Purity: 95% | 3,4-Dichloro-2-methoxybenzoic acid | ESD-899695-1G |
Cas.: 155382-86-8 | Purity: 95% | 3,4-Dichloro-2-methoxybenzoic acid | ESD-899695-5G |
Cas.: 155382-86-8 | Purity: 95% | 3,4-Dichloro-2-methoxybenzoic acid | ESD-899695-10G |
Cas.: 162147-12-8 | Purity: 97% | 2-Bromo-5-isopropoxybenzaldehyde | ESD-899696-1G |
Cas.: 162147-12-8 | Purity: 97% | 2-Bromo-5-isopropoxybenzaldehyde | ESD-899696-5G |
Cas.: 162147-12-8 | Purity: 97% | 2-Bromo-5-isopropoxybenzaldehyde | ESD-899696-10G |
Cas.: 61494-42-6 | Purity: 95% | N,2-Dihydroxy-5-nitrobenzamide | ESD-899697-1G |
Cas.: 61494-42-6 | Purity: 95% | N,2-Dihydroxy-5-nitrobenzamide | ESD-899697-5G |
Cas.: 61494-42-6 | Purity: 95% | N,2-Dihydroxy-5-nitrobenzamide | ESD-899697-10G |
Cas.: 467458-02-2 | Purity: ≥98% | Lu AE58054 Hydrochloride | ESD-899698-2MG |
Cas.: 467458-02-2 | Purity: ≥98% | Lu AE58054 Hydrochloride | ESD-899698-5MG |
Cas.: 467458-02-2 | Purity: ≥98% | Lu AE58054 Hydrochloride | ESD-899698-10MG |
Cas.: 53978-73-7 | Purity: ≥95% | ZDN-Me-Val-OH | ESD-899699-1G |
Cas.: 53978-73-7 | Purity: ≥95% | ZDN-Me-Val-OH | ESD-899699-5G |
Cas.: 53978-73-7 | Purity: ≥95% | ZDN-Me-Val-OH | ESD-899699-10G |
Cas.: 79069-15-1 | Purity: 97% | N-Boc-(S)-2-amino-3-benzyloxy-1-propanol | ESD-899700-1G |
Cas.: 79069-15-1 | Purity: 97% | N-Boc-(S)-2-amino-3-benzyloxy-1-propanol | ESD-899700-5G |
Cas.: 79069-15-1 | Purity: 97% | N-Boc-(S)-2-amino-3-benzyloxy-1-propanol | ESD-899700-10G |
Cas.: 2994-69-6 | Purity: 97% | 2-Chloro-4-(chloromethyl)-1-fluorobenzene | ESD-899701-1G |
Cas.: 2994-69-6 | Purity: 97% | 2-Chloro-4-(chloromethyl)-1-fluorobenzene | ESD-899701-5G |
Cas.: 2994-69-6 | Purity: 97% | 2-Chloro-4-(chloromethyl)-1-fluorobenzene | ESD-899701-10G |
Cas.: 746658-74-2 | Purity: 97% | 1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid | ESD-899702-1G |
Cas.: 746658-74-2 | Purity: 97% | 1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid | ESD-899702-5G |
Cas.: 746658-74-2 | Purity: 97% | 1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid | ESD-899702-10G |
Cas.: 58588-64-0 | Purity: 97% | 3-Chloro-4-formylbenzonitrile | ESD-899703-1G |
Cas.: 58588-64-0 | Purity: 97% | 3-Chloro-4-formylbenzonitrile | ESD-899703-5G |
Cas.: 58588-64-0 | Purity: 97% | 3-Chloro-4-formylbenzonitrile | ESD-899703-10G |
Cas.: 17826-05-0 | Purity: ≥95% | 5,6-Dibromoindoline-2,3-dione | ESD-899704-1G |
Cas.: 17826-05-0 | Purity: ≥95% | 5,6-Dibromoindoline-2,3-dione | ESD-899704-5G |
Cas.: 17826-05-0 | Purity: ≥95% | 5,6-Dibromoindoline-2,3-dione | ESD-899704-10G |
Cas.: 202932-05-6 | Purity: 97% | (3,5-Dimethylpyridin-2-yl)methanol | ESD-899705-1G |
Cas.: 202932-05-6 | Purity: 97% | (3,5-Dimethylpyridin-2-yl)methanol | ESD-899705-5G |
Cas.: 202932-05-6 | Purity: 97% | (3,5-Dimethylpyridin-2-yl)methanol | ESD-899705-10G |
Cas.: 279262-15-6 | Purity: 97% | (4-(2-Ethoxyethoxy)phenyl)boronic acid | ESD-899706-1G |
Cas.: 279262-15-6 | Purity: 97% | (4-(2-Ethoxyethoxy)phenyl)boronic acid | ESD-899706-5G |
Cas.: 279262-15-6 | Purity: 97% | (4-(2-Ethoxyethoxy)phenyl)boronic acid | ESD-899706-10G |
Cas.: 448947-81-7 | Purity: ≥98% | Yoda 1 | ESD-899707-1MG |
Cas.: 448947-81-7 | Purity: ≥98% | Yoda 1 | ESD-899707-5MG |
Cas.: 448947-81-7 | Purity: ≥98% | Yoda 1 | ESD-899707-10MG |
Cas.: 51818-99-6 | Purity: 97% | 4-Amino-3-nitrobenzaldehyde | ESD-899708-1G |
Cas.: 51818-99-6 | Purity: 97% | 4-Amino-3-nitrobenzaldehyde | ESD-899708-5G |
Cas.: 51818-99-6 | Purity: 97% | 4-Amino-3-nitrobenzaldehyde | ESD-899708-10G |
Cas.: 3179-09-7 | Purity: 97% | 1-Methoxy-3-(2-nitrovinyl)benzene | ESD-899709-1G |
Cas.: 3179-09-7 | Purity: 97% | 1-Methoxy-3-(2-nitrovinyl)benzene | ESD-899709-5G |
Cas.: 3179-09-7 | Purity: 97% | 1-Methoxy-3-(2-nitrovinyl)benzene | ESD-899709-10G |
Cas.: 1194374-24-7 | Purity: 95% | 2-Chloro-5-methylthiazole-4-carboxylic acid | ESD-899710-1G |
Cas.: 1194374-24-7 | Purity: 95% | 2-Chloro-5-methylthiazole-4-carboxylic acid | ESD-899710-5G |
Cas.: 1194374-24-7 | Purity: 95% | 2-Chloro-5-methylthiazole-4-carboxylic acid | ESD-899710-10G |
Cas.: 1284248-73-2 | Purity: 98% | cis-3-Aminocyclopentanol hydrochloride | ESD-899711-1G |
Cas.: 1284248-73-2 | Purity: 98% | cis-3-Aminocyclopentanol hydrochloride | ESD-899711-5G |
Cas.: 1284248-73-2 | Purity: 98% | cis-3-Aminocyclopentanol hydrochloride | ESD-899711-10G |
Cas.: 1039815-76-3 | Purity: ≥95% | 2-Amino-6-chloro-3-fluorobenzoic acid | ESD-899712-1G |
Cas.: 1039815-76-3 | Purity: ≥95% | 2-Amino-6-chloro-3-fluorobenzoic acid | ESD-899712-5G |
Cas.: 1039815-76-3 | Purity: ≥95% | 2-Amino-6-chloro-3-fluorobenzoic acid | ESD-899712-10G |
Cas.: 1197230-88-8 | Purity: ≥98% | 1H-Pyrazole-4-carbaldehyde hydrochloride | ESD-899713-1G |
Cas.: 1197230-88-8 | Purity: ≥98% | 1H-Pyrazole-4-carbaldehyde hydrochloride | ESD-899713-5G |
Cas.: 1197230-88-8 | Purity: ≥98% | 1H-Pyrazole-4-carbaldehyde hydrochloride | ESD-899713-10G |
Cas.: 87375-38-0 | Purity: 97% | 1-(1,3-Dimethyl-1H-pyrazol-5-yl)ethanone | ESD-899714-1G |
Cas.: 569687-82-7 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)picolinic acid | ESD-899715-1G |
Cas.: 569687-82-7 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)picolinic acid | ESD-899715-5G |
Cas.: 569687-82-7 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)picolinic acid | ESD-899715-10G |
Cas.: 4770-41-6 | Purity: 97% | 6-Methoxyindoline hydrochloride | ESD-899716-1G |
Cas.: 4770-41-6 | Purity: 97% | 6-Methoxyindoline hydrochloride | ESD-899716-5G |
Cas.: 4770-41-6 | Purity: 97% | 6-Methoxyindoline hydrochloride | ESD-899716-10G |
Cas.: 113421-98-0 | Purity: 97% | 4-Fluoro-3-(trifluoromethoxy)aniline | ESD-899717-1G |
Cas.: 113421-98-0 | Purity: 97% | 4-Fluoro-3-(trifluoromethoxy)aniline | ESD-899717-5G |
Cas.: 113421-98-0 | Purity: 97% | 4-Fluoro-3-(trifluoromethoxy)aniline | ESD-899717-10G |
Cas.: 100058-61-5 | Purity: 97% | 3-(Benzyloxy)cyclobutanol | ESD-899718-1G |
Cas.: 100058-61-5 | Purity: 97% | 3-(Benzyloxy)cyclobutanol | ESD-899718-5G |
Cas.: 100058-61-5 | Purity: 97% | 3-(Benzyloxy)cyclobutanol | ESD-899718-10G |
Cas.: 2488-14-4 | Purity: 97% | Boc-His-OMe | ESD-899719-1G |
Cas.: 2488-14-4 | Purity: 97% | Boc-His-OMe | ESD-899719-5G |
Cas.: 2488-14-4 | Purity: 97% | Boc-His-OMe | ESD-899719-10G |
Cas.: 13477-53-7 | Purity: ≥98% | 4-Amino-2-hydroxybutanoic acid | ESD-899720-1G |
Cas.: 13477-53-7 | Purity: ≥98% | 4-Amino-2-hydroxybutanoic acid | ESD-899720-5G |
Cas.: 13477-53-7 | Purity: ≥98% | 4-Amino-2-hydroxybutanoic acid | ESD-899720-10G |
Cas.: 110764-79-9 | Purity: ≥95% | 5′-O-(4,4′-Dimethoxytrityl)-2′-O-methyluridine-3′-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | ESD-899721-1G |
Cas.: 110764-79-9 | Purity: ≥95% | 5′-O-(4,4′-Dimethoxytrityl)-2′-O-methyluridine-3′-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | ESD-899721-5G |
Cas.: 110764-79-9 | Purity: ≥95% | 5′-O-(4,4′-Dimethoxytrityl)-2′-O-methyluridine-3′-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | ESD-899721-10G |
Cas.: 237064-47-0 | Purity: 97% | Isobutylhydrazine hydrochloride | ESD-899722-1G |
Cas.: 237064-47-0 | Purity: 97% | Isobutylhydrazine hydrochloride | ESD-899722-5G |
Cas.: 237064-47-0 | Purity: 97% | Isobutylhydrazine hydrochloride | ESD-899722-10G |
Cas.: 1100318-96-4 | Purity: ≥95% | 4-Iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-899723-1G |
Cas.: 1100318-96-4 | Purity: ≥95% | 4-Iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-899723-5G |
Cas.: 1100318-96-4 | Purity: ≥95% | 4-Iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-899723-10G |
Cas.: 1123171-91-4 | Purity: ≥95% | Methyl 4-amino-3-bromo-5-fluorobenzoate | ESD-899724-1G |
Cas.: 1123171-91-4 | Purity: ≥95% | Methyl 4-amino-3-bromo-5-fluorobenzoate | ESD-899724-5G |
Cas.: 1123171-91-4 | Purity: ≥95% | Methyl 4-amino-3-bromo-5-fluorobenzoate | ESD-899724-10G |
Cas.: 23012-17-1 | Purity: 98% | 2-Methyloxazole-4-carboxylic acid | ESD-899725-1G |
Cas.: 23012-17-1 | Purity: 98% | 2-Methyloxazole-4-carboxylic acid | ESD-899725-5G |
Cas.: 23012-17-1 | Purity: 98% | 2-Methyloxazole-4-carboxylic acid | ESD-899725-10G |
Cas.: 535924-73-3 | Purity: 97% | 3-Ethoxyazetidine hydrochloride | ESD-899726-1G |
Cas.: 535924-73-3 | Purity: 97% | 3-Ethoxyazetidine hydrochloride | ESD-899726-5G |
Cas.: 535924-73-3 | Purity: 97% | 3-Ethoxyazetidine hydrochloride | ESD-899726-10G |
Cas.: 450412-22-3 | Purity: ≥95% | 1-Bromo-2-iodo-3-methoxybenzene | ESD-899727-1G |
Cas.: 450412-22-3 | Purity: ≥95% | 1-Bromo-2-iodo-3-methoxybenzene | ESD-899727-5G |
Cas.: 450412-22-3 | Purity: ≥95% | 1-Bromo-2-iodo-3-methoxybenzene | ESD-899727-10G |
Cas.: 24211-55-0 | Purity: 95% | (S)-Piperidin-3-ol | ESD-899728-1G |
Cas.: 24211-55-0 | Purity: 95% | (S)-Piperidin-3-ol | ESD-899728-5G |
Cas.: 24211-55-0 | Purity: 95% | (S)-Piperidin-3-ol | ESD-899728-10G |
Cas.: 1188265-21-5 | Purity: 97% | 1-Benzylpyrrolidine-3-carbonitrile oxalate | ESD-899729-1G |
Cas.: 1188265-21-5 | Purity: 97% | 1-Benzylpyrrolidine-3-carbonitrile oxalate | ESD-899729-5G |
Cas.: 1188265-21-5 | Purity: 97% | 1-Benzylpyrrolidine-3-carbonitrile oxalate | ESD-899729-10G |
Cas.: 62965-37-1 | Purity: 98% | Dicyclohexylamine (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoate | ESD-899730-1G |
Cas.: 62965-37-1 | Purity: 98% | Dicyclohexylamine (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoate | ESD-899730-5G |
Cas.: 62965-37-1 | Purity: 98% | Dicyclohexylamine (S)-2-(((benzyloxy)carbonyl)amino)-3,3-dimethylbutanoate | ESD-899730-10G |
Cas.: 214958-32-4 | Purity: 98% | Ethyl 6-iodoimidazo[1,2-a]pyridine-2-carboxylate | ESD-899731-1G |
Cas.: 214958-32-4 | Purity: 98% | Ethyl 6-iodoimidazo[1,2-a]pyridine-2-carboxylate | ESD-899731-5G |
Cas.: 214958-32-4 | Purity: 98% | Ethyl 6-iodoimidazo[1,2-a]pyridine-2-carboxylate | ESD-899731-10G |
Cas.: 886365-47-5 | Purity: 95% | 1-(5-Bromo-2-chloropyridin-3-yl)ethanone | ESD-899732-1G |
Cas.: 886365-47-5 | Purity: 95% | 1-(5-Bromo-2-chloropyridin-3-yl)ethanone | ESD-899732-5G |
Cas.: 886365-47-5 | Purity: 95% | 1-(5-Bromo-2-chloropyridin-3-yl)ethanone | ESD-899732-10G |
Cas.: 109384-27-2 | Purity: 97% | 1-Methylpiperazin-2-one hydrochloride | ESD-899733-1G |
Cas.: 109384-27-2 | Purity: 97% | 1-Methylpiperazin-2-one hydrochloride | ESD-899733-5G |
Cas.: 109384-27-2 | Purity: 97% | 1-Methylpiperazin-2-one hydrochloride | ESD-899733-10G |
Cas.: 18719-24-9 | Purity: 97% | Oct-7-enoic acid | ESD-899734-1G |
Cas.: 123173-60-4 | Purity: ≥95% | 2,3-Difluoro-4-nitrophenol | ESD-899735-1G |
Cas.: 123173-60-4 | Purity: ≥95% | 2,3-Difluoro-4-nitrophenol | ESD-899735-5G |
Cas.: 123173-60-4 | Purity: ≥95% | 2,3-Difluoro-4-nitrophenol | ESD-899735-10G |
Cas.: 953039-63-9 | Purity: 97% | 8-Bromo-2-chloro-6-fluoroquinazoline | ESD-899736-1G |
Cas.: 953039-63-9 | Purity: 97% | 8-Bromo-2-chloro-6-fluoroquinazoline | ESD-899736-5G |
Cas.: 953039-63-9 | Purity: 97% | 8-Bromo-2-chloro-6-fluoroquinazoline | ESD-899736-10G |
Cas.: 1185293-84-8 | Purity: 97% | 3-Methylpiperidin-4-ol hydrochloride | ESD-899737-1G |
Cas.: 1185293-84-8 | Purity: 97% | 3-Methylpiperidin-4-ol hydrochloride | ESD-899737-5G |
Cas.: 1185293-84-8 | Purity: 97% | 3-Methylpiperidin-4-ol hydrochloride | ESD-899737-10G |
Cas.: 1016167-99-9 | Purity: 97% | (S)-tert-butyl (pipidin-3-ylmethyl)carbamate | ESD-899738-1G |
Cas.: 1016167-99-9 | Purity: 97% | (S)-tert-butyl (pipidin-3-ylmethyl)carbamate | ESD-899738-5G |
Cas.: 1016167-99-9 | Purity: 97% | (S)-tert-butyl (pipidin-3-ylmethyl)carbamate | ESD-899738-10G |
Cas.: 78238-14-9 | Purity: 97% | 3-Hydroxy-5-nitrobenzoic acid | ESD-899739-1G |